{"meta":{"query_hash":"685268ecd29a","filters":{"venue":"Haematologica"},"cohort_total":466,"direct_labels_cover":0,"predictions_cover":466,"exported":466,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/685268ecd29a","api":"https://metacan.xera.ac/api/v1/cohort?venue=Haematologica"},"results":[{"id":"W1792060848","doi":"10.3324/haematol.2014.117721","title":"Aging and malignant hemopathies","year":2015,"lang":"en","type":"editorial","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Incidence (geometry); Session (web analytics); Medicine; Gerontology; Plenary session; Library science; Computer science; Mathematics","score_opus":0.030407990995152814,"score_gpt":0.33102798289917235,"score_spread":0.30061999190401956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1792060848","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000096423864,0.022590203,0.00023402782,0.03345149,0.9420765,0.000020907404,0.000034095832,0.000054579326,0.0014417871],"genre_scores_gemma":[0.00048860937,0.011694712,0.00016276978,0.014739937,0.96908486,0.0000117999125,0.000021948012,0.000014246476,0.0037811035],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980691,0.0003967256,0.00035575283,0.00023335179,0.0008050095,0.00014004599],"domain_scores_gemma":[0.9904184,0.004937936,0.0005683703,0.0002841033,0.0027767431,0.0010145451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043723094,0.0032400738,0.0025131209,0.0020011305,0.0015561151,0.003766206,0.0026449312,0.010871375,0.006326448],"category_scores_gemma":[0.011540719,0.0008393116,0.0023046308,0.00084288203,0.0024071261,0.0045062704,0.0014457378,0.022099493,0.006103975],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062096275,0.000033736378,0.00011182256,0.0003963868,0.000033709654,0.00026861727,0.00002327123,0.00006210866,0.00013188036,0.0007642786,0.97445345,0.023658657],"study_design_scores_gemma":[0.00008516396,0.000058348804,0.0008263393,0.0005775849,0.00007097072,0.0010071506,0.000051372663,0.00026486468,0.00016642822,0.0021036142,0.99476045,0.000027779784],"about_ca_topic_score_codex":0.0010134904,"about_ca_topic_score_gemma":0.002571668,"teacher_disagreement_score":0.010871375,"about_ca_system_score_codex":0.0020178526,"about_ca_system_score_gemma":0.0015623575,"threshold_uncertainty_score":0.023123264},"labels":[],"label_agreement":null},{"id":"W1833477067","doi":"10.3324/haematol.2015.130898","title":"Response to comments from Drs. Alter and Rosenberg","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"","keywords":"Myelodysplastic syndromes; Medicine; Psychoanalysis; Psychology; Gerontology; Internal medicine; Bone marrow","score_opus":0.056557573008704586,"score_gpt":0.3344096317781854,"score_spread":0.2778520587694808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1833477067","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027476795,0.0013537831,0.00008392353,0.96680295,0.029507615,0.000017842298,0.00004799939,0.000055067485,0.0018560064],"genre_scores_gemma":[0.0034696818,0.00075795257,0.00016967248,0.96710056,0.022925047,0.00003935228,0.00003253821,0.000024352661,0.0054808445],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966755,0.0010456749,0.00036519903,0.00042635485,0.0010971462,0.00039007462],"domain_scores_gemma":[0.99147004,0.003417467,0.0008960528,0.0002435154,0.0028282257,0.0011447135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037235268,0.0011797261,0.0013773553,0.0008808047,0.0029926454,0.0027182216,0.0021726855,0.029634085,0.009506847],"category_scores_gemma":[0.035987373,0.00077358756,0.0010034613,0.0007721077,0.0020587386,0.0026784407,0.0015998778,0.024754724,0.011099793],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002239199,0.000008540691,0.00016413552,0.000024566652,0.000004847672,0.0007682371,0.000062476356,0.000022833741,0.000039792154,0.00041910558,0.9961403,0.002322814],"study_design_scores_gemma":[0.00007161796,0.00006806872,0.001060937,0.00029645153,0.000024426903,0.0062942533,0.00042768545,0.0003232922,0.00023188643,0.002110747,0.98902285,0.000067687055],"about_ca_topic_score_codex":0.0037585797,"about_ca_topic_score_gemma":0.0042542014,"teacher_disagreement_score":0.029634085,"about_ca_system_score_codex":0.0047491603,"about_ca_system_score_gemma":0.003053308,"threshold_uncertainty_score":0.034457743},"labels":[],"label_agreement":null},{"id":"W1859347718","doi":"10.3324/haematol.2015.126656","title":"Primary diffuse large B-cell lymphoma associated with clonally-related monoclonal B lymphocytosis indicates a common precursor cell","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Kreftforeningen","keywords":"Lymphocytosis; Bone marrow; Monoclonal; Lymphoma; Pathology; Diffuse large B-cell lymphoma; Medicine; Monoclonal antibody; Immunology; Antibody","score_opus":0.018170999321482813,"score_gpt":0.23208852591256693,"score_spread":0.21391752659108412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1859347718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8809556,0.009051395,0.0024340167,0.04320091,0.0012528863,0.00016904788,0.0003246244,0.00035458733,0.06225699],"genre_scores_gemma":[0.9815041,0.002273865,0.00091313326,0.007324124,0.0028736892,0.000028482602,0.00010911711,0.000023495559,0.0049500037],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995927,0.00011844705,0.00003413804,0.00007407062,0.000078721685,0.00010194807],"domain_scores_gemma":[0.99917525,0.00032804205,0.00011723101,0.000091660775,0.00009085453,0.00019695472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026646798,0.00056905625,0.0005588074,0.0006063892,0.0008770938,0.00085680356,0.00049592956,0.003005054,0.0031484056],"category_scores_gemma":[0.0018495709,0.0003659232,0.00029566127,0.0006930154,0.0012038293,0.00077762717,0.00036763056,0.0017943726,0.0014946759],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005131198,0.0002808695,0.09009292,0.00027175623,0.000051813877,0.856505,0.00028575302,0.0002522115,0.00907375,0.001216063,0.016970368,0.024486361],"study_design_scores_gemma":[0.0001232377,0.00034682496,0.045191657,0.00007323392,0.000037039918,0.93544084,0.00021043904,0.0012574088,0.0019236291,0.0011674874,0.014212704,0.000015381349],"about_ca_topic_score_codex":0.0011244206,"about_ca_topic_score_gemma":0.002024707,"teacher_disagreement_score":0.0031484056,"about_ca_system_score_codex":0.00097419746,"about_ca_system_score_gemma":0.00041402553,"threshold_uncertainty_score":0.010532498},"labels":[],"label_agreement":null},{"id":"W1865125576","doi":"10.3324/haematol.2015.127175","title":"PACE4 (PCSK6): another proprotein convertase link to iron homeostasis?","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Proprotein convertase; Iron homeostasis; PCSK9; Hepcidin; Proprotein Convertases; Medicine; Internal medicine; Cholesterol; Inflammation; LDL receptor; Lipoprotein; Metabolism","score_opus":0.04962170253058388,"score_gpt":0.2819668294353916,"score_spread":0.23234512690480771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1865125576","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029326787,0.015900685,0.0005658061,0.9461953,0.032932635,0.000014789652,0.000059348695,0.00005340545,0.0013453269],"genre_scores_gemma":[0.04077968,0.017361403,0.0008201483,0.6240232,0.31113294,0.000044899185,0.00007012568,0.000045610115,0.0057220124],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989955,0.00028598323,0.00017529953,0.00018746458,0.00019916413,0.00015668663],"domain_scores_gemma":[0.9971796,0.0014752444,0.00036327523,0.000101303536,0.00041763985,0.0004630101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013132298,0.0009929508,0.0015256178,0.00055358955,0.0012256714,0.0020026697,0.0015891606,0.020002354,0.0025906318],"category_scores_gemma":[0.00841172,0.0005829917,0.00089658087,0.00046506632,0.0022990347,0.0036408736,0.0010399028,0.022592232,0.002608987],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005580275,0.00013399596,0.0044575552,0.0006049162,0.00017765535,0.092020646,0.00035784004,0.0002850677,0.001976282,0.008754783,0.8497393,0.040933825],"study_design_scores_gemma":[0.00053861534,0.00044506678,0.005193361,0.00080143084,0.00022346263,0.1967133,0.000706582,0.0022026005,0.0027423718,0.038048442,0.75216854,0.00021626212],"about_ca_topic_score_codex":0.00071840006,"about_ca_topic_score_gemma":0.0008954309,"teacher_disagreement_score":0.020002354,"about_ca_system_score_codex":0.0018962033,"about_ca_system_score_gemma":0.00064365123,"threshold_uncertainty_score":0.013758004},"labels":[],"label_agreement":null},{"id":"W1865212210","doi":"10.3324/haematol.2015.126227","title":"Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Samsung; Chonnam National University Hwasun Hospital; National Research Foundation of Korea; Kyungpook National University Hospital; Korea Research Institute of Bioscience and Biotechnology; National Research Foundation; University of Toronto; Ministry of Education, Science and Technology; Kyungpook National University; Catholic University of Korea; Chonnam National University; Dong-A University","keywords":"Myeloid leukemia; Karyotype; Medicine; Oncology; Internal medicine; Mutation; Adverse effect; Cancer research; Genetics; Biology; Gene; Chromosome","score_opus":0.013902527992961034,"score_gpt":0.26301818645545605,"score_spread":0.249115658462495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1865212210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9591793,0.0033788953,0.00040092538,0.027887814,0.0007797472,0.000017016338,0.0006300386,0.000058791175,0.0076675923],"genre_scores_gemma":[0.9946517,0.00047026214,0.00016266448,0.002790309,0.0012602402,0.000006964687,0.00020080022,0.000005655677,0.00045143033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950683,0.0001795752,0.00004357756,0.00005918098,0.0000915444,0.00011923461],"domain_scores_gemma":[0.99820805,0.0007749438,0.00022449718,0.00012372718,0.00023758055,0.0004310689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039525382,0.00018395147,0.00061602436,0.00044668693,0.00045421958,0.0004326026,0.00037998,0.001294323,0.0015812425],"category_scores_gemma":[0.0038897125,0.00012716824,0.00032982082,0.00070671603,0.0002932987,0.00031659714,0.00028489417,0.0012791711,0.00040164794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002050391,0.00008373868,0.9301083,0.0000491835,0.00010566619,0.02723847,0.00015966839,0.0004526492,0.002239,0.00047301414,0.010833713,0.026206138],"study_design_scores_gemma":[0.00024646902,0.0007354257,0.88990813,0.000081623846,0.00031454873,0.08770716,0.00042727333,0.0051363637,0.0016203005,0.0039981427,0.009743091,0.00008145238],"about_ca_topic_score_codex":0.0010015382,"about_ca_topic_score_gemma":0.0012940309,"teacher_disagreement_score":0.0015812425,"about_ca_system_score_codex":0.0005532417,"about_ca_system_score_gemma":0.00036939027,"threshold_uncertainty_score":0.005289793},"labels":[],"label_agreement":null},{"id":"W1880343369","doi":"10.3324/haematol.2014.121384","title":"The international prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary General Hospital; University of Calgary","funders":"Novo Nordisk","keywords":"Recombinant factor VIIa; Medicine; Platelet; Recombinant DNA; Glanzmann's thrombasthenia; Platelet transfusion; Thrombasthenia; Surgery; Internal medicine; Biochemistry","score_opus":0.03133696005214449,"score_gpt":0.3189892173289682,"score_spread":0.2876522572768237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1880343369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86028665,0.007131029,0.0019273271,0.000706969,0.00013190147,0.0005824291,0.11795071,0.00015914436,0.01112384],"genre_scores_gemma":[0.811246,0.003947162,0.0015814069,0.0003074595,0.00015930069,0.0012429745,0.18018132,0.000071668495,0.0012628003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815255,0.00058094726,0.00039924838,0.00034720794,0.00034665145,0.00017343079],"domain_scores_gemma":[0.9945668,0.00070598547,0.0030020024,0.00060677115,0.0006850549,0.00043344832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018300758,0.00039850207,0.00076144986,0.0016734576,0.0002407122,0.00070733926,0.0005027367,0.00050683785,0.0019851727],"category_scores_gemma":[0.004344531,0.0002805633,0.0006588823,0.0038876105,0.00019349431,0.0008490406,0.00069497974,0.0006995911,0.0006861204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025804297,0.00014779948,0.9690535,0.0003884286,0.0007915857,0.00009489317,0.00008131302,0.00053619326,0.00024489834,0.00036723548,0.01589133,0.009822329],"study_design_scores_gemma":[0.00061287393,0.00022939546,0.9948473,0.00009359887,0.00031603573,0.00032752196,0.000086570675,0.00041792536,0.000092419,0.00014222924,0.0028132186,0.000020905934],"about_ca_topic_score_codex":0.0031984202,"about_ca_topic_score_gemma":0.003952095,"teacher_disagreement_score":0.0031984202,"about_ca_system_score_codex":0.0005271829,"about_ca_system_score_gemma":0.00089750224,"threshold_uncertainty_score":0.009678483},"labels":[],"label_agreement":null},{"id":"W1895738210","doi":"10.3324/haematol.2015.128025","title":"Clinical profile and treatment outcome of older (&gt;75 years) patients with systemic AL amyloidosis","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"McKnight Foundation","keywords":"Medicine; Amyloidosis; AL amyloidosis; Internal medicine; Systemic therapy; Survival analysis; Surgery; Cancer; Immunology","score_opus":0.03333785387169814,"score_gpt":0.30934787938295527,"score_spread":0.27601002551125714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1895738210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988279,0.00042039444,0.000028702934,0.000066775916,0.000005769857,0.000003873562,0.0001554034,0.0000020940627,0.00048918853],"genre_scores_gemma":[0.99947196,0.00010531095,0.000017222836,0.000042933072,0.000011627044,0.0000036450847,0.00024765063,7.6573997e-7,0.00009889342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978966,0.000039073017,0.000032843716,0.00003266965,0.000044522338,0.00006112605],"domain_scores_gemma":[0.99904615,0.00013035061,0.00041197584,0.000027414117,0.00008634782,0.00029774307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002923261,0.0001560606,0.00031171643,0.00043943137,0.00035055506,0.0005012899,0.00014160648,0.00034731996,0.0008473457],"category_scores_gemma":[0.001497292,0.00009791361,0.00025804283,0.0006219329,0.00024766132,0.00042586267,0.0002815078,0.00039769636,0.00024211833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019474892,0.000036233592,0.99653375,0.000008032087,0.00002223414,0.00042085449,0.00009688006,0.00009506015,0.00021880638,0.000012374102,0.00015663818,0.002204303],"study_design_scores_gemma":[0.000008957602,0.0002382175,0.998259,0.000007709088,0.000016602758,0.00095778436,0.0001588794,0.00008602008,0.000028516435,0.00003547314,0.00019853239,0.000004370711],"about_ca_topic_score_codex":0.002538759,"about_ca_topic_score_gemma":0.0035141374,"teacher_disagreement_score":0.002538759,"about_ca_system_score_codex":0.0002780954,"about_ca_system_score_gemma":0.00016809389,"threshold_uncertainty_score":0.0050479174},"labels":[],"label_agreement":null},{"id":"W1963911253","doi":"10.3324/haematol.11938","title":"Acute pancreatitis preceding thrombotic thrombocytopenic Purpura","year":2007,"lang":"en","type":"letter","venue":"Haematologica","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute; Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Thrombotic thrombocytopenic purpura; Acute pancreatitis; Medicine; Pancreatitis; Purpura (gastropod); Internal medicine; Gastroenterology; Platelet; Pediatrics","score_opus":0.03978107334847369,"score_gpt":0.29077815494818815,"score_spread":0.25099708159971446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963911253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42868006,0.02468677,0.004011196,0.3070852,0.01716681,0.0005144459,0.00072966795,0.0006455462,0.21648036],"genre_scores_gemma":[0.89451844,0.0076589007,0.001496285,0.046005454,0.03652573,0.000073747135,0.0002179135,0.00007566957,0.013427933],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99846387,0.00058058614,0.00016779714,0.00025737644,0.00021516462,0.000315107],"domain_scores_gemma":[0.994266,0.0036119774,0.0006113609,0.00029900784,0.0004962997,0.0007154881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010568666,0.0013186252,0.0014795519,0.0010887105,0.0024525623,0.0015362889,0.0015154333,0.011903783,0.008059837],"category_scores_gemma":[0.010461487,0.00084843073,0.00073182164,0.0015594874,0.001823414,0.002331768,0.0007034252,0.007340029,0.0035775339],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043432444,0.00017086786,0.016256908,0.00018293182,0.0000430094,0.9511854,0.0003675107,0.00019157017,0.00080193946,0.0010831332,0.023386495,0.0058959024],"study_design_scores_gemma":[0.00018671068,0.0003987562,0.015873034,0.00024051713,0.000090547874,0.9584052,0.0004871371,0.0012201184,0.0006589245,0.0018206985,0.020569917,0.00004847862],"about_ca_topic_score_codex":0.0024809334,"about_ca_topic_score_gemma":0.0031509404,"teacher_disagreement_score":0.011903783,"about_ca_system_score_codex":0.001384922,"about_ca_system_score_gemma":0.00063591753,"threshold_uncertainty_score":0.026962817},"labels":[],"label_agreement":null},{"id":"W1968450817","doi":"10.3324/haematol.2014.117408","title":"Hb S/ +-thalassemia due to Hb sickle and a novel deletion of DNase I hypersensitive sites HS3 and HS4 of the   locus control region","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program; Hamilton Health Sciences; Hospital for Sick Children","funders":"","keywords":"Thalassemia; Locus control region; Hemolytic anemia; Mutation; Hemoglobinopathy; Locus (genetics); Hemoglobin; Medicine; Genetics; Biology; Immunology; Gene; Internal medicine","score_opus":0.02048328375029363,"score_gpt":0.23344891697009704,"score_spread":0.2129656332198034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968450817","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23664293,0.011381572,0.0029850965,0.66513234,0.0177986,0.00030197852,0.00037300523,0.0003138535,0.06507062],"genre_scores_gemma":[0.734542,0.0064924806,0.002349252,0.19292049,0.03675172,0.00014070659,0.0002024869,0.00005608692,0.026544763],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99944216,0.00017079018,0.000052211653,0.00010840038,0.0000932176,0.00013322505],"domain_scores_gemma":[0.9992518,0.00031481028,0.00010754104,0.00005647489,0.00008485699,0.00018452953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004499798,0.00089713116,0.0007820272,0.0006502182,0.0014354276,0.0010539718,0.00082566263,0.011131887,0.0031026215],"category_scores_gemma":[0.0029727279,0.00052025163,0.00092563924,0.00043751558,0.0014506557,0.0015346681,0.00056090375,0.0070725535,0.0014915868],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017560138,0.00014902967,0.0060841204,0.00009484021,0.000035601664,0.94014096,0.00026314802,0.0002422971,0.0020689373,0.004031365,0.03937443,0.007339725],"study_design_scores_gemma":[0.00018589129,0.00023142133,0.009091023,0.00013992084,0.000053584656,0.94575024,0.00034417733,0.0017964024,0.0007289024,0.0046763537,0.036964178,0.0000378828],"about_ca_topic_score_codex":0.0019604987,"about_ca_topic_score_gemma":0.00215184,"teacher_disagreement_score":0.011131887,"about_ca_system_score_codex":0.0018799406,"about_ca_system_score_gemma":0.00079854764,"threshold_uncertainty_score":0.013640046},"labels":[],"label_agreement":null},{"id":"W1969714279","doi":"10.3324/haematol.2009.017814","title":"Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenstrom's macroglobulinemia. Results of a retrospective analysis of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Celgene","keywords":"Medicine; Hematopoietic stem cell transplantation; Macroglobulinemia; Transplantation; Stem cell; Haematopoiesis; Hematopoietic cell; Retrospective cohort study; Oncology; Immunology; Internal medicine; Multiple myeloma; Biology; Genetics","score_opus":0.013381095656380645,"score_gpt":0.2815847595531309,"score_spread":0.26820366389675027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969714279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99882656,0.00067369686,0.000076315104,0.000014344134,0.000001701037,0.0000033270942,0.00028023947,0.0000025636123,0.00012123363],"genre_scores_gemma":[0.99943143,0.00012287774,0.00002672815,0.0000067338997,0.000004380265,0.0000020819032,0.0003754559,7.85366e-7,0.000029381486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996424,0.00010717346,0.000054250333,0.00006372621,0.00008937614,0.00004307694],"domain_scores_gemma":[0.9982949,0.00048171362,0.0007524766,0.00016320142,0.0001247703,0.00018306372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007330086,0.00015539285,0.00018804881,0.000780803,0.00015778025,0.00041055336,0.00019374983,0.00020478595,0.0007099965],"category_scores_gemma":[0.0018716039,0.00008976353,0.00023490883,0.0007077968,0.00023937011,0.00023556351,0.00025333336,0.00016549758,0.00019538701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016985477,0.00000881271,0.99653,0.000008845446,0.000035856498,0.00020572882,0.00003341785,0.000041190597,0.00029892573,0.000008337065,0.000073433126,0.0025856693],"study_design_scores_gemma":[0.00001094205,0.00012677038,0.99711454,0.000007369047,0.00006687392,0.0017181213,0.000056589666,0.00014701905,0.00034787413,0.000012902504,0.00038857805,0.0000025126303],"about_ca_topic_score_codex":0.0012008192,"about_ca_topic_score_gemma":0.0014916053,"teacher_disagreement_score":0.0012008192,"about_ca_system_score_codex":0.00027034563,"about_ca_system_score_gemma":0.00017496991,"threshold_uncertainty_score":0.0038765073},"labels":[],"label_agreement":null},{"id":"W1976649109","doi":"10.3324/haematol.12199","title":"Surgical treatment of a foscavir-resistant atypical Cytomegalovirus pneumonia in an allogeneic stem cell transplant recipient","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Cytomegalovirus; Stem cell; Medicine; Pneumonia; Transplantation; Aspergillosis; Immunology; Cytomegalovirus infections; Human cytomegalovirus; Herpesviridae; Internal medicine; Viral disease; Virus; Biology","score_opus":0.07233178469757054,"score_gpt":0.31791116742100717,"score_spread":0.24557938272343663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976649109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882041,0.0018983533,0.0010802187,0.0013382217,0.0002443935,0.000055397755,0.00010331577,0.000051479434,0.00702434],"genre_scores_gemma":[0.99787235,0.00049389515,0.00025693368,0.00020213879,0.000112641275,0.000007971235,0.00007150661,0.0000044845847,0.000978099],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99991345,0.000012930777,0.000009142017,0.000008820412,0.00001699242,0.000038562594],"domain_scores_gemma":[0.99975103,0.00004432519,0.00004061078,0.000014200782,0.000008591355,0.00014123763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017227579,0.0002813393,0.00022088336,0.00033556586,0.0006532226,0.00030558626,0.00026059087,0.0006167047,0.0029769423],"category_scores_gemma":[0.0005204357,0.000103919396,0.00043774483,0.00014306234,0.00033017065,0.00028413223,0.00022745482,0.00080522185,0.00041151742],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045821927,0.0013885776,0.13743466,0.00027471597,0.0001999505,0.75153124,0.00029309368,0.0008759136,0.031782456,0.0017910793,0.00405313,0.06579306],"study_design_scores_gemma":[0.0002712292,0.0057653706,0.18918942,0.000091150665,0.00010843999,0.7797914,0.00067853054,0.0028293363,0.012569726,0.0013003278,0.00736129,0.00004378189],"about_ca_topic_score_codex":0.00043565134,"about_ca_topic_score_gemma":0.0011386073,"teacher_disagreement_score":0.0029769423,"about_ca_system_score_codex":0.000316164,"about_ca_system_score_gemma":0.00034984792,"threshold_uncertainty_score":0.009958923},"labels":[],"label_agreement":null},{"id":"W1977314095","doi":"10.3324/haematol.2009.013318","title":"Lymphoma stem cells: enough evidence to support their existence?","year":2010,"lang":"en","type":"review","venue":"Haematologica","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; Deutsche Krebshilfe; Ministerio de Ciencia e Innovación; Terry Fox Foundation","keywords":"Stem cell; Lymphoma; Medicine; Cancer research; Biology; Immunology; Genetics","score_opus":0.21763087573801798,"score_gpt":0.3831264085353868,"score_spread":0.16549553279736884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977314095","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16137633,0.7318947,0.009817977,0.059683423,0.0037068315,0.000103555205,0.00087910343,0.00030901664,0.03222907],"genre_scores_gemma":[0.62452257,0.3278606,0.006695686,0.020883314,0.008869447,0.00012452074,0.0017114502,0.00007019097,0.009262244],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995584,0.00007458168,0.000050890176,0.00012230562,0.00010842498,0.00008543463],"domain_scores_gemma":[0.9958734,0.0018051009,0.0005848357,0.00040202317,0.0009177726,0.000416913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001357715,0.0004037297,0.00078196195,0.0012278886,0.0004283387,0.002188716,0.0010994645,0.0029544511,0.0058228574],"category_scores_gemma":[0.002065077,0.00020354862,0.00036182988,0.0008177641,0.0023932687,0.0029716708,0.0011984092,0.0024085073,0.0022016126],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037916657,0.00058145437,0.07224342,0.017858155,0.0017249627,0.01623631,0.0027874806,0.00049739744,0.12795015,0.1678513,0.02885416,0.5596235],"study_design_scores_gemma":[0.00054769777,0.0009902654,0.048666622,0.0046738014,0.00092138164,0.022730678,0.007241072,0.0010771354,0.048699897,0.084216245,0.78004754,0.0001877054],"about_ca_topic_score_codex":0.00043342507,"about_ca_topic_score_gemma":0.0005311848,"teacher_disagreement_score":0.0058228574,"about_ca_system_score_codex":0.00040971037,"about_ca_system_score_gemma":0.0005805718,"threshold_uncertainty_score":0.019479454},"labels":[],"label_agreement":null},{"id":"W1978101826","doi":"10.3324/haematol.2010.027086","title":" -catenin is constitutively active and increases STAT3 expression/activation in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Terry Fox Foundation; Alberta Cancer Foundation; Cancer Research Institute","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; Cancer research; Lymphoma; Biology; Cell growth; Cell culture; Catenin; Signal transduction; Pathology; Wnt signaling pathway; Medicine; Cell biology; Immunology; Biochemistry","score_opus":0.007329888307830495,"score_gpt":0.22679528598100795,"score_spread":0.21946539767317746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978101826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634844,0.001842791,0.0004733954,0.00007237412,0.000021744747,0.000015490406,0.0002132021,0.000050823546,0.000961745],"genre_scores_gemma":[0.9984366,0.00033514903,0.00023454835,0.000028892904,0.00000769433,0.000014640314,0.00032667795,0.0000038880044,0.0006118907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998286,0.000021750413,0.00001391522,0.000027726843,0.000070460046,0.000037523256],"domain_scores_gemma":[0.999866,0.000024714875,0.000043179993,0.000012761365,0.0000141191185,0.00003928176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017788415,0.00024933426,0.00018930543,0.0005182948,0.00020880521,0.00044248265,0.0001471555,0.0003096785,0.0024297093],"category_scores_gemma":[0.00018795829,0.00014014482,0.00025235847,0.00030462316,0.00026553342,0.00017997496,0.00014855448,0.00053126505,0.0005334195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016736874,0.00005617068,0.0017274229,0.000038337712,0.0000075354906,0.00020232277,0.000018745437,0.000031685628,0.99665964,0.000055123703,0.000073929456,0.00096178165],"study_design_scores_gemma":[0.00017120328,0.0014864431,0.10281945,0.000025602008,0.00011075082,0.0047794785,0.00023236795,0.002028421,0.88019985,0.0002275452,0.007903411,0.000015470756],"about_ca_topic_score_codex":0.00036436404,"about_ca_topic_score_gemma":0.0007800058,"teacher_disagreement_score":0.0024297093,"about_ca_system_score_codex":0.0004021293,"about_ca_system_score_gemma":0.00017347366,"threshold_uncertainty_score":0.008128226},"labels":[],"label_agreement":null},{"id":"W1981684224","doi":"10.3324/haematol.2010.036343","title":"T-lymphoid differentiation potential measured in vitro is higher in CD34+CD38-/lo hematopoietic stem cells from umbilical cord blood than from bone marrow and is an intrinsic property of the cells","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Vlaamse regering; Fonds Wetenschappelijk Onderzoek","keywords":"Stem cell; Haematopoiesis; Bone marrow; Cord blood; Biology; CD34; Immunology; Myeloid; Umbilical cord; Hematopoietic stem cell; Cell biology","score_opus":0.03731440278706067,"score_gpt":0.22382441689651528,"score_spread":0.1865100141094546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981684224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98329663,0.0021495007,0.010034278,0.000039767205,0.000016116728,0.00008106787,0.0010788214,0.000116871386,0.0031869807],"genre_scores_gemma":[0.98440385,0.0009606188,0.008294041,0.000045419732,0.000017801081,0.00015194486,0.0030941227,0.000047296387,0.002984938],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998149,0.000035737452,0.000023985987,0.00004186731,0.000054643137,0.000028920405],"domain_scores_gemma":[0.9997557,0.00006636475,0.000047300917,0.000029046027,0.000043445852,0.000058130874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025415423,0.00032336434,0.00021162328,0.0003358068,0.00012710204,0.00023207975,0.0001708464,0.00016849267,0.0029141535],"category_scores_gemma":[0.00014510792,0.00007664309,0.00016166909,0.00027555955,0.00012714557,0.00018711945,0.00025275772,0.00044403423,0.000914425],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006567063,0.00002543372,0.0006757717,0.000032580396,0.0000032605838,0.000021673748,0.000021151636,0.00002617102,0.9979334,0.00003463359,0.000018965286,0.0011413489],"study_design_scores_gemma":[0.000011609375,0.00044949254,0.008584329,0.000011923327,0.000018643708,0.0002027328,0.00002937221,0.0004363092,0.9889281,0.00005888832,0.0012656356,0.0000030171338],"about_ca_topic_score_codex":0.00043981,"about_ca_topic_score_gemma":0.0004720852,"teacher_disagreement_score":0.0029141535,"about_ca_system_score_codex":0.00018835961,"about_ca_system_score_gemma":0.0001470862,"threshold_uncertainty_score":0.0097488165},"labels":[],"label_agreement":null},{"id":"W1984003054","doi":"10.3324/haematol.2013.085340","title":"Impact of promoter polymorphisms in key regulators of the intrinsic apoptosis pathway on the outcome of childhood acute lymphoblastic leukemia","year":2013,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Sinai Health System; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research; National Institutes of Health; National Cancer Institute; Genome Canada","keywords":"MCL1; Apoptosis; Biology; Programmed cell death; Leukemia; Gene; Cancer research; Allele; Haematopoiesis; Immunology; Genetics; Downregulation and upregulation; Stem cell","score_opus":0.0176132477233794,"score_gpt":0.2675597047388014,"score_spread":0.249946457015422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984003054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993531,0.00019456353,0.00022862156,0.000010954762,0.0000022283282,0.0000033893737,0.0000925178,0.000003551772,0.000111079295],"genre_scores_gemma":[0.99959654,0.00006944244,0.00017707163,0.000006115315,0.000001820118,0.0000038157223,0.0000708847,0.000003970619,0.0000703985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994886,0.00021308818,0.000039438444,0.000101903635,0.00008691411,0.0000700799],"domain_scores_gemma":[0.9991264,0.00042849666,0.00026503272,0.00006366672,0.00003609131,0.000080359874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004469774,0.00026732168,0.00024935137,0.00048336064,0.00011742403,0.00022667545,0.00014091305,0.00017873647,0.00093107554],"category_scores_gemma":[0.00082317274,0.0001394986,0.0002908197,0.00039715442,0.00026066366,0.0000942181,0.00015096144,0.00030418407,0.000110757785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046577738,0.00023886947,0.8028583,0.000062264,0.00045111895,0.0006678013,0.0002871768,0.00096120976,0.17624639,0.00028616513,0.0000771998,0.013205668],"study_design_scores_gemma":[0.000052483432,0.00087700173,0.9733794,0.000014767872,0.00028492315,0.0012089519,0.000116310184,0.0013371914,0.0220533,0.00014972812,0.00051534595,0.00001067795],"about_ca_topic_score_codex":0.0011494905,"about_ca_topic_score_gemma":0.0014675837,"teacher_disagreement_score":0.0011494905,"about_ca_system_score_codex":0.00023145304,"about_ca_system_score_gemma":0.00019564446,"threshold_uncertainty_score":0.00311476},"labels":[],"label_agreement":null},{"id":"W1989402731","doi":"10.3324/haematol.11203","title":"Pediatric acute myeloid leukemia: towards high-quality cure of all patients","year":2007,"lang":"en","type":"review","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Myeloid leukemia; Pharmacogenomics; Minimal residual disease; Oncology; Disease; Internal medicine; Leukemia; Intensive care medicine; Pharmacology","score_opus":0.11254359432220473,"score_gpt":0.41814936660063895,"score_spread":0.3056057722784342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989402731","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020970426,0.9973706,0.00022577081,0.0007474253,0.00024946072,0.000006214624,0.000012219658,0.000011756138,0.0011668846],"genre_scores_gemma":[0.0009013889,0.9977005,0.0004217728,0.000296434,0.00022755127,0.000007411942,0.000023930583,0.0000014376518,0.00041960712],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968255,0.00007286062,0.000045074168,0.000035316825,0.00013957263,0.000024693049],"domain_scores_gemma":[0.9995989,0.00012803072,0.00007294727,0.000013067466,0.00013717194,0.00004995961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010278808,0.00063960976,0.001462507,0.0014518808,0.0002831962,0.00075976504,0.0008031486,0.00092223514,0.0026678815],"category_scores_gemma":[0.0011266834,0.0001787692,0.00031286807,0.0018238315,0.00035858585,0.0010975165,0.0005254836,0.0011914632,0.0026628901],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050137583,0.000039388207,0.00037293517,0.007539143,0.00005851172,0.00024832843,0.00004637083,0.00023235354,0.0007155464,0.0021497707,0.034451738,0.9540957],"study_design_scores_gemma":[0.000033349337,0.00009773446,0.0014446676,0.0030661414,0.00008654567,0.0025505528,0.00008868121,0.00006959679,0.00037470483,0.0013954308,0.9907836,0.000009033414],"about_ca_topic_score_codex":0.0009084217,"about_ca_topic_score_gemma":0.0013943347,"teacher_disagreement_score":0.0026678815,"about_ca_system_score_codex":0.0007173311,"about_ca_system_score_gemma":0.0014201839,"threshold_uncertainty_score":0.0089249015},"labels":[],"label_agreement":null},{"id":"W1994932701","doi":"10.3324/haematol.2011.055269","title":"Telomere length is associated with disease severity and declines with age in dyskeratosis congenita","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":235,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of British Columbia","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; U.S. Public Health Service; Bernische Krebsliga; Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Dyskeratosis congenita; Telomere; Bone marrow failure; Fluorescence in situ hybridization; Dyskeratosis; Aplastic anemia; Telomerase; Biology; Medicine; Pathology; Genetics; Bone marrow; Hyperkeratosis; Gene; Chromosome; Stem cell","score_opus":0.047812147767898446,"score_gpt":0.24638318339641127,"score_spread":0.19857103562851283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994932701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993932,0.00021542981,0.0001502228,0.000012602411,0.0000016779818,0.0000023918878,0.000066128014,0.000009209522,0.00014914107],"genre_scores_gemma":[0.9996278,0.000042118398,0.00013206327,0.0000063316957,0.0000041298767,0.000002737393,0.0000723767,0.0000023761277,0.00011003332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998067,0.000041648655,0.000025598352,0.000066521425,0.000035128454,0.000024341845],"domain_scores_gemma":[0.9982992,0.00035792627,0.0009889146,0.00008049506,0.00011739347,0.00015617743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035311244,0.00034379077,0.00023134227,0.0010161051,0.00018712107,0.00029688294,0.00017378872,0.0004093358,0.0014480354],"category_scores_gemma":[0.0018535279,0.00016523898,0.00013722334,0.0005512725,0.00022662162,0.00022058385,0.00019682398,0.00033804565,0.0002589609],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006751347,0.000041346997,0.97830987,0.000021231268,0.00004961427,0.00039219364,0.00015373778,0.00014730719,0.014908239,0.000022301927,0.00007437678,0.0052047153],"study_design_scores_gemma":[0.0000082603065,0.00019958132,0.9954379,0.0000045941565,0.000035599736,0.0024158428,0.000050034185,0.00023642063,0.0014164576,0.000039993196,0.00015035406,0.0000048963384],"about_ca_topic_score_codex":0.00045449415,"about_ca_topic_score_gemma":0.00043523166,"teacher_disagreement_score":0.0014480354,"about_ca_system_score_codex":0.00017521734,"about_ca_system_score_gemma":0.00006139165,"threshold_uncertainty_score":0.0048441887},"labels":[],"label_agreement":null},{"id":"W2003181078","doi":"10.3324/haematol.2014.104109","title":"Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naive patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III)","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Bortezomib; Cyclophosphamide; Dexamethasone; Internal medicine; AL amyloidosis; Regimen; Cohort; Amyloidosis; Surgery; Chemotherapy; Multiple myeloma; Immunology","score_opus":0.007995014435383987,"score_gpt":0.24747480473891004,"score_spread":0.23947979030352606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003181078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99798113,0.0014070257,0.000038709004,0.000105856285,0.000016252547,0.000019032092,0.00005449139,0.00000593675,0.00037158126],"genre_scores_gemma":[0.9991949,0.0003739794,0.000073511765,0.00007162345,0.000037098238,0.000012743037,0.00013294503,0.0000012354125,0.000102074795],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996778,0.00016969658,0.000034984987,0.0000384092,0.00004319501,0.000035902038],"domain_scores_gemma":[0.9993612,0.00016223737,0.00016439306,0.000037361133,0.000041246214,0.0002335218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007933805,0.00025899868,0.0005466601,0.0002511705,0.00026382602,0.00039410553,0.00020396047,0.0003322278,0.00040981584],"category_scores_gemma":[0.0012395314,0.00012109858,0.00044074678,0.00023517707,0.00022929804,0.00026332441,0.0001650634,0.0005210869,0.00013396461],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.109183215,0.009529783,0.67295766,0.00031431118,0.0013530178,0.0015457533,0.0005441298,0.0023661067,0.021910999,0.00010108794,0.002737855,0.17745611],"study_design_scores_gemma":[0.0098856995,0.09919402,0.8803545,0.000062803985,0.00077257515,0.0019340423,0.00016869379,0.001437222,0.0036639704,0.0001241443,0.0023664292,0.000035859448],"about_ca_topic_score_codex":0.00065041287,"about_ca_topic_score_gemma":0.0014628342,"teacher_disagreement_score":0.0007933805,"about_ca_system_score_codex":0.00033577753,"about_ca_system_score_gemma":0.00023228273,"threshold_uncertainty_score":0.004195869},"labels":[],"label_agreement":null},{"id":"W2007027997","doi":"10.3324/haematol.13326","title":"Gene expression signatures in follicular lymphoma: are they ready for the clinic?","year":2008,"lang":"en","type":"editorial","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Comparative genomic hybridization; Follicular lymphoma; SNP array; Gene expression profiling; Single-nucleotide polymorphism; Biology; Computational biology; SNP; Genetics; Gene expression; Gene; Genome; Lymphoma; Genotype; Immunology","score_opus":0.03799693587896399,"score_gpt":0.3181259929605036,"score_spread":0.2801290570815396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007027997","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007557544,0.01946519,0.00036099082,0.05918412,0.9199607,0.000018389843,0.00007101559,0.000074099895,0.00078990386],"genre_scores_gemma":[0.0005844408,0.010439605,0.00031583407,0.043086536,0.9426543,0.000020812075,0.00003973526,0.000025292533,0.0028334588],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962941,0.0009937043,0.0007154442,0.00041960363,0.0013194238,0.00025770033],"domain_scores_gemma":[0.9736863,0.013128489,0.0012916486,0.00073075644,0.0093462635,0.0018165635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00846482,0.0027143115,0.0049613197,0.0032178834,0.0018615421,0.0054037827,0.004226423,0.016871603,0.0035285703],"category_scores_gemma":[0.019747658,0.0011562267,0.00269839,0.0014199304,0.0027881505,0.0039642504,0.0013425057,0.021919029,0.0039258916],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008755983,0.000014553958,0.000090439964,0.00035747685,0.000041693474,0.00026335637,0.000014077622,0.000032685595,0.00010984768,0.0003261048,0.98696613,0.011696024],"study_design_scores_gemma":[0.0001837762,0.00012304979,0.0011235813,0.0009062619,0.00033952948,0.0012034753,0.00007657476,0.00047549917,0.00032837474,0.0016032602,0.9935688,0.00006780837],"about_ca_topic_score_codex":0.0023749424,"about_ca_topic_score_gemma":0.005918196,"teacher_disagreement_score":0.016871603,"about_ca_system_score_codex":0.002122233,"about_ca_system_score_gemma":0.002552194,"threshold_uncertainty_score":0.044766724},"labels":[],"label_agreement":null},{"id":"W2010567185","doi":"10.3324/haematol.2010.022210","title":"CKS1B nuclear expression is inversely correlated with p27Kip1 expression and is predictive of an adverse survival in patients with multiple myeloma","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":34,"is_retracted":true,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Leukemia and Lymphoma Society of Canada","keywords":"Multiple myeloma; Internal medicine; Oncology; Expression (computer science); Overall survival; Medicine; Adverse effect; Cancer research","score_opus":0.01226226489713932,"score_gpt":0.24420793155145465,"score_spread":0.23194566665431532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010567185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990089,0.0005988813,0.000090833,0.000042115287,0.0000041576163,0.0000021350672,0.000063554595,0.00000442717,0.0001848905],"genre_scores_gemma":[0.999635,0.00012713882,0.000053444375,0.000007630708,0.000008339864,0.0000029104278,0.00008266559,0.0000010792672,0.0000818414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986076,0.000025624675,0.000014558121,0.000037486832,0.000036640107,0.000024969708],"domain_scores_gemma":[0.9990746,0.00018888211,0.00044094052,0.00003627069,0.00008980259,0.00016948958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024923444,0.0002964592,0.00025483314,0.0005677057,0.00037131357,0.0003183335,0.00021581091,0.00033210492,0.0013997715],"category_scores_gemma":[0.0011515948,0.00019395888,0.00017161065,0.0004950341,0.00033293897,0.00022638752,0.00025074388,0.00039057352,0.00020952898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019780573,0.000010725019,0.9966724,0.00000998966,0.0000228457,0.00015406641,0.000028266606,0.000060279785,0.0016467762,0.00000646943,0.00006886413,0.0011215177],"study_design_scores_gemma":[0.00000780535,0.00005275749,0.99764353,0.0000033979684,0.000027802329,0.0014488497,0.000041919015,0.00022192909,0.00036920057,0.000017219665,0.00016359001,0.000001922595],"about_ca_topic_score_codex":0.0010529076,"about_ca_topic_score_gemma":0.0013914534,"teacher_disagreement_score":0.0013997715,"about_ca_system_score_codex":0.00027700752,"about_ca_system_score_gemma":0.00017778072,"threshold_uncertainty_score":0.0046827197},"labels":[],"label_agreement":null},{"id":"W2016011302","doi":"10.3324/haematol.2009.011692","title":"Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medizinische Universität Graz; Austrian Science Fund; Karl-Franzens-Universität Graz; Deutsche Forschungsgemeinschaft; Stem Cell Network","keywords":"Mesenchymal stem cell; Senescence; Stromal cell; Biology; Cell biology; Cell culture; Cancer research; Cell growth; Bone marrow; Cell cycle; Cell; Immunology; Genetics","score_opus":0.039794263361792856,"score_gpt":0.32236559266328285,"score_spread":0.28257132930149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016011302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922667,0.002163591,0.0036273992,0.00004135814,0.000022903434,0.00004051035,0.0005876454,0.000044998767,0.0012048988],"genre_scores_gemma":[0.989062,0.0013953561,0.005990814,0.00007528548,0.000021730493,0.00014052779,0.0019541048,0.000026530519,0.0013336326],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996388,0.0000869508,0.000048892103,0.000068999165,0.0001014226,0.00005502164],"domain_scores_gemma":[0.99938023,0.00024103245,0.00012562558,0.0000657728,0.00012909231,0.00005826697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039394494,0.00026698777,0.00023204542,0.0005791901,0.0001760881,0.00039194425,0.00011262156,0.00026809328,0.0010536375],"category_scores_gemma":[0.000539698,0.0001406372,0.00039783082,0.00042446886,0.0002669651,0.00025095436,0.0001715645,0.00035101836,0.00037556855],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115571354,0.000012184733,0.0008949466,0.000024981118,0.0000075232365,0.00002093033,0.00004333401,0.000021377633,0.99781275,0.000022813867,0.000009872411,0.0010136577],"study_design_scores_gemma":[0.0000105703575,0.0006577358,0.03978738,0.000010684152,0.00005466288,0.000355641,0.00014587991,0.00030154895,0.9571302,0.00007863771,0.0014566144,0.000010378114],"about_ca_topic_score_codex":0.00018401358,"about_ca_topic_score_gemma":0.00021593791,"teacher_disagreement_score":0.0010536375,"about_ca_system_score_codex":0.00018162181,"about_ca_system_score_gemma":0.00014745412,"threshold_uncertainty_score":0.0035247207},"labels":[],"label_agreement":null},{"id":"W2024119815","doi":"10.3324/haematol.2011.054361","title":"Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival","year":2012,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"Lady Tata Memorial Trust; European Hematology Association","keywords":"CEBPA; Germline mutation; Germline; Myeloid leukemia; Cancer research; Monosomy; Mutation; Chromosome 7 (human); Myelodysplastic syndromes; Biology; Genetics; Acute leukemia; Leukemia; Medicine; Immunology; Karyotype; Chromosome; Gene; Bone marrow","score_opus":0.029065012473407464,"score_gpt":0.28838651818110395,"score_spread":0.25932150570769646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024119815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995009,0.00009359329,0.00010077184,0.000018792567,0.0000021733738,0.0000025251036,0.000021190517,0.0000046510077,0.00025543768],"genre_scores_gemma":[0.99974257,0.000039603354,0.0000800951,0.000007882518,0.0000035505277,9.918922e-7,0.000030814193,0.0000010833776,0.00009337091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999186,0.000021086396,0.00000895608,0.000015516034,0.000015731035,0.00002015587],"domain_scores_gemma":[0.9998666,0.000038329326,0.000034635683,0.000007113585,0.000011343154,0.000041979623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000146316,0.00031848348,0.00012318097,0.0005834617,0.00020970347,0.00014316045,0.00012554516,0.00031814876,0.0008747452],"category_scores_gemma":[0.00041594318,0.00012710264,0.00012876747,0.00020344037,0.0002466504,0.000102660946,0.00017745014,0.00019335766,0.00016166754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012527063,0.00015668114,0.5543703,0.000075157215,0.000104799925,0.28473237,0.00048945466,0.0006758392,0.14521882,0.00032974983,0.0006614974,0.0119326245],"study_design_scores_gemma":[0.000102957805,0.00078360725,0.51343566,0.000019658632,0.00014631664,0.462335,0.00023968775,0.001898291,0.019289818,0.0003397742,0.0013900219,0.000019343834],"about_ca_topic_score_codex":0.00087748043,"about_ca_topic_score_gemma":0.0012703835,"teacher_disagreement_score":0.00087748043,"about_ca_system_score_codex":0.0001639744,"about_ca_system_score_gemma":0.00011843441,"threshold_uncertainty_score":0.0029263496},"labels":[],"label_agreement":null},{"id":"W2024483006","doi":"10.3324/haematol.2014.121079","title":"The closely related rare and severe acute myeloid leukemias carrying EVI1 or PRDM16 rearrangements share singular biological features","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"","keywords":"Dysplasia; Medicine; Myeloid; Bone marrow; Myeloid leukemia; Chromosomal translocation; Gastroenterology; Population; Megakaryocyte; CEBPA; Internal medicine; Pathology; Biology; Gene; Genetics; Haematopoiesis","score_opus":0.06178628481314611,"score_gpt":0.31755517810562645,"score_spread":0.2557688932924803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024483006","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21741629,0.013794884,0.00382626,0.6934122,0.011369392,0.000196033,0.00031031866,0.00020711531,0.05946751],"genre_scores_gemma":[0.7866371,0.006503743,0.0033890011,0.15723944,0.03525567,0.000094470284,0.00027114307,0.000050490595,0.010559003],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9992842,0.00019941785,0.000111340065,0.000098322875,0.00014663288,0.0001600205],"domain_scores_gemma":[0.99867934,0.0006024153,0.00019401895,0.000120368844,0.0001448512,0.00025895023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063777174,0.0003881991,0.0006532024,0.00039297348,0.0011259629,0.0011234847,0.0006095922,0.006356085,0.0017093387],"category_scores_gemma":[0.0058251075,0.00026245043,0.0005105294,0.00048379146,0.0013669312,0.0010256501,0.0008838502,0.005880589,0.0013179968],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042209268,0.0001308363,0.040994648,0.0002635993,0.00008566007,0.73789126,0.0008959463,0.00060468965,0.006862076,0.019366324,0.13101006,0.06147284],"study_design_scores_gemma":[0.000111062895,0.00019499303,0.0132431025,0.000102536294,0.000054626813,0.8439557,0.00073021336,0.0011195954,0.0015345466,0.017325036,0.121582374,0.000046188707],"about_ca_topic_score_codex":0.00048645958,"about_ca_topic_score_gemma":0.0008906171,"teacher_disagreement_score":0.006356085,"about_ca_system_score_codex":0.001250874,"about_ca_system_score_gemma":0.00044892757,"threshold_uncertainty_score":0.00907582},"labels":[],"label_agreement":null},{"id":"W2026548922","doi":"10.3324/haematol.2011.040402","title":"Genomic profiles of MALT lymphomas: variability across anatomical sites","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Associazione Italiana per la Ricerca sul Cancro; Oncosuisse; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Biology; Chromosome; Comparative genomic hybridization; MALT lymphoma; Chromosomal translocation; Genetics; Pathology; Evolutionary biology; Gene; Medicine","score_opus":0.05047863974647793,"score_gpt":0.2929303381884109,"score_spread":0.24245169844193298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026548922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985232,0.00029368885,0.00047944416,0.000016581405,0.0000012020469,0.0000039368106,0.00022557282,0.000016615151,0.0004398536],"genre_scores_gemma":[0.99927276,0.00013174997,0.00016771605,0.000011185703,0.0000025311715,0.000004575284,0.0002858156,0.000006261974,0.00011739975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997569,0.000045206758,0.000025654726,0.00006409986,0.00006190368,0.00004629832],"domain_scores_gemma":[0.99934417,0.0002457571,0.00017615623,0.000070589034,0.000097003394,0.000066339075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018748897,0.00008992434,0.00022736353,0.0009657982,0.00010950451,0.0003314135,0.00011456189,0.00021316783,0.0012053221],"category_scores_gemma":[0.0012682115,0.00009225912,0.00012376554,0.00046554845,0.00016999053,0.00017389018,0.00035178737,0.00016341654,0.00033850744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070936704,0.000028812721,0.77660495,0.000050556468,0.00014532097,0.0007847643,0.0004904905,0.00032540713,0.19040734,0.00011493292,0.0002030081,0.030134993],"study_design_scores_gemma":[0.000003887417,0.000075480275,0.9914452,0.0000035226656,0.000032666332,0.0024421269,0.0001440674,0.00016595695,0.004978182,0.00011148454,0.00059237325,0.0000049447076],"about_ca_topic_score_codex":0.0003698429,"about_ca_topic_score_gemma":0.00049813424,"teacher_disagreement_score":0.0012053221,"about_ca_system_score_codex":0.00010227127,"about_ca_system_score_gemma":0.000047084835,"threshold_uncertainty_score":0.0040321946},"labels":[],"label_agreement":null},{"id":"W2029993391","doi":"10.3324/haematol.2014.115709","title":"Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades","year":2014,"lang":"en","type":"letter","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"Skånes universitetssjukhus; Hospital for Sick Children; Lunds Universitet","keywords":"Medicine; Clotting factor; Haemophilia; Factor IX; Arthropathy; Hemarthrosis; Coagulopathy; Surgery; Pediatrics; Prophylactic treatment; Factor VIIa; Intensive care medicine; Internal medicine; Coagulation; Alternative medicine; Osteoarthritis","score_opus":0.03848889974916503,"score_gpt":0.32662392638426047,"score_spread":0.28813502663509544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029993391","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022871085,0.020349992,0.00026802515,0.95878077,0.013186038,0.000010487745,0.000016700798,0.000018967161,0.0050819013],"genre_scores_gemma":[0.032832935,0.02697995,0.00057248934,0.7940751,0.14301582,0.000028487986,0.000051048024,0.000030931264,0.0024132486],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967709,0.0012045972,0.0004949886,0.00033751447,0.00083788595,0.0003540479],"domain_scores_gemma":[0.9915206,0.004620575,0.00082406553,0.00019568008,0.0014631959,0.0013758817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034947593,0.000518319,0.0009588444,0.0008588998,0.0019687049,0.0017286325,0.00096253253,0.013685333,0.003477905],"category_scores_gemma":[0.017717235,0.0003352878,0.0005807744,0.0007588602,0.0026265476,0.0032796394,0.0011865784,0.017648986,0.002245874],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019907909,0.00022249408,0.005200924,0.000633379,0.000049286904,0.026308948,0.0005826725,0.00035774038,0.0005502976,0.021805204,0.8286595,0.11543047],"study_design_scores_gemma":[0.0003185784,0.00032236765,0.0055101872,0.0041652597,0.000090097245,0.12558696,0.0012319966,0.0012250624,0.0004130044,0.032304153,0.82873034,0.000102032616],"about_ca_topic_score_codex":0.0021918768,"about_ca_topic_score_gemma":0.0036803074,"teacher_disagreement_score":0.013685333,"about_ca_system_score_codex":0.0067424383,"about_ca_system_score_gemma":0.0035112647,"threshold_uncertainty_score":0.048919976},"labels":[],"label_agreement":null},{"id":"W2032532029","doi":"10.3324/haematol.11572","title":"Hb Evora [ 2 35, Ser-&gt;Pro], a novel hemoglobin variant associated with an  -thalassemia phenotype","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Missense mutation; Phenotype; Thalassemia; Genetics; Mutation; Hemoglobinopathy; Biology; Hemoglobin; Amino acid substitution; Gene; Molecular biology; Hemolytic anemia; Immunology; Biochemistry","score_opus":0.019544050927914,"score_gpt":0.26202194499075593,"score_spread":0.24247789406284193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032532029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99505377,0.0004711873,0.0011776672,0.00043417036,0.000084777035,0.000026904021,0.00013215397,0.00007046491,0.0025489314],"genre_scores_gemma":[0.9979887,0.00013313106,0.0008536321,0.00015403672,0.000059950362,0.0000039461274,0.000091786744,0.0000071402883,0.00070760655],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99991786,0.000012307991,0.000008798817,0.000023180182,0.000014503395,0.00002322663],"domain_scores_gemma":[0.99987125,0.000034294608,0.000043486234,0.0000075488583,0.0000105514055,0.00003273207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009538544,0.00058671477,0.00015539241,0.000460614,0.00028050286,0.00021145972,0.00019568011,0.00051550224,0.0009129215],"category_scores_gemma":[0.00037618165,0.00012280063,0.00012743213,0.0002708526,0.00029663058,0.000111475536,0.00015201519,0.0003023951,0.00016190017],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031460726,0.0001062118,0.04291988,0.0000802379,0.000057186975,0.8363355,0.00039033423,0.000345456,0.1001071,0.0019670646,0.002537561,0.014838961],"study_design_scores_gemma":[0.000083197745,0.0003080752,0.07152132,0.000025437312,0.00007646678,0.9084225,0.0001371474,0.0016341477,0.010488165,0.00088292384,0.0063920375,0.000028551322],"about_ca_topic_score_codex":0.0006940028,"about_ca_topic_score_gemma":0.0015311198,"teacher_disagreement_score":0.0009129215,"about_ca_system_score_codex":0.00010027319,"about_ca_system_score_gemma":0.00012471649,"threshold_uncertainty_score":0.0030540824},"labels":[],"label_agreement":null},{"id":"W2033482115","doi":"10.3324/haematol.2013.092114","title":"Commemorating Professor Renzo Galanello (July 21st 1948 - May 13th 2013)","year":2013,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Francophone University Association","funders":"Leslie Dan Faculty of Pharmacy, University of Toronto; University of Toronto","keywords":"Battle; Wife; Medicine; Classics; Art; History; Ancient history; Philosophy; Theology","score_opus":0.036464433359462846,"score_gpt":0.30915243486372146,"score_spread":0.2726880015042586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033482115","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011800419,0.044580474,0.00062389334,0.6218966,0.30623603,0.000074017524,0.0002229882,0.00024850323,0.024937464],"genre_scores_gemma":[0.016722243,0.039919466,0.0010286085,0.28220946,0.14212522,0.000107078034,0.00039001668,0.00037589716,0.51712203],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983531,0.0003228346,0.000058843925,0.00028093916,0.00057862484,0.00040572003],"domain_scores_gemma":[0.99553645,0.0002673065,0.00018252307,0.00008954364,0.0011938957,0.0027303577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028506508,0.00057228986,0.00064506277,0.0009208487,0.0019769452,0.0024572508,0.0009894515,0.0036840616,0.042135622],"category_scores_gemma":[0.009227243,0.00035495,0.00045314492,0.00040032304,0.0011784065,0.0012278318,0.0024529512,0.008289258,0.026199793],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025852849,0.000010415533,0.00021143921,0.000033843855,0.0000026416067,0.00014229392,0.00005613941,0.000013338604,0.00007968092,0.0006102544,0.9868838,0.011930275],"study_design_scores_gemma":[0.0000071157283,0.000027035307,0.00044209964,0.00008731741,0.0000028077186,0.00038670638,0.000077632234,0.000012313592,0.00009225275,0.00032950702,0.9985286,0.0000067108354],"about_ca_topic_score_codex":0.005299336,"about_ca_topic_score_gemma":0.01728001,"teacher_disagreement_score":0.042135622,"about_ca_system_score_codex":0.0033827284,"about_ca_system_score_gemma":0.0048994087,"threshold_uncertainty_score":0.14095771},"labels":[],"label_agreement":null},{"id":"W2034781156","doi":"10.3324/haematol.2012.068288","title":"CD20 has no prognostic significance in children with precursor B-cell acute lymphoblastic leukemia","year":2012,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Hospital for Sick Children; University of Toronto","keywords":"Medicine; Minimal residual disease; Internal medicine; Oncology; Log-rank test; Lymphoblastic Leukemia; Proportional hazards model; Survival analysis; Leukemia; Pediatrics","score_opus":0.01863836450510044,"score_gpt":0.2576372170730993,"score_spread":0.23899885256799883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034781156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905752,0.006323431,0.00008685725,0.00046064897,0.00005565001,0.000008750547,0.00033242328,0.00001630646,0.0021406747],"genre_scores_gemma":[0.99802554,0.0009976461,0.0001123065,0.00009152178,0.000093613744,0.0000057294747,0.0004875583,0.000008083222,0.00017792845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992391,0.00018013043,0.00007228443,0.00014110272,0.00018113284,0.00018620303],"domain_scores_gemma":[0.99604875,0.0011961095,0.0012121412,0.0002478608,0.00037146357,0.00092371384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090432144,0.0004541369,0.00050900195,0.0012963136,0.0005573428,0.0010551423,0.0009030126,0.0011022971,0.0029173114],"category_scores_gemma":[0.008621133,0.0002893939,0.00029100914,0.0019324137,0.0008202842,0.001293987,0.00069338374,0.0010666619,0.00073629525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003075831,0.000014436952,0.99377114,0.00001980031,0.000017946699,0.00052077795,0.000038374495,0.00005700828,0.00025222654,0.00005687979,0.00038751212,0.0045563155],"study_design_scores_gemma":[0.00005061833,0.00034649196,0.9874608,0.000049244958,0.0000925682,0.008002727,0.0002889513,0.00038925832,0.00034423106,0.00039701184,0.0025637767,0.000014136433],"about_ca_topic_score_codex":0.0048723463,"about_ca_topic_score_gemma":0.004833296,"teacher_disagreement_score":0.0048723463,"about_ca_system_score_codex":0.0007406651,"about_ca_system_score_gemma":0.0007751261,"threshold_uncertainty_score":0.009759426},"labels":[],"label_agreement":null},{"id":"W2039543380","doi":"10.3324/haematol.2011.051433","title":"Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mach-Gaensslen Foundation of Canada; University of Bern; National Science Foundation; National Institutes of Health; National Heart, Lung, and Blood Institute; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"ADAMTS13; Autoantibody; Thrombotic thrombocytopenic purpura; Medicine; Immunology; Von Willebrand factor; Internal medicine; Antibody; Platelet","score_opus":0.1554405688723648,"score_gpt":0.32904417117447626,"score_spread":0.17360360230211147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039543380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966395,0.0018655978,0.0006760924,0.000096760974,0.000014954801,0.0000067389024,0.00005423271,0.00002604013,0.00062004256],"genre_scores_gemma":[0.99924076,0.00023139128,0.00026831645,0.000042361902,0.000038094004,0.0000042883844,0.00005919762,0.0000037002926,0.00011195147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996376,0.00005970195,0.000054093227,0.00008617141,0.000097955875,0.00006441121],"domain_scores_gemma":[0.9962059,0.0012702883,0.0015551427,0.0002832086,0.000341151,0.00034429604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007291374,0.00029174756,0.00031035594,0.00063433126,0.000250376,0.00044471366,0.00046002516,0.0008087758,0.001638509],"category_scores_gemma":[0.002796873,0.00013277453,0.0002604982,0.0003286225,0.00044275203,0.0003764209,0.00026890042,0.00055181637,0.00031254668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014310046,0.00030056536,0.85097116,0.0002468383,0.0002231934,0.022798622,0.00054972165,0.0003742639,0.07859565,0.00042190953,0.00056236546,0.043524716],"study_design_scores_gemma":[0.000050291037,0.0017535812,0.84757155,0.000043925866,0.00028608865,0.13246526,0.00016036873,0.0010703021,0.013590474,0.00027813838,0.0027102698,0.000019800053],"about_ca_topic_score_codex":0.00032084473,"about_ca_topic_score_gemma":0.00022264465,"teacher_disagreement_score":0.001638509,"about_ca_system_score_codex":0.00020787674,"about_ca_system_score_gemma":0.00013131723,"threshold_uncertainty_score":0.0054813623},"labels":[],"label_agreement":null},{"id":"W2044240154","doi":"10.3324/haematol.2015.124008","title":"Tumor-associated macrophages in diffuse large B-cell lymphoma","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"University of British Columbia; Ligue Genevoise Contre le Cancer; Michael Smith Health Research BC","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Medicine; Refractory (planetary science); Internal medicine; Disease; Oncology; Pathology; Biology","score_opus":0.024532070276834118,"score_gpt":0.26239133987691127,"score_spread":0.23785926960007714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044240154","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10350898,0.027748922,0.0021781132,0.7950161,0.014705774,0.00014475395,0.000121272635,0.00021535004,0.056360673],"genre_scores_gemma":[0.6916171,0.01898582,0.002022899,0.20761123,0.06600722,0.000112694084,0.00010608317,0.000045313893,0.013491704],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99942243,0.00023708507,0.0000611022,0.000050349903,0.00013097227,0.00009807929],"domain_scores_gemma":[0.99891543,0.00060094486,0.00009928539,0.000067385954,0.00016448749,0.00015248265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007794615,0.00042236954,0.00058966526,0.00058262673,0.0011172898,0.0010844992,0.0005975884,0.0069473404,0.0023475997],"category_scores_gemma":[0.0047069583,0.00029346012,0.00046513413,0.0003446954,0.0011972813,0.0011122613,0.0006135868,0.004582156,0.001699638],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004657795,0.00026407477,0.03341108,0.0005040626,0.000062579675,0.63930434,0.0006280313,0.0006833636,0.0037976229,0.00995151,0.24858911,0.062338505],"study_design_scores_gemma":[0.0005056022,0.00036112985,0.018782059,0.0011711699,0.00010773812,0.7686411,0.0012633017,0.0031423273,0.0013704553,0.024757188,0.17983492,0.000063016414],"about_ca_topic_score_codex":0.0010072879,"about_ca_topic_score_gemma":0.0013207318,"teacher_disagreement_score":0.0069473404,"about_ca_system_score_codex":0.0012854695,"about_ca_system_score_gemma":0.00066651235,"threshold_uncertainty_score":0.009326756},"labels":[],"label_agreement":null},{"id":"W2046217643","doi":"10.3324/haematol.11604","title":"Rapid desensitization for chlorambucil drug fever","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Humber River Regional Hospital; Health Sciences Centre; Western University; Sunnybrook Health Science Centre","funders":"","keywords":"Chlorambucil; Desensitization (medicine); Drug; Medicine; Pharmacology; Internal medicine; Chemotherapy","score_opus":0.04447659047139698,"score_gpt":0.3122120784271372,"score_spread":0.26773548795574026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046217643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97755563,0.010181346,0.004316401,0.0005816795,0.0002632748,0.00046336403,0.000049606853,0.00024263354,0.0063461023],"genre_scores_gemma":[0.99663335,0.0010971118,0.0010429164,0.00023787902,0.00006367645,0.000046538553,0.000035216424,0.00001524177,0.0008279673],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9998275,0.00007845722,0.0000094486,0.000017303833,0.000030084515,0.00003722027],"domain_scores_gemma":[0.9997886,0.00009876016,0.000027081169,0.000038300866,0.000008223607,0.00003904042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005177677,0.00025834955,0.0003624546,0.00013385518,0.00014639694,0.00015539257,0.0002748383,0.00034865545,0.0028609463],"category_scores_gemma":[0.0007530995,0.000093603245,0.00026499145,0.00006260378,0.00018619416,0.00022406958,0.00019079425,0.0009780676,0.0005986651],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016931377,0.00416413,0.008427098,0.0008786486,0.00014614049,0.008972734,0.00072379265,0.0011589752,0.31029603,0.0015289905,0.0071869553,0.63958514],"study_design_scores_gemma":[0.026402868,0.20058432,0.24121282,0.0009085075,0.00050744024,0.15880188,0.0009534998,0.010684946,0.21047096,0.0024778952,0.1468161,0.00017873867],"about_ca_topic_score_codex":0.00029716326,"about_ca_topic_score_gemma":0.00033394413,"teacher_disagreement_score":0.0028609463,"about_ca_system_score_codex":0.0001603451,"about_ca_system_score_gemma":0.00013991837,"threshold_uncertainty_score":0.009570777},"labels":[],"label_agreement":null},{"id":"W2048293097","doi":"10.3324/haematol.2014.112557","title":"Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma","year":2014,"lang":"en","type":"letter","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Vancouver General Hospital","funders":"Erasmus Medisch Centrum; King's College London; University of Alberta; Celgene","keywords":"Pomalidomide; Dexamethasone; Medicine; Multiple myeloma; Refractory (planetary science); Internal medicine; Oncology; Quality of life (healthcare); Lenalidomide","score_opus":0.1214802133070783,"score_gpt":0.3563383526192474,"score_spread":0.2348581393121691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048293097","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026321486,0.005953812,0.00016159369,0.9458501,0.0074636135,0.00008169224,0.00081568625,0.000030852847,0.013321194],"genre_scores_gemma":[0.17385301,0.0038027854,0.00053748314,0.78810436,0.023878967,0.00024441132,0.0006029129,0.00003042675,0.008945726],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99730384,0.0015573845,0.00023847692,0.00020401747,0.00041108756,0.0002850971],"domain_scores_gemma":[0.9950429,0.0032585615,0.00043715836,0.00009274694,0.0004470279,0.0007216185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030540803,0.00039023577,0.0014249247,0.00038256258,0.0015015125,0.0015171864,0.0009601544,0.009285618,0.004510017],"category_scores_gemma":[0.013203517,0.00026850333,0.0010122258,0.00060063915,0.0008508835,0.00090824254,0.00045815017,0.0067920415,0.00082223985],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02570662,0.0010063594,0.029412825,0.00058449747,0.00095280283,0.010339633,0.00027621092,0.0014408354,0.0012975336,0.0059316345,0.81855124,0.10449977],"study_design_scores_gemma":[0.07449756,0.0077922572,0.09382941,0.0021967872,0.0045557306,0.022099886,0.0014854943,0.012555908,0.0047120815,0.04981393,0.7260382,0.0004227683],"about_ca_topic_score_codex":0.003321083,"about_ca_topic_score_gemma":0.0076179793,"teacher_disagreement_score":0.009285618,"about_ca_system_score_codex":0.0038904164,"about_ca_system_score_gemma":0.0021624607,"threshold_uncertainty_score":0.028227031},"labels":[],"label_agreement":null},{"id":"W2049141040","doi":"10.3324/haematol.2013.100818","title":"R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"F. Hoffmann-La Roche","keywords":"Medicine; CHOP; Rituximab; Internal medicine; Vincristine; Gastroenterology; Hazard ratio; Diffuse large B-cell lymphoma; Bevacizumab; Lymphoma; Surgery; Confidence interval; Oncology; Cyclophosphamide; Chemotherapy","score_opus":0.014153833998881038,"score_gpt":0.25063564342900474,"score_spread":0.2364818094301237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049141040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95602566,0.031943228,0.0010922501,0.00070455734,0.0004562674,0.0015439154,0.0031274145,0.00008845965,0.0050182953],"genre_scores_gemma":[0.9878834,0.0045334175,0.0006416785,0.0008674532,0.0006188952,0.0013614175,0.0025645448,0.000024065615,0.0015051308],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99835855,0.0008613256,0.00015831561,0.0002371715,0.00013696802,0.00024768306],"domain_scores_gemma":[0.9981699,0.00069362903,0.0005452642,0.000098112505,0.00012761014,0.00036553302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002944671,0.0012203029,0.002936941,0.00059008354,0.00031133747,0.0015678313,0.00052454387,0.0012658137,0.0029817785],"category_scores_gemma":[0.0027406514,0.00038924895,0.005065047,0.00059563323,0.00043165084,0.0011414732,0.00058264646,0.0018098302,0.00038671558],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9216317,0.0023314152,0.012623475,0.0026352233,0.013607115,0.00016570187,0.0000675262,0.0009760272,0.0014994672,0.00018318799,0.0013779378,0.042901233],"study_design_scores_gemma":[0.6262954,0.21878347,0.1080574,0.0008723734,0.031388093,0.0004957752,0.00014269014,0.0022107386,0.0024002285,0.0010982516,0.008150175,0.00010538313],"about_ca_topic_score_codex":0.00047310558,"about_ca_topic_score_gemma":0.001246727,"teacher_disagreement_score":0.0029817785,"about_ca_system_score_codex":0.0006853643,"about_ca_system_score_gemma":0.00078807055,"threshold_uncertainty_score":0.015573144},"labels":[],"label_agreement":null},{"id":"W2055338669","doi":"10.3324/haematol.12320","title":"Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fondation Pour La Conservation Du Saumon Atlantique","keywords":"D-dimer; Medicine; Venous thromboembolism; Discontinuation; Antagonism; Internal medicine; Hazard ratio; Gastroenterology; Vitamin k; Surgery; Confidence interval; Thrombosis","score_opus":0.04675828547302436,"score_gpt":0.3609892755392832,"score_spread":0.3142309900662589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055338669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974254,0.0009398711,0.00093647477,0.000051843537,0.00008042091,0.00006559421,0.00014001734,0.000011960127,0.00034842902],"genre_scores_gemma":[0.9988331,0.00007382498,0.000470337,0.00005401805,0.000065507054,0.000102661754,0.0002286975,0.000015280802,0.00015654137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9867698,0.009489699,0.00059809664,0.0015190772,0.0009927895,0.0006305783],"domain_scores_gemma":[0.94974184,0.04383721,0.002107541,0.002067091,0.0013543444,0.000892013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014994485,0.0008046275,0.0022724678,0.00054814736,0.0002819612,0.0011559443,0.0007281337,0.0008528726,0.0013787892],"category_scores_gemma":[0.020077791,0.000355846,0.0030073626,0.00035924194,0.0005063115,0.0007321366,0.0005208195,0.0012614081,0.00016053786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32984456,0.00077793817,0.6288796,0.0003179558,0.014365553,0.00035312874,0.00037920102,0.0014122537,0.00566153,0.00020367224,0.0010084715,0.016796181],"study_design_scores_gemma":[0.010717542,0.05534374,0.89937544,0.00007731856,0.01260341,0.00067887147,0.0004678458,0.014825159,0.0035738412,0.0003622331,0.0018617965,0.00011280069],"about_ca_topic_score_codex":0.00038250716,"about_ca_topic_score_gemma":0.00040511918,"teacher_disagreement_score":0.014994485,"about_ca_system_score_codex":0.0003076457,"about_ca_system_score_gemma":0.00032440553,"threshold_uncertainty_score":0.07929939},"labels":[],"label_agreement":null},{"id":"W2057046347","doi":"10.3324/haematol.2012.071068","title":"Mutations in the telomere capping complex in bone marrow failure and related syndromes","year":2012,"lang":"en","type":"article","venue":"Haematologica","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"Wellcome Trust","keywords":"Dyskeratosis congenita; Telomere; Phenotype; Biology; Telomere-binding protein; Genetics; Mutation; Bone marrow failure; Shelterin; DNA; Gene; Stem cell; Haematopoiesis","score_opus":0.04760938936269726,"score_gpt":0.2877051440021218,"score_spread":0.24009575463942456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057046347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99706084,0.0009636905,0.00035090712,0.000054321445,0.0000050595618,0.0000141522,0.00006181156,0.000015532749,0.0014736002],"genre_scores_gemma":[0.99928635,0.00019609793,0.00025948772,0.000025420788,0.000008036534,0.0000036040765,0.000050025406,0.000002878173,0.00016816294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998035,0.000037000944,0.000028225284,0.000039733488,0.000059792204,0.000031700238],"domain_scores_gemma":[0.9997683,0.00007119989,0.00007403172,0.000012210093,0.000017263417,0.000057011588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018448968,0.00056549854,0.00020566848,0.0010499266,0.00044406383,0.00022521269,0.00016717656,0.00031725343,0.0015238486],"category_scores_gemma":[0.00079761946,0.00014526614,0.00010884781,0.0006017516,0.00033450907,0.00013422777,0.00037470434,0.00021748448,0.00018671436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013225147,0.00022168597,0.60544986,0.00028928719,0.00018100695,0.16457596,0.0013885401,0.0008811073,0.17221291,0.0021966638,0.0017645456,0.049515944],"study_design_scores_gemma":[0.000112005626,0.00032898973,0.6421677,0.000066683344,0.00015421408,0.3342872,0.0003035318,0.0008432954,0.016726002,0.0008776315,0.0041084224,0.00002436366],"about_ca_topic_score_codex":0.0013369038,"about_ca_topic_score_gemma":0.0018226687,"teacher_disagreement_score":0.0015238486,"about_ca_system_score_codex":0.00019363938,"about_ca_system_score_gemma":0.00017894144,"threshold_uncertainty_score":0.0050978065},"labels":[],"label_agreement":null},{"id":"W2058663390","doi":"10.3324/haematol.10317","title":"APRIL but not BLyS serum levels are increased in chronic lymphocytic leukemia: prognostic relevance of APRIL for survival","year":2007,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Universidad de Jaén; Fondation de France; Association pour la Recherche sur le Cancer","keywords":"B-cell activating factor; Chronic lymphocytic leukemia; Clinical significance; Medicine; Immunology; CD20; Leukemia; Lymphocyte; Internal medicine; Oncology; B cell; Antibody","score_opus":0.0689201530676397,"score_gpt":0.32353673284256834,"score_spread":0.25461657977492863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058663390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9542463,0.006577432,0.0006650238,0.029196458,0.00054568186,0.000034818313,0.00023401191,0.000073512616,0.008426861],"genre_scores_gemma":[0.99058086,0.0015404233,0.00041449768,0.0044048526,0.0014066926,0.000019503455,0.000113548536,0.000007947846,0.001511755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974245,0.00008798882,0.000032194344,0.000031410502,0.000045559533,0.000060404025],"domain_scores_gemma":[0.99909306,0.0005169534,0.000101243866,0.000046470817,0.00012775593,0.00011454798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003221796,0.00023922522,0.00043551743,0.0004144514,0.00035656217,0.00046018304,0.00020945488,0.0015054173,0.00129213],"category_scores_gemma":[0.0015874517,0.00015082202,0.00014915843,0.00044112295,0.00046460368,0.00042055978,0.00012835312,0.0008576816,0.0006066504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004488373,0.00020866105,0.7539711,0.00022686066,0.000077634075,0.09872354,0.0004637883,0.0004002498,0.03227142,0.00082713267,0.023745995,0.084595144],"study_design_scores_gemma":[0.0005418392,0.0019413079,0.5925409,0.00013956199,0.00020031426,0.32732487,0.0010020481,0.004763604,0.015585929,0.0045300936,0.051353913,0.00007560485],"about_ca_topic_score_codex":0.0005645894,"about_ca_topic_score_gemma":0.0008008983,"teacher_disagreement_score":0.0015054173,"about_ca_system_score_codex":0.0004684962,"about_ca_system_score_gemma":0.00015035708,"threshold_uncertainty_score":0.004322648},"labels":[],"label_agreement":null},{"id":"W2059117184","doi":"10.3324/haematol.2012.062059","title":"Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research","year":2012,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Cancer Institute; CellGenix; Genentech; Health Resources and Services Administration; Sigma-Tau Pharmaceuticals; Therakos; Kiadis Pharma; Amgen; Otsuka America Pharmaceutical; National Heart, Lung, and Blood Institute; Blue Cross and Blue Shield Association; Otsuka America; National Center for Advancing Translational Sciences; Teva Pharmaceutical Industries; WellPoint; Celgene; Takeda Oncology; Ariad Pharmaceuticals; GlaxoSmithKline; Swedish Orphan Biovitrum; Office of Naval Research; Be The Match Foundation; Medical College of Wisconsin; U.S. Department of Health and Human Services","keywords":"Medicine; Cumulative incidence; Transplantation; Myeloid leukemia; Bone marrow; Internal medicine; Leukemia; Gastroenterology; Incidence (geometry); Surgery","score_opus":0.07775151225751975,"score_gpt":0.36749665238917967,"score_spread":0.2897451401316599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059117184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988759,0.0005093598,0.00010940455,0.00004371379,0.0000067364876,0.00003883538,0.0002622342,0.0000040651585,0.00014968339],"genre_scores_gemma":[0.9980762,0.00055792177,0.00019372192,0.00008856371,0.00003712975,0.00008388051,0.0008638798,0.000005876477,0.000092857095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99380714,0.004251621,0.0004076528,0.0005406974,0.0005937403,0.0003990322],"domain_scores_gemma":[0.99000424,0.0037844314,0.003691257,0.0010430885,0.00040930213,0.0010677361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071417782,0.00038083454,0.00094121596,0.0009259988,0.00057323626,0.001025106,0.00071444694,0.00067322387,0.0013838909],"category_scores_gemma":[0.01037878,0.0004772771,0.0014090443,0.0016553995,0.0005130121,0.0012388817,0.00086866313,0.0010377616,0.00046657133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011350021,0.0015755096,0.97801185,0.00012676584,0.000971378,0.00034096575,0.00046159333,0.00023000762,0.0004387077,0.00008321875,0.00042570167,0.005984307],"study_design_scores_gemma":[0.0045042397,0.01970772,0.9666727,0.00009689706,0.0017721882,0.0023865884,0.0015458333,0.0011298723,0.0007353429,0.00014258889,0.0012526034,0.00005338569],"about_ca_topic_score_codex":0.0018379792,"about_ca_topic_score_gemma":0.0026276293,"teacher_disagreement_score":0.0071417782,"about_ca_system_score_codex":0.00056281075,"about_ca_system_score_gemma":0.0012010187,"threshold_uncertainty_score":0.037769794},"labels":[],"label_agreement":null},{"id":"W2064638441","doi":"10.3324/haematol.12152","title":"Sickle cell disease-related organ damage occurs irrespective of pain rate: implications for clinical practice","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Microalbuminuria; Disease; Acute chest syndrome; Priapism; Chest pain; Sickle cell anemia; Internal medicine; Surgery","score_opus":0.04890125592743564,"score_gpt":0.35497936767394583,"score_spread":0.3060781117465102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064638441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9062225,0.038115818,0.0040523126,0.037893932,0.00070027,0.00024236138,0.0005545919,0.00015189138,0.012066336],"genre_scores_gemma":[0.99235535,0.0033111044,0.0020286553,0.001402589,0.0005082978,0.000052504918,0.00009094125,0.000008642884,0.0002419376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929391,0.0040784264,0.0009730176,0.0007023725,0.0010393577,0.00026767352],"domain_scores_gemma":[0.94597197,0.031888623,0.012058628,0.0015375196,0.0048237843,0.003719485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008349566,0.00040799528,0.0009260839,0.0015955466,0.0005894096,0.0015718223,0.0009010298,0.0016698295,0.002379767],"category_scores_gemma":[0.0644188,0.0004197141,0.00019385645,0.0015722488,0.0012548448,0.0023976443,0.0007449119,0.0010991697,0.0006756825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032764653,0.00010773881,0.95253617,0.00022631392,0.000037100897,0.0011636101,0.00059088634,0.00014554556,0.00027486315,0.00027077034,0.0029470378,0.041372266],"study_design_scores_gemma":[0.00008169313,0.00068072544,0.97903216,0.0007435464,0.00009148761,0.0071635605,0.0037826593,0.002823414,0.00019937102,0.0025694906,0.0027602674,0.00007154565],"about_ca_topic_score_codex":0.0025315965,"about_ca_topic_score_gemma":0.0027938227,"teacher_disagreement_score":0.008349566,"about_ca_system_score_codex":0.00054148905,"about_ca_system_score_gemma":0.0010536867,"threshold_uncertainty_score":0.044157267},"labels":[],"label_agreement":null},{"id":"W2066523152","doi":"10.3324/haematol.2010.037408","title":"High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"International Prognostic Index; Medicine; Rituximab; Lymphoma; Internal medicine; Diffuse large B-cell lymphoma; Microvessel; Oncology; Pathology; Cohort; Proportional hazards model; Angiogenesis","score_opus":0.011536105414878135,"score_gpt":0.21269570766142515,"score_spread":0.20115960224654703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066523152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996785,0.00013134985,0.0000369204,0.000013774821,0.000001752555,0.0000024358194,0.000024486211,0.0000019039342,0.000108949775],"genre_scores_gemma":[0.99981314,0.000038143822,0.000035817702,0.000006540268,0.0000050804088,0.0000026053472,0.00007243529,6.3700213e-7,0.000025669413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981636,0.000058666395,0.000016348344,0.00003735306,0.000040231982,0.000031072028],"domain_scores_gemma":[0.9993303,0.00016605154,0.0002784234,0.000028972485,0.00005443761,0.00014182283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003552472,0.00017869625,0.00023285972,0.00047309947,0.00023344459,0.000325659,0.00019162579,0.0002542439,0.000910905],"category_scores_gemma":[0.0012168827,0.00012590867,0.00015475141,0.00035695583,0.00023774656,0.00017631105,0.00023885898,0.00024445995,0.00012551236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002463716,0.000025419069,0.99667114,0.0000057376437,0.00002373898,0.00010423269,0.000021411148,0.0000630057,0.0010615251,0.000007712315,0.00006999561,0.0016997363],"study_design_scores_gemma":[0.000015026421,0.0001275505,0.99861157,0.0000031131447,0.000026757187,0.0006286809,0.00003835163,0.00025723412,0.00016997322,0.00001375032,0.00010604535,0.0000019430388],"about_ca_topic_score_codex":0.00072282774,"about_ca_topic_score_gemma":0.00094784744,"teacher_disagreement_score":0.000910905,"about_ca_system_score_codex":0.00024400586,"about_ca_system_score_gemma":0.00015871292,"threshold_uncertainty_score":0.0030472875},"labels":[],"label_agreement":null},{"id":"W2067685415","doi":"10.3324/haematol.2008.001024","title":"CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant cause of R-CHOP failure","year":2009,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Rituximab; CD20; Epitope; CHOP; Lymphoma; Diffuse large B-cell lymphoma; Medicine; B cell; Immunophenotyping; Cancer research; Antigen; Immunology; Pathology; Antibody","score_opus":0.0215030188867451,"score_gpt":0.2558321422840284,"score_spread":0.2343291233972833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067685415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989454,0.0005613922,0.000117207164,0.000023176177,0.0000017273629,0.0000026457337,0.000012973248,0.000009012302,0.00032642175],"genre_scores_gemma":[0.9997366,0.00011039742,0.000047198948,0.000015368842,0.000007889715,8.68085e-7,0.000023690967,0.000002352837,0.00005562164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997038,0.000058097154,0.0000366619,0.00006440749,0.00006150449,0.00007548822],"domain_scores_gemma":[0.9990251,0.00032256055,0.00036073773,0.00010110171,0.00006659956,0.00012391541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030579817,0.00025928702,0.00039690745,0.0004452791,0.00021060737,0.00038748997,0.00026395786,0.00045353553,0.0008012635],"category_scores_gemma":[0.0026922738,0.00022353698,0.0001443986,0.000224696,0.0004165892,0.00025207904,0.00015012114,0.00030930436,0.00028244848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007575694,0.000109436296,0.8933159,0.00009030695,0.00008224416,0.039657228,0.00029832192,0.00031966224,0.034541793,0.0001309791,0.00041301397,0.03028358],"study_design_scores_gemma":[0.000091007925,0.0008353197,0.7861223,0.000034133995,0.00013099094,0.20045625,0.00023545224,0.00087256654,0.009704847,0.00017962162,0.0013219981,0.000015609585],"about_ca_topic_score_codex":0.0006346627,"about_ca_topic_score_gemma":0.00082550023,"teacher_disagreement_score":0.0008012635,"about_ca_system_score_codex":0.00019443587,"about_ca_system_score_gemma":0.00012491275,"threshold_uncertainty_score":0.0026804805},"labels":[],"label_agreement":null},{"id":"W2071134744","doi":"10.3324/haematol.2011.047670","title":"Second-line salvage chemotherapy for transplant-eligible patients with Hodgkin's lymphoma resistant to platinum-containing first-line salvage chemotherapy","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Salvage therapy; Chemotherapy; Medicine; Gemcitabine; Oncology; Internal medicine; Lymphoma; Refractory (planetary science); Cisplatin; Transplantation; Surgery; Materials science","score_opus":0.02961090295293868,"score_gpt":0.2552838877525562,"score_spread":0.22567298479961756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071134744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986873,0.0008149757,0.000090974005,0.000058111575,0.0000057763727,0.000027061868,0.00004471464,0.0000066209705,0.00026432748],"genre_scores_gemma":[0.9990244,0.00039075015,0.0001465271,0.00011017295,0.000028141174,0.000022600469,0.00017886024,0.0000018755513,0.000096722426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998771,0.0000389431,0.000015907643,0.000016202068,0.000025173498,0.00002679214],"domain_scores_gemma":[0.999508,0.00013566509,0.00017585761,0.000019922176,0.000030026757,0.00013047893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034301684,0.00015182036,0.00041425452,0.0002513775,0.00018693185,0.00036166125,0.00020138093,0.0002451976,0.001246403],"category_scores_gemma":[0.001005811,0.00006252801,0.00026289973,0.00025073742,0.00015828478,0.0001820945,0.00015039551,0.0002624477,0.00020105591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003464959,0.000446604,0.93977505,0.00017486504,0.00011929322,0.0032102987,0.00024801338,0.00048259392,0.0064355955,0.000047957,0.0008506631,0.04474414],"study_design_scores_gemma":[0.0009832712,0.010061651,0.9624768,0.00008660674,0.00024765503,0.016601589,0.0003512963,0.0019136067,0.0043002763,0.0001551013,0.0028095385,0.000012540276],"about_ca_topic_score_codex":0.00025948437,"about_ca_topic_score_gemma":0.0007741625,"teacher_disagreement_score":0.001246403,"about_ca_system_score_codex":0.0002828176,"about_ca_system_score_gemma":0.00028979898,"threshold_uncertainty_score":0.0041695833},"labels":[],"label_agreement":null},{"id":"W2075574622","doi":"10.3324/haematol.2011.040121","title":"Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemia","year":2011,"lang":"en","type":"review","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Fondation Charles-Bruneau; Leukemia and Lymphoma Society of Canada; Mersin Üniversitesi; Kay Kendall Leukaemia Fund; Canadian Institutes of Health Research; Compagnia di San Paolo; Leukemia and Lymphoma Society","keywords":"Medicine; Acute lymphocytic leukemia; Leukemia; Penetrance; Genome-wide association study; Single-nucleotide polymorphism; Childhood leukemia; Genetics; Immunology; Oncology; Lymphoblastic Leukemia; Biology; Gene; Genotype; Phenotype","score_opus":0.09014294134175513,"score_gpt":0.3820084439961173,"score_spread":0.2918655026543622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075574622","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045648824,0.029376773,0.07492628,0.47849283,0.058772467,0.07667044,0.016857745,0.0010015253,0.21825314],"genre_scores_gemma":[0.16273315,0.009553385,0.17777933,0.31439286,0.01823492,0.24953583,0.015315647,0.00056908827,0.051885772],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.93024737,0.042935796,0.004905748,0.0061980146,0.011025394,0.004687607],"domain_scores_gemma":[0.895067,0.025151717,0.0048228167,0.014152206,0.035602096,0.025204185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0943465,0.0013047433,0.001313054,0.003592097,0.0050492454,0.005589175,0.0055718664,0.007165882,0.012666524],"category_scores_gemma":[0.08991201,0.00086869457,0.002275941,0.005046257,0.0050444617,0.0030357216,0.010597299,0.009811017,0.0031175117],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005049637,0.0010031274,0.113044575,0.0021027508,0.000514004,0.001227948,0.004175467,0.0009516941,0.0013906222,0.29697046,0.44430032,0.12926936],"study_design_scores_gemma":[0.004162432,0.0010182628,0.058479827,0.006474982,0.0007943553,0.0013687322,0.0029912442,0.0013793028,0.0010274536,0.031466328,0.8905726,0.00026436284],"about_ca_topic_score_codex":0.016069984,"about_ca_topic_score_gemma":0.024543872,"teacher_disagreement_score":0.0943465,"about_ca_system_score_codex":0.004719516,"about_ca_system_score_gemma":0.026605394,"threshold_uncertainty_score":0.49895793},"labels":[],"label_agreement":null},{"id":"W2090582630","doi":"10.3324/haematol.2010.029678","title":"Extent of hematopoietic involvement by TET2 mutations in JAK2V617F polycythemia vera","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; National Cancer Institute; Institut National Du Cancer; Fondation de France; Ligue Contre le Cancer; Institut National de la Santé et de la Recherche Médicale","keywords":"Polycythemia vera; clone (Java method); Biology; Haematopoiesis; Somatic cell; Mutation; Progenitor cell; Cancer research; CD34; Germline mutation; Myeloproliferative neoplasm; Molecular biology; Genetics; Stem cell; Immunology; Myelofibrosis; Gene; Bone marrow","score_opus":0.0431385331944375,"score_gpt":0.27588322941015275,"score_spread":0.23274469621571525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090582630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974425,0.0009615669,0.00022722941,0.000021649332,0.000002158926,0.0000079559395,0.00003310072,0.000009286572,0.0012946099],"genre_scores_gemma":[0.99961734,0.00012347521,0.00010748685,0.000008609258,0.0000029747266,0.000002276456,0.000024287338,0.0000015926452,0.00011192982],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99974114,0.00010006318,0.00002238677,0.000035041834,0.0000674241,0.000033895114],"domain_scores_gemma":[0.99970454,0.00010841861,0.000080007165,0.000024784873,0.000027062628,0.000055203596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023459905,0.000118424694,0.00011622704,0.00086769566,0.00016075047,0.0002646372,0.00007391994,0.00025447574,0.0008395715],"category_scores_gemma":[0.00055942265,0.00014115269,0.00006108424,0.00026972592,0.00028001977,0.00013570377,0.00015090677,0.00017045993,0.000111007415],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012036273,0.0001686578,0.24265605,0.00009562476,0.000066711655,0.007059224,0.00023869274,0.00050547614,0.71915597,0.00038158195,0.00017474778,0.02829359],"study_design_scores_gemma":[0.000053631127,0.0010644692,0.86592716,0.00002282701,0.000099432706,0.030042045,0.00015909984,0.0017235868,0.098567724,0.00034707508,0.001977966,0.000014985573],"about_ca_topic_score_codex":0.0004919767,"about_ca_topic_score_gemma":0.00079185405,"teacher_disagreement_score":0.00086769566,"about_ca_system_score_codex":0.0002306153,"about_ca_system_score_gemma":0.000066873086,"threshold_uncertainty_score":0.0028086305},"labels":[],"label_agreement":null},{"id":"W2095913486","doi":"10.3324/haematol.2010.025338","title":"Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Research Institute; Cancer Research Institute","keywords":"IGHV@; Internal medicine; Randomization; Oncology; Randomized controlled trial; Medicine; Beta-2 microglobulin; Chronic lymphocytic leukemia; Relative risk; Progression-free survival; Overall survival; Leukemia; Confidence interval","score_opus":0.05414269921170813,"score_gpt":0.32897521799457874,"score_spread":0.2748325187828706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095913486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928289,0.0038787737,0.00054218894,0.0007296902,0.0000644124,0.00036346965,0.00041778965,0.000034898858,0.0011399187],"genre_scores_gemma":[0.99647,0.00033884155,0.00073798466,0.0004822753,0.000114311864,0.00069631677,0.00066799123,0.000007259756,0.00048512054],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9967049,0.0023711578,0.00013344557,0.0002482425,0.00019864172,0.0003436479],"domain_scores_gemma":[0.9973092,0.0012402252,0.0007038369,0.00019727086,0.000098369914,0.0004511559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054715704,0.0008225149,0.0019175747,0.00048367868,0.00032125303,0.0011395172,0.0006144503,0.0015699398,0.0025174732],"category_scores_gemma":[0.0053453194,0.00025674707,0.001777349,0.00037532515,0.00063178904,0.0010465871,0.0007819788,0.0018926626,0.00021223961],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89636064,0.0012335022,0.052405052,0.0003509092,0.0016532906,0.00008160847,0.00010928068,0.0017860205,0.0015464453,0.00023181761,0.0013549996,0.042886514],"study_design_scores_gemma":[0.6813651,0.113295265,0.18085907,0.00043494778,0.0063013737,0.00040669108,0.00021255598,0.00751626,0.0016092877,0.0035425895,0.0043227663,0.00013407259],"about_ca_topic_score_codex":0.000532811,"about_ca_topic_score_gemma":0.0010554418,"teacher_disagreement_score":0.0054715704,"about_ca_system_score_codex":0.0007883647,"about_ca_system_score_gemma":0.0012256795,"threshold_uncertainty_score":0.028936803},"labels":[],"label_agreement":null},{"id":"W2095934415","doi":"10.3324/haematol.2014.120857","title":"Somatic calreticulin mutations in patients with Budd-Chiari syndrome and portal vein thrombosis","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Institut National de la Santé et de la Recherche Médicale","keywords":"Budd–Chiari syndrome; Calreticulin; Medicine; Portal vein thrombosis; Thrombosis; Internal medicine; Gastroenterology; Inferior vena cava; Biology; Genetics","score_opus":0.02343537249997888,"score_gpt":0.260084234927091,"score_spread":0.2366488624271121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095934415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997135,0.00008735602,0.000033613156,0.0000136397675,0.0000013393534,0.0000018854364,0.000017830527,0.0000013217866,0.00012951693],"genre_scores_gemma":[0.9998029,0.000050882776,0.00005942692,0.000011360034,0.000006081168,0.0000015442625,0.000031349373,8.230625e-7,0.000035611345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970907,0.000074869306,0.00003757262,0.00007051575,0.00005902272,0.00004900824],"domain_scores_gemma":[0.99924624,0.0002744081,0.000260354,0.00004882445,0.000041662475,0.00012848328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032855387,0.00025119566,0.0002809434,0.00086625875,0.00039655724,0.00046510578,0.0002033752,0.0004223307,0.0010173881],"category_scores_gemma":[0.0020603684,0.00026283806,0.00017275529,0.0005763727,0.0003934287,0.0003142722,0.00030252946,0.0002979917,0.00015153935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015730468,0.000028591196,0.99038225,0.00000671838,0.000018795788,0.004841856,0.00014219373,0.000067117166,0.002068512,0.00003527095,0.000044706518,0.0022066433],"study_design_scores_gemma":[0.00004050243,0.00026845446,0.95908725,0.000008338038,0.000043119995,0.038403336,0.00026000175,0.00050131325,0.0009766783,0.00007909756,0.00032373818,0.000008036397],"about_ca_topic_score_codex":0.0010217562,"about_ca_topic_score_gemma":0.00091618364,"teacher_disagreement_score":0.0010217562,"about_ca_system_score_codex":0.00023166632,"about_ca_system_score_gemma":0.00017702715,"threshold_uncertainty_score":0.0034034848},"labels":[],"label_agreement":null},{"id":"W2096179016","doi":"10.3324/haematol.2014.108563","title":"Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Centre Hospitalier Universitaire de Nantes; Ligue Contre le Cancer; National Cancer Institute; Institut National Du Cancer; Fondation de France; Association pour la Recherche sur le Cancer","keywords":"Busulfan; Clofarabine; Medicine; Myeloid leukemia; Internal medicine; Transplantation; Regimen; Gastroenterology; Leukemia; Cumulative incidence; Acute leukemia; Surgery; Hematopoietic stem cell transplantation; Cytarabine","score_opus":0.03173495571091613,"score_gpt":0.29545310455945895,"score_spread":0.26371814884854283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096179016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956232,0.0028473993,0.00015780311,0.00011977685,0.000026724398,0.00031530162,0.00022829627,0.00001669435,0.0006649223],"genre_scores_gemma":[0.99232364,0.002494983,0.0007263962,0.0006868287,0.00012583371,0.00050789054,0.002394868,0.000013481145,0.0007260291],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993581,0.0004669773,0.000027750266,0.00005088493,0.000041931595,0.000054319742],"domain_scores_gemma":[0.99927205,0.0002005919,0.0001688802,0.000051832198,0.000039636165,0.00026689595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018197362,0.00065529684,0.0009185524,0.00013886727,0.00020729187,0.000646471,0.00037151366,0.00052188867,0.0011807757],"category_scores_gemma":[0.00095029577,0.00014105513,0.0004653018,0.00021138733,0.0003521859,0.0003035864,0.00018539802,0.0009581243,0.0002251399],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77525294,0.025709199,0.02871909,0.0007297457,0.0015429634,0.00039919588,0.0002735816,0.0028119546,0.03186436,0.00027819787,0.0035077287,0.12891096],"study_design_scores_gemma":[0.33883426,0.58875066,0.052805547,0.00013010607,0.001302948,0.0006697845,0.00009643356,0.0014735331,0.007284364,0.00017190256,0.008442846,0.00003765316],"about_ca_topic_score_codex":0.00044448226,"about_ca_topic_score_gemma":0.0014259197,"teacher_disagreement_score":0.0018197362,"about_ca_system_score_codex":0.00037019968,"about_ca_system_score_gemma":0.000846863,"threshold_uncertainty_score":0.009623766},"labels":[],"label_agreement":null},{"id":"W2097367878","doi":"10.3324/haematol.2012.072090","title":"Classical Hodgkin's lymphoma: the Lymphoma Study Association guidelines for relapsed and refractory adult patients eligible for transplant","year":2013,"lang":"en","type":"review","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Centre Léon Bérard; Centre hospitalier universitaire Sainte-Justine; Institut Gustave-Roussy","keywords":"Medicine; Lymphoma; Oncology; Internal medicine; Salvage therapy; Autologous stem-cell transplantation; Transplantation; Refractory (planetary science); Clinical trial; Brentuximab vedotin; Hodgkin lymphoma; Classical Hodgkin lymphoma; Chemotherapy","score_opus":0.10536846001959649,"score_gpt":0.3775607193242865,"score_spread":0.27219225930469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097367878","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004449708,0.98445916,0.0008098282,0.0065521784,0.0013492831,0.0011508553,0.0017310053,0.000039400085,0.0034634175],"genre_scores_gemma":[0.006013551,0.9621091,0.010537521,0.006922862,0.00091928034,0.003674608,0.0065653445,0.00003728703,0.0032205214],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973763,0.0009097123,0.0010084349,0.0001172486,0.00047799278,0.00011026353],"domain_scores_gemma":[0.99495465,0.0016466101,0.0015097297,0.00009923608,0.0015252128,0.00026453187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053609386,0.0010067107,0.0030062874,0.004966942,0.0004606206,0.0011363085,0.0019816405,0.0016204478,0.0033166476],"category_scores_gemma":[0.0076563116,0.00048590905,0.0027418935,0.004999767,0.0005424414,0.0011786653,0.0011077193,0.0022509517,0.0013316738],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042883845,0.00013369154,0.002595772,0.079921775,0.0007925742,0.0002439186,0.00022638017,0.00033520424,0.00058195845,0.0033692273,0.3647029,0.5466677],"study_design_scores_gemma":[0.0006283833,0.00011965555,0.0106638735,0.119693056,0.001894558,0.0012672222,0.0002601482,0.0002229622,0.00021934541,0.0027576513,0.8622233,0.00004979307],"about_ca_topic_score_codex":0.010564167,"about_ca_topic_score_gemma":0.01797843,"teacher_disagreement_score":0.010564167,"about_ca_system_score_codex":0.0021695143,"about_ca_system_score_gemma":0.008937385,"threshold_uncertainty_score":0.028351724},"labels":[],"label_agreement":null},{"id":"W2098189184","doi":"10.3324/haematol.2012.062885","title":"Variations in non-pharmacological anti-infective measures in childhood leukemia - results of an international survey","year":2012,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Myeloid leukemia; Childhood leukemia; Leukemia; Acute leukemia; Environmental health; Family medicine; Intensive care medicine; Pediatrics; Internal medicine; Lymphoblastic Leukemia","score_opus":0.04053151650102109,"score_gpt":0.3491545487385964,"score_spread":0.3086230322375753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098189184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98837215,0.0014048435,0.00058981613,0.000371703,0.000022944498,0.00010240694,0.0064625083,0.000027483553,0.0026462455],"genre_scores_gemma":[0.9952141,0.00063208776,0.0003803779,0.00014450893,0.0000118805365,0.000093828436,0.0034263881,0.000009835719,0.00008695713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9896159,0.0049615647,0.002293113,0.0009490436,0.00160084,0.00057942094],"domain_scores_gemma":[0.969898,0.0068345754,0.017929595,0.0017594206,0.0024006024,0.0011778107],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008123502,0.00028053147,0.0004463694,0.0021273447,0.00019908573,0.0008620581,0.0005768228,0.00044298888,0.0011207338],"category_scores_gemma":[0.017865155,0.0002041025,0.0006688744,0.0048736385,0.00047959795,0.00062575715,0.0009773644,0.00051438186,0.00027585158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030445692,0.000011459778,0.99727887,0.000055760367,0.000050328857,0.000008608454,0.00013221022,0.00004999228,0.000034937133,0.000016655553,0.00019087574,0.002139858],"study_design_scores_gemma":[0.0000018120005,0.000024145633,0.9993678,0.000020587666,0.000010736582,0.000037102105,0.0001885984,0.000034310957,0.000030966552,0.000005655025,0.0002760432,0.0000023826453],"about_ca_topic_score_codex":0.0065964865,"about_ca_topic_score_gemma":0.0055113253,"teacher_disagreement_score":0.9918765,"about_ca_system_score_codex":0.0008939314,"about_ca_system_score_gemma":0.0006864353,"threshold_uncertainty_score":0.042961717},"labels":[],"label_agreement":null},{"id":"W2098388627","doi":"10.3324/haematol.10937","title":"Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":350,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Hospital for Sick Children; U.S. Public Health Service; Wellcome Trust","keywords":"Medicine; Pediatrics; Interquartile range; Cohort; Sepsis; Pneumococcal conjugate vaccine; Thalassemia; Confidence interval; Transcranial Doppler; Sickle cell anemia; Streptococcus pneumoniae; Internal medicine; Disease","score_opus":0.009462221804418917,"score_gpt":0.26449165945301717,"score_spread":0.25502943764859826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098388627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992304,0.00015568545,0.000027261634,0.000043840704,0.0000031884526,0.000010083929,0.00035857357,0.0000013115542,0.00016958942],"genre_scores_gemma":[0.99908686,0.00019606364,0.00003924,0.000033011045,0.0000043934665,0.000020431136,0.00045267786,0.0000015476265,0.00016579781],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932265,0.00016045517,0.00012998689,0.00013610837,0.0001182247,0.00013265741],"domain_scores_gemma":[0.9982418,0.00018008852,0.00084630994,0.00010616127,0.00028788054,0.00033779998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063252164,0.00036495226,0.0004704637,0.0007372547,0.00045683663,0.0008776067,0.0005298922,0.00043017557,0.00090592593],"category_scores_gemma":[0.0025133002,0.00034047494,0.00039391377,0.00085395813,0.000461367,0.00076356763,0.0010657558,0.00045713398,0.00023354031],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033121065,0.0000072242774,0.9987029,0.000008067507,0.000016767515,0.0003682894,0.00038450654,0.000025431445,0.00007468454,0.000009502838,0.000065155924,0.0003043901],"study_design_scores_gemma":[0.0000059145177,0.000055422912,0.9982674,0.000016292937,0.000010446632,0.00052206963,0.00087920186,0.00005581835,0.000028710256,0.0000066889047,0.00014779429,0.000004208132],"about_ca_topic_score_codex":0.09841698,"about_ca_topic_score_gemma":0.086166814,"teacher_disagreement_score":0.09841698,"about_ca_system_score_codex":0.0015506601,"about_ca_system_score_gemma":0.00080521195,"threshold_uncertainty_score":0.19568825},"labels":[],"label_agreement":null},{"id":"W2099016852","doi":"10.3324/haematol.2010.038281","title":"Clonal evolution in myelodysplastic syndromes with isolated del(5q): the importance of genetic monitoring","year":2011,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Myelodysplastic syndromes; Macrocytic anemia; Somatic evolution in cancer; Myeloid leukemia; Myeloid; Biology; Cytogenetics; Chromosome; Anemia; Medicine; Immunology; Genetics; Internal medicine; Gene; Bone marrow","score_opus":0.03348741278418695,"score_gpt":0.2733394353099151,"score_spread":0.23985202252572815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099016852","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38352573,0.01727276,0.0053971917,0.52325904,0.007236002,0.00021808861,0.00022458796,0.00037831732,0.06248828],"genre_scores_gemma":[0.8648943,0.008492218,0.0034084085,0.086700626,0.029949732,0.00008170524,0.00013985459,0.00007388785,0.0062593273],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9991903,0.00031913214,0.00010722219,0.00009093877,0.00016107336,0.0001313676],"domain_scores_gemma":[0.9972139,0.0016860793,0.0002817911,0.00014114185,0.00034585048,0.0003313895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008395091,0.0006290106,0.0007301352,0.00081118813,0.001073654,0.00099814,0.0010617544,0.008695697,0.0016081325],"category_scores_gemma":[0.0066442126,0.00044464308,0.0005297392,0.0006723461,0.0013965751,0.0015786911,0.0005008624,0.004209711,0.0013187967],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043555122,0.000110379995,0.046181887,0.00024337467,0.00004447773,0.8380556,0.0005410312,0.00065256684,0.0035628262,0.0020434211,0.066084184,0.042044688],"study_design_scores_gemma":[0.00014233956,0.00020568134,0.018825326,0.00023600337,0.00006121015,0.9362176,0.00048092072,0.0030134395,0.0011370927,0.0040882253,0.035549577,0.00004261713],"about_ca_topic_score_codex":0.0013523954,"about_ca_topic_score_gemma":0.0024681874,"teacher_disagreement_score":0.008695697,"about_ca_system_score_codex":0.0013395306,"about_ca_system_score_gemma":0.0006105947,"threshold_uncertainty_score":0.009718955},"labels":[],"label_agreement":null},{"id":"W2099825600","doi":"10.3324/haematol.2009.017079","title":"PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers","year":2010,"lang":"en","type":"review","venue":"Haematologica","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":368,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Gertrude von Meissner-Stiftung; Karolinska Institutet; VINNOVA; Novartis Foundation; Krebsliga Beider Basel; Stiftelsen för Strategisk Forskning; Knut och Alice Wallenbergs Stiftelse; National Research Foundation; Genome Canada; GlaxoSmithKline; Ontario Innovation Trust; Wellcome Trust","keywords":"PIM1; Kinase; Biology; Cancer research; AKT3; Kinome; Serine; Threonine; Cell biology; Phosphorylation","score_opus":0.06871072317786502,"score_gpt":0.3507607535035781,"score_spread":0.2820500303257131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099825600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024566293,0.99786526,0.00019776504,0.00019530804,0.00012746103,0.000006729685,0.000010174855,0.000009626958,0.0013420125],"genre_scores_gemma":[0.0013958497,0.9970317,0.00037792537,0.00014907983,0.00017932248,0.000009352164,0.000025924923,0.0000013815387,0.0008294591],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998869,0.000022507953,0.000014785366,0.000016217082,0.00004731335,0.000012343272],"domain_scores_gemma":[0.9998915,0.000043311833,0.000016894082,0.00000418234,0.000026205047,0.000017856151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044936384,0.00069326116,0.00090700114,0.0015640461,0.00023043266,0.0005381469,0.00059276616,0.0006607881,0.0020094144],"category_scores_gemma":[0.00029677906,0.00015121918,0.0003003568,0.001494441,0.0003688561,0.000729226,0.00041601458,0.0012789262,0.002042578],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001188155,0.00010760582,0.00017643759,0.0062367427,0.00006497892,0.000335553,0.000043747066,0.00041568055,0.0039807875,0.0028741676,0.017772408,0.96787316],"study_design_scores_gemma":[0.000036644153,0.00014686008,0.0013944631,0.0011560367,0.00009166015,0.0025758692,0.000045758432,0.00013130311,0.0015195302,0.0020468223,0.99083894,0.000016072601],"about_ca_topic_score_codex":0.00053637073,"about_ca_topic_score_gemma":0.0009885097,"teacher_disagreement_score":0.0020094144,"about_ca_system_score_codex":0.0005391609,"about_ca_system_score_gemma":0.00058664125,"threshold_uncertainty_score":0.006722212},"labels":[],"label_agreement":null},{"id":"W2100197564","doi":"10.3324/haematol.2009.007203","title":"Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP","year":2009,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; Deutsche Forschungsgemeinschaft; Michael Smith Health Research BC; Lymphoma Research Foundation","keywords":"CHOP; BCL6; Diffuse large B-cell lymphoma; Lymphoma; Internal medicine; Medicine; Vincristine; Cancer research; Outcome (game theory); Rituximab; Oncology; Gastroenterology; B cell; Chemotherapy; Immunology; Mathematics; Cyclophosphamide; Antibody","score_opus":0.0197562111914154,"score_gpt":0.2564587346492451,"score_spread":0.23670252345782972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100197564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994362,0.00030544004,0.00004135251,0.000020236455,0.0000028350194,0.0000021283915,0.00003962582,0.0000021645496,0.00014982236],"genre_scores_gemma":[0.99977225,0.000054846296,0.00001930259,0.00000854022,0.000006466076,0.0000026884068,0.00010817002,7.964593e-7,0.000026970776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981827,0.00004966215,0.000020179466,0.000035012872,0.000037047746,0.000039902145],"domain_scores_gemma":[0.9990169,0.00028029553,0.00037480582,0.00003241693,0.00008459129,0.00021106064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003114497,0.0001471826,0.00027535626,0.00035361032,0.00020633667,0.00029678727,0.00018583713,0.00031637476,0.00095903483],"category_scores_gemma":[0.0013628919,0.000086898304,0.00020305994,0.00035601412,0.00022163332,0.0002205235,0.00019679322,0.00039552333,0.00014683508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006513531,0.000032099928,0.99618226,0.0000069507414,0.00004596169,0.00017245146,0.000028367585,0.00011432889,0.0008966045,0.0000068253444,0.000054974855,0.001807793],"study_design_scores_gemma":[0.00003476304,0.0004431273,0.9974613,0.00000488162,0.00006221443,0.0011483346,0.00007698907,0.00035817572,0.00021336942,0.00002828391,0.00016482755,0.0000037403634],"about_ca_topic_score_codex":0.00041950028,"about_ca_topic_score_gemma":0.0006502235,"teacher_disagreement_score":0.00095903483,"about_ca_system_score_codex":0.00021468436,"about_ca_system_score_gemma":0.0001358261,"threshold_uncertainty_score":0.0032082796},"labels":[],"label_agreement":null},{"id":"W2100545079","doi":"10.3324/haematol.2014.108191","title":"Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting","year":2014,"lang":"en","type":"letter","venue":"Haematologica","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University College London; University of Alberta","keywords":"AL amyloidosis; Amyloidosis; Autologous stem-cell transplantation; Transplantation; Medicine; Selection (genetic algorithm); Stem cell; Immunoglobulin light chain; Oncology; Surgery; Internal medicine; Immunology; Computer science; Biology","score_opus":0.007206170657029226,"score_gpt":0.21388401350753683,"score_spread":0.2066778428505076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100545079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7688146,0.014051757,0.001884255,0.17904842,0.003005223,0.00007522844,0.0005141671,0.00017756519,0.03242884],"genre_scores_gemma":[0.9558519,0.0023583232,0.0010877252,0.034213815,0.003924793,0.000049124636,0.00044561163,0.000030610438,0.0020380674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943215,0.00023156035,0.00006503527,0.000057453002,0.00010721276,0.0001065108],"domain_scores_gemma":[0.9965738,0.0018309362,0.00040928778,0.00018201084,0.00030087374,0.00070307846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086146774,0.00017196758,0.0005268606,0.0002144945,0.0005763211,0.00090469973,0.00032007362,0.0012553864,0.0015642599],"category_scores_gemma":[0.0068447404,0.00007625096,0.00042398155,0.00044878764,0.00033652983,0.0006027785,0.0004696496,0.0016823194,0.0004666752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006470831,0.0013681756,0.47093976,0.00013140588,0.00024014956,0.022691669,0.00042779002,0.001490067,0.0045046215,0.0029768036,0.117926784,0.3708319],"study_design_scores_gemma":[0.0015900101,0.0048784935,0.7943917,0.0003926005,0.0005445024,0.08647028,0.0008526362,0.0047581745,0.0042588795,0.027087431,0.07463341,0.00014185322],"about_ca_topic_score_codex":0.0003867952,"about_ca_topic_score_gemma":0.0012825002,"teacher_disagreement_score":0.0015642599,"about_ca_system_score_codex":0.0007296855,"about_ca_system_score_gemma":0.00046582657,"threshold_uncertainty_score":0.0052942038},"labels":[],"label_agreement":null},{"id":"W2103945928","doi":"10.3324/haematol.2012.066068","title":"Correlation of clinical response and response duration with miR-145 induction by lenalidomide in CD34+ cells from patients with del(5q) myelodysplastic syndrome","year":2012,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Celgene","keywords":"Lenalidomide; CD34; Myelodysplastic syndromes; Progenitor cell; Haematopoiesis; Medicine; Stem cell; microRNA; Cancer research; Gene knockdown; Immunology; Internal medicine; Bone marrow; Oncology; Biology; Cell culture; Multiple myeloma; Gene; Cell biology","score_opus":0.02584716796054585,"score_gpt":0.3004767009760496,"score_spread":0.27462953301550375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103945928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99882144,0.00053375756,0.000150295,0.000014469197,0.0000027610968,0.000015949212,0.00020929294,0.000007861343,0.0002442343],"genre_scores_gemma":[0.9984505,0.00017323358,0.00032522896,0.00003055979,0.000004935412,0.000026536198,0.0007153703,0.0000028101722,0.00027074924],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981433,0.00003067174,0.00002764183,0.00004961149,0.000051132465,0.00002658352],"domain_scores_gemma":[0.99979717,0.000044446013,0.00006349941,0.00001499679,0.000031015803,0.000048929236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018892891,0.000121161764,0.00034050952,0.00033665742,0.000119753895,0.0003505532,0.00010880858,0.0002046657,0.00087487354],"category_scores_gemma":[0.0003912331,0.000115670024,0.00015226645,0.00023558104,0.00010615328,0.000088417764,0.00013709281,0.00030249314,0.00022775038],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004897569,0.00026870574,0.435672,0.00011683555,0.0001435283,0.0004834347,0.0002592362,0.0005179439,0.53244585,0.00006442643,0.0002498552,0.024880696],"study_design_scores_gemma":[0.00007220575,0.0026198234,0.9338348,0.000009321862,0.000104187806,0.0018966971,0.00014513062,0.0012484819,0.058315475,0.000056001947,0.0016844793,0.0000133120975],"about_ca_topic_score_codex":0.00031130807,"about_ca_topic_score_gemma":0.00063869025,"teacher_disagreement_score":0.00087487354,"about_ca_system_score_codex":0.00019724577,"about_ca_system_score_gemma":0.00008347924,"threshold_uncertainty_score":0.0029267669},"labels":[],"label_agreement":null},{"id":"W2104952531","doi":"10.3324/haematol.2014.120220","title":"Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study","year":2014,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"National Cancer Institute; Institut National Du Cancer","keywords":"Chemoimmunotherapy; Medicine; Vincristine; Dexamethasone; Internal medicine; Blinatumomab; Oncology; Lymphoblastic Leukemia; Refractory (planetary science); Leukemia; Chemotherapy; Chronic lymphocytic leukemia; Cyclophosphamide; Biology","score_opus":0.024572678894894274,"score_gpt":0.3097826535611139,"score_spread":0.2852099746662196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104952531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99083436,0.0045731827,0.00015752034,0.001552991,0.00020446327,0.00035999453,0.00046917025,0.000020921807,0.0018273386],"genre_scores_gemma":[0.9902604,0.003915795,0.00044039843,0.002019009,0.0003135836,0.00039152184,0.00073043327,0.000014767918,0.0019141743],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99961436,0.00017105386,0.000027126021,0.00006378231,0.000037093425,0.00008652853],"domain_scores_gemma":[0.99921155,0.00026267153,0.000100449775,0.00006456563,0.000029921186,0.00033083922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010059999,0.0006088046,0.0016693671,0.00023042892,0.00035859045,0.00087288144,0.0006966724,0.0012272059,0.0023755278],"category_scores_gemma":[0.0011252117,0.00031142385,0.00091880135,0.00043974505,0.0005041994,0.00075799366,0.0002135882,0.002640859,0.00048333942],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.57626927,0.043530036,0.036854554,0.00094526703,0.0022536337,0.003148052,0.00072352454,0.0024175607,0.024498932,0.00062951184,0.008971164,0.29975834],"study_design_scores_gemma":[0.53419894,0.35656157,0.076337196,0.00014460928,0.0015449472,0.0031068479,0.0002909623,0.0013730795,0.003397635,0.00071761676,0.022259003,0.000067585104],"about_ca_topic_score_codex":0.00087203394,"about_ca_topic_score_gemma":0.0029943972,"teacher_disagreement_score":0.0023755278,"about_ca_system_score_codex":0.000923569,"about_ca_system_score_gemma":0.00082867465,"threshold_uncertainty_score":0.0079469085},"labels":[],"label_agreement":null},{"id":"W2105830018","doi":"10.3324/haematol.2011.044933","title":"Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"WSP (Canada)","funders":"St. Antonius Ziekenhuis; Universidad de Navarra; Erasmus Universitair Medisch Centrum Rotterdam; Universiteit van Amsterdam; Medisch Spectrum Twente","keywords":"Acute promyelocytic leukemia; Tandem exon duplication; Anthracycline; Gene duplication; Internal medicine; Oncology; Biology; Medicine; Cancer research; Retinoic acid; Immunology; Cancer; Genetics; Gene","score_opus":0.009622277325783102,"score_gpt":0.223581109928651,"score_spread":0.21395883260286788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105830018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999432,0.000280458,0.000025897798,0.000030667878,0.0000033236201,0.0000028107625,0.00007258059,0.0000016919792,0.00015042862],"genre_scores_gemma":[0.9997482,0.00004568789,0.00003165456,0.000011998296,0.00000795227,0.0000026752498,0.00011465282,6.4443947e-7,0.00003646407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997012,0.00007837604,0.000041298317,0.00006089582,0.00006196071,0.00005619914],"domain_scores_gemma":[0.9986369,0.00035186458,0.0006402002,0.00004069653,0.00006866483,0.00026165615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039133997,0.00015487437,0.00036058007,0.00041763653,0.00024301218,0.0004067134,0.00024624952,0.00049109093,0.00079257647],"category_scores_gemma":[0.0020929938,0.00011415417,0.0002706587,0.00059123454,0.00023158417,0.00030231755,0.00019438192,0.00039559006,0.0001431524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008660074,0.000031565516,0.9958175,0.0000060497573,0.000031056465,0.00026920013,0.000033143628,0.00013148048,0.00071947795,0.000012359395,0.000068943125,0.0020132884],"study_design_scores_gemma":[0.000052492738,0.0003417214,0.9964708,0.000007447858,0.00005317278,0.0018198993,0.00008021946,0.0005113766,0.00037127556,0.000038922888,0.0002469089,0.000005805356],"about_ca_topic_score_codex":0.0010150868,"about_ca_topic_score_gemma":0.0014792427,"teacher_disagreement_score":0.0010150868,"about_ca_system_score_codex":0.00038487592,"about_ca_system_score_gemma":0.00030642824,"threshold_uncertainty_score":0.0027925372},"labels":[],"label_agreement":null},{"id":"W2106429556","doi":"10.3324/haematol.2012.076349","title":"Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study","year":2013,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Princess Margaret Cancer Centre","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; National Heart, Lung, and Blood Institute; Takeda Oncology; Chugai Pharmaceutical; Merck Sharp and Dohme; IC Design Education Center; Astellas Pharma; Eisai; Genentech; CellGenix; Bayer HealthCare; Otsuka America; American Society for Blood and Marrow Transplantation; National Institutes of Health; BioMarin Pharmaceutical; Kiadis Pharma; Therakos; Les Laboratories Pierre Fabre; WellPoint; Teva Pharmaceutical Industries; HistoGenetics; Medical College of Wisconsin; StemCyte; Sanofi; Enzon Pharmaceuticals; Alexion Pharmaceuticals; Health Resources and Services Administration; Viropharma; U.S. Navy; Centers for Disease Control and Prevention; Osiris Therapeutics; Celgene; Pfizer; Biogen; Baxter International; U.S. Public Health Service; U.S. Department of Defense; U.S. Department of Health and Human Services; Astellas Pharma US; National Research Foundation; Otsuka America Pharmaceutical; Amgen; Blue Cross and Blue Shield Association; Be The Match Foundation; National Cancer Institute; Gilead Sciences","keywords":"Transplantation; Medicine; Population; Hematopoietic stem cell transplantation; Leukemia; Myelodysplastic syndromes; Stem cell; Hematopoietic stem cell; Internal medicine; Immunology; Haematopoiesis; Environmental health; Bone marrow; Biology","score_opus":0.18392094977762818,"score_gpt":0.3623463507827868,"score_spread":0.17842540100515863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106429556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997729,0.00046383633,0.00010849771,0.00007416272,0.0000049896194,0.000009888788,0.0012954326,0.000003675888,0.00031059262],"genre_scores_gemma":[0.9987618,0.00021332897,0.00006291257,0.000044386143,0.000004931013,0.000011684297,0.0008556101,0.0000026316548,0.000042737833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899584,0.00036546515,0.00015891693,0.00022397652,0.000110129775,0.00014570316],"domain_scores_gemma":[0.9959478,0.0008973108,0.0021681949,0.00035887142,0.00027976616,0.0003481457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015877843,0.00026616277,0.00038245614,0.0009916627,0.0002560506,0.000717948,0.00036029608,0.0005577432,0.0010389448],"category_scores_gemma":[0.003576523,0.00037027962,0.00073400646,0.0028909196,0.0006557466,0.0010206292,0.00078645244,0.0006375563,0.00022520259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046234312,0.00001546092,0.99895287,0.000022121967,0.00007406487,0.000028954115,0.00016847918,0.00003157459,0.00004026192,0.00002398488,0.00007837438,0.0005176254],"study_design_scores_gemma":[0.0000043328578,0.00005678814,0.9989974,0.000012921383,0.0000323462,0.00011822432,0.00046834696,0.00010080545,0.000015999753,0.0000238601,0.00016387843,0.000005107015],"about_ca_topic_score_codex":0.0066530965,"about_ca_topic_score_gemma":0.0050382763,"teacher_disagreement_score":0.0066530965,"about_ca_system_score_codex":0.0003994811,"about_ca_system_score_gemma":0.00034301585,"threshold_uncertainty_score":0.013228774},"labels":[],"label_agreement":null},{"id":"W2106592889","doi":"10.3324/haematol.11201","title":"Role of mutation independent constitutive activation of FLT3 in juvenile myelomonocytic leukemia","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child, Adolescent and Family Mental Health","funders":"","keywords":"Juvenile myelomonocytic leukemia; Cancer research; Mutation; Myeloid leukemia; Myeloid; Biology; Molecular biology; Gene; Genetics; Haematopoiesis; Stem cell","score_opus":0.02223505742380733,"score_gpt":0.3065633143863526,"score_spread":0.28432825696254527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106592889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957409,0.002645813,0.0004314815,0.00005747449,0.000007898376,0.000006815127,0.00008327584,0.000029829944,0.0009963263],"genre_scores_gemma":[0.9990728,0.00042046784,0.00016798964,0.000012599198,0.000007115968,0.0000021350165,0.00008216462,0.0000054899647,0.00022931765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997522,0.000056405297,0.000027282973,0.000034615347,0.000073057876,0.000056378136],"domain_scores_gemma":[0.99939907,0.00014541556,0.00021414264,0.00007060059,0.000046135443,0.00012467551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031150106,0.00013928142,0.000183962,0.00036758414,0.00023973006,0.00041541873,0.00012862585,0.00020443671,0.00081191043],"category_scores_gemma":[0.0006036507,0.0000972342,0.00011527495,0.00021274532,0.00040803652,0.0001697008,0.00020701082,0.00025112214,0.00018801136],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063962076,0.000068140806,0.052662052,0.00014670934,0.000016328933,0.006160854,0.00018307651,0.00014799275,0.9199181,0.0010750741,0.00029434622,0.018687593],"study_design_scores_gemma":[0.0001449591,0.0013254044,0.61359894,0.000051890544,0.00014195497,0.05312287,0.00043087936,0.0019611104,0.31181484,0.0009690016,0.01640058,0.000037590547],"about_ca_topic_score_codex":0.001334713,"about_ca_topic_score_gemma":0.0017378994,"teacher_disagreement_score":0.001334713,"about_ca_system_score_codex":0.0004403279,"about_ca_system_score_gemma":0.0003485438,"threshold_uncertainty_score":0.003194809},"labels":[],"label_agreement":null},{"id":"W2107091218","doi":"10.3324/haematol.2010.030171","title":"Dynamic chromosomal rearrangements in Hodgkin's lymphoma are due to ongoing three-dimensional nuclear remodeling and breakage-bridge-fusion cycles","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; University of Manitoba; University of Toronto; CancerCare Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Breakage; Fusion; Lymphoma; Bridge (graph theory); Cancer research; Medicine; Biology; Pathology; Internal medicine; Computer science; Philosophy","score_opus":0.007803453761874171,"score_gpt":0.2271145058532765,"score_spread":0.21931105209140234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107091218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968256,0.0005248004,0.0021520096,0.00001299397,0.000002024238,0.0000071705267,0.000046171335,0.00005591289,0.00037334496],"genre_scores_gemma":[0.9988555,0.00020002757,0.0006876046,0.000007562046,0.0000031490845,0.000010127032,0.00009543404,0.0000050370245,0.00013567379],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999057,0.000013329009,0.000006645233,0.000020155147,0.00003588934,0.000018233648],"domain_scores_gemma":[0.9998293,0.000048321468,0.00006276624,0.000020858339,0.000017990891,0.000020660362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011477129,0.00014513655,0.00009765066,0.00034974288,0.0001451796,0.0003889789,0.0001384063,0.00020529737,0.00065545825],"category_scores_gemma":[0.00039394645,0.00018613682,0.0001018622,0.00023230577,0.0002482109,0.00028326182,0.0002729599,0.00017502681,0.00014623064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020637226,0.000021760108,0.017011195,0.00007051102,0.000022473234,0.0005328538,0.0001446733,0.0008743103,0.9727591,0.00044889242,0.00007108906,0.007836602],"study_design_scores_gemma":[0.000045214038,0.00038018145,0.3359691,0.000021651438,0.000069147165,0.009470521,0.00028896486,0.009484607,0.63746583,0.0016687098,0.005100552,0.000035488465],"about_ca_topic_score_codex":0.00034288442,"about_ca_topic_score_gemma":0.00040578665,"teacher_disagreement_score":0.00065545825,"about_ca_system_score_codex":0.0003193695,"about_ca_system_score_gemma":0.000088125176,"threshold_uncertainty_score":0.0023172498},"labels":[],"label_agreement":null},{"id":"W2107224115","doi":"10.3324/haematol.2014.109884","title":"Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Centre hospitalier de l'Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Transplantation; Hazard ratio; Biology; Internal medicine; Medicine","score_opus":0.017828787608152145,"score_gpt":0.28316256882311425,"score_spread":0.2653337812149621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107224115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990103,0.0003958886,0.0001507606,0.000038295293,0.0000047031276,0.0000020935347,0.00011706843,0.0000037505758,0.0002770863],"genre_scores_gemma":[0.999713,0.00005750051,0.00004725237,0.000008696193,0.000010289501,0.0000013574222,0.00007299338,0.000001182376,0.000087700384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997342,0.00011604353,0.000020682604,0.000055444987,0.000033660817,0.000039953007],"domain_scores_gemma":[0.9987986,0.0003790742,0.00047619885,0.00007855757,0.00004984364,0.00021776477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027709972,0.00019308849,0.00017850331,0.00032173793,0.00016198988,0.00031079684,0.00012669788,0.0002921163,0.0018078362],"category_scores_gemma":[0.0012303079,0.000079354475,0.00030728162,0.0003850635,0.00017112518,0.00014030101,0.00016867285,0.0003915148,0.00014461491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003755733,0.000017697532,0.99622107,0.0000056203576,0.00010832072,0.000103625556,0.0000098091095,0.00008733456,0.0012209009,0.000020785423,0.000028203223,0.0018010393],"study_design_scores_gemma":[0.000007982493,0.000121426725,0.99862444,0.0000018667952,0.000060939914,0.00040698604,0.00001947038,0.0003795968,0.00023211092,0.000035869652,0.00010720287,0.0000019147242],"about_ca_topic_score_codex":0.00075851206,"about_ca_topic_score_gemma":0.00084421557,"teacher_disagreement_score":0.0018078362,"about_ca_system_score_codex":0.00008995838,"about_ca_system_score_gemma":0.00016385468,"threshold_uncertainty_score":0.006047845},"labels":[],"label_agreement":null},{"id":"W2108495564","doi":"10.3324/haematol.2010.030296","title":"Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":201,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Universität Heidelberg; Deutsche Forschungsgemeinschaft; Stem Cell Network","keywords":"Multiple myeloma; Beta-2 microglobulin; Internal medicine; Oncology; Cancer research; Medicine; Chemotherapy; Proliferation index; Hematology; Bone marrow; Biology; Immunohistochemistry","score_opus":0.040330963112175724,"score_gpt":0.3031161525604666,"score_spread":0.2627851894482909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108495564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901494,0.00735513,0.0010963423,0.00027109022,0.000022147937,0.00001921939,0.00029222804,0.00003996606,0.00075447833],"genre_scores_gemma":[0.9981323,0.0008939569,0.00049518346,0.000045937966,0.000057300087,0.0000112661855,0.00022752646,0.0000042287857,0.0001323712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982125,0.0000475581,0.000010643481,0.000040828694,0.000055114822,0.000024770823],"domain_scores_gemma":[0.9996269,0.00009329727,0.00018186533,0.000022258404,0.000035806454,0.000039898652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048185315,0.00023188311,0.00042771033,0.00040874854,0.00020556142,0.0004144291,0.00020076301,0.0001901468,0.0008557865],"category_scores_gemma":[0.0008441677,0.00010154604,0.00014845196,0.00048257227,0.0002448026,0.00018189441,0.0002595299,0.0003587426,0.00016533339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022225475,0.00016908837,0.83249784,0.00022916614,0.0001380296,0.0002588492,0.00008171567,0.0014952789,0.054119032,0.00021601545,0.0010125797,0.10755995],"study_design_scores_gemma":[0.00003959437,0.0009877108,0.97740173,0.00003053704,0.00013504512,0.0014410117,0.000085286825,0.0030660143,0.013411675,0.00057016494,0.00281904,0.000012124158],"about_ca_topic_score_codex":0.00028733694,"about_ca_topic_score_gemma":0.00038736255,"teacher_disagreement_score":0.0008557865,"about_ca_system_score_codex":0.00034702558,"about_ca_system_score_gemma":0.0002904127,"threshold_uncertainty_score":0.0028628707},"labels":[],"label_agreement":null},{"id":"W2108880951","doi":"10.3324/haematol.2013.098103","title":"p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"Celgene","keywords":"Myelodysplastic syndromes; Oncology; Internal medicine; Medicine; Outcome (game theory); Protein expression; Biology; Genetics; Gene; Bone marrow","score_opus":0.01351225560887367,"score_gpt":0.24831775188288377,"score_spread":0.2348054962740101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108880951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99966586,0.00013856684,0.000033756947,0.000015677702,0.000001708983,0.0000024489136,0.000029072127,0.0000017886842,0.00011124447],"genre_scores_gemma":[0.99978083,0.000040757644,0.000023517352,0.00000842063,0.0000047685535,0.0000018704046,0.00009053359,3.766009e-7,0.000049017268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998299,0.00004795744,0.000021094844,0.000033555574,0.000034479028,0.00003301531],"domain_scores_gemma":[0.9995048,0.00010788428,0.00020977797,0.000027237516,0.00003647467,0.00011378476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046402393,0.00023796585,0.00023343592,0.00037860108,0.00017511511,0.0003630432,0.00016183766,0.00026955598,0.00056203455],"category_scores_gemma":[0.0009907933,0.00013082055,0.0002120703,0.0002547476,0.00024381913,0.0001769205,0.00032669856,0.00036339535,0.00016518164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006049342,0.000040827545,0.9949024,0.0000065570302,0.00003747211,0.00006561894,0.000023472694,0.00010349964,0.0016802496,0.000009568241,0.000049474605,0.0024759572],"study_design_scores_gemma":[0.000028335306,0.00032422444,0.99819285,0.0000034082802,0.0000455143,0.0003127098,0.000036311503,0.0005004091,0.00038518052,0.000028960545,0.00013975153,0.0000023438422],"about_ca_topic_score_codex":0.0005003898,"about_ca_topic_score_gemma":0.0008986784,"teacher_disagreement_score":0.00056203455,"about_ca_system_score_codex":0.00016191036,"about_ca_system_score_gemma":0.00013811639,"threshold_uncertainty_score":0.0024540424},"labels":[],"label_agreement":null},{"id":"W2109183702","doi":"10.3324/haematol.2008.002691","title":"CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UK","year":2009,"lang":"en","type":"article","venue":"Haematologica","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"National Institute for Health and Care Research","keywords":"Immunosuppression; Medicine; Lymphoma; Incidence (geometry); Systemic therapy; Internal medicine; Hodgkin lymphoma; Non-Hodgkin's lymphoma; Antiretroviral therapy; Immunology; Human immunodeficiency virus (HIV); Oncology; Cancer; Viral load; Breast cancer","score_opus":0.008002461004428946,"score_gpt":0.23790424278778194,"score_spread":0.229901781783353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109183702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968459,0.0021289662,0.00003182991,0.00024724504,0.000016970935,0.0000053424387,0.0001431963,0.0000027726728,0.0005777532],"genre_scores_gemma":[0.99905485,0.0006203691,0.000024066861,0.000054533215,0.000013486968,0.0000024217034,0.00008245271,7.350209e-7,0.00014723225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996619,0.00011554693,0.00005205725,0.00003756892,0.0000629736,0.00006994662],"domain_scores_gemma":[0.9988569,0.00021707288,0.00054057915,0.000033155375,0.0001375637,0.00021470191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026872125,0.0001363189,0.00022306622,0.0006218303,0.0002578837,0.0005395529,0.00017863578,0.00040184634,0.0013991859],"category_scores_gemma":[0.0028699983,0.00019535051,0.00017210258,0.00099665,0.00023133545,0.0002993314,0.0004023895,0.00045765587,0.00015540308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013359226,0.000010832945,0.99567395,0.000018550692,0.00002355362,0.0003433728,0.00008865508,0.000038741695,0.00010955275,0.000020692938,0.0002606344,0.0032777959],"study_design_scores_gemma":[0.000014572393,0.000063824475,0.99845576,0.000036278903,0.00001993545,0.00073063787,0.00017975953,0.00012518578,0.000033911827,0.000022918663,0.00031307837,0.000004232961],"about_ca_topic_score_codex":0.0319363,"about_ca_topic_score_gemma":0.025794951,"teacher_disagreement_score":0.0319363,"about_ca_system_score_codex":0.00055326434,"about_ca_system_score_gemma":0.00028169868,"threshold_uncertainty_score":0.06350082},"labels":[],"label_agreement":null},{"id":"W2110734772","doi":"10.3324/haematol.2010.029389","title":"Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"Bundesministerium für Bildung und Forschung; European Commission","keywords":"Hemophagocytic lymphohistiocytosis; Immunology; CD8; Cytotoxic T cell; Natural killer cell; Degranulation; Biology; Medicine; Disease; Immune system; Pathology; Internal medicine; Genetics; In vitro","score_opus":0.010981373341857016,"score_gpt":0.2641260837821603,"score_spread":0.2531447104403033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110734772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992556,0.0001367409,0.00018843987,0.000008701521,0.0000021519338,0.0000048447055,0.000032090684,0.0000058648507,0.00036558876],"genre_scores_gemma":[0.9997249,0.000032039414,0.00012345823,0.000008096485,0.000005693791,0.0000025943377,0.00006200273,0.0000015501724,0.00003958574],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99975854,0.00003676089,0.00004000889,0.00007589674,0.0000346515,0.000054051656],"domain_scores_gemma":[0.9994123,0.00016052098,0.0002236685,0.000035415156,0.000037170237,0.00013097319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019328907,0.0005406064,0.0002875611,0.0005490397,0.00038232672,0.00027776626,0.00017521465,0.00042710223,0.0020642271],"category_scores_gemma":[0.00091076567,0.00017295753,0.00022980713,0.00049504475,0.00039919806,0.00019233805,0.0003476549,0.00019244206,0.00019646963],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061624724,0.00007094038,0.87393093,0.00011439118,0.000103560575,0.08759597,0.00036534033,0.00026570406,0.02981754,0.00016243108,0.0003164339,0.0066405023],"study_design_scores_gemma":[0.000055456854,0.00018503926,0.6403447,0.000028549275,0.00007966664,0.35350782,0.00018047189,0.00045491642,0.00412983,0.00018358754,0.00084093516,0.000009071422],"about_ca_topic_score_codex":0.00049058447,"about_ca_topic_score_gemma":0.0007659639,"teacher_disagreement_score":0.0020642271,"about_ca_system_score_codex":0.00022068716,"about_ca_system_score_gemma":0.00013429267,"threshold_uncertainty_score":0.0069055557},"labels":[],"label_agreement":null},{"id":"W2110993734","doi":"10.3324/haematol.2009.010306","title":"Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia","year":2009,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; Australian Government","keywords":"CD20; Medicine; Cumulative incidence; Internal medicine; White blood cell; Rituximab; Lymphoblastic Leukemia; Oncology; Philadelphia chromosome; Incidence (geometry); Acute lymphocytic leukemia; Immunology; Leukemia; Gastroenterology; Lymphoma; Biology; Gene; Cohort","score_opus":0.012023147265197131,"score_gpt":0.2584060356743247,"score_spread":0.24638288840912756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110993734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962909,0.0027397815,0.00004524068,0.0001506621,0.000009199375,0.000005104796,0.00014616104,0.0000030930105,0.0006098261],"genre_scores_gemma":[0.99930537,0.00031832536,0.000049311868,0.00006202792,0.00002715814,0.0000044612466,0.00017441642,0.000001260507,0.0000576291],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995036,0.00022529656,0.000050640967,0.0000613726,0.00009182128,0.00006722755],"domain_scores_gemma":[0.9982849,0.0005623023,0.0006839604,0.000049472525,0.00012501536,0.00029438728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005707858,0.00015484293,0.0003318957,0.00028047932,0.00016616216,0.0004102292,0.00016030551,0.0004021253,0.00069480453],"category_scores_gemma":[0.0026360457,0.00011161093,0.0001515463,0.0005472095,0.0002747733,0.00032873623,0.00021409524,0.0005582753,0.00013355391],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025593527,0.00004378463,0.9831403,0.000037644953,0.000053561802,0.00037208205,0.00004238033,0.00012233171,0.0009563881,0.00004915248,0.00037377584,0.012249288],"study_design_scores_gemma":[0.00010426566,0.00075508043,0.99534,0.000019371284,0.00010473315,0.0018675601,0.00006959322,0.00039812207,0.00046930983,0.00011636013,0.0007492112,0.0000063038033],"about_ca_topic_score_codex":0.0006707665,"about_ca_topic_score_gemma":0.0013014799,"teacher_disagreement_score":0.00069480453,"about_ca_system_score_codex":0.00025220378,"about_ca_system_score_gemma":0.00017565445,"threshold_uncertainty_score":0.0030186772},"labels":[],"label_agreement":null},{"id":"W2111099034","doi":"10.3324/haematol.2010.026682","title":"Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Health Resources and Services Administration; U.S. Department of Health and Human Services","keywords":"Medicine; Transplantation; Sibling; Aplastic anemia; Internal medicine; Proportional hazards model; Pediatrics; Surgery; Bone marrow","score_opus":0.03377049944666958,"score_gpt":0.32443012832120066,"score_spread":0.29065962887453106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111099034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99912935,0.00050931243,0.000080249985,0.000039164013,0.00000664115,0.000001964716,0.000064182655,0.000002153727,0.00016685066],"genre_scores_gemma":[0.9997912,0.00007520522,0.00002066336,0.000008496723,0.0000085311995,0.000001179629,0.00006594528,0.0000010019787,0.000027637607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851245,0.00075373275,0.00010612861,0.00016378684,0.00022944424,0.00023430458],"domain_scores_gemma":[0.98995566,0.004567289,0.0036991087,0.00034480504,0.00034641562,0.001086834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031258008,0.0002759642,0.00031267962,0.00059876865,0.00024576494,0.00053737493,0.00027358992,0.0003410451,0.0012709129],"category_scores_gemma":[0.008834611,0.00010933037,0.00072896713,0.0005501167,0.00035957445,0.00049938506,0.0004977263,0.0005851095,0.00014296784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033517295,0.000016767695,0.9976617,0.000006076228,0.00009158209,0.000083232946,0.000027838045,0.00011742037,0.00006790852,0.000019854315,0.00003976546,0.00153275],"study_design_scores_gemma":[0.000012077816,0.00030918102,0.9983596,0.000009122434,0.00010720797,0.0004051958,0.00006371015,0.0004874349,0.00008627631,0.00006764417,0.00008771498,0.0000048563224],"about_ca_topic_score_codex":0.0010284705,"about_ca_topic_score_gemma":0.0013170249,"teacher_disagreement_score":0.0031258008,"about_ca_system_score_codex":0.000304312,"about_ca_system_score_gemma":0.00031402515,"threshold_uncertainty_score":0.01653099},"labels":[],"label_agreement":null},{"id":"W2111181123","doi":"10.3324/haematol.13359","title":"Enhanced alternative splicing of the FLVCR1 gene in Diamond Blackfan anemia disrupts FLVCR1 expression and function that are critical for erythropoiesis","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre; University Health Network; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Diamond–Blackfan anemia; Erythropoiesis; Biology; Ineffective erythropoiesis; Alternative splicing; Haematopoiesis; Cell biology; Myeloid; Myelopoiesis; Anemia; Cancer research; Stem cell; Genetics; Gene; RNA; Gene isoform; Internal medicine; Medicine","score_opus":0.02931776947713871,"score_gpt":0.2814989816257482,"score_spread":0.2521812121486095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111181123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945919,0.0005294657,0.0036909943,0.00007589118,0.00002562169,0.000051623938,0.0003671319,0.00009537523,0.00057197124],"genre_scores_gemma":[0.99391794,0.00025927834,0.0039976803,0.000052796942,0.000009438027,0.000050667564,0.0005234527,0.000030665768,0.0011580548],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998154,0.00003306613,0.000024521372,0.000048132228,0.000053633765,0.0000252264],"domain_scores_gemma":[0.99984825,0.00004152355,0.000056844907,0.000018485736,0.0000071670042,0.000027689654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019723429,0.0004585008,0.00021413037,0.0002939011,0.00014229136,0.0002076048,0.00034638087,0.0005275601,0.001444932],"category_scores_gemma":[0.0001293831,0.00015284716,0.00025783575,0.00012546881,0.00033950838,0.00009052056,0.00023341164,0.00047703218,0.00041114105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038075734,0.000020499612,0.00022029979,0.000018380431,0.000004243231,0.00016751677,0.000011650357,0.00011444828,0.99857295,0.0001118758,0.000025741176,0.0006942341],"study_design_scores_gemma":[0.000049021197,0.00028336587,0.0058700102,0.0000104480205,0.000029907585,0.0024086463,0.000026830829,0.0020561584,0.9860319,0.00006699872,0.003156138,0.000010653225],"about_ca_topic_score_codex":0.0005405144,"about_ca_topic_score_gemma":0.0008548855,"teacher_disagreement_score":0.001444932,"about_ca_system_score_codex":0.00034784107,"about_ca_system_score_gemma":0.00019768972,"threshold_uncertainty_score":0.0048338175},"labels":[],"label_agreement":null},{"id":"W2111606093","doi":"10.3324/haematol.2013.085175","title":"Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features","year":2013,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children; Leukaemia and Lymphoma Research; Kay Kendall Leukaemia Fund","keywords":"CDKN2A; Cytogenetics; Leukemia; Biology; Multiplex ligation-dependent probe amplification; Acute lymphocytic leukemia; Copy-number variation; CDKN2B; Karyotype; Chromosomal translocation; Immunophenotyping; Cancer research; Oncology; Immunology; Genetics; Gene; Chromosome; Medicine; Lymphoblastic Leukemia; Flow cytometry","score_opus":0.012997858226794204,"score_gpt":0.2749340297644282,"score_spread":0.261936171537634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111606093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99905807,0.0004384036,0.00012340437,0.000012912302,0.0000015762147,0.0000048872016,0.00015238885,0.0000052259493,0.00020312381],"genre_scores_gemma":[0.9992888,0.00021364316,0.0001672766,0.0000073979104,0.0000041174235,0.000006446673,0.00023143309,0.0000022383972,0.00007868132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975425,0.000046764133,0.000028761739,0.00006412317,0.00006324708,0.00004290721],"domain_scores_gemma":[0.99940896,0.0001609891,0.00023529431,0.000050310875,0.00005073396,0.00009372169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017980086,0.00022414351,0.00026066392,0.001154599,0.00019354082,0.0003274332,0.000220789,0.0002225602,0.00087748584],"category_scores_gemma":[0.0011408308,0.00013705164,0.00012033529,0.0010298186,0.00031621373,0.00018988264,0.00025986193,0.0002363419,0.00015381094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019516895,0.00002223529,0.979054,0.00003307246,0.00003328265,0.0012409274,0.00009841594,0.00011823334,0.01243469,0.00004694255,0.000095220945,0.00662782],"study_design_scores_gemma":[0.0000036051767,0.000043002423,0.99231124,0.0000031946709,0.00001860174,0.006244912,0.00006840546,0.0000927936,0.00085209345,0.000036475187,0.00032298238,0.000002773136],"about_ca_topic_score_codex":0.0014133259,"about_ca_topic_score_gemma":0.0017087532,"teacher_disagreement_score":0.0014133259,"about_ca_system_score_codex":0.00015542131,"about_ca_system_score_gemma":0.00019732627,"threshold_uncertainty_score":0.0029355288},"labels":[],"label_agreement":null},{"id":"W2112000215","doi":"10.3324/haematol.2013.087650","title":"Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies","year":2013,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Placebo; Adverse effect; Myelofibrosis; Quality of life (healthcare); Internal medicine; Surgery; Pathology; Bone marrow; Alternative medicine","score_opus":0.18569937186375002,"score_gpt":0.4288866127252391,"score_spread":0.24318724086148907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112000215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96813446,0.02580029,0.0008143234,0.0004158796,0.00041275282,0.0015759815,0.0006334604,0.000054260818,0.002158686],"genre_scores_gemma":[0.9911432,0.004924689,0.0008526129,0.00033928864,0.00027245455,0.0014297212,0.00039755047,0.000009535843,0.00063091103],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99807465,0.0013696309,0.00018335493,0.000118386895,0.00014260018,0.00011131118],"domain_scores_gemma":[0.9976661,0.0012038877,0.00057924935,0.00010156156,0.00011912733,0.000330148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002403339,0.00054445217,0.0025368012,0.00054401514,0.00023552826,0.00075728213,0.000535139,0.0011956539,0.0041640606],"category_scores_gemma":[0.0026548353,0.0003593279,0.002035496,0.00039439302,0.00053145114,0.00067888113,0.00032444112,0.0011040958,0.00021002782],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9690428,0.003341831,0.00070892,0.0013796212,0.0018632323,0.00005577532,0.00006138867,0.0002771675,0.003967225,0.00016271336,0.00034262863,0.018796748],"study_design_scores_gemma":[0.6171094,0.36382467,0.010378232,0.00032497488,0.002712602,0.00010481436,0.000112773305,0.0006918646,0.0020322101,0.0003879832,0.002281757,0.000038745053],"about_ca_topic_score_codex":0.00016937184,"about_ca_topic_score_gemma":0.00069292955,"teacher_disagreement_score":0.0041640606,"about_ca_system_score_codex":0.00033238842,"about_ca_system_score_gemma":0.0006123372,"threshold_uncertainty_score":0.0139302015},"labels":[],"label_agreement":null},{"id":"W2112114252","doi":"10.3324/haematol.10625","title":"IL-7 mediated protection against minor antigen-mismatched allograft rejection is associated with enhanced recovery of regulatory T cells","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"FOXP3; IL-2 receptor; Bone marrow; Immunology; Transplantation; T cell; Medicine; Antigen; Immune system; Interleukin-7 receptor; Regulatory T cell; Internal medicine","score_opus":0.018650206912109692,"score_gpt":0.24035733135030435,"score_spread":0.22170712443819465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112114252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99475795,0.0023259472,0.0018221685,0.00008874381,0.000054170607,0.000035829897,0.00010344909,0.00007507959,0.00073667563],"genre_scores_gemma":[0.9968836,0.00089938217,0.001047357,0.000054676766,0.00006134344,0.000037330115,0.00019333235,0.000014399263,0.0008085868],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998016,0.000036464768,0.00002402988,0.000030543386,0.000053968375,0.000053324417],"domain_scores_gemma":[0.99976426,0.000038753027,0.00009515391,0.000024721081,0.000022486292,0.000054678367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020973786,0.00051621004,0.00037953706,0.00023771143,0.00008043917,0.00022705829,0.00019339417,0.00023552959,0.0015705468],"category_scores_gemma":[0.00016061548,0.00008503131,0.00027895177,0.00006911135,0.00029092317,0.00015721544,0.00014982054,0.00070756546,0.0003269812],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056167255,0.00012849158,0.00048473076,0.000083438295,0.0000068768613,0.000047001857,0.000009580896,0.00004602015,0.9951652,0.00002687608,0.000026931011,0.0034130884],"study_design_scores_gemma":[0.0001149355,0.0047529233,0.011078314,0.000026496014,0.000058266203,0.0006102645,0.000032021893,0.0004236441,0.9817821,0.000051201154,0.0010657172,0.0000041752255],"about_ca_topic_score_codex":0.000051150615,"about_ca_topic_score_gemma":0.00008518299,"teacher_disagreement_score":0.0015705468,"about_ca_system_score_codex":0.0000661583,"about_ca_system_score_gemma":0.00015117796,"threshold_uncertainty_score":0.00525403},"labels":[],"label_agreement":null},{"id":"W2112325849","doi":"10.3324/haematol.2011.041277","title":"Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Central nervous system; Lymphoma; Diffuse large B-cell lymphoma; Oncology; Internal medicine; Pathology","score_opus":0.021197024169364427,"score_gpt":0.2162208885891669,"score_spread":0.1950238644198025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112325849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994814,0.00028933387,0.000018214008,0.000022630009,0.0000013702689,0.0000017121992,0.000051334588,0.0000013198096,0.00013261396],"genre_scores_gemma":[0.99979705,0.00006914712,0.000011484003,0.000008476223,0.0000056921494,0.0000011640929,0.00008309645,3.8159254e-7,0.000023492874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997985,0.000053682288,0.000017568564,0.00004062599,0.000037601687,0.0000521125],"domain_scores_gemma":[0.9989416,0.00019575079,0.00042441345,0.000037388814,0.00009496615,0.000305919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037893362,0.00015976928,0.00024958543,0.0004194363,0.00024763463,0.0004281115,0.000218142,0.00029448312,0.0008535339],"category_scores_gemma":[0.0011900907,0.00010551144,0.0001789783,0.00049989705,0.00025275553,0.0002463991,0.00027519252,0.0003438331,0.00012946677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012416295,0.000012193939,0.99835145,0.0000044547824,0.000020458316,0.00030133745,0.000017873252,0.0000405489,0.00011107236,0.0000042396937,0.00005704144,0.00095529685],"study_design_scores_gemma":[0.000016025397,0.000080690996,0.99679923,0.00000739871,0.00002572895,0.0026589334,0.000062135725,0.00018162072,0.00004564366,0.000016842638,0.000102663864,0.0000029685223],"about_ca_topic_score_codex":0.002289677,"about_ca_topic_score_gemma":0.0031374237,"teacher_disagreement_score":0.002289677,"about_ca_system_score_codex":0.00031587237,"about_ca_system_score_gemma":0.00024372477,"threshold_uncertainty_score":0.0045526624},"labels":[],"label_agreement":null},{"id":"W2112843683","doi":"10.3324/haematol.2008.005348","title":"Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review","year":2009,"lang":"en","type":"review","venue":"Haematologica","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital; McMaster University","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Thrombocytopenic purpura; Internal medicine; Helicobacter pylori; Odds ratio; Adverse effect; Immune system; Hematology; Immunology; Gastroenterology; Randomized controlled trial; Platelet","score_opus":0.0305027893274073,"score_gpt":0.3056950531228374,"score_spread":0.2751922637954301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112843683","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025985343,0.99652594,0.000060243914,0.00013542967,0.00007752606,0.00017120586,0.00024106646,0.0000066226958,0.00018339073],"genre_scores_gemma":[0.0349914,0.9632029,0.0004346514,0.0004926356,0.000110763125,0.00042331882,0.00023355045,0.000005564866,0.000105247746],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99516726,0.0016921221,0.0019349887,0.0003659111,0.0007217331,0.00011789365],"domain_scores_gemma":[0.9793992,0.01413414,0.004442703,0.00021643646,0.001547341,0.00026020274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046188273,0.0010302843,0.009764991,0.0067151925,0.00048245522,0.0018701695,0.0015552324,0.001599631,0.003267044],"category_scores_gemma":[0.022531131,0.0008713881,0.0068523623,0.0079925945,0.0007740684,0.0013714358,0.00094856217,0.0008506622,0.00018650776],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005345271,0.000024747984,0.0011125066,0.95885926,0.015299615,0.00010560857,0.00012934719,0.000067745714,0.00012641681,0.00007481052,0.00083582784,0.022829544],"study_design_scores_gemma":[0.0014806938,0.00076827814,0.012930214,0.7452931,0.2254018,0.0007698558,0.00037256352,0.00016485433,0.0002972126,0.0002366892,0.012222319,0.00006242258],"about_ca_topic_score_codex":0.0066277003,"about_ca_topic_score_gemma":0.01585065,"teacher_disagreement_score":0.009764991,"about_ca_system_score_codex":0.0025848178,"about_ca_system_score_gemma":0.0054087695,"threshold_uncertainty_score":0.024426937},"labels":[],"label_agreement":null},{"id":"W2114908650","doi":"10.3324/haematol.2011.054254","title":"Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model","year":2012,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute; CRIS Cancer Foundation; University of Toronto; Ontario Institute for Cancer Research; University Health Network","keywords":"Clonogenic assay; Cytotoxicity; Cancer research; Multiple myeloma; Lymphokine-activated killer cell; Bone marrow; Biology; Natural killer cell; Immunology; Progenitor cell; Cell culture; Stem cell; Interleukin 21; T cell; In vitro; Cell biology; Immune system","score_opus":0.03143935893418044,"score_gpt":0.2802471565983891,"score_spread":0.24880779766420869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114908650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9584369,0.003205289,0.032827437,0.00030814245,0.00010157652,0.00033955043,0.0011106984,0.00086452847,0.0028058416],"genre_scores_gemma":[0.9661841,0.0022850235,0.020691747,0.00011633437,0.000028303079,0.00046490764,0.0017919582,0.00014280634,0.008294889],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994493,0.000071049195,0.000051536113,0.00013573944,0.00020655418,0.00008574984],"domain_scores_gemma":[0.99964356,0.00006468799,0.00011518538,0.00005931554,0.000051675925,0.00006543104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050515,0.0010233271,0.0007917077,0.0005838989,0.00017875845,0.00041385763,0.0005407288,0.0005302876,0.0027366818],"category_scores_gemma":[0.00014979669,0.0002239459,0.00043833753,0.00031414762,0.0003486257,0.0004376199,0.00028609397,0.0016966786,0.0008591728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011108793,0.00015936591,0.00019192936,0.00005143666,0.000007908902,0.000032437478,0.00001697112,0.00008562216,0.9979716,0.000087261884,0.00008265422,0.0012017678],"study_design_scores_gemma":[0.000026168329,0.0007328092,0.0009305701,0.0000050717235,0.000016952064,0.00019618294,0.000010607582,0.00061449996,0.9962457,0.00001914713,0.0011989655,0.000003343689],"about_ca_topic_score_codex":0.00065873447,"about_ca_topic_score_gemma":0.0010109248,"teacher_disagreement_score":0.0027366818,"about_ca_system_score_codex":0.000560041,"about_ca_system_score_gemma":0.00037867457,"threshold_uncertainty_score":0.009155154},"labels":[],"label_agreement":null},{"id":"W2115551074","doi":"10.3324/haematol.2010.023929","title":"Fertility recovery and pregnancy after allogeneic hematopoietic stem cell transplantation in Fanconi anemia patients","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Fanconi anemia; Savior sibling; Medicine; Transplantation; Hematopoietic stem cell transplantation; Stem cell; Anemia; Pregnancy; Internal medicine; Biology","score_opus":0.01211538388308938,"score_gpt":0.2371111986478861,"score_spread":0.22499581476479671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115551074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991379,0.00051172846,0.00004061553,0.000028529214,0.0000027697026,0.0000019278489,0.00002659527,0.0000029120338,0.0002470855],"genre_scores_gemma":[0.99975926,0.00011381915,0.000019369425,0.000014895932,0.0000076183496,0.0000012487718,0.00003714235,7.700375e-7,0.00004585274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997446,0.000084882326,0.000024500934,0.000037848902,0.000049166614,0.00005887522],"domain_scores_gemma":[0.99894077,0.00037825815,0.00044077844,0.000048637514,0.000036616137,0.0001550328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052478764,0.00012283694,0.00021648666,0.00070447614,0.00043186528,0.00036099192,0.0001745252,0.0003259528,0.0009507037],"category_scores_gemma":[0.0028319762,0.00013789347,0.00020856527,0.0005586357,0.000446101,0.00028644167,0.0001730933,0.00035069627,0.0001271201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029574102,0.000032668133,0.9890113,0.000010227725,0.000023430304,0.003431963,0.00017324147,0.00008318076,0.0005864966,0.00007210411,0.00013453771,0.0061450754],"study_design_scores_gemma":[0.00002169513,0.00054530345,0.95874715,0.000014068945,0.00004381417,0.03857467,0.00034062684,0.0002965261,0.00067860744,0.00013089004,0.0005969129,0.000009714254],"about_ca_topic_score_codex":0.0005776916,"about_ca_topic_score_gemma":0.00047544175,"teacher_disagreement_score":0.0009507037,"about_ca_system_score_codex":0.00020476329,"about_ca_system_score_gemma":0.00018394095,"threshold_uncertainty_score":0.0031803846},"labels":[],"label_agreement":null},{"id":"W2117793275","doi":"10.3324/haematol.13422","title":"STAT6-mediated suppression of erythropoiesis in an experimental model of malarial anemia","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Malaria Research and Control","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Reticulocytosis; Parasitemia; Plasmodium chabaudi; STAT6; Erythropoiesis; Biology; Cytokine; Immunology; Erythropoietin; Anemia; STAT protein; Endocrinology; Internal medicine; Interleukin 4; STAT3; Medicine; Malaria; Plasmodium falciparum; Signal transduction; Cell biology","score_opus":0.05273893510853034,"score_gpt":0.3191013224765463,"score_spread":0.266362387368016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117793275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993704,0.0016388266,0.0022342468,0.0002492177,0.00011254117,0.00017944469,0.00056321477,0.00018904216,0.0011294474],"genre_scores_gemma":[0.9904771,0.0013992374,0.0031393468,0.00013815491,0.000058305814,0.00028109326,0.00096524187,0.000031585645,0.003509895],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999731,0.00006307424,0.000027977017,0.000037447597,0.00007941868,0.00006106011],"domain_scores_gemma":[0.999742,0.000025232921,0.000103670674,0.000024050569,0.000018094035,0.00008695678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037821312,0.0007273337,0.00045061682,0.0005182281,0.00021105002,0.00030738916,0.0003798025,0.00045646905,0.0019860722],"category_scores_gemma":[0.0001244835,0.00021375115,0.00034678515,0.0002007479,0.0005934722,0.00026519742,0.0002008128,0.0013315502,0.0004478227],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018269888,0.000796857,0.00037720962,0.00015297056,0.000014899918,0.00014170825,0.00003661322,0.00019297242,0.9940346,0.00026515144,0.00017272748,0.0019873087],"study_design_scores_gemma":[0.00055609137,0.012587427,0.006672148,0.000043698194,0.00007647996,0.0011061371,0.00007477238,0.003020061,0.97138983,0.0001745013,0.004281421,0.000017484555],"about_ca_topic_score_codex":0.00022798874,"about_ca_topic_score_gemma":0.0004217596,"teacher_disagreement_score":0.0019860722,"about_ca_system_score_codex":0.00034969402,"about_ca_system_score_gemma":0.00032471778,"threshold_uncertainty_score":0.0066441298},"labels":[],"label_agreement":null},{"id":"W2119156186","doi":"10.3324/haematol.2014.109306","title":"Erythrocytosis associated with a novel missense mutation in the BPGM gene","year":2014,"lang":"en","type":"letter","venue":"Haematologica","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Biotechnology and Biological Sciences Research Council; Centre National de la Recherche Scientifique; Queen's University; NIHR Oxford Biomedical Research Centre; University of Oxford; Imperial College London; Wellcome Trust; British Heart Foundation; Academy of Medical Sciences; National Institute for Health and Care Research","keywords":"Missense mutation; Mutation; Gene isoform; Gene; Biology; Transcription factor; Mutant; Hydroxylation; Hypoxia-inducible factors; Genetics; Molecular biology; Biochemistry; Enzyme","score_opus":0.022586502556323412,"score_gpt":0.24084943204490347,"score_spread":0.21826292948858006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119156186","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94485086,0.0037638498,0.0042170784,0.024145931,0.0019663132,0.00015463095,0.00036017015,0.00040839295,0.020132877],"genre_scores_gemma":[0.9908381,0.0006984928,0.0013758332,0.0026461317,0.0013597899,0.000022872075,0.00008003278,0.00003164493,0.0029470772],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996407,0.00005582514,0.00003552769,0.0000961486,0.0000718331,0.000099984834],"domain_scores_gemma":[0.9991322,0.00033801136,0.00015751236,0.000058971054,0.00008213958,0.00023118399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029957807,0.0010605257,0.0007640739,0.0008248613,0.0009673563,0.00058751134,0.00072950893,0.004305138,0.0014718419],"category_scores_gemma":[0.0023662106,0.0003502941,0.00047184472,0.00073326146,0.0010011576,0.00067367736,0.00057709805,0.0022528642,0.0005554757],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055903056,0.000029331179,0.0021215617,0.000019067913,0.000007088708,0.9926899,0.00005427769,0.00006495842,0.002028602,0.00026993908,0.0011161201,0.0015432702],"study_design_scores_gemma":[0.000035086974,0.000071747185,0.005418955,0.000014966602,0.000014516949,0.99024826,0.000046434438,0.00065159716,0.0012614405,0.00040613857,0.0018217071,0.000009141748],"about_ca_topic_score_codex":0.0011750018,"about_ca_topic_score_gemma":0.0011503027,"teacher_disagreement_score":0.004305138,"about_ca_system_score_codex":0.0009973942,"about_ca_system_score_gemma":0.0003966538,"threshold_uncertainty_score":0.0072366595},"labels":[],"label_agreement":null},{"id":"W2121399230","doi":"10.3324/haematol.11644","title":"Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Thalidomide; Dexamethasone; Internal medicine; Vincristine; Complete response; Adverse effect; Melphalan; Multiple myeloma; Randomized controlled trial; Gastroenterology; Chemotherapy; Induction chemotherapy; Urology; Cyclophosphamide","score_opus":0.029433587298597613,"score_gpt":0.3032299416468039,"score_spread":0.27379635434820626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121399230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939932,0.004245733,0.00019122641,0.00020169836,0.000047079797,0.00009951958,0.00011938295,0.000052192612,0.0010499095],"genre_scores_gemma":[0.99749374,0.00095078483,0.00031695075,0.0002471223,0.00006775304,0.000067450674,0.00034074736,0.0000101066125,0.0005054037],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992132,0.00048414842,0.000033148925,0.00007578998,0.000075292315,0.00011843563],"domain_scores_gemma":[0.9992084,0.00028929455,0.00022808716,0.00006513956,0.000018298422,0.00019077834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018088372,0.0002881264,0.0011410547,0.00028822973,0.0002123151,0.0006787359,0.000453445,0.00067738176,0.0012998123],"category_scores_gemma":[0.0012496618,0.00019844211,0.0007122203,0.0003288143,0.00046318158,0.0003209448,0.00029008035,0.0014563999,0.00025240105],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.564483,0.009830195,0.03137692,0.0006626896,0.0024160668,0.00019360818,0.00027097645,0.0019033257,0.04182211,0.0005258968,0.0042120903,0.34230307],"study_design_scores_gemma":[0.28954816,0.4122733,0.26729557,0.00017944463,0.0020714186,0.0010944331,0.00009245043,0.0025598884,0.015617013,0.00064465904,0.008558696,0.00006499342],"about_ca_topic_score_codex":0.00065362116,"about_ca_topic_score_gemma":0.0018461567,"teacher_disagreement_score":0.0018088372,"about_ca_system_score_codex":0.0005785644,"about_ca_system_score_gemma":0.00036962467,"threshold_uncertainty_score":0.009566188},"labels":[],"label_agreement":null},{"id":"W2121578398","doi":"10.3324/haematol.2014.103580","title":"Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Aplastic anemia; Bone marrow; Mesenchymal stem cell; Stem cell; Bone marrow failure; Haematopoiesis; Immunology; Pancytopenia; Medicine; Hematopoietic stem cell; Clinical uses of mesenchymal stem cells; CD34; Pathogenesis; Cancer research; Biology; Pathology; Adult stem cell; Endothelial stem cell; Cell biology; In vitro","score_opus":0.021340504857120596,"score_gpt":0.20780888934172143,"score_spread":0.18646838448460082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121578398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99335736,0.0031472468,0.0012416528,0.000187433,0.000026671518,0.000032723343,0.0003163332,0.00004659618,0.0016440003],"genre_scores_gemma":[0.9977452,0.0005135138,0.0005669816,0.00012544291,0.000021390135,0.000013311122,0.00060097146,0.000005396377,0.00040774376],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999846,0.000025266418,0.000027733435,0.00002069494,0.00006134129,0.000018930008],"domain_scores_gemma":[0.9998048,0.000042133004,0.000050801948,0.00001986871,0.00003782679,0.000044696164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015497897,0.00021524432,0.00030563495,0.0005951909,0.00016297943,0.0003226816,0.00013308723,0.00025762615,0.0018145759],"category_scores_gemma":[0.00060294656,0.00009065134,0.00016583689,0.00030807566,0.00019821897,0.0001285963,0.00018457837,0.00034199646,0.00036797734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021880062,0.00019213483,0.20291099,0.000318649,0.00015058891,0.006481868,0.00052381895,0.0003455519,0.6926189,0.0008415885,0.0010581253,0.09236981],"study_design_scores_gemma":[0.0003356855,0.0040188693,0.6901665,0.00011672438,0.00047938572,0.06930883,0.0007417543,0.0017594349,0.20338102,0.0012035813,0.028458236,0.000029935647],"about_ca_topic_score_codex":0.00031514262,"about_ca_topic_score_gemma":0.00034201538,"teacher_disagreement_score":0.0018145759,"about_ca_system_score_codex":0.00010340676,"about_ca_system_score_gemma":0.00015262667,"threshold_uncertainty_score":0.0060703754},"labels":[],"label_agreement":null},{"id":"W2121970890","doi":"10.3324/haematol.2014.108258","title":"Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma","year":2014,"lang":"en","type":"letter","venue":"Haematologica","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Institute of Allergy and Infectious Diseases; Universitetet i Oslo; Medical Center, University of Rochester; Tampereen Yliopisto; Gentofte Hospital; Karolinska Institutet; University of Texas MD Anderson Cancer Center; Cancer Care Ontario; National Cancer Institute; University of Toronto; University of Rochester; U.S. Department of Veterans Affairs; Helsingin ja Uudenmaan Sairaanhoitopiiri; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Medicine; Lymphoma; Radiation therapy; Internal medicine; Hodgkin lymphoma; Oncology; Adverse effect; Cancer; Esophageal cancer","score_opus":0.02342477348110182,"score_gpt":0.30883694137542916,"score_spread":0.28541216789432733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121970890","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5652766,0.026920002,0.0029790793,0.25677451,0.005294717,0.00013500368,0.0007710864,0.0003425103,0.14150643],"genre_scores_gemma":[0.93112504,0.005904386,0.0009729377,0.044871353,0.00785703,0.00003670379,0.0004075971,0.00003391394,0.008791148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995776,0.00013630302,0.00003425375,0.00004539053,0.00011545392,0.00009106604],"domain_scores_gemma":[0.9985297,0.0005118874,0.0003019194,0.00013859956,0.0002383046,0.00027965032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004311142,0.00017359627,0.00046680047,0.00043303604,0.0007484422,0.0007189449,0.00034159387,0.0031078851,0.0034904862],"category_scores_gemma":[0.0039480347,0.00017741005,0.00061004556,0.00061496964,0.00039157673,0.00049859076,0.00047796205,0.0021924544,0.0011062536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010322918,0.00024079303,0.6442473,0.00024369115,0.00022159296,0.16126841,0.0004237531,0.000924334,0.002016722,0.0032924642,0.104567684,0.08152091],"study_design_scores_gemma":[0.00020510917,0.00087430945,0.33330965,0.0005835432,0.00033363383,0.5710961,0.0011666386,0.004357766,0.0012047506,0.011684114,0.07507986,0.00010440754],"about_ca_topic_score_codex":0.0019662122,"about_ca_topic_score_gemma":0.004528526,"teacher_disagreement_score":0.0034904862,"about_ca_system_score_codex":0.001024142,"about_ca_system_score_gemma":0.0005299233,"threshold_uncertainty_score":0.011676788},"labels":[],"label_agreement":null},{"id":"W2122398847","doi":"10.3324/haematol.2013.096859","title":"The importance of calcium in the regulation of megakaryocyte function","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"National Institute of Biomedical Imaging and Bioengineering","keywords":"Megakaryocyte; Cell biology; Extracellular; ORAI1; Calcium; Calcium in biology; Thrombopoiesis; Calcium signaling; Chemistry; Phospholipase C; Intracellular; Biochemistry; Biology; Voltage-dependent calcium channel; Signal transduction; Stem cell; Progenitor cell","score_opus":0.024897050955237598,"score_gpt":0.27351114469430304,"score_spread":0.24861409373906546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122398847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77737665,0.20429982,0.007468247,0.0016507588,0.00021787513,0.00008661194,0.0003833862,0.00012650236,0.008390124],"genre_scores_gemma":[0.9666522,0.029290142,0.002300821,0.0001361309,0.00014003484,0.000040387615,0.00013048851,0.000013142661,0.0012965814],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985564,0.000027383787,0.000013917083,0.000032064938,0.000036731723,0.00003428668],"domain_scores_gemma":[0.99991155,0.000029548952,0.00002260113,0.0000072574944,0.0000122542715,0.00001670277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016373754,0.0002452701,0.00026731938,0.0002858276,0.0002892855,0.0006274634,0.0002490793,0.0004997732,0.0006345801],"category_scores_gemma":[0.00022627834,0.000114509465,0.0001278334,0.00022258097,0.0002936006,0.00030455523,0.0003324277,0.00040298954,0.00014751374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007816092,0.000049279304,0.0015413574,0.00040421495,0.000020119554,0.0009498414,0.00011282609,0.00027012968,0.9711482,0.002349256,0.0003009333,0.022072315],"study_design_scores_gemma":[0.000330242,0.0016625135,0.087117024,0.00021808638,0.00020236144,0.006127871,0.0003778897,0.0030945095,0.8398452,0.005050133,0.055917427,0.000056778867],"about_ca_topic_score_codex":0.00042684848,"about_ca_topic_score_gemma":0.00056936766,"teacher_disagreement_score":0.0006345801,"about_ca_system_score_codex":0.0002975718,"about_ca_system_score_gemma":0.00029192228,"threshold_uncertainty_score":0.002159059},"labels":[],"label_agreement":null},{"id":"W2123152742","doi":"10.3324/haematol.13733","title":"Shwachman-Diamond syndrome neutrophils have altered chemoattractant-induced F-actin polymerization and polarization characteristics","year":2009,"lang":"en","type":"article","venue":"Haematologica","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Universiteit van Amsterdam","keywords":"Chemotaxis; Actin; Cytoskeleton; Immunology; Neutropenia; Wiskott–Aldrich syndrome; Cell biology; Medicine; Biology; Internal medicine; Cell; Gene; Genetics","score_opus":0.011989963666442966,"score_gpt":0.23998011514518044,"score_spread":0.22799015147873747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123152742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998278,0.00043552072,0.00075882167,0.00002926086,0.000005329022,0.000006898082,0.00011588091,0.000014046531,0.0003561683],"genre_scores_gemma":[0.9986639,0.00021263376,0.00053122075,0.000014148767,0.000001942655,0.0000085147885,0.00015563074,0.0000023862408,0.0004097093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999306,0.000010208096,0.0000073354004,0.000015114367,0.0000208663,0.000015746835],"domain_scores_gemma":[0.9999422,0.000009924134,0.000016625854,0.0000058155997,0.000008578399,0.000016968683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057231784,0.00021141859,0.00009601649,0.00022784183,0.000093807605,0.00010776454,0.00007005538,0.00019428704,0.0011498968],"category_scores_gemma":[0.00014086913,0.00006848103,0.00010236113,0.0000932124,0.0001363436,0.000078402365,0.0001176308,0.00015425935,0.00013413091],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018491787,0.000024236522,0.011209694,0.000048335278,0.000013893118,0.0012913116,0.000044204568,0.00006224225,0.98226017,0.0002095142,0.000118995005,0.0045324024],"study_design_scores_gemma":[0.00006391183,0.0007554802,0.31308344,0.000022529266,0.000045803965,0.025102714,0.00020172437,0.0012047046,0.6525803,0.0003523807,0.0065666093,0.000020279016],"about_ca_topic_score_codex":0.0007501145,"about_ca_topic_score_gemma":0.0010812198,"teacher_disagreement_score":0.0011498968,"about_ca_system_score_codex":0.00013138837,"about_ca_system_score_gemma":0.0000644893,"threshold_uncertainty_score":0.0038467646},"labels":[],"label_agreement":null},{"id":"W2123303925","doi":"10.3324/haematol.2014.112821","title":"Alloantibodies to therapeutic factor VIII in hemophilia A: the role of von Willebrand factor in regulating factor VIII immunogenicity","year":2015,"lang":"en","type":"review","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Grifols; Swedish Orphan Biovitrum; Biogen; Pfizer","keywords":"Von Willebrand factor; Immunogenicity; Immunology; Antibody; Factor IX; Antigen; Immune system; Recombinant DNA; Medicine; Biology; Internal medicine; Genetics; Gene; Platelet","score_opus":0.10232411967621508,"score_gpt":0.37984142754775707,"score_spread":0.277517307871542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123303925","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012091005,0.99920243,0.000045882345,0.00015054646,0.00006292035,0.0000023188848,0.000009422588,0.000002676167,0.00040298988],"genre_scores_gemma":[0.0005801657,0.99904233,0.0000700052,0.00006712223,0.00006621174,0.0000024344895,0.000013320776,4.9748513e-7,0.00015786571],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998368,0.000032055137,0.00003289981,0.000025813311,0.000059474067,0.000012910638],"domain_scores_gemma":[0.9995882,0.00022568552,0.00007030103,0.000009548024,0.0000802129,0.000026046633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004375936,0.00047914076,0.0010251518,0.0025916141,0.00023337116,0.00083670043,0.0005043465,0.0007920223,0.0030205057],"category_scores_gemma":[0.00092794443,0.00016655127,0.00047386106,0.0021182066,0.00036192217,0.00082269404,0.00044601382,0.000993927,0.0010508902],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007293491,0.00006631458,0.00031627715,0.03614032,0.00013559431,0.0003355934,0.000094572555,0.00020572149,0.0012678322,0.0019053092,0.017230205,0.9422293],"study_design_scores_gemma":[0.000022940101,0.0001361571,0.0022888673,0.012263417,0.00041434527,0.004763517,0.00013047966,0.00007613424,0.0006430199,0.0021066926,0.97713214,0.0000222958],"about_ca_topic_score_codex":0.0008695389,"about_ca_topic_score_gemma":0.0011719882,"teacher_disagreement_score":0.0030205057,"about_ca_system_score_codex":0.0003282064,"about_ca_system_score_gemma":0.0009338204,"threshold_uncertainty_score":0.010104537},"labels":[],"label_agreement":null},{"id":"W2123967889","doi":"10.3324/haematol.12212","title":"Characterization of compound 584, an Abl kinase inhibitor with lasting effects","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; Associazione Italiana per la Ricerca sul Cancro; Centre National de la Recherche Scientifique; European Commission","keywords":"Nilotinib; Dasatinib; Tyrosine kinase; Imatinib; ABL; Chemistry; LYN; Kinase; Bosutinib; Proto-oncogene tyrosine-protein kinase Src; Tyrosine-kinase inhibitor; Pharmacology; Imatinib mesylate; IC50; Cancer research; Molecular biology; Biochemistry; Biology; In vitro; Signal transduction","score_opus":0.02235335089522569,"score_gpt":0.24931301543303974,"score_spread":0.22695966453781405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123967889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97991,0.003869735,0.0067315856,0.00015802345,0.00004283988,0.00020859594,0.0018559792,0.00008541873,0.007137748],"genre_scores_gemma":[0.9798369,0.0018606734,0.006581871,0.000114034585,0.000027363627,0.0001353293,0.005083554,0.000048679216,0.0063117053],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993074,0.000007950393,0.0000045291936,0.000013315621,0.00002680958,0.000016614964],"domain_scores_gemma":[0.9999112,0.000016389891,0.000018848179,0.000006039385,0.000029045172,0.000018431692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117547825,0.00040891633,0.00022684688,0.0002835923,0.00010877196,0.00015390849,0.00031786828,0.0002475258,0.0037888323],"category_scores_gemma":[0.00025861274,0.000085165935,0.00023855195,0.00017542145,0.00013830182,0.00016331856,0.000140684,0.0003062422,0.0012223329],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035331663,0.00014637089,0.00055361754,0.0001433524,0.00001825407,0.0002206207,0.000018343944,0.0012316002,0.98387975,0.00016869228,0.00025641386,0.013009666],"study_design_scores_gemma":[0.00022938987,0.0041493233,0.0041310857,0.00002017677,0.000072688454,0.0011778452,0.000026652879,0.0025893499,0.97219515,0.00019463888,0.015197054,0.000016795868],"about_ca_topic_score_codex":0.00045413795,"about_ca_topic_score_gemma":0.00028291176,"teacher_disagreement_score":0.0037888323,"about_ca_system_score_codex":0.00023561878,"about_ca_system_score_gemma":0.00038004247,"threshold_uncertainty_score":0.012674868},"labels":[],"label_agreement":null},{"id":"W2124881596","doi":"10.3324/haematol.2014.110742","title":"Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Izaak Walton Killam Health Centre; Dalhousie University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Nova Scotia Health Research Foundation; Terry Fox Foundation; Beatrice Hunter Cancer Research Institute; California HIV/AIDS Research Program; Cancer Research Institute","keywords":"Zebrafish; Xenotransplantation; Leukemia; CRISPR; Cancer research; Cancer; Lymphoblastic Leukemia; Computational biology; PI3K/AKT/mTOR pathway; Medicine; Sanger sequencing; Genome editing; Mutation; Synthetic lethality; Biology; Bioinformatics; Immunology; Transplantation; Gene; Genetics; Internal medicine; Signal transduction; Mutant","score_opus":0.03345092067895968,"score_gpt":0.32917707558063475,"score_spread":0.2957261549016751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124881596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8784142,0.0026125188,0.10474006,0.0013608212,0.00017371762,0.0005933965,0.0015275994,0.001478997,0.009098685],"genre_scores_gemma":[0.94844705,0.002372996,0.04358639,0.0002084138,0.000014755141,0.00027503798,0.00051417097,0.00009863274,0.0044825478],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982184,0.000031994947,0.0000090578715,0.000038311384,0.00007144462,0.00002742813],"domain_scores_gemma":[0.9999249,0.00001564111,0.000024495565,0.0000123127975,0.000008674692,0.0000139857975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032552303,0.000473673,0.0002736439,0.0003511578,0.0002588409,0.0003751318,0.00035769027,0.00051058,0.0016688466],"category_scores_gemma":[0.00018519943,0.00021064552,0.00040734315,0.00015397293,0.0005011117,0.00027915265,0.0004528236,0.0006713876,0.00031687887],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055314093,0.000018342089,0.00016812501,0.000036258854,0.0000051930706,0.0000844815,0.00001855462,0.00072108855,0.99548966,0.00078079134,0.00015418325,0.0024680719],"study_design_scores_gemma":[0.000045864115,0.0006416457,0.0016109473,0.000014323518,0.000036002897,0.0004187928,0.000029089877,0.0037068503,0.98521465,0.00032617466,0.00793475,0.000020776815],"about_ca_topic_score_codex":0.0031948495,"about_ca_topic_score_gemma":0.0048192316,"teacher_disagreement_score":0.0031948495,"about_ca_system_score_codex":0.000984783,"about_ca_system_score_gemma":0.0007455539,"threshold_uncertainty_score":0.0071451664},"labels":[],"label_agreement":null},{"id":"W2125213800","doi":"10.3324/haematol.11680","title":"Alterations in creatine kinase, phosphate and lipid values in patients with chronic myeloid leukemia during treatment with imatinib","year":2008,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Associazione Italiana per la Ricerca sul Cancro; Jewish General Hospital; Agenzia Italiana del Farmaco, Ministero della Salute; McGill University","keywords":"Imatinib; Myeloid leukemia; Creatine kinase; Medicine; Creatine; Internal medicine; Cholesterol; Endocrinology; Cancer research","score_opus":0.012412933668236417,"score_gpt":0.23054926538786524,"score_spread":0.21813633171962882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125213800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98994535,0.0014164943,0.0002635439,0.0035076025,0.00008922052,0.00002463468,0.00012472236,0.000016849017,0.0046115927],"genre_scores_gemma":[0.9972017,0.0005923544,0.00015492905,0.0012010137,0.00027260295,0.000010935839,0.00009978503,0.0000036571446,0.00046300862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937433,0.00022011733,0.00008298949,0.00008035022,0.0001309245,0.00011123463],"domain_scores_gemma":[0.9986829,0.0006167407,0.0003335387,0.0000705243,0.00012246458,0.00017377848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000436767,0.00030783523,0.0004562496,0.00066544546,0.0005869581,0.00052627287,0.00027653415,0.0018675188,0.0007713505],"category_scores_gemma":[0.003324132,0.00021209255,0.00024277734,0.00087851647,0.00043063116,0.00045720235,0.0002089058,0.00075002306,0.0002815172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010238802,0.00010291307,0.82163095,0.000059150396,0.00005365004,0.15412273,0.00048110375,0.000213953,0.005710647,0.00019131109,0.0022532358,0.014156503],"study_design_scores_gemma":[0.00009061093,0.00076248695,0.6197265,0.000047991976,0.000076437515,0.3713647,0.00046059754,0.0010082063,0.0016792055,0.00041597156,0.004337064,0.000030179528],"about_ca_topic_score_codex":0.0011681725,"about_ca_topic_score_gemma":0.0019655966,"teacher_disagreement_score":0.0018675188,"about_ca_system_score_codex":0.0004160447,"about_ca_system_score_gemma":0.00026326068,"threshold_uncertainty_score":0.0030186176},"labels":[],"label_agreement":null},{"id":"W2125502424","doi":"10.3324/haematol.2012.083063","title":"Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries","year":2013,"lang":"en","type":"letter","venue":"Haematologica","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Merck Sharp and Dohme; Robert Koch Institut; Masarykova Univerzita; Universität zu Köln; Julius-Maximilians-Universität Würzburg; Celgene; Universität des Saarlandes; Astellas Pharma; Universitätsklinikum Köln; Bundesministerium für Bildung und Forschung; Pfizer Pharmaceuticals; McGill University; Deutsches Zentrum für Infektionsforschung; BioCryst; Central European Institute of Technology; Gilead Sciences; Pfizer; Viropharma; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology","keywords":"Mucormycosis; Antifungal; Amphotericin B; Medicine; Internal medicine; Hematologic Neoplasms; Hematopoietic stem cell transplantation; Leukemia; Intensive care medicine; Transplantation; Surgery; Dermatology","score_opus":0.02397617729043418,"score_gpt":0.23985988686912169,"score_spread":0.2158837095786875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125502424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71010643,0.026067596,0.00205202,0.20006226,0.0027294958,0.00016296636,0.00083557307,0.00012564872,0.057857983],"genre_scores_gemma":[0.94532776,0.0073627452,0.0010780275,0.03760014,0.0046373853,0.000041090323,0.00036611952,0.000026595872,0.00356016],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99929225,0.0002008268,0.00011153651,0.00006793944,0.00019595365,0.00013147025],"domain_scores_gemma":[0.998777,0.00035920698,0.00030447365,0.00006837326,0.00019293501,0.00029810288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000479289,0.00023891634,0.00029622923,0.0005126103,0.00076153694,0.0006044821,0.00044686496,0.002268564,0.0009878065],"category_scores_gemma":[0.002157506,0.00015391891,0.00041467077,0.0007018948,0.00039481418,0.00046920095,0.00041765944,0.0016672853,0.0003651369],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005625262,0.0004217424,0.33351615,0.0001571248,0.00012349592,0.505849,0.00068013894,0.00035510547,0.0044784583,0.0008628462,0.08828001,0.064713456],"study_design_scores_gemma":[0.0002589431,0.0005422504,0.17419729,0.00029429223,0.00018999413,0.7562695,0.0013514521,0.0016043581,0.0018172115,0.0010015593,0.062416274,0.000056897657],"about_ca_topic_score_codex":0.0033416108,"about_ca_topic_score_gemma":0.008255029,"teacher_disagreement_score":0.0033416108,"about_ca_system_score_codex":0.0008070024,"about_ca_system_score_gemma":0.0009868603,"threshold_uncertainty_score":0.0066443086},"labels":[],"label_agreement":null},{"id":"W2125523937","doi":"10.3324/haematol.2011.056531","title":"A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quest University Canada; University of Alberta","funders":"","keywords":"International Prognostic Index; Medicine; Epoch (astronomy); Rituximab; Vincristine; Diffuse large B-cell lymphoma; Lymphoma; Internal medicine; Etoposide; Cancer; Germinal center; Single Center; Prednisone; Oncology; Cyclophosphamide; B cell; Chemotherapy; Immunology","score_opus":0.03265571834827629,"score_gpt":0.280381009607812,"score_spread":0.24772529125953568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125523937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993438,0.00021941187,0.0000715468,0.000031586977,0.00000525198,0.000050071245,0.00011088489,0.0000029038588,0.00016449136],"genre_scores_gemma":[0.9989503,0.000082168415,0.000121374986,0.00007336702,0.000027273598,0.000059158858,0.00047616332,0.0000035948538,0.00020657472],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9988631,0.0006401847,0.000053857846,0.00020506656,0.00009824715,0.00013965159],"domain_scores_gemma":[0.9984273,0.00020438973,0.0004009102,0.00014293095,0.00013744445,0.0006871038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002120756,0.0008910431,0.000683222,0.0005509943,0.00070046005,0.0007196636,0.0005416263,0.0007799036,0.0011076096],"category_scores_gemma":[0.0014167407,0.0005795369,0.00056555076,0.00068374275,0.0004941645,0.00056815904,0.0005126421,0.0007802838,0.00042786732],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043173574,0.0037181866,0.9406677,0.00005835537,0.0009623634,0.00051287556,0.0003244543,0.0002482364,0.003784731,0.000055493667,0.0004412692,0.006052827],"study_design_scores_gemma":[0.010433185,0.018865699,0.9663095,0.000018936304,0.00044529568,0.0014550885,0.00018413768,0.00085843384,0.00049929426,0.000058508536,0.0008463418,0.000025650888],"about_ca_topic_score_codex":0.002166499,"about_ca_topic_score_gemma":0.0020454212,"teacher_disagreement_score":0.002166499,"about_ca_system_score_codex":0.0008009986,"about_ca_system_score_gemma":0.00062704517,"threshold_uncertainty_score":0.011215806},"labels":[],"label_agreement":null},{"id":"W2125610771","doi":"10.3324/haematol.11755","title":"Inflammation and oxidant-stress in  -thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Center for Research Resources; Translational Cancer Research Network; Children's Hospital of Philadelphia; University College London; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; New England Research Institutes","keywords":"Deferasirox; Malondialdehyde; Deferoxamine; Ferritin; Oxidative stress; Transferrin saturation; Medicine; Internal medicine; Transferrin; Deferiprone; Thalassemia; Gastroenterology; Serum ferritin","score_opus":0.020414249651859954,"score_gpt":0.24101753036686246,"score_spread":0.22060328071500251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125610771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99705863,0.00229537,0.00004909657,0.00012433219,0.000024031215,0.00012148992,0.000096548116,0.000004464395,0.00022604031],"genre_scores_gemma":[0.9981248,0.0006814305,0.00017725407,0.00022897271,0.000099457844,0.00014288668,0.0003386057,0.0000017624457,0.0002048671],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.999049,0.0006321322,0.000046477988,0.00008720093,0.00007643029,0.00010876452],"domain_scores_gemma":[0.9985475,0.0003463191,0.00041896524,0.00010350484,0.00008943385,0.00049420574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025487454,0.00068315293,0.0014538241,0.00018319077,0.00030053296,0.0006541948,0.0004224616,0.00075832853,0.0013508069],"category_scores_gemma":[0.0014557767,0.0003221443,0.0009653226,0.000221635,0.00048753564,0.00033803645,0.00030110485,0.0011799604,0.00020962949],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87414694,0.007325813,0.07044245,0.0006932492,0.0023574834,0.00021685164,0.00019774304,0.00035604747,0.008082081,0.000095034084,0.00095993694,0.0351264],"study_design_scores_gemma":[0.44058722,0.3133976,0.2373405,0.00020468161,0.0031882455,0.0005380473,0.00013932062,0.0009029318,0.0016529023,0.00014597444,0.001848669,0.000053944295],"about_ca_topic_score_codex":0.00091040734,"about_ca_topic_score_gemma":0.0015718401,"teacher_disagreement_score":0.0025487454,"about_ca_system_score_codex":0.00048233292,"about_ca_system_score_gemma":0.00075869786,"threshold_uncertainty_score":0.013479173},"labels":[],"label_agreement":null},{"id":"W2126532431","doi":"10.3324/haematol.2014.119545","title":"A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":253,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center","keywords":"Ruxolitinib; Medicine; Hazard ratio; Internal medicine; Myelofibrosis; Placebo; Survival analysis; Confidence interval; Crossover study; Proportional hazards model; Surgery; Pathology","score_opus":0.1259945300572344,"score_gpt":0.39007178443101137,"score_spread":0.26407725437377694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126532431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8881131,0.100676775,0.0050074817,0.00025124842,0.0004061324,0.0010580805,0.0031394002,0.00014515442,0.0012026754],"genre_scores_gemma":[0.99239445,0.0035157856,0.0014052799,0.00017783632,0.0001416551,0.0005481355,0.0014569677,0.000016552558,0.00034345422],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98657554,0.010785852,0.0009246252,0.0008945176,0.00054407254,0.00027540902],"domain_scores_gemma":[0.9936724,0.0035308856,0.0015419039,0.00071997853,0.00034213215,0.00019275848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015224882,0.0021646845,0.0069249664,0.0011766236,0.0002291267,0.0011256037,0.0006349797,0.0011208699,0.0014819814],"category_scores_gemma":[0.011239265,0.0008109423,0.017604059,0.0008957407,0.00043486402,0.00072294316,0.00079607044,0.00088665396,0.000117509946],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5386801,0.0003127957,0.016111542,0.008408027,0.40733936,0.00021474413,0.000094117575,0.0034066963,0.004338185,0.00018563759,0.0011515031,0.019757327],"study_design_scores_gemma":[0.15784663,0.049043342,0.10450092,0.0007717679,0.67526895,0.0004346541,0.00016298852,0.0052810125,0.0032195128,0.00057178765,0.0027702712,0.00012816781],"about_ca_topic_score_codex":0.00081529573,"about_ca_topic_score_gemma":0.001990558,"teacher_disagreement_score":0.015224882,"about_ca_system_score_codex":0.0006730603,"about_ca_system_score_gemma":0.0005993947,"threshold_uncertainty_score":0.08051789},"labels":[],"label_agreement":null},{"id":"W2127765975","doi":"10.3324/haematol.2013.101386","title":"Impact of MLL5 expression on decitabine efficacy and DNA methylation in acute myeloid leukemia","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Hector Stiftung; Deutsche Krebshilfe; José Carreras Leukämie-Stiftung; Bundesministerium für Bildung und Forschung; Medizinischen Hochschule Hannover; Deutsche Forschungsgemeinschaft","keywords":"Decitabine; Myeloid leukemia; DNA methylation; Myelodysplastic syndromes; Internal medicine; Azacitidine; Medicine; Hypomethylating agent; Biology; Leukemia; Oncology; Cancer research; Bone marrow; Gene expression; Genetics; Gene","score_opus":0.024916716205095293,"score_gpt":0.33503992879084227,"score_spread":0.310123212585747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127765975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990238,0.0006446251,0.00008965162,0.000026136304,0.0000018658291,0.0000030030344,0.000030695872,0.0000031839045,0.00017698602],"genre_scores_gemma":[0.999713,0.00008442626,0.0000568415,0.00000665952,8.310189e-7,0.0000019014232,0.000036040285,7.731438e-7,0.00009952352],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983394,0.00006020228,0.0000152357525,0.000021654578,0.000037008882,0.00003187388],"domain_scores_gemma":[0.9998293,0.00004906997,0.000055666915,0.000012244199,0.000011423073,0.000042293053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022068,0.000094714,0.00017435687,0.00014252723,0.00009052125,0.00032308765,0.00009547799,0.00012503729,0.00053409283],"category_scores_gemma":[0.0003898277,0.000056688063,0.00008955055,0.00012542671,0.00015309805,0.00011684121,0.00012331047,0.00025431515,0.000087605695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008410786,0.00029952862,0.1386565,0.00010269731,0.000114269234,0.00030840765,0.000118690055,0.0007546,0.81584847,0.00018053631,0.00013333563,0.03507212],"study_design_scores_gemma":[0.00012439597,0.0062395413,0.6158172,0.000020823158,0.00018219037,0.001305842,0.00019472439,0.0030731012,0.37023604,0.00016081768,0.0026307858,0.000014555968],"about_ca_topic_score_codex":0.00070813816,"about_ca_topic_score_gemma":0.0010799658,"teacher_disagreement_score":0.00070813816,"about_ca_system_score_codex":0.00043810968,"about_ca_system_score_gemma":0.00012776283,"threshold_uncertainty_score":0.0031787157},"labels":[],"label_agreement":null},{"id":"W2128185662","doi":"10.3324/haematol.2012.079012","title":"HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapy","year":2013,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Blood Cancer UK; Queen's University","keywords":"Myeloid leukemia; Leukemia; Gene knockdown; Cancer research; Gene signature; Biology; Myeloid; Microarray analysis techniques; Chemotherapy; Gene; Microarray; Acute leukemia; Induction chemotherapy; Oncology; Immunology; Gene expression; Medicine; Genetics","score_opus":0.011518499260826579,"score_gpt":0.2593300131477613,"score_spread":0.2478115138869347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128185662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978167,0.00023126764,0.00087732304,0.000030518408,0.00000868537,0.000019449435,0.00049566437,0.00005893572,0.00046141536],"genre_scores_gemma":[0.99781954,0.00015231507,0.0005634586,0.000024652814,0.0000017493778,0.000027861732,0.0006606858,0.0000071768554,0.00074255775],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998584,0.000012280012,0.000015460157,0.000032102358,0.000048322232,0.000033496006],"domain_scores_gemma":[0.99993587,0.000012479977,0.000016479007,0.000011955862,0.000005183026,0.000018109284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105245155,0.00016366667,0.00028363176,0.00015277664,0.000120769684,0.00024795547,0.00011135411,0.000119380835,0.0010581133],"category_scores_gemma":[0.00010876148,0.00009548236,0.00016204659,0.00013587883,0.00016148588,0.00007410005,0.00017304298,0.00035116498,0.0002131392],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012408107,0.000027171165,0.0006783237,0.000016567728,0.000008080529,0.000020657884,0.000011694857,0.00020482417,0.9975084,0.000047502825,0.000054769036,0.0012979807],"study_design_scores_gemma":[0.000028611788,0.00081328274,0.054456085,0.0000061405813,0.00002893807,0.00025432362,0.00006418226,0.003395653,0.93851066,0.00009584202,0.0023389116,0.0000074163486],"about_ca_topic_score_codex":0.00065618334,"about_ca_topic_score_gemma":0.0013001598,"teacher_disagreement_score":0.0010581133,"about_ca_system_score_codex":0.00020097733,"about_ca_system_score_gemma":0.00017655834,"threshold_uncertainty_score":0.0035396814},"labels":[],"label_agreement":null},{"id":"W2128816533","doi":"10.3324/haematol.2009.017178","title":"Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Medical Research Council; Cancer Research UK","keywords":"Mesenchymal stem cell; Myeloid leukemia; Cancer research; Imatinib; Stromal cell; Bone marrow; Progenitor cell; Leukemia; Imatinib mesylate; Stem cell; Immunology; Biology; Cell biology","score_opus":0.014258445648139571,"score_gpt":0.24676444514542967,"score_spread":0.2325059994972901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128816533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946374,0.002024958,0.0012814787,0.0000981338,0.000022559496,0.000044294633,0.0004147408,0.000056108,0.0014202462],"genre_scores_gemma":[0.995832,0.00081890606,0.00087506307,0.00005387039,0.00001324663,0.0000533369,0.0007695926,0.000007782007,0.0015761383],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986553,0.000020047144,0.000015164189,0.000016751626,0.000047987607,0.00003453452],"domain_scores_gemma":[0.9999317,0.000009647887,0.000022452385,0.000009232446,0.000008122244,0.000018918816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011106216,0.00027635097,0.00022680666,0.00015810903,0.00010133759,0.00021315932,0.00011181824,0.00015879088,0.0018630045],"category_scores_gemma":[0.00006960065,0.00006970898,0.00018910518,0.00012438372,0.00016738263,0.00010489878,0.00014550556,0.00040653357,0.00045058975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022313008,0.000071687675,0.0004237359,0.00006322242,0.00000858822,0.000046900266,0.000017675575,0.00005680786,0.99638665,0.00011182873,0.00008895915,0.0025008516],"study_design_scores_gemma":[0.00009442289,0.0013835147,0.009416491,0.000014244132,0.00003589875,0.00052617345,0.000043948847,0.00060154736,0.9831791,0.000059358026,0.004641578,0.000003782618],"about_ca_topic_score_codex":0.00033462935,"about_ca_topic_score_gemma":0.000706092,"teacher_disagreement_score":0.0018630045,"about_ca_system_score_codex":0.0001449779,"about_ca_system_score_gemma":0.00022181385,"threshold_uncertainty_score":0.006232381},"labels":[],"label_agreement":null},{"id":"W2129355608","doi":"10.3324/haematol.11606","title":"Differential role of CD97 in interleukin-8-induced and granulocyte-colony stimulating factor-induced hematopoietic stem and progenitor cell mobilization","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Leids Universitair Medisch Centrum; KWF Kankerbestrijding; Universiteit Leiden","keywords":"Haematopoiesis; Mobilization; Granulocyte colony-stimulating factor; Granulocyte; Progenitor cell; Interleukin 3; Hematopoietic growth factor; Stem cell; Internal medicine; Interleukin; Biology; Immunology; Endocrinology; Medicine; Cytokine; Cell biology; Chemotherapy; Antigen","score_opus":0.03270150285625094,"score_gpt":0.25546805348595286,"score_spread":0.2227665506297019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129355608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99804616,0.0005683886,0.00042714403,0.000039303486,0.0000066447014,0.0000098715755,0.00010309222,0.000010999753,0.0007882983],"genre_scores_gemma":[0.99805695,0.0002977261,0.0006298754,0.00002391319,0.000004632716,0.000026732074,0.00020750645,0.0000049828027,0.00074763864],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998356,0.00003406723,0.000016880109,0.000015875916,0.00004252004,0.000054943426],"domain_scores_gemma":[0.999894,0.000024861141,0.000025009864,0.000015640284,0.0000060991465,0.00003436001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011707698,0.00019758267,0.00020432584,0.00025282855,0.000101056095,0.00029735683,0.00013954489,0.000271888,0.0014248359],"category_scores_gemma":[0.0001376255,0.00009160802,0.00015096016,0.00013011455,0.00025558524,0.00023523359,0.00020164953,0.0005057344,0.0002985502],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003093995,0.00004495479,0.0004590013,0.000023739987,0.0000028836262,0.00013106373,0.00001234499,0.000032022876,0.99720794,0.00017608202,0.000026646925,0.0015738767],"study_design_scores_gemma":[0.000042484397,0.00033492772,0.008854416,0.000009539987,0.000016836886,0.0005090532,0.000057349807,0.00048297254,0.9882415,0.000090917405,0.0013561125,0.0000037765817],"about_ca_topic_score_codex":0.00006433058,"about_ca_topic_score_gemma":0.00011900248,"teacher_disagreement_score":0.0014248359,"about_ca_system_score_codex":0.00012768403,"about_ca_system_score_gemma":0.00012154826,"threshold_uncertainty_score":0.0047665834},"labels":[],"label_agreement":null},{"id":"W2131236362","doi":"10.3324/haematol.10616","title":"A clinically significant incidence of bleeding in critically ill children receiving therapeutic doses of unfractionated heparin: a prospective cohort study","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"Hospital for Sick Children; Austrian Science Fund","keywords":"Medicine; Prospective cohort study; Heparin; Thrombosis; Incidence (geometry); Cohort; Cohort study; Internal medicine; Surgery; Major bleeding","score_opus":0.03307020865336616,"score_gpt":0.3408378763714658,"score_spread":0.3077676677180996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131236362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995079,0.00013108307,0.00005854168,0.00001913373,0.0000033826002,0.000009847096,0.00014510969,0.000001928881,0.00012306307],"genre_scores_gemma":[0.99952316,0.00010408014,0.00009617582,0.000018674695,0.0000095980595,0.000010417204,0.00019097808,0.0000014815996,0.000045425124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917054,0.00021562411,0.000084075844,0.00021814086,0.00016533246,0.00014628324],"domain_scores_gemma":[0.9972838,0.0005518799,0.001127626,0.00032066222,0.00022334312,0.00049256743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009678187,0.00036453063,0.0005106231,0.0008356853,0.0004248678,0.00064318307,0.0004254518,0.0005570243,0.0012725814],"category_scores_gemma":[0.003152476,0.0004261703,0.00070426165,0.000911894,0.00046163576,0.00064530445,0.00038005406,0.00086731464,0.00018943001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001644639,0.000035974997,0.99893886,0.0000046058976,0.0000428164,0.00011211507,0.00005121814,0.000013641162,0.00012455833,0.000011917714,0.00003774342,0.00046199682],"study_design_scores_gemma":[0.0000294814,0.00043411128,0.99805105,0.0000053912913,0.000045094777,0.0010069786,0.00012921687,0.00010333486,0.000069879265,0.000010883015,0.00010854443,0.000006079568],"about_ca_topic_score_codex":0.004504521,"about_ca_topic_score_gemma":0.003138408,"teacher_disagreement_score":0.004504521,"about_ca_system_score_codex":0.00036691382,"about_ca_system_score_gemma":0.00047342066,"threshold_uncertainty_score":0.008956611},"labels":[],"label_agreement":null},{"id":"W2132410859","doi":"10.3324/haematol.2010.037978","title":"Cancer testis antigens in newly diagnosed and relapse multiple myeloma: prognostic markers and potential targets for immunotherapy","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Stem Cell Network","keywords":"Antigen; Cancer; Multiple myeloma; Internal medicine; Medicine; Oncology; Immunotherapy; Cancer research; Biology; Immunology","score_opus":0.018509287959409152,"score_gpt":0.23985335944651587,"score_spread":0.22134407148710672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132410859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953715,0.0036196029,0.00019635525,0.000060436378,0.000005881044,0.000015389767,0.0004048931,0.000009630615,0.00031619353],"genre_scores_gemma":[0.9975992,0.0006924402,0.00027866513,0.000033933306,0.00003213602,0.000016336393,0.0011595595,0.0000034187826,0.00018431539],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970967,0.00006627613,0.00002582638,0.000059666236,0.00008738701,0.000051100254],"domain_scores_gemma":[0.9993868,0.00014105307,0.0002608308,0.000039884166,0.00005788597,0.000113558104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006839347,0.00018020337,0.0005367847,0.00065594324,0.00021917836,0.0005306663,0.00027215615,0.0003039568,0.00069755793],"category_scores_gemma":[0.000868724,0.00009303568,0.00021289749,0.0009645177,0.00018911256,0.00024445413,0.0002351394,0.0003398476,0.00013094673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026705111,0.000103272694,0.95809966,0.00012508492,0.00016400962,0.00029945537,0.00009646144,0.00024739385,0.010729443,0.00005066019,0.0004450334,0.026968956],"study_design_scores_gemma":[0.000084606065,0.0006103901,0.9936249,0.000019050358,0.00016761062,0.0015803932,0.00007956863,0.00058575824,0.0021271058,0.00013327526,0.0009813652,0.000005915855],"about_ca_topic_score_codex":0.0005852657,"about_ca_topic_score_gemma":0.0009849656,"teacher_disagreement_score":0.00069755793,"about_ca_system_score_codex":0.00038562663,"about_ca_system_score_gemma":0.0002434145,"threshold_uncertainty_score":0.0036170483},"labels":[],"label_agreement":null},{"id":"W2133005406","doi":"10.3324/haematol.2009.019943","title":"Different response to salvage chemotherapy but similar post-transplant outcomes in patients with relapsed and refractory Hodgkin's lymphoma","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Salvage therapy; Refractory (planetary science); Chemotherapy; Transplantation; Internal medicine; Surgery; Lymphoma; Oncology; Cohort","score_opus":0.0058981634693385555,"score_gpt":0.22754268173314432,"score_spread":0.22164451826380577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133005406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996723,0.00015513138,0.0000215996,0.000012094261,0.0000019193967,0.0000027719932,0.00003399008,0.0000010029044,0.00009930918],"genre_scores_gemma":[0.9997855,0.00003104897,0.000014774761,0.000016394944,0.0000057438383,0.0000028976326,0.00012403112,7.8337575e-7,0.000018846958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958557,0.00012720312,0.000049014987,0.000086278764,0.000064432425,0.000087544315],"domain_scores_gemma":[0.9986732,0.00038358333,0.0005497895,0.00006950279,0.00007143187,0.00025255067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006064302,0.00017319336,0.00043078678,0.0005475035,0.00021561756,0.0005227766,0.0002486171,0.00044473697,0.00093565416],"category_scores_gemma":[0.0022912626,0.00011203233,0.00040453413,0.0005118462,0.0003375246,0.00029656437,0.00029820058,0.00033084562,0.00017420333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007499164,0.000048926137,0.9949752,0.000013853708,0.00009258827,0.0005940517,0.00009966825,0.0001350331,0.00056486,0.000020594438,0.00005794971,0.002647409],"study_design_scores_gemma":[0.00006206254,0.00049092533,0.99618834,0.000008329907,0.00005980102,0.002486755,0.00014387582,0.00026513965,0.00013051086,0.000056052475,0.00010227203,0.0000059742624],"about_ca_topic_score_codex":0.0005199297,"about_ca_topic_score_gemma":0.0006627571,"teacher_disagreement_score":0.00093565416,"about_ca_system_score_codex":0.00037465824,"about_ca_system_score_gemma":0.00021011535,"threshold_uncertainty_score":0.0032071471},"labels":[],"label_agreement":null},{"id":"W2133225333","doi":"10.3324/haematol.2013.100263","title":"Understanding antifungal prophylaxis with posaconazole in hematology patients: an evolving bedside to bench story","year":2014,"lang":"en","type":"editorial","venue":"Haematologica","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Posaconazole; Hematology; Bench to bedside; Medicine; Antifungal; Intensive care medicine; Internal medicine; Medical physics; Voriconazole; Dermatology","score_opus":0.03588883364448356,"score_gpt":0.28773611860322,"score_spread":0.25184728495873643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133225333","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013346961,0.4807868,0.004527385,0.50511956,0.005940636,0.000029616354,0.00010535969,0.000066972294,0.0020889633],"genre_scores_gemma":[0.027260516,0.5944442,0.0087699825,0.2509176,0.117537364,0.00011651044,0.00016173435,0.0001328367,0.00065931474],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98548627,0.0067546205,0.0022037744,0.0016971967,0.003366557,0.0004915607],"domain_scores_gemma":[0.7854856,0.18474014,0.006211042,0.0033355905,0.014396153,0.005831449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.039460372,0.0015469894,0.0053676376,0.0035693948,0.0023755967,0.011301114,0.0044680405,0.016439963,0.0041180504],"category_scores_gemma":[0.08984921,0.001554222,0.0014968407,0.0026559278,0.01494187,0.026902772,0.005497337,0.034013644,0.0014662552],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077531696,0.00069530454,0.0061800964,0.011558446,0.00047494532,0.0012862843,0.002394577,0.0018801776,0.0012620062,0.115842395,0.24271138,0.61493903],"study_design_scores_gemma":[0.00033567892,0.0017228919,0.006351068,0.023982223,0.00044737474,0.0020894255,0.0047814837,0.004029949,0.0008034431,0.29781199,0.65731436,0.00033001992],"about_ca_topic_score_codex":0.0032214918,"about_ca_topic_score_gemma":0.0035803453,"teacher_disagreement_score":0.039460372,"about_ca_system_score_codex":0.0059691635,"about_ca_system_score_gemma":0.008082261,"threshold_uncertainty_score":0.20868891},"labels":[],"label_agreement":null},{"id":"W2133581509","doi":"10.3324/haematol.13044","title":"Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETO","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"Studienstiftung des Deutschen Volkes","keywords":"Myeloid leukemia; Leukemia; Downregulation and upregulation; Cancer research; Myeloid; Biology; Microarray analysis techniques; Cell growth; Molecular biology; Cell culture; Gene expression; Gene; Immunology; Genetics","score_opus":0.053897946218395276,"score_gpt":0.2971970424751597,"score_spread":0.24329909625676444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133581509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99337125,0.00063288223,0.0033776031,0.00010193255,0.000023185406,0.000055180437,0.0012239823,0.000118558855,0.0010955255],"genre_scores_gemma":[0.9875465,0.000630419,0.0054654954,0.000044973283,0.000012416379,0.000096658805,0.0025251703,0.000036118032,0.003642286],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998343,0.00002300059,0.000016995062,0.000029240424,0.000057514724,0.00003880978],"domain_scores_gemma":[0.999894,0.000021461954,0.000028037379,0.000012761661,0.00001411608,0.000029686864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012842852,0.00032587576,0.00031674025,0.00035707105,0.00023154508,0.00031191474,0.00016048811,0.00017573501,0.0014164748],"category_scores_gemma":[0.00013070111,0.00016698458,0.0001963432,0.0003345247,0.00027561342,0.00014974,0.0001938097,0.000587985,0.0004634793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005906278,0.000021861777,0.00011840634,0.000014936514,0.0000017364698,0.000032159747,0.000011831147,0.000046398847,0.9991824,0.000074518444,0.00003380204,0.00040287574],"study_design_scores_gemma":[0.000017716171,0.00016354518,0.003758506,0.0000026721743,0.0000092534465,0.00017791866,0.000021839864,0.00091174344,0.99235404,0.000032522905,0.0025469062,0.0000032952137],"about_ca_topic_score_codex":0.00094489305,"about_ca_topic_score_gemma":0.0012694389,"teacher_disagreement_score":0.0014164748,"about_ca_system_score_codex":0.00038721305,"about_ca_system_score_gemma":0.0002248503,"threshold_uncertainty_score":0.0047385693},"labels":[],"label_agreement":null},{"id":"W2134625781","doi":"10.3324/haematol.2010.023614","title":"Low molecular weight heparin for the treatment of retinal vein occlusion: a systematic review and meta-analysis of randomized trials","year":2010,"lang":"en","type":"review","venue":"Haematologica","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Central retinal vein occlusion; Visual acuity; Cochrane Library; Low molecular weight heparin; Randomized controlled trial; Ophthalmology; Branch retinal vein occlusion; Meta-analysis; Fluorescein angiography; Surgery; Heparin; Internal medicine; Macular edema","score_opus":0.13824677480320632,"score_gpt":0.418206579188262,"score_spread":0.27995980438505563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134625781","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032775728,0.9955017,0.00027758456,0.00013347121,0.00010529724,0.00027065878,0.00025609115,0.000015665926,0.00016185759],"genre_scores_gemma":[0.09637758,0.8988305,0.0018378057,0.000790962,0.0002420303,0.0011182514,0.0005085193,0.000021593538,0.00027279733],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9904891,0.004939947,0.0025803703,0.0007727414,0.00096352457,0.00025423878],"domain_scores_gemma":[0.98428345,0.011282029,0.0028092428,0.00037348084,0.0010483792,0.00020340901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0118523,0.0022996322,0.0180255,0.0051570977,0.0005488312,0.0027960606,0.0015726404,0.0019769075,0.0035311498],"category_scores_gemma":[0.026180858,0.0011641113,0.026259953,0.0059693055,0.00060042104,0.0014289477,0.0010494421,0.0016562499,0.00027836225],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032108808,0.000034377506,0.002007459,0.48023376,0.4972107,0.000109317145,0.00006591495,0.00039915188,0.00024651168,0.00012171228,0.00066990673,0.015690332],"study_design_scores_gemma":[0.0012572322,0.000301212,0.0026554794,0.035253763,0.95837945,0.00008241309,0.000038084952,0.00016084584,0.00012880165,0.00017302776,0.0015482022,0.000021477364],"about_ca_topic_score_codex":0.005794637,"about_ca_topic_score_gemma":0.013338753,"teacher_disagreement_score":0.0180255,"about_ca_system_score_codex":0.0025315133,"about_ca_system_score_gemma":0.0033399644,"threshold_uncertainty_score":0.062681675},"labels":[],"label_agreement":null},{"id":"W2135067956","doi":"10.3324/haematol.2009.021766","title":"Vascularization predicts overall survival and risk of transformation in follicular lymphoma","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; Fundação para a Ciência e a Tecnologia; Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Follicular lymphoma; Follicular phase; Lymphoma; Medicine; Internal medicine; CD34; Pathology; Angiogenesis; Microvessel; Prognostic variable; Survival analysis; Oncology; Multivariate analysis; Biology","score_opus":0.010060671104852398,"score_gpt":0.23402911254233863,"score_spread":0.22396844143748623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135067956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995421,0.00016996927,0.00010682364,0.000012346632,7.0029864e-7,0.0000015383645,0.000014994208,0.0000034221691,0.00014810132],"genre_scores_gemma":[0.9998487,0.00002924411,0.000048432674,0.0000026885302,0.0000024159706,0.0000010176017,0.00003120706,6.9096706e-7,0.00003560469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988747,0.000040075265,0.00000946087,0.000018971188,0.000019301815,0.000024770266],"domain_scores_gemma":[0.9993389,0.00021124873,0.00024560752,0.00003484296,0.000040421935,0.0001288835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002902394,0.00012913794,0.0001342316,0.0003691289,0.0001098861,0.000273361,0.000112801245,0.00023841985,0.0007799601],"category_scores_gemma":[0.0013321659,0.000107479245,0.00010615936,0.00026632167,0.000255433,0.00018996885,0.00021755355,0.00029581916,0.00011974647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023082802,0.00001679371,0.9940989,0.000003602023,0.000012601609,0.00007286262,0.000026128804,0.0001304778,0.0017880625,0.000016389766,0.000040646155,0.0035627452],"study_design_scores_gemma":[0.0000056451204,0.00014703402,0.9982008,0.0000016883256,0.00001743615,0.000525476,0.00005325615,0.0005641383,0.0003297169,0.000060745017,0.00009194776,0.0000020642876],"about_ca_topic_score_codex":0.0005222455,"about_ca_topic_score_gemma":0.0006152484,"teacher_disagreement_score":0.0007799601,"about_ca_system_score_codex":0.00013362907,"about_ca_system_score_gemma":0.00007632633,"threshold_uncertainty_score":0.0026091933},"labels":[],"label_agreement":null},{"id":"W2136504668","doi":"10.3324/haematol.2013.092411","title":"Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitors","year":2013,"lang":"en","type":"article","venue":"Haematologica","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Myeloid leukemia; Leukemia; Proteasome; Bortezomib; Proteasome inhibitor; Medicine; Acute lymphocytic leukemia; Myeloid; Cancer research; Acute leukemia; Immunology; Pharmacology; Multiple myeloma; Biology; Lymphoblastic Leukemia; Biochemistry","score_opus":0.027865285506768995,"score_gpt":0.25698354417133096,"score_spread":0.22911825866456195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136504668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905489,0.003895094,0.00345937,0.000028960474,0.0000151006,0.000027163587,0.0006967467,0.000063383624,0.001265236],"genre_scores_gemma":[0.99381435,0.001677255,0.0022860037,0.000026318014,0.0000143132365,0.000053660846,0.0010951412,0.000010571103,0.0010222407],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974674,0.000047140715,0.000030050833,0.00005380077,0.00008313388,0.00003904288],"domain_scores_gemma":[0.9998677,0.000031939828,0.000036948313,0.000015816398,0.0000275143,0.000020051048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015107174,0.00025715376,0.00032146444,0.00031381924,0.000101966674,0.0003436312,0.00011679888,0.00017638737,0.0012782502],"category_scores_gemma":[0.0001638778,0.000111378526,0.00014890832,0.00033650224,0.00014663347,0.0002149447,0.00016962104,0.00042148712,0.0002683541],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001527847,0.000040213978,0.0026513326,0.000044135428,0.000010204454,0.000037734724,0.000039326544,0.0000718751,0.99477345,0.000041079544,0.000023500896,0.0021143437],"study_design_scores_gemma":[0.000010466456,0.000784973,0.04407831,0.00000596463,0.000028744225,0.00046791564,0.00007873391,0.0005529122,0.9523663,0.000045996836,0.0015749208,0.0000048712263],"about_ca_topic_score_codex":0.00024156216,"about_ca_topic_score_gemma":0.00028167156,"teacher_disagreement_score":0.0012782502,"about_ca_system_score_codex":0.00015869598,"about_ca_system_score_gemma":0.00010539981,"threshold_uncertainty_score":0.0042761564},"labels":[],"label_agreement":null},{"id":"W2138597400","doi":"10.3324/haematol.2010.025767","title":"The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Lymphoma; B cell; Germinal center; Biology; Cancer research; Chromosomal translocation; Immunoglobulin light chain; Diffuse large B-cell lymphoma; Pathology; Haematopoiesis; Antibody; Immunology; Medicine; Stem cell; Gene; Genetics","score_opus":0.0173749675604189,"score_gpt":0.23917187742203694,"score_spread":0.22179690986161804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138597400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98496246,0.005316821,0.0074903043,0.00008342542,0.000010575696,0.000035649333,0.0002432735,0.00016620074,0.0016914025],"genre_scores_gemma":[0.99332076,0.0009551031,0.0049927393,0.000032281503,0.00001262745,0.000014464731,0.00036858465,0.0000105319905,0.0002928918],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983644,0.000033627522,0.00001819105,0.000040666917,0.00003905357,0.000031868305],"domain_scores_gemma":[0.99976426,0.000046794226,0.000073754614,0.000025229441,0.0000412708,0.000048659644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028435144,0.00030797318,0.0001886634,0.0010950664,0.00016633178,0.00027563734,0.00030234118,0.000463725,0.0012094941],"category_scores_gemma":[0.0003617278,0.000110139976,0.00012814999,0.00036716825,0.00027268444,0.00020388796,0.0002462176,0.00027062438,0.00050063763],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024450416,0.000024565185,0.045260653,0.000115917996,0.000022738739,0.0008268764,0.00002881948,0.00007292319,0.94149137,0.0000830768,0.00016205217,0.011666438],"study_design_scores_gemma":[0.0000661452,0.0005888568,0.32866034,0.000078316436,0.00016007955,0.064698525,0.00023347994,0.0038950713,0.59049934,0.00040107712,0.010696139,0.000022580294],"about_ca_topic_score_codex":0.00047192952,"about_ca_topic_score_gemma":0.0005000634,"teacher_disagreement_score":0.0012094941,"about_ca_system_score_codex":0.00019863977,"about_ca_system_score_gemma":0.00013245914,"threshold_uncertainty_score":0.0040462017},"labels":[],"label_agreement":null},{"id":"W2138924647","doi":"10.3324/haematol.13827","title":"In HPA 1a-immunized women the decrease in anti-HPA 1a antibody level during pregnancy is not associated with anti-idiotypic antibodies","year":2009,"lang":"en","type":"letter","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Neonatal alloimmune thrombocytopenia; Antibody; Medicine; Pregnancy; Immunology; Intervention (counseling); Biology; Fetus; Genetics; Psychiatry","score_opus":0.0308254490250642,"score_gpt":0.27945766250538584,"score_spread":0.24863221348032163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138924647","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3353269,0.012206088,0.004841731,0.4711853,0.011118341,0.000251656,0.0005597731,0.00047001228,0.1640401],"genre_scores_gemma":[0.8558233,0.0076905433,0.0014166059,0.0875583,0.018909058,0.00009077087,0.00018694214,0.000065214714,0.02825918],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995732,0.00015596121,0.00003556305,0.00006907411,0.000076117365,0.000090085065],"domain_scores_gemma":[0.99902964,0.00055000413,0.00012299011,0.00008970867,0.00008498211,0.00012263522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033044684,0.0005858777,0.00068820495,0.00036165523,0.0008408225,0.0007492826,0.0005230281,0.0072920043,0.0054006265],"category_scores_gemma":[0.0033715118,0.00025392242,0.0003658836,0.00034588788,0.00097242533,0.0009665641,0.00020507726,0.0040865075,0.003928171],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010525374,0.00049276673,0.09147198,0.00043719896,0.000080618025,0.7175345,0.00061185495,0.00032263913,0.00887843,0.0034445904,0.09747475,0.07819821],"study_design_scores_gemma":[0.00014883761,0.00095630134,0.056187812,0.00024399326,0.000051679704,0.85040736,0.0005666722,0.0014082186,0.0019353757,0.004402826,0.08363413,0.000056680354],"about_ca_topic_score_codex":0.0011516941,"about_ca_topic_score_gemma":0.0014835205,"teacher_disagreement_score":0.0072920043,"about_ca_system_score_codex":0.00065847463,"about_ca_system_score_gemma":0.00026235337,"threshold_uncertainty_score":0.018066883},"labels":[],"label_agreement":null},{"id":"W2139026714","doi":"10.3324/haematol.11168","title":"Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity; Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Medicine; Melphalan; Multiple myeloma; Cyclophosphamide; Internal medicine; Total body irradiation; Regimen; Chemotherapy; Randomized controlled trial; Surgery; Oncology","score_opus":0.06266984780719237,"score_gpt":0.3249320796119417,"score_spread":0.26226223180474934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139026714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892855,0.007935313,0.00019275784,0.0005231271,0.0001875705,0.00041818767,0.0004862185,0.000013371882,0.00095803564],"genre_scores_gemma":[0.9941048,0.0018361101,0.00042771973,0.00061434926,0.00022013944,0.00072150596,0.00085757056,0.0000095167425,0.001208328],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99795437,0.001548713,0.00006231699,0.00018764626,0.00008521387,0.00016179205],"domain_scores_gemma":[0.99806124,0.00055059243,0.0006519338,0.00018243118,0.00008862068,0.00046516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034062902,0.00069390825,0.002203958,0.00021292835,0.00035599648,0.00100837,0.000668508,0.0012955619,0.0018166776],"category_scores_gemma":[0.0026181368,0.00028478145,0.0016342906,0.0003148132,0.00056610926,0.000551886,0.0003524527,0.0015035407,0.00020765806],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97433394,0.0018238252,0.0043166503,0.00026245016,0.0024283822,0.000035642755,0.000032425625,0.00042798993,0.0009033886,0.00007591448,0.00072332175,0.0146361105],"study_design_scores_gemma":[0.84124184,0.10629188,0.043951295,0.00021361612,0.0036814113,0.00013722033,0.00006461525,0.00081337354,0.00064203417,0.00042745782,0.0024960719,0.000039175506],"about_ca_topic_score_codex":0.0019982983,"about_ca_topic_score_gemma":0.0045923092,"teacher_disagreement_score":0.0034062902,"about_ca_system_score_codex":0.001002874,"about_ca_system_score_gemma":0.0011963825,"threshold_uncertainty_score":0.018014371},"labels":[],"label_agreement":null},{"id":"W2139663853","doi":"10.3324/haematol.2014.117457","title":"The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid transformation in inherited bone marrow failure syndromes","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Janeway Children's Health and Rehabilitation Centre; McMaster University; McMaster Children's Hospital; Alberta Health; University of Alberta; University of British Columbia; Centre Hospitalier Universitaire de Sherbrooke; Queen's University; Centre Hospitalier Universitaire Sainte-Justine; Population Health Research Institute; Children's Hospital of Western Ontario; Children's Hospital of Eastern Ontario; Princess Margaret Cancer Centre; Alberta Children's Hospital; Izaak Walton Killam Health Centre; University of Saskatchewan; Hospital for Sick Children; Health Sciences Centre; CancerCare Manitoba; BC Children's Hospital; Montreal Children's Hospital; University of Toronto","funders":"","keywords":"Bone marrow failure; Cytogenetics; Myelodysplastic syndromes; Cytopathology; Myeloid; Bone marrow; Myeloid leukemia; Somatic evolution in cancer; Medicine; Hematopathology; Pathology; Leukemia; Neoplastic transformation; Immunology; Oncology; Internal medicine; Biology; Cancer; Haematopoiesis; Stem cell; Genetics; Cytology; Chromosome; Carcinogenesis","score_opus":0.04833145918210546,"score_gpt":0.3331537975892342,"score_spread":0.28482233840712873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139663853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821764,0.0003174689,0.00015257913,0.000055756038,0.0000036242016,0.000009008734,0.00046038342,0.0000043791406,0.0007791854],"genre_scores_gemma":[0.9994005,0.00007208185,0.00008779228,0.00000972517,0.0000030123088,0.0000023243113,0.00034442797,0.0000017452104,0.00007833998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991721,0.00028630154,0.000042856467,0.00007774215,0.00028261947,0.000138378],"domain_scores_gemma":[0.99584526,0.0016837324,0.0013148497,0.00022575704,0.00046621668,0.00046423305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012092947,0.00022965162,0.00016429195,0.0009845345,0.00032357496,0.0004303119,0.00033626927,0.00022897472,0.0011023874],"category_scores_gemma":[0.0069570425,0.00008758381,0.00032382648,0.0009197995,0.00040213086,0.00021164105,0.00037310107,0.0002728712,0.000107643136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003479702,0.0000028250938,0.998423,0.0000024795877,0.000011955101,0.000033113138,0.00001594163,0.000065721026,0.000051238236,0.000010392439,0.000027259044,0.0013213456],"study_design_scores_gemma":[0.0000019258969,0.000029784258,0.9992176,0.0000036762674,0.00001923908,0.0002613271,0.000047448546,0.00023657532,0.00005236511,0.000022247363,0.000105688465,0.0000021390315],"about_ca_topic_score_codex":0.120088995,"about_ca_topic_score_gemma":0.21123856,"teacher_disagreement_score":0.120088995,"about_ca_system_score_codex":0.0010245792,"about_ca_system_score_gemma":0.0019634892,"threshold_uncertainty_score":0.23878002},"labels":[],"label_agreement":null},{"id":"W2139931147","doi":"10.3324/haematol.2012.082065","title":"Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension","year":2013,"lang":"en","type":"article","venue":"Haematologica","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Heart, Lung, and Blood Institute; National Institutes of Health; Translational Cancer Research Network; Harvard Catalyst; New England Research Institutes; University Health Network; U.S. Food and Drug Administration; American University of Beirut; Bunning Food Allergy Institute, Ann and Robert H. Lurie Children's Hospital of Chicago; University College London; Children's Hospital of Philadelphia","keywords":"Sildenafil; Medicine; Pulmonary hypertension; Internal medicine; Cardiology; Doppler echocardiography; Adverse effect; Population; Diastole; Anesthesia; Blood pressure","score_opus":0.020634911660184052,"score_gpt":0.23973257404994378,"score_spread":0.21909766238975972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139931147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99846834,0.0010176064,0.00011125871,0.000055106164,0.000016390639,0.000063465166,0.00002636137,0.000009888352,0.00023145444],"genre_scores_gemma":[0.9987859,0.00040728718,0.00031546724,0.00016221666,0.000056204848,0.00007501219,0.00007077515,0.0000014824834,0.00012566443],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99971765,0.00015197246,0.000026721478,0.000036351157,0.0000335623,0.00003369241],"domain_scores_gemma":[0.99961996,0.00013593285,0.000078418554,0.000021496135,0.000016568509,0.00012759301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007042385,0.00047660494,0.0012484965,0.00015331981,0.00025738653,0.000458682,0.00016906558,0.0004255634,0.0008183106],"category_scores_gemma":[0.0007079803,0.00021132044,0.0004026913,0.00015810058,0.00028828578,0.00024777278,0.00018851952,0.00088910945,0.00011065517],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38561717,0.029220043,0.21521561,0.0008101047,0.0012584914,0.001988857,0.0010489769,0.0019074327,0.18764752,0.0002836963,0.0011430335,0.17385906],"study_design_scores_gemma":[0.070267335,0.4116447,0.5014125,0.00007630926,0.0010516227,0.0015031431,0.00029159526,0.0034241946,0.007636292,0.00018774538,0.0024533519,0.000051242463],"about_ca_topic_score_codex":0.00033010961,"about_ca_topic_score_gemma":0.000604423,"teacher_disagreement_score":0.0012484965,"about_ca_system_score_codex":0.00018144128,"about_ca_system_score_gemma":0.00031467908,"threshold_uncertainty_score":0.0037244558},"labels":[],"label_agreement":null},{"id":"W2140996066","doi":"10.3324/haematol.12352","title":"Safety and efficacy of pegylated interferon  -2a and ribavirin for the treatment of hepatitis C in patients with thalassemia","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Hepatitis C virus research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Center for Research Resources; National Institutes of Health; National Heart, Lung, and Blood Institute; New England Research Institutes; Deutsches Krebsforschungszentrum","keywords":"Ribavirin; Medicine; Neutropenia; Pegylated interferon; Gastroenterology; Thalassemia; Internal medicine; Liver biopsy; Hepatitis C; Hepatitis C virus; Immunology; Biopsy; Virus; Chemotherapy","score_opus":0.03172767783409712,"score_gpt":0.2944683417804853,"score_spread":0.2627406639463882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140996066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99441284,0.004210239,0.00019875843,0.0001794467,0.00001575918,0.000018399134,0.000036607387,0.000007782456,0.000920213],"genre_scores_gemma":[0.9990369,0.00044693472,0.00016481025,0.00011328604,0.000042136395,0.000008518506,0.000052998308,0.0000014655144,0.000132851],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994005,0.0003616957,0.00004402491,0.000031274594,0.00013093904,0.00003147243],"domain_scores_gemma":[0.9988071,0.0005180168,0.0003897694,0.00005029218,0.0000835729,0.00015125205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013186717,0.00016445777,0.00036695163,0.000212809,0.0001947669,0.00031780862,0.00012366833,0.00029963805,0.0005205741],"category_scores_gemma":[0.0027908657,0.00009313989,0.00031359252,0.00017107184,0.00021564409,0.00020985027,0.00009377067,0.00044299202,0.00013279529],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10299202,0.003656904,0.31310287,0.0004523881,0.00081114477,0.0017007765,0.00051917153,0.0020137464,0.032466676,0.00033807952,0.0014600579,0.54048616],"study_design_scores_gemma":[0.012625098,0.14846675,0.79711515,0.00019206286,0.0012650636,0.009887318,0.0003430532,0.00627602,0.016440047,0.00062148,0.0067164605,0.000051552015],"about_ca_topic_score_codex":0.0002462615,"about_ca_topic_score_gemma":0.00037983112,"teacher_disagreement_score":0.0013186717,"about_ca_system_score_codex":0.00031862408,"about_ca_system_score_gemma":0.00027350045,"threshold_uncertainty_score":0.0069739223},"labels":[],"label_agreement":null},{"id":"W2142866011","doi":"10.3324/haematol.11366","title":"Improved purification of hematopoietic stem cells based on their elevated aldehyde dehydrogenase activity","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Heart, Lung, and Blood Institute; U.S. Public Health Service; University of British Columbia; Deutsche Forschungsgemeinschaft; Genome British Columbia; National Cancer Institute; National Institutes of Health; Michael Smith Health Research BC","keywords":"Aldehyde dehydrogenase; Cord blood; Stem cell; Haematopoiesis; Biology; Population; Myeloid; Molecular biology; Immunology; Chemistry; Biochemistry; Cell biology; Medicine; Enzyme","score_opus":0.02816526969184888,"score_gpt":0.2653788334748141,"score_spread":0.23721356378296524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142866011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9429117,0.0034619665,0.049710013,0.00019095534,0.00004880279,0.00037851624,0.0010922969,0.00037255406,0.0018333147],"genre_scores_gemma":[0.9258596,0.002533627,0.0626606,0.00015060032,0.000058861748,0.00020568453,0.0054388903,0.000105278246,0.0029869583],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998252,0.000034810215,0.000021272199,0.000026399002,0.00007001264,0.000022444],"domain_scores_gemma":[0.99985087,0.000025289926,0.000031301286,0.000022771432,0.00004108438,0.000028606943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002843322,0.00041710815,0.0002551054,0.0004314892,0.00010421204,0.00035759786,0.0002101392,0.00020684529,0.0009697293],"category_scores_gemma":[0.00024259178,0.00010639853,0.0002416179,0.0003920941,0.00013976183,0.00015579803,0.00039116133,0.00052196183,0.0007018332],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000581051,0.000018939638,0.00045184424,0.000033874345,0.0000049384953,0.000028578126,0.000013297213,0.00007197632,0.9953956,0.000053270072,0.00004783088,0.0038216603],"study_design_scores_gemma":[0.00002335451,0.00036365178,0.0057124915,0.000014166254,0.00004924128,0.0004240146,0.000016412485,0.0010188863,0.98733056,0.000058931117,0.004983724,0.0000046692317],"about_ca_topic_score_codex":0.00019939594,"about_ca_topic_score_gemma":0.00034474093,"teacher_disagreement_score":0.0009697293,"about_ca_system_score_codex":0.0001680181,"about_ca_system_score_gemma":0.00017406336,"threshold_uncertainty_score":0.003244102},"labels":[],"label_agreement":null},{"id":"W2144716232","doi":"10.3324/haematol.2013.095257","title":"The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Genentech; GlaxoSmithKline; Pfizer","keywords":"Follicular lymphoma; Lymphoma; Flow cytometry; Pathology; Medicine; Biomarker; Immunophenotyping; Tumor microenvironment; Tissue microarray; Cytometry; Immunohistochemistry; Oncology; Biology; Immunology; Immune system","score_opus":0.012448043695978454,"score_gpt":0.2525029391425586,"score_spread":0.24005489544658015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144716232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98029697,0.0021563857,0.012715726,0.00029561183,0.00010484742,0.00043745214,0.000995483,0.00021310587,0.0027844773],"genre_scores_gemma":[0.988598,0.0001810252,0.0070999926,0.000249789,0.00006786542,0.00041646892,0.0026784628,0.000091434275,0.00061689096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9739622,0.010741503,0.002399826,0.004794574,0.0073792953,0.0007226584],"domain_scores_gemma":[0.9564983,0.014034407,0.005257427,0.008620774,0.014618262,0.00097080367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.038106933,0.00062482775,0.0007888069,0.0025027345,0.0009965369,0.0016612967,0.0014501923,0.0012457572,0.0010449024],"category_scores_gemma":[0.038063295,0.00041923064,0.00082160387,0.0013304644,0.0012384775,0.00071136316,0.0014555134,0.0004837153,0.00073269295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012153863,0.00032338747,0.92686105,0.00023386857,0.0007794719,0.0002546517,0.0012816298,0.0010821266,0.028881835,0.00023488828,0.0018842842,0.03696748],"study_design_scores_gemma":[0.00016362216,0.0010795984,0.9586983,0.00012524414,0.0006469281,0.0010355781,0.00047224318,0.0053300257,0.023758342,0.00029161127,0.008329031,0.00006951561],"about_ca_topic_score_codex":0.0037189075,"about_ca_topic_score_gemma":0.003193418,"teacher_disagreement_score":0.038106933,"about_ca_system_score_codex":0.00091053656,"about_ca_system_score_gemma":0.0008604931,"threshold_uncertainty_score":0.20153111},"labels":[],"label_agreement":null},{"id":"W2146185798","doi":"10.3324/haematol.2009.015917","title":"Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Celgene","keywords":"Lenalidomide; Medicine; Complete response; Dexamethasone; Multiple myeloma; Refractory (planetary science); Adverse effect; Internal medicine; Progressive disease; Surgery; Chemotherapy; Materials science","score_opus":0.0662267828043679,"score_gpt":0.375866646101104,"score_spread":0.3096398632967361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146185798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829312,0.015139778,0.0005178045,0.000151742,0.000022160779,0.000066646535,0.0006210052,0.000024601342,0.00052502984],"genre_scores_gemma":[0.9987723,0.000499992,0.00013884096,0.00006510213,0.000044005632,0.000019929907,0.0003992213,0.000004114703,0.00005648161],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99713564,0.0015253016,0.00043222273,0.0004083312,0.00037754563,0.00012096401],"domain_scores_gemma":[0.9894567,0.002701189,0.0063541364,0.0006325333,0.00041178789,0.000443719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069928668,0.00043432816,0.0014766594,0.00086903694,0.0002658579,0.0009469187,0.00039908526,0.00051780354,0.0011317908],"category_scores_gemma":[0.007880978,0.000273706,0.0018560799,0.0010207434,0.00032316835,0.00043147846,0.000522606,0.00048586132,0.00014579263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013487857,0.00010905853,0.9580062,0.00035784536,0.009235134,0.000070992675,0.000045909903,0.0005326945,0.0013027285,0.00002623575,0.00024351022,0.016581846],"study_design_scores_gemma":[0.00075018784,0.0027292776,0.99025714,0.00006431342,0.0039932467,0.0004881484,0.000042529377,0.00046703973,0.0004889102,0.000068697576,0.0006329544,0.000017513246],"about_ca_topic_score_codex":0.00046226132,"about_ca_topic_score_gemma":0.00063305907,"teacher_disagreement_score":0.0069928668,"about_ca_system_score_codex":0.00039123796,"about_ca_system_score_gemma":0.0003396842,"threshold_uncertainty_score":0.03698224},"labels":[],"label_agreement":null},{"id":"W2146586379","doi":"10.3324/haematol.2011.050724","title":"Atypical autoimmune hemolytic anemia","year":2011,"lang":"fi","type":"letter","venue":"Haematologica","topic":"Blood groups and transfusion","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Autoimmune hemolytic anemia; Medicine; Hemolytic anemia; Anemia; Immunology; Internal medicine","score_opus":0.03271697741986876,"score_gpt":0.24754423359562192,"score_spread":0.21482725617575316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146586379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5520053,0.052188903,0.01906176,0.019735921,0.0029441766,0.0027930394,0.011859625,0.0032428282,0.3361685],"genre_scores_gemma":[0.9289898,0.008304284,0.0042128456,0.005102894,0.001036483,0.0002489557,0.004323241,0.00014892744,0.047632586],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99936837,0.00013100966,0.000047760353,0.00018389153,0.0001263209,0.00014263803],"domain_scores_gemma":[0.9993067,0.00023029566,0.000099094555,0.000083239334,0.00013134422,0.00014932967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038988792,0.0022475543,0.0013368133,0.0019619602,0.00081305584,0.00053704396,0.0009145156,0.0011212672,0.022155868],"category_scores_gemma":[0.001717656,0.00038722059,0.00071155606,0.0011698623,0.00037491624,0.000613938,0.0006097723,0.0017887095,0.0044569722],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010975115,0.00087414915,0.065546654,0.0006825863,0.00031306202,0.79817617,0.0006401682,0.0004098688,0.01664405,0.0055555087,0.045813415,0.064246915],"study_design_scores_gemma":[0.0002515258,0.0006871341,0.08207725,0.0003984752,0.00019685125,0.8377493,0.00022812921,0.001504422,0.0023281965,0.003455737,0.071042895,0.0000801216],"about_ca_topic_score_codex":0.00236297,"about_ca_topic_score_gemma":0.0017684147,"teacher_disagreement_score":0.022155868,"about_ca_system_score_codex":0.0005941868,"about_ca_system_score_gemma":0.00047384482,"threshold_uncertainty_score":0.07411879},"labels":[],"label_agreement":null},{"id":"W2147426382","doi":"10.3324/haematol.2009.016220","title":"Impact of genomic risk factors on outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukemia","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Genetics","funders":"Medical Research Council; National Research Foundation; Amgen; European Commission; Les Laboratories Pierre Fabre; Gilead Sciences; F. Hoffmann-La Roche","keywords":"Transplantation; Oncology; Hematopoietic stem cell transplantation; Internal medicine; Immunology; Myeloid leukemia; Medicine; Biology","score_opus":0.012753935256534158,"score_gpt":0.25878793689998686,"score_spread":0.2460340016434527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147426382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99964845,0.00013369056,0.000082704006,0.000019009714,0.0000023881287,0.0000015356375,0.000043105432,0.0000016106577,0.00006747979],"genre_scores_gemma":[0.9998153,0.000025993162,0.000047231206,0.0000047915664,0.000004480642,0.0000015850367,0.000070100396,8.3752013e-7,0.000029681894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963963,0.00016717071,0.000023860419,0.00006220128,0.00006010551,0.00004709065],"domain_scores_gemma":[0.99837697,0.0008067206,0.00043978376,0.000104347586,0.00007919849,0.00019307526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006585057,0.0002870196,0.00028041328,0.0002893277,0.00020180129,0.00028793392,0.00018435057,0.00028057242,0.0010201106],"category_scores_gemma":[0.0023796356,0.000068357454,0.00031797166,0.00032014595,0.0002962928,0.00016382062,0.00025755345,0.00036384875,0.00013146996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003064484,0.000029264065,0.9966085,0.000006503749,0.00005645435,0.0000623953,0.000018503195,0.00019194435,0.00043551883,0.000010390097,0.000027229857,0.0022469284],"study_design_scores_gemma":[0.000012652922,0.00034193663,0.9980678,0.0000037362324,0.00008647009,0.00032761722,0.000041651816,0.0006495838,0.00032149543,0.00006136193,0.000082750994,0.000002920874],"about_ca_topic_score_codex":0.0005896934,"about_ca_topic_score_gemma":0.0008430628,"teacher_disagreement_score":0.0010201106,"about_ca_system_score_codex":0.00016952484,"about_ca_system_score_gemma":0.0002507647,"threshold_uncertainty_score":0.0034825802},"labels":[],"label_agreement":null},{"id":"W2147758514","doi":"10.3324/haematol.2009.010264","title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype","year":2009,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":402,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Instituto de Salud Carlos III; Julius-Maximilians-Universität Würzburg","keywords":"Mantle cell lymphoma; Cyclin D1; Cancer research; Lymphoma; BCL10; Biology; Cyclin D2; Pathology; Medicine; Cell; Cell cycle; Immunology; Genetics","score_opus":0.025375690484738173,"score_gpt":0.2710360779570358,"score_spread":0.24566038747229765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147758514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983309,0.00037938534,0.00048271284,0.000013346285,0.0000024413346,0.0000048020925,0.00012607765,0.000011204827,0.00064922764],"genre_scores_gemma":[0.9986148,0.0002151124,0.00051537884,0.000010387469,0.0000070479114,0.0000070097567,0.00040405648,0.0000043161976,0.00022203862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998772,0.000014140217,0.000013016495,0.0000385345,0.00003533536,0.00002180961],"domain_scores_gemma":[0.999605,0.000112780916,0.00015428147,0.000030520492,0.000049957915,0.00004748985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001885697,0.00015026478,0.00013111829,0.0006910464,0.00015208653,0.00031250287,0.00012965457,0.00019060714,0.0019972117],"category_scores_gemma":[0.0005125871,0.00010118617,0.000112511414,0.00042584908,0.00029178703,0.00013626523,0.00014658761,0.00011162712,0.0003659647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004591334,0.000025096766,0.607297,0.000120783465,0.000043085405,0.0016586408,0.0001867241,0.00008627099,0.37860942,0.00009970325,0.00029356024,0.011120619],"study_design_scores_gemma":[0.000026288673,0.00012266073,0.9193177,0.00002044946,0.00005478805,0.013612495,0.00029695412,0.0005976556,0.062407553,0.00014655193,0.0033902165,0.0000066131993],"about_ca_topic_score_codex":0.0004415904,"about_ca_topic_score_gemma":0.000835988,"teacher_disagreement_score":0.0019972117,"about_ca_system_score_codex":0.00016984827,"about_ca_system_score_gemma":0.00009609142,"threshold_uncertainty_score":0.006681323},"labels":[],"label_agreement":null},{"id":"W2148382458","doi":"10.3324/haematol.2014.109280","title":"Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children; Sahlgrenska Universitetssjukhuset; Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu; Rigshospitalet; Fondazione IRCCS Policlinico San Matteo; Ege Üniversitesi; Centro Nazionale Sangue; Helsingin Yliopisto; Akdeniz Üniversitesi; King Faisal Specialist Hospital and Research Centre; National Institute for Health and Care Research","keywords":"Medicine; Cumulative incidence; Umbilical cord; Transplantation; Umbilical Cord Blood Transplantation; Surgery; Regimen; Incidence (geometry); Internal medicine; Gastroenterology; Hematopoietic stem cell transplantation; Immunology","score_opus":0.022457058221704757,"score_gpt":0.26271965016207777,"score_spread":0.240262591940373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148382458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99979883,0.00008656341,0.00004555932,0.000003584533,5.4580073e-7,0.0000012424208,0.000012422035,0.0000013851775,0.00004994373],"genre_scores_gemma":[0.9998652,0.000036263787,0.00002263848,0.0000029545874,0.0000011598426,0.0000012156065,0.000041076422,7.719324e-7,0.000028623017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979514,0.00006512438,0.000025211435,0.000030019546,0.000038205388,0.00004623161],"domain_scores_gemma":[0.9987809,0.00037150917,0.0005638891,0.00007714182,0.00005258739,0.00015392982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044118438,0.00016739604,0.00022666398,0.00038041983,0.00014632227,0.00040341367,0.00014864148,0.00021267371,0.00048989983],"category_scores_gemma":[0.002034637,0.0001072941,0.00019682944,0.00035257978,0.00023330309,0.00029582,0.00022599738,0.00028637095,0.00015830515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011683269,0.000069342066,0.9863131,0.000010968242,0.00004788256,0.0005995103,0.00013144186,0.0010142372,0.004197234,0.000041952968,0.000046032925,0.006359922],"study_design_scores_gemma":[0.000025647096,0.0012914754,0.9894729,0.000010018378,0.000051072217,0.0027194093,0.00014852372,0.002286435,0.003626986,0.0000872366,0.0002681475,0.000012249666],"about_ca_topic_score_codex":0.0010026514,"about_ca_topic_score_gemma":0.00059752184,"teacher_disagreement_score":0.0010026514,"about_ca_system_score_codex":0.00036939766,"about_ca_system_score_gemma":0.00012526427,"threshold_uncertainty_score":0.0026801825},"labels":[],"label_agreement":null},{"id":"W2149546612","doi":"10.3324/haematol.2014.111245","title":"A phase I trial of ribavirin and low-dose cytarabine for the treatment of relapsed and refractory acute myeloid leukemia with elevated eIF4E","year":2014,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer; Jewish General Hospital","funders":"U.S. Public Health Service; National Institutes of Health; Université de Montréal; Jewish General Hospital; Centre National de la Recherche Scientifique; McGill University; Leukemia and Lymphoma Society","keywords":"Cytarabine; Medicine; Refractory (planetary science); Ribavirin; Myeloid leukemia; Internal medicine; Acute leukemia; Myeloid; Gastroenterology; Oncology; Pharmacology; Leukemia; Virology; Biology","score_opus":0.036414860354981995,"score_gpt":0.31857175451332226,"score_spread":0.2821568941583403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149546612","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32178897,0.012064994,0.0022402545,0.6162902,0.017052257,0.00082740746,0.000906411,0.00023250193,0.028596919],"genre_scores_gemma":[0.66579264,0.0053038374,0.0030399642,0.29184332,0.016895283,0.0003927743,0.0009877435,0.00006921298,0.01567525],"study_design_codex":"not_applicable","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999337,0.0003119366,0.000049192433,0.00008333686,0.000110131565,0.000108358494],"domain_scores_gemma":[0.9989531,0.00056680554,0.00007363211,0.000030539995,0.0000753339,0.00030059626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000958658,0.00048233246,0.0008899557,0.00021450759,0.0009017814,0.00088826317,0.00084376475,0.005786687,0.0016553922],"category_scores_gemma":[0.0029524826,0.00025681197,0.0006390023,0.00024331846,0.0007424881,0.00075536815,0.0002535252,0.006371025,0.0006976693],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05446179,0.005840249,0.02777112,0.0007627814,0.0007346336,0.14229122,0.00072059355,0.0024815318,0.02377502,0.009961161,0.51268953,0.21851042],"study_design_scores_gemma":[0.15317738,0.052019417,0.0540724,0.0006659296,0.0010450778,0.16680017,0.00091328204,0.019145971,0.016713712,0.028142976,0.5070184,0.00028525834],"about_ca_topic_score_codex":0.0008049376,"about_ca_topic_score_gemma":0.002394635,"teacher_disagreement_score":0.005786687,"about_ca_system_score_codex":0.001713638,"about_ca_system_score_gemma":0.000904131,"threshold_uncertainty_score":0.01243335},"labels":[],"label_agreement":null},{"id":"W2150839845","doi":"10.3324/haematol.13690","title":"Caspase-independent type III programmed cell death in chronic lymphocytic leukemia: the key role of the F-actin cytoskeleton","year":2009,"lang":"en","type":"article","venue":"Haematologica","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"Ligue Contre le Cancer; Fondation de France; Association pour la Recherche sur le Cancer","keywords":"Programmed cell death; Chronic lymphocytic leukemia; Cell biology; Biology; Apoptosis; Caspase; Cell; Leukemia; Immunology; Biochemistry","score_opus":0.014411454275946058,"score_gpt":0.23636434257031955,"score_spread":0.22195288829437348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150839845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99272776,0.004121707,0.0022422082,0.00006923432,0.000007892414,0.000029730943,0.0001786361,0.000021089032,0.0006017348],"genre_scores_gemma":[0.9962373,0.0018499831,0.0012313101,0.0000299925,0.000016974149,0.000024011235,0.00024432628,0.0000040383284,0.00036204956],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992824,0.000014680486,0.0000062289146,0.000014310548,0.0000139230715,0.000022629783],"domain_scores_gemma":[0.999933,0.000011098704,0.000026914391,0.0000071321883,0.000010742593,0.000011087131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012964109,0.0002828055,0.00009374482,0.00019838329,0.0001225052,0.00021443622,0.000108304455,0.00019369238,0.00049823587],"category_scores_gemma":[0.00008503722,0.000049648253,0.0001086287,0.000114787705,0.00023484835,0.00020039812,0.000093935254,0.000237891,0.00014014082],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028422262,0.00004872888,0.004822194,0.00010515075,0.0000050598724,0.00020748314,0.000031823183,0.00007204698,0.9894727,0.00017199777,0.000051459912,0.004727089],"study_design_scores_gemma":[0.000067650355,0.0010724707,0.10746373,0.00003266497,0.00004375256,0.0037933001,0.000119595235,0.0014293569,0.881608,0.000365736,0.00399346,0.000010209527],"about_ca_topic_score_codex":0.00026122644,"about_ca_topic_score_gemma":0.00034469756,"teacher_disagreement_score":0.00049823587,"about_ca_system_score_codex":0.00030381483,"about_ca_system_score_gemma":0.00012030614,"threshold_uncertainty_score":0.0022043586},"labels":[],"label_agreement":null},{"id":"W2153333353","doi":"10.3324/haematol.10963","title":"Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports","year":2007,"lang":"en","type":"review","venue":"Haematologica","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mach-Gaensslen Foundation of Canada","keywords":"Thrombotic thrombocytopenic purpura; Medicine; Pancreatitis; Acute pancreatitis; Etiology; Internal medicine; Gastroenterology; Platelet","score_opus":0.02529547746938631,"score_gpt":0.3088290440220717,"score_spread":0.28353356655268536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153333353","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04537031,0.9498325,0.00036654432,0.000471674,0.00017088783,0.00041083051,0.0024309875,0.000025295487,0.00092104945],"genre_scores_gemma":[0.25442755,0.73832303,0.0019292759,0.0013477139,0.00027372988,0.000749534,0.0027522454,0.000028362561,0.0001685253],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98561794,0.0023180163,0.008658102,0.00115023,0.0019770165,0.00027879493],"domain_scores_gemma":[0.9556126,0.020164074,0.017851382,0.0013809927,0.004327524,0.00066345907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057934145,0.0009209768,0.0033373288,0.020785391,0.00097582315,0.002419972,0.001215722,0.0014546037,0.0012106807],"category_scores_gemma":[0.02590191,0.0008891984,0.002941958,0.02347305,0.0011895037,0.00171846,0.0016511392,0.00059442385,0.00025791224],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010490409,0.00014985222,0.17779237,0.64356375,0.023882518,0.01981979,0.0038897824,0.00022140282,0.0022529503,0.00041347166,0.0073443186,0.11962078],"study_design_scores_gemma":[0.00051115156,0.0008651787,0.2748068,0.4892703,0.115595065,0.05831628,0.0040911105,0.00030524205,0.0020657107,0.0004892187,0.05343152,0.00025244858],"about_ca_topic_score_codex":0.0031797965,"about_ca_topic_score_gemma":0.009509326,"teacher_disagreement_score":0.020785391,"about_ca_system_score_codex":0.00175059,"about_ca_system_score_gemma":0.005698616,"threshold_uncertainty_score":0.030638814},"labels":[],"label_agreement":null},{"id":"W2153524572","doi":"10.3324/haematol.2011.047050","title":"Family-directed umbilical cord blood banking","year":2011,"lang":"en","type":"review","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu; University of Cape Town; Università degli Studi di Torino; Hospital for Sick Children; Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu; Sahlgrenska Universitetssjukhuset; Akdeniz Üniversitesi; Medizinischen Hochschule Hannover; Hacettepe Üniversitesi; Rigshospitalet; Radboud Universiteit; Institut National de la Santé et de la Recherche Médicale; Imperial College London; King Faisal Specialist Hospital and Research Centre; Fondazione IRCCS Policlinico San Matteo; Universität Heidelberg; Friedrich-Schiller-Universität Jena; Helsingin Yliopisto; National Institute for Health and Care Research; Ankara Universitesi; Ege Üniversitesi","keywords":"Cord blood; Umbilical cord; Medicine; Transplantation; Sibling; Haematopoiesis; Hematopoietic stem cell transplantation; Stem cell; Immunology; Intensive care medicine; Surgery; Biology; Psychology","score_opus":0.12528113140216768,"score_gpt":0.3488847944632607,"score_spread":0.22360366306109303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153524572","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025785938,0.99715805,0.00023557513,0.00017603005,0.00010238037,0.000005151266,0.000017024287,0.000010866467,0.0020371336],"genre_scores_gemma":[0.0025683797,0.99626094,0.00023135719,0.00013872028,0.000106644,0.0000068645422,0.000044696153,0.0000021794249,0.000640226],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997222,0.00005761884,0.00004450906,0.00005984364,0.00009424869,0.000021585314],"domain_scores_gemma":[0.9994642,0.0002709089,0.00009548018,0.000029653906,0.000103731756,0.00003602661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063654693,0.00069904764,0.000971727,0.0019954056,0.00021630345,0.0007961011,0.0008276918,0.0007519904,0.003971966],"category_scores_gemma":[0.0014884326,0.00013932858,0.00042949885,0.0022597753,0.00042622394,0.0008748535,0.0005007882,0.0008205637,0.0023668883],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028547205,0.00003219839,0.0005675685,0.0057426677,0.000059711674,0.00045100963,0.000032078184,0.000111034096,0.00047677674,0.0011466214,0.014360606,0.97699124],"study_design_scores_gemma":[0.000025975292,0.00008913324,0.0044228216,0.006781336,0.00021444418,0.015215104,0.00013751967,0.00011272978,0.0013003753,0.00189546,0.9697845,0.0000205351],"about_ca_topic_score_codex":0.0010269505,"about_ca_topic_score_gemma":0.001283231,"teacher_disagreement_score":0.003971966,"about_ca_system_score_codex":0.0003985051,"about_ca_system_score_gemma":0.0007991898,"threshold_uncertainty_score":0.013287544},"labels":[],"label_agreement":null},{"id":"W2153616582","doi":"10.3324/haematol.2013.090142","title":"High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Università degli Studi del Piemonte Orientale; Fondazione Umberto Veronesi; Università di Catania","keywords":"IRF4; Multiple myeloma; Bortezomib; XBP1; Transcription factor; Cancer research; Bone marrow; Monoclonal antibody; Antibody; Interferon regulatory factors; Medicine; Molecular biology; Immunology; Internal medicine; Biology; Gene","score_opus":0.028084629137060443,"score_gpt":0.27910227334030424,"score_spread":0.2510176442032438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153616582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99856025,0.0008666639,0.000070849776,0.000025011923,0.0000062456324,0.000010708802,0.00021753265,0.000005231756,0.00023745504],"genre_scores_gemma":[0.99909854,0.00023865874,0.00007433014,0.000028446479,0.000021422848,0.000015197854,0.00036705926,0.0000019691554,0.00015437811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981874,0.000030353507,0.000022156477,0.00004975433,0.000046831778,0.000032116888],"domain_scores_gemma":[0.99949515,0.000076418786,0.00024791347,0.000021697753,0.000037857906,0.00012089611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026770835,0.0002876587,0.00058025727,0.0005448958,0.00039511992,0.00049263507,0.0001905897,0.00029842413,0.001187634],"category_scores_gemma":[0.00069576467,0.00019543045,0.00023176684,0.0005866642,0.00018669103,0.0002303503,0.0002997935,0.0004447391,0.00019043982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002501817,0.00008571923,0.9870968,0.00003158126,0.00010314461,0.00017148365,0.000057351815,0.0000956986,0.004728645,0.000012585889,0.0001525977,0.004962639],"study_design_scores_gemma":[0.00003579609,0.0003276182,0.9983354,0.000004992271,0.000054690485,0.0003695294,0.000034205998,0.00014132632,0.00040772223,0.0000130193475,0.0002725641,0.0000032961543],"about_ca_topic_score_codex":0.00067873,"about_ca_topic_score_gemma":0.0007059244,"teacher_disagreement_score":0.001187634,"about_ca_system_score_codex":0.00024373988,"about_ca_system_score_gemma":0.0001677978,"threshold_uncertainty_score":0.003973007},"labels":[],"label_agreement":null},{"id":"W2154092055","doi":"10.3324/haematol.2014.108530","title":"Markedly perturbed hematopoiesis in acid ceramidase deficient mice","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research; National Institutes of Health; National Institute of Neurological Disorders and Stroke; University of Toronto","keywords":"Ceramide; Sphingolipid; Inflammation; Disease; Biochemistry; Haematopoiesis; Cancer; Diabetes mellitus; Chemistry; Cancer research; Internal medicine; Biology; Medicine; Endocrinology; Cell biology; Apoptosis; Stem cell","score_opus":0.02243007129139411,"score_gpt":0.24663201643177401,"score_spread":0.22420194514037992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154092055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79123557,0.019035967,0.03402138,0.08390121,0.005236669,0.0005987063,0.0038241125,0.006896153,0.055250227],"genre_scores_gemma":[0.94369304,0.005727877,0.01314994,0.018841365,0.0013585464,0.00023424167,0.00081050367,0.00029288896,0.015891623],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996331,0.0000651099,0.000027789103,0.00009244581,0.00013570757,0.000045898047],"domain_scores_gemma":[0.99960965,0.00012374055,0.00009537439,0.000048090027,0.000021947199,0.00010134723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033580538,0.0006135704,0.00041162694,0.0003558436,0.00030777857,0.0005388835,0.00045901508,0.0021010973,0.0024826166],"category_scores_gemma":[0.00076247007,0.00021663657,0.00027389842,0.00017863799,0.00071464514,0.0003243706,0.0004314982,0.0024617233,0.0012179886],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024888015,0.0002698001,0.0035308425,0.00042088382,0.0000765471,0.14513834,0.000308619,0.00075427035,0.72786987,0.01572759,0.032734208,0.07068022],"study_design_scores_gemma":[0.0009948474,0.002290603,0.026716564,0.00040781216,0.00020303916,0.41167074,0.000250691,0.0071303984,0.2890737,0.019329568,0.24178016,0.00015187424],"about_ca_topic_score_codex":0.00015806094,"about_ca_topic_score_gemma":0.00033179065,"teacher_disagreement_score":0.0024826166,"about_ca_system_score_codex":0.0005691862,"about_ca_system_score_gemma":0.00015382179,"threshold_uncertainty_score":0.008305192},"labels":[],"label_agreement":null},{"id":"W2154610817","doi":"10.3324/haematol.2011.049676","title":"Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience","year":2012,"lang":"en","type":"article","venue":"Haematologica","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Etablissement Français du Sang; GIS-Institut des Maladies Rares","keywords":"ADAMTS13; Thrombotic thrombocytopenic purpura; Medicine; Purpura (gastropod); Thrombocytopenic purpura; Internal medicine; Immunology; Pediatrics; Platelet","score_opus":0.08371613946296001,"score_gpt":0.2979102285476568,"score_spread":0.21419408908469678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154610817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98055995,0.0006691707,0.01615041,0.0003125731,0.00006896508,0.00015470656,0.0010039983,0.00035581476,0.0007243697],"genre_scores_gemma":[0.9902587,0.00019305864,0.0070954133,0.00005277839,0.000037720343,0.00011013249,0.0019806381,0.000021437216,0.00025012705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990125,0.0005464098,0.00006123957,0.00018120493,0.000109069246,0.00008964812],"domain_scores_gemma":[0.99518484,0.0032221144,0.00026822262,0.00020792526,0.0008591141,0.00025777603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064637926,0.0012228499,0.0010200625,0.001626827,0.0004758323,0.0014647905,0.0009389379,0.0008460702,0.0011697788],"category_scores_gemma":[0.009181635,0.0002512675,0.0008974232,0.0005822895,0.00024355101,0.00034922428,0.00052766124,0.00083305134,0.0004099835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025791782,0.0006952576,0.8388837,0.000099467616,0.00069138955,0.0004427839,0.00018900818,0.05610224,0.0012579084,0.00021046613,0.0045188563,0.09432973],"study_design_scores_gemma":[0.00024953962,0.0010067363,0.18469687,0.00007448893,0.00039697115,0.0003718041,0.0002003773,0.81071025,0.0008523319,0.00036823828,0.0010363925,0.00003597343],"about_ca_topic_score_codex":0.021405624,"about_ca_topic_score_gemma":0.008061424,"teacher_disagreement_score":0.021405624,"about_ca_system_score_codex":0.0009485581,"about_ca_system_score_gemma":0.001494394,"threshold_uncertainty_score":0.042562068},"labels":[],"label_agreement":null},{"id":"W2154663549","doi":"10.3324/haematol.2011.060657","title":"Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded","year":2012,"lang":"en","type":"article","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Thrombosis and Atherosclerosis Research Institute; McMaster University Medical Centre","funders":"","keywords":"Deep vein; D-dimer; Thrombosis; Medicine; Value (mathematics); Internal medicine; Cardiology; Surgery; Statistics; Mathematics","score_opus":0.06642581865203963,"score_gpt":0.336319196925367,"score_spread":0.2698933782733274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154663549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825937,0.0005474779,0.0006297644,0.00004773361,0.000010999188,0.000011933722,0.00011185774,0.000010065276,0.00037083373],"genre_scores_gemma":[0.99901056,0.00013577771,0.0005982207,0.000034177814,0.000024068022,0.000008875045,0.00016003956,0.0000016043427,0.000026720105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985936,0.00062138657,0.00016012172,0.0002258242,0.00032182893,0.00007722009],"domain_scores_gemma":[0.9906281,0.005078632,0.00290292,0.00050826796,0.00047082722,0.00041118148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029451319,0.0003038968,0.00042939017,0.0006387079,0.00014361957,0.0005138274,0.00026995258,0.00052537996,0.0007075547],"category_scores_gemma":[0.010094899,0.00013222607,0.00037347293,0.00044650643,0.00024105322,0.0004777792,0.00032818512,0.0003858088,0.00018727474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028756348,0.000036902635,0.99237144,0.000015594564,0.000043418324,0.000051904553,0.000022640112,0.00012578626,0.0005091148,0.000017132865,0.00010755068,0.0064111],"study_design_scores_gemma":[0.00003665784,0.00048459723,0.9967002,0.000018739944,0.0000781161,0.0008298459,0.00002266033,0.0009784019,0.00047747043,0.00006227555,0.00030561938,0.0000053557164],"about_ca_topic_score_codex":0.0003149465,"about_ca_topic_score_gemma":0.00042040824,"teacher_disagreement_score":0.0029451319,"about_ca_system_score_codex":0.00017178697,"about_ca_system_score_gemma":0.00018153472,"threshold_uncertainty_score":0.015575469},"labels":[],"label_agreement":null},{"id":"W2156365530","doi":"10.3324/haematol.13071","title":"Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Institutes of Health; National Cancer Institute; Instituto de Salud Carlos III; Julius-Maximilians-Universität Würzburg; Comisión Interministerial de Ciencia y Tecnología","keywords":"Comparative genomic hybridization; Biology; Lymphoma; Gene; Gene expression; Genetics; Burkitt's lymphoma; Cancer research; Genome; Immunology","score_opus":0.03160698927732969,"score_gpt":0.2620339191997436,"score_spread":0.23042692992241393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156365530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994623,0.00019333752,0.0001658065,0.00000578513,6.8468336e-7,0.00000403048,0.00004480148,0.000003188694,0.00011998007],"genre_scores_gemma":[0.9996296,0.000046529578,0.0001464197,0.000007335493,0.0000018892415,0.0000073123115,0.00013342961,0.0000012296108,0.000026273396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977213,0.00003879645,0.0000265172,0.000072457675,0.000038658243,0.000051570856],"domain_scores_gemma":[0.9996816,0.00010995636,0.00011680072,0.000024159644,0.00003280692,0.000034752808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020919561,0.00019143039,0.00021920074,0.00086746836,0.00019377052,0.00030405333,0.00015919551,0.00027478693,0.0007257492],"category_scores_gemma":[0.00077757606,0.000103286344,0.00011114066,0.0006155701,0.00027085876,0.0001731742,0.0003191911,0.00016619432,0.0001323088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011163143,0.000042943164,0.7275367,0.00006853749,0.0000722904,0.00258719,0.0006394487,0.00027168443,0.25853,0.00018866741,0.00009184241,0.008854436],"study_design_scores_gemma":[0.000039298306,0.00043517022,0.964023,0.000009729295,0.0000796321,0.014433773,0.00071921136,0.00067063415,0.018232308,0.00031141483,0.001035935,0.000010028969],"about_ca_topic_score_codex":0.0004436107,"about_ca_topic_score_gemma":0.00053313887,"teacher_disagreement_score":0.00086746836,"about_ca_system_score_codex":0.00024549116,"about_ca_system_score_gemma":0.00009074475,"threshold_uncertainty_score":0.002427876},"labels":[],"label_agreement":null},{"id":"W2157045826","doi":"10.3324/haematol.2008.001743","title":"International recommendations on the diagnosis and treatment of patients with acquired hemophilia A","year":2009,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":430,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Genentech; Ipsen; American Heart Association; Novo Nordisk; Grifols; Bayer HealthCare","keywords":"Medicine; Intensive care medicine; Rituximab; Coagulation; Prothrombin complex concentrate; Autoantibody; Coagulopathy; Recombinant factor VIIa; Factor IX; Pediatrics; Internal medicine; Warfarin; Immunology; Antibody","score_opus":0.061380283113684174,"score_gpt":0.32598292267929685,"score_spread":0.2646026395656127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157045826","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010448158,0.1260634,0.062707216,0.52607864,0.027373482,0.003629774,0.0041838232,0.0017848355,0.23773062],"genre_scores_gemma":[0.0822331,0.1581517,0.5222363,0.14226992,0.0112581095,0.009622131,0.01547056,0.0005688585,0.058189362],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98801744,0.005016838,0.003295009,0.00032008675,0.0027761462,0.00057446305],"domain_scores_gemma":[0.97438407,0.0063211774,0.0025891317,0.0008436463,0.013983165,0.0018788012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0129095,0.0014576355,0.0013580266,0.0033660224,0.001294815,0.0015508455,0.004360769,0.0059531312,0.006653673],"category_scores_gemma":[0.026508195,0.00055894325,0.0019484959,0.0028204839,0.0012829639,0.0013589154,0.0017484814,0.0074621616,0.0033823925],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010710986,0.00048337888,0.006185438,0.0013104996,0.000086666456,0.0009766337,0.0006161502,0.0011839197,0.00077019,0.0057913014,0.6619018,0.32058698],"study_design_scores_gemma":[0.00027033084,0.00026389718,0.01801149,0.008003869,0.00029752025,0.0032394766,0.001022998,0.0013027462,0.00092474086,0.007829795,0.9587431,0.000089948655],"about_ca_topic_score_codex":0.010719399,"about_ca_topic_score_gemma":0.0116311675,"teacher_disagreement_score":0.0129095,"about_ca_system_score_codex":0.0021252907,"about_ca_system_score_gemma":0.009363743,"threshold_uncertainty_score":0.06827277},"labels":[],"label_agreement":null},{"id":"W2158156680","doi":"10.3324/haematol.2011.047811","title":"European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Myelofibrosis; Medicine; Essential thrombocythemia; Thrombocytosis; Bone marrow; Internal medicine; Pathology; Polycythemia vera; Platelet","score_opus":0.07262760918209814,"score_gpt":0.2989729651666889,"score_spread":0.22634535598459077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158156680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976363,0.00813933,0.0024406489,0.001160303,0.00096746976,0.0037109782,0.0021763297,0.00007465137,0.0049672322],"genre_scores_gemma":[0.9895409,0.00049868756,0.0027598732,0.00085084897,0.00028239572,0.0024388195,0.0024860923,0.000043574368,0.0010989398],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.95865697,0.033951145,0.0015901426,0.0028597969,0.0021727895,0.0007691587],"domain_scores_gemma":[0.92816216,0.03563566,0.012957432,0.013844247,0.005823395,0.0035770594],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.062209304,0.0012161748,0.0022898167,0.00081673113,0.0009871409,0.002324322,0.0016782657,0.0034886906,0.002581022],"category_scores_gemma":[0.06416973,0.00062299275,0.0016090623,0.00088509877,0.0017238363,0.0016243855,0.0016928077,0.0018500552,0.0005082396],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77508175,0.0022906803,0.17435792,0.0006746345,0.0065342723,0.000167196,0.000591259,0.0015885776,0.0016858304,0.0012294727,0.004594761,0.031203615],"study_design_scores_gemma":[0.37612128,0.0428921,0.5486658,0.0012358449,0.006658287,0.0005947928,0.00045754097,0.007552278,0.0032492273,0.002397094,0.009939071,0.00023673227],"about_ca_topic_score_codex":0.0016992845,"about_ca_topic_score_gemma":0.001104797,"teacher_disagreement_score":0.9377907,"about_ca_system_score_codex":0.0010104458,"about_ca_system_score_gemma":0.0012234872,"threshold_uncertainty_score":0.3289982},"labels":[],"label_agreement":null},{"id":"W2158196950","doi":"10.3324/haematol.13151","title":"Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Lymphocytosis; Dasatinib; Natural killer cell; Lymphocyte; Immunology; CD16; CD3; Biology; Medicine; Cytotoxicity; Myeloid leukemia; CD8; Imatinib; Immune system","score_opus":0.03405269464848501,"score_gpt":0.2943099288139732,"score_spread":0.2602572341654882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158196950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980573,0.0003842849,0.00045170233,0.0000523036,0.0000049236073,0.000019555073,0.000022199645,0.000015366748,0.0009923909],"genre_scores_gemma":[0.99967647,0.00009139724,0.00009262032,0.000021005733,0.000010218133,0.0000031979966,0.000027614702,0.000001691599,0.000075806245],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99973685,0.000063455256,0.00003590988,0.00004478392,0.00004299141,0.000076049495],"domain_scores_gemma":[0.999373,0.00020726156,0.00021725631,0.00005496831,0.000034462977,0.00011309397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016303369,0.00031661164,0.0004035981,0.00034437617,0.00030459065,0.00029603133,0.00015472516,0.0003610861,0.00090295455],"category_scores_gemma":[0.0012055914,0.00013390894,0.00020650752,0.00034176945,0.0004477032,0.0002826796,0.00026012195,0.00037804458,0.0002110955],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024162089,0.00024188118,0.65757847,0.00019619292,0.000095085095,0.2381774,0.000484606,0.00065605587,0.052495748,0.0002805563,0.0007187144,0.046659075],"study_design_scores_gemma":[0.00021038164,0.0018094354,0.2896168,0.00001877668,0.0001146409,0.6888719,0.00025789,0.0013507014,0.015204639,0.00023900281,0.0022837985,0.000022040185],"about_ca_topic_score_codex":0.00034682715,"about_ca_topic_score_gemma":0.00055312645,"teacher_disagreement_score":0.00090295455,"about_ca_system_score_codex":0.0002283255,"about_ca_system_score_gemma":0.00024158333,"threshold_uncertainty_score":0.0030206442},"labels":[],"label_agreement":null},{"id":"W2158290056","doi":"10.3324/haematol.2010.022459","title":"Replication analysis confirms the association of ARID5B with childhood B-cell acute lymphoblastic leukemia","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Leukemia; Medicine; Immunology; Hematology; Acute lymphocytic leukemia; Single-nucleotide polymorphism; Oncology; Lymphoblastic Leukemia; Internal medicine; Cancer research; Biology; Gene; Genetics; Genotype","score_opus":0.0038423789808905624,"score_gpt":0.21861258787334326,"score_spread":0.21477020889245269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158290056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843322,0.0021582432,0.0031854622,0.00035371547,0.00010392464,0.00008838352,0.0048797373,0.00016645323,0.0047318186],"genre_scores_gemma":[0.99420786,0.000422364,0.0018169453,0.00011133143,0.000022668428,0.00003251224,0.002169858,0.00003106964,0.0011852476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987876,0.00032677533,0.00009824609,0.0003037727,0.0003233196,0.00016045492],"domain_scores_gemma":[0.9974843,0.0005090874,0.0004109487,0.0007110128,0.00059453165,0.00029010553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002331545,0.00039567004,0.0004723366,0.00076914014,0.00088153227,0.0005883163,0.00046051282,0.00031143663,0.004977039],"category_scores_gemma":[0.0046408856,0.0001930723,0.00068757235,0.0009699414,0.00043923853,0.00012003628,0.0004884767,0.0003980664,0.0007847247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002584436,0.0001349424,0.83426946,0.00027458058,0.0012040656,0.0016391517,0.0008738837,0.0003591787,0.123483084,0.00076886185,0.0033381965,0.031070093],"study_design_scores_gemma":[0.00011431519,0.00034153415,0.9819614,0.000026126327,0.00027333677,0.0016980529,0.00020753613,0.00019229113,0.007589048,0.00020789407,0.007376462,0.000011922316],"about_ca_topic_score_codex":0.06441038,"about_ca_topic_score_gemma":0.06692046,"teacher_disagreement_score":0.06441038,"about_ca_system_score_codex":0.0007425305,"about_ca_system_score_gemma":0.0009736486,"threshold_uncertainty_score":0.12807095},"labels":[],"label_agreement":null},{"id":"W2159601358","doi":"10.3324/haematol.2011.043422","title":"Familial myelodysplastic syndromes: a review of the literature","year":2011,"lang":"en","type":"review","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Myelodysplastic syndromes; Platelet disorder; Medicine; RUNX1; Myeloid leukemia; Transplantation; Hematopoietic stem cell transplantation; Leukemia; Immunology; Disease; Internal medicine; Stem cell; Genetics; Haematopoiesis; Biology; Bone marrow; Platelet","score_opus":0.08086625824052283,"score_gpt":0.35863915398657736,"score_spread":0.2777728957460545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159601358","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012911343,0.99690634,0.00013300114,0.0003302564,0.0003683054,0.000007265942,0.00009339612,0.000023996814,0.0008463356],"genre_scores_gemma":[0.004521648,0.993193,0.00043931813,0.0004916478,0.00079710846,0.000011911238,0.00020785232,0.000004734283,0.00033282815],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965477,0.000046601977,0.00013687839,0.000061845196,0.000073653544,0.00002620554],"domain_scores_gemma":[0.999025,0.0004573666,0.00025374265,0.000021844433,0.0001512637,0.00009072374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037837392,0.0009697414,0.0014494489,0.008421455,0.0004930459,0.0009523873,0.0009627793,0.00084325444,0.0040124385],"category_scores_gemma":[0.0012116058,0.0003121438,0.000596528,0.007311342,0.00048320612,0.0015036516,0.00056064053,0.0007970151,0.0011980189],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001773476,0.000117662785,0.006764495,0.050456654,0.00048744853,0.017936883,0.00062264904,0.00063467986,0.0020440693,0.0011366479,0.10469206,0.81492937],"study_design_scores_gemma":[0.0000433252,0.0002411458,0.02131456,0.028289353,0.001425045,0.15843944,0.00082378316,0.0002514229,0.00052371057,0.0018592543,0.78668344,0.00010547445],"about_ca_topic_score_codex":0.0012183198,"about_ca_topic_score_gemma":0.0021552828,"teacher_disagreement_score":0.008421455,"about_ca_system_score_codex":0.00040739306,"about_ca_system_score_gemma":0.00088469696,"threshold_uncertainty_score":0.013422906},"labels":[],"label_agreement":null},{"id":"W2160076308","doi":"10.3324/haematol.11579","title":"SBDS-deficient cells undergo accelerated apoptosis through the Fas-pathway","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Population Health Research Institute; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Apoptosis; Gene knockdown; Programmed cell death; Cancer research; Bone marrow; Small hairpin RNA; Biology; Cell biology; Immunology; Genetics","score_opus":0.03756747326322372,"score_gpt":0.24872298310449462,"score_spread":0.2111555098412709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160076308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473983,0.0007931622,0.0033552414,0.00006891628,0.000019144607,0.00001936821,0.00045189742,0.00007202273,0.00048047333],"genre_scores_gemma":[0.99311465,0.00049596943,0.0030127415,0.000040296407,0.000004502294,0.00004394999,0.0010551363,0.000010134762,0.0022226654],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990296,0.0000089286505,0.000014303473,0.000021882739,0.00003866773,0.0000133304475],"domain_scores_gemma":[0.9998952,0.000022960241,0.000033438704,0.0000113724545,0.00001695527,0.000020015013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008782542,0.0002960234,0.00018718405,0.0001667879,0.00010485438,0.00022216924,0.00015008851,0.00022363693,0.0017313196],"category_scores_gemma":[0.00009140792,0.00010518145,0.00016274588,0.0001138463,0.00016989362,0.00013794634,0.000111169385,0.00042437803,0.00045869377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006203462,0.000007618322,0.0003543562,0.00002859816,0.000004687491,0.000046777313,0.0000102096865,0.000029427532,0.9988426,0.00004448182,0.000025858348,0.0005434049],"study_design_scores_gemma":[0.000022771606,0.00019908087,0.004565104,0.000004897606,0.00001183886,0.00040179063,0.000026311312,0.0005712998,0.99196035,0.00004328617,0.0021899734,0.00000330765],"about_ca_topic_score_codex":0.00047080265,"about_ca_topic_score_gemma":0.00076412485,"teacher_disagreement_score":0.0017313196,"about_ca_system_score_codex":0.00028394398,"about_ca_system_score_gemma":0.00015179561,"threshold_uncertainty_score":0.0057917833},"labels":[],"label_agreement":null},{"id":"W2161021913","doi":"10.3324/haematol.2014.115840","title":"Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":329,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Stanford Cancer Institute; National Heart, Lung, and Blood Institute; University of Texas MD Anderson Cancer Center; Weill Cornell Medical College; University of California, Los Angeles; Monash University; Hollings Cancer Center, Medical University of South Carolina; Northwestern University; Incyte; NIH Clinical Center; Townsville Hospital and Health Service; Emory University; Huntsman Cancer Institute; University of Toronto; Tower Cancer Research Foundation; London Health Sciences Centre; Barbara Ann Karmanos Cancer Institute; Rush University; University of Louisville; Georgetown University; National Cancer Institute; Wake Forest University; Kaiser Permanente; Cleveland Clinic; George Washington University; University of Pennsylvania; Vanderbilt University; University of Southern California; Park Nicollet Foundation","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Internal medicine; Oncology; Surgery; Bone marrow","score_opus":0.025920741236176364,"score_gpt":0.25619804275661573,"score_spread":0.23027730152043938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161021913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965114,0.0022818625,0.0002021673,0.00010938086,0.000011345139,0.000055858978,0.00033208268,0.000014071828,0.0004817699],"genre_scores_gemma":[0.9983156,0.00035633036,0.0001788537,0.00011584813,0.00003054526,0.00003886486,0.0007612375,0.0000029060932,0.00019977897],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9989863,0.00040250045,0.00011027396,0.00014848071,0.00020827171,0.00014408177],"domain_scores_gemma":[0.9975719,0.0005493705,0.0009473108,0.00021890401,0.00026571206,0.00044681467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045191296,0.00046758444,0.0012463684,0.0002924864,0.00044164533,0.0008097046,0.0003460543,0.000757403,0.0008393311],"category_scores_gemma":[0.0029254758,0.00018384767,0.0019742262,0.00046138148,0.00032867293,0.00064717035,0.00040240947,0.0010991718,0.00025481125],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23250593,0.0058822855,0.5836546,0.00052057527,0.003687802,0.00070842943,0.0005942368,0.0030428823,0.012906032,0.00011335108,0.001564092,0.1548197],"study_design_scores_gemma":[0.00823939,0.08980159,0.89216936,0.00007524232,0.0023849024,0.0006616196,0.00016764538,0.0015328274,0.0028297727,0.00015612667,0.0019142936,0.000067220884],"about_ca_topic_score_codex":0.0006447558,"about_ca_topic_score_gemma":0.0009782293,"teacher_disagreement_score":0.0045191296,"about_ca_system_score_codex":0.0005793281,"about_ca_system_score_gemma":0.00046835665,"threshold_uncertainty_score":0.023899734},"labels":[],"label_agreement":null},{"id":"W2161183750","doi":"10.3324/haematol.2010.026989","title":"Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors","year":2010,"lang":"en","type":"review","venue":"Haematologica","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McMaster University","funders":"National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Institutes of Health; Heart and Stroke Foundation of Canada","keywords":"Post-thrombotic syndrome; Medicine; Prospective cohort study; Venous thrombosis; Confidence interval; Internal medicine; Thrombosis; Quality of life (healthcare); Intensive care medicine; Pediatrics","score_opus":0.10753807877910042,"score_gpt":0.34602681321829165,"score_spread":0.23848873443919122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161183750","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028089762,0.99602157,0.00008068981,0.00010712176,0.000043850003,0.00012292492,0.00067108264,0.000004124785,0.00013971231],"genre_scores_gemma":[0.041892648,0.9561332,0.00059785624,0.00028513678,0.00006420863,0.00040417883,0.00056758645,0.000005147417,0.000049994575],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99162513,0.0023684497,0.003905381,0.00070618175,0.0012039336,0.00019098527],"domain_scores_gemma":[0.9496831,0.03799488,0.00905726,0.0005871615,0.00236432,0.00031336833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0078035584,0.0011360807,0.0062436378,0.009870997,0.00044247461,0.0019761259,0.001416968,0.0012841626,0.0021390927],"category_scores_gemma":[0.042645186,0.00077997416,0.0049016806,0.01180221,0.00091078336,0.0015989032,0.0011043982,0.00077804446,0.0001388458],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002590867,0.000013210642,0.006110503,0.95008034,0.012751934,0.00014958608,0.0002480486,0.00007986968,0.00009826406,0.00016654495,0.00094613247,0.029096493],"study_design_scores_gemma":[0.00025621767,0.00033460517,0.030872872,0.8469462,0.1034303,0.0011571358,0.00051865925,0.000088817345,0.00018971713,0.00022157663,0.015934557,0.00004928221],"about_ca_topic_score_codex":0.007986562,"about_ca_topic_score_gemma":0.017194822,"teacher_disagreement_score":0.009870997,"about_ca_system_score_codex":0.0026724327,"about_ca_system_score_gemma":0.00788222,"threshold_uncertainty_score":0.04126966},"labels":[],"label_agreement":null},{"id":"W2164059454","doi":"10.3324/haematol.2011.040840","title":"TET2 mutations in secondary acute myeloid leukemias: a French retrospective study","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Myeloid leukemia; Medicine; Chromosomal translocation; Myeloid; Retrospective cohort study; Internal medicine; Karyotype; Mutation; Hematology; Oncology; Gastroenterology; Immunology; Cancer research; Gene; Biology; Genetics; Chromosome","score_opus":0.04183800821531778,"score_gpt":0.3073875758651325,"score_spread":0.2655495676498147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164059454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863464,0.00046190218,0.00010868168,0.000029754336,0.0000034618272,0.000009459998,0.00016014984,0.0000041073413,0.00058790756],"genre_scores_gemma":[0.99927956,0.00024932442,0.00003821028,0.000026013273,0.000009476595,0.000005938763,0.0002640442,0.0000019666197,0.00012538194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995714,0.00009102657,0.000046485085,0.000112635455,0.000087527216,0.000090919166],"domain_scores_gemma":[0.99882823,0.00021889497,0.00044784392,0.00010931256,0.00021731749,0.00017846155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005202008,0.00030908623,0.00034104768,0.0012018346,0.0005052689,0.00045813704,0.00021306361,0.00030808535,0.0022529585],"category_scores_gemma":[0.0015526318,0.00023130723,0.0004090337,0.0007509252,0.00032695904,0.00021961056,0.000277363,0.00020473108,0.00029449575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096063435,0.000017452658,0.9944991,0.000017531496,0.00003908612,0.0015843419,0.00012322656,0.000030317893,0.000523591,0.000024039231,0.00015311623,0.0028922046],"study_design_scores_gemma":[0.000017962337,0.0002408462,0.9844057,0.000013465182,0.000056611818,0.013201922,0.0002687997,0.000111571586,0.00028078078,0.000018886332,0.0013770409,0.0000064709875],"about_ca_topic_score_codex":0.012182003,"about_ca_topic_score_gemma":0.011283142,"teacher_disagreement_score":0.012182003,"about_ca_system_score_codex":0.0006425655,"about_ca_system_score_gemma":0.00044093694,"threshold_uncertainty_score":0.024222195},"labels":[],"label_agreement":null},{"id":"W2164667231","doi":"10.3324/haematol.2014.120121","title":"Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); Vancouver General Hospital; University of Calgary; Hôpital Notre-Dame; London Health Sciences Centre","funders":"Celgene","keywords":"Thalidomide; Lenalidomide; Medicine; Melphalan; Prednisone; Dexamethasone; Multiple myeloma; Internal medicine; Oncology; Surgery; Gastroenterology","score_opus":0.11451472248451337,"score_gpt":0.3505249363184556,"score_spread":0.23601021383394222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164667231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99664634,0.00220508,0.00007693909,0.00021299877,0.000064940075,0.00032869555,0.00021419735,0.000006186142,0.00024463833],"genre_scores_gemma":[0.99708694,0.000708649,0.0003545503,0.00025598676,0.0001235219,0.0005871625,0.00050357793,0.0000032318765,0.00037629445],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992261,0.00045404417,0.000050220853,0.00009677775,0.00006196328,0.00011089129],"domain_scores_gemma":[0.9982992,0.0005902974,0.00048397365,0.000073740426,0.00006517539,0.00048764667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026039209,0.0008220965,0.0030248612,0.000242463,0.00026847568,0.00090697134,0.00064679445,0.0008253554,0.0019358062],"category_scores_gemma":[0.0024545009,0.00035495963,0.002207583,0.00025294645,0.00041244604,0.0005883931,0.00044371665,0.002177387,0.00017046253],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9601953,0.008677669,0.007751117,0.00040829004,0.0013597802,0.000047980026,0.000085044805,0.0011024545,0.0024141811,0.000051803036,0.0003226381,0.017583745],"study_design_scores_gemma":[0.5539171,0.40864828,0.031774513,0.000094658935,0.001599802,0.00014383114,0.00008188923,0.0014402469,0.0013012198,0.00011188396,0.00085572904,0.000030788342],"about_ca_topic_score_codex":0.00087956345,"about_ca_topic_score_gemma":0.0025333022,"teacher_disagreement_score":0.0030248612,"about_ca_system_score_codex":0.001247085,"about_ca_system_score_gemma":0.0015501014,"threshold_uncertainty_score":0.0137709975},"labels":[],"label_agreement":null},{"id":"W2165746197","doi":"10.3324/haematol.2009.020636","title":"Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"National Health and Medical Research Council; Medical Research Council; Fondation de France","keywords":"Myeloid leukemia; Imatinib mesylate; Imatinib; microRNA; Medicine; Leukemia; TaqMan; Cancer research; Oncology; Real-time polymerase chain reaction; Internal medicine; Biology; Gene; Genetics","score_opus":0.008674175181232518,"score_gpt":0.2498548977066989,"score_spread":0.24118072252546638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165746197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988943,0.00047458868,0.000090223715,0.000036723155,0.000004608389,0.000011840849,0.00018635797,0.0000049645664,0.0002963475],"genre_scores_gemma":[0.9994407,0.00007597065,0.00011055331,0.00003157772,0.0000073725155,0.000012622436,0.00023654646,0.0000011091224,0.000083509],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983525,0.000028843042,0.000019543466,0.000054618926,0.000038054048,0.000023717337],"domain_scores_gemma":[0.9996699,0.00007491137,0.00015559804,0.000012043487,0.000034386463,0.00005307859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018434215,0.0002098927,0.00031835507,0.00028219275,0.00018402112,0.00023132928,0.000102039034,0.00029530856,0.0010609395],"category_scores_gemma":[0.00060734845,0.000070951304,0.00015002525,0.00027492477,0.00013883496,0.00013098396,0.00015940088,0.00020826481,0.00014661053],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031722144,0.00007809478,0.9571844,0.000057969846,0.000068855996,0.00059161446,0.000085395804,0.00020002697,0.028688079,0.000032962,0.00020164176,0.009638795],"study_design_scores_gemma":[0.00003719339,0.0006059102,0.99570197,0.0000049118944,0.00003866781,0.0011182348,0.000046049892,0.00028736124,0.0017213431,0.000028062646,0.00040630324,0.0000039795755],"about_ca_topic_score_codex":0.00037218237,"about_ca_topic_score_gemma":0.00053792074,"teacher_disagreement_score":0.0010609395,"about_ca_system_score_codex":0.00021626428,"about_ca_system_score_gemma":0.00012041047,"threshold_uncertainty_score":0.0035491586},"labels":[],"label_agreement":null},{"id":"W2168801827","doi":"10.3324/haematol.2013.102897","title":"Severe platelet desialylation in a patient with glycoprotein Ib/IX antibody-mediated immune thrombocytopenia and fatal pulmonary hemorrhage","year":2014,"lang":"en","type":"letter","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; University of Toronto; Canadian Blood Services","keywords":"Immune thrombocytopenia; Platelet; Antibody; Pulmonary hemorrhage; Glycoprotein; Immunology; Medicine; Immune system; Platelet membrane glycoprotein; Glycoprotein Ib; Isoantibodies; Hematology; Internal medicine; Chemistry; Biochemistry; Lung","score_opus":0.013333537695772469,"score_gpt":0.2381136306282262,"score_spread":0.22478009293245374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168801827","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43283322,0.013210734,0.005767157,0.44725913,0.016266707,0.0005128356,0.0006369078,0.00065075344,0.08286253],"genre_scores_gemma":[0.8976829,0.003929343,0.0022073076,0.0716488,0.016858522,0.0000767355,0.00023335424,0.000082406164,0.007280653],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999079,0.00020601993,0.00010317253,0.00017496594,0.00016292886,0.0002739723],"domain_scores_gemma":[0.99846244,0.00068994454,0.00013375358,0.00010842981,0.00016206659,0.0004433268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068308075,0.0011861863,0.0013960394,0.0012469033,0.0018310159,0.0012691536,0.0012002896,0.01166213,0.0023252557],"category_scores_gemma":[0.0052321586,0.00071043475,0.0013927725,0.00087311974,0.0013724582,0.001649063,0.0007172823,0.0069618337,0.001133671],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013712868,0.00008626373,0.006016554,0.000049184604,0.000024187922,0.9771189,0.00015035726,0.00017893568,0.00063122646,0.00096205756,0.011471924,0.00317324],"study_design_scores_gemma":[0.00015249367,0.0002845204,0.009342225,0.00012513532,0.00007038218,0.97632265,0.00031837923,0.0020821837,0.0006233637,0.0027837583,0.007841983,0.00005291075],"about_ca_topic_score_codex":0.0030867588,"about_ca_topic_score_gemma":0.00367062,"teacher_disagreement_score":0.01166213,"about_ca_system_score_codex":0.0025033464,"about_ca_system_score_gemma":0.0010436086,"threshold_uncertainty_score":0.018163145},"labels":[],"label_agreement":null},{"id":"W2169866483","doi":"10.3324/haematol.10696","title":"Lack of correlation between heparin dose and standard clinical monitoring tests in treatment with unfractionated heparin in critically III children","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; University of Alberta","funders":"Hospital for Sick Children; Austrian Science Fund","keywords":"Partial thromboplastin time; Medicine; Heparin; Coagulation; Prospective cohort study; Anticoagulant; Internal medicine; Anesthesia; Intensive care medicine","score_opus":0.10266072720110964,"score_gpt":0.41214702071004633,"score_spread":0.3094862935089367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169866483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994049,0.00021969852,0.000086227716,0.000047846028,0.0000052352125,0.000004019635,0.000058585352,0.0000025120169,0.00017094855],"genre_scores_gemma":[0.9997658,0.00004133984,0.000066800894,0.000014665731,0.0000058296596,0.0000034003162,0.00007495922,0.0000012994624,0.000026024938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845314,0.00054972374,0.00020223677,0.00022941029,0.00036270777,0.00020282414],"domain_scores_gemma":[0.98968107,0.003764501,0.004951601,0.00036458514,0.0007256978,0.00051254954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013777175,0.00024465396,0.00032577265,0.0005095372,0.00025013284,0.0004776544,0.00032568196,0.0004953192,0.0011988282],"category_scores_gemma":[0.013071757,0.00022377878,0.0002726907,0.0005819197,0.000538397,0.00044882295,0.00027058905,0.00070769497,0.00017317983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006266772,0.0000069715716,0.99903995,0.0000044141075,0.000009099914,0.000062734456,0.000035645444,0.000018191851,0.00011107944,0.0000062123636,0.000036968915,0.0006061797],"study_design_scores_gemma":[0.000008173821,0.0002759132,0.9979631,0.000008114119,0.000017798764,0.0011373137,0.000099699355,0.00016317301,0.00019141719,0.000010477664,0.00012240469,0.0000024418925],"about_ca_topic_score_codex":0.0030251269,"about_ca_topic_score_gemma":0.0024329568,"teacher_disagreement_score":0.0030251269,"about_ca_system_score_codex":0.0005133484,"about_ca_system_score_gemma":0.0004920301,"threshold_uncertainty_score":0.0072861314},"labels":[],"label_agreement":null},{"id":"W2169979115","doi":"10.3324/haematol.2010.029702","title":"Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fonds De La Recherche Scientifique - FNRS; National Heart, Lung, and Blood Institute; National Cancer Institute; National Institutes of Health; Fondation contre le Cancer; Terry Fox Foundation","keywords":"Fludarabine; Total body irradiation; Medicine; Transplantation; Cyclophosphamide; Hematopoietic stem cell transplantation; Stem cell; CD8; Internal medicine; Gastroenterology; Lymphocyte; Immunology; Immune system; Chemotherapy; Biology","score_opus":0.009655898165566076,"score_gpt":0.2318726510811421,"score_spread":0.22221675291557602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169979115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991454,0.0005816885,0.000043825985,0.000008673975,0.0000023990542,0.0000023338275,0.000020207739,0.0000016336477,0.00019378652],"genre_scores_gemma":[0.9996495,0.00018564,0.00001968229,0.000017018081,0.000009677108,0.0000021832036,0.000060304938,6.9837967e-7,0.000055291497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987686,0.000026147298,0.000013367246,0.000025150646,0.000020816724,0.000037571474],"domain_scores_gemma":[0.9994444,0.00013565595,0.00021541619,0.000029428224,0.000024121868,0.00015100473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022575511,0.00014915616,0.00036688146,0.00019525796,0.0002194659,0.00028361284,0.00009164095,0.00016629229,0.0012835292],"category_scores_gemma":[0.0007451199,0.00006435734,0.00017131538,0.0001409527,0.0002105084,0.00020374727,0.0002410098,0.00016905366,0.00021011115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001757747,0.00010790315,0.96355426,0.000054155073,0.0000764816,0.0015145374,0.00022218848,0.000081302045,0.015150017,0.000034755794,0.000135775,0.017310973],"study_design_scores_gemma":[0.000037736838,0.0013776019,0.99080795,0.000018742565,0.00007910633,0.005624411,0.00016609023,0.00010031795,0.0011362219,0.000033322878,0.0006149602,0.0000034615218],"about_ca_topic_score_codex":0.00017368418,"about_ca_topic_score_gemma":0.00028444282,"teacher_disagreement_score":0.0012835292,"about_ca_system_score_codex":0.000086216605,"about_ca_system_score_gemma":0.00013317546,"threshold_uncertainty_score":0.0042937994},"labels":[],"label_agreement":null},{"id":"W2170974745","doi":"10.3324/haematol.2014.118927","title":"Endogenous megakaryocytic colonies underline association between megakaryocytes and calreticulin mutations in essential thrombocythemia","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Université de Montpellier; Institut Gustave-Roussy; Centre National de la Recherche Scientifique; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche","keywords":"Calreticulin; Essential thrombocythemia; Myelofibrosis; Exon; Myeloproliferative Disorders; Mutation; Biology; Cancer research; Genetics; Polycythemia vera; Gene; Immunology","score_opus":0.05822365109552091,"score_gpt":0.2963325217382911,"score_spread":0.2381088706427702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170974745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4394616,0.022345278,0.0034203436,0.43538296,0.014524983,0.00014129741,0.0008761488,0.00045876953,0.08338878],"genre_scores_gemma":[0.9180902,0.0047139046,0.0016029506,0.03865181,0.028299784,0.00003110641,0.00021221724,0.00006615088,0.008331835],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99954164,0.00010706929,0.000068786896,0.000065484295,0.00010292757,0.00011409462],"domain_scores_gemma":[0.997589,0.0014158131,0.00030684203,0.00014610046,0.0002489534,0.00029337406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036270623,0.00048492345,0.000618673,0.00064766704,0.0006704822,0.0010451917,0.0006230717,0.006912065,0.003594231],"category_scores_gemma":[0.004397229,0.0003180884,0.00045256212,0.00042183115,0.0009872989,0.00075480045,0.00055848603,0.003966373,0.0012782594],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020844082,0.000029645238,0.013677891,0.000110778026,0.000025582789,0.94773185,0.00016723282,0.00015361683,0.002992613,0.0018920201,0.025781952,0.007228321],"study_design_scores_gemma":[0.00011834696,0.00010123157,0.01655937,0.00011260301,0.0000668383,0.9393229,0.00027516755,0.0012363542,0.0023787664,0.003146856,0.036659263,0.000022274791],"about_ca_topic_score_codex":0.0006751682,"about_ca_topic_score_gemma":0.0006898196,"teacher_disagreement_score":0.006912065,"about_ca_system_score_codex":0.0009212848,"about_ca_system_score_gemma":0.0002826222,"threshold_uncertainty_score":0.012023866},"labels":[],"label_agreement":null},{"id":"W2173631987","doi":"10.3324/haematol.2015.126938","title":"Gene-expression and in vitro function of mesenchymal stromal cells are affected in juvenile myelomonocytic leukemia","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Leids Universitair Medisch Centrum; Stichting Kinderen Kankervrij; Universiteit Leiden","keywords":"Mesenchymal stem cell; Biology; Haematopoiesis; Stromal cell; Juvenile myelomonocytic leukemia; Cancer research; Bone marrow; Chronic myelomonocytic leukemia; Leukemia; Stem cell; Immunology; Cell biology; Myelodysplastic syndromes","score_opus":0.0343891697055586,"score_gpt":0.28186470427964533,"score_spread":0.24747553457408672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2173631987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986708,0.00047085158,0.00036195555,0.0000072400394,0.000002520938,0.0000048564,0.00028818066,0.000011313803,0.00018222153],"genre_scores_gemma":[0.9986571,0.00025369154,0.00037309824,0.000010909217,0.0000019205404,0.000010337774,0.00047245383,0.0000052458336,0.0002151242],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998305,0.000030195844,0.000022535382,0.00003775463,0.00004558476,0.000033518078],"domain_scores_gemma":[0.99985886,0.00002801103,0.000055258846,0.000013507197,0.0000140232305,0.000030270108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088424094,0.00019479883,0.00017045051,0.000270897,0.00011516629,0.00027430506,0.00005796411,0.00014274335,0.00050808967],"category_scores_gemma":[0.00018772259,0.00007166113,0.00013671737,0.00027163356,0.00016091639,0.00007111048,0.00013301618,0.00015776027,0.0001275452],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012994192,0.0000070558135,0.0066174953,0.000022444981,0.0000067448573,0.00024189774,0.000055078144,0.000042536867,0.99162054,0.000019543264,0.000010612657,0.0012261873],"study_design_scores_gemma":[0.000015567772,0.0005112756,0.39965168,0.000011987194,0.00007984542,0.0039188745,0.00039184227,0.00087841775,0.59125054,0.00010014983,0.0031780202,0.000011836697],"about_ca_topic_score_codex":0.0005268041,"about_ca_topic_score_gemma":0.0006909431,"teacher_disagreement_score":0.0005268041,"about_ca_system_score_codex":0.00012454881,"about_ca_system_score_gemma":0.00008068654,"threshold_uncertainty_score":0.0016997457},"labels":[],"label_agreement":null},{"id":"W2174938993","doi":"10.3324/haematol.2015.125864","title":"Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; Vancouver General Hospital","funders":"Celgene","keywords":"Pomalidomide; Dexamethasone; Lenalidomide; Medicine; Internal medicine; Thalidomide; Refractory (planetary science); Multiple myeloma; Tolerability; Oncology; Gastroenterology; Adverse effect; Biology","score_opus":0.12101848918118802,"score_gpt":0.3982900003491797,"score_spread":0.2772715111679917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174938993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972857,0.0015148283,0.0001548638,0.00010391483,0.000040271694,0.00023050819,0.00023804334,0.00001416467,0.00041767495],"genre_scores_gemma":[0.99810237,0.00037804738,0.00033096777,0.00022018337,0.0000657411,0.00021536545,0.00034938083,0.0000062085523,0.0003317227],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991702,0.00055686437,0.000041125026,0.00007997744,0.000054671575,0.00009725418],"domain_scores_gemma":[0.9986193,0.00048053337,0.0003199463,0.00006662307,0.000030521638,0.00048306628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020022343,0.0007054722,0.0011264778,0.00025475028,0.00020742494,0.00073261297,0.00044326787,0.0007743856,0.0018761238],"category_scores_gemma":[0.0015522157,0.0002415709,0.0016655427,0.00026138313,0.00045447942,0.00046230535,0.0003487723,0.0014649176,0.00018755672],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95333487,0.006387237,0.00972329,0.0001457899,0.001005734,0.000038104758,0.000048215807,0.0006912911,0.005280694,0.00006556405,0.0003198852,0.022959344],"study_design_scores_gemma":[0.39721268,0.50517654,0.084867306,0.000087679786,0.0021195586,0.00023107685,0.000071413124,0.003265577,0.004480125,0.0005473463,0.0018852149,0.000055557222],"about_ca_topic_score_codex":0.0006165445,"about_ca_topic_score_gemma":0.0014487104,"teacher_disagreement_score":0.0020022343,"about_ca_system_score_codex":0.00063188694,"about_ca_system_score_gemma":0.0007994137,"threshold_uncertainty_score":0.010589004},"labels":[],"label_agreement":null},{"id":"W2181099113","doi":"10.3324/haematol.2015.131573","title":"Deficiency of the ribosome biogenesis gene Sbds in hematopoietic stem and progenitor cells causes neutropenia in mice by attenuating lineage progression in myelocytes","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"KWF Kankerbestrijding; Nederlandse Organisatie voor Wetenschappelijk Onderzoek","keywords":"Biology; Ribosome biogenesis; Progenitor cell; Myeloid; Haematopoiesis; Stem cell; Cancer research; Cell biology; Immunology; Genetics; Gene; Ribosome; RNA","score_opus":0.016953925153084592,"score_gpt":0.2511868862908955,"score_spread":0.2342329611378109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2181099113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920736,0.0009836727,0.004920862,0.00011348694,0.000019626283,0.000042676682,0.0005151587,0.00024071005,0.0010902431],"genre_scores_gemma":[0.99369735,0.0007457499,0.003155785,0.00003761699,0.0000064131636,0.00004809093,0.00035202387,0.00004260612,0.0019144437],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998771,0.000023334493,0.000015254074,0.000025141251,0.000035762583,0.000023425442],"domain_scores_gemma":[0.9998821,0.000019293004,0.00004440653,0.0000103049215,0.000005706456,0.000038118567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011183156,0.0004604593,0.0002187894,0.0005190433,0.00013700081,0.00022495624,0.0002343299,0.00031033403,0.00112595],"category_scores_gemma":[0.00010775437,0.00023815538,0.00017509291,0.00017146835,0.00039529413,0.00013647132,0.00023814174,0.0004963313,0.00028195477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010874774,0.000015903357,0.00017472029,0.00001747162,0.0000037802795,0.00006567914,0.000007631671,0.00008316521,0.998094,0.0002296751,0.000029368905,0.0011698221],"study_design_scores_gemma":[0.000058502836,0.00034549754,0.003340362,0.000011331356,0.00002126101,0.00030334102,0.000025555608,0.001275474,0.99177414,0.00017234373,0.0026659246,0.0000062802965],"about_ca_topic_score_codex":0.0007687291,"about_ca_topic_score_gemma":0.0016177462,"teacher_disagreement_score":0.00112595,"about_ca_system_score_codex":0.00030427022,"about_ca_system_score_gemma":0.0003348157,"threshold_uncertainty_score":0.0037667155},"labels":[],"label_agreement":null},{"id":"W2189254605","doi":"10.3324/haematol.2015.126870","title":"Mice are poor heme absorbers and do not require intestinal Hmox1 for dietary heme iron assimilation","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; McGill University","keywords":"Hemoglobin; Heme; Anemia; Myoglobin; Iron deficiency; Chemistry; Iron-deficiency anemia; Food science; Biochemistry; Physiology; Internal medicine; Biology; Medicine","score_opus":0.06218688890852884,"score_gpt":0.29882415835511444,"score_spread":0.2366372694465856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2189254605","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2971461,0.049743023,0.023341227,0.49785602,0.016647767,0.0005711132,0.0030383416,0.0033740313,0.10828243],"genre_scores_gemma":[0.731936,0.021214237,0.011830756,0.17712177,0.008364054,0.00043120692,0.001237212,0.00038442167,0.047480304],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994861,0.00016047912,0.000042216245,0.00008518796,0.00011702727,0.00010903876],"domain_scores_gemma":[0.99894124,0.0004942307,0.0002352396,0.00013339927,0.000089714165,0.000106233536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072935596,0.00051270437,0.00064934907,0.00022680084,0.0004671272,0.00087476266,0.0006782574,0.0038239441,0.0036104305],"category_scores_gemma":[0.0021962966,0.0002527936,0.00029777188,0.00018340313,0.000962821,0.0008128463,0.0003230753,0.003281467,0.0034248047],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003269211,0.00082241936,0.023375966,0.0011597772,0.00023777879,0.1930366,0.0005580764,0.00056853186,0.1073709,0.028675321,0.4945555,0.14636995],"study_design_scores_gemma":[0.0005751936,0.00097446004,0.015199663,0.0004687404,0.00012057311,0.37223998,0.0003191351,0.0019722357,0.02045457,0.014458495,0.57310563,0.00011135685],"about_ca_topic_score_codex":0.00038318604,"about_ca_topic_score_gemma":0.0006387925,"teacher_disagreement_score":0.0038239441,"about_ca_system_score_codex":0.0005114948,"about_ca_system_score_gemma":0.0001858864,"threshold_uncertainty_score":0.012078106},"labels":[],"label_agreement":null},{"id":"W2189263041","doi":"10.3324/haematol.2015.128066","title":"Comment on: \"The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid transformation in inherited bone marrow failure syndromes\"","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytopathology; Cytogenetics; Transformation (genetics); Myeloid; Bone marrow; Medicine; Malignant transformation; Pathology; Somatic evolution in cancer; Immunology; Cancer research; Biology; Genetics; Internal medicine; Cancer; Cytology; Chromosome; Gene","score_opus":0.05633848446140335,"score_gpt":0.32228155396511143,"score_spread":0.2659430695037081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2189263041","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00070950657,0.00074561825,0.00007830391,0.9774185,0.0189866,0.000012019818,0.00016196145,0.000055134045,0.0018325073],"genre_scores_gemma":[0.0043921433,0.0004515205,0.000107053915,0.9633968,0.028469663,0.000018069519,0.00006197514,0.000022334232,0.0030804386],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970951,0.00068740844,0.0003971194,0.0004675017,0.0009090795,0.00044384776],"domain_scores_gemma":[0.99325025,0.003234405,0.0006707985,0.00023415431,0.0016121063,0.000998385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00304548,0.0008209371,0.0013731525,0.0008722848,0.002916826,0.0021633601,0.0026825848,0.03341183,0.0064342543],"category_scores_gemma":[0.020050392,0.0006483986,0.001042975,0.0010694711,0.0023056373,0.002505493,0.0012183435,0.025794968,0.008125543],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005045362,0.000022037433,0.00093672716,0.000027896687,0.000008632363,0.0012142068,0.000079969686,0.000037911752,0.00009613932,0.0008724004,0.99341935,0.0032342724],"study_design_scores_gemma":[0.00021290545,0.00022499329,0.0070585604,0.0005286617,0.000087307,0.0075366627,0.00075415225,0.00089435873,0.00097412866,0.008000879,0.9735344,0.00019296358],"about_ca_topic_score_codex":0.009801983,"about_ca_topic_score_gemma":0.012575436,"teacher_disagreement_score":0.03341183,"about_ca_system_score_codex":0.0044525163,"about_ca_system_score_gemma":0.004313797,"threshold_uncertainty_score":0.03230536},"labels":[],"label_agreement":null},{"id":"W2191867422","doi":"10.3324/haematol.2015.133629","title":"Impact of renal impairment on outcomes with lenalidomide and dexamethasone treatment in the FIRST trial, a randomized, open-label phase 3 trial in transplant-ineligible patients with multiple myeloma","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"Celgene","keywords":"Lenalidomide; Medicine; Dexamethasone; Multiple myeloma; Thalidomide; Internal medicine; Prednisone; Melphalan; Renal function; Urology; Gastroenterology; Surgery","score_opus":0.09147771662842669,"score_gpt":0.3836690187173586,"score_spread":0.2921913020889319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2191867422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99069947,0.0054037063,0.00033114388,0.0008712618,0.00021126553,0.00071779266,0.00075796444,0.000034298144,0.0009730293],"genre_scores_gemma":[0.99562174,0.00094764074,0.00052801246,0.00056866306,0.0002309357,0.0006944036,0.00082957745,0.000009246735,0.0005698153],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984022,0.0011854379,0.00005331838,0.0001420888,0.00008069868,0.00013629474],"domain_scores_gemma":[0.99654585,0.0011691302,0.0011576344,0.00024808975,0.00012187341,0.0007574169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034482353,0.001097216,0.0021419963,0.00028131864,0.00036494408,0.0012688496,0.00067905907,0.0011248684,0.0018510654],"category_scores_gemma":[0.003574347,0.00026127175,0.003036537,0.00026975368,0.00067519874,0.0008464419,0.0004814126,0.003103483,0.00016294804],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97760403,0.0025627257,0.0032288292,0.00024416766,0.0014260862,0.000030935895,0.000033332934,0.000663099,0.001331532,0.00010523646,0.00066766585,0.012102269],"study_design_scores_gemma":[0.8675803,0.111537084,0.014556807,0.00011335023,0.00194929,0.000106247266,0.000033841563,0.0013664144,0.0009489238,0.0005778541,0.0011871161,0.000042741376],"about_ca_topic_score_codex":0.0006682749,"about_ca_topic_score_gemma":0.0018055238,"teacher_disagreement_score":0.0034482353,"about_ca_system_score_codex":0.000990404,"about_ca_system_score_gemma":0.001298669,"threshold_uncertainty_score":0.01823622},"labels":[],"label_agreement":null},{"id":"W2196382270","doi":"10.3324/haematol.2014.121475","title":"The international prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes in non-surgical bleeding episodes in Glanzmann thrombasthenia patients","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary General Hospital; University of Calgary","funders":"Novo Nordisk","keywords":"Medicine; Glanzmann's thrombasthenia; Thrombasthenia; Platelet; Platelet transfusion; Adverse effect; Antifibrinolytic; Surgery; Tranexamic acid; Recombinant DNA; Internal medicine; Gastroenterology","score_opus":0.022912696941329136,"score_gpt":0.28742698207640455,"score_spread":0.2645142851350754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2196382270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9267268,0.0040408466,0.000593947,0.00028429076,0.00005379003,0.00025148698,0.061041936,0.000080408056,0.0069264635],"genre_scores_gemma":[0.90688086,0.0020080328,0.00057211553,0.00013632247,0.00007935265,0.00047736982,0.089003876,0.0000405109,0.0008015335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990089,0.00025437432,0.00022366652,0.0002055996,0.00018829168,0.000119215685],"domain_scores_gemma":[0.99655956,0.00046293892,0.0019261457,0.00030777388,0.00039357366,0.000350033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011228101,0.00029542655,0.0005979206,0.0018111822,0.00020650988,0.00063411734,0.00035104348,0.00035645798,0.0019151935],"category_scores_gemma":[0.0027783066,0.00019144973,0.000496381,0.0039067306,0.00015027194,0.0007756149,0.00049438595,0.0005862265,0.0005194403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013470043,0.00012461864,0.9845709,0.00019741966,0.00030564654,0.00010628106,0.00007258745,0.000288079,0.00016880789,0.00017940535,0.0062604737,0.006378796],"study_design_scores_gemma":[0.00018276594,0.00019116605,0.99718815,0.000054910837,0.00012979799,0.00034882902,0.00008961772,0.00021489504,0.00008023549,0.00007187361,0.001436115,0.000011611677],"about_ca_topic_score_codex":0.00312545,"about_ca_topic_score_gemma":0.0030562368,"teacher_disagreement_score":0.00312545,"about_ca_system_score_codex":0.00036818592,"about_ca_system_score_gemma":0.00056534196,"threshold_uncertainty_score":0.006406963},"labels":[],"label_agreement":null},{"id":"W2256505962","doi":"10.3324/haematol.2015.139717","title":"Acute myeloid leukemia patients clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts","year":2016,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Flow cytometry; Mdm2; Biomarker; Medicine; Myeloid leukemia; Clinical trial; Oncology; Internal medicine; Cancer research; Immunology; Biology; Cell culture","score_opus":0.0318626593060773,"score_gpt":0.3298666151708328,"score_spread":0.29800395586475553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2256505962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7365498,0.011576972,0.0021346712,0.18140733,0.0025042794,0.00020432724,0.0013460185,0.00018248582,0.06409418],"genre_scores_gemma":[0.95267844,0.003466808,0.0015489848,0.028109567,0.002152551,0.000087090055,0.0005714691,0.00002152206,0.011363599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995659,0.00014669912,0.000050341525,0.00006512503,0.000110861736,0.0000612197],"domain_scores_gemma":[0.99934214,0.00031747634,0.00009546124,0.000040341496,0.00012121249,0.000083451894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045609675,0.0001159399,0.00027861845,0.0001993872,0.00034111648,0.0005299604,0.00017774022,0.0009874824,0.0024360663],"category_scores_gemma":[0.001904314,0.00006835732,0.00012942679,0.00026888528,0.00028872286,0.00024613756,0.000153252,0.0010862227,0.001064094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005725486,0.00060227566,0.3876549,0.00043953717,0.00008931324,0.043299362,0.0007957628,0.00057606836,0.05448547,0.0057031102,0.17150024,0.3291284],"study_design_scores_gemma":[0.0007674881,0.002826606,0.33798566,0.00048785438,0.0002231529,0.1463852,0.0017894086,0.0051390454,0.044543125,0.012339332,0.44743267,0.000080541016],"about_ca_topic_score_codex":0.0003758805,"about_ca_topic_score_gemma":0.0009892305,"teacher_disagreement_score":0.0024360663,"about_ca_system_score_codex":0.0007246082,"about_ca_system_score_gemma":0.00029360817,"threshold_uncertainty_score":0.008149445},"labels":[],"label_agreement":null},{"id":"W2264688301","doi":"10.3324/haematol.2015.134049","title":"Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Medicine; Lenalidomide; Multiple myeloma; Internal medicine; Population; Melphalan; Cohort; Oncology; Transplantation; Malignancy; Myelodysplastic syndromes; Cancer; Bone marrow","score_opus":0.05383425820085901,"score_gpt":0.30255229735905703,"score_spread":0.248718039158198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2264688301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762315,0.0006199438,0.0001202115,0.00006574489,0.000018930896,0.00003469912,0.001263599,0.000006910757,0.00024672056],"genre_scores_gemma":[0.99757534,0.00041806145,0.00016489293,0.00009384668,0.000051925756,0.00006127571,0.0014698589,0.000006393349,0.00015823079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989297,0.00022207982,0.00012902917,0.0004322305,0.00014874796,0.0001381601],"domain_scores_gemma":[0.99831176,0.00021098048,0.00056707807,0.0003156626,0.00020608192,0.00038835348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013931919,0.0007701034,0.0010862274,0.0013492646,0.0009309031,0.0012450656,0.0008648088,0.0013401482,0.0015678677],"category_scores_gemma":[0.0024895156,0.0008421375,0.0019097578,0.0025103707,0.00041002783,0.0012830672,0.0012700477,0.0013691887,0.0005150587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003811443,0.00010365601,0.99756265,0.000029663637,0.0006258156,0.00017522716,0.000113251954,0.000057234785,0.00016042283,0.000019939302,0.00018860922,0.00058234297],"study_design_scores_gemma":[0.00008292698,0.00037168482,0.9972777,0.000020277195,0.00053378125,0.00064052135,0.0003079586,0.00029804342,0.000040222432,0.000040887222,0.0003674931,0.000018578003],"about_ca_topic_score_codex":0.0069145374,"about_ca_topic_score_gemma":0.0070821135,"teacher_disagreement_score":0.0069145374,"about_ca_system_score_codex":0.00063271914,"about_ca_system_score_gemma":0.00063843676,"threshold_uncertainty_score":0.013748586},"labels":[],"label_agreement":null},{"id":"W2276396753","doi":"10.3324/haematol.2015.129866","title":"Increased pressure alters plasma membrane dynamics and renders acute myeloid leukemia cells resistant to daunorubicin","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Daunorubicin; Myeloid leukemia; HL60; Cell culture; Leukemia; Chemistry; Cancer research; Myeloid; Internal medicine; Medicine; Biology; Genetics","score_opus":0.02170130638992337,"score_gpt":0.24829060731921426,"score_spread":0.2265893009292909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2276396753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967439,0.00060715305,0.001404211,0.000095802905,0.000029167202,0.000024529598,0.0002770711,0.000053109496,0.0007650444],"genre_scores_gemma":[0.9970505,0.0005270182,0.001374047,0.00008414442,0.000010049464,0.000043363103,0.00026450047,0.000016528536,0.0006296497],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997881,0.000021911066,0.00001754459,0.00003815014,0.00008616976,0.000048113663],"domain_scores_gemma":[0.999918,0.000019622701,0.00002960937,0.0000074072927,0.000008041237,0.000017453325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012194845,0.00020506533,0.0001846368,0.00010807893,0.00014859982,0.0003569368,0.00016405806,0.00022711244,0.0011681502],"category_scores_gemma":[0.00016864455,0.00013871322,0.00017511129,0.00011129571,0.00018389887,0.00024328851,0.00026585208,0.00039460065,0.00022491162],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004453462,0.000018630059,0.00011710147,0.00001851011,0.00000232509,0.000024451247,0.000012991497,0.000054274064,0.9989911,0.00003666533,0.000034900193,0.00064449763],"study_design_scores_gemma":[0.000020722115,0.0005475143,0.007805312,0.000007716264,0.00000996829,0.00011481405,0.000039337843,0.0017622721,0.9873345,0.000042613687,0.0023072546,0.000007905121],"about_ca_topic_score_codex":0.00041356342,"about_ca_topic_score_gemma":0.000516658,"teacher_disagreement_score":0.0011681502,"about_ca_system_score_codex":0.00024778696,"about_ca_system_score_gemma":0.00012175335,"threshold_uncertainty_score":0.003907919},"labels":[],"label_agreement":null},{"id":"W2288284178","doi":"10.3324/haematol.2015.139741","title":"Response to: Dietary and pharmacological factors affecting iron absorption in mice and man","year":2016,"lang":"en","type":"letter","venue":"Haematologica","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"","keywords":"Heme; Biochemistry; Extracellular; Iron deficiency; Chemistry; Bioavailability; Intracellular; Gastrointestinal tract; Heme oxygenase; Hemeprotein; DMT1; Iron-deficiency anemia; Biology; Transporter; Anemia; Enzyme; Pharmacology; Internal medicine; Medicine","score_opus":0.01908079783030485,"score_gpt":0.2722747238041162,"score_spread":0.25319392597381135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2288284178","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36244223,0.024225332,0.0048344457,0.49560732,0.056486227,0.0010296064,0.0071880077,0.0033095577,0.044877313],"genre_scores_gemma":[0.7136595,0.011363035,0.0040860525,0.14200012,0.029132182,0.0012593125,0.003581841,0.00040219695,0.09451576],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99924445,0.0002904667,0.00007509202,0.00014821911,0.00010912724,0.00013277054],"domain_scores_gemma":[0.99898213,0.0003506462,0.00016531628,0.000114071765,0.00015242073,0.00023538366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001333309,0.0007525915,0.00066709606,0.00070000964,0.0003567609,0.00050057203,0.0008319487,0.0036574148,0.016977264],"category_scores_gemma":[0.0018571331,0.00018414645,0.0005588175,0.00021943892,0.00079529325,0.0004326818,0.00060532923,0.0016704235,0.004035583],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019095493,0.0026533932,0.025015516,0.001877518,0.00034643905,0.01960712,0.00086687726,0.0003461725,0.11130398,0.0034480207,0.7211585,0.0942809],"study_design_scores_gemma":[0.0008076738,0.010056583,0.122912064,0.0004170558,0.00025338208,0.021328343,0.0009250499,0.0012048585,0.042757988,0.0017531181,0.79738134,0.00020252615],"about_ca_topic_score_codex":0.00031581725,"about_ca_topic_score_gemma":0.0003429011,"teacher_disagreement_score":0.016977264,"about_ca_system_score_codex":0.0005801227,"about_ca_system_score_gemma":0.0001520571,"threshold_uncertainty_score":0.056794584},"labels":[],"label_agreement":null},{"id":"W2292251821","doi":"10.3324/haematol.2015.137380","title":"Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Asparaginase; Medicine; Lymphoblastic Leukemia; Antibody; Immunology; Intensive care medicine; Leukemia","score_opus":0.056859683970737984,"score_gpt":0.34078537270542647,"score_spread":0.2839256887346885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292251821","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005629193,0.2532121,0.118836924,0.48416457,0.023532702,0.014494372,0.004832018,0.0018906707,0.09340748],"genre_scores_gemma":[0.045428146,0.18448827,0.57293254,0.132815,0.007049862,0.018146675,0.011224714,0.0005448344,0.027369956],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.96517897,0.014365975,0.011178635,0.0011669775,0.0066566253,0.0014528297],"domain_scores_gemma":[0.906711,0.022931824,0.005758026,0.0018858786,0.05938928,0.0033241136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.041700076,0.0018031853,0.002814739,0.007869056,0.002167394,0.003046705,0.009431219,0.013750498,0.009322023],"category_scores_gemma":[0.06858565,0.0011472224,0.0069897915,0.004198957,0.001654317,0.0039355173,0.0036389278,0.008760124,0.006889974],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002454947,0.00044982927,0.0021907461,0.01560311,0.0003234196,0.0020782307,0.0016293825,0.0017428272,0.0017842517,0.006934217,0.45706582,0.50995266],"study_design_scores_gemma":[0.0004453113,0.0002478356,0.0035913729,0.06801357,0.0009298945,0.0027231057,0.0021690738,0.0017139129,0.001471443,0.015552299,0.90291214,0.00023008011],"about_ca_topic_score_codex":0.008635536,"about_ca_topic_score_gemma":0.012014203,"teacher_disagreement_score":0.041700076,"about_ca_system_score_codex":0.004514578,"about_ca_system_score_gemma":0.016970523,"threshold_uncertainty_score":0.22053373},"labels":[],"label_agreement":null},{"id":"W2295530774","doi":"10.3324/haematol.2015.135418","title":"Activity of the Janus kinase inhibitor ruxolitinib in chronic lymphocytic leukemia: results of a phase II trial","year":2016,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto East General Hospital; Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Leukemia and Lymphoma Society of Canada; University of Toronto; Leukemia and Lymphoma Society","keywords":"Ruxolitinib; Idelalisib; Janus kinase; Myelofibrosis; Venetoclax; Medicine; Chronic lymphocytic leukemia; Ibrutinib; Oncology; STAT protein; Internal medicine; Janus kinase 1; Clinical trial; stat; Clinical endpoint; Cancer research; Tolerability; STAT3; Leukemia; Signal transduction; Chemistry; Adverse effect; Receptor; Bone marrow","score_opus":0.046861909385239535,"score_gpt":0.3334470027006804,"score_spread":0.28658509331544085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2295530774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8978514,0.06599122,0.0009774291,0.013835765,0.0011790944,0.0014300555,0.0020577896,0.00018491005,0.016492376],"genre_scores_gemma":[0.97290844,0.0129371965,0.00084330066,0.0063773035,0.0008787294,0.0006164017,0.0019405924,0.000020222698,0.0034777862],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996239,0.00018508073,0.000033712615,0.00004363244,0.000052507894,0.0000610608],"domain_scores_gemma":[0.9992704,0.00027725095,0.00012981289,0.00003648288,0.000060358405,0.00022568478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015325207,0.0005068016,0.0010948521,0.00016049593,0.00028162697,0.0006742934,0.00037078882,0.0009792411,0.0024090481],"category_scores_gemma":[0.0013344728,0.00011018997,0.0005934199,0.00025632198,0.00032697243,0.00042878155,0.0001495545,0.0019405826,0.00049551163],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25962555,0.0065687983,0.0128622,0.0030454085,0.001381108,0.0011347971,0.00027893414,0.0014670262,0.017863708,0.0012277866,0.038209267,0.6563355],"study_design_scores_gemma":[0.6303535,0.21159288,0.05896073,0.0013568974,0.0019824982,0.003438711,0.00022046549,0.005256829,0.0073950645,0.0021638353,0.0771937,0.0000849032],"about_ca_topic_score_codex":0.00046144554,"about_ca_topic_score_gemma":0.0018312861,"teacher_disagreement_score":0.0024090481,"about_ca_system_score_codex":0.0009271977,"about_ca_system_score_gemma":0.00061891985,"threshold_uncertainty_score":0.008104861},"labels":[],"label_agreement":null},{"id":"W2297856459","doi":"10.3324/haematol.2015.140335","title":"Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS)","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Quality of life (healthcare); Psychosocial; International Prognostic Scoring System; Medicine; Cohort; Myelodysplastic syndromes; Scale (ratio); Gerontology; Internal medicine; Psychology; Psychiatry","score_opus":0.040397248204170844,"score_gpt":0.34331150305323793,"score_spread":0.3029142548490671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2297856459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97113436,0.0015979239,0.0046391655,0.00040193816,0.00013951457,0.0028760245,0.0097609935,0.00007966573,0.0093704425],"genre_scores_gemma":[0.96525574,0.00061361934,0.009080098,0.00030038,0.00006318828,0.0036237633,0.018796617,0.00003013632,0.0022364685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784684,0.0008880556,0.00034921843,0.00021963987,0.0005423136,0.0001539251],"domain_scores_gemma":[0.99083734,0.0014509595,0.0028971008,0.0006982392,0.0034260252,0.0006904326],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.007972529,0.00041864402,0.0003263863,0.0017695525,0.00047180537,0.0005818124,0.00044568104,0.00033450878,0.002202716],"category_scores_gemma":[0.011573592,0.00016124295,0.00057746534,0.0013633287,0.00044401916,0.0005510881,0.0013447002,0.0007136937,0.0006017519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026906692,0.0003057016,0.9585767,0.00007162596,0.00013471328,0.000040052848,0.00037136336,0.00022918909,0.00042001155,0.0003439919,0.002212668,0.03702491],"study_design_scores_gemma":[0.000098175515,0.0008164976,0.99255437,0.00006954819,0.000040873496,0.0002236495,0.00017698931,0.0003402112,0.00027200615,0.00018285346,0.0052125813,0.000012297216],"about_ca_topic_score_codex":0.0018898544,"about_ca_topic_score_gemma":0.003590481,"teacher_disagreement_score":0.99202746,"about_ca_system_score_codex":0.00042504034,"about_ca_system_score_gemma":0.00071324356,"threshold_uncertainty_score":0.042163253},"labels":[],"label_agreement":null},{"id":"W2304098313","doi":"10.3324/haematol.2015.132712","title":"Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; University College London Hospitals NHS Foundation Trust; National Institute for Health and Care Research; Cancer Research UK","keywords":"Adoptive cell transfer; Immunology; Receptor; Biology; Cell therapy; T cell; Chimeric antigen receptor; Antigen; Graft-versus-host disease; Endogeny; Cancer research; Receptor expression; Immune system; Stem cell; Cell biology; Endocrinology","score_opus":0.03489163423556973,"score_gpt":0.29882062272251286,"score_spread":0.26392898848694313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2304098313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992851,0.0018193295,0.0036435043,0.00005428081,0.00003848322,0.000046847992,0.00006813593,0.00006886117,0.0014094982],"genre_scores_gemma":[0.99672,0.00088338007,0.0011973963,0.000027198279,0.000012786783,0.000021273892,0.00009270695,0.000010706686,0.0010344229],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998323,0.000030493504,0.000012632211,0.000026272306,0.0000470297,0.000051196475],"domain_scores_gemma":[0.9999279,0.0000136392455,0.00002200097,0.000010765285,0.000007535504,0.000018156608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011522703,0.00045492302,0.00033428243,0.0002198869,0.0000731398,0.000259743,0.00017736555,0.00026799386,0.0008446134],"category_scores_gemma":[0.0000930371,0.000078866906,0.00019835055,0.00009483003,0.00013660738,0.0001249958,0.00014083514,0.0006199958,0.00025390353],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006975485,0.000095226824,0.000080397214,0.00002848841,0.0000049172204,0.000030666873,0.000009192992,0.00011944324,0.9976775,0.00008050249,0.000023296576,0.0017806303],"study_design_scores_gemma":[0.00003679041,0.0018198945,0.001373771,0.0000057535563,0.00005165825,0.00042770096,0.000009230009,0.0010440351,0.99275607,0.00004396287,0.0024276336,0.0000034863085],"about_ca_topic_score_codex":0.00020106703,"about_ca_topic_score_gemma":0.00024899808,"teacher_disagreement_score":0.0008446134,"about_ca_system_score_codex":0.00013115817,"about_ca_system_score_gemma":0.00014821716,"threshold_uncertainty_score":0.0028255582},"labels":[],"label_agreement":null},{"id":"W2333810059","doi":"10.3324/haematol.2015.139931","title":"Securing reimbursement for patient centered haemophilia care: major collaborative efforts are needed","year":2016,"lang":"en","type":"editorial","venue":"Haematologica","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Hospital for Sick Children; Novo Nordisk; Bayer HealthCare; CSL Behring; Baxalta; Sick Kids Foundation; Biogen; Pfizer","keywords":"Reimbursement; Haemophilia; Business; Medicine; Cost–benefit analysis; Health care; Intensive care medicine; Medical emergency; Political science; Surgery","score_opus":0.031195118780093522,"score_gpt":0.2879831488459305,"score_spread":0.256788030065837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333810059","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033436972,0.010305504,0.00022276556,0.18355577,0.8048394,0.000017278338,0.000039057202,0.000054206947,0.0009326362],"genre_scores_gemma":[0.00042329045,0.011495578,0.0003849477,0.053982314,0.92962915,0.000021384749,0.000031013722,0.00005033664,0.003982021],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98436177,0.003956368,0.0030450337,0.0011854098,0.0067147412,0.00073677866],"domain_scores_gemma":[0.8850331,0.070869625,0.00490727,0.0028270173,0.028441347,0.00792162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027164733,0.0031991669,0.005527726,0.0026778104,0.003043607,0.012946911,0.0043024714,0.029849727,0.012363046],"category_scores_gemma":[0.09043769,0.0012735019,0.003932924,0.0021220047,0.0044977902,0.013539325,0.0021462892,0.049823765,0.008099585],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017859895,0.000016116463,0.00002628983,0.00021540241,0.00002617445,0.00004954383,0.00002106852,0.0000415984,0.000020404852,0.0010816782,0.9899422,0.0085415365],"study_design_scores_gemma":[0.000074393094,0.000027449585,0.0003466014,0.0012008613,0.00007092218,0.00013756886,0.00008479219,0.00028886026,0.000060739945,0.0072154207,0.9904463,0.00004601019],"about_ca_topic_score_codex":0.0023680248,"about_ca_topic_score_gemma":0.0054117665,"teacher_disagreement_score":0.029849727,"about_ca_system_score_codex":0.004524414,"about_ca_system_score_gemma":0.008682078,"threshold_uncertainty_score":0.14366251},"labels":[],"label_agreement":null},{"id":"W2335826388","doi":"10.3324/haematol.2015.137083","title":"Analysis of renal impairment in MM-003, a phase III study of pomalidomide + low - dose dexamethasone versus high - dose dexamethasone in refractory or relapsed and refractory multiple myeloma","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Vancouver General Hospital","funders":"Celgene","keywords":"Pomalidomide; Dexamethasone; Medicine; Refractory (planetary science); Lenalidomide; Multiple myeloma; Creatinine; Internal medicine; Urology; Gastroenterology; Materials science","score_opus":0.052192227517079505,"score_gpt":0.35049796612858714,"score_spread":0.2983057386115076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335826388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565226,0.0018462195,0.00036821375,0.00014148504,0.000058301503,0.0006779799,0.00059657166,0.000022942904,0.0006360786],"genre_scores_gemma":[0.9951444,0.00066097506,0.000752837,0.00034325648,0.0000835595,0.0008140637,0.0015173855,0.00001530642,0.0006682612],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9982666,0.0012617145,0.000055512264,0.000114123075,0.00013155796,0.00017049139],"domain_scores_gemma":[0.99836797,0.0004424203,0.00037487756,0.00016294619,0.000079939455,0.00057175686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005035514,0.001126758,0.0022395635,0.00037463667,0.00030509869,0.0009886096,0.000912628,0.00069913024,0.001820514],"category_scores_gemma":[0.0020606802,0.0003235796,0.002754071,0.00066181,0.0006877368,0.00047255887,0.00048705627,0.0020141168,0.00033900255],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94866425,0.010353431,0.011666213,0.00023024644,0.0025778695,0.000064989596,0.00006690579,0.0008361945,0.0074590393,0.00011261798,0.0006105949,0.017357636],"study_design_scores_gemma":[0.45556444,0.45486176,0.07708185,0.00005081262,0.0029820506,0.00021285786,0.00006852985,0.0022339534,0.004222177,0.00040057162,0.0022751961,0.000045844085],"about_ca_topic_score_codex":0.001328166,"about_ca_topic_score_gemma":0.0021544695,"teacher_disagreement_score":0.005035514,"about_ca_system_score_codex":0.001102786,"about_ca_system_score_gemma":0.0019282254,"threshold_uncertainty_score":0.0266307},"labels":[],"label_agreement":null},{"id":"W2336872381","doi":"10.3324/haematol.2014.117077","title":"Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; Vancouver General Hospital","funders":"Celgene","keywords":"Pomalidomide; Dexamethasone; Medicine; Lenalidomide; Refractory (planetary science); Internal medicine; Discontinuation; Multiple myeloma; Gastroenterology; Surgery; Oncology; Biology","score_opus":0.05052684580106229,"score_gpt":0.2953094141086336,"score_spread":0.2447825683075713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336872381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99670887,0.0024379867,0.00006254094,0.00017152527,0.000018274892,0.000011255152,0.00012894113,0.0000070622614,0.0004533902],"genre_scores_gemma":[0.9989993,0.0003151368,0.000045735724,0.000092238944,0.000027917002,0.000009090557,0.00031724095,0.0000013126347,0.00019215028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997787,0.000068306916,0.000023615787,0.000039794657,0.000049317397,0.000040224135],"domain_scores_gemma":[0.999081,0.0001622943,0.00035722236,0.000036437097,0.00006623811,0.0002968929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052453985,0.00019795871,0.00046568047,0.0003960108,0.00025905375,0.00035925236,0.00023092753,0.00039101293,0.00086450117],"category_scores_gemma":[0.0016061708,0.00012726079,0.00044432445,0.00032068448,0.00020966168,0.00042395122,0.0002497537,0.00047765777,0.00016054735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025483454,0.00045793017,0.91927975,0.000096482465,0.0007738309,0.00061073364,0.00020660686,0.0012329743,0.0060466183,0.00011837693,0.00089049345,0.044802792],"study_design_scores_gemma":[0.0006531224,0.004549799,0.9917875,0.000022627115,0.00028999048,0.0007988021,0.00009623675,0.0004761462,0.00041819928,0.00010850186,0.00078110467,0.000017891636],"about_ca_topic_score_codex":0.0016831693,"about_ca_topic_score_gemma":0.0022893483,"teacher_disagreement_score":0.0016831693,"about_ca_system_score_codex":0.0005099667,"about_ca_system_score_gemma":0.0002817129,"threshold_uncertainty_score":0.0037000775},"labels":[],"label_agreement":null},{"id":"W2396715364","doi":"10.3324/haematol.2016.146126","title":"Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity","year":2016,"lang":"en","type":"letter","venue":"Haematologica","topic":"Blood groups and transfusion","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Helse Sør-Øst RHF; Kreftforeningen","keywords":"Cold agglutinin disease; Antibody; Immunoglobulin light chain; Cold Agglutinin; Immunoglobulin heavy chain; Gene; Disease; Immunology; Medicine; Biology; Genetics; Pathology; Autoantibody","score_opus":0.008607088845290645,"score_gpt":0.20575633550386352,"score_spread":0.19714924665857286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396715364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981248,0.0001939419,0.00007844253,0.0002500153,0.000014901138,0.0000044539875,0.00004373164,0.0000036073927,0.0012861416],"genre_scores_gemma":[0.99946314,0.00008597835,0.000063148575,0.000106719286,0.00005541785,0.000003905323,0.00004311142,0.0000016337449,0.00017697488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995833,0.000093711766,0.000056158333,0.00009006983,0.000066221124,0.00011056633],"domain_scores_gemma":[0.99858874,0.0006854639,0.00021870104,0.000097729244,0.0001318402,0.00027751666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025477336,0.00039630817,0.0003602547,0.000738144,0.0006002691,0.00049991184,0.00026570258,0.0009833768,0.0021579475],"category_scores_gemma":[0.0018603659,0.0002822899,0.00021876876,0.0007437632,0.00063810433,0.00038307207,0.0002534341,0.0006160552,0.00040110268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002951576,0.00006767248,0.96072733,0.000014472008,0.000022851631,0.030441338,0.00021077311,0.00004908468,0.004826509,0.000060872222,0.00029372438,0.00299023],"study_design_scores_gemma":[0.000039108163,0.00035227792,0.8337246,0.000012256411,0.000035985413,0.1627976,0.0004695816,0.00047292415,0.0010606134,0.00017003097,0.0008544041,0.000010573811],"about_ca_topic_score_codex":0.001121818,"about_ca_topic_score_gemma":0.0011794093,"teacher_disagreement_score":0.0021579475,"about_ca_system_score_codex":0.00031134696,"about_ca_system_score_gemma":0.00016073268,"threshold_uncertainty_score":0.007219076},"labels":[],"label_agreement":null},{"id":"W2414354258","doi":"10.3324/haematol.2016.143271","title":"Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Human leukocyte antigen; Transplantation; Hazard ratio; Medicine; Hematopoietic stem cell transplantation; Immunology; Graft-versus-host disease; Histocompatibility; Hematopoietic cell; Antigen; Haematopoiesis; Internal medicine; Biology; Stem cell; Genetics","score_opus":0.023069867335561305,"score_gpt":0.2601794026681586,"score_spread":0.2371095353325973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414354258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991893,0.00041621726,0.00017973385,0.000031105832,0.000007500124,0.000006872505,0.000011183959,0.0000022137933,0.00015580218],"genre_scores_gemma":[0.99942064,0.00028897324,0.000117369775,0.00003682133,0.000017777382,0.0000034373677,0.000055567856,0.0000012990013,0.00005810796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995396,0.00017064776,0.000046035955,0.00006090735,0.00013156816,0.000051278665],"domain_scores_gemma":[0.99911743,0.00034465812,0.00025018115,0.00009762073,0.00007679698,0.00011318145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011524579,0.00020406727,0.000218469,0.00021398872,0.00020487049,0.00025748226,0.00017579568,0.00020530482,0.00033525648],"category_scores_gemma":[0.001961922,0.00008096957,0.0002740815,0.0002809884,0.00024748262,0.00017208765,0.00015940664,0.0003758051,0.00008063323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017826983,0.0003087065,0.9571724,0.000035606343,0.0001344423,0.0023857346,0.00024459412,0.00021728131,0.0029531412,0.00007222813,0.00026188442,0.034431286],"study_design_scores_gemma":[0.00013584303,0.0040882444,0.9784782,0.000020708956,0.00027737836,0.009654484,0.00023737062,0.0010211369,0.0046530636,0.00010879524,0.00130729,0.00001747165],"about_ca_topic_score_codex":0.00086054887,"about_ca_topic_score_gemma":0.0008414292,"teacher_disagreement_score":0.0011524579,"about_ca_system_score_codex":0.00021723808,"about_ca_system_score_gemma":0.00026992144,"threshold_uncertainty_score":0.0060948133},"labels":[],"label_agreement":null},{"id":"W2418937816","doi":"10.3324/haematol.2016.143677","title":"Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Open label; Snapshot (computer storage); Oncology; Internal medicine; Clinical trial; Phases of clinical research; Bone marrow; Computer science","score_opus":0.08403487765658953,"score_gpt":0.3716524044608081,"score_spread":0.2876175268042186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2418937816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99723333,0.00080494507,0.00021498617,0.0002028855,0.000019352905,0.00027112727,0.0007167459,0.000026435995,0.0005101297],"genre_scores_gemma":[0.99143,0.00057093176,0.001026818,0.0005978311,0.00010500246,0.00072110683,0.004821213,0.000018074848,0.00070918485],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9985072,0.00086144643,0.00007891973,0.000137689,0.00023302846,0.00018165488],"domain_scores_gemma":[0.9978987,0.00037443775,0.000565534,0.000195099,0.00021583671,0.00075040286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047902954,0.0007373024,0.0019888235,0.0004126911,0.0005091002,0.0013022096,0.0006308805,0.0010583567,0.0015244787],"category_scores_gemma":[0.00285636,0.00041450575,0.001185548,0.0005437847,0.00060895144,0.001007226,0.0007021537,0.0020018932,0.00037790352],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7096591,0.017014265,0.14481148,0.0004722022,0.0031328874,0.00041804704,0.00054220535,0.0028328928,0.03067587,0.00035522765,0.005798537,0.08428715],"study_design_scores_gemma":[0.318332,0.24467497,0.41921288,0.00009249322,0.0019847245,0.00088078255,0.00033166402,0.0044810693,0.0038001016,0.00055578427,0.005468997,0.00018457418],"about_ca_topic_score_codex":0.0006033717,"about_ca_topic_score_gemma":0.0016741403,"teacher_disagreement_score":0.0047902954,"about_ca_system_score_codex":0.0005826628,"about_ca_system_score_gemma":0.00096247566,"threshold_uncertainty_score":0.025333762},"labels":[],"label_agreement":null},{"id":"W2423969118","doi":"10.3324/haematol.2016.144550","title":"Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas","year":2016,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Rituximab; Medicine; CHOP; Pathological; Internal medicine; Oncology; Chemotherapy; Vincristine; Pathology; Cyclophosphamide","score_opus":0.008859314499504379,"score_gpt":0.2305589043802064,"score_spread":0.221699589880702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2423969118","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87726,0.028315406,0.0014509403,0.054808892,0.0014704296,0.00013020025,0.00017292312,0.00017752107,0.036213547],"genre_scores_gemma":[0.98331696,0.0037458746,0.0004925703,0.0084283585,0.0019170803,0.000034566223,0.0001029841,0.000012416894,0.0019492421],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966264,0.00011273473,0.000039504605,0.000043115495,0.000057764228,0.00008418475],"domain_scores_gemma":[0.99893206,0.0005065059,0.00016766254,0.000054862587,0.00008013189,0.0002586958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036949257,0.0002793683,0.00052801287,0.00040035893,0.00071076147,0.00071808795,0.0006262011,0.0023088206,0.0014077097],"category_scores_gemma":[0.0034951693,0.00018557275,0.00032212067,0.0005204436,0.00044676723,0.0006858632,0.00025247157,0.0015068637,0.0005335655],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005199369,0.0007545853,0.18865034,0.0004211224,0.00014684288,0.5983608,0.0008987539,0.001346779,0.009825293,0.001361738,0.036472593,0.1565619],"study_design_scores_gemma":[0.0010068286,0.0033979206,0.175558,0.0005785523,0.00030700685,0.7614736,0.0010010615,0.0049538543,0.0027219942,0.0042578583,0.044671506,0.00007180653],"about_ca_topic_score_codex":0.0014445825,"about_ca_topic_score_gemma":0.003305687,"teacher_disagreement_score":0.0023088206,"about_ca_system_score_codex":0.0011442673,"about_ca_system_score_gemma":0.00066747447,"threshold_uncertainty_score":0.008302212},"labels":[],"label_agreement":null},{"id":"W2462762289","doi":"10.3324/haematol.2016.148809","title":"Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"University of Nebraska Medical Center","keywords":"Lymphoma; Hodgkin lymphoma; Medicine; Oncology; Classical Hodgkin lymphoma; Hodgkin's lymphoma; Internal medicine","score_opus":0.07290797828020769,"score_gpt":0.33914493590097056,"score_spread":0.2662369576207629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462762289","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18798092,0.80520415,0.0006428704,0.00034036004,0.00021125932,0.00021029683,0.002542306,0.000029165114,0.0028386612],"genre_scores_gemma":[0.35277057,0.6404697,0.0011807526,0.00045421027,0.0001948604,0.00021334695,0.004300463,0.00001907338,0.00039706155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880135,0.00018982858,0.00050721975,0.00015692665,0.00027758052,0.00006711251],"domain_scores_gemma":[0.9980609,0.0006198175,0.0006352593,0.00011335056,0.00047581218,0.0000949331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019378149,0.0003691507,0.000871171,0.006285034,0.00040741253,0.00059531117,0.00061037706,0.00030223167,0.0012130685],"category_scores_gemma":[0.0025465968,0.00031047786,0.000561888,0.008521864,0.00045008902,0.00077886786,0.00046029207,0.00020428804,0.00029356644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034946087,0.000061029208,0.47986883,0.019253593,0.00077521155,0.008799819,0.0014927994,0.00017324348,0.001968801,0.00022842357,0.010303642,0.47672522],"study_design_scores_gemma":[0.000061876664,0.00017311127,0.8982635,0.008633911,0.0013993053,0.024513084,0.001559178,0.00011624456,0.00061866664,0.00011527508,0.06450398,0.000041880987],"about_ca_topic_score_codex":0.007855681,"about_ca_topic_score_gemma":0.009923607,"teacher_disagreement_score":0.007855681,"about_ca_system_score_codex":0.0005244111,"about_ca_system_score_gemma":0.0010791466,"threshold_uncertainty_score":0.015619934},"labels":[],"label_agreement":null},{"id":"W2477939303","doi":"","title":"The Maintenance of Tolerance After Successful Immune Tolerance Induction in Hemophilia A and B: The North American Registry","year":2000,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Regimen; Immune tolerance; Clotting factor; Cohort; Surgery; Maintenance therapy; Internal medicine; Pediatrics; Immune system; Chemotherapy; Immunology","score_opus":0.011121283941567502,"score_gpt":0.26148005343697495,"score_spread":0.2503587694954074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2477939303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99269146,0.0008620552,0.00052426447,0.0002510892,0.000018735942,0.000068034795,0.0010841164,0.000040444324,0.0044598724],"genre_scores_gemma":[0.9964,0.00077156234,0.00050144247,0.0000948358,0.000028707645,0.00008981158,0.0015544891,0.0000137545985,0.00054529385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724483,0.0012795872,0.00033558454,0.00025675274,0.00063185545,0.00025141166],"domain_scores_gemma":[0.9785322,0.004789408,0.00945401,0.0026939933,0.0030856812,0.0014447258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005943903,0.00009002901,0.00022400571,0.0017610053,0.00065209676,0.00073547475,0.00057298335,0.00027246593,0.0012912307],"category_scores_gemma":[0.009959163,0.0001262755,0.00018901414,0.0023945281,0.0004888533,0.0008904074,0.00067164964,0.00041575788,0.00035288846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018222198,0.00006760048,0.97533256,0.00003592759,0.0000121033845,0.00016715634,0.0004328523,0.000066159584,0.00019883804,0.00019163637,0.0018908429,0.021422029],"study_design_scores_gemma":[0.000019443503,0.00036810842,0.99184626,0.00004601186,0.000024694933,0.0012000606,0.000632766,0.00033336636,0.0004028238,0.00010019904,0.005015031,0.000011197422],"about_ca_topic_score_codex":0.0054827314,"about_ca_topic_score_gemma":0.005348959,"teacher_disagreement_score":0.005943903,"about_ca_system_score_codex":0.0004493253,"about_ca_system_score_gemma":0.0014220536,"threshold_uncertainty_score":0.031434774},"labels":[],"label_agreement":null},{"id":"W2497935705","doi":"10.3324/haematol.2016.142810","title":"Innovative approach to older patients with malignant hemopathies","year":2016,"lang":"en","type":"editorial","venue":"Haematologica","topic":"Frailty in Older Adults","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Internal medicine; Gerontology; Intensive care medicine","score_opus":0.011568700071233647,"score_gpt":0.2597224867590249,"score_spread":0.24815378668779123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2497935705","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008781232,0.03856577,0.00012348141,0.059047863,0.9006001,0.000025002746,0.000036103942,0.000037563932,0.0014763817],"genre_scores_gemma":[0.00042805035,0.019392837,0.00006525703,0.019726165,0.9583469,0.000016437838,0.000013828721,0.000010706204,0.0019998173],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99749315,0.00056917424,0.0005260122,0.0002642066,0.0009864818,0.0001609696],"domain_scores_gemma":[0.9864265,0.007630796,0.00087299355,0.00027591604,0.0031132516,0.0016805612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00419333,0.0027675538,0.0035888643,0.0034260938,0.0020810885,0.0047840574,0.003086138,0.015742311,0.007525257],"category_scores_gemma":[0.024792241,0.00085210736,0.0026678285,0.0013681165,0.0017231813,0.004005137,0.0016202327,0.02254861,0.003980179],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005545651,0.000026321837,0.000075260694,0.000971442,0.00004809459,0.0003938731,0.000035199344,0.000044144308,0.0000593376,0.0003715514,0.97781473,0.0201046],"study_design_scores_gemma":[0.00020475323,0.00009834056,0.00084102555,0.0034752372,0.00022632041,0.001755979,0.00011882245,0.0002226517,0.00013214769,0.0016561123,0.99122846,0.000040198705],"about_ca_topic_score_codex":0.0017407316,"about_ca_topic_score_gemma":0.004470351,"teacher_disagreement_score":0.015742311,"about_ca_system_score_codex":0.002704401,"about_ca_system_score_gemma":0.002610248,"threshold_uncertainty_score":0.025174499},"labels":[],"label_agreement":null},{"id":"W2504660737","doi":"10.3324/haematol.2016.145847","title":"The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Ferritin; Medicine; Albumin; Internal medicine; Myelodysplastic syndromes; Transplantation; Myeloid leukemia; C-reactive protein; Gastroenterology; Hematopoietic stem cell transplantation; Biomarker; Immunology; Acute leukemia; Population; Serum albumin; Leukemia; Bone marrow; Biology; Biochemistry","score_opus":0.015946926581086724,"score_gpt":0.27295262317914226,"score_spread":0.25700569659805556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2504660737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996686,0.00018018775,0.0000409652,0.000026585707,0.0000035725898,0.00000168968,0.000020347008,0.0000013251198,0.000056842662],"genre_scores_gemma":[0.9998235,0.000030244915,0.000044087334,0.00001169712,0.000012266007,0.000001230443,0.00005154941,5.928532e-7,0.000024946596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951386,0.00020792038,0.000044604603,0.00007052458,0.000092077054,0.00007105141],"domain_scores_gemma":[0.99686074,0.0010504578,0.0011204627,0.00013867533,0.00018164146,0.00064799003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009238916,0.00036812364,0.0003218536,0.0006274078,0.00022764444,0.00044207645,0.00027757356,0.00046770976,0.00056256994],"category_scores_gemma":[0.004811173,0.00016803524,0.00027868408,0.0004341934,0.00044346336,0.00039766377,0.0003126921,0.00065885537,0.00012309995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035708866,0.000028306811,0.9978987,0.0000036572133,0.000023557266,0.000074518866,0.00001755536,0.00007860987,0.00022586751,0.000008457057,0.00002910885,0.0012544718],"study_design_scores_gemma":[0.00003180221,0.0004878935,0.99708086,0.0000055340643,0.000045363682,0.0007355557,0.000077777826,0.0010954246,0.00028622593,0.00005811839,0.000088049055,0.000007424284],"about_ca_topic_score_codex":0.0013009736,"about_ca_topic_score_gemma":0.0018103393,"teacher_disagreement_score":0.0013009736,"about_ca_system_score_codex":0.0002366646,"about_ca_system_score_gemma":0.0003489459,"threshold_uncertainty_score":0.004886031},"labels":[],"label_agreement":null},{"id":"W2509658736","doi":"10.3324/haematol.2016.149740","title":"CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research","keywords":"ETV6; Biology; Cancer research; Gene silencing; Chromatin immunoprecipitation; Gene; Cell biology; Chromosomal translocation; Gene expression; Genetics","score_opus":0.01792296124747704,"score_gpt":0.2739570040392629,"score_spread":0.2560340427917858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2509658736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99217415,0.002431383,0.0026910133,0.000113173206,0.000018139375,0.000027992117,0.0014173302,0.00008951534,0.0010374078],"genre_scores_gemma":[0.994097,0.00075271155,0.0019626368,0.00010662163,0.0000074502527,0.000010570762,0.0019798032,0.00001607115,0.001067145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999393,0.0000044177186,0.0000046174628,0.000020528858,0.00001781071,0.000013279972],"domain_scores_gemma":[0.9999682,0.0000047515955,0.000011110849,0.0000023479388,0.0000033834704,0.000010319874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000038784296,0.00022429571,0.00017862147,0.00027464994,0.00013591796,0.000211968,0.00014668297,0.00033112263,0.0006548302],"category_scores_gemma":[0.000059166436,0.00008085491,0.00015845586,0.00032181616,0.00013777702,0.00008761404,0.00014319322,0.00027812747,0.0002429786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002191853,0.000014194574,0.0057192054,0.00009462196,0.00001099985,0.0018319513,0.000042554468,0.00033255387,0.98610735,0.00018710527,0.00014353727,0.005296649],"study_design_scores_gemma":[0.000059127873,0.00035784478,0.21238665,0.00003966619,0.00012794527,0.015917202,0.00019246245,0.00453804,0.7435178,0.00040626756,0.022430396,0.00002662196],"about_ca_topic_score_codex":0.0010298893,"about_ca_topic_score_gemma":0.0014739331,"teacher_disagreement_score":0.0010298893,"about_ca_system_score_codex":0.00044896823,"about_ca_system_score_gemma":0.00014248496,"threshold_uncertainty_score":0.003257513},"labels":[],"label_agreement":null},{"id":"W2511586498","doi":"10.3324/haematol.2016.151449","title":"The impact of anemia on overall survival in patients with myelofibrosis treated with ruxolitinib in the COMFORT studies","year":2016,"lang":"en","type":"letter","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health; Incyte","keywords":"Ruxolitinib; Myelofibrosis; Polycythemia vera; Medicine; Anemia; Internal medicine; Overall survival; Myeloproliferative neoplasm; Gastroenterology; Bone marrow","score_opus":0.03352389522912173,"score_gpt":0.3046890616389881,"score_spread":0.2711651664098664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511586498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78408504,0.027181681,0.00027062139,0.16463646,0.0019191313,0.000041836767,0.0015546697,0.00002885384,0.02028177],"genre_scores_gemma":[0.9630571,0.005361733,0.00034894465,0.027126294,0.0023652753,0.000030541494,0.00047635852,0.000009396757,0.0012243727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990752,0.00044892842,0.00014119816,0.000071384464,0.00015308465,0.000110197776],"domain_scores_gemma":[0.9960271,0.002177637,0.00059518404,0.000121210396,0.00045555123,0.00062324805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014487512,0.00011463588,0.00047427235,0.00025051663,0.00034481738,0.00072490936,0.0002896382,0.00086646836,0.0010776956],"category_scores_gemma":[0.006839012,0.00010050562,0.0004309885,0.00061160227,0.00019276234,0.00045907457,0.00029291896,0.0010620549,0.00017403382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009078025,0.00028397588,0.7606547,0.00044922403,0.0008409379,0.009532206,0.00035981816,0.00067343545,0.0015728851,0.0011872716,0.06804329,0.14732419],"study_design_scores_gemma":[0.0015551491,0.0025484602,0.89599884,0.00082468404,0.001880239,0.020724606,0.001263965,0.0019187245,0.0013477079,0.0031755657,0.06868215,0.00007980007],"about_ca_topic_score_codex":0.001568929,"about_ca_topic_score_gemma":0.0060795792,"teacher_disagreement_score":0.001568929,"about_ca_system_score_codex":0.000837295,"about_ca_system_score_gemma":0.00067377364,"threshold_uncertainty_score":0.0076618195},"labels":[],"label_agreement":null},{"id":"W2513682947","doi":"10.3324/haematol.2016.147116","title":"Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute for Health and Care Research","keywords":"Medicine; Lymphoma; Cancer; Malignancy; Hodgkin lymphoma; Internal medicine; Ataxia-telangiectasia; Incidence (geometry); Pediatrics; Epidemiology; Non-Hodgkin's lymphoma; Cumulative incidence; Oncology; Cohort","score_opus":0.03482524352224295,"score_gpt":0.34146321822440817,"score_spread":0.30663797470216525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513682947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996772,0.00012211558,0.000016729557,0.0000059202894,0.0000010877428,0.000006861829,0.00008802402,8.974832e-7,0.00008117625],"genre_scores_gemma":[0.99937904,0.00014418448,0.000037233036,0.000012860768,0.0000046094124,0.000015933128,0.00032878589,0.000001182203,0.00007609634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997526,0.000046166682,0.00003440689,0.00004779895,0.00005003658,0.00006900933],"domain_scores_gemma":[0.9994166,0.00013205451,0.00020752773,0.00003156413,0.000051695784,0.00016057314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037764315,0.0002135053,0.00034692948,0.0010470508,0.00042198578,0.000487018,0.00023837255,0.00041337835,0.000882648],"category_scores_gemma":[0.0010439099,0.00037038323,0.00026733978,0.0009646124,0.00037575173,0.0003996742,0.00043096382,0.00038577057,0.0002234428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052996325,0.000032116746,0.99893945,0.000004056169,0.000005351188,0.00029351248,0.000101811616,0.000013996368,0.000099615376,0.0000069167286,0.000022944661,0.00042722674],"study_design_scores_gemma":[0.000012295894,0.00020405906,0.9975547,0.000007364472,0.0000131300185,0.0015568674,0.0003499766,0.00007363051,0.000056354682,0.000012867334,0.00015583297,0.000002950995],"about_ca_topic_score_codex":0.0049756905,"about_ca_topic_score_gemma":0.00531054,"teacher_disagreement_score":0.0049756905,"about_ca_system_score_codex":0.00043491193,"about_ca_system_score_gemma":0.0003261577,"threshold_uncertainty_score":0.009893417},"labels":[],"label_agreement":null},{"id":"W2514277111","doi":"10.3324/haematol.2016.145821","title":"Response to treatment with azacitidine in children with advanced myelodysplastic syndrome prior to hematopoietic stem cell transplantation","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Children's Hospital of Eastern Ontario; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Azacitidine; Medicine; Myelodysplastic syndromes; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Leukemia; Myeloid leukemia; Oncology; Gastroenterology; Bone marrow; Surgery; Biology","score_opus":0.012551107800142756,"score_gpt":0.2570567888220094,"score_spread":0.24450568102186662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514277111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672794,0.0024757476,0.00006942194,0.000087809385,0.00000691032,0.000009033762,0.0000738799,0.000007717809,0.00054155523],"genre_scores_gemma":[0.99865484,0.00085680006,0.0001248148,0.000069721915,0.000015698184,0.000006468317,0.00020870676,0.0000026639957,0.000060192844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974865,0.00006242213,0.000032215496,0.000045053035,0.000068719695,0.00004292498],"domain_scores_gemma":[0.9992538,0.00023537515,0.00029928517,0.000019015915,0.000049825427,0.00014275381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003108893,0.00016391672,0.00048001093,0.00043430086,0.00021498058,0.00027156755,0.00015627965,0.00028995593,0.00052742864],"category_scores_gemma":[0.0016224262,0.000096963005,0.00032051667,0.00048333046,0.00023748532,0.00019382797,0.00016726714,0.00056568556,0.00010291923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010220698,0.00010031531,0.9740492,0.00008046875,0.00009576254,0.0031462302,0.00027320173,0.00039117364,0.0040661274,0.0000432,0.00032008518,0.016412118],"study_design_scores_gemma":[0.000097658834,0.0012704885,0.981306,0.00005743241,0.00011145876,0.01368038,0.00026275686,0.0004454491,0.0013726897,0.000042700132,0.0013438833,0.000009101749],"about_ca_topic_score_codex":0.0015406155,"about_ca_topic_score_gemma":0.0027643484,"teacher_disagreement_score":0.0015406155,"about_ca_system_score_codex":0.0004918606,"about_ca_system_score_gemma":0.00032854822,"threshold_uncertainty_score":0.003568709},"labels":[],"label_agreement":null},{"id":"W2514747241","doi":"10.3324/haematol.2016.146894","title":"Erlotinib synergizes with the poly(ADP-ribose) glycohydrolase inhibitor ethacridine in acute myeloid leukemia cells","year":2016,"lang":"en","type":"letter","venue":"Haematologica","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"","keywords":"Myeloid leukemia; Myeloid; Cancer research; Pharmacology; Leukemia; Chemistry; Medicine; Immunology","score_opus":0.017470193773265478,"score_gpt":0.2635668604704489,"score_spread":0.24609666669718344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514747241","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09697406,0.021691907,0.001657638,0.8122653,0.022595694,0.0001700112,0.00070456864,0.00046554848,0.04347537],"genre_scores_gemma":[0.5948498,0.023262052,0.0029272619,0.2985187,0.030878946,0.0002493667,0.0008164225,0.00007237964,0.048425008],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99951184,0.00014035548,0.00006503995,0.000033681135,0.0001561387,0.00009296317],"domain_scores_gemma":[0.99944526,0.00027434868,0.00006324375,0.000037233516,0.00006393984,0.00011586393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005477512,0.00037258386,0.00087013067,0.00019865719,0.00070960145,0.001147295,0.0004379596,0.005044811,0.0024459148],"category_scores_gemma":[0.0025851547,0.00017768075,0.0005075751,0.0002438675,0.00037571715,0.0006262205,0.00033158073,0.004663,0.0018474171],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033146562,0.00080686837,0.008632572,0.0005345741,0.00015533333,0.049857922,0.00021615704,0.00244564,0.021783322,0.007930393,0.657104,0.24721858],"study_design_scores_gemma":[0.0032271422,0.0027263039,0.014429331,0.00030055124,0.00020738876,0.05830261,0.000363468,0.0103015015,0.021815425,0.014922922,0.87331307,0.000090377405],"about_ca_topic_score_codex":0.0006025677,"about_ca_topic_score_gemma":0.0017967024,"teacher_disagreement_score":0.005044811,"about_ca_system_score_codex":0.001243413,"about_ca_system_score_gemma":0.00051908835,"threshold_uncertainty_score":0.00902164},"labels":[],"label_agreement":null},{"id":"W2521045502","doi":"10.3324/haematol.2016.148924","title":"A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital; University of Toronto","funders":"National Cancer Institute; Gilead Sciences; European Hematology Association; American Society of Hematology","keywords":"Myelofibrosis; Medicine; Administration (probate law); Phase (matter); Phases of clinical research; Open label; Ruxolitinib; Internal medicine; Adverse effect; Clinical trial; Chemistry; Political science; Bone marrow","score_opus":0.18015390891044974,"score_gpt":0.4582531616756482,"score_spread":0.2780992527651985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521045502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945879,0.0011245761,0.00054833945,0.00021699505,0.00010490533,0.0020024942,0.00058656733,0.00007447249,0.0007537457],"genre_scores_gemma":[0.98998356,0.0012429785,0.0020512308,0.00071035995,0.00019095956,0.0026446716,0.0013357843,0.000022436345,0.0018180351],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99971014,0.0001267358,0.000015512178,0.000060059094,0.00003331977,0.00005418126],"domain_scores_gemma":[0.99956435,0.00007965284,0.00008263917,0.000038873783,0.000038078837,0.00019623444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013670927,0.0011261146,0.0020630036,0.00043416175,0.00033847938,0.00060759106,0.00060187717,0.0011690084,0.002185751],"category_scores_gemma":[0.0007470834,0.0005316941,0.00085380196,0.0002789007,0.0005751838,0.00070895586,0.0002250888,0.0021146387,0.0005058935],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6353773,0.16845867,0.0048343767,0.0009636801,0.0009765752,0.00049681513,0.00022941706,0.0017187977,0.10329189,0.00026779986,0.0031503509,0.080234334],"study_design_scores_gemma":[0.52361,0.45996892,0.008070615,0.000020907626,0.00023674211,0.00024737013,0.00003166612,0.0012142009,0.0049645244,0.00014969854,0.0014577735,0.000027551781],"about_ca_topic_score_codex":0.0004023191,"about_ca_topic_score_gemma":0.0011419555,"teacher_disagreement_score":0.002185751,"about_ca_system_score_codex":0.00043866294,"about_ca_system_score_gemma":0.0008344166,"threshold_uncertainty_score":0.007312119},"labels":[],"label_agreement":null},{"id":"W2528750776","doi":"10.3324/haematol.2016.147835","title":"Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"Radboud Universitair Medisch Centrum; Erasmus Medisch Centrum; Vrije Universiteit Amsterdam; Radboud Universiteit","keywords":"Myelodysplastic syndromes; Flow cytometry; Cohort; Medicine; International Prognostic Scoring System; Dysplasia; Internal medicine; Confidence interval; Pathology; Oncology; Immunology; Bone marrow","score_opus":0.03187328569843767,"score_gpt":0.28627629038101154,"score_spread":0.2544030046825739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528750776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934274,0.0013194036,0.0026791983,0.00006348403,0.000017278708,0.00009376473,0.00064023543,0.00004164905,0.0017175265],"genre_scores_gemma":[0.993457,0.00071191,0.004309517,0.000063562315,0.00001811555,0.000057879006,0.00092961057,0.000009774947,0.0004427338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951434,0.00012531671,0.00008208085,0.000078845944,0.00015070107,0.000048676626],"domain_scores_gemma":[0.9992067,0.00024015801,0.00017879804,0.00005803328,0.00022264959,0.00009364467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018132094,0.00034178412,0.00021816322,0.0026184132,0.00020152633,0.00027700412,0.00032663843,0.00030603586,0.0006892939],"category_scores_gemma":[0.0017626305,0.000102518505,0.00025244534,0.00053438736,0.00026387986,0.00016531967,0.00037999355,0.00019227552,0.00022710075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056271243,0.000059119935,0.85634565,0.00011103175,0.000074887714,0.002503807,0.0003328395,0.00032531813,0.10973599,0.00018197359,0.0007574362,0.029009178],"study_design_scores_gemma":[0.0000333828,0.0003978116,0.93512404,0.00006537899,0.000090457776,0.015673047,0.00021447864,0.0023017211,0.042364616,0.00015530775,0.003565533,0.000014166718],"about_ca_topic_score_codex":0.0009946944,"about_ca_topic_score_gemma":0.0011200992,"teacher_disagreement_score":0.0026184132,"about_ca_system_score_codex":0.00021397832,"about_ca_system_score_gemma":0.00014875662,"threshold_uncertainty_score":0.009589255},"labels":[],"label_agreement":null},{"id":"W2544907814","doi":"10.3324/haematol.2016.151126","title":"Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health","keywords":"Myelofibrosis; Open label; Medicine; Ruxolitinib; Internal medicine; Oncology; Clinical trial; Pharmacology","score_opus":0.02871582059334091,"score_gpt":0.3091379193859089,"score_spread":0.28042209879256796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544907814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987823,0.0025260425,0.0010893656,0.0005668544,0.00018556668,0.0034295563,0.0021053874,0.00014198464,0.0021321056],"genre_scores_gemma":[0.98704535,0.0013271085,0.0020643235,0.0010848715,0.00027861487,0.0032561186,0.0031230773,0.0000369437,0.0017837379],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99892443,0.0005923973,0.000051744737,0.0001648035,0.00009046743,0.00017599712],"domain_scores_gemma":[0.9981516,0.0003299406,0.00034243675,0.00016883922,0.00013352615,0.00087363267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029335455,0.0017261673,0.00324279,0.00041324933,0.00046487706,0.0013131441,0.0009511182,0.0011255179,0.0037792698],"category_scores_gemma":[0.0017096936,0.0008265045,0.0017680732,0.00051387446,0.0011469864,0.0008982346,0.00046542863,0.0036974507,0.0010191562],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90796,0.03325245,0.003995809,0.0005259378,0.0011696818,0.00013840984,0.000109250046,0.0012060285,0.019725796,0.00015080087,0.002106099,0.029659612],"study_design_scores_gemma":[0.72987336,0.25557378,0.00928847,0.00002453659,0.00057747524,0.00013630184,0.00003533296,0.00097267627,0.0020529605,0.00013810687,0.0013012321,0.000025755799],"about_ca_topic_score_codex":0.000787887,"about_ca_topic_score_gemma":0.0025163922,"teacher_disagreement_score":0.0037792698,"about_ca_system_score_codex":0.0009742638,"about_ca_system_score_gemma":0.002025316,"threshold_uncertainty_score":0.015514255},"labels":[],"label_agreement":null},{"id":"W2547656462","doi":"10.3324/haematol.2016.152421","title":"Decreased numbers of dense granules in fetal and neonatal platelets","year":2016,"lang":"en","type":"letter","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Mount Sinai Hospital; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Platelet; Fetus; Andrology; Medicine; Obstetrics; Pregnancy; Biology; Internal medicine; Genetics","score_opus":0.015596495565175995,"score_gpt":0.25120670938209816,"score_spread":0.23561021381692215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547656462","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41463,0.03761673,0.0033404566,0.4719528,0.021514783,0.0001421567,0.00086469064,0.00049312564,0.04944531],"genre_scores_gemma":[0.9006212,0.0066652857,0.00208985,0.06327863,0.019297862,0.00006885454,0.00023062625,0.00005802377,0.007689679],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99935704,0.00018363605,0.00012219379,0.00008676835,0.00016421014,0.00008615044],"domain_scores_gemma":[0.99802774,0.0012035382,0.0002279513,0.00016253469,0.00020472024,0.00017349033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053688243,0.00051955663,0.0006128644,0.00076716923,0.00062116096,0.001149491,0.0009286901,0.0060507646,0.0019315511],"category_scores_gemma":[0.0064525823,0.00035807138,0.0004346009,0.00049007335,0.0008505685,0.0008702865,0.00037008536,0.0038306615,0.00077257614],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013058285,0.00009677121,0.02726481,0.000409369,0.00007891745,0.87181073,0.00066315854,0.00018353303,0.0068186666,0.0027093699,0.045854073,0.04280475],"study_design_scores_gemma":[0.00015778354,0.00037104904,0.031495675,0.00022875718,0.00009720715,0.922374,0.0005946341,0.0009270217,0.005691733,0.003944754,0.034065094,0.000052283824],"about_ca_topic_score_codex":0.000812348,"about_ca_topic_score_gemma":0.00067829876,"teacher_disagreement_score":0.0060507646,"about_ca_system_score_codex":0.00087785756,"about_ca_system_score_gemma":0.00025489292,"threshold_uncertainty_score":0.00646168},"labels":[],"label_agreement":null},{"id":"W2573426943","doi":"10.3324/haematol.2016.150375","title":"<i>Gfi1b</i> controls integrin signaling-dependent cytoskeleton dynamics and organization in megakaryocytes","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Cell biology; Megakaryocyte; Cytoskeleton; Biology; Integrin; Actin; Actin cytoskeleton; Tubulin; Microtubule; Genetics; Cell; Stem cell; Haematopoiesis","score_opus":0.013149097644713248,"score_gpt":0.26288720468522525,"score_spread":0.249738107040512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573426943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924132,0.0014981182,0.002236286,0.00020415026,0.000029771198,0.00001633801,0.0009225503,0.00028138014,0.002398115],"genre_scores_gemma":[0.9941717,0.00056091545,0.0014638698,0.000096259384,0.00001131097,0.00004233146,0.0008532174,0.00015965688,0.0026408462],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998945,0.000018638211,0.000011112087,0.000026011663,0.000027015752,0.000022718736],"domain_scores_gemma":[0.9998443,0.00001545783,0.00006552574,0.0000132982395,0.000010412545,0.000050937175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008717843,0.00046765,0.000229872,0.00032698584,0.00021120564,0.0003315314,0.0002751049,0.0004119341,0.001741996],"category_scores_gemma":[0.00012452186,0.00023894347,0.0001689299,0.00013792477,0.0002981497,0.000112707494,0.00028980256,0.0005679311,0.0010913127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044653058,0.0000053042877,0.000104249295,0.000009086289,0.0000014281744,0.0000509987,0.000005273671,0.000027698707,0.9993142,0.00005932337,0.000041660463,0.00033611368],"study_design_scores_gemma":[0.000038958162,0.00007934779,0.014061823,0.00001674442,0.000012351907,0.0007573467,0.000036285786,0.0015982924,0.9787957,0.00008794365,0.0045057735,0.0000094625],"about_ca_topic_score_codex":0.0010784601,"about_ca_topic_score_gemma":0.0012191667,"teacher_disagreement_score":0.001741996,"about_ca_system_score_codex":0.0003508347,"about_ca_system_score_gemma":0.00012007692,"threshold_uncertainty_score":0.0058276057},"labels":[],"label_agreement":null},{"id":"W2580493818","doi":"10.3324/haematol.2016.154377","title":"Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Pharmacyclics; Servier","keywords":"Medicine; Follicular lymphoma; Adverse effect; Internal medicine; Neutropenia; Lymphoma; Histone deacetylase inhibitor; Gastroenterology; Chronic lymphocytic leukemia; Oncology; Pharmacology; Histone deacetylase; Immunology; Leukemia; Chemotherapy; Biology","score_opus":0.01595690113616621,"score_gpt":0.3266580733588823,"score_spread":0.3107011722227161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580493818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930218,0.0033191475,0.0005619421,0.00024344199,0.000042753745,0.0010803507,0.0005835371,0.00004881011,0.0010981584],"genre_scores_gemma":[0.99217176,0.0026319933,0.0007898168,0.00065889,0.000093183575,0.00087748887,0.0016324365,0.000019628413,0.0011247098],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993979,0.0003202061,0.00004664771,0.000071273964,0.00007045031,0.000093578295],"domain_scores_gemma":[0.9990747,0.00020787936,0.00021237358,0.000087289794,0.000082995546,0.00033470118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025474655,0.00071313314,0.0019149318,0.00029585272,0.000291337,0.00067312253,0.0005650058,0.00085583585,0.0012303699],"category_scores_gemma":[0.00094245706,0.0003438413,0.0010871006,0.00032953796,0.0005987735,0.0006779459,0.00019576913,0.0017255914,0.00035960617],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47317985,0.09472377,0.03424184,0.001615168,0.0026505126,0.001027436,0.00061904965,0.0030914384,0.11376845,0.00034209708,0.0049824673,0.26975796],"study_design_scores_gemma":[0.25362635,0.6544256,0.07257574,0.000078929595,0.0010283248,0.0009349428,0.00012960788,0.0017148204,0.009667411,0.0002472241,0.0055269734,0.000044075798],"about_ca_topic_score_codex":0.0006444148,"about_ca_topic_score_gemma":0.0015758924,"teacher_disagreement_score":0.0025474655,"about_ca_system_score_codex":0.000701283,"about_ca_system_score_gemma":0.0009177317,"threshold_uncertainty_score":0.013472497},"labels":[],"label_agreement":null},{"id":"W2583258861","doi":"10.3324/haematol.2016.159905","title":"Hyper-CVAD + epratuzumab as a salvage regimen for younger patients with relapsed/refractory CD22-positive precursor B-cell acute lymphocytic leukemia","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Institut National Du Cancer","keywords":"CD22; Refractory (planetary science); Regimen; Medicine; Salvage therapy; Oncology; Internal medicine; B cell; Immunology; Biology; Chemotherapy; Antibody","score_opus":0.016730707934114904,"score_gpt":0.2785180608918325,"score_spread":0.2617873529577176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583258861","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70574856,0.021941936,0.0013684011,0.21160927,0.005853573,0.00020402238,0.0007001267,0.00018278751,0.052391306],"genre_scores_gemma":[0.93184215,0.00623308,0.0010805717,0.044081647,0.0062777204,0.000076410375,0.00035023995,0.000032898974,0.0100253755],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998919,0.000027838001,0.000012761756,0.000015232887,0.000018862704,0.00003343438],"domain_scores_gemma":[0.9996178,0.00015378313,0.00003564447,0.000017342412,0.000019229372,0.00015627578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020114546,0.00020738915,0.00047086342,0.00017445865,0.0005857398,0.00047473612,0.00043234415,0.0017269794,0.0023659642],"category_scores_gemma":[0.0013979945,0.000119205884,0.0003467303,0.00020598364,0.00030669977,0.00048095582,0.00023452593,0.0018363056,0.0007126093],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073237047,0.0014131789,0.07976193,0.00046149007,0.00017970253,0.4822954,0.0008286033,0.0024200561,0.01143001,0.0045400686,0.15691635,0.25242957],"study_design_scores_gemma":[0.004222072,0.006211652,0.10403016,0.0006574839,0.00035652058,0.6274968,0.0010285802,0.0058481735,0.0052349567,0.013801684,0.2310207,0.00009121894],"about_ca_topic_score_codex":0.0009566935,"about_ca_topic_score_gemma":0.0032211412,"teacher_disagreement_score":0.0023659642,"about_ca_system_score_codex":0.0009332915,"about_ca_system_score_gemma":0.0006355479,"threshold_uncertainty_score":0.00791496},"labels":[],"label_agreement":null},{"id":"W2584734171","doi":"10.3324/haematol.2016.159087","title":"Genetic polymorphism at <i>BCL2</i> as a predictor for rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone efficacy in patients with diffuse large B-cell lymphoma","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Jubilee Hospital; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Public Health Ontario; University of Toronto; Simon Fraser University; BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Agency; Terry Fox Research Institute; Genome Canada; Canadian Institutes of Health Research; Genome British Columbia","keywords":"Rituximab; Prednisone; Vincristine; Cyclophosphamide; Medicine; Lymphoma; Doxorubicin; Internal medicine; Oncology; Diffuse large B-cell lymphoma; Cancer research; Chemotherapy","score_opus":0.008323216266862688,"score_gpt":0.22480587435944302,"score_spread":0.21648265809258033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584734171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90158427,0.0054256166,0.0003437533,0.0774261,0.0014498988,0.000037563408,0.00042838414,0.000035167017,0.013269248],"genre_scores_gemma":[0.98620254,0.0008987125,0.00021631981,0.008943384,0.0022960077,0.000016586106,0.00015701696,0.000007747611,0.0012615722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995376,0.00019571054,0.0000560066,0.00006078705,0.00007784895,0.00007208095],"domain_scores_gemma":[0.9987041,0.0007585073,0.00013046987,0.00005545017,0.00012370085,0.0002277354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004935288,0.0002463526,0.0003922958,0.00031977196,0.00046392175,0.0005038341,0.00037370835,0.0018198696,0.0012584158],"category_scores_gemma":[0.0028944982,0.00015927508,0.00025522802,0.0005385143,0.00040308363,0.00035411835,0.00014276594,0.0016292157,0.0003515289],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003756093,0.0003619213,0.82217366,0.00012200239,0.00020279361,0.088654704,0.00032100428,0.00064191886,0.0064502098,0.00074319344,0.040363576,0.036208924],"study_design_scores_gemma":[0.00096568366,0.0011642849,0.78558636,0.00024770977,0.0005450574,0.16694906,0.0009950507,0.00685078,0.0021761893,0.00477212,0.029677616,0.00007007221],"about_ca_topic_score_codex":0.0015328396,"about_ca_topic_score_gemma":0.0028023617,"teacher_disagreement_score":0.0018198696,"about_ca_system_score_codex":0.0006488428,"about_ca_system_score_gemma":0.00042363288,"threshold_uncertainty_score":0.004707694},"labels":[],"label_agreement":null},{"id":"W2586723043","doi":"10.3324/haematol.2016.157495","title":"Deltex-1 mutations predict poor survival in diffuse large B-cell lymphoma","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; University of Toronto; Helsingin Yliopisto","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Cancer research; Mutation; Biology; Internal medicine; Genetics; Oncology; Medicine; Immunology; Gene","score_opus":0.02855342721875413,"score_gpt":0.2795198590606242,"score_spread":0.25096643184187006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586723043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70097655,0.011545272,0.001263932,0.23284951,0.0041364236,0.000078005905,0.0009916838,0.00018239114,0.047976263],"genre_scores_gemma":[0.96642995,0.0026488737,0.0007433964,0.021542171,0.0042258822,0.00002820104,0.0003322459,0.00002171635,0.00402749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975985,0.00006411203,0.000024914149,0.00003768161,0.000053023967,0.000060455215],"domain_scores_gemma":[0.999231,0.00032712249,0.00005872276,0.00006248061,0.00015290789,0.0001677759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003563552,0.0002539735,0.00038824795,0.00031428243,0.0005246989,0.0006886589,0.00034337593,0.0022989474,0.002540908],"category_scores_gemma":[0.0025335033,0.00016626407,0.0002114472,0.0003523721,0.00046043072,0.0005609588,0.00029019377,0.0016670456,0.001280204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013962063,0.00022104837,0.54205024,0.00022495117,0.00011047324,0.17311852,0.0005492324,0.00091728626,0.014078955,0.002496449,0.15195484,0.11288174],"study_design_scores_gemma":[0.0005641946,0.0004953644,0.33379072,0.00039143598,0.00024707438,0.5141977,0.001903466,0.009930587,0.004364511,0.014052383,0.11994533,0.00011716411],"about_ca_topic_score_codex":0.001378824,"about_ca_topic_score_gemma":0.0019296795,"teacher_disagreement_score":0.002540908,"about_ca_system_score_codex":0.00063966674,"about_ca_system_score_gemma":0.00034622112,"threshold_uncertainty_score":0.008500218},"labels":[],"label_agreement":null},{"id":"W2591816604","doi":"10.3324/haematol.2016.158808","title":"A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndrome","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Wiskott–Aldrich syndrome; Umbilical Cord Blood Transplantation; Umbilical cord; Transplantation; Cumulative incidence; Internal medicine; Cord blood; Gastroenterology; Hematopoietic stem cell transplantation; Hematology; Surgery; Immunology; Biology","score_opus":0.01884460750505398,"score_gpt":0.28319939833069274,"score_spread":0.2643547908256388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591816604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994462,0.00018937036,0.000088960755,0.000021255073,0.0000042914753,0.000002605231,0.00010617457,0.0000029256416,0.00013819702],"genre_scores_gemma":[0.9995148,0.00006297424,0.00005637174,0.0000065210916,0.000007652935,0.0000038712205,0.00029215124,0.000002366599,0.00005331914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959797,0.00012540432,0.00004089599,0.00006974212,0.00008406274,0.000082074715],"domain_scores_gemma":[0.9981166,0.0005092799,0.00083841564,0.00007815799,0.00009357051,0.00036402637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006273121,0.00042179963,0.00033565285,0.0006296983,0.00019034834,0.00041933378,0.0002935754,0.00043407755,0.0009905437],"category_scores_gemma":[0.002137482,0.00011004769,0.0009204175,0.00077765866,0.00022286533,0.00031085877,0.0003637352,0.0007602166,0.00015699973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032535725,0.000018607827,0.9975412,0.00000423366,0.000071473485,0.00018932547,0.000019683814,0.00014643214,0.0001734676,0.000019208119,0.00005348595,0.0014373901],"study_design_scores_gemma":[0.000017570464,0.00033325065,0.9976292,0.000006293849,0.000089826055,0.0007335833,0.000065273045,0.00077219855,0.00017016039,0.0000362591,0.00014045578,0.000005927553],"about_ca_topic_score_codex":0.0017844731,"about_ca_topic_score_gemma":0.0015354333,"teacher_disagreement_score":0.0017844731,"about_ca_system_score_codex":0.00033054576,"about_ca_system_score_gemma":0.00042990787,"threshold_uncertainty_score":0.0035480857},"labels":[],"label_agreement":null},{"id":"W2592957633","doi":"10.3324/haematol.2016.159053","title":"Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Arsenic trioxide; Aldehyde dehydrogenase; Cancer research; Haematopoiesis; Myelodysplastic syndromes; Stem cell; Myeloid leukemia; Cyclophosphamide; Leukemia; Myeloid; Biology; Immunology; Chemistry; Medicine; Chemotherapy; Internal medicine; Apoptosis; Bone marrow; Biochemistry; Cell biology; Enzyme","score_opus":0.08955761268395121,"score_gpt":0.3647987528107573,"score_spread":0.2752411401268061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592957633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832118,0.005424032,0.007080214,0.0003618705,0.000067689245,0.000237313,0.00022569366,0.00020428961,0.0031870415],"genre_scores_gemma":[0.9909195,0.0039550113,0.0025965134,0.00011868599,0.000024485886,0.000079176454,0.00033328522,0.000009970747,0.0019634652],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999664,0.000006092542,0.0000026748796,0.000005113134,0.000010289155,0.000009509073],"domain_scores_gemma":[0.9999747,0.000003606676,0.000008148485,0.0000041848266,0.00000306729,0.0000063246457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008831454,0.000257578,0.0003054092,0.00021671137,0.00014927924,0.00020902493,0.00016509,0.0001353125,0.0008120543],"category_scores_gemma":[0.000061747975,0.000063408595,0.00017382087,0.00015179387,0.00011193782,0.0001398618,0.00015179343,0.00041115787,0.00023213749],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082952075,0.00064904656,0.0018697623,0.00021391122,0.000045813587,0.00048415264,0.00007485703,0.0009640727,0.905696,0.001043456,0.0010884972,0.08704098],"study_design_scores_gemma":[0.0007531534,0.011624367,0.020832853,0.000052298652,0.0002600278,0.00539774,0.0001272937,0.0040534004,0.8995797,0.0011424585,0.05615808,0.000018604778],"about_ca_topic_score_codex":0.00023275494,"about_ca_topic_score_gemma":0.00079608645,"teacher_disagreement_score":0.0008120543,"about_ca_system_score_codex":0.00015559969,"about_ca_system_score_gemma":0.00017167955,"threshold_uncertainty_score":0.002716601},"labels":[],"label_agreement":null},{"id":"W2595098826","doi":"10.3324/haematol.2016.156356","title":"Improved survival after acute graft- <i>versus</i> -host disease diagnosis in the modern era","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia; University of Calgary","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Genentech; Health Resources and Services Administration; Swedish Orphan Biovitrum; Otsuka Pharmaceutical; Astellas Pharma; Otsuka America; bluebird bio; Janssen Scientific Affairs; Telomere Diagnostics; Sunesis; Medac; Jazz Pharmaceuticals; Medical College of Wisconsin; Takeda Oncology; University of Minnesota; Spectrum Pharmaceuticals; Alexion Pharmaceuticals; U.S. Navy; Celgene; National Center for Advancing Translational Sciences; HistoGenetics; WellPoint; Onyx Pharmaceuticals; U.S. Department of Defense; Sanofi; Bristol-Myers Squibb; AstraZeneca; U.S. Department of Health and Human Services; Astellas Pharma US; Amgen; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Incyte; Pfizer; Patient-Centered Outcomes Research Institute; National Cancer Institute; Gilead Sciences","keywords":"Medicine; Graft-versus-host disease; Acute leukemia; Disease; Internal medicine; Transplantation; Hematopoietic stem cell transplantation; Cohort; Myelodysplastic syndromes; Myeloid leukemia; Regimen; Gastroenterology; Surgery; Leukemia; Immunology; Bone marrow","score_opus":0.034571677387496114,"score_gpt":0.3014838367217284,"score_spread":0.2669121593342323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595098826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96879286,0.021145355,0.0009333921,0.0018629276,0.00046365257,0.000011487194,0.00026322863,0.00003842574,0.0064886906],"genre_scores_gemma":[0.9970804,0.0017759111,0.00020437501,0.00018671378,0.00027084042,0.000003501855,0.00018610917,0.0000039985425,0.0002880644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997987,0.00007817555,0.000011403024,0.000020023639,0.000031109492,0.000060615],"domain_scores_gemma":[0.9994692,0.00016064207,0.00015592507,0.000041764313,0.00004039618,0.00013204219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006249475,0.00015761351,0.00023254464,0.00028326153,0.0001980601,0.00052706,0.00017952986,0.0002970219,0.0019690196],"category_scores_gemma":[0.0013692407,0.000036520167,0.0001564656,0.0002789555,0.00032695592,0.0006167608,0.0004710347,0.0005224471,0.00024985874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011612206,0.0005995793,0.62421685,0.00032139677,0.0003525259,0.0033962359,0.00030145637,0.0009388498,0.0069280635,0.0032381222,0.0064105345,0.34168413],"study_design_scores_gemma":[0.00041145735,0.008460387,0.9404555,0.00026118426,0.00048016515,0.01639174,0.00047312974,0.001865501,0.003335549,0.007017114,0.020800896,0.000047463735],"about_ca_topic_score_codex":0.00022756177,"about_ca_topic_score_gemma":0.0004895376,"teacher_disagreement_score":0.0019690196,"about_ca_system_score_codex":0.00035175335,"about_ca_system_score_gemma":0.00028369747,"threshold_uncertainty_score":0.006586969},"labels":[],"label_agreement":null},{"id":"W2597657343","doi":"10.3324/haematol.2017.164459","title":"Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute","keywords":"Globulin; Aplastic anemia; Medicine; Horse; Transplantation; Bone marrow; Immunosuppression; Immunology; Internal medicine; Gastroenterology; Biology","score_opus":0.018319121319967914,"score_gpt":0.3011277074789704,"score_spread":0.28280858615900245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597657343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99935955,0.00023602678,0.000041009636,0.000020436635,0.0000034813272,0.0000024885594,0.000058694983,0.0000012497092,0.0002770838],"genre_scores_gemma":[0.99974674,0.00005240073,0.000010748625,0.000009120761,0.0000059330177,0.0000016901408,0.00009898657,9.328007e-7,0.00007337567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994849,0.00017748342,0.00004717248,0.00005610618,0.00012204669,0.000112256625],"domain_scores_gemma":[0.9981249,0.0005756616,0.0007904402,0.00008411965,0.0000937781,0.00033118553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009467063,0.00011444769,0.00021167414,0.0003648199,0.00014685538,0.00042470725,0.00025862534,0.00018985005,0.0007998339],"category_scores_gemma":[0.0020450747,0.00006213416,0.00037385104,0.00038030016,0.00022822667,0.00026584245,0.00032156007,0.00037768492,0.00013653185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018318068,0.00010683235,0.98821133,0.000012670423,0.00018709313,0.0001996188,0.000061631305,0.00024034576,0.0009506103,0.000041716346,0.00012656709,0.008029895],"study_design_scores_gemma":[0.000021361317,0.0007442402,0.9981128,0.000006458188,0.00005364895,0.0002881441,0.00006818224,0.00020891361,0.00030105945,0.0000330544,0.00015931217,0.000002828928],"about_ca_topic_score_codex":0.0008137139,"about_ca_topic_score_gemma":0.0021170266,"teacher_disagreement_score":0.0009467063,"about_ca_system_score_codex":0.00039787235,"about_ca_system_score_gemma":0.00027897942,"threshold_uncertainty_score":0.005006671},"labels":[],"label_agreement":null},{"id":"W2602665283","doi":"10.3324/haematol.2017.164012","title":"Venous thromboembolism is associated with graft-<i>versus</i>-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantation","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Cumulative incidence; Transplantation; Thrombosis; Venous thrombosis; Incidence (geometry); Hematopoietic stem cell transplantation; Surgery; Confidence interval; Proportional hazards model; Body mass index","score_opus":0.024099723906466638,"score_gpt":0.2667924689432085,"score_spread":0.24269274503674187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602665283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984623,0.0009414181,0.000104863495,0.00006247954,0.0000066529265,0.0000034003617,0.000079401674,0.000004522387,0.00033496512],"genre_scores_gemma":[0.9994844,0.00026746714,0.000032126853,0.000017497927,0.000029069704,0.0000017096411,0.000104620354,0.0000013420597,0.00006166123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924076,0.00022820182,0.00010613271,0.000107564876,0.00020537195,0.00011196044],"domain_scores_gemma":[0.99609405,0.0006293307,0.0025176865,0.00018286529,0.00014541953,0.00043058695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008299858,0.00019130448,0.0003150459,0.0005079345,0.00021532418,0.00063336355,0.00030355688,0.0003414789,0.0014535278],"category_scores_gemma":[0.003046757,0.00019481016,0.00055403746,0.00075919257,0.00032607466,0.00031136416,0.00039604967,0.00084195856,0.00013960466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001491436,0.00002200208,0.99785405,0.0000097235015,0.00006345255,0.00009394105,0.000013600422,0.000051614712,0.000121212885,0.000014467457,0.000058268113,0.0015485773],"study_design_scores_gemma":[0.000006481988,0.00006887973,0.99888617,0.0000074993072,0.00003593477,0.0005935927,0.000024505662,0.0002071606,0.00006662784,0.00003494515,0.000065871325,0.0000023697976],"about_ca_topic_score_codex":0.0014146079,"about_ca_topic_score_gemma":0.0013260065,"teacher_disagreement_score":0.0014535278,"about_ca_system_score_codex":0.00027609497,"about_ca_system_score_gemma":0.00029559672,"threshold_uncertainty_score":0.0048624873},"labels":[],"label_agreement":null},{"id":"W2604831554","doi":"10.3324/haematol.2016.160754","title":"Bleeding risk of surgery and its prevention in patients with inherited platelet disorders","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Pontificia Universidad Católica de Chile; Universitair Ziekenhuis Gent; Universidad de Murcia; Universiteit Gent; Queen's University; Ain Shams University; Inselspital, Universitätsspital Bern; Instituto de Salud Carlos III; European Hematology Association; Fondazione Umberto Veronesi; University of Pennsylvania","keywords":"Medicine; Platelet disorder; Platelet; Bleeding diathesis; Bernard–Soulier syndrome; Incidence (geometry); Surgery; Blood Platelet Disorders; Desmopressin; Internal medicine; Pediatrics; Platelet aggregation","score_opus":0.026208891038710422,"score_gpt":0.2644127558795973,"score_spread":0.23820386484088685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604831554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968522,0.0024478422,0.00010344676,0.000062677835,0.0000054820844,0.000003848266,0.00008424506,0.000002019641,0.00043830086],"genre_scores_gemma":[0.9991829,0.00054151367,0.000106585016,0.000015285701,0.000020943546,0.0000031179095,0.0000857359,5.487678e-7,0.000043338387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960595,0.00015965644,0.00005923592,0.00004888616,0.00008812257,0.00003817733],"domain_scores_gemma":[0.9985648,0.00030777144,0.00084200996,0.000059848855,0.00008370688,0.00014194833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045957285,0.000185348,0.00027560449,0.00073866046,0.00020189174,0.00030737303,0.00012692038,0.00032184224,0.00058907515],"category_scores_gemma":[0.002244876,0.000090211885,0.00036699325,0.00079697487,0.0001526849,0.00020265143,0.00021748905,0.00034996084,0.00007711845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017742417,0.000014584976,0.99554056,0.000015655096,0.00004759607,0.00026447902,0.000025963114,0.00004355445,0.00013520096,0.000024689149,0.0000509155,0.003659414],"study_design_scores_gemma":[0.000010011994,0.0002459411,0.99686325,0.000011522911,0.000050495823,0.002289903,0.00006400631,0.00014364194,0.00007019173,0.000052598818,0.00019368847,0.000004731686],"about_ca_topic_score_codex":0.0007347935,"about_ca_topic_score_gemma":0.0006420852,"teacher_disagreement_score":0.00073866046,"about_ca_system_score_codex":0.00015465243,"about_ca_system_score_gemma":0.00016980294,"threshold_uncertainty_score":0.002430439},"labels":[],"label_agreement":null},{"id":"W2606755458","doi":"10.3324/haematol.2017.165415","title":"Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Genentech; Celgene; Teva Pharmaceutical Industries; GlaxoSmithKline; Pfizer","keywords":"Follicular lymphoma; Lymphoma; Tissue microarray; Medicine; Rituximab; BCL6; Oncology; Internal medicine; Biomarker; CD163; Diffuse large B-cell lymphoma; Pathology; Cancer research; Immunology; Immunohistochemistry; Biology; Germinal center; B cell","score_opus":0.02448926550737075,"score_gpt":0.2778355668725093,"score_spread":0.2533463013651386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606755458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99938583,0.00026430938,0.00013850519,0.000016921664,0.000001695435,0.000016444736,0.00006441286,0.0000020929676,0.00010979161],"genre_scores_gemma":[0.99949014,0.00005185523,0.00017763507,0.000018740695,0.000007725134,0.000018780218,0.00016744884,0.000002260625,0.00006539885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987908,0.00066438434,0.00006293229,0.00024758052,0.00015538043,0.00007886946],"domain_scores_gemma":[0.9985488,0.0004412796,0.0003984987,0.00022041424,0.00019285323,0.000198102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026793848,0.0002751054,0.0004982499,0.0007488971,0.00027099077,0.0006531632,0.0002925698,0.0003035456,0.00054601935],"category_scores_gemma":[0.0034282093,0.0002198012,0.00031470726,0.0005735748,0.0003226853,0.00035384364,0.00057330535,0.00023409855,0.00014188232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032036353,0.00008764639,0.9859963,0.000024122051,0.00022582206,0.00014997156,0.00009630141,0.00016210163,0.0026910158,0.000038355367,0.00013247077,0.0071923314],"study_design_scores_gemma":[0.00044582295,0.001284849,0.99282235,0.000015455322,0.00038864888,0.00097064045,0.00014633637,0.0011447862,0.0016395734,0.00010343229,0.0010252158,0.000012983583],"about_ca_topic_score_codex":0.0008600328,"about_ca_topic_score_gemma":0.0009913533,"teacher_disagreement_score":0.0026793848,"about_ca_system_score_codex":0.00038564423,"about_ca_system_score_gemma":0.00035166115,"threshold_uncertainty_score":0.014170051},"labels":[],"label_agreement":null},{"id":"W2613829040","doi":"10.3324/haematol.2016.155671","title":"Extracellular glycine is necessary for optimal hemoglobinization of erythroid cells","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McGill University; Spartan Bioscience (Canada); Jewish General Hospital; University of Ottawa; Ottawa Hospital","funders":"Canadian Institutes of Health Research","keywords":"Glycine; Heme; Biochemistry; Chemistry; Hemoglobin; Extracellular; Amino acid; Biology; Enzyme","score_opus":0.023632248585831368,"score_gpt":0.28655490434815895,"score_spread":0.2629226557623276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613829040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931015,0.0023106497,0.0021087842,0.00015490298,0.00002606249,0.000014377256,0.00068732735,0.000102574224,0.0014938929],"genre_scores_gemma":[0.99471813,0.0007913532,0.0024037238,0.00004138692,0.000013551282,0.000020422387,0.00079376844,0.000046158555,0.0011715965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998739,0.000023675857,0.000016379561,0.000028817845,0.000032100714,0.000025197916],"domain_scores_gemma":[0.9997775,0.00004025532,0.00007689552,0.000019210504,0.0000289049,0.000057215828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010381194,0.000291081,0.00027229942,0.0001621919,0.00014835573,0.00031575043,0.0001438427,0.0002596868,0.0011360619],"category_scores_gemma":[0.00021250952,0.00013575087,0.00012035158,0.00009840615,0.00018035634,0.00018970529,0.0002973727,0.00026826613,0.00041194077],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006846859,0.000002877131,0.00035635705,0.000027146652,0.0000020562948,0.00012303477,0.000011021442,0.000019351945,0.99886644,0.000046387933,0.000019026245,0.00045795366],"study_design_scores_gemma":[0.000015912714,0.00013454212,0.023628151,0.000013583477,0.000011894737,0.0011904174,0.000056646153,0.00021643405,0.97048575,0.000094725416,0.004145677,0.000006217042],"about_ca_topic_score_codex":0.0004212897,"about_ca_topic_score_gemma":0.0008143061,"teacher_disagreement_score":0.0011360619,"about_ca_system_score_codex":0.0002404853,"about_ca_system_score_gemma":0.0002351522,"threshold_uncertainty_score":0.0038005114},"labels":[],"label_agreement":null},{"id":"W2624005914","doi":"10.3324/haematol.2016.163436","title":"Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Austrian Science Fund","keywords":"Cancer research; Myeloid leukemia; Tyrosine kinase; K562 cells; Haematopoiesis; Chemistry; Biology; Stem cell; Leukemia; Pharmacology; Signal transduction; Cell biology; Immunology","score_opus":0.027134315873230307,"score_gpt":0.2831470672737546,"score_spread":0.2560127514005243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624005914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97878575,0.0053353594,0.0117986305,0.00031416747,0.00008222275,0.00015883545,0.00040789598,0.00021523601,0.0029018233],"genre_scores_gemma":[0.98837614,0.0019997957,0.006331705,0.00012769875,0.00001672006,0.00007405927,0.00031586856,0.00001346717,0.0027445883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999232,0.00000786973,0.0000055060364,0.000015892334,0.000022055445,0.00002541742],"domain_scores_gemma":[0.99998045,0.0000024293506,0.0000045325123,0.0000026847872,0.0000023635098,0.000007573465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106222236,0.00031041008,0.00029780765,0.000260827,0.00011322714,0.00025181336,0.00027001588,0.00025652343,0.00078533584],"category_scores_gemma":[0.000035565816,0.00009969123,0.00023895987,0.0001810861,0.0001354797,0.00020305645,0.00028769957,0.00045899578,0.00018178484],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013474822,0.00011741252,0.0002095717,0.00008977964,0.000014089777,0.00004313294,0.000017714183,0.00037814214,0.98692757,0.0004672557,0.00016939212,0.01143119],"study_design_scores_gemma":[0.00013928239,0.0013722101,0.0018846426,0.000009611695,0.00005338784,0.00030720735,0.00001487851,0.0027694714,0.98055387,0.00010210556,0.012781077,0.0000121963285],"about_ca_topic_score_codex":0.0005401766,"about_ca_topic_score_gemma":0.0016814788,"teacher_disagreement_score":0.00078533584,"about_ca_system_score_codex":0.00035220216,"about_ca_system_score_gemma":0.00019223006,"threshold_uncertainty_score":0.0026271343},"labels":[],"label_agreement":null},{"id":"W2692859861","doi":"10.3324/haematol.2017.168815","title":"Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: a report from the Children’s Oncology Group","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute","keywords":"Medicine; Adverse effect; Myeloid leukemia; Clinical trial; Oncology; Internal medicine; Event (particle physics); Pediatric oncology; Center (category theory); Pediatrics; Cancer","score_opus":0.5675975619002257,"score_gpt":0.5693340134520334,"score_spread":0.0017364515518076828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2692859861","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14861465,0.00775618,0.013996174,0.80357176,0.0057042716,0.0002053325,0.0055852304,0.000635153,0.013931313],"genre_scores_gemma":[0.76493865,0.002222988,0.013317788,0.20653953,0.009054627,0.00025421687,0.0017652358,0.00027319355,0.0016338028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.8538867,0.09851501,0.020154309,0.0077989427,0.017463114,0.0021818518],"domain_scores_gemma":[0.28464448,0.6087814,0.049482778,0.029054577,0.024899645,0.003137112],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.11699389,0.00021759172,0.0009912957,0.0010291326,0.0007928231,0.0025993711,0.0018858064,0.0059248903,0.0013009803],"category_scores_gemma":[0.44884005,0.00055775675,0.0013535854,0.0035008457,0.0020840445,0.0013959429,0.001127595,0.0055655716,0.00068230875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042233383,0.00014451366,0.60944194,0.00032911976,0.002559111,0.0016869013,0.0014117052,0.0047009387,0.00056323153,0.0059783687,0.23071873,0.13824214],"study_design_scores_gemma":[0.004582702,0.0021819908,0.6682826,0.00138438,0.0047544274,0.009704684,0.001971295,0.050751034,0.006468009,0.046567567,0.20269038,0.00066084485],"about_ca_topic_score_codex":0.011798051,"about_ca_topic_score_gemma":0.015852211,"teacher_disagreement_score":0.8830061,"about_ca_system_score_codex":0.003986094,"about_ca_system_score_gemma":0.004544213,"threshold_uncertainty_score":0.6187302},"labels":[],"label_agreement":null},{"id":"W2728246735","doi":"10.3324/haematol.2017.166827","title":"Reliable subtype classification of diffuse large B-cell lymphoma samples from GELA LNH2003 trials using the Lymph2Cx gene expression assay","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Molecular biology; Medicine; Cancer research; Biology; Pathology","score_opus":0.13163995836435766,"score_gpt":0.3298766199857031,"score_spread":0.19823666162134546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2728246735","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09483049,0.010492429,0.00822061,0.8027957,0.026473705,0.00050003093,0.006347457,0.0005810431,0.04975856],"genre_scores_gemma":[0.4476201,0.0047358708,0.014975855,0.4668994,0.03109108,0.0010517696,0.0061469204,0.00043938335,0.027039602],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99666613,0.0014136403,0.00047653634,0.00028970867,0.0007903462,0.00036358196],"domain_scores_gemma":[0.99212587,0.0044453195,0.0004070183,0.0005312915,0.0019592142,0.0005312254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052019428,0.00030876993,0.0010518508,0.000538378,0.0005664579,0.0020947722,0.0006803452,0.0038426074,0.002522494],"category_scores_gemma":[0.015552435,0.00025359774,0.00050077983,0.0006345045,0.00066006865,0.00080008205,0.00039434116,0.003945298,0.0026006473],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026243513,0.00022380574,0.07031133,0.00032558263,0.00013338025,0.0024186021,0.00040724096,0.00057294976,0.01529291,0.0031879821,0.69588023,0.20862165],"study_design_scores_gemma":[0.0018587615,0.0020589475,0.09846438,0.0007954712,0.00045003698,0.009600684,0.0011509251,0.006464872,0.024644459,0.017882636,0.8364959,0.00013285343],"about_ca_topic_score_codex":0.0010488104,"about_ca_topic_score_gemma":0.004474202,"teacher_disagreement_score":0.0052019428,"about_ca_system_score_codex":0.0012695978,"about_ca_system_score_gemma":0.0008115422,"threshold_uncertainty_score":0.027510822},"labels":[],"label_agreement":null},{"id":"W2732727228","doi":"10.3324/haematol.2016.162230","title":"High-throughput profiling of signaling networks identifies mechanism-based combination therapy to eliminate microenvironmental resistance in acute myeloid leukemia","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Leukemia and Lymphoma Society","keywords":"Myeloid leukemia; Temsirolimus; Leukemia; Cancer research; Tumor microenvironment; PI3K/AKT/mTOR pathway; Biology; Bone marrow; Signal transduction; Immunology; Cell biology","score_opus":0.025313561182599316,"score_gpt":0.29439122386803,"score_spread":0.2690776626854307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2732727228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871076,0.002847353,0.007798749,0.00006836815,0.000011629697,0.00010724457,0.0010297657,0.00022554572,0.0008038389],"genre_scores_gemma":[0.98562837,0.0022839096,0.009355625,0.000053627802,0.00001012449,0.00012348856,0.0015761346,0.00002265689,0.0009462192],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982566,0.000022512371,0.0000100495545,0.000036812195,0.0000752818,0.000029725714],"domain_scores_gemma":[0.99994767,0.000012819752,0.000014226404,0.00000828112,0.000010185136,0.000006917202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001786804,0.00031056785,0.0004327476,0.00048717097,0.00012658509,0.00043497057,0.00017008651,0.00014533888,0.0005583418],"category_scores_gemma":[0.000135031,0.00014237754,0.0002173854,0.00040390968,0.00010461569,0.00015895056,0.00012666069,0.00026311688,0.00019170658],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019302909,0.00006836147,0.0018753643,0.000039951894,0.000021491493,0.000018052799,0.000007293948,0.0006446876,0.98860884,0.000050248676,0.00009419291,0.0083785225],"study_design_scores_gemma":[0.000041320305,0.00085341063,0.04012731,0.0000058953883,0.000120188124,0.0002810073,0.000025448473,0.010826747,0.94419116,0.00016074868,0.0033570465,0.000009666016],"about_ca_topic_score_codex":0.0002854703,"about_ca_topic_score_gemma":0.0008662818,"teacher_disagreement_score":0.0005583418,"about_ca_system_score_codex":0.00024796044,"about_ca_system_score_gemma":0.00021320526,"threshold_uncertainty_score":0.0018678308},"labels":[],"label_agreement":null},{"id":"W2737663958","doi":"10.3324/haematol.2017.170340","title":"Mutational status of <i>IGHV</i> is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Università degli Studi del Piemonte Orientale; Institute for Oil Sands Innovation, University of Alberta; Associazione Italiana per la Ricerca sul Cancro; Ministero della Salute","keywords":"IGHV@; Trisomy; Chronic lymphocytic leukemia; Leukemia; Aneuploidy; Medicine; Oncology; Internal medicine; Biology; Chromosome; Genetics; Gene","score_opus":0.0332763963390192,"score_gpt":0.30400975155762583,"score_spread":0.27073335521860664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737663958","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10075948,0.009895899,0.00084471697,0.84823155,0.0108303595,0.00003665013,0.00048494322,0.00010468527,0.028811738],"genre_scores_gemma":[0.72731745,0.010623823,0.0014802905,0.19922745,0.046358403,0.000071115974,0.0006526663,0.00009603263,0.014172838],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99946755,0.00019652948,0.00006923009,0.00005060506,0.00009852979,0.00011757885],"domain_scores_gemma":[0.9976992,0.0013822048,0.00013635212,0.000121012985,0.00038559095,0.00027574555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000667659,0.00026748155,0.00054658245,0.00042170595,0.0007372224,0.0008933286,0.0005174209,0.004110396,0.0026805727],"category_scores_gemma":[0.0077304817,0.00017989536,0.00025502077,0.00038435604,0.0008081337,0.0008504044,0.0003342681,0.0037040063,0.0022301641],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012121099,0.00020478627,0.17109257,0.0003231273,0.000076356715,0.12128528,0.0005465841,0.0009043012,0.0064058634,0.005769196,0.5434907,0.14868917],"study_design_scores_gemma":[0.00050434226,0.0009426358,0.096024476,0.0011607014,0.0002511685,0.30277616,0.0023437804,0.006121031,0.006386669,0.035028823,0.5483402,0.000119965785],"about_ca_topic_score_codex":0.0012649129,"about_ca_topic_score_gemma":0.0014669494,"teacher_disagreement_score":0.004110396,"about_ca_system_score_codex":0.0009470666,"about_ca_system_score_gemma":0.00056203536,"threshold_uncertainty_score":0.0089674},"labels":[],"label_agreement":null},{"id":"W2739393823","doi":"10.3324/haematol.2017.171041","title":"Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"National Cancer Institute; Pharmacyclics","keywords":"Ibrutinib; Medicine; Internal medicine; Discontinuation; Mantle cell lymphoma; Atrial fibrillation; Cumulative incidence; Adverse effect; Chronic lymphocytic leukemia; Hazard ratio; Oncology; Confidence interval; Leukemia; Lymphoma; Cohort","score_opus":0.08473874912293827,"score_gpt":0.384229192574077,"score_spread":0.29949044345113873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739393823","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32662585,0.4889215,0.045841478,0.0052814116,0.003284367,0.044547603,0.05910684,0.0010825065,0.025308404],"genre_scores_gemma":[0.87370056,0.032158673,0.014214861,0.0042710435,0.0012323747,0.04838104,0.024303539,0.000281096,0.001456923],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.75153804,0.12687877,0.087092295,0.014638897,0.017244542,0.0026075228],"domain_scores_gemma":[0.71019673,0.17177217,0.09170375,0.014457317,0.010231533,0.0016385432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.13302682,0.0016735323,0.007429526,0.0061110808,0.0008610959,0.004314018,0.0024305289,0.0026113768,0.005494921],"category_scores_gemma":[0.20497909,0.00094809855,0.012630008,0.009576873,0.0012967563,0.0030036888,0.002247817,0.0035683059,0.00063376414],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20487405,0.00091270567,0.15843013,0.14089818,0.28674707,0.0009014295,0.0010937004,0.004513875,0.0021212148,0.0065891226,0.023665711,0.16925281],"study_design_scores_gemma":[0.16595589,0.016296815,0.39477003,0.034247063,0.22907673,0.004356586,0.00089285214,0.014129276,0.0042421217,0.023859706,0.11128629,0.0008867027],"about_ca_topic_score_codex":0.00064693874,"about_ca_topic_score_gemma":0.0011035405,"teacher_disagreement_score":0.13302682,"about_ca_system_score_codex":0.0015348603,"about_ca_system_score_gemma":0.0020301791,"threshold_uncertainty_score":0.7035215},"labels":[],"label_agreement":null},{"id":"W2740395975","doi":"10.3324/haematol.2017.170118","title":"Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone <i>vs</i> . placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Takeda Oncology","keywords":"Ixazomib; Lenalidomide; Medicine; Multiple myeloma; Placebo; Internal medicine; Thalidomide; Dexamethasone; Population; Oncology; Carfilzomib; Pathology","score_opus":0.03835956097297118,"score_gpt":0.3196807159182124,"score_spread":0.28132115494524124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740395975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967109,0.0026071456,0.000043071905,0.00009952574,0.000021809155,0.00002377527,0.00009680168,0.0000065484146,0.00039047835],"genre_scores_gemma":[0.9990004,0.00045748096,0.000059890783,0.000098857505,0.000031356696,0.000015350788,0.00016891304,0.0000015568404,0.00016619154],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99948186,0.00026622182,0.00003474772,0.000065063316,0.00006584131,0.00008620706],"domain_scores_gemma":[0.9991291,0.00036337678,0.00024835573,0.000051844505,0.000026180349,0.00018109236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012276851,0.00024745148,0.0007169245,0.00018257121,0.00014892253,0.00058753934,0.00017810514,0.00034265945,0.0009674306],"category_scores_gemma":[0.0012463583,0.0001502089,0.0012821734,0.00017263212,0.00025298746,0.0002933043,0.00022632017,0.00081952044,0.00008858883],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66892767,0.0026234319,0.13360307,0.0005793335,0.00420279,0.00021838988,0.00022490154,0.002507193,0.02273612,0.00020363982,0.0010015246,0.16317187],"study_design_scores_gemma":[0.039538212,0.22221076,0.7200858,0.00012217442,0.0037674042,0.0005355771,0.0001357753,0.0039106514,0.0060125715,0.0003156661,0.003312857,0.000052558342],"about_ca_topic_score_codex":0.0009484225,"about_ca_topic_score_gemma":0.003231732,"teacher_disagreement_score":0.0012276851,"about_ca_system_score_codex":0.0005297947,"about_ca_system_score_gemma":0.0004129272,"threshold_uncertainty_score":0.006492734},"labels":[],"label_agreement":null},{"id":"W2745596189","doi":"10.3324/haematol.2017.169581","title":"Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Hematopoietic cell; Transplantation; Disease; Hematopoietic stem cell transplantation; Medicine; Intensive care medicine; Health care; Haematopoiesis; Internal medicine; Stem cell; Biology; Genetics","score_opus":0.20365176892538828,"score_gpt":0.42149493632411034,"score_spread":0.21784316739872206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745596189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810734,0.0014700543,0.00045358393,0.0005073092,0.00002637452,0.000019760198,0.015275143,0.000022350789,0.001152015],"genre_scores_gemma":[0.99002063,0.0005845554,0.00031618474,0.00009981831,0.000022594882,0.000020100886,0.008708858,0.000006269671,0.00022100993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986759,0.0005381589,0.00026017436,0.00021413957,0.00018501897,0.00012664829],"domain_scores_gemma":[0.99692094,0.0008111021,0.0015959891,0.00023771518,0.00025238254,0.00018186252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001350998,0.00016386983,0.0002616931,0.0013744079,0.00018494973,0.00072338874,0.00033035927,0.00029144812,0.0022741843],"category_scores_gemma":[0.0066575976,0.00025328432,0.00084606936,0.0030695857,0.000112965405,0.0008480222,0.0010724125,0.0005913402,0.00021115207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001103612,0.000018914385,0.99579525,0.000031169653,0.0005306264,0.00002522672,0.00004074962,0.00011952458,0.00005093926,0.000079982565,0.0010482889,0.0021489337],"study_design_scores_gemma":[0.000021115662,0.000027095059,0.99685776,0.000035483496,0.00032954878,0.00019035787,0.00024650965,0.0011414187,0.000071139875,0.00010714198,0.0009671218,0.0000053164995],"about_ca_topic_score_codex":0.021702982,"about_ca_topic_score_gemma":0.028873764,"teacher_disagreement_score":0.021702982,"about_ca_system_score_codex":0.00037102235,"about_ca_system_score_gemma":0.0006091084,"threshold_uncertainty_score":0.043153286},"labels":[],"label_agreement":null},{"id":"W2759397991","doi":"10.3324/haematol.2017.170928","title":"CD56 <sup>bright</sup> natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft- <i>versus</i> -host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; Vancouver General Hospital; Princess Margaret Cancer Centre; BC Cancer Agency; McMaster University; Hospital for Sick Children; Université de Montréal; Hôpital Maisonneuve-Rosemont; University of Toronto; Dalhousie University; Hamilton Health Sciences; BC Children's Hospital; CancerCare Manitoba; Health Sciences Centre; University of British Columbia","funders":"National Cancer Institute","keywords":"Filgrastim; Immunology; Bone marrow; Medicine; Apheresis; Graft-versus-host disease; Myeloid; Immune system; Natural killer cell; Granulocyte colony-stimulating factor; Transplantation; Cytotoxic T cell; Internal medicine; Biology; Chemotherapy; Platelet","score_opus":0.017809653360701127,"score_gpt":0.24700774741147366,"score_spread":0.22919809405077254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2759397991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955823,0.00198001,0.00018055364,0.00021266974,0.00012898922,0.00088023394,0.00025232093,0.000024289555,0.0007586499],"genre_scores_gemma":[0.9961249,0.0010757028,0.00060594827,0.00037740776,0.000103791295,0.00039438266,0.00034255933,0.0000053132603,0.0009699222],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99941635,0.000221048,0.000034650544,0.00007611558,0.0001000927,0.00015171152],"domain_scores_gemma":[0.9995604,0.00009059999,0.00009035141,0.000033160824,0.000040370327,0.00018504639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015973822,0.000535178,0.0009286746,0.0002249215,0.00041930482,0.0008070348,0.00043109572,0.0005809504,0.0017792162],"category_scores_gemma":[0.0008269083,0.00027382973,0.0007280914,0.00025476096,0.0007760582,0.00024059102,0.00018738066,0.0010652164,0.00015241376],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92608696,0.00940214,0.007634648,0.0003997981,0.0008805735,0.0000561482,0.000058814254,0.00020040708,0.011604869,0.0001568241,0.00094813464,0.04257068],"study_design_scores_gemma":[0.61901176,0.30990842,0.054401632,0.00007994846,0.0024114742,0.00012498716,0.00007285509,0.000547317,0.009085654,0.00023224729,0.0040872754,0.00003650424],"about_ca_topic_score_codex":0.009126172,"about_ca_topic_score_gemma":0.02804824,"teacher_disagreement_score":0.9908738,"about_ca_system_score_codex":0.00124246,"about_ca_system_score_gemma":0.0026061942,"threshold_uncertainty_score":0.018146157},"labels":[],"label_agreement":null},{"id":"W2766129023","doi":"10.3324/haematol.2017.176719","title":"Single-molecule DNA sequencing of acute myeloid leukemia and myelodysplastic syndromes with multiple <i>TP53</i> alterations","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital du Saint-Sacrement","funders":"Centre Hospitalier Universitaire de Nantes; Science for Life Laboratory; Radiumhemmets Forskningsfonder; Cancerfonden","keywords":"Myeloid leukemia; Myelodysplastic syndromes; Clinical significance; Somatic cell; Myeloid; Cancer research; Mutation; Leukemia; Karyotype; Medicine; Biology; Immunology; Internal medicine; Genetics; Gene; Bone marrow; Chromosome","score_opus":0.03837447523164675,"score_gpt":0.2796043368568231,"score_spread":0.24122986162517637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766129023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5291461,0.012501537,0.0056970697,0.37109002,0.012888675,0.00027163414,0.0011299481,0.00035425933,0.066920824],"genre_scores_gemma":[0.90257853,0.0050255987,0.0030064648,0.06630884,0.009105827,0.00008697694,0.0004782386,0.000068864356,0.013340707],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.999488,0.00013723849,0.00006662368,0.00008593835,0.0001140067,0.000108222215],"domain_scores_gemma":[0.9987225,0.0006636009,0.00012619134,0.000078681216,0.00019174397,0.00021722756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037385034,0.00033421008,0.00032191066,0.0005602204,0.00062589196,0.0005721175,0.00047356982,0.004425377,0.002316197],"category_scores_gemma":[0.0033672317,0.00022645961,0.00026742875,0.00028739226,0.0006805119,0.00054665154,0.00029409057,0.0022439118,0.0012750844],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074981654,0.00013659634,0.030001758,0.00021593325,0.000060984945,0.790232,0.00075143395,0.0006241476,0.023921615,0.004211685,0.102013424,0.047080606],"study_design_scores_gemma":[0.00013681447,0.00033552572,0.018237796,0.00017857234,0.00012045704,0.82873374,0.00081020483,0.0031188582,0.017549291,0.00847221,0.12226533,0.000041137413],"about_ca_topic_score_codex":0.0008821208,"about_ca_topic_score_gemma":0.0013353481,"teacher_disagreement_score":0.004425377,"about_ca_system_score_codex":0.00071563065,"about_ca_system_score_gemma":0.00046762233,"threshold_uncertainty_score":0.0077484846},"labels":[],"label_agreement":null},{"id":"W2766663088","doi":"10.3324/haematol.2017.179309","title":"A bioclinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphoma","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of Toronto; Alberta Health Services; Queen's University; University of Calgary; University of Saskatchewan","funders":"Canadian Cancer Society Research Institute; Alberta Cancer Foundation","keywords":"BCL6; Tissue microarray; Immunohistochemistry; Diffuse large B-cell lymphoma; Internal medicine; Oncology; Fluorescence in situ hybridization; Lymphoma; Gene expression profiling; Cancer research; Biology; Pathology; Gene expression; Medicine; Gene; Antibody; Immunology; B cell; Germinal center","score_opus":0.08115966950695878,"score_gpt":0.34242491001075404,"score_spread":0.26126524050379524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766663088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862049,0.00027957407,0.009600589,0.0003809368,0.000035796296,0.0001052492,0.0013006368,0.00015244703,0.0019399256],"genre_scores_gemma":[0.995229,0.000041105923,0.0032453858,0.000027661714,0.000026871445,0.000047549787,0.0011140847,0.000013910563,0.0002545238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990963,0.00046510232,0.00004798925,0.00016133075,0.0001375969,0.000091732756],"domain_scores_gemma":[0.9978709,0.0010174302,0.00042449016,0.00016723211,0.00029207297,0.00022789181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025378729,0.0006925981,0.000587927,0.0016191007,0.00047370707,0.0010942082,0.00081012055,0.00041148253,0.0021238371],"category_scores_gemma":[0.004688213,0.00018068752,0.0005963751,0.0005895877,0.00033684407,0.00027908612,0.00076139363,0.0004450158,0.0005586591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010305998,0.00012823305,0.95630217,0.000024585877,0.00021726043,0.00011056045,0.000042479576,0.01971575,0.0003929286,0.00029055143,0.0016768097,0.020068057],"study_design_scores_gemma":[0.00027176653,0.000944913,0.41164562,0.000042944037,0.00043495043,0.0011715712,0.00022031844,0.5794475,0.0005131869,0.0017980735,0.0034603982,0.000048805297],"about_ca_topic_score_codex":0.0064988825,"about_ca_topic_score_gemma":0.0070851482,"teacher_disagreement_score":0.0064988825,"about_ca_system_score_codex":0.00092434464,"about_ca_system_score_gemma":0.0013028249,"threshold_uncertainty_score":0.013421714},"labels":[],"label_agreement":null},{"id":"W2766970124","doi":"10.3324/haematol.2017.172353","title":"Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leukemia","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Queen Elizabeth II Health Sciences Centre; CancerCare Manitoba","funders":"Celgene","keywords":"Lenalidomide; Medicine; Azacitidine; Myelodysplastic syndromes; Internal medicine; Myeloid leukemia; Oncology; Adverse effect; Multiple myeloma; Bone marrow","score_opus":0.03213945077736108,"score_gpt":0.3138549973378398,"score_spread":0.2817155465604787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766970124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956126,0.00087748235,0.0002822036,0.00026152184,0.00019714178,0.0018454841,0.0003309836,0.000026140577,0.0005665362],"genre_scores_gemma":[0.9939355,0.00067299063,0.00083157397,0.0007074687,0.00028455534,0.0020670812,0.0005874266,0.000009527234,0.0009038227],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987331,0.0008423736,0.00007340103,0.00016774636,0.000067014225,0.00011625293],"domain_scores_gemma":[0.9976089,0.00083649805,0.00044608142,0.00017474631,0.000113671435,0.0008200477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002672973,0.0012370945,0.002132492,0.00037295185,0.00043949715,0.0009901257,0.0008329969,0.0014609903,0.0034723682],"category_scores_gemma":[0.0027468214,0.000703627,0.0015852412,0.00033228574,0.0011400268,0.000799245,0.0005608933,0.0028011573,0.00046744992],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97789955,0.012431103,0.0016312163,0.00011435396,0.0006838277,0.00002884238,0.000038778475,0.00021704046,0.0013019573,0.00005041308,0.00026314222,0.0053398265],"study_design_scores_gemma":[0.9300235,0.06664612,0.0022778206,0.000008845847,0.00027764787,0.000019908035,0.000015882624,0.00026630436,0.00017715992,0.000052806085,0.00022711582,0.0000069218636],"about_ca_topic_score_codex":0.0015212955,"about_ca_topic_score_gemma":0.0032156527,"teacher_disagreement_score":0.0034723682,"about_ca_system_score_codex":0.00072435,"about_ca_system_score_gemma":0.0013763352,"threshold_uncertainty_score":0.014136195},"labels":[],"label_agreement":null},{"id":"W2769684200","doi":"10.3324/haematol.2017.175380","title":"Survival adjusting for crossover: phase 3 study of ibrutinib <i>vs</i> . chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphoma","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; Pharmacyclics","keywords":"Ibrutinib; Chlorambucil; Chronic lymphocytic leukemia; Internal medicine; Medicine; Leukemia; Lymphoma; Oncology; Hematology; Chemotherapy; Immunology; Cyclophosphamide","score_opus":0.04148799816424028,"score_gpt":0.3180868482053957,"score_spread":0.2765988500411554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769684200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906218,0.003541907,0.0003246587,0.0028047264,0.00042833947,0.00014621434,0.0008968172,0.00002857919,0.0012069744],"genre_scores_gemma":[0.9934011,0.00085779594,0.00040038925,0.0030488183,0.0006775572,0.00016277323,0.00092528947,0.000010104385,0.0005161268],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986375,0.0008009486,0.00008343966,0.00022727437,0.00010098165,0.00014984747],"domain_scores_gemma":[0.99645376,0.0014397833,0.00077289063,0.00046903046,0.00020014866,0.0006642989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033495112,0.00039938913,0.001631677,0.00016050083,0.00053554744,0.0009116239,0.00056203024,0.0016154121,0.0013841063],"category_scores_gemma":[0.0042800596,0.0002787545,0.002130427,0.0005613736,0.00042670913,0.0009196019,0.00029799368,0.002713052,0.00021769672],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80862236,0.0036823289,0.098275796,0.00030795336,0.0029852956,0.00079833117,0.00022304556,0.00094820355,0.0041459263,0.00029327456,0.007898081,0.07181948],"study_design_scores_gemma":[0.3776775,0.16358246,0.42611024,0.0002104884,0.008744106,0.0016124852,0.00029239434,0.0040873233,0.0021726799,0.0024766696,0.01290469,0.00012897844],"about_ca_topic_score_codex":0.0013997776,"about_ca_topic_score_gemma":0.0028860674,"teacher_disagreement_score":0.0033495112,"about_ca_system_score_codex":0.0010286723,"about_ca_system_score_gemma":0.00096463173,"threshold_uncertainty_score":0.017714143},"labels":[],"label_agreement":null},{"id":"W2772537975","doi":"10.3324/haematol.2017.167973","title":"Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomas","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Assistance publique-Hôpitaux de Paris; Institut Gustave-Roussy; Institut National Du Cancer; Campbell Family Institute for Breast Cancer Research; Fondation pour la Recherche Médicale; Université Paris-Sud; Centre Hospitalier Universitaire Vaudois","keywords":"5-Hydroxymethylcytosine; Epigenetics; Biology; Peripheral T-cell lymphoma; Peripheral; Cancer research; Genetics; DNA methylation; T cell; Medicine; Immunology; Internal medicine; Immune system; Gene; Gene expression","score_opus":0.02077635458514958,"score_gpt":0.2801925643707508,"score_spread":0.2594162097856012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772537975","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20547526,0.031168245,0.0031650648,0.68115246,0.010537124,0.00011776666,0.0003576047,0.0005684859,0.06745799],"genre_scores_gemma":[0.78445154,0.015091988,0.0014640822,0.15607405,0.02555362,0.00006785417,0.00019486905,0.00006484145,0.017037164],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99963284,0.00013295877,0.000026619056,0.00004499926,0.00008848268,0.00007405939],"domain_scores_gemma":[0.9992446,0.00030923323,0.000111820016,0.00007030106,0.00013920767,0.00012480374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003120218,0.00026122716,0.0004549224,0.00030413622,0.0007060727,0.0006262019,0.00039244487,0.004464712,0.0025233787],"category_scores_gemma":[0.0026978694,0.00018327167,0.0002191884,0.0003604902,0.0007686877,0.0007295614,0.0003376477,0.0032610109,0.0025006284],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074509985,0.00016765084,0.041682635,0.00037808885,0.00007711588,0.5563484,0.00054938724,0.0004988296,0.01524904,0.00603188,0.27513766,0.1031342],"study_design_scores_gemma":[0.00015220462,0.00027926636,0.017779406,0.00023209275,0.000059199083,0.7185183,0.0005115457,0.0015868421,0.0035615326,0.007955217,0.2493192,0.000045158777],"about_ca_topic_score_codex":0.000660556,"about_ca_topic_score_gemma":0.0007885105,"teacher_disagreement_score":0.004464712,"about_ca_system_score_codex":0.0009138418,"about_ca_system_score_gemma":0.0003397935,"threshold_uncertainty_score":0.008441567},"labels":[],"label_agreement":null},{"id":"W2775826629","doi":"10.3324/haematol.2017.177485","title":"Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Myeloid leukemia; Leukemia; Myeloid; Cancer research; Medicine; Internal medicine; Chemistry","score_opus":0.029660900517050837,"score_gpt":0.3095504216536833,"score_spread":0.27988952113663246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775826629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98981595,0.0025417153,0.003851251,0.0001740542,0.00006544142,0.000028268994,0.00023819381,0.000112706584,0.0031723576],"genre_scores_gemma":[0.9953754,0.00046789108,0.0017973015,0.000046134555,0.000007707248,0.000014341148,0.00023714098,0.00001172565,0.0020423257],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998234,0.000025953568,0.000018053399,0.000043303306,0.000060433693,0.000028945122],"domain_scores_gemma":[0.99990153,0.000019324465,0.000029953044,0.000013666085,0.0000077089035,0.000027752094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014656455,0.00021532233,0.00017351833,0.00022302476,0.00016989929,0.00029314106,0.00016895455,0.0002468633,0.0014209483],"category_scores_gemma":[0.00018225779,0.00015322657,0.00018357877,0.00009209957,0.00026823595,0.00018470616,0.00017236911,0.00049679494,0.00052421924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004161313,0.000007517812,0.00030898533,0.000014372708,0.0000024859391,0.000058737332,0.0000061042483,0.0000314776,0.99860245,0.00015926466,0.000025874502,0.0007411034],"study_design_scores_gemma":[0.000009649323,0.0002040837,0.0061647426,0.0000048276647,0.000012718876,0.0007030383,0.000022921042,0.0005147243,0.9885697,0.0000739786,0.003716816,0.0000028095756],"about_ca_topic_score_codex":0.0003104767,"about_ca_topic_score_gemma":0.00056545757,"teacher_disagreement_score":0.0014209483,"about_ca_system_score_codex":0.00030496373,"about_ca_system_score_gemma":0.00017572715,"threshold_uncertainty_score":0.00475353},"labels":[],"label_agreement":null},{"id":"W2777262489","doi":"10.3324/haematol.2017.181404","title":"Emergence and evolution of <i>TP53</i> mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"Institut National Du Cancer","keywords":"Lenalidomide; Myelodysplastic syndromes; Disease; Library science; Medicine; Political science; Internal medicine; Multiple myeloma; Computer science; Bone marrow","score_opus":0.011336250537362402,"score_gpt":0.2666876846676132,"score_spread":0.2553514341302508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2777262489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91681623,0.00494044,0.0006898821,0.047135007,0.00068274135,0.00006129671,0.0003203743,0.00010586123,0.029248098],"genre_scores_gemma":[0.9892526,0.0013422774,0.00034496473,0.005520681,0.0013982037,0.000014954505,0.00013959745,0.000011800353,0.0019749324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970776,0.000072832096,0.00002940977,0.00005232429,0.000052247397,0.00008545767],"domain_scores_gemma":[0.9992188,0.0002783005,0.00016331743,0.000065402994,0.00009307792,0.00018111241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022617156,0.00018440351,0.00031811843,0.0003951979,0.0006167608,0.000789641,0.00030400956,0.0022183035,0.0016543777],"category_scores_gemma":[0.0017755666,0.00015611925,0.00022303901,0.00044931693,0.0005493297,0.0006254334,0.00020401883,0.0017169996,0.0006829212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002564419,0.00026846112,0.5654678,0.00015873912,0.0000638838,0.2986922,0.0006760424,0.0005172676,0.018611081,0.0021972817,0.031889595,0.07889334],"study_design_scores_gemma":[0.00021573527,0.0007355008,0.36965096,0.0001414651,0.00011553294,0.5743833,0.0009437004,0.00321171,0.0042075547,0.0043255724,0.042016484,0.00005238269],"about_ca_topic_score_codex":0.0011927543,"about_ca_topic_score_gemma":0.0016519009,"teacher_disagreement_score":0.0022183035,"about_ca_system_score_codex":0.000662484,"about_ca_system_score_gemma":0.0003629413,"threshold_uncertainty_score":0.00553447},"labels":[],"label_agreement":null},{"id":"W2781841028","doi":"10.3324/haematol.2017.180059","title":"Desmopressin in moderate hemophilia A patients: a treatment worth considering","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Institute for Clinical Evaluative Sciences; SickKids Foundation; St. Paul's Hospital; Hospital for Sick Children","funders":"Novo Nordisk","keywords":"Desmopressin; Medicine; Von Willebrand factor; Internal medicine; Risk factor; Gastroenterology; Endocrinology","score_opus":0.061702825560276085,"score_gpt":0.3276232791043853,"score_spread":0.26592045354410926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781841028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832101,0.012914397,0.0005336952,0.0020226084,0.00006128526,0.000031061973,0.0001283806,0.000016019692,0.0010824339],"genre_scores_gemma":[0.99668545,0.0021578453,0.0003684345,0.00028506602,0.00015219593,0.00001050264,0.000098483586,0.0000028850166,0.00023921278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998845,0.000048945414,0.000016943966,0.000011702565,0.000020637654,0.000017287486],"domain_scores_gemma":[0.9997321,0.000060187303,0.00007676724,0.00000798577,0.000012929542,0.000110143264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023371296,0.000168724,0.0003781637,0.00022227813,0.0001662674,0.00029312764,0.00009750541,0.00031209263,0.00068186806],"category_scores_gemma":[0.00058681204,0.000060012273,0.00023968733,0.0003022988,0.00011110908,0.00020115142,0.00010988747,0.00033895764,0.000121090256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028103413,0.00028440193,0.917355,0.0001813223,0.000120805824,0.003443335,0.00012366274,0.00016283942,0.0066380156,0.00015250183,0.0011819043,0.067545764],"study_design_scores_gemma":[0.00012637576,0.002056451,0.9874441,0.00011193709,0.000095717754,0.005067623,0.00027724172,0.00044287898,0.0009515252,0.00023876474,0.0031734796,0.000013983233],"about_ca_topic_score_codex":0.0004244883,"about_ca_topic_score_gemma":0.0010653209,"teacher_disagreement_score":0.00068186806,"about_ca_system_score_codex":0.00010271293,"about_ca_system_score_gemma":0.00021316318,"threshold_uncertainty_score":0.0022811294},"labels":[],"label_agreement":null},{"id":"W2792280225","doi":"10.3324/haematol.2017.178368","title":"Iron overload in transfusion-dependent survivors of hemoglobin Bart’s hydrops fetalis","year":2018,"lang":"en","type":"letter","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; McMaster Children's Hospital; Children's Hospital of Eastern Ontario; Hospital for Sick Children; University of Ottawa","funders":"Thalassemia Foundation of Canada; University of Toronto; McMaster University; Hospital for Sick Children; University of Ottawa","keywords":"Hydrops fetalis; Medicine; Hemoglobin; Fetal hemoglobin; Obstetrics; Pregnancy; Internal medicine; Fetus; Biology; Genetics","score_opus":0.013377859969676246,"score_gpt":0.24128775231931307,"score_spread":0.22790989234963682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792280225","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8916138,0.007716847,0.00060553703,0.08107627,0.0020349019,0.00007131167,0.00016526566,0.000082399696,0.016633715],"genre_scores_gemma":[0.98678243,0.001638551,0.0001767199,0.007323949,0.0029709244,0.000014632896,0.00005804624,0.000009424616,0.001025338],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979347,0.00006632778,0.000023016592,0.000024568375,0.00003454244,0.00005805667],"domain_scores_gemma":[0.99906653,0.00040887736,0.0001347925,0.00004194579,0.00008376244,0.000264066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023973921,0.00033692052,0.00056162407,0.0006648362,0.0011392306,0.0004951915,0.0006524337,0.0035276634,0.0010864016],"category_scores_gemma":[0.0034052636,0.00028833968,0.00035535885,0.000569897,0.00055181555,0.0006363134,0.00038437065,0.0027584198,0.0003119281],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037458385,0.00008350821,0.06349092,0.00006435137,0.000024135768,0.91831285,0.00048918114,0.00014839957,0.0008579937,0.00035618106,0.008874114,0.0069237873],"study_design_scores_gemma":[0.000101594625,0.00041487167,0.08677562,0.00017592053,0.00009521722,0.90126747,0.0011393157,0.001267635,0.0005632534,0.0017705959,0.0063875243,0.000041069397],"about_ca_topic_score_codex":0.0026080627,"about_ca_topic_score_gemma":0.0021178538,"teacher_disagreement_score":0.0035276634,"about_ca_system_score_codex":0.00090561435,"about_ca_system_score_gemma":0.00040841068,"threshold_uncertainty_score":0.0065707564},"labels":[],"label_agreement":null},{"id":"W2792952263","doi":"10.3324/haematol.2018.187773","title":"Impact of age on genetics and treatment efficacy in follicular lymphoma","year":2018,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"Follicular lymphoma; Lymphoma; Medicine; Oncology; Internal medicine; Follicular phase","score_opus":0.04232993865396901,"score_gpt":0.3164919456697417,"score_spread":0.2741620070157727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792952263","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30714676,0.112207554,0.00084669946,0.521442,0.0032955545,0.000042210097,0.00030545532,0.00007358862,0.05464018],"genre_scores_gemma":[0.8720411,0.019599266,0.00050321326,0.089174956,0.015358215,0.000027688318,0.00012848071,0.000018760797,0.003148333],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992545,0.00036597805,0.00006510909,0.000056047633,0.00016053637,0.00009765264],"domain_scores_gemma":[0.9978282,0.0013375769,0.00030129755,0.000058572525,0.00017064778,0.0003036184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071054033,0.000096350166,0.0003600063,0.00030860392,0.00042337432,0.00058549223,0.00022880972,0.0016274785,0.0017147461],"category_scores_gemma":[0.0065951184,0.000058460108,0.00016645204,0.00040092762,0.00042026342,0.00070273574,0.00028095813,0.0018582881,0.00058333046],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018610716,0.0005045017,0.34348875,0.00048764978,0.000121886405,0.050154585,0.0010207994,0.0008907129,0.0036877957,0.0073065064,0.15738726,0.43308848],"study_design_scores_gemma":[0.00041253932,0.0024864718,0.41603142,0.0022006556,0.0002895474,0.22169371,0.0025411656,0.0028705478,0.0024543346,0.0385511,0.31031483,0.00015369918],"about_ca_topic_score_codex":0.00097098807,"about_ca_topic_score_gemma":0.002020593,"teacher_disagreement_score":0.0017147461,"about_ca_system_score_codex":0.0012694207,"about_ca_system_score_gemma":0.00037586316,"threshold_uncertainty_score":0.0092102885},"labels":[],"label_agreement":null},{"id":"W2799608052","doi":"10.3324/haematol.2018.189852","title":"Dexamethasone promotes durable factor VIII-specific tolerance in hemophilia A mice via thymic mechanisms","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Janeway Children's Health and Rehabilitation Centre; Memorial University of Newfoundland; Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Dexamethasone; Immunology; Medicine; Internal medicine; Antibody; Immune system; Immune tolerance; Factor IX; Antigen; Endocrinology; Pharmacology","score_opus":0.04584113112229286,"score_gpt":0.3029143180218155,"score_spread":0.25707318689952263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799608052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961152,0.0012000239,0.0010409496,0.00010127737,0.000055956814,0.000044660213,0.000265982,0.00015254365,0.0010234219],"genre_scores_gemma":[0.9951443,0.00076280045,0.0010617214,0.00008061505,0.000035367953,0.00006815181,0.00025811262,0.00002872363,0.0025602046],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997012,0.00005478683,0.00002697542,0.000070532544,0.00007665317,0.00006992455],"domain_scores_gemma":[0.99949896,0.00005764411,0.000158224,0.000051246465,0.000026635855,0.00020717958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001954269,0.00048306058,0.0004131345,0.00037121234,0.00015018786,0.00037938525,0.0003650871,0.00041011657,0.0019178742],"category_scores_gemma":[0.00021377194,0.00019209081,0.0003067451,0.00013369063,0.00035120567,0.00026533147,0.00025102374,0.0013310227,0.0004572488],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087449816,0.00033381433,0.00024434982,0.00004910065,0.0000083860505,0.00007211006,0.000025535273,0.000067655834,0.995736,0.00011797081,0.00006470762,0.002405759],"study_design_scores_gemma":[0.00038290868,0.0070278808,0.007844486,0.000040026967,0.00005274689,0.00052015024,0.000084744366,0.0011681531,0.97820026,0.00017846443,0.0044807093,0.00001952946],"about_ca_topic_score_codex":0.0003231492,"about_ca_topic_score_gemma":0.00066516356,"teacher_disagreement_score":0.0019178742,"about_ca_system_score_codex":0.00020724583,"about_ca_system_score_gemma":0.00023958473,"threshold_uncertainty_score":0.0064159036},"labels":[],"label_agreement":null},{"id":"W2800708348","doi":"10.3324/haematol.2017.180844","title":"GFI1 is required for <i>RUNX1/ETO</i> positive acute myeloid leukemia","year":2018,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Myeloid leukemia; Art; Theology; Art history; Philosophy; Medicine; Internal medicine","score_opus":0.03831771610229713,"score_gpt":0.3187925590230001,"score_spread":0.28047484292070296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800708348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5310921,0.012857491,0.0019196596,0.36524424,0.011653603,0.00010773599,0.00081168005,0.0006688973,0.075644575],"genre_scores_gemma":[0.9409494,0.0038318392,0.0010679902,0.03450148,0.0048438916,0.000041645322,0.00042378367,0.00009105895,0.014248977],"study_design_codex":"case_report","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997788,0.00004068366,0.000022766097,0.000033528748,0.00006608392,0.000058160058],"domain_scores_gemma":[0.99960333,0.00015131736,0.00007720446,0.00003679909,0.000043020937,0.00008837802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023621191,0.0001985093,0.00028500173,0.00026650762,0.00064492755,0.0006253634,0.00040116694,0.0022095395,0.0033279762],"category_scores_gemma":[0.0016669743,0.00014006735,0.00027498402,0.00019344507,0.00074413285,0.00037444368,0.00033785007,0.0016516455,0.0015369582],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001636319,0.00025406273,0.06445066,0.00031551102,0.00006973937,0.42765453,0.0006274153,0.00074104196,0.11002549,0.017117463,0.2880335,0.089074224],"study_design_scores_gemma":[0.00042284233,0.0004894585,0.061210025,0.00014817908,0.00012370238,0.46411595,0.0011547146,0.0023519956,0.033767138,0.014238092,0.42192596,0.000051884508],"about_ca_topic_score_codex":0.000629263,"about_ca_topic_score_gemma":0.00085886783,"teacher_disagreement_score":0.0033279762,"about_ca_system_score_codex":0.001003295,"about_ca_system_score_gemma":0.00035712094,"threshold_uncertainty_score":0.011133134},"labels":[],"label_agreement":null},{"id":"W2804990894","doi":"10.3324/haematol.2017.171249","title":"Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Pfizer","keywords":"Bosutinib; Medicine; Cumulative incidence; Internal medicine; Nausea; Myeloid leukemia; Adverse effect; Imatinib; Gastroenterology; Rash; Mucositis; Oncology; Dasatinib; Surgery; Toxicity; Cohort","score_opus":0.03689671586753953,"score_gpt":0.344653472804586,"score_spread":0.3077567569370465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804990894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99690515,0.0014624551,0.00031734642,0.000088894056,0.000025350635,0.00023917448,0.00044722218,0.000023627588,0.00049081503],"genre_scores_gemma":[0.99692,0.00045097078,0.0002093133,0.00021534308,0.000056005923,0.0001744803,0.00143588,0.000006341593,0.00053171517],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993599,0.00021806717,0.000051954245,0.000096881406,0.00012795298,0.00014520573],"domain_scores_gemma":[0.99876934,0.00014599446,0.00041755236,0.0000938903,0.00014031435,0.00043288837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030043314,0.0008247996,0.0013831127,0.00030350508,0.0003664535,0.0008055868,0.00045284888,0.0008427294,0.0008912121],"category_scores_gemma":[0.0010660873,0.00024223606,0.0012364921,0.00028778793,0.000401922,0.0005380212,0.00024196,0.001512103,0.00032495713],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42741686,0.06843876,0.16772945,0.0007729593,0.003812361,0.001025589,0.00067435915,0.0054859035,0.10767388,0.00022137568,0.00531328,0.21143514],"study_design_scores_gemma":[0.06915899,0.5904337,0.32137007,0.000039605977,0.0014435706,0.00086509844,0.00009918909,0.001973382,0.0104066515,0.00007906686,0.004075587,0.000055119977],"about_ca_topic_score_codex":0.00073326356,"about_ca_topic_score_gemma":0.0012673211,"teacher_disagreement_score":0.0030043314,"about_ca_system_score_codex":0.00065115653,"about_ca_system_score_gemma":0.00070301536,"threshold_uncertainty_score":0.015888572},"labels":[],"label_agreement":null},{"id":"W2807339320","doi":"10.3324/haematol.2017.185165","title":"Impaired mitochondrial activity explains platelet dysfunction in thrombocytopenic cancer patients undergoing chemotherapy","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"European Hematology Association","keywords":"Platelet; Medicine; Chemotherapy; Multiple myeloma; Internal medicine; Malignancy; Cancer; Phosphatidylserine; Platelet activation; Gastroenterology; Immunology; Biology","score_opus":0.024890600824630186,"score_gpt":0.2906062416423515,"score_spread":0.2657156408177213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807339320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99904233,0.00045223805,0.00008206399,0.000028227072,0.000002257624,0.0000056283357,0.000043311178,0.000002190039,0.00034174212],"genre_scores_gemma":[0.9997559,0.00011248137,0.00002412377,0.000009533592,0.0000042912334,0.0000017198336,0.00005434354,5.8220377e-7,0.000037069785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990034,0.000019452671,0.000016268312,0.000019054985,0.00001928714,0.000025650532],"domain_scores_gemma":[0.9997768,0.000046682755,0.00010095079,0.000017818484,0.000021634967,0.000036100206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012317697,0.00020321063,0.00026746345,0.00058626314,0.0002321574,0.00043658176,0.000170418,0.00029862107,0.0012126247],"category_scores_gemma":[0.000793399,0.00012569981,0.00014664451,0.0005565383,0.00018049275,0.00019379251,0.000269657,0.00025244436,0.00022879662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017093202,0.00009155289,0.9675541,0.000046632384,0.00007581218,0.0052543497,0.0002478575,0.00017974467,0.01484056,0.00017074734,0.00024013783,0.009589153],"study_design_scores_gemma":[0.000037550017,0.00042636978,0.9808358,0.000016689117,0.00009045115,0.0145514365,0.0003106127,0.0008704249,0.0020943119,0.00021484144,0.0005456164,0.0000059675785],"about_ca_topic_score_codex":0.00063444674,"about_ca_topic_score_gemma":0.0005266028,"teacher_disagreement_score":0.0012126247,"about_ca_system_score_codex":0.00017946944,"about_ca_system_score_gemma":0.000076937824,"threshold_uncertainty_score":0.0040566325},"labels":[],"label_agreement":null},{"id":"W2810970248","doi":"10.3324/haematol.2017.185991","title":"A phase I/II dose-escalation study investigating all-oral ixazomib-melphalan-prednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagnosed multiple myeloma","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia","funders":"Takeda Oncology","keywords":"Ixazomib; Medicine; Melphalan; Prednisone; Multiple myeloma; Maintenance therapy; Internal medicine; Adverse effect; Surgery; Lenalidomide; Chemotherapy; Carfilzomib","score_opus":0.08065535250103235,"score_gpt":0.3476845975581068,"score_spread":0.2670292450570745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810970248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964379,0.00056524976,0.00040523123,0.00015155251,0.000048200618,0.001628703,0.00021710446,0.000034533445,0.0005114585],"genre_scores_gemma":[0.99202526,0.0011096033,0.002313746,0.0005346914,0.0001223051,0.0017958722,0.000754586,0.000015324564,0.0013285939],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99953175,0.00020451262,0.000030018422,0.00008654985,0.000052848525,0.00009426067],"domain_scores_gemma":[0.99921167,0.00011228546,0.00018034707,0.00008340798,0.000038667535,0.0003735563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016313136,0.001320538,0.0019199986,0.00052641286,0.00044592074,0.00062665506,0.00084355817,0.00079606514,0.0017273839],"category_scores_gemma":[0.0008187812,0.00063100073,0.0010422455,0.00042274134,0.00085277343,0.0006000232,0.0003292029,0.0033712443,0.0003589754],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5217544,0.23847729,0.009694832,0.0008078249,0.0010668385,0.00047454625,0.00057356287,0.0043856036,0.112437665,0.00037812736,0.0018446454,0.10810475],"study_design_scores_gemma":[0.2693664,0.7167722,0.007285528,0.000020251524,0.00022884071,0.00017221036,0.00003780251,0.00091552257,0.004092021,0.00011478753,0.0009725377,0.00002192654],"about_ca_topic_score_codex":0.00066866283,"about_ca_topic_score_gemma":0.0019223191,"teacher_disagreement_score":0.0019199986,"about_ca_system_score_codex":0.0008206403,"about_ca_system_score_gemma":0.0015896887,"threshold_uncertainty_score":0.008627355},"labels":[],"label_agreement":null},{"id":"W2845051690","doi":"10.3324/haematol.2018.188219","title":"N-linked glycosylation modulates the immunogenicity of recombinant human factor VIII in hemophilia A mice","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Queen's University","funders":"","keywords":"Chinese hamster ovary cell; Immunogenicity; Antibody; Biology; Immunoglobulin G; Baby hamster kidney cell; Hamster; Glycosylation; Molecular biology; Mesocricetus; Immune system; Immunology; Biochemistry; Receptor","score_opus":0.0582808155778413,"score_gpt":0.33817069374960423,"score_spread":0.2798898781717629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2845051690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99909484,0.00021453119,0.00023681462,0.000028170223,0.000005386235,0.000008136455,0.00006539363,0.000015561363,0.00033122674],"genre_scores_gemma":[0.99841607,0.00024387015,0.00027439307,0.000041878768,0.000006258622,0.000014016276,0.00013490875,0.000013049738,0.000855471],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983656,0.000045365156,0.000013247139,0.000030526513,0.000029371233,0.00004500199],"domain_scores_gemma":[0.9997292,0.000035427027,0.000099634824,0.000021942793,0.000018470479,0.00009531596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017186333,0.00028763048,0.00016377393,0.00031420062,0.0000962252,0.0003161197,0.00014236438,0.00031355995,0.0008717963],"category_scores_gemma":[0.00023040191,0.00011549544,0.00020996596,0.00013519076,0.0001930896,0.00016774757,0.000121010155,0.0006572767,0.00026810757],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003429885,0.00009204611,0.00041853185,0.000011256123,0.000005591327,0.000043348504,0.0000137332645,0.000030729607,0.9983512,0.0000338881,0.000020720994,0.00063602126],"study_design_scores_gemma":[0.00012466178,0.0042677512,0.056912888,0.000019418783,0.00007520079,0.000829758,0.00010906199,0.0022600484,0.9325935,0.00021079525,0.0025797954,0.000017209079],"about_ca_topic_score_codex":0.00036242453,"about_ca_topic_score_gemma":0.00021892357,"teacher_disagreement_score":0.0008717963,"about_ca_system_score_codex":0.00022478234,"about_ca_system_score_gemma":0.00009867424,"threshold_uncertainty_score":0.0029165149},"labels":[],"label_agreement":null},{"id":"W2861492704","doi":"10.3324/haematol.2017.187385","title":"CD16<sup>+</sup>NK-92 and anti-CD123 monoclonal antibody prolongs survival in primary human acute myeloid leukemia xenografted mice","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Université de Sherbrooke; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Myeloid leukemia; CD16; Cancer research; Monoclonal antibody; Antibody; Cytotoxic T cell; Stem cell; Leukemia; Immunology; NK-92; Fc receptor; Antigen; Biology; Interleukin 21; In vitro; CD8; Cell biology","score_opus":0.01430704504637206,"score_gpt":0.2574949571213214,"score_spread":0.24318791207494936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2861492704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922374,0.0022980492,0.0029304517,0.0001392285,0.00007216718,0.00006280184,0.00049098744,0.00019696442,0.0015720006],"genre_scores_gemma":[0.9895846,0.0015387273,0.0035240415,0.00006927077,0.000023077848,0.000118608084,0.0011747511,0.00004870485,0.0039181793],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998535,0.000023975754,0.000015232099,0.000029538727,0.000040046092,0.000037610353],"domain_scores_gemma":[0.99990904,0.000013756518,0.000023457424,0.000014478226,0.000009949221,0.000029315348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018124036,0.00054923806,0.0004353012,0.00020302314,0.00009721594,0.00024062407,0.0003094014,0.0002961414,0.0010077448],"category_scores_gemma":[0.00006614045,0.00016700164,0.00026670154,0.00015789163,0.00015691771,0.000248818,0.00013988382,0.00077387877,0.00042232286],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005098308,0.00024680307,0.000105105995,0.00003870747,0.000012263462,0.000028545455,0.000014359005,0.0001449492,0.9963003,0.00008325685,0.00012813896,0.0023877602],"study_design_scores_gemma":[0.000091378,0.0033270938,0.0024182464,0.0000053324184,0.000035038072,0.0002524503,0.000011512106,0.0012146754,0.9904793,0.00003501583,0.0021258742,0.00000400401],"about_ca_topic_score_codex":0.00056893285,"about_ca_topic_score_gemma":0.0008926917,"teacher_disagreement_score":0.0010077448,"about_ca_system_score_codex":0.00018046351,"about_ca_system_score_gemma":0.00019078769,"threshold_uncertainty_score":0.0033712387},"labels":[],"label_agreement":null},{"id":"W2866628310","doi":"10.3324/haematol.2018.196782","title":"Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD","year":2018,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Interim; Stage (stratigraphy); Lymphoma; Hodgkin lymphoma; Oncology; Chemotherapy; Internal medicine; Cyclophosphamide; Vincristine; Biology","score_opus":0.04868299079263632,"score_gpt":0.28875085606207046,"score_spread":0.24006786526943413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2866628310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53616357,0.0354142,0.004976244,0.3174401,0.0103521375,0.00047181128,0.0009206083,0.00041549176,0.0938458],"genre_scores_gemma":[0.9349821,0.006553942,0.0018786241,0.038635515,0.011242056,0.00009094484,0.00044344453,0.000052243806,0.0061212066],"study_design_codex":"case_report","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996542,0.00009740397,0.000039428545,0.000041261766,0.000048742386,0.00011896582],"domain_scores_gemma":[0.99916327,0.0003625904,0.00005814548,0.000048307524,0.000074705364,0.00029301128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004236246,0.0004888274,0.0007980011,0.000656968,0.0014888778,0.0010741538,0.00075674214,0.004912778,0.002213222],"category_scores_gemma":[0.0031161562,0.0003675039,0.0008107152,0.00046621187,0.0007769494,0.0008214008,0.00047023935,0.003807036,0.0008047037],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000824471,0.00031551943,0.020925365,0.00017680277,0.000050179846,0.9256973,0.0002335099,0.0007653224,0.0022504043,0.0012277053,0.024939824,0.022593625],"study_design_scores_gemma":[0.00038941292,0.00095474656,0.025274714,0.00034695535,0.00018995817,0.91750973,0.00046988318,0.00479069,0.0022390464,0.0049019973,0.042888574,0.00004425233],"about_ca_topic_score_codex":0.0018406879,"about_ca_topic_score_gemma":0.003827724,"teacher_disagreement_score":0.004912778,"about_ca_system_score_codex":0.0018141718,"about_ca_system_score_gemma":0.00078981556,"threshold_uncertainty_score":0.013162792},"labels":[],"label_agreement":null},{"id":"W2886320425","doi":"10.3324/haematol.2018.188987","title":"Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for Philadelphia chromosome-positive leukemia","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre","funders":"National Cancer Institute; Bristol-Myers Squibb","keywords":"Dasatinib; Medicine; Internal medicine; Imatinib; Pleural effusion; Myeloid leukemia; Oncology; Philadelphia chromosome; Population; Gastroenterology; Chromosomal translocation","score_opus":0.02326542935298994,"score_gpt":0.2916060793368093,"score_spread":0.2683406499838194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886320425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959282,0.0019129888,0.00017316417,0.00016106738,0.000012827745,0.000038409005,0.00081658416,0.000008642368,0.0009480065],"genre_scores_gemma":[0.9985442,0.00040283793,0.000071692055,0.00006333575,0.000025949026,0.000025036867,0.0007898403,0.0000027377291,0.00007423019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857867,0.0004761258,0.00023784288,0.00025416975,0.00029266923,0.00016049205],"domain_scores_gemma":[0.99536926,0.0009153523,0.0026955616,0.00020060503,0.00027787522,0.0005413553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001134477,0.00015884751,0.00069513806,0.00056121446,0.00031742133,0.0007218915,0.00036126754,0.0005474581,0.00080906786],"category_scores_gemma":[0.004690835,0.00019037338,0.00068217417,0.0014857309,0.00026943805,0.000662513,0.0005291011,0.000958537,0.0001396587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011709062,0.000063983345,0.9919686,0.000034598623,0.0001334133,0.00015663497,0.000038068505,0.000120478195,0.00021589296,0.000035567602,0.00035565346,0.005706093],"study_design_scores_gemma":[0.00011273745,0.000471687,0.99696296,0.000020480853,0.00012244246,0.0011154109,0.00009294168,0.0004337048,0.00009668545,0.000114266375,0.0004435865,0.000013187014],"about_ca_topic_score_codex":0.0010329738,"about_ca_topic_score_gemma":0.0013700363,"teacher_disagreement_score":0.001134477,"about_ca_system_score_codex":0.000402086,"about_ca_system_score_gemma":0.0004477412,"threshold_uncertainty_score":0.005999744},"labels":[],"label_agreement":null},{"id":"W2886835568","doi":"10.3324/haematol.2018.194951","title":"Incidence of upper-extremity deep vein thrombosis in western France: a community-based study","year":2018,"lang":"en","type":"letter","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Deep vein; Incidence (geometry); Thrombosis; Medicine; Post-thrombotic syndrome; Surgery","score_opus":0.049415793721863874,"score_gpt":0.3218901565234817,"score_spread":0.2724743628016178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886835568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982504,0.0002923346,0.00005707501,0.00031203995,0.0000095957985,0.000007960289,0.00030245853,0.0000059811846,0.00076211174],"genre_scores_gemma":[0.99882406,0.00022570105,0.00007185057,0.00024526034,0.000049172624,0.0000132078,0.00030356424,0.000002538552,0.00026459296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944645,0.0001957532,0.00005878356,0.000113728966,0.00009129477,0.00009399841],"domain_scores_gemma":[0.9988047,0.00018694144,0.00042187772,0.00008101751,0.0002530288,0.0002524799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054725754,0.00038178565,0.0004944741,0.0014177064,0.00078041916,0.0013774761,0.0005343003,0.0014325066,0.0019312422],"category_scores_gemma":[0.0016958001,0.00032272807,0.0004656505,0.0016574811,0.000520308,0.00079371664,0.0004390458,0.00057329197,0.00042056118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029773502,0.00003558219,0.9987081,0.0000054533657,0.000033035656,0.00017606409,0.00014327717,0.000008535012,0.00005665152,0.000014558364,0.00021845056,0.00057058234],"study_design_scores_gemma":[0.00001014026,0.00008118334,0.99812585,0.000010588036,0.000025671956,0.0007534532,0.0005949086,0.000057998044,0.000011620346,0.000015267186,0.00030866705,0.000004550862],"about_ca_topic_score_codex":0.027689762,"about_ca_topic_score_gemma":0.025575627,"teacher_disagreement_score":0.027689762,"about_ca_system_score_codex":0.0010160848,"about_ca_system_score_gemma":0.0005871066,"threshold_uncertainty_score":0.055057168},"labels":[],"label_agreement":null},{"id":"W2889930434","doi":"10.3324/haematol.2018.192823","title":"Transglutaminase 2 programs differentiating acute promyelocytic leukemia cells in all-trans retinoic acid treatment to inflammatory stage through NF-κB activation","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Blood properties and coagulation","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Tissue transglutaminase; Acute promyelocytic leukemia; Retinoic acid; Tretinoin; Cancer research; Tumor necrosis factor alpha; Cytokine; Biology; Molecular biology; Chemistry; Immunology; Cell biology; Biochemistry; Enzyme","score_opus":0.055657010177624845,"score_gpt":0.29626468350112345,"score_spread":0.2406076733234986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889930434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899278,0.0022049977,0.0049906503,0.00011238593,0.00006843361,0.00006838358,0.0003565458,0.00014365841,0.0021271151],"genre_scores_gemma":[0.99148905,0.0012133648,0.0027212938,0.00008596756,0.000015608866,0.0000739035,0.00047199606,0.000026362944,0.0039025573],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998387,0.00002833324,0.000027957305,0.00003514841,0.000037807262,0.000032001404],"domain_scores_gemma":[0.9998976,0.000008946348,0.000029587001,0.000016837776,0.000016733915,0.000030309819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016012095,0.00034478973,0.00026281452,0.00022763599,0.00013235612,0.0003236592,0.00015085381,0.00022064695,0.0012820985],"category_scores_gemma":[0.00008518461,0.00014271571,0.00029471004,0.00013936458,0.00023121791,0.00022726254,0.00023144708,0.0007406581,0.00053274824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008086508,0.000020119718,0.00013639471,0.000027694046,0.0000022200973,0.00003910861,0.000019194324,0.00002165508,0.9989555,0.00006453426,0.000016209733,0.0006163942],"study_design_scores_gemma":[0.000034315482,0.00037485978,0.0033271618,0.000010623882,0.000023565373,0.00026812553,0.00006615945,0.00055506115,0.99000335,0.000070677204,0.0052617323,0.0000043752234],"about_ca_topic_score_codex":0.00040220487,"about_ca_topic_score_gemma":0.00057288964,"teacher_disagreement_score":0.0012820985,"about_ca_system_score_codex":0.00016547235,"about_ca_system_score_gemma":0.0001915341,"threshold_uncertainty_score":0.004289031},"labels":[],"label_agreement":null},{"id":"W2890347208","doi":"10.3324/haematol.2018.196568","title":"Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in <i>in vivo</i> preclinical models of hematopoietic reconstitution and severe colitis","year":2018,"lang":"en","type":"letter","venue":"Haematologica","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Christian ministry; Mesenchymal stem cell; Bone marrow; Internal medicine; Oncology; Cancer research; Pathology; Political science","score_opus":0.03588783827418238,"score_gpt":0.2718389579882562,"score_spread":0.23595111971407381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890347208","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036563657,0.0127460705,0.001016074,0.879932,0.020036845,0.00011833247,0.00033331258,0.00021181222,0.049041867],"genre_scores_gemma":[0.33746576,0.020618608,0.0024943205,0.51862955,0.052388936,0.00022471353,0.0006729988,0.00012990285,0.067375205],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99963593,0.0001376199,0.000038886803,0.00003464064,0.00009445028,0.00005849498],"domain_scores_gemma":[0.9992649,0.00038591458,0.000051786366,0.000048957132,0.00011782045,0.00013064203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050063094,0.00023368842,0.0005043172,0.00026662656,0.0008002807,0.0009937902,0.00041398228,0.004650704,0.005302521],"category_scores_gemma":[0.0029988592,0.00014673962,0.0003194794,0.00026691522,0.00054693705,0.0006122161,0.00029893641,0.0040209447,0.0041458677],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001023846,0.00030877016,0.0096152,0.0002656593,0.000042152024,0.10963103,0.0003903362,0.00025929144,0.005845079,0.00916047,0.69619876,0.16725942],"study_design_scores_gemma":[0.0003954166,0.00045352295,0.008149715,0.0002803271,0.000050366885,0.08805666,0.00053502596,0.0010997893,0.002811763,0.011924105,0.88621014,0.000033180462],"about_ca_topic_score_codex":0.00060912373,"about_ca_topic_score_gemma":0.0016895458,"teacher_disagreement_score":0.005302521,"about_ca_system_score_codex":0.000860048,"about_ca_system_score_gemma":0.0005411637,"threshold_uncertainty_score":0.0177387},"labels":[],"label_agreement":null},{"id":"W2890977830","doi":"10.3324/haematol.2018.194282","title":"Daratumumab plus lenalidomide and dexamethasone <i>versus</i> lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":210,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary; University of British Columbia; University of Alberta; Queen Elizabeth II Health Sciences Centre; Université Laval; Dalhousie University","funders":"Raymond and Beverly Sackler Institute for Biological, Physical and Engineering Sciences, Yale University; Yale University","keywords":"Lenalidomide; Daratumumab; Dexamethasone; Medicine; Hazard ratio; Multiple myeloma; Internal medicine; Oncology; Confidence interval; Gastroenterology","score_opus":0.06103873061989124,"score_gpt":0.341154983171765,"score_spread":0.2801162525518738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890977830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93120587,0.061988354,0.0008706765,0.0005858658,0.0002758053,0.00024416362,0.0025134294,0.000056043616,0.0022597495],"genre_scores_gemma":[0.98545295,0.01015961,0.0007841694,0.0005368547,0.00028653283,0.000105400286,0.0017628231,0.000018810386,0.00089294557],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99788696,0.0013516203,0.0001446808,0.00021168661,0.00028052749,0.00012456479],"domain_scores_gemma":[0.9973569,0.001360412,0.00072449306,0.00020781484,0.00014763596,0.0002026509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046670493,0.00060300983,0.0021355199,0.00061393634,0.0001678719,0.0011135155,0.00073471357,0.00042928153,0.0016592599],"category_scores_gemma":[0.0035751113,0.0003182385,0.004091956,0.00083940517,0.0002788313,0.00056844857,0.0004454345,0.0011265418,0.00016871115],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5945466,0.0010195052,0.10459624,0.0045568054,0.06261363,0.00028879504,0.00018922922,0.0034989505,0.0039931387,0.00043357696,0.004323686,0.21993987],"study_design_scores_gemma":[0.17236032,0.0933557,0.5062202,0.0010088932,0.19288976,0.0012296552,0.0003001162,0.005021052,0.0055287774,0.0012140556,0.0206765,0.00019483748],"about_ca_topic_score_codex":0.0023676709,"about_ca_topic_score_gemma":0.0053801923,"teacher_disagreement_score":0.0046670493,"about_ca_system_score_codex":0.0006456976,"about_ca_system_score_gemma":0.00075582543,"threshold_uncertainty_score":0.024681985},"labels":[],"label_agreement":null},{"id":"W2891400988","doi":"10.3324/haematol.2018.196295","title":"Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study","year":2018,"lang":"en","type":"letter","venue":"Haematologica","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McMaster University; University of Toronto; University Health Network","funders":"Medizinische Fakultät der Albert-Ludwigs-Universität Freiburg; School of Medicine, Emory University; Universität Heidelberg; Children's Healthcare of Atlanta; University of Vermont; McMaster University; St. Jude Children's Research Hospital; University of Missouri; Ohio State University; Weill Cornell Medical College; University of Pennsylvania; Children's Hospital of Michigan; Children's Mercy Hospital; Wayne State University; Perelman School of Medicine, University of Pennsylvania; Nationwide Children's Hospital; Children's Hospital of Philadelphia; University of Toronto; Albert-Ludwigs-Universität Freiburg; Emory University; Aflac","keywords":"Pyruvate kinase deficiency; Pyruvate kinase; PKM2; Dihydrolipoyl transacetylase; Pyruvate dehydrogenase complex; Natural history; Pyruvate decarboxylation; Medicine; Chemistry; Glycolysis; Biochemistry; Internal medicine; Enzyme","score_opus":0.03026470639958197,"score_gpt":0.26360454569800684,"score_spread":0.23333983929842486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891400988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9564802,0.0036935494,0.00049796765,0.027434578,0.00026688527,0.00005537123,0.00047400608,0.00003568587,0.011061744],"genre_scores_gemma":[0.9917298,0.0012288148,0.00028720027,0.0052339784,0.00064780307,0.000019645207,0.00018452916,0.0000057136804,0.00066260516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941146,0.00022289791,0.00008931596,0.000074408184,0.00012979456,0.000072109186],"domain_scores_gemma":[0.9990651,0.00035001864,0.00023805453,0.000050097107,0.00015396377,0.0001426814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043791908,0.00018093198,0.00024356495,0.0005550412,0.00049505744,0.00039708742,0.00029551305,0.0012096098,0.00079338613],"category_scores_gemma":[0.0026386206,0.00016835857,0.00012886008,0.00069075904,0.000337059,0.00038985556,0.00026118435,0.0006649788,0.00031361525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013262716,0.00010012025,0.89648515,0.00003584027,0.000018841196,0.07972123,0.00074150425,0.00006797974,0.0009954078,0.00026617557,0.011093416,0.01034163],"study_design_scores_gemma":[0.000042192958,0.00019468731,0.7059149,0.00011296785,0.000034170396,0.28017175,0.0013626206,0.00067055284,0.00044813348,0.0004945068,0.010523904,0.000029573424],"about_ca_topic_score_codex":0.0024307626,"about_ca_topic_score_gemma":0.0018054774,"teacher_disagreement_score":0.0024307626,"about_ca_system_score_codex":0.00039668125,"about_ca_system_score_gemma":0.00029956634,"threshold_uncertainty_score":0.004833162},"labels":[],"label_agreement":null},{"id":"W2892342442","doi":"10.3324/haematol.2018.203224","title":"<i>JUNB</i>, <i>DUSP2</i>, <i>SGK1</i>, <i>SOCS1</i> and <i>CREBBP</i> are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Deutsche Forschungsgemeinschaft","keywords":"Lymphoma; Somatic hypermutation; JUNB; Pathology; Histiocyte; Cancer research; BCL6; B cell; Germinal center; Biology; Medicine; Immunology; Genetics; Gene; Gene expression","score_opus":0.012321291891290267,"score_gpt":0.24434431335100992,"score_spread":0.23202302145971965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892342442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990821,0.00021548849,0.00035131295,0.00000732652,0.0000011189901,0.0000037094806,0.00009704271,0.000012964769,0.00022891819],"genre_scores_gemma":[0.9993352,0.00007979902,0.00030855372,0.00000977712,0.0000018097189,0.0000035994228,0.00017348418,0.0000030370106,0.00008469922],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99988496,0.000012204089,0.000012871231,0.000036090067,0.000028576944,0.000025196656],"domain_scores_gemma":[0.9998233,0.000020859843,0.00009520056,0.000016286056,0.000015634525,0.000028781065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001331253,0.0002088321,0.00013976316,0.00050157355,0.00013906564,0.00019393521,0.00014507386,0.00019471323,0.0004314242],"category_scores_gemma":[0.00026352736,0.00014337507,0.00019298818,0.00036452423,0.00031030772,0.00011346817,0.000230926,0.00015230828,0.00013521216],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036002375,0.000020984055,0.16540477,0.000115409224,0.00009397981,0.0026421002,0.00017568543,0.00029260374,0.8229267,0.00011509235,0.00011293173,0.0077397237],"study_design_scores_gemma":[0.000033614608,0.00021299455,0.8280515,0.000017230384,0.00017584684,0.024546526,0.0003180046,0.0016771624,0.1422207,0.0003445905,0.0023865863,0.000015240097],"about_ca_topic_score_codex":0.00061260303,"about_ca_topic_score_gemma":0.0011853436,"teacher_disagreement_score":0.00061260303,"about_ca_system_score_codex":0.00016467982,"about_ca_system_score_gemma":0.000106403604,"threshold_uncertainty_score":0.0014432669},"labels":[],"label_agreement":null},{"id":"W2892431967","doi":"10.3324/haematol.2018.201194","title":"Highly sensitive methods are required to detect mutations in histiocytoses","year":2018,"lang":"en","type":"letter","venue":"Haematologica","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Mutation; Erdheim–Chester disease; Genetics; Medicine; Cancer research; Computational biology; Biology; Histiocytosis; Internal medicine; Gene","score_opus":0.05598754510934373,"score_gpt":0.359167103244918,"score_spread":0.3031795581355743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892431967","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028051553,0.02990715,0.023506414,0.8003428,0.030021684,0.00034464552,0.00043517316,0.00072040665,0.086670235],"genre_scores_gemma":[0.33236334,0.024558347,0.044921927,0.46884003,0.07333598,0.00051388977,0.0005349321,0.00030792423,0.054623634],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99872655,0.00044828843,0.00014425945,0.00010577493,0.00038452094,0.00019055765],"domain_scores_gemma":[0.99466646,0.003356895,0.00031096974,0.00025650905,0.0010231459,0.00038590355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001374364,0.0006599347,0.00064018916,0.0009938243,0.00085797714,0.0015682045,0.00061059615,0.0056607723,0.009262909],"category_scores_gemma":[0.008079046,0.00029104468,0.0005182178,0.00029069747,0.0013316529,0.0013566654,0.00051595055,0.007966611,0.006628928],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034115618,0.00029310244,0.034703877,0.00079577556,0.00006375281,0.08971,0.00052033603,0.0007385711,0.036874708,0.011677983,0.596353,0.22792771],"study_design_scores_gemma":[0.00010301437,0.00032848612,0.019820645,0.0009866263,0.00007782299,0.12789683,0.0018339962,0.002198486,0.017280234,0.036759365,0.79264206,0.0000724438],"about_ca_topic_score_codex":0.00058259175,"about_ca_topic_score_gemma":0.0009650854,"teacher_disagreement_score":0.009262909,"about_ca_system_score_codex":0.00091650925,"about_ca_system_score_gemma":0.00045730328,"threshold_uncertainty_score":0.03098756},"labels":[],"label_agreement":null},{"id":"W2899225691","doi":"10.3324/haematol.2018.202093","title":"Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Epigenetics; Exome sequencing; Cancer research; Hematologic malignancy; Bromodomain; Malignancy; Exome; Epigenesis; Biology; Medicine; Gene; Genetics; Mutation; DNA methylation; Internal medicine; Gene expression","score_opus":0.01868401955377211,"score_gpt":0.2812417373954823,"score_spread":0.26255771784171017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899225691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933473,0.001100613,0.00286411,0.00026488295,0.000010797205,0.00003914662,0.00048302734,0.000036188205,0.0018539795],"genre_scores_gemma":[0.99616635,0.0004076541,0.0022306,0.00010582302,0.0000052935934,0.000019368887,0.00036864303,0.000007793719,0.00068846537],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993753,0.000008879435,0.0000031574184,0.000017405528,0.000022239474,0.000010744835],"domain_scores_gemma":[0.99995995,0.000013073632,0.000009172773,0.0000049346213,0.0000069233715,0.0000059903755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011969418,0.00011957508,0.00018477683,0.0001907495,0.00014786172,0.00025602768,0.00010706608,0.00020201613,0.0011638126],"category_scores_gemma":[0.00019276216,0.00006278494,0.00009968258,0.00017865059,0.00015881647,0.00011311545,0.00014039669,0.0002567691,0.00015381885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003531521,0.00007424586,0.030179279,0.000109072855,0.000042760497,0.0009066735,0.00007654557,0.00064117054,0.9163177,0.0004714593,0.00039920484,0.05042888],"study_design_scores_gemma":[0.00012014781,0.0008167924,0.28428555,0.000041252395,0.00021659053,0.009819356,0.00030770365,0.0062380093,0.676781,0.0017375402,0.019620823,0.000015218909],"about_ca_topic_score_codex":0.00021383168,"about_ca_topic_score_gemma":0.0005278433,"teacher_disagreement_score":0.0011638126,"about_ca_system_score_codex":0.00017854024,"about_ca_system_score_gemma":0.00018871052,"threshold_uncertainty_score":0.0038933158},"labels":[],"label_agreement":null},{"id":"W2901234593","doi":"10.3324/haematol.2018.199356","title":"Trypsin-encoding <i>PRSS1-PRSS2</i> variations influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group report","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Pancreatitis Pathology and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Institute of Environmental Health Sciences; Barncancerfonden; Blood Cancer UK; Rigshospitalet; Børnecancerfonden; Kræftens Bekæmpelse","keywords":"Asparaginase; Lymphoblastic Leukemia; Medicine; Pancreatitis; Oncology; Internal medicine; Toxicity; Leukemia; Gastroenterology; Pediatrics","score_opus":0.011335035741701556,"score_gpt":0.2438319169626636,"score_spread":0.23249688122096204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901234593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98677987,0.008692681,0.0007578193,0.00045686532,0.00004649363,0.000052980755,0.0016899819,0.00002507421,0.001498153],"genre_scores_gemma":[0.99642146,0.0013701787,0.0005333054,0.0002154615,0.000057343772,0.000032418488,0.0008349479,0.000017474726,0.0005174458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865997,0.0006674945,0.00010920808,0.00029703448,0.0001731728,0.00009308338],"domain_scores_gemma":[0.9976144,0.0009933264,0.0007913509,0.00028093214,0.00016310884,0.0001568713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019415165,0.00043627925,0.00040786734,0.0004022712,0.00021772186,0.0010709128,0.0003574368,0.00049036025,0.0015279439],"category_scores_gemma":[0.004015168,0.0002315773,0.001070307,0.0009858387,0.0003315143,0.0003088226,0.00038882857,0.00048241683,0.00016734864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004575808,0.00006985177,0.9704047,0.00013998634,0.002133377,0.00017641268,0.0001123081,0.0002890439,0.0022075279,0.0001256615,0.0012375832,0.018527787],"study_design_scores_gemma":[0.00053610513,0.00085265556,0.9889475,0.00008200264,0.0030413857,0.00051657687,0.00007527749,0.0005025892,0.0012062779,0.00028535252,0.0039397753,0.000014300034],"about_ca_topic_score_codex":0.0026900095,"about_ca_topic_score_gemma":0.0023860512,"teacher_disagreement_score":0.0026900095,"about_ca_system_score_codex":0.00040094403,"about_ca_system_score_gemma":0.0004087133,"threshold_uncertainty_score":0.010267854},"labels":[],"label_agreement":null},{"id":"W2905400988","doi":"10.3324/haematol.2018.195172","title":"The thymidine dideoxynucleoside analog, alovudine, inhibits the mitochondrial DNA polymerase γ, impairs oxidative phosphorylation and promotes monocytic differentiation in acute myeloid leukemia","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research; Leukemia and Lymphoma Society","keywords":"Biology; Mitochondrial DNA; Oxidative phosphorylation; Respiratory chain; Mitochondrial respiratory chain; Myeloid leukemia; Mitochondrion; Molecular biology; Polymerase; DNA polymerase; Cellular differentiation; Cell biology; Cancer research; Biochemistry; DNA; Gene","score_opus":0.016604256531932135,"score_gpt":0.2778918988496143,"score_spread":0.26128764231768214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905400988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794176,0.013528057,0.0040096114,0.00026098074,0.00007760978,0.000069933754,0.0002921453,0.0000771037,0.0022669658],"genre_scores_gemma":[0.99223435,0.004036226,0.001850415,0.0000548314,0.00001373144,0.00002311937,0.0002854901,0.000008075685,0.0014936294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988973,0.000022890634,0.00001301039,0.0000151523545,0.000037982016,0.00002118722],"domain_scores_gemma":[0.9999585,0.000008751499,0.000010240031,0.000005361615,0.0000071328805,0.000009998816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012345024,0.00020751635,0.00015889433,0.00021398831,0.00013055836,0.0002871816,0.00015994487,0.0001583995,0.00067573914],"category_scores_gemma":[0.00012397899,0.000096280724,0.000112979404,0.00015799238,0.00013179568,0.00014659614,0.00009001347,0.00042279295,0.00016090658],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015136607,0.00007226111,0.00033407638,0.00005697814,0.000006425225,0.00003410916,0.000011333223,0.00011587922,0.99213237,0.00030984104,0.00007436611,0.006701116],"study_design_scores_gemma":[0.000057481844,0.0005918699,0.0027405198,0.000006582201,0.000017494112,0.00019611516,0.000013047146,0.00063731876,0.9885981,0.0001069024,0.0070309914,0.0000036112194],"about_ca_topic_score_codex":0.00060052495,"about_ca_topic_score_gemma":0.0015961325,"teacher_disagreement_score":0.00067573914,"about_ca_system_score_codex":0.00028435388,"about_ca_system_score_gemma":0.00023731467,"threshold_uncertainty_score":0.0022605658},"labels":[],"label_agreement":null},{"id":"W2905627019","doi":"10.3324/haematol.2018.205096","title":"Mogamulizumab <i>versus</i> investigator’s choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Internal medicine; Regimen; Hazard ratio; Lymphoma; Adult T-cell leukemia/lymphoma; Chemotherapy regimen; Oncology; Chemotherapy; Gastroenterology; T-cell leukemia; Confidence interval","score_opus":0.01946078763361982,"score_gpt":0.24664039158622283,"score_spread":0.227179603952603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905627019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948515,0.0029864558,0.0003405022,0.00025912072,0.00010424998,0.00026671073,0.000091408816,0.000027883032,0.0010721253],"genre_scores_gemma":[0.9974884,0.0010165374,0.00045076146,0.00029150554,0.0001058028,0.00023444518,0.00009885993,0.0000063534676,0.0003074294],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988926,0.00081519486,0.00006178084,0.000087384564,0.00004781343,0.00009511984],"domain_scores_gemma":[0.99924576,0.00028026724,0.00019249925,0.00007393618,0.000025783394,0.0001818019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022744483,0.0003395877,0.0013533649,0.00032090896,0.00018381419,0.0004358792,0.0003403406,0.00053234474,0.0011884656],"category_scores_gemma":[0.0012224313,0.00023938494,0.0009935119,0.00021319183,0.0004004681,0.00047140013,0.00019751149,0.0012078396,0.00020356862],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84352183,0.010350807,0.004447021,0.0005185195,0.001381228,0.000095589814,0.00012042811,0.0012761498,0.012502261,0.00032144264,0.0013352798,0.124129415],"study_design_scores_gemma":[0.391603,0.5598333,0.030761208,0.0001513621,0.00229592,0.0002940249,0.00009002157,0.0044538933,0.005106633,0.0009503183,0.004411314,0.000049007547],"about_ca_topic_score_codex":0.0003838467,"about_ca_topic_score_gemma":0.0011450463,"teacher_disagreement_score":0.0022744483,"about_ca_system_score_codex":0.0004920998,"about_ca_system_score_gemma":0.00054827536,"threshold_uncertainty_score":0.012028575},"labels":[],"label_agreement":null},{"id":"W2907285051","doi":"10.3324/haematol.2018.209114","title":"The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":322,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Universitätsklinikum Köln; Tianjin Medical University; University College London Hospitals NHS Foundation Trust; Medizinische Universität Wien; National and Kapodistrian University of Athens; Università degli Studi di Roma Tor Vergata; Universitair Medisch Centrum Groningen; Cleveland Clinic; University College London; University of Toronto; University of Oklahoma Health Sciences Center; Universität Wien; Cardiff University; University of Washington; University of Oklahoma; Samsung; Pusan National University; University of Ottawa; Ohio State University","keywords":"Medicine; Ambulatory; Internal medicine; Incidence (geometry); Framingham Risk Score; Meta-analysis; Venous thromboembolism; Thrombosis; Disease","score_opus":0.16741654481687118,"score_gpt":0.3819672575359277,"score_spread":0.2145507127190565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907285051","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035206075,0.99541205,0.00026219856,0.0001585029,0.000092389666,0.0001588558,0.00024612586,0.0000137831685,0.00013541254],"genre_scores_gemma":[0.160667,0.8335894,0.002438708,0.000997738,0.0005185027,0.0008364903,0.00067773456,0.000024007597,0.00025042603],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9890132,0.0051713474,0.003085144,0.0009966061,0.0014361421,0.00029754563],"domain_scores_gemma":[0.9697865,0.02286335,0.0044365753,0.00076123315,0.0018559496,0.00029632702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016721489,0.0025610656,0.018474128,0.008173684,0.0006550624,0.0034309847,0.0019878044,0.0022878698,0.0029271313],"category_scores_gemma":[0.038220074,0.0013465316,0.03594538,0.007882466,0.0007065897,0.0020821264,0.0013219687,0.0016792478,0.00026355826],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001802622,0.000030428675,0.00903724,0.33425328,0.6394335,0.0001162815,0.00006384231,0.00042929407,0.0001458355,0.00010382423,0.00056596874,0.014017951],"study_design_scores_gemma":[0.0005937799,0.00018186055,0.0061667343,0.024517616,0.96676105,0.00011722331,0.000028014905,0.00025807027,0.000061775405,0.00016268156,0.0011264288,0.000024738398],"about_ca_topic_score_codex":0.007043646,"about_ca_topic_score_gemma":0.015284917,"teacher_disagreement_score":0.018474128,"about_ca_system_score_codex":0.0022510716,"about_ca_system_score_gemma":0.0037309474,"threshold_uncertainty_score":0.08843273},"labels":[],"label_agreement":null},{"id":"W2907895732","doi":"10.3324/haematol.2018.205948","title":"Gemtuzumab ozogamicin in acute myeloid leukemia: act 2, with perhaps more to come","year":2018,"lang":"en","type":"editorial","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Gemtuzumab ozogamicin; Myeloid leukemia; Calicheamicin; Medicine; Leukemia; Oncology; Internal medicine; CD33; Biology; Genetics; Stem cell","score_opus":0.015626789455013577,"score_gpt":0.31325345522887643,"score_spread":0.2976266657738629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907895732","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000068941044,0.021359237,0.00011142783,0.03419301,0.94335014,0.0000136244125,0.000040612536,0.000046195397,0.00081685185],"genre_scores_gemma":[0.00052326615,0.011681149,0.0001232517,0.03194638,0.9515202,0.000015766767,0.000032135078,0.000022374801,0.004135381],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970522,0.00062161754,0.0005208509,0.00034476243,0.0012132733,0.00024729667],"domain_scores_gemma":[0.99053067,0.0035436708,0.00081509317,0.0002553256,0.0033462222,0.0015090173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005430123,0.002538689,0.003332991,0.002124284,0.0015781275,0.005070476,0.0027307826,0.011452693,0.0065413006],"category_scores_gemma":[0.015775954,0.0008957074,0.0023489513,0.0010589638,0.001459827,0.0038260117,0.0010870078,0.017051758,0.00524841],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013850497,0.000021679214,0.000045789144,0.00044350696,0.000049409206,0.0001560872,0.000009136367,0.00003341027,0.00008996142,0.00028280108,0.98728997,0.011439729],"study_design_scores_gemma":[0.00033961638,0.00013907965,0.00048915815,0.0008264899,0.00026786915,0.00061409816,0.000040634222,0.00023838867,0.00019901866,0.0010010959,0.99581075,0.000033799224],"about_ca_topic_score_codex":0.0012137562,"about_ca_topic_score_gemma":0.0028100584,"teacher_disagreement_score":0.011452693,"about_ca_system_score_codex":0.0022474783,"about_ca_system_score_gemma":0.002486978,"threshold_uncertainty_score":0.028717577},"labels":[],"label_agreement":null},{"id":"W2908171531","doi":"10.3324/haematol.2018.209031","title":"Convergence of risk prediction models in follicular lymphoma","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Follicular lymphoma; Lymphoma; Internal medicine; Medicine; Oncology; Follicular phase","score_opus":0.024587332290219584,"score_gpt":0.24158274211294123,"score_spread":0.21699540982272164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908171531","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31564417,0.020288313,0.46537176,0.16009274,0.0030798775,0.00027120012,0.0024819942,0.0019550184,0.03081497],"genre_scores_gemma":[0.8954747,0.0045968825,0.07915928,0.010440059,0.0035547372,0.00024117016,0.0019891323,0.00034847474,0.004195612],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99289566,0.005400517,0.00024599157,0.000574774,0.00063466025,0.0002484196],"domain_scores_gemma":[0.93518674,0.0569889,0.0013848348,0.0019238924,0.0036302556,0.00088543416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017556474,0.0009881016,0.0015373761,0.0014048865,0.0007737826,0.0032208075,0.0016635609,0.0023494477,0.004085964],"category_scores_gemma":[0.1122791,0.00062046404,0.0010170455,0.0010749757,0.00081570906,0.0025968368,0.0023437107,0.005827143,0.0019084014],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031200272,0.00039659263,0.1682256,0.00029776932,0.0010199323,0.0016376438,0.0006711877,0.28466204,0.0006431155,0.046735175,0.071540564,0.42105034],"study_design_scores_gemma":[0.00014927094,0.00019487103,0.009036705,0.00018539654,0.00009118634,0.00069824606,0.00016870037,0.8722906,0.00033142767,0.1108348,0.00596373,0.000055015924],"about_ca_topic_score_codex":0.011529345,"about_ca_topic_score_gemma":0.0074004466,"teacher_disagreement_score":0.017556474,"about_ca_system_score_codex":0.0021041858,"about_ca_system_score_gemma":0.0013072025,"threshold_uncertainty_score":0.0928486},"labels":[],"label_agreement":null},{"id":"W2908902338","doi":"10.3324/haematol.2018.211235","title":"Persistence with generic imatinib for chronic myeloid leukemia: a matched cohort study","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; McGill University; Jewish General Hospital","funders":"","keywords":"Imatinib; Persistence (discontinuity); Myeloid leukemia; Medicine; Cohort; Chronic myeloid leukaemia; Oncology; Internal medicine; Cohort study; Leukemia","score_opus":0.039788586859992175,"score_gpt":0.27108964129736374,"score_spread":0.23130105443737156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908902338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957497,0.0006326922,0.00009593561,0.0017742633,0.00006022214,0.000021307611,0.0007298654,0.0000046077116,0.0009312869],"genre_scores_gemma":[0.9967964,0.0004088287,0.00007041002,0.0015150774,0.00016549612,0.000016311093,0.00042859715,0.0000033765266,0.00059557677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999228,0.00018447693,0.00008717182,0.00017880561,0.00010614249,0.00021542625],"domain_scores_gemma":[0.99775225,0.00043118797,0.0008166509,0.0003091645,0.00019465966,0.00049609906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087360153,0.00021805444,0.0004886989,0.0006571756,0.0008444484,0.0012444467,0.0005462874,0.0013015858,0.003358217],"category_scores_gemma":[0.0031547572,0.00040524662,0.0008232457,0.0015973335,0.00043945486,0.0012786959,0.00055914145,0.0017393054,0.000575027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009823997,0.00026578183,0.99122214,0.000016110791,0.00023648234,0.002074755,0.0001658043,0.000020089095,0.00036165706,0.00010268235,0.001269767,0.003282376],"study_design_scores_gemma":[0.00023396661,0.00082053564,0.98998684,0.000027664464,0.00026616748,0.0055643623,0.0008442405,0.00033929915,0.00008002833,0.00021894173,0.0015925274,0.00002542724],"about_ca_topic_score_codex":0.007894695,"about_ca_topic_score_gemma":0.0063796067,"teacher_disagreement_score":0.007894695,"about_ca_system_score_codex":0.00091895415,"about_ca_system_score_gemma":0.00068958296,"threshold_uncertainty_score":0.01569748},"labels":[],"label_agreement":null},{"id":"W2910217751","doi":"10.3324/haematol.2018.200378","title":"Mechanisms of thrombocytopenia in platelet-type von Willebrand disease","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Università degli Studi di Perugia; Queen's University; Fondazione Cariplo","keywords":"Platelet; GPVI; Megakaryocyte; Thrombopoiesis; Megakaryocytopoiesis; Von Willebrand factor; Von Willebrand disease; Chemistry; Immunology; Platelet Glycoprotein GPIb-IX Complex; Bone marrow; Ristocetin; Platelet membrane glycoprotein; Endocrinology; Cell biology; Internal medicine; Haematopoiesis; Biology; Medicine; Stem cell","score_opus":0.01584517417583293,"score_gpt":0.2616321639105532,"score_spread":0.2457869897347203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910217751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73126185,0.23847389,0.017527085,0.0017495945,0.00031625215,0.00022734191,0.0006851765,0.0004897864,0.009269006],"genre_scores_gemma":[0.94443345,0.04856196,0.0031809018,0.0005296657,0.00029330334,0.00013293442,0.0005958994,0.00001654294,0.0022554637],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998148,0.000051574825,0.000019439749,0.000027751883,0.000053330565,0.00003316765],"domain_scores_gemma":[0.99988616,0.000019495166,0.000045217002,0.000011816818,0.0000132513205,0.000024071065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024688378,0.00067871,0.00040171572,0.0006560345,0.00020553221,0.00056873227,0.00041176015,0.0010214647,0.00090650056],"category_scores_gemma":[0.00020311357,0.00022082732,0.0003515755,0.0002518542,0.00042009717,0.00041793086,0.00052953954,0.00065720815,0.00023545216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014668707,0.00033055432,0.010390353,0.001791525,0.00028909888,0.016155811,0.0002886201,0.0012413302,0.88741297,0.018546674,0.0028659645,0.05922022],"study_design_scores_gemma":[0.0009351484,0.008559075,0.19617404,0.0007329089,0.0014483613,0.15178952,0.0006985353,0.010877605,0.48576975,0.03245042,0.1103886,0.00017613498],"about_ca_topic_score_codex":0.0002000951,"about_ca_topic_score_gemma":0.00013299285,"teacher_disagreement_score":0.0010214647,"about_ca_system_score_codex":0.00028386142,"about_ca_system_score_gemma":0.00013355238,"threshold_uncertainty_score":0.0030325651},"labels":[],"label_agreement":null},{"id":"W2910821491","doi":"10.3324/haematol.2018.203943","title":"Resolution of celiac disease, IgA deficiency and platelet refractoriness after allogeneic bone marrow transplantation for acute leukemia","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Transplantation; Stem cell; Immunology; Hematology; Immune system; Disease; Bone marrow; Leukemia; Acute leukemia; Platelet; Internal medicine","score_opus":0.02151216357234776,"score_gpt":0.29430982506398956,"score_spread":0.2727976614916418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910821491","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31330156,0.018290851,0.0030360562,0.57186323,0.024694,0.00029097399,0.00025135477,0.0003158562,0.06795613],"genre_scores_gemma":[0.8105712,0.007026786,0.001214748,0.13174284,0.03130053,0.0000624601,0.00019057316,0.00005419739,0.01783665],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999358,0.00021983094,0.00007161799,0.000070083304,0.00011412338,0.0001663156],"domain_scores_gemma":[0.99876094,0.0005513199,0.00012595321,0.00007884303,0.00013101795,0.00035194316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065760943,0.0006867491,0.0007684445,0.00073719455,0.0019320383,0.0010939471,0.0011781421,0.008745752,0.0014239257],"category_scores_gemma":[0.0046850364,0.00035512328,0.0010975375,0.0007810646,0.0010708934,0.0010447367,0.00048479173,0.0064915717,0.000898872],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035143815,0.00017617573,0.013626204,0.000091947106,0.000043723983,0.9415991,0.00028987136,0.00028890625,0.0011244981,0.0017688957,0.028837502,0.0118017625],"study_design_scores_gemma":[0.0003823888,0.000580764,0.023312112,0.00021122549,0.00010245007,0.9101382,0.0006848146,0.0026016016,0.0011087973,0.004681727,0.05614043,0.000055525103],"about_ca_topic_score_codex":0.0031962073,"about_ca_topic_score_gemma":0.0057640024,"teacher_disagreement_score":0.008745752,"about_ca_system_score_codex":0.0023876498,"about_ca_system_score_gemma":0.0010169046,"threshold_uncertainty_score":0.017323613},"labels":[],"label_agreement":null},{"id":"W2913401942","doi":"10.3324/haematol.2018.211433","title":"Recurrent stroke: the role of thrombophilia in a large international pediatric stroke population","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Stroke (engine); Hazard ratio; Thrombophilia; Internal medicine; Risk factor; Population; Confidence interval; Pediatrics; Factor V Leiden; Antithrombin; Proportional hazards model; Surgery; Thrombosis; Heparin; Venous thrombosis","score_opus":0.015405589626881525,"score_gpt":0.27481494102433085,"score_spread":0.2594093513974493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913401942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98899406,0.008784248,0.00037319702,0.00035884065,0.000018185965,0.000013739471,0.0008097291,0.000014887099,0.0006330768],"genre_scores_gemma":[0.9956533,0.0033251499,0.0002125152,0.00004848438,0.000047059406,0.000014954613,0.00063179765,0.000005488258,0.00006128087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868256,0.00058713596,0.00013060823,0.00027167902,0.0002179046,0.00011014512],"domain_scores_gemma":[0.9970306,0.0007455448,0.0014902615,0.0002659866,0.0002478868,0.00021968762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002410582,0.00043184453,0.00067094585,0.0013766348,0.00029045448,0.0010099121,0.00050446525,0.0006390678,0.0008686479],"category_scores_gemma":[0.005596216,0.0003320318,0.0009452367,0.0024552927,0.00046651243,0.00083884946,0.0005578389,0.00068878237,0.00017649018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006952502,0.000006672699,0.9966545,0.000022223501,0.00012708051,0.000091919224,0.000054709733,0.000055571873,0.0000540001,0.000023435767,0.0001299482,0.002710446],"study_design_scores_gemma":[0.0000048399215,0.00005416789,0.9985279,0.00002546725,0.00015204979,0.0006581123,0.00013338466,0.00016322723,0.00003283904,0.000024801948,0.00021995019,0.0000031102068],"about_ca_topic_score_codex":0.010274027,"about_ca_topic_score_gemma":0.008063582,"teacher_disagreement_score":0.010274027,"about_ca_system_score_codex":0.00032643546,"about_ca_system_score_gemma":0.00042245653,"threshold_uncertainty_score":0.02042842},"labels":[],"label_agreement":null},{"id":"W2913806361","doi":"10.3324/haematol.2018.205526","title":"IgG4-related disease: what a hematologist needs to know","year":2019,"lang":"en","type":"review","venue":"Haematologica","topic":"IgG4-Related and Inflammatory Diseases","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; IgG4-related disease; Retroperitoneal fibrosis; Rituximab; Autoimmune pancreatitis; Lymphoplasmacytic Lymphoma; Lymphoma; Pathology; Disease; Eosinophilia; Bone marrow; Lymphoproliferative disorders; Fibrosis; Hypergammaglobulinemia; Waldenstrom macroglobulinemia","score_opus":0.05655250605357538,"score_gpt":0.34915730279394286,"score_spread":0.2926047967403675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913806361","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011862573,0.76716536,0.0013700806,0.19836445,0.026461689,0.0000364108,0.000121942714,0.00014917753,0.005144672],"genre_scores_gemma":[0.009035561,0.748828,0.0029256227,0.14822404,0.08551269,0.00006749887,0.0003542754,0.00005231107,0.0050000497],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990441,0.0002446121,0.00016472957,0.00009930728,0.00033821916,0.00010897122],"domain_scores_gemma":[0.9938939,0.0026565718,0.00034314406,0.00019028503,0.0017942945,0.0011218251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018591541,0.0010193164,0.002664922,0.0017611855,0.0012133694,0.002910743,0.0013168581,0.006704422,0.007000934],"category_scores_gemma":[0.008027569,0.00046238312,0.0010492931,0.0011570696,0.0015081894,0.008924971,0.0013256365,0.009428012,0.0036804162],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094398434,0.00012688617,0.0037663619,0.0047198026,0.00010098482,0.0053712875,0.00050232455,0.00018040645,0.0004609534,0.0018221717,0.49779132,0.48506317],"study_design_scores_gemma":[0.00007544787,0.00011735045,0.0057309107,0.017957637,0.00013405204,0.04841772,0.0025706089,0.00023449653,0.00017340395,0.012137361,0.91233546,0.0001154724],"about_ca_topic_score_codex":0.003979969,"about_ca_topic_score_gemma":0.004874626,"teacher_disagreement_score":0.007000934,"about_ca_system_score_codex":0.001297114,"about_ca_system_score_gemma":0.0026114897,"threshold_uncertainty_score":0.023420393},"labels":[],"label_agreement":null},{"id":"W2914988374","doi":"10.3324/haematol.2018.207837","title":"ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Bijzonder Onderzoeksfonds UGent; Universiteit Gent; Vlaamse regering; National Health and Medical Research Council; Swiss Bridge Foundation; European Hematology Association","keywords":"Biology; Cancer research; Progenitor cell; Transcription factor; Haematopoiesis; Cell biology; Cellular differentiation; Stem cell; Leukemia; Immunology; Genetics; Gene","score_opus":0.007954733886676247,"score_gpt":0.23922216608475683,"score_spread":0.23126743219808057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914988374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99410987,0.00039935746,0.0028619247,0.00006871453,0.000011635012,0.000058623,0.0003138643,0.00008443918,0.0020916902],"genre_scores_gemma":[0.99370766,0.00033853995,0.002037785,0.00004849913,0.000006976888,0.00007793186,0.00046887383,0.00003910831,0.003274516],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997389,0.00004355414,0.000027061285,0.000043125077,0.00008043981,0.00006696954],"domain_scores_gemma":[0.99984384,0.000026923903,0.000049593513,0.00001740267,0.00000799497,0.00005420101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001571522,0.00031032518,0.0001999511,0.00034118837,0.00015257792,0.00046769922,0.00020178995,0.00023848825,0.0012729276],"category_scores_gemma":[0.000116552226,0.00018503088,0.00015324206,0.00018116918,0.00030603673,0.00023695473,0.00038009594,0.00076059706,0.00033223792],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098375975,0.000044503908,0.00030454755,0.00001320323,0.0000028741706,0.000049081125,0.00002381959,0.000060489307,0.9981585,0.00055972015,0.000025697487,0.0006591468],"study_design_scores_gemma":[0.00005484088,0.0003519431,0.0030828412,0.000004551568,0.000016762635,0.0004765563,0.000058461046,0.001439146,0.99047333,0.00013000553,0.0039068814,0.00000477023],"about_ca_topic_score_codex":0.0004431154,"about_ca_topic_score_gemma":0.0009396963,"teacher_disagreement_score":0.0012729276,"about_ca_system_score_codex":0.00041467274,"about_ca_system_score_gemma":0.00025543128,"threshold_uncertainty_score":0.0042583346},"labels":[],"label_agreement":null},{"id":"W2916869227","doi":"10.3324/haematol.2018.214593","title":"Bone marrow endothelial cell-derived interleukin-4 contributes to thrombocytopenia in acute myeloid leukemia","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Agriculture","funders":"National Key Research and Development Program of China; Chinese Academy of Medical Sciences Initiative for Innovative Medicine; National Natural Science Foundation of China","keywords":"Myeloid leukemia; Thrombopoiesis; Bone marrow; Haematopoiesis; Leukemia; Medicine; Immunology; Cancer research; Acute leukemia; Myeloid; Megakaryocyte; Stem cell; Biology; Cell biology","score_opus":0.01190285207895406,"score_gpt":0.2531779952257883,"score_spread":0.24127514314683426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916869227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821436,0.011987817,0.0031060656,0.00032433815,0.000034922417,0.000042235657,0.00019943228,0.000102423655,0.0020591626],"genre_scores_gemma":[0.99455947,0.0036437192,0.0006329688,0.000094549374,0.000032091833,0.00002074919,0.00023106692,0.0000058824817,0.00077937543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999244,0.000027619391,0.0000087156695,0.000006786696,0.000017626497,0.000014865935],"domain_scores_gemma":[0.9999342,0.0000121357125,0.000026767724,0.000006189018,0.000005227605,0.000015436814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117687676,0.00021375544,0.0001338026,0.0003059568,0.00009110831,0.00021864049,0.00013959361,0.00019670035,0.00090688275],"category_scores_gemma":[0.0001485086,0.00008053326,0.00013324532,0.00019023748,0.00016293561,0.00008999168,0.00023484275,0.00045046327,0.00016667265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009613854,0.0002150136,0.012550199,0.00027584686,0.00004432658,0.0034053803,0.00008583619,0.0004767597,0.94843996,0.0017279523,0.0008329818,0.030984348],"study_design_scores_gemma":[0.0006392114,0.0036044992,0.3138093,0.00015738205,0.00077805,0.031879626,0.00035316937,0.01214122,0.5783224,0.00430074,0.053978596,0.000035733807],"about_ca_topic_score_codex":0.00022399268,"about_ca_topic_score_gemma":0.00024091927,"teacher_disagreement_score":0.00090688275,"about_ca_system_score_codex":0.00015363636,"about_ca_system_score_gemma":0.0001419144,"threshold_uncertainty_score":0.0030338168},"labels":[],"label_agreement":null},{"id":"W2917196540","doi":"10.3324/haematol.2019.216796","title":"The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mach-Gaensslen Foundation of Canada; Baxalta; National Science Foundation; National Institutes of Health; National Heart, Lung, and Blood Institute; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"ADAMTS13; Compound heterozygosity; Medicine; Thrombotic thrombocytopenic purpura; Gastroenterology; Internal medicine; Disease; Genotype; Allele; Age of onset; Pediatrics; Genetics; Biology; Gene; Platelet","score_opus":0.022099107912404194,"score_gpt":0.25729035820357293,"score_spread":0.23519125029116875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917196540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8073208,0.0013328688,0.0014708929,0.001098828,0.00028164155,0.0013120858,0.1654092,0.00021205374,0.02156162],"genre_scores_gemma":[0.78594023,0.0014890865,0.0021203652,0.0009901668,0.0004235317,0.0039964844,0.19548143,0.00024002884,0.009318754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842846,0.00016183664,0.0002143104,0.0004111261,0.00040109464,0.0003831022],"domain_scores_gemma":[0.99657804,0.00023005372,0.0010521509,0.0003344248,0.0010240511,0.0007813573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001327287,0.0002883042,0.00057172996,0.0014712155,0.0008045634,0.0010697697,0.00071620237,0.00046392708,0.0060252775],"category_scores_gemma":[0.0046874164,0.0002387358,0.00036359302,0.0024941105,0.00020658235,0.001245282,0.0014895806,0.0009070003,0.0032079981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048669352,0.00017219974,0.9605324,0.00010244871,0.00003747434,0.0006196605,0.00037507378,0.00010543429,0.0006540274,0.00031382058,0.02395169,0.012649038],"study_design_scores_gemma":[0.000042434694,0.00012633983,0.97007173,0.00013598023,0.000041577357,0.001492187,0.00047087154,0.00017766109,0.00037353125,0.00017687953,0.026865842,0.000024869343],"about_ca_topic_score_codex":0.0064092143,"about_ca_topic_score_gemma":0.005370892,"teacher_disagreement_score":0.0064092143,"about_ca_system_score_codex":0.00079595856,"about_ca_system_score_gemma":0.0023310327,"threshold_uncertainty_score":0.020156562},"labels":[],"label_agreement":null},{"id":"W2917444309","doi":"10.3324/haematol.2018.209619","title":"Mode of delivery in hemophilia: vaginal delivery and Cesarean section carry similar risks for intracranial hemorrhages and other major bleeds","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Grifols; Skånes universitetssjukhus; Lunds Universitet; Institut National de la Santé et de la Recherche Médicale; Helsingin ja Uudenmaan Sairaanhoitopiiri; Pfizer; Hospital for Sick Children; Great Ormond Street Hospital for Children; Swedish Orphan Biovitrum; Aix-Marseille Université; Institut National de la Recherche Agronomique; Baxalta; CSL Behring; Helsingin Yliopisto; Bayer","keywords":"Medicine; Vaginal delivery; Intracranial Hemorrhages; Incidence (geometry); Obstetrics; Cesarean delivery; Pediatrics; Pregnancy; Surgery","score_opus":0.03410179109182764,"score_gpt":0.31381053151399274,"score_spread":0.2797087404221651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917444309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715376,0.0019492602,0.00024840285,0.00009989991,0.000011170918,0.0000066897696,0.00010101603,0.000003780466,0.00042590176],"genre_scores_gemma":[0.99885166,0.00059666845,0.00025521746,0.000031413834,0.000021783686,0.000006997071,0.00010375057,0.0000035715943,0.00012889132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911076,0.00045723448,0.000078166915,0.00010220685,0.00017268417,0.000078939054],"domain_scores_gemma":[0.9959435,0.0014460663,0.0017686563,0.00026698818,0.0001513208,0.00042344767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015594949,0.00019652602,0.00031523456,0.00054522674,0.0002031471,0.0004493666,0.0003270002,0.0004795712,0.0019573914],"category_scores_gemma":[0.0047944095,0.00013934266,0.0005040988,0.00053082994,0.0003221655,0.00026673157,0.0004076378,0.0005767552,0.0002216498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046249153,0.000019169831,0.9949862,0.000021361562,0.00009208884,0.00021277663,0.00004185084,0.000028387187,0.0003676712,0.000031909905,0.000046715646,0.0036893901],"study_design_scores_gemma":[0.00001943297,0.00031229926,0.9958268,0.000042225955,0.00007436854,0.002938556,0.00013836619,0.00016642766,0.00016815081,0.000093333685,0.00021557353,0.0000043767504],"about_ca_topic_score_codex":0.0008008952,"about_ca_topic_score_gemma":0.0008036926,"teacher_disagreement_score":0.0019573914,"about_ca_system_score_codex":0.00016225083,"about_ca_system_score_gemma":0.00024626523,"threshold_uncertainty_score":0.008247495},"labels":[],"label_agreement":null},{"id":"W2918035369","doi":"10.3324/haematol.2018.207548","title":"Long-term follow up after third-party viral-specific cytotoxic lymphocytes for immunosuppression- and Epstein-Barr virus-associated lymphoproliferative disease","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Skånes universitetssjukhus; University of Aberdeen; Universiteit Leiden; Newcastle University; Hospital for Sick Children; Royal Devon and Exeter NHS Foundation Trust; Wellcome Trust; James Cook University; University of Nottingham","keywords":"Lymphoproliferative disease; Immunosuppression; Virology; Cytotoxic T cell; Immunology; Medicine; Epstein–Barr virus; Virus; Disease; Lymphoproliferative disorders; Term (time); Biology; Lymphoma; Pathology; Genetics","score_opus":0.019045199998360504,"score_gpt":0.26200250503100203,"score_spread":0.2429573050326415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918035369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81434184,0.0139439255,0.0013831964,0.12720963,0.0033060673,0.00009945403,0.0004764238,0.00008134382,0.03915806],"genre_scores_gemma":[0.96417123,0.0017051667,0.00024392447,0.025596224,0.0029014482,0.000024413075,0.00018953173,0.000014347423,0.005153699],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994815,0.00009117764,0.000050522198,0.00006169164,0.00007837474,0.00023669265],"domain_scores_gemma":[0.9977926,0.00085441803,0.000341264,0.00015250049,0.00032442287,0.00053484074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048634742,0.00020409666,0.00046463625,0.00038402822,0.0021152513,0.0007215126,0.000490432,0.004309093,0.0018061092],"category_scores_gemma":[0.003245584,0.00012577882,0.00058686495,0.00048939016,0.0005130615,0.0008807317,0.00040505797,0.003347188,0.0007209885],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010714307,0.00043223627,0.35630852,0.00010179285,0.000075742246,0.5885923,0.0011990819,0.00019719327,0.0024146205,0.0013319011,0.018049516,0.03022565],"study_design_scores_gemma":[0.00020094457,0.0018931885,0.3593676,0.0005371287,0.00032540248,0.5732757,0.0024718056,0.0018186605,0.0024724677,0.0034960252,0.054034907,0.000106151114],"about_ca_topic_score_codex":0.0032717243,"about_ca_topic_score_gemma":0.0060364082,"teacher_disagreement_score":0.004309093,"about_ca_system_score_codex":0.0016578924,"about_ca_system_score_gemma":0.00071753113,"threshold_uncertainty_score":0.012028873},"labels":[],"label_agreement":null},{"id":"W2921220965","doi":"10.3324/haematol.2018.202283","title":"Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Amgen","keywords":"Romiplostim; Immune thrombocytopenia; Medicine; Platelet; Term (time); Immune system; Thrombopoietin; Immunology; Pediatrics; Biology","score_opus":0.015680505865902944,"score_gpt":0.2567007271871789,"score_spread":0.24102022132127596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921220965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993192,0.00039362442,0.00003376314,0.000025665126,0.000003174203,0.000013401914,0.000054513323,0.0000025542583,0.00015405862],"genre_scores_gemma":[0.9993783,0.00020377748,0.00007269438,0.000041321175,0.00000818119,0.000028774295,0.00015591356,0.0000013438807,0.00010959421],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995697,0.00014087468,0.00004128178,0.00004043906,0.00007471366,0.00013307166],"domain_scores_gemma":[0.99908817,0.0002455691,0.00035338785,0.00004208827,0.000052467043,0.00021824709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085835165,0.00021460927,0.00048425602,0.00021180093,0.00023863929,0.00028327506,0.0002178967,0.00030124036,0.0004991031],"category_scores_gemma":[0.0009862337,0.00015272683,0.00050747837,0.00025900855,0.00029233837,0.00028009614,0.0002481771,0.0007647634,0.00010344917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01890452,0.0028142193,0.9140133,0.00023851747,0.0003026191,0.0020695413,0.00083572825,0.0006634053,0.00846568,0.00009887778,0.0007536669,0.05083991],"study_design_scores_gemma":[0.002775803,0.058631208,0.9295583,0.00006183882,0.00019953615,0.0031680462,0.00034629868,0.00041416,0.002392611,0.00003106025,0.0024075094,0.000013661553],"about_ca_topic_score_codex":0.0015966189,"about_ca_topic_score_gemma":0.002918148,"teacher_disagreement_score":0.0015966189,"about_ca_system_score_codex":0.00048028465,"about_ca_system_score_gemma":0.00049741636,"threshold_uncertainty_score":0.00453943},"labels":[],"label_agreement":null},{"id":"W2922443156","doi":"10.3324/haematol.2018.209924","title":"Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University; Ottawa Hospital; Thrombosis and Atherosclerosis Research Institute","funders":"Bayer","keywords":"Vignette; Venous thromboembolism; Anticoagulant therapy; Medicine; Anticoagulant; Fractional factorial design; Internal medicine; Intensive care medicine; Factorial experiment; Mathematics; Thrombosis; Statistics","score_opus":0.07872900564231253,"score_gpt":0.3621470513603932,"score_spread":0.2834180457180807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922443156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99220407,0.000997587,0.00062942645,0.0038873628,0.00015248195,0.00018070349,0.00036937074,0.0000062591744,0.0015728092],"genre_scores_gemma":[0.9948907,0.00045842584,0.0013195521,0.0021919792,0.00023941661,0.0002452319,0.00019974668,0.0000024225124,0.0004524259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98899907,0.009570616,0.00039762424,0.00039365405,0.0003693721,0.00026965275],"domain_scores_gemma":[0.978986,0.016054051,0.002076746,0.0008869525,0.0010849833,0.0009112685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007218141,0.00062158715,0.0010247115,0.00065854494,0.0012563415,0.0012375708,0.00066060014,0.0025081676,0.003997496],"category_scores_gemma":[0.02391396,0.00041016546,0.00056856533,0.0015655801,0.00091421284,0.0014608956,0.0005522915,0.0012135064,0.0006372857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14084536,0.037146624,0.72014517,0.0010433441,0.003859485,0.010133248,0.0058084866,0.0010572184,0.0024647391,0.0066900295,0.016708422,0.054097924],"study_design_scores_gemma":[0.06983565,0.10964062,0.7303918,0.0012807939,0.005463147,0.02381622,0.01194963,0.018230835,0.0008678874,0.010449818,0.017585048,0.00048859586],"about_ca_topic_score_codex":0.0023578282,"about_ca_topic_score_gemma":0.0026181506,"teacher_disagreement_score":0.007218141,"about_ca_system_score_codex":0.001180706,"about_ca_system_score_gemma":0.00073140993,"threshold_uncertainty_score":0.038173616},"labels":[],"label_agreement":null},{"id":"W2926348605","doi":"10.3324/haematol.2018.206540","title":"Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Center for Advancing Translational Sciences; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; Frank A. Campini Foundation","keywords":"Medicine; Aplastic anemia; Internal medicine; Anemia; Hematopoietic stem cell transplantation; Refractory (planetary science); Gastroenterology; Pediatrics; Surgery; Transplantation; Bone marrow","score_opus":0.01735950502544225,"score_gpt":0.2738170451576972,"score_spread":0.25645754013225497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2926348605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99733317,0.0008691247,0.00010134831,0.00014658098,0.0000074799827,0.000070153474,0.0009933951,0.000003276997,0.00047538753],"genre_scores_gemma":[0.995808,0.0009874277,0.00023966114,0.00014621034,0.00003738762,0.00014612613,0.0024906928,0.0000051466973,0.00013936621],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99723357,0.0013943907,0.00026978742,0.00031675783,0.0005745395,0.00021107003],"domain_scores_gemma":[0.9934546,0.0010317959,0.0030725182,0.000542794,0.00095974124,0.0009386397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036429928,0.00033619124,0.00048878364,0.0009042188,0.00045771146,0.0010386439,0.00062675274,0.0005121883,0.00097147096],"category_scores_gemma":[0.004366211,0.0003209521,0.00052417896,0.0032133851,0.00036190648,0.00064948644,0.00095326686,0.00057777914,0.00016533212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023522454,0.000100452766,0.9970252,0.000034225144,0.00016473724,0.00008169556,0.00014446628,0.000055724973,0.00005180826,0.000032330994,0.0004635169,0.001610649],"study_design_scores_gemma":[0.00010499069,0.0001794069,0.9979236,0.00004097345,0.00014390859,0.00026470734,0.00039452678,0.00019262204,0.000035495963,0.000015061505,0.00069904473,0.0000055998694],"about_ca_topic_score_codex":0.013293676,"about_ca_topic_score_gemma":0.016795574,"teacher_disagreement_score":0.013293676,"about_ca_system_score_codex":0.0010559764,"about_ca_system_score_gemma":0.0021117316,"threshold_uncertainty_score":0.026432633},"labels":[],"label_agreement":null},{"id":"W2926630840","doi":"10.3324/haematol.2018.209528","title":"THROMBOTECT takes the lead","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Lead (geology); Medicine; Intensive care medicine; Biology","score_opus":0.06572114236027245,"score_gpt":0.28877072286259026,"score_spread":0.22304958050231782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2926630840","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047976262,0.0036484182,0.00008570889,0.9596846,0.026031025,0.000009494137,0.00003096474,0.00003305444,0.009996962],"genre_scores_gemma":[0.008843988,0.0023552962,0.0002717863,0.90213984,0.06720513,0.000029092984,0.000030144927,0.00003852085,0.019086275],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99683267,0.000972004,0.0003271257,0.0003927706,0.00093405426,0.0005413942],"domain_scores_gemma":[0.9957047,0.001805978,0.0003070723,0.00018610123,0.0005660804,0.0014301157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018844814,0.00084028865,0.0017725781,0.0010272983,0.0050141322,0.005687064,0.0014741045,0.068119414,0.014437332],"category_scores_gemma":[0.014286862,0.0007563972,0.0014048524,0.00080576533,0.003268291,0.0034995237,0.0018411452,0.050197616,0.008087194],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001262115,0.000084748775,0.001049443,0.00008850311,0.000048728707,0.0090305805,0.00011818203,0.00011952929,0.0002559858,0.0066872775,0.96873516,0.013655701],"study_design_scores_gemma":[0.00021339973,0.00015345325,0.0013970654,0.0005096941,0.000050591978,0.006863748,0.00040474048,0.00054626475,0.0002627524,0.019606717,0.96991616,0.0000752972],"about_ca_topic_score_codex":0.0044124443,"about_ca_topic_score_gemma":0.010127285,"teacher_disagreement_score":0.068119414,"about_ca_system_score_codex":0.0038676066,"about_ca_system_score_gemma":0.0035689115,"threshold_uncertainty_score":0.048297644},"labels":[],"label_agreement":null},{"id":"W2928049355","doi":"10.3324/haematol.2018.211086","title":"Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Autoantibody; Glycoprotein; Antigen; Platelet; Avidity; Antibody; Platelet membrane glycoprotein; Immunology; Monoclonal antibody; Medicine; Immune system; Immune thrombocytopenia; Molecular biology; Biology","score_opus":0.006762883703364924,"score_gpt":0.2206216580224373,"score_spread":0.21385877431907238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2928049355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958187,0.003128573,0.00016493192,0.000056827266,0.000009925299,0.000005498863,0.00005706492,0.00000622839,0.00075223006],"genre_scores_gemma":[0.9994216,0.00035003334,0.00006121045,0.000030466186,0.000013336514,0.0000021921849,0.000054423635,0.0000010802952,0.00006565814],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995308,0.00013009833,0.00006605965,0.000089971174,0.000120506396,0.000062702165],"domain_scores_gemma":[0.99943584,0.00021623146,0.0001986103,0.000032266344,0.000058172052,0.000058908758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032123772,0.00027173615,0.00042601308,0.0007731679,0.00030980576,0.0004646077,0.00019580571,0.000530529,0.0008956361],"category_scores_gemma":[0.0018499468,0.00015894935,0.00025153477,0.0009335219,0.00020800564,0.0003576158,0.00021751643,0.00040296515,0.00019205271],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025203178,0.000021387403,0.9900771,0.000041612715,0.000040191357,0.0010219268,0.000079522906,0.00003009806,0.0014122016,0.000036549096,0.00010558448,0.0068817693],"study_design_scores_gemma":[0.000013086567,0.00030567445,0.9864334,0.000030454878,0.00010071453,0.011329117,0.00018105049,0.0002251719,0.00058775744,0.00009183868,0.0006963374,0.0000053635613],"about_ca_topic_score_codex":0.00056519645,"about_ca_topic_score_gemma":0.0005044559,"teacher_disagreement_score":0.0008956361,"about_ca_system_score_codex":0.00016042539,"about_ca_system_score_gemma":0.00017016291,"threshold_uncertainty_score":0.002996266},"labels":[],"label_agreement":null},{"id":"W2938912331","doi":"10.3324/haematol.2018.213512","title":"ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Anaplastic large-cell lymphoma; Medicine; Oncology; Lymphoma; Internal medicine; Anaplastic lymphoma kinase; Cancer research","score_opus":0.014647189949418797,"score_gpt":0.2568785740166578,"score_spread":0.24223138406723901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2938912331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902013,0.004418902,0.0008877549,0.000034814897,0.000024606295,0.00006030472,0.0037909758,0.000020605183,0.00056075974],"genre_scores_gemma":[0.99407554,0.00066211174,0.00032667792,0.00004677979,0.00003123055,0.000045934878,0.004637832,0.000012094988,0.0001616496],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9971438,0.0010466287,0.00045389766,0.0008029278,0.00036834847,0.00018436518],"domain_scores_gemma":[0.99759454,0.00077029504,0.0007699323,0.00045862386,0.0002913298,0.00011524839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025584276,0.00063771586,0.0017713365,0.0010824812,0.00035363628,0.00090397766,0.00042030244,0.000446406,0.0010115596],"category_scores_gemma":[0.0034864247,0.00062073465,0.0026885543,0.0021862972,0.00026910123,0.00060083123,0.000669531,0.00045285514,0.000243692],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008034419,0.000086321845,0.9574854,0.00041187563,0.02115076,0.00058509276,0.00023022233,0.0005165602,0.0013121689,0.00006721598,0.0009836989,0.009136227],"study_design_scores_gemma":[0.0005588401,0.00081413763,0.9795752,0.00007862419,0.014372658,0.001049725,0.00040191828,0.00077768794,0.0003641406,0.0000678405,0.0019006017,0.00003860535],"about_ca_topic_score_codex":0.0027361743,"about_ca_topic_score_gemma":0.0044543175,"teacher_disagreement_score":0.0027361743,"about_ca_system_score_codex":0.00054670207,"about_ca_system_score_gemma":0.0004586855,"threshold_uncertainty_score":0.013530433},"labels":[],"label_agreement":null},{"id":"W2941404034","doi":"10.3324/haematol.2018.214957","title":"Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Epigenetics; Genetics; Biology; DNA sequencing; Computational biology; Evolutionary biology; Gene","score_opus":0.13369967544279251,"score_gpt":0.31145699692775386,"score_spread":0.17775732148496134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941404034","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007470743,0.010575481,0.0018884088,0.95862556,0.010158533,0.000021715725,0.00031631486,0.00011689785,0.010826437],"genre_scores_gemma":[0.13934551,0.027717276,0.0044649835,0.67650914,0.12609312,0.000111714406,0.00041511015,0.00015821846,0.025184868],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99924743,0.00025715574,0.000062310915,0.000108335036,0.0001995117,0.00012522614],"domain_scores_gemma":[0.9967939,0.0021944076,0.00015729891,0.00012563936,0.00037556945,0.00035305717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015128065,0.000316965,0.0006372948,0.00038423255,0.0007575863,0.0013517515,0.000512537,0.008040639,0.006028717],"category_scores_gemma":[0.006131457,0.00020353639,0.00040941424,0.00029413376,0.0009477093,0.0011893497,0.00057361776,0.008953736,0.0020744966],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045699743,0.000097840486,0.011297379,0.00026939833,0.000104842955,0.024220737,0.000387029,0.00068760803,0.012556025,0.008707417,0.74915606,0.19205873],"study_design_scores_gemma":[0.00018914868,0.00019607654,0.008728441,0.000352638,0.00011935262,0.0301693,0.0008399275,0.0023930036,0.004764537,0.04588279,0.90628964,0.00007519496],"about_ca_topic_score_codex":0.001115589,"about_ca_topic_score_gemma":0.0023449555,"teacher_disagreement_score":0.008040639,"about_ca_system_score_codex":0.0011042168,"about_ca_system_score_gemma":0.00072029245,"threshold_uncertainty_score":0.020168066},"labels":[],"label_agreement":null},{"id":"W2945827479","doi":"10.3324/haematol.2018.215202","title":"Alternative donor transplantation for acute myeloid leukemia in patients aged ≥50 years: young HLA-matched unrelated or haploidentical donor?","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute; Health Resources and Services Administration; Office of Naval Research; U.S. Department of Defense; National Heart, Lung, and Blood Institute; U.S. Navy","keywords":"Medicine; Hazard ratio; Transplantation; Internal medicine; Myeloid leukemia; Graft-versus-host disease; Sibling; Leukemia; Gastroenterology; Surgery; Immunology; Confidence interval","score_opus":0.01952168664170772,"score_gpt":0.28401988166212866,"score_spread":0.26449819502042093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945827479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99912614,0.000656992,0.000043139647,0.000025181138,0.000007417905,0.0000015354208,0.00002666172,6.439384e-7,0.00011228441],"genre_scores_gemma":[0.99952424,0.00029625287,0.000024923722,0.00003308113,0.000016415814,0.0000014204732,0.00006115098,3.488427e-7,0.000042206266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985397,0.000047467667,0.00001048867,0.000028739352,0.00002018234,0.000039218296],"domain_scores_gemma":[0.9995585,0.00010973311,0.00018639103,0.000018887802,0.000012147199,0.00011429519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004175161,0.00010991471,0.00019990631,0.00021256992,0.00021289769,0.00035326983,0.00011480138,0.0002300542,0.0011497934],"category_scores_gemma":[0.00094198395,0.00007097607,0.00026420737,0.00033187322,0.00020881837,0.0002875918,0.00023534463,0.0003082446,0.00012551092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008064687,0.000077613535,0.9906336,0.000025177656,0.0000578791,0.00051939674,0.000067765875,0.00006257184,0.0004845707,0.000061026436,0.00008129633,0.0071226335],"study_design_scores_gemma":[0.00009498294,0.0014713836,0.99304914,0.000036634243,0.0001068304,0.0034984436,0.00034493709,0.00033631836,0.00028291412,0.00017534215,0.00059632165,0.000006746591],"about_ca_topic_score_codex":0.00075194635,"about_ca_topic_score_gemma":0.0016555736,"teacher_disagreement_score":0.0011497934,"about_ca_system_score_codex":0.00018503175,"about_ca_system_score_gemma":0.00021659466,"threshold_uncertainty_score":0.0038464665},"labels":[],"label_agreement":null},{"id":"W2945961964","doi":"10.3324/haematol.2019.216986","title":"High activation of STAT5A drives peripheral T-cell lymphoma and leukemia","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"STAT5; Cancer research; Lymphoma; CD8; T cell; Haematopoiesis; Biology; Anaplastic large-cell lymphoma; Cytokine; Immunology; Medicine; Stem cell; Signal transduction; Immune system; Cell biology","score_opus":0.0072399445658656286,"score_gpt":0.19987590946208345,"score_spread":0.19263596489621782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945961964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668545,0.0005336401,0.0013815472,0.000046907353,0.000009662301,0.000015192701,0.00020573149,0.00008650437,0.0010354896],"genre_scores_gemma":[0.99860674,0.00012750817,0.00049427495,0.00002104474,0.0000036233262,0.000010623964,0.00017599821,0.000008597577,0.00055166206],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997769,0.00004645865,0.000022415687,0.00004738929,0.000050846476,0.000055994635],"domain_scores_gemma":[0.99989986,0.000021699232,0.000024065681,0.000012488552,0.00000596271,0.00003595494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000148206,0.00018700425,0.00016862607,0.00035609456,0.00015615186,0.00033148113,0.00011872523,0.00023423875,0.0018033587],"category_scores_gemma":[0.00010138804,0.0001162788,0.0001611329,0.00020616107,0.00031768563,0.00014017396,0.0002098877,0.00057456654,0.0003512159],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007947639,0.000029318591,0.00045367255,0.000013308223,0.0000028459797,0.0000466149,0.000011931894,0.000034081495,0.9983845,0.00014660414,0.000023586881,0.0007740673],"study_design_scores_gemma":[0.000030415486,0.0007161983,0.011773733,0.000007902395,0.000018647093,0.0011543992,0.00006422768,0.0018820096,0.9823486,0.0001330459,0.0018665633,0.0000041916746],"about_ca_topic_score_codex":0.00045427735,"about_ca_topic_score_gemma":0.0006575778,"teacher_disagreement_score":0.0018033587,"about_ca_system_score_codex":0.00037085492,"about_ca_system_score_gemma":0.00014839634,"threshold_uncertainty_score":0.006032884},"labels":[],"label_agreement":null},{"id":"W2946604950","doi":"10.3324/haematol.2018.212266","title":"Sialyltransferase inhibition leads to inhibition of tumor cell interactions with E-selectin, VCAM1, and MADCAM1, and improves survival in a human multiple myeloma mouse model","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases; University of Galway; Health Research Board; Massachusetts General Hospital; National Institute of General Medical Sciences; Maine Medical Center Research Institute; American Cancer Society","keywords":"Bortezomib; Sialyltransferase; Multiple myeloma; In vivo; Proteasome inhibitor; Cancer research; Stromal cell; Plasma cell; Tumor microenvironment; Bone marrow; Chemistry; Immunology; Medicine; Immune system; Pharmacology; Biology; Sialic acid; Biochemistry","score_opus":0.012338106528150105,"score_gpt":0.25625402471220426,"score_spread":0.24391591818405417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946604950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964753,0.0013523038,0.0008824888,0.00009245563,0.000024112443,0.000017723198,0.00030219258,0.00008690912,0.00076656527],"genre_scores_gemma":[0.99451375,0.0011497276,0.0009883617,0.00006400129,0.0000093167555,0.000028012459,0.0005465711,0.000014938325,0.0026852866],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998932,0.000012638499,0.000011011318,0.000021632948,0.000029340363,0.000032197513],"domain_scores_gemma":[0.9999455,0.0000048735737,0.00001758882,0.000006882161,0.0000040666678,0.000020990257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009755731,0.0005177591,0.00036490004,0.00024615656,0.00011330156,0.00020869439,0.00022287447,0.00027312365,0.0008677966],"category_scores_gemma":[0.000051145056,0.00013036243,0.0002889319,0.00016976554,0.00014410945,0.00014675711,0.00011563661,0.000710729,0.00018641425],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003025579,0.00007873035,0.0001435155,0.000022186614,0.000012480876,0.00003272665,0.000009039863,0.00010628208,0.9975485,0.00005401128,0.000064500724,0.0016255227],"study_design_scores_gemma":[0.000047524303,0.0017059213,0.0037183485,0.0000047348253,0.000041241226,0.00020633597,0.000013851796,0.0009799781,0.99128646,0.00004077335,0.0019499044,0.000004881572],"about_ca_topic_score_codex":0.0011267425,"about_ca_topic_score_gemma":0.0016072968,"teacher_disagreement_score":0.0011267425,"about_ca_system_score_codex":0.00024035922,"about_ca_system_score_gemma":0.000183152,"threshold_uncertainty_score":0.0029030442},"labels":[],"label_agreement":null},{"id":"W2950359233","doi":"10.3324/haematol.2019.217448","title":"Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studies","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Daratumumab; Dexamethasone; Medicine; Lenalidomide; Internal medicine; Hazard ratio; Neutropenia; Bortezomib; Multiple myeloma; Progression-free survival; Confidence interval; Oncology; Gastroenterology; Surgery; Chemotherapy","score_opus":0.02860394486689076,"score_gpt":0.3202406490927045,"score_spread":0.2916367042258137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950359233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97501296,0.021802517,0.00031909705,0.00019075045,0.00007304159,0.00031489017,0.0010286482,0.000021494901,0.001236745],"genre_scores_gemma":[0.99665076,0.0018348463,0.00015250914,0.00014810196,0.00006701592,0.00010243979,0.00081550545,0.000007834817,0.00022097156],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99823254,0.00085485965,0.0002675651,0.0001778968,0.00026118182,0.00020607185],"domain_scores_gemma":[0.9985233,0.0005692417,0.0004553482,0.0001820581,0.000101152255,0.00016896655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033074345,0.0006117929,0.0025926298,0.0007537331,0.00026750757,0.00088116445,0.00031402122,0.00046188117,0.0011334328],"category_scores_gemma":[0.002659014,0.00027073795,0.0041902447,0.0010470289,0.00019895726,0.00045607367,0.00037767048,0.0006881944,0.00015101544],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42837858,0.0012217045,0.31631827,0.0022541475,0.06819534,0.00093864475,0.00032273613,0.0017593164,0.015673926,0.00025754358,0.003380938,0.16129884],"study_design_scores_gemma":[0.048981417,0.031467944,0.86505145,0.00028124373,0.03664521,0.0017322273,0.00033396066,0.0016054898,0.0030200097,0.0006585895,0.010128454,0.00009408777],"about_ca_topic_score_codex":0.00052581285,"about_ca_topic_score_gemma":0.0019267172,"teacher_disagreement_score":0.0033074345,"about_ca_system_score_codex":0.00038767452,"about_ca_system_score_gemma":0.00039387567,"threshold_uncertainty_score":0.017491579},"labels":[],"label_agreement":null},{"id":"W2952692503","doi":"10.3324/haematol.2019.220475","title":"Variable global distribution of cell-of-origin from the ROBUST phase III study in diffuse large B-cell lymphoma","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Celgene","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Distribution (mathematics); Variable (mathematics); Medicine; Pathology; Mathematics; Mathematical analysis","score_opus":0.027482284971366486,"score_gpt":0.2800336963888145,"score_spread":0.25255141141744797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952692503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4707823,0.025657086,0.0066142515,0.4357716,0.0069119283,0.0002573578,0.0037870284,0.0003410348,0.04987741],"genre_scores_gemma":[0.87174165,0.0025761824,0.001922114,0.11198174,0.0067329407,0.000114902425,0.0010952874,0.00023082278,0.0036043697],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983108,0.00095777604,0.00014194864,0.00013983644,0.00025190567,0.00019768492],"domain_scores_gemma":[0.9916943,0.0052439054,0.00060669717,0.00064011395,0.0010905364,0.0007244106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004861386,0.00017520814,0.00091825833,0.00025428872,0.00048320726,0.0014753353,0.0005196698,0.0016731229,0.0011425078],"category_scores_gemma":[0.0094044525,0.00014566534,0.00025365746,0.0005539018,0.0005238913,0.0006983528,0.00043296587,0.0022212912,0.0005083692],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020249613,0.00039190231,0.21413805,0.0005085323,0.0005685063,0.011533401,0.00063889264,0.0020379915,0.018161973,0.0049538002,0.31105313,0.41576418],"study_design_scores_gemma":[0.0039901454,0.0066553154,0.49100003,0.0005341307,0.0012647087,0.03176327,0.0010664058,0.007661945,0.015599348,0.016837575,0.42349273,0.00013438414],"about_ca_topic_score_codex":0.0010070897,"about_ca_topic_score_gemma":0.0027051328,"teacher_disagreement_score":0.004861386,"about_ca_system_score_codex":0.0016228404,"about_ca_system_score_gemma":0.0006070357,"threshold_uncertainty_score":0.025709748},"labels":[],"label_agreement":null},{"id":"W2954881683","doi":"10.3324/haematol.2019.222828","title":"Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism: a systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Ottawa Hospital; University of Ottawa","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Confidence interval; Meta-analysis; Internal medicine; Venous thromboembolism; Anticoagulant therapy; Thrombosis","score_opus":0.06730849768831643,"score_gpt":0.33285654658064,"score_spread":0.2655480488923236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954881683","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006657439,0.9918573,0.0004515147,0.00015900185,0.000108247375,0.00020327746,0.00034616605,0.000017719973,0.00019933221],"genre_scores_gemma":[0.30609924,0.6873754,0.0030647565,0.0009823298,0.00037421146,0.00086874195,0.0009294912,0.00003806564,0.00026772486],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9825434,0.008114189,0.0053866613,0.0016195267,0.0019803336,0.00035595556],"domain_scores_gemma":[0.9616628,0.02888209,0.005277005,0.0011059014,0.0027341451,0.0003381123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023651255,0.0027550166,0.021884946,0.0074617383,0.00074423,0.0040226616,0.0023719424,0.002620572,0.001699858],"category_scores_gemma":[0.051231846,0.001540512,0.05737487,0.0072595915,0.0010298191,0.0024951333,0.0015911357,0.0021996002,0.00021037838],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002425722,0.000023277169,0.009954341,0.22155459,0.75382674,0.00008868933,0.00008870371,0.000690619,0.00012004668,0.00009126645,0.00036445705,0.010771619],"study_design_scores_gemma":[0.00038473506,0.00012830667,0.0036699793,0.011287995,0.983528,0.000055982997,0.0000281101,0.00026705704,0.00006224104,0.00012565101,0.00043708325,0.000024888617],"about_ca_topic_score_codex":0.0120347375,"about_ca_topic_score_gemma":0.027208148,"teacher_disagreement_score":0.023651255,"about_ca_system_score_codex":0.0033893888,"about_ca_system_score_gemma":0.003719273,"threshold_uncertainty_score":0.1250813},"labels":[],"label_agreement":null},{"id":"W2954898755","doi":"10.3324/haematol.2019.219725","title":"Conditions associated with polyclonal hypergammaglobulinemia in the IgG4-related disease era: a retrospective study from a hematology tertiary care center","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"IgG4-Related and Inflammatory Diseases","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Tertiary care; Hematology; Medicine; Internal medicine; Retrospective cohort study; Center (category theory); Hypergammaglobulinemia; Polyclonal antibodies; Oncology; Disease; Immunology; Chemistry; Antibody","score_opus":0.006137392419775965,"score_gpt":0.23758539949813892,"score_spread":0.23144800707836297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954898755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990695,0.00018850865,0.000040831863,0.00003185911,0.0000044403223,0.000009116512,0.00009759268,0.0000021752282,0.0005560383],"genre_scores_gemma":[0.99939,0.00016232576,0.00005317087,0.00008373356,0.000023036768,0.000006325223,0.00017125031,0.0000021815986,0.000107991604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993767,0.00010752669,0.00008944762,0.00012654754,0.00009626192,0.00020347848],"domain_scores_gemma":[0.99883264,0.00020788709,0.00043416815,0.00009023011,0.00012496901,0.000310144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035854548,0.000341167,0.00043177474,0.0013116953,0.0013905957,0.0009523773,0.0004619274,0.00062496716,0.0037258621],"category_scores_gemma":[0.0012268078,0.0005582415,0.0004070532,0.0017552754,0.0005669946,0.00066929596,0.00089227036,0.0006314772,0.00046757734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004082051,0.000058934824,0.99750465,0.0000069238486,0.000015754345,0.0015732313,0.00011522097,0.000012918931,0.00019039004,0.000018856992,0.00006307047,0.0003992886],"study_design_scores_gemma":[0.0000123567615,0.00020974236,0.9867577,0.000017224485,0.00004548368,0.00993589,0.0023816794,0.00011970151,0.00014359236,0.000029113471,0.0003381416,0.000009320917],"about_ca_topic_score_codex":0.005654482,"about_ca_topic_score_gemma":0.0066770096,"teacher_disagreement_score":0.005654482,"about_ca_system_score_codex":0.0006484984,"about_ca_system_score_gemma":0.0010916741,"threshold_uncertainty_score":0.012464225},"labels":[],"label_agreement":null},{"id":"W2956022946","doi":"10.3324/haematol.2018.207811","title":"CD117<sup>hi</sup> expression identifies a human fetal hematopoietic stem cell population with high proliferation and self-renewal potential","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université de Paris; Institute of Cancer Research; Institut National Du Cancer; Association Française de la Maladie de Fanconi; Université Pierre et Marie Curie; Ligue Contre le Cancer; Université Paris Descartes; Commissariat à l'Énergie Atomique et aux Énergies Alternatives; Centre National de la Recherche Scientifique; Institut National de la Santé et de la Recherche Médicale","keywords":"Stem cell; Haematopoiesis; Biology; Cell biology; CD117; Population; Cell growth; Hematopoietic stem cell; Cancer research; Immunology; Genetics; CD34; Medicine","score_opus":0.025311903528613303,"score_gpt":0.29389452068653593,"score_spread":0.26858261715792264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956022946","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065153125,0.0010853781,0.00024003,0.96102023,0.015832193,0.000020764497,0.00015195318,0.000047032067,0.015087072],"genre_scores_gemma":[0.06821408,0.0022744855,0.0006650718,0.8261028,0.054724563,0.00009169045,0.00024275458,0.00006509383,0.047619447],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992132,0.00024170455,0.000102422644,0.000069295755,0.00018989926,0.00018342322],"domain_scores_gemma":[0.9970914,0.0019032325,0.00015990692,0.000089111854,0.0004350433,0.00032129488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009396009,0.00032634617,0.00053049135,0.0003869088,0.0014456132,0.0017403922,0.00044543808,0.015231596,0.0049277013],"category_scores_gemma":[0.0059241042,0.00023777488,0.0004141568,0.00029363055,0.0008528152,0.00069752074,0.0005557993,0.007928927,0.0039678426],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023107594,0.00006746417,0.003948432,0.000085776766,0.000014217038,0.020179296,0.00018029573,0.00011816688,0.0031170347,0.0028337138,0.9424142,0.026810179],"study_design_scores_gemma":[0.0001613836,0.00022216969,0.009370179,0.00025113975,0.000054995522,0.02193575,0.00089957623,0.0012634732,0.003394912,0.010027769,0.952366,0.000052659478],"about_ca_topic_score_codex":0.0024743043,"about_ca_topic_score_gemma":0.0043203393,"teacher_disagreement_score":0.015231596,"about_ca_system_score_codex":0.0022806192,"about_ca_system_score_gemma":0.00094766106,"threshold_uncertainty_score":0.016547143},"labels":[],"label_agreement":null},{"id":"W2958122699","doi":"10.3324/haematol.2018.213348","title":"Atherogenic lipid stress induces platelet hyperactivity through CD36-mediated hyposensitivity to prostacyclin: the role of phosphodiesterase 3A","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Biotechnology and Biological Sciences Research Council; RWTH Aachen University; British Heart Foundation","keywords":"Prostacyclin; Platelet activation; Endocrinology; Internal medicine; CD36; Platelet; Cyclic adenosine monophosphate; Phosphodiesterase; Signal transduction; Chemistry; Medicine; Biochemistry; Receptor; Enzyme","score_opus":0.012808694681206238,"score_gpt":0.24818343581369018,"score_spread":0.23537474113248394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2958122699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944317,0.002711306,0.0018028531,0.00020864196,0.000021957736,0.000021679269,0.00014153468,0.000028922277,0.0006315433],"genre_scores_gemma":[0.9963407,0.0015073237,0.00082630885,0.000086706495,0.00002313866,0.000029286211,0.00015854035,0.0000052916225,0.0010226611],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989283,0.000020666643,0.000011128592,0.000021706719,0.00002291895,0.000030762974],"domain_scores_gemma":[0.9999404,0.000005234477,0.000019919125,0.000008180884,0.000005759875,0.00002056313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014463892,0.00032191802,0.00022202606,0.00023253224,0.00013940885,0.00028419154,0.00012896063,0.0002681628,0.00075814535],"category_scores_gemma":[0.00008341884,0.0001746464,0.0002509352,0.00015210306,0.00026227382,0.00016023277,0.00023932722,0.0005895593,0.00017632988],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029332796,0.000024050974,0.0003578822,0.000030120482,0.000004286844,0.000110509936,0.000016078206,0.000011571709,0.9980716,0.00010072193,0.000023417711,0.00095643726],"study_design_scores_gemma":[0.00010416777,0.001179585,0.04243643,0.0000206095,0.00006158049,0.0018315808,0.00006921634,0.0010444575,0.9501714,0.00036265384,0.0027085147,0.000009716705],"about_ca_topic_score_codex":0.0003508797,"about_ca_topic_score_gemma":0.0003517262,"teacher_disagreement_score":0.00075814535,"about_ca_system_score_codex":0.00026996416,"about_ca_system_score_gemma":0.00015307704,"threshold_uncertainty_score":0.0025362372},"labels":[],"label_agreement":null},{"id":"W2966280182","doi":"10.3324/haematol.2019.222695","title":"Predicting risk for recurrence of arterial ischemic stroke in children: thrombophilia as another piece of the puzzle","year":2019,"lang":"en","type":"editorial","venue":"Haematologica","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Thrombophilia; Arterial Ischemic Stroke; Medicine; Ischemic stroke; Stroke (engine); Internal medicine; Cardiology; Ischemia; Thrombosis","score_opus":0.015423507242443695,"score_gpt":0.2742938251090765,"score_spread":0.25887031786663284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966280182","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009933621,0.017826987,0.00015172697,0.053647622,0.92753726,0.000017501254,0.000114891074,0.00004727034,0.00055745395],"genre_scores_gemma":[0.000610435,0.0083979685,0.000102381884,0.019125974,0.97014445,0.000018953164,0.00004230404,0.000016116574,0.0015414869],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960569,0.0011165017,0.00084377057,0.00054221717,0.0012155221,0.00022507252],"domain_scores_gemma":[0.9592893,0.02657723,0.001655477,0.0006769254,0.008947338,0.002853773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008960289,0.0040519666,0.0068598525,0.0031495881,0.0016724603,0.006360794,0.0046575833,0.017231025,0.0049239965],"category_scores_gemma":[0.03369885,0.001633802,0.0033410648,0.0016054254,0.0017664294,0.003377182,0.0010994194,0.026913749,0.004123199],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020086818,0.000028794899,0.00024491985,0.0006761896,0.00021334784,0.00020834325,0.00002288575,0.00005591057,0.000054163,0.00031748923,0.98898566,0.008991472],"study_design_scores_gemma":[0.0014537423,0.0003167986,0.004581869,0.005214048,0.002224354,0.0015339445,0.00025928058,0.0019354109,0.00030255062,0.003763356,0.97824746,0.00016724039],"about_ca_topic_score_codex":0.004044119,"about_ca_topic_score_gemma":0.007886845,"teacher_disagreement_score":0.017231025,"about_ca_system_score_codex":0.0028546522,"about_ca_system_score_gemma":0.0025326852,"threshold_uncertainty_score":0.047387123},"labels":[],"label_agreement":null},{"id":"W2967499714","doi":"10.3324/haematol.2018.211201","title":"Meningioma 1 is indispensable for mixed lineage leukemia-rearranged acute myeloid leukemia","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Deutsche Krebshilfe; Medizinischen Hochschule Hannover; Deutsche Forschungsgemeinschaft; European Commission","keywords":"Cancer research; Myeloid leukemia; Leukemia; Biology; Myeloid; MCL1; Haematopoiesis; Acute leukemia; Progenitor cell; Immunology; Stem cell; Cell biology; Gene; Genetics","score_opus":0.029336498116598806,"score_gpt":0.305588594474818,"score_spread":0.2762520963582192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967499714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99061286,0.0032404053,0.002610152,0.0001881271,0.000052348583,0.000020278818,0.0009954819,0.00029040355,0.0019899015],"genre_scores_gemma":[0.995369,0.0006323019,0.0011042022,0.000042276148,0.000005934644,0.000009698057,0.00074167846,0.00002671936,0.0020681866],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998946,0.000013164519,0.000009316197,0.00002319769,0.00004058985,0.000019031484],"domain_scores_gemma":[0.999864,0.000020485344,0.000050023973,0.000014476373,0.000009742902,0.00004125351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008531436,0.0003115331,0.00020912004,0.00022338996,0.00023360044,0.0003213376,0.0001688304,0.00021674298,0.0022098161],"category_scores_gemma":[0.00016318547,0.00010055816,0.00021391876,0.00011757506,0.00020193894,0.00013075334,0.00022705918,0.0004133061,0.00062441285],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009999157,0.000013300676,0.0008994896,0.000040810843,0.0000051696534,0.00021506715,0.00001228701,0.00008167116,0.996698,0.00018180086,0.00009702854,0.0016552756],"study_design_scores_gemma":[0.000022130545,0.00014723148,0.027376384,0.000018453802,0.000034125576,0.0017270531,0.00006537826,0.0015474665,0.9538809,0.00018778018,0.01498317,0.000009832477],"about_ca_topic_score_codex":0.001309562,"about_ca_topic_score_gemma":0.0023138411,"teacher_disagreement_score":0.0022098161,"about_ca_system_score_codex":0.0005448568,"about_ca_system_score_gemma":0.0003733896,"threshold_uncertainty_score":0.0073925853},"labels":[],"label_agreement":null},{"id":"W2967535150","doi":"10.3324/haematol.2019.221093","title":"Hemophilia A and B: molecular and clinical similarities and differences","year":2019,"lang":"en","type":"review","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Factor IX; Coagulation; Medicine; Coagulopathy; Gene; Hematology; Genetics; Internal medicine; Biology","score_opus":0.19487917312064362,"score_gpt":0.4379213097387315,"score_spread":0.24304213661808788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967535150","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002613625,0.9981756,0.000100372534,0.00028790045,0.00008534461,0.0000058562664,0.000033850716,0.000004533142,0.0010451041],"genre_scores_gemma":[0.0019481998,0.9971608,0.00017136999,0.00022407845,0.0001261039,0.000006698244,0.00006450567,0.0000012288594,0.00029715427],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997081,0.00004788424,0.000061994586,0.00005188341,0.00009889179,0.00003124409],"domain_scores_gemma":[0.9996805,0.00014531745,0.00007175146,0.000008291337,0.00007186624,0.000022263252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038534732,0.00047951614,0.0012104847,0.0020767,0.00019023693,0.0011367281,0.0005326216,0.00069569645,0.002307314],"category_scores_gemma":[0.0010159861,0.00015196622,0.00062030583,0.002365776,0.0005077537,0.0008647689,0.0004255435,0.001118908,0.0007832992],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008430616,0.00003305285,0.0010190345,0.012616062,0.00022131385,0.000531727,0.00010917052,0.0001592227,0.0011484267,0.004199647,0.021125954,0.9587522],"study_design_scores_gemma":[0.00003711956,0.00007065746,0.005130293,0.0073216446,0.00040518152,0.010603923,0.00016282234,0.000060948252,0.0003254303,0.0037630901,0.9720844,0.000034576475],"about_ca_topic_score_codex":0.0017731333,"about_ca_topic_score_gemma":0.0019567683,"teacher_disagreement_score":0.002307314,"about_ca_system_score_codex":0.00041544548,"about_ca_system_score_gemma":0.0010650291,"threshold_uncertainty_score":0.0077188015},"labels":[],"label_agreement":null},{"id":"W2969992885","doi":"10.3324/haematol.2019.224204","title":"Chimeric antigen receptor T-cell therapy for multiple myeloma: a consensus statement from The European Myeloma Network","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Chimeric antigen receptor; Multiple myeloma; Medicine; Cell therapy; Clinical trial; Antigen; Daratumumab; Monoclonal antibody; Immunology; Targeted therapy; Bortezomib; Cancer research; Immunotherapy; Oncology; Cancer; Internal medicine; Antibody; Cell; Biology","score_opus":0.04202163171986532,"score_gpt":0.2957468530958976,"score_spread":0.25372522137603226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969992885","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020381792,0.4795946,0.008488391,0.4610085,0.031712838,0.0005402317,0.0009527625,0.00019959372,0.015464956],"genre_scores_gemma":[0.023059113,0.60440326,0.03544489,0.27574128,0.023841295,0.0014471291,0.0038008296,0.00021550791,0.03204675],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948331,0.0012234816,0.0010135109,0.00035329338,0.0021261035,0.00045042823],"domain_scores_gemma":[0.99254274,0.001725065,0.0010717701,0.00019153609,0.0033394457,0.0011294538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015779918,0.00080894027,0.0016393001,0.0013381534,0.0009113946,0.0024596995,0.003338909,0.0085886475,0.0015056961],"category_scores_gemma":[0.0062754694,0.0004007247,0.0015100188,0.0017729788,0.0016521605,0.0018591796,0.0019763515,0.009386226,0.0022544402],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031257657,0.0002765604,0.0009674721,0.0041643726,0.00012734518,0.00059883686,0.0001743486,0.0009567302,0.005102194,0.011345328,0.60026735,0.3757069],"study_design_scores_gemma":[0.00010105225,0.00012976406,0.0013129504,0.0024910918,0.000095086914,0.0005685005,0.00008404694,0.00022602479,0.0012865099,0.0028642283,0.99081296,0.000027660575],"about_ca_topic_score_codex":0.0042231954,"about_ca_topic_score_gemma":0.0055818385,"teacher_disagreement_score":0.015779918,"about_ca_system_score_codex":0.0025645567,"about_ca_system_score_gemma":0.012707413,"threshold_uncertainty_score":0.08345318},"labels":[],"label_agreement":null},{"id":"W2970999010","doi":"10.3324/haematol.2019.223073","title":"Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation","year":2019,"lang":"en","type":"review","venue":"Haematologica","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Astellas Pharma; Gilead Sciences; Pfizer","keywords":"Medicine; Hematopoietic stem cell transplantation; Human herpesvirus 6; Disease; Transplantation; Encephalitis; Hematologic disease; Stem cell; Immunology; Population; Hematopoietic stem cell; Intensive care medicine; Human immunodeficiency virus (HIV); Haematopoiesis; Internal medicine; Viral disease; Herpesviridae; Biology; Virus","score_opus":0.12334746218705059,"score_gpt":0.35608406905288476,"score_spread":0.23273660686583417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970999010","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040986986,0.9398493,0.0013044855,0.027337011,0.010244118,0.00053680816,0.0014587352,0.00011146454,0.01874823],"genre_scores_gemma":[0.0023625935,0.95239776,0.006017154,0.01998861,0.002765784,0.00070721057,0.003883057,0.000038481292,0.011839387],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99816376,0.0005287269,0.0005200757,0.00009958113,0.0005711261,0.00011669447],"domain_scores_gemma":[0.9967828,0.0007449714,0.00050042546,0.000057146484,0.0017297252,0.00018497072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002559858,0.00089536,0.0015305023,0.0034035293,0.0005384409,0.0014447592,0.0016827896,0.0028555496,0.009770963],"category_scores_gemma":[0.0062680873,0.0002862214,0.0016747366,0.0024408125,0.0004771563,0.0014958262,0.0012071903,0.0027236184,0.0051997346],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007122926,0.0000738964,0.00032854133,0.015803302,0.00009554791,0.0003527739,0.00013721368,0.0001898201,0.0006248837,0.0034615244,0.5409853,0.437876],"study_design_scores_gemma":[0.00002685441,0.000022943565,0.0005084353,0.014747119,0.000091037226,0.0005907109,0.000050804898,0.000026683569,0.0001013674,0.00089979573,0.9829206,0.000013620747],"about_ca_topic_score_codex":0.0038624315,"about_ca_topic_score_gemma":0.0075273165,"teacher_disagreement_score":0.009770963,"about_ca_system_score_codex":0.0013517167,"about_ca_system_score_gemma":0.0056038126,"threshold_uncertainty_score":0.032687128},"labels":[],"label_agreement":null},{"id":"W2974306493","doi":"10.3324/haematol.2019.219790","title":"Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Donor lymphocyte infusion; Minimal residual disease; Transplantation; Hematopoietic stem cell transplantation; Human leukocyte antigen; Lymphocyte; Immunology; Leukemia; Disease; Acute leukemia; Oncology; Intensive care medicine; Internal medicine; Antigen","score_opus":0.04367591063350241,"score_gpt":0.3336190730132487,"score_spread":0.2899431623797463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974306493","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028602781,0.5351316,0.018312737,0.4018202,0.021139337,0.0011928965,0.0015751694,0.00031838162,0.017649414],"genre_scores_gemma":[0.033542674,0.66536033,0.12145078,0.1432969,0.015113346,0.003924533,0.005009248,0.00040307423,0.011899171],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98180425,0.0067553194,0.0054863403,0.0009099504,0.004313053,0.0007310374],"domain_scores_gemma":[0.96541584,0.012390841,0.0039634863,0.00077673304,0.015442858,0.002010289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031093374,0.0009616328,0.0026844086,0.0032018684,0.0012480321,0.003430243,0.0052869585,0.0061864103,0.0031083447],"category_scores_gemma":[0.036722574,0.0005923965,0.003495603,0.0022952787,0.0018674762,0.0022842775,0.0027330313,0.008902444,0.0033226982],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047067238,0.00021349001,0.0017402195,0.021107376,0.00046763552,0.00055705564,0.00071092864,0.0012196024,0.0020882795,0.0071486165,0.30964413,0.654632],"study_design_scores_gemma":[0.00026098656,0.0002517797,0.0026238074,0.039819628,0.0010325048,0.0008977281,0.00079755974,0.0005264261,0.0013334753,0.009707551,0.9426482,0.00010053344],"about_ca_topic_score_codex":0.004035495,"about_ca_topic_score_gemma":0.0054573333,"teacher_disagreement_score":0.031093374,"about_ca_system_score_codex":0.0025810688,"about_ca_system_score_gemma":0.01469402,"threshold_uncertainty_score":0.16443944},"labels":[],"label_agreement":null},{"id":"W2974456904","doi":"10.3324/haematol.2019.227561","title":"Extensive multilineage analysis in patients with mixed chimerism after allogeneic transplantation for sickle cell disease: insight into hematopoiesis and engraftment thresholds for gene therapy","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Agence Nationale de la Recherche","keywords":"Immunology; Haematopoiesis; Hematopoietic stem cell transplantation; Transplantation Chimera; Transplantation; Progenitor cell; Stem cell; Biology; Disease; Medicine; Hematopoietic cell; Internal medicine; Genetics","score_opus":0.00567557052555529,"score_gpt":0.22191001822212508,"score_spread":0.2162344476965698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974456904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99963343,0.00008814634,0.00017322558,0.0000032196224,4.6043613e-7,0.0000029890045,0.000011884174,0.0000025365587,0.000084175954],"genre_scores_gemma":[0.9998281,0.000022278558,0.000090480215,0.000004011213,8.439306e-7,0.0000021514381,0.00001901081,0.0000011267986,0.000031995572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987924,0.00002678096,0.000012966417,0.000026921134,0.000027866336,0.00002615023],"domain_scores_gemma":[0.9997378,0.000081969636,0.00007300842,0.000023303935,0.000019678475,0.00006420937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002457914,0.00015500188,0.00023403628,0.0005939875,0.00027449182,0.0003113354,0.0001021589,0.00016910542,0.00061699864],"category_scores_gemma":[0.00068964146,0.000095831354,0.00012634332,0.00020846646,0.00020819649,0.000122048245,0.00026350626,0.00021265302,0.00009111013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016246529,0.00011978039,0.9021174,0.000031922784,0.000055533907,0.0049039475,0.00084550184,0.00065651047,0.070860654,0.00016009537,0.000063979445,0.018560074],"study_design_scores_gemma":[0.00005189768,0.0017706461,0.94636333,0.000012584993,0.00012415981,0.0247987,0.0004454708,0.0018181803,0.023690565,0.0001962577,0.0007107248,0.000017458342],"about_ca_topic_score_codex":0.00032661602,"about_ca_topic_score_gemma":0.00036363894,"teacher_disagreement_score":0.00061699864,"about_ca_system_score_codex":0.0001861269,"about_ca_system_score_gemma":0.00009336781,"threshold_uncertainty_score":0.0020640492},"labels":[],"label_agreement":null},{"id":"W2974951843","doi":"10.3324/haematol.2019.227876","title":"Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Fondazione Umberto Veronesi; Université de Strasbourg; Università degli Studi di Padova; Università degli Studi di Milano; Università degli Studi di Pavia; European Hematology Association","keywords":"Medicine; Antithrombotic; Low molecular weight heparin; Incidence (geometry); Thrombosis; Orthopedic surgery; Venous thromboembolism; Surgery; Anticoagulant; Venous thrombosis; Heparin; Intensive care medicine; Internal medicine","score_opus":0.009453632389824723,"score_gpt":0.2252449972851209,"score_spread":0.21579136489529618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974951843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467754,0.0042319144,0.000114403054,0.00008447974,0.00001768235,0.000033481043,0.00044102818,0.0000029310145,0.0003966614],"genre_scores_gemma":[0.9979474,0.00078903633,0.00017734498,0.000066363595,0.000046756788,0.000038325135,0.000808896,0.000001312694,0.00012459896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945563,0.00025606516,0.000084234845,0.00006237932,0.000096083415,0.000045669512],"domain_scores_gemma":[0.9987974,0.00024437733,0.0006150217,0.00006052814,0.000075254175,0.00020740589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008444972,0.0003619679,0.00047255593,0.0006492256,0.00017031663,0.0003754982,0.00020647445,0.0003976196,0.00058838556],"category_scores_gemma":[0.0016697635,0.00015874955,0.0007299383,0.00066049275,0.00012973421,0.00020977887,0.00031958666,0.00045768247,0.00009402702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024521172,0.00011117881,0.99233377,0.000055404453,0.000457271,0.000074257165,0.00002471452,0.00006489791,0.00040121365,0.000031418065,0.00019304555,0.0038006455],"study_design_scores_gemma":[0.000418249,0.0014271446,0.9964792,0.000022735498,0.00037016484,0.00041837184,0.00003293368,0.00022440673,0.000102828715,0.000033272987,0.00046705946,0.0000035824644],"about_ca_topic_score_codex":0.00096964475,"about_ca_topic_score_gemma":0.0012636568,"teacher_disagreement_score":0.00096964475,"about_ca_system_score_codex":0.00015687732,"about_ca_system_score_gemma":0.00029162128,"threshold_uncertainty_score":0.004466176},"labels":[],"label_agreement":null},{"id":"W2975917046","doi":"10.3324/haematol.2019.220756","title":"Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre; CancerCare Manitoba; BC Children's Hospital; University of British Columbia","funders":"Janssen Pharmaceuticals; National Institute of Allergy and Infectious Diseases; Office of Naval Research; National Heart, Lung, and Blood Institute; Adaptive Biotechnologies; Astellas Pharma; Daiichi-Sankyo; Janssen Scientific Affairs; Incyte; bluebird bio; Chimerix; Medical College of Wisconsin; Bristol-Myers Squibb; CSL Behring; Janssen Biotech; HistoGenetics; Celgene; Karyopharm Therapeutics; Atara Biotherapeutics; Actinium Pharmaceuticals; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; GlaxoSmithKline; Health Resources and Services Administration; U.S. Department of Health and Human Services; Astellas Pharma US; Amgen; Jazz Pharmaceuticals; Be The Match Foundation","keywords":"Hazard ratio; Transplantation; Internal medicine; Monosomy; Medicine; Cytogenetics; Leukemia; Hematopoietic stem cell transplantation; Oncology; Acute lymphocytic leukemia; Acute leukemia; Karyotype; Confidence interval; Biology; Lymphoblastic Leukemia; Genetics","score_opus":0.026895934963424233,"score_gpt":0.31202471121886705,"score_spread":0.2851287762554428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975917046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99950945,0.00024593098,0.000040541614,0.000028047158,0.0000030335302,0.0000035897824,0.000071153896,0.0000011252636,0.00009723034],"genre_scores_gemma":[0.99965906,0.00008907241,0.000015768492,0.000015227743,0.000011154154,0.0000041918283,0.0001757943,0.0000012832164,0.000028451173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901843,0.00043268444,0.0000886803,0.00012744853,0.00021576056,0.00011690917],"domain_scores_gemma":[0.99721575,0.0006649394,0.0012152245,0.00020738812,0.00024125128,0.00045546656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016548188,0.00029823242,0.000331921,0.00043674512,0.00021308636,0.0005625793,0.00032361198,0.000439454,0.0004978739],"category_scores_gemma":[0.0037355707,0.00016395673,0.00044751586,0.0009541969,0.00029886974,0.0004193352,0.000442024,0.0006171671,0.00013594504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036645858,0.000032845594,0.9980445,0.000004540594,0.00006369265,0.000039660856,0.00003993561,0.00004632475,0.000100068995,0.000008079538,0.0000410745,0.0012126851],"study_design_scores_gemma":[0.000019727178,0.00021106497,0.99933463,0.0000031063798,0.000047150595,0.00010289644,0.00004197634,0.000118639946,0.0000414761,0.000010802181,0.000066324465,0.000002183178],"about_ca_topic_score_codex":0.0021397686,"about_ca_topic_score_gemma":0.0022478215,"teacher_disagreement_score":0.0021397686,"about_ca_system_score_codex":0.0003201682,"about_ca_system_score_gemma":0.00041998588,"threshold_uncertainty_score":0.008751631},"labels":[],"label_agreement":null},{"id":"W2978153272","doi":"10.3324/haematol.2019.232884","title":"Safety of using direct oral anticoagulants in the diagnostic workup of outpatients with suspicion of acute venous thromboembolism","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Department of Medicine, Ottawa Hospital; National Institute for Health and Care Research; Ottawa Hospital Research Institute; University of Ottawa; Heart and Stroke Foundation of Canada","keywords":"Medicine; Venous thromboembolism; Intensive care medicine; Internal medicine; Thrombosis","score_opus":0.03411553747755935,"score_gpt":0.2876161270903636,"score_spread":0.25350058961280425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978153272","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22040723,0.0073811472,0.0009059264,0.705281,0.0056933207,0.0000559702,0.0003357453,0.00011332479,0.059826374],"genre_scores_gemma":[0.7792546,0.0031649852,0.0014559077,0.19559225,0.015349027,0.00004018261,0.00016879606,0.00004513111,0.004929097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667215,0.0015819974,0.00051784655,0.0002128666,0.00077972753,0.00023534473],"domain_scores_gemma":[0.9705071,0.020115066,0.002948511,0.0007077189,0.0039129187,0.001808695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020629065,0.00022160565,0.0005530445,0.0007282409,0.0012726821,0.0017179503,0.00068294955,0.009656685,0.002143298],"category_scores_gemma":[0.038308933,0.00024200592,0.00034430737,0.0007024207,0.0007800544,0.0006633284,0.00031376898,0.003919101,0.0011642732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025875901,0.00071868184,0.5198757,0.000407374,0.00014458544,0.1508266,0.002314698,0.000984459,0.004166786,0.0033764136,0.20387654,0.1107206],"study_design_scores_gemma":[0.0010619746,0.004776548,0.29645085,0.0036449772,0.0005484255,0.38646257,0.007699333,0.016766174,0.006062108,0.014452347,0.2618112,0.00026354202],"about_ca_topic_score_codex":0.0064407135,"about_ca_topic_score_gemma":0.005782003,"teacher_disagreement_score":0.009656685,"about_ca_system_score_codex":0.0023489424,"about_ca_system_score_gemma":0.002002852,"threshold_uncertainty_score":0.017042875},"labels":[],"label_agreement":null},{"id":"W2978446598","doi":"10.3324/haematol.2019.220434","title":"A high-content cytokine screen identifies myostatin propeptide as a positive regulator of primitive chronic myeloid leukemia cells","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Biology; Haematopoiesis; Stromal cell; Myostatin; Stem cell; Myeloid leukemia; CD34; Cancer research; Myeloid; Cytokine; Regulator; Bone marrow; Cell biology; STAT5; Leukemia; Immunology; Signal transduction; Endocrinology; Genetics; Muscle hypertrophy","score_opus":0.016825982131862684,"score_gpt":0.24041571984963858,"score_spread":0.2235897377177759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978446598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99500555,0.0010392477,0.0018281238,0.00006176443,0.000010520677,0.00006603583,0.00086988794,0.00003311705,0.0010857865],"genre_scores_gemma":[0.98948574,0.001106954,0.0054393304,0.00008925508,0.00001981358,0.00008136492,0.0019608834,0.000012076712,0.001804621],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999057,0.000014770902,0.000008246593,0.000013958361,0.000039038143,0.00001825397],"domain_scores_gemma":[0.9999279,0.000024597703,0.000011297836,0.0000049750056,0.0000111476875,0.000019996836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008845875,0.00027859563,0.00018901774,0.00029397453,0.00009640153,0.00013065539,0.000081332815,0.0001225198,0.0014644747],"category_scores_gemma":[0.00009704782,0.000066650704,0.00011427953,0.00019749229,0.00009103041,0.000059669703,0.00013411428,0.00018716727,0.00030744864],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070828166,0.00001195857,0.0005649289,0.000012019889,0.000001563144,0.000074777854,0.000003842901,0.00003100362,0.99808997,0.000009413094,0.000020130487,0.0011095959],"study_design_scores_gemma":[0.000030162908,0.0009521674,0.02832468,0.000007741232,0.000028173488,0.0011015476,0.000031011947,0.00078009476,0.9661379,0.000035875168,0.0025663816,0.00000418978],"about_ca_topic_score_codex":0.00017059587,"about_ca_topic_score_gemma":0.00040878286,"teacher_disagreement_score":0.0014644747,"about_ca_system_score_codex":0.00008614569,"about_ca_system_score_gemma":0.00012743748,"threshold_uncertainty_score":0.004899204},"labels":[],"label_agreement":null},{"id":"W2981831649","doi":"10.3324/haematol.2019.231407","title":"Hydroxyurea to lower transcranial Doppler velocities and prevent primary stroke: the Uganda NOHARM sickle cell anemia cohort","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Fogarty International Center; Canadian Institute for Advanced Research; Cincinnati Children's Hospital Medical Center","keywords":"Transcranial Doppler; Medicine; Cohort; Stroke (engine); Sickle cell anemia; Anemia; Internal medicine; Pediatrics; Disease","score_opus":0.007784249854740441,"score_gpt":0.21219948069863767,"score_spread":0.20441523084389723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981831649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933294,0.0023661936,0.00015963378,0.00031496608,0.00004104484,0.00018062882,0.0023168805,0.00000860363,0.0012826666],"genre_scores_gemma":[0.9926993,0.0018450526,0.00038311965,0.00044458217,0.00010659587,0.00042942615,0.0021106307,0.000017642134,0.0019635903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995291,0.00018112961,0.00004272224,0.00007415086,0.00007090581,0.00010192759],"domain_scores_gemma":[0.9989793,0.00012692997,0.00024433326,0.00019473222,0.0001288079,0.0003257949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010745242,0.00055553264,0.0010422663,0.00048089278,0.0009503515,0.0008935482,0.00043851061,0.0006042473,0.0026010666],"category_scores_gemma":[0.0022452169,0.0006064161,0.0008035172,0.0008288232,0.00031520452,0.0005788645,0.0010020946,0.0010067371,0.00049227313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047299378,0.0043336716,0.8879255,0.0009512879,0.0027028979,0.0011138868,0.002264877,0.000365503,0.0024377857,0.0006888417,0.009523682,0.040392745],"study_design_scores_gemma":[0.00755272,0.009782194,0.9667225,0.00037615246,0.0018779206,0.0010852645,0.0013709437,0.00051678653,0.00036409352,0.0005354879,0.009729275,0.00008661115],"about_ca_topic_score_codex":0.00611036,"about_ca_topic_score_gemma":0.0068661515,"teacher_disagreement_score":0.00611036,"about_ca_system_score_codex":0.00036387946,"about_ca_system_score_gemma":0.00085058267,"threshold_uncertainty_score":0.012149632},"labels":[],"label_agreement":null},{"id":"W2987067520","doi":"10.3324/haematol.2019.227892","title":"Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Provincial Health Services Authority","funders":"F. Hoffmann-La Roche","keywords":"Cell of origin; Diffuse large B-cell lymphoma; Biology; Lymphoma; Large-cell lymphoma; Somatic cell; Proportional hazards model; Large cell; Cancer research; Mutation; Hazard ratio; Gene; Oncology; Cancer; Internal medicine; Pathology; Genetics; Adenocarcinoma; Medicine; Immunology; Confidence interval","score_opus":0.059598015126062255,"score_gpt":0.3559190621808619,"score_spread":0.2963210470547996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987067520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99393094,0.0032214154,0.00023439614,0.00006405101,0.000005825455,0.000043014,0.0020126149,0.00000782742,0.00048002816],"genre_scores_gemma":[0.99415946,0.0007078816,0.00019464841,0.00007694534,0.000013481147,0.00005320184,0.0046965955,0.000009881207,0.00008787643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988582,0.0006103658,0.0000956904,0.00016738352,0.00019478718,0.00007350339],"domain_scores_gemma":[0.99767596,0.0009745675,0.0006494232,0.00029057387,0.00017713063,0.00023246794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028156543,0.00031806718,0.0007753264,0.0005194826,0.00020999479,0.0006896,0.00042573846,0.0004089598,0.0005750177],"category_scores_gemma":[0.0024448028,0.00016986528,0.00057524326,0.0010118855,0.00036973762,0.00030684922,0.0004668229,0.0003890985,0.00014546547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02141243,0.00020159045,0.94933814,0.00023468527,0.0018085599,0.00020641493,0.00013008498,0.0014679844,0.006754989,0.00005884945,0.0010142117,0.017372103],"study_design_scores_gemma":[0.0019209799,0.0015025843,0.99266726,0.000034414315,0.00079321436,0.00043216275,0.000071588234,0.0005510183,0.0005938256,0.000072580064,0.0013441453,0.000016129294],"about_ca_topic_score_codex":0.0014941378,"about_ca_topic_score_gemma":0.003843064,"teacher_disagreement_score":0.0028156543,"about_ca_system_score_codex":0.00035647888,"about_ca_system_score_gemma":0.00027570856,"threshold_uncertainty_score":0.01489073},"labels":[],"label_agreement":null},{"id":"W2988993561","doi":"10.3324/haematol.2019.225086","title":"Novel evidence for a greater burden of ambient air pollution on cardiovascular disease","year":2019,"lang":"en","type":"review","venue":"Haematologica","topic":"Air Quality and Health Impacts","field":"Environmental Science","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Air pollution; Environmental health; Life expectancy; Particulates; Cardiovascular health; Disease; Coronary artery disease; Diabetes mellitus; Air pollutants; Particulate pollution; Heart failure; Adverse effect; Burden of disease; Disease burden; Intensive care medicine; Cardiology; Internal medicine; Population; Endocrinology","score_opus":0.30372845814452265,"score_gpt":0.39400743196921234,"score_spread":0.09027897382468969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988993561","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007994947,0.9989856,0.000037981845,0.00026743236,0.00018119659,0.000001754105,0.000019153447,0.0000026321063,0.0004242705],"genre_scores_gemma":[0.0006618061,0.9988188,0.00005063128,0.0001666069,0.0001542022,0.0000021983785,0.000020367766,6.0677905e-7,0.00012483638],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997353,0.00006494583,0.000044801232,0.00005257102,0.00008050782,0.000021858337],"domain_scores_gemma":[0.99921894,0.00045879013,0.00009555767,0.00001756555,0.00017383097,0.00003531371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007953221,0.00062874414,0.0011929498,0.0016832887,0.00017208666,0.0009631586,0.00075177936,0.00106543,0.0066724103],"category_scores_gemma":[0.0018352965,0.00017684174,0.00095969334,0.0018189715,0.00036125534,0.0008111105,0.000557891,0.0013878682,0.0012594488],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018430382,0.00006455245,0.00046130831,0.08745473,0.0006332632,0.00031645226,0.00010891132,0.00024365324,0.0012810099,0.004540717,0.04265488,0.86205614],"study_design_scores_gemma":[0.000055611603,0.00017179445,0.0034955658,0.025154097,0.0010991242,0.0018159547,0.00011533173,0.00008857695,0.0004454101,0.0029676456,0.96456146,0.000029424866],"about_ca_topic_score_codex":0.00083921204,"about_ca_topic_score_gemma":0.0013910162,"teacher_disagreement_score":0.0066724103,"about_ca_system_score_codex":0.0004555013,"about_ca_system_score_gemma":0.0013800359,"threshold_uncertainty_score":0.022321463},"labels":[],"label_agreement":null},{"id":"W2990275983","doi":"10.3324/haematol.2019.227579","title":"Targeting CD47/TNFAIP8 by miR-155 overcomes drug resistance and inhibits tumor growth through induction of phagocytosis and apoptosis in multiple myeloma","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Leukemia and Lymphoma Research; Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"CD47; Multiple myeloma; Bortezomib; Cancer research; Phagocytosis; Apoptosis; Downregulation and upregulation; Drug resistance; In vivo; Medicine; Biology; Immunology","score_opus":0.011304713301687702,"score_gpt":0.21718373684767736,"score_spread":0.20587902354598966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990275983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99373394,0.003132175,0.0015285346,0.00012179544,0.000047210564,0.000023513063,0.000085095715,0.00010304186,0.0012246907],"genre_scores_gemma":[0.9970284,0.00073139084,0.0012124983,0.00004267477,0.000009411443,0.000013798705,0.000115045215,0.000008541085,0.0008383338],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999018,0.000015498945,0.000013082824,0.000017125103,0.000030702107,0.000021755553],"domain_scores_gemma":[0.99996376,0.0000056468557,0.000013418145,0.0000052241116,0.0000041926664,0.000007771561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106376414,0.00017042646,0.00027867506,0.00015075647,0.00012684923,0.0003165564,0.00012853132,0.00017298754,0.0006024437],"category_scores_gemma":[0.000091096066,0.00009942693,0.00019839256,0.00008594204,0.00017265847,0.00012329672,0.00014288035,0.00042021295,0.00019855492],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016347585,0.000047229085,0.00034063042,0.00004154725,0.000008859166,0.00005586354,0.000016403972,0.00008194659,0.99504197,0.000089178975,0.000083431616,0.004029443],"study_design_scores_gemma":[0.000040618877,0.00089945714,0.0046723518,0.000007343953,0.00004341902,0.000597351,0.00003230843,0.0010925445,0.9865802,0.000047565605,0.0059822015,0.0000047384297],"about_ca_topic_score_codex":0.00027485506,"about_ca_topic_score_gemma":0.00049825845,"teacher_disagreement_score":0.0006024437,"about_ca_system_score_codex":0.00027846018,"about_ca_system_score_gemma":0.00014315349,"threshold_uncertainty_score":0.002020359},"labels":[],"label_agreement":null},{"id":"W2991451501","doi":"10.3324/haematol.2019.222596","title":"Dominant negative Gfi1b mutations cause moderate thrombocytopenia and an impaired stress thrombopoiesis associated with mild erythropoietic abnormalities in mice","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Dalhousie University; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Thrombopoiesis; Haematopoiesis; Thrombopoietin; Biology; Allele; Megakaryocyte; Platelet; Cancer research; Erythropoiesis; Molecular biology; Internal medicine; Immunology; Cell biology; Genetics; Medicine; Stem cell; Gene; Anemia","score_opus":0.015762680940316222,"score_gpt":0.26064543078487523,"score_spread":0.24488274984455902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991451501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9653988,0.0021831642,0.015596449,0.0005020078,0.00011419914,0.0003583082,0.008451878,0.0014122296,0.0059830453],"genre_scores_gemma":[0.959279,0.0026365982,0.014444171,0.0003610643,0.000045959678,0.0007266546,0.008564567,0.000616214,0.013325623],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99935144,0.000083171486,0.00010028359,0.00017898741,0.0001887837,0.0000973197],"domain_scores_gemma":[0.99949825,0.00006783024,0.00015118132,0.00004576127,0.000027710836,0.00020922834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045640054,0.0013564179,0.0005385415,0.0017591754,0.0003974288,0.00060804177,0.00070453755,0.0014655525,0.0036283762],"category_scores_gemma":[0.00032352965,0.00065516913,0.0008951136,0.00043247317,0.0006802771,0.0002541639,0.00054556906,0.0017575175,0.0017627354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021148237,0.000090037,0.0003101042,0.000069520946,0.00002996773,0.0003779682,0.00005412304,0.00011303428,0.9966304,0.00033063508,0.00024536456,0.0015374119],"study_design_scores_gemma":[0.00060634344,0.0010231172,0.0200772,0.0001808905,0.00023463997,0.009826535,0.0001355549,0.0038385254,0.94503087,0.0005103567,0.01846413,0.000071847535],"about_ca_topic_score_codex":0.0011067663,"about_ca_topic_score_gemma":0.0016563957,"teacher_disagreement_score":0.0036283762,"about_ca_system_score_codex":0.00047560487,"about_ca_system_score_gemma":0.00029482497,"threshold_uncertainty_score":0.012138128},"labels":[],"label_agreement":null},{"id":"W2991725433","doi":"10.3324/haematol.2019.231753","title":"Are we ready to use precision medicine in chronic myeloid leukemia practice?","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Myeloid leukemia; Precision medicine; Medicine; Internal medicine; Oncology; Intensive care medicine; Pathology","score_opus":0.09269146297885146,"score_gpt":0.36623405593882224,"score_spread":0.2735425929599708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991725433","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007975196,0.0004689266,0.000028712593,0.99499536,0.0035090947,0.0000023693042,0.0000067219103,0.000005722771,0.00090335263],"genre_scores_gemma":[0.002234293,0.0010567688,0.000221554,0.975895,0.018752081,0.000017862934,0.000010842355,0.000011168311,0.0018005146],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9868443,0.004899237,0.0017572688,0.0011522126,0.003601372,0.0017455427],"domain_scores_gemma":[0.9422844,0.027086047,0.0044320426,0.001668147,0.007391832,0.017137531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010301686,0.0006260629,0.001291131,0.0010764181,0.008267864,0.008951422,0.0017832419,0.06810464,0.019804219],"category_scores_gemma":[0.09062319,0.0010083613,0.0011503673,0.001082124,0.007817734,0.009732703,0.005067474,0.056066908,0.008974128],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004541954,0.00004458894,0.0014041993,0.00010863448,0.000017352266,0.0015334315,0.00026842149,0.000097359814,0.00012098,0.0077990578,0.9698748,0.018685741],"study_design_scores_gemma":[0.00020119871,0.000111419984,0.0015069296,0.0011088743,0.000033352473,0.0029480846,0.001257528,0.00040247437,0.00018299148,0.032867663,0.95926476,0.00011479635],"about_ca_topic_score_codex":0.010609234,"about_ca_topic_score_gemma":0.01924922,"teacher_disagreement_score":0.06810464,"about_ca_system_score_codex":0.009071769,"about_ca_system_score_gemma":0.021734355,"threshold_uncertainty_score":0.066251695},"labels":[],"label_agreement":null},{"id":"W2994869882","doi":"10.3324/haematol.2019.223040","title":"Humanized zebrafish enhance human hematopoietic stem cell survival and promote acute myeloid leukemia clonal diversity","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Memorial University of Newfoundland; Izaak Walton Killam Health Centre; University of Ottawa; Dalhousie University","funders":"Natural Sciences and Engineering Research Council of Canada; Cancer Research Institute; Terry Fox Research Institute; Hope Foundation; Beatrice Hunter Cancer Research Institute; Nova Scotia Health Research Foundation","keywords":"Zebrafish; Xenotransplantation; Biology; Haematopoiesis; Leukemia; Homing (biology); Myeloid leukemia; Stem cell; Progenitor cell; Cancer research; Hematopoietic stem cell; Immunology; Transplantation; Cell biology; Medicine; Genetics; Internal medicine; Gene","score_opus":0.014546826255976702,"score_gpt":0.27035309105827543,"score_spread":0.25580626480229873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994869882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651276,0.00096725463,0.0242563,0.00041027286,0.000075423915,0.00024066975,0.0013552316,0.0008206822,0.0067465617],"genre_scores_gemma":[0.9720905,0.001176957,0.016454846,0.000117110074,0.000010147058,0.00016252782,0.0009097799,0.00012937831,0.008948819],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998623,0.000021964663,0.000009559736,0.000026602373,0.00005628308,0.000023326584],"domain_scores_gemma":[0.9999039,0.000017756403,0.00003399277,0.000011525686,0.000014830894,0.000017980723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029666873,0.000372303,0.00017927856,0.00040552102,0.00020490705,0.00024230561,0.00018632007,0.00025913995,0.0033030643],"category_scores_gemma":[0.0001600425,0.0001473851,0.00021988711,0.000113171554,0.00028500688,0.00021527718,0.0002634492,0.00045353186,0.0003538953],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059685415,0.000019655468,0.0001500723,0.000026654101,0.0000036908189,0.000032978394,0.000022151777,0.00020446593,0.99691725,0.00042453426,0.00014770972,0.001991169],"study_design_scores_gemma":[0.000041921503,0.0006985871,0.0022175247,0.00001630809,0.000028766732,0.00022098108,0.000040245293,0.0015762899,0.98444796,0.00017991198,0.010522997,0.00000854916],"about_ca_topic_score_codex":0.0022672154,"about_ca_topic_score_gemma":0.0072441334,"teacher_disagreement_score":0.0033030643,"about_ca_system_score_codex":0.0005041091,"about_ca_system_score_gemma":0.00047750032,"threshold_uncertainty_score":0.011049807},"labels":[],"label_agreement":null},{"id":"W2995710548","doi":"10.3324/haematol.2019.236737","title":"Long-term outcomes after splenectomy in children with immune thrombocytopenia: an update on the registry data from the Intercontinental Cooperative ITP Study Group","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Splenectomy; Immune thrombocytopenia; Medicine; Term (time); Pediatrics; Immune system; Internal medicine; Immunology; Platelet; Spleen","score_opus":0.043182101686548686,"score_gpt":0.3010163514763502,"score_spread":0.2578342497898015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995710548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70570207,0.04247538,0.0010164008,0.19282778,0.0045483094,0.00007312389,0.034669247,0.00013685192,0.018550882],"genre_scores_gemma":[0.90874815,0.019225793,0.0014535912,0.044682145,0.0058915773,0.00017267486,0.017042456,0.000060895178,0.0027226948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865013,0.00043451317,0.00031868447,0.00011739286,0.00033260405,0.00014664663],"domain_scores_gemma":[0.99052656,0.0036532718,0.0034459103,0.00040518344,0.0013717348,0.00059732393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016510417,0.00015032568,0.00039362456,0.00069205055,0.0003068255,0.00089672225,0.00037658366,0.001241075,0.00083913363],"category_scores_gemma":[0.009025732,0.00012803907,0.0004001094,0.002714012,0.00025998979,0.00071665266,0.00040028166,0.0011783234,0.00034470545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019998729,0.000031290492,0.9002623,0.00012811532,0.000115103,0.0021175914,0.00029066746,0.00009833393,0.0002111616,0.0002860023,0.0728045,0.023454973],"study_design_scores_gemma":[0.0001297513,0.00008664418,0.94223225,0.00054751144,0.00021350793,0.005751554,0.0007900649,0.0002966071,0.00026971943,0.00045199197,0.0491928,0.000037631835],"about_ca_topic_score_codex":0.005608773,"about_ca_topic_score_gemma":0.012361718,"teacher_disagreement_score":0.005608773,"about_ca_system_score_codex":0.0007408049,"about_ca_system_score_gemma":0.0009900404,"threshold_uncertainty_score":0.011152267},"labels":[],"label_agreement":null},{"id":"W2995858855","doi":"10.3324/haematol.2019.226795","title":"The novel L-nucleoside analogue, 5-Fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Myeloid leukemia; Nucleoside analogue; Medicine; Nucleoside; Leukemia; Myeloid; Cancer research; Pharmacology; Chemistry; Immunology; Stereochemistry","score_opus":0.026645746346510693,"score_gpt":0.28190972480066717,"score_spread":0.2552639784541565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995858855","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40435472,0.061079614,0.0024328837,0.4222338,0.013237935,0.00015891719,0.000529501,0.00044857088,0.09552398],"genre_scores_gemma":[0.8566722,0.020212816,0.001599962,0.085907966,0.013212554,0.00008605943,0.00029085545,0.0000549232,0.021962745],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998523,0.00003731346,0.00001469007,0.00001805237,0.000034845205,0.00004288233],"domain_scores_gemma":[0.9997428,0.00014675964,0.000031835552,0.000012970634,0.000023279332,0.000042379346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002709324,0.00021395487,0.00044567703,0.00012643298,0.00040209448,0.00057317584,0.0003258071,0.003167287,0.0012942916],"category_scores_gemma":[0.0008380633,0.00010178667,0.00014979696,0.00017318576,0.0004184593,0.00033515162,0.00015342174,0.0018097527,0.00088780286],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005808996,0.00077128585,0.010529304,0.0011136064,0.00008870146,0.08310619,0.00050484325,0.0019766036,0.13973834,0.0151809305,0.35594878,0.3852324],"study_design_scores_gemma":[0.0024461949,0.0052465284,0.016290521,0.00019015605,0.00011799707,0.079336196,0.00023679528,0.0046842094,0.0585159,0.0054044724,0.82745785,0.00007317269],"about_ca_topic_score_codex":0.0006413226,"about_ca_topic_score_gemma":0.0016139231,"teacher_disagreement_score":0.003167287,"about_ca_system_score_codex":0.00093652547,"about_ca_system_score_gemma":0.00026262013,"threshold_uncertainty_score":0.006794989},"labels":[],"label_agreement":null},{"id":"W2997127334","doi":"10.3324/haematol.2019.235721","title":"Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research; Princess Margaret Cancer Foundation","keywords":"Myeloid leukemia; Medicine; Internal medicine; Minimal residual disease; Oncology; Chemotherapy; Leukemia; Gastroenterology; Pathology","score_opus":0.04661541952459586,"score_gpt":0.28505376704147734,"score_spread":0.23843834751688148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997127334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966473,0.0021804064,0.0006594906,0.00007332727,0.000009403773,0.000011538921,0.00007701579,0.000019448089,0.0003221124],"genre_scores_gemma":[0.9992556,0.00024716108,0.00023797575,0.000034079818,0.000011246609,0.0000063705656,0.00012503147,0.0000036229426,0.00007895584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995048,0.00014446002,0.00004706674,0.0001057009,0.00012955365,0.00006843626],"domain_scores_gemma":[0.99874085,0.00035336916,0.00058288453,0.000106895706,0.00008911918,0.00012678427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096453296,0.00017868569,0.00055757334,0.00019950187,0.00016477217,0.0006103997,0.00026779363,0.00027778375,0.0005269651],"category_scores_gemma":[0.002103356,0.00013046962,0.00027307784,0.00026202988,0.0002744162,0.00039798403,0.00028533154,0.0003636374,0.0001809696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035941377,0.00021795076,0.8901098,0.000109284956,0.000085044434,0.00050630944,0.00012626444,0.0009762842,0.0150009245,0.00012094538,0.00038704535,0.08876596],"study_design_scores_gemma":[0.00010195371,0.0074627115,0.9731165,0.000048295107,0.00028213803,0.0030569055,0.00018303549,0.002805538,0.009997741,0.00027191598,0.002654446,0.000018789759],"about_ca_topic_score_codex":0.00046677244,"about_ca_topic_score_gemma":0.00091658527,"teacher_disagreement_score":0.00096453296,"about_ca_system_score_codex":0.00030571304,"about_ca_system_score_gemma":0.00034772386,"threshold_uncertainty_score":0.005101025},"labels":[],"label_agreement":null},{"id":"W2998593800","doi":"10.3324/haematol.2019.235291","title":"The long non-coding RNA &lt;i&gt;Cancer Susceptibility 15&lt;/i&gt; (&lt;i&gt;CASC15&lt;/i&gt;) is induced by isocitrate dehydrogenase (IDH) mutations and maintains an immature phenotype in adult acute myeloid leukemia","year":2020,"lang":"en","type":"letter","venue":"Haematologica","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; Universität Ulm; Helmholtz Zentrum München; School of Medicine, Stanford University; Ludwig-Maximilians-Universität München","keywords":"Isocitrate dehydrogenase; IDH1; Molecular biology; Long non-coding RNA; RNA; Cancer research; Chemistry; Biology; Gene; Mutation; Enzyme; Biochemistry","score_opus":0.012620415396468233,"score_gpt":0.2663825028896349,"score_spread":0.25376208749316664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998593800","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7386043,0.01029296,0.011066276,0.13815235,0.011565405,0.00028241318,0.027945027,0.0012435213,0.060847733],"genre_scores_gemma":[0.91110295,0.00454316,0.005232482,0.040226202,0.0058422764,0.0001593959,0.011622683,0.00029605802,0.020974789],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99959475,0.000056349152,0.000043351865,0.00012680545,0.00012187563,0.00005687593],"domain_scores_gemma":[0.99890995,0.0004062575,0.000131095,0.00017175068,0.0002151169,0.0001657585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003830047,0.00016074463,0.00020567847,0.0004118995,0.00047926916,0.00048424982,0.00018239461,0.0005612286,0.0036063227],"category_scores_gemma":[0.0016837454,0.00011117807,0.00009163256,0.0004812443,0.00036672255,0.00018786207,0.00022170346,0.0008091303,0.0025340589],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043408917,0.00021521527,0.14504674,0.0005270515,0.00011440991,0.021607535,0.00054848974,0.0009562803,0.15151553,0.006349884,0.4451672,0.22361079],"study_design_scores_gemma":[0.00020861247,0.0005025612,0.15823574,0.00016222356,0.00011794431,0.061028857,0.0004485942,0.0042217774,0.08168631,0.00788707,0.6854308,0.00006943567],"about_ca_topic_score_codex":0.0008362983,"about_ca_topic_score_gemma":0.0018858337,"teacher_disagreement_score":0.0036063227,"about_ca_system_score_codex":0.00044869975,"about_ca_system_score_gemma":0.00028407425,"threshold_uncertainty_score":0.012064338},"labels":[],"label_agreement":null},{"id":"W2998875317","doi":"10.3324/haematol.2019.226126","title":"HES1 and HES4 have non-redundant roles downstream of Notch during early human T-cell development","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; European Hematology Association","keywords":"HES1; Haematopoiesis; Biology; Progenitor cell; Notch signaling pathway; Cell biology; Myeloid; Lineage (genetic); Gene knockdown; Lymphopoiesis; Stem cell; T cell; Cellular differentiation; Psychological repression; Genetics; Cancer research; Gene; Signal transduction; Gene expression; Immune system","score_opus":0.010141834932139385,"score_gpt":0.21842311657948688,"score_spread":0.2082812816473475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998875317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882301,0.003985545,0.004756455,0.00006838079,0.000011992099,0.000019716985,0.00059947034,0.00013617323,0.0021921587],"genre_scores_gemma":[0.9912788,0.0019114587,0.0023436404,0.000043046264,0.0000062507443,0.000019755738,0.00075294473,0.00002107159,0.0036229377],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989796,0.000017313325,0.000009325936,0.000025076451,0.00003113131,0.000019288198],"domain_scores_gemma":[0.99994946,0.000008133807,0.000017474427,0.0000063595653,0.0000081939115,0.000010254068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010769109,0.00021605857,0.00015062914,0.00017239821,0.00011433369,0.00029256282,0.0001606386,0.0001529981,0.0011831152],"category_scores_gemma":[0.00008880367,0.00012509871,0.0001423246,0.00015193898,0.00016980374,0.00014360562,0.00016372818,0.00017275926,0.00058016717],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012390729,0.0000073125357,0.0009246508,0.000055593526,0.000006519727,0.00009568142,0.000023789815,0.00020209332,0.99411196,0.00015112998,0.00004876221,0.0042485045],"study_design_scores_gemma":[0.000007100021,0.000115791525,0.014208787,0.000007658131,0.000024305251,0.0006843089,0.00003945835,0.00065297587,0.9792085,0.000116088406,0.0049294233,0.000005564989],"about_ca_topic_score_codex":0.00027861475,"about_ca_topic_score_gemma":0.00029448647,"teacher_disagreement_score":0.0011831152,"about_ca_system_score_codex":0.00015650022,"about_ca_system_score_gemma":0.00018063858,"threshold_uncertainty_score":0.003957927},"labels":[],"label_agreement":null},{"id":"W2999855906","doi":"10.3324/haematol.2019.229989","title":"Innate immune cells, major protagonists of sickle cell disease pathophysiology","year":2020,"lang":"en","type":"review","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"Agence Nationale de la Recherche","keywords":"Pathophysiology; Disease; Immunology; Inflammation; Immune system; Innate immune system; Medicine; Pathology","score_opus":0.0189284851360099,"score_gpt":0.2765282941016702,"score_spread":0.25759980896566026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999855906","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000121755074,0.9987746,0.000069542664,0.00022024846,0.00016416406,0.0000022776885,0.000018909488,0.0000047411604,0.0006237029],"genre_scores_gemma":[0.0007692697,0.99838614,0.00012195021,0.0001488073,0.0001878245,0.0000031101094,0.000031817646,8.559035e-7,0.00035029632],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998653,0.000027616838,0.000026107227,0.000019070789,0.000046927402,0.000014910645],"domain_scores_gemma":[0.9997812,0.00011176937,0.00003351943,0.000005214428,0.000050603463,0.000017747487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032134526,0.0005510277,0.0008109192,0.0015646203,0.0002011984,0.00079511973,0.00041391284,0.00068394124,0.0032217475],"category_scores_gemma":[0.0005421142,0.00014092997,0.00030454187,0.0012840678,0.00024099165,0.00079432566,0.00049806206,0.000968582,0.0012660603],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098319746,0.000047856436,0.0002891807,0.021226821,0.000109783854,0.0003151427,0.000089486064,0.00021173665,0.002512478,0.00357275,0.02992957,0.9415969],"study_design_scores_gemma":[0.000012205855,0.00006168728,0.0009721788,0.004706432,0.0001208805,0.0018085741,0.00007443419,0.000052960644,0.00048742708,0.0017690449,0.9899204,0.000013850754],"about_ca_topic_score_codex":0.0005635472,"about_ca_topic_score_gemma":0.000966594,"teacher_disagreement_score":0.0032217475,"about_ca_system_score_codex":0.00033266578,"about_ca_system_score_gemma":0.0008353629,"threshold_uncertainty_score":0.010777831},"labels":[],"label_agreement":null},{"id":"W3000359647","doi":"10.3324/haematol.2019.239160","title":"Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B: a PedNet study","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Skånes universitetssjukhus; Medizinische Universität Wien; Hospital for Sick Children; Great Ormond Street Hospital for Children; Lunds Universitet; Institut National de la Recherche Agronomique; Institut National de la Santé et de la Recherche Médicale; University of Bern; Universität Wien; Helsingin Yliopisto","keywords":"Medicine; Incidence (geometry); Cumulative incidence; Internal medicine; Prospective cohort study; Cohort; Gastroenterology; Missense mutation; Haemophilia; Pediatrics; Mutation; Biology; Genetics; Gene","score_opus":0.02725189121489065,"score_gpt":0.28972216537662665,"score_spread":0.262470274161736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000359647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992084,0.00020168994,0.00004683105,0.000008573322,0.000002074455,0.000008932699,0.00030815694,0.0000016278889,0.00021379573],"genre_scores_gemma":[0.9986092,0.00026559265,0.00007705562,0.00002722962,0.000011126012,0.000013402704,0.000838276,0.0000021189821,0.00015607552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953556,0.000114127986,0.000053348114,0.00014918322,0.000087883316,0.00005978707],"domain_scores_gemma":[0.9990834,0.00017965841,0.00034254434,0.00009985554,0.00009197396,0.00020254514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004909816,0.0003007769,0.0004590857,0.00084600406,0.0003345751,0.0007127315,0.00032562762,0.00048938085,0.0011929043],"category_scores_gemma":[0.0012756427,0.0003896226,0.00039761016,0.0008649844,0.0002510089,0.00062148494,0.0004684953,0.0004352319,0.00035108248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015767015,0.000041612533,0.99856913,0.000010152604,0.000041713258,0.00016029656,0.000046014648,0.00002379907,0.00012919608,0.000009670117,0.000067933084,0.00074273365],"study_design_scores_gemma":[0.000016384118,0.00026326603,0.9986099,0.000004704059,0.000024224986,0.00065149274,0.0000882147,0.000087905064,0.000030942036,0.000007929085,0.0002122264,0.000002778994],"about_ca_topic_score_codex":0.0025766606,"about_ca_topic_score_gemma":0.0023265148,"teacher_disagreement_score":0.0025766606,"about_ca_system_score_codex":0.00033738322,"about_ca_system_score_gemma":0.0002564271,"threshold_uncertainty_score":0.0051233172},"labels":[],"label_agreement":null},{"id":"W3003971267","doi":"10.3324/haematol.2019.237230","title":"Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group phase III study AALL0433","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health; Children's Hospital of Philadelphia","keywords":"Medicine; Internal medicine; Vincristine; Minimal residual disease; Bone marrow; Calla; Chemotherapy; Oncology; Acute lymphocytic leukemia; Induction chemotherapy; Randomization; Hematopoietic stem cell transplantation; Transplantation; Leukemia; Clinical trial; Lymphoblastic Leukemia; Cyclophosphamide; Immunology; Antibody","score_opus":0.013167492933858207,"score_gpt":0.2657685661765715,"score_spread":0.2526010732427133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003971267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99382293,0.003738563,0.00015543832,0.00020983441,0.000015753485,0.000032833923,0.0013954936,0.000013529858,0.00061561825],"genre_scores_gemma":[0.9963354,0.00088672404,0.00010085739,0.00021571202,0.00003481784,0.00004343212,0.0022431058,0.000007543535,0.0001324651],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987367,0.00058505795,0.00010789054,0.00014244975,0.00027725383,0.0001506828],"domain_scores_gemma":[0.99492884,0.0013446468,0.0024990817,0.00030619517,0.0003856216,0.00053558836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027433985,0.00034159323,0.0006343141,0.00040169255,0.00027974197,0.00079399155,0.00045732225,0.00046965378,0.00035681855],"category_scores_gemma":[0.0035447397,0.00020559417,0.00071607233,0.00084478204,0.00034560837,0.00042732028,0.00043191592,0.00081382476,0.00013606552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004497523,0.00019069052,0.9785971,0.00007638813,0.00047104896,0.00015322721,0.0001303181,0.0002543781,0.0004032286,0.00003536579,0.0013895893,0.013801101],"study_design_scores_gemma":[0.00039254807,0.0012277731,0.996265,0.000023502715,0.00028848587,0.00049992825,0.00006961659,0.00012419994,0.00019461842,0.000028774248,0.0008735483,0.000012034674],"about_ca_topic_score_codex":0.0033152087,"about_ca_topic_score_gemma":0.0055669416,"teacher_disagreement_score":0.0033152087,"about_ca_system_score_codex":0.0007812205,"about_ca_system_score_gemma":0.00062733516,"threshold_uncertainty_score":0.014508605},"labels":[],"label_agreement":null},{"id":"W3004873674","doi":"10.3324/haematol.2019.220962","title":"Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children’s Oncology Group","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Bortezomib; Medicine; Internal medicine; Chemotherapy; Randomized controlled trial; Myeloid leukemia; Oncology; Induction chemotherapy; Multiple myeloma; Leukemia; Surgery","score_opus":0.020542026871820936,"score_gpt":0.29994620438021874,"score_spread":0.2794041775083978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004873674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73817945,0.22591056,0.000922542,0.018208086,0.0017446511,0.0005295756,0.0028250401,0.00011601124,0.011564159],"genre_scores_gemma":[0.8888634,0.09193604,0.0027498933,0.009531951,0.0013092398,0.0004901025,0.003003592,0.00005658154,0.0020591898],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99847287,0.00061781355,0.00017986208,0.00017670632,0.00043471844,0.00011802136],"domain_scores_gemma":[0.9930835,0.004030398,0.0014015348,0.00033717125,0.00069287705,0.00045447852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039512464,0.00027174028,0.0009186386,0.00022233068,0.00020806534,0.000563046,0.0003324721,0.00059025537,0.0016736535],"category_scores_gemma":[0.008946846,0.00014523319,0.0013955456,0.0007369719,0.00038073852,0.00048527395,0.00033030196,0.001637207,0.00015846008],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07433932,0.0019672972,0.060769767,0.0034033172,0.0052073384,0.00042934512,0.00035818462,0.0009602463,0.0041162358,0.0015039456,0.028168198,0.8187768],"study_design_scores_gemma":[0.11393029,0.08584152,0.5651998,0.003384328,0.020518491,0.002087898,0.00042480265,0.0010311482,0.008650446,0.001672094,0.19710183,0.00015739299],"about_ca_topic_score_codex":0.0042861355,"about_ca_topic_score_gemma":0.0071228854,"teacher_disagreement_score":0.0042861355,"about_ca_system_score_codex":0.0014089409,"about_ca_system_score_gemma":0.0019142595,"threshold_uncertainty_score":0.020896494},"labels":[],"label_agreement":null},{"id":"W3006606775","doi":"10.3324/haematol.2019.245167","title":"SIRPαFc treatment targets human acute myeloid leukemia stem cells","year":2020,"lang":"en","type":"letter","venue":"Haematologica","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Trillium Therapeutics (Canada); Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"Hospital for Sick Children; University of Toronto; Government of Canada; Government of Ontario; Department of Medicine, University of Toronto; Ontario Genomics Institute; Genome Canada","keywords":"Myeloid leukemia; Stem cell; Myeloid cells; Myeloid; Medicine; Cancer research; Immunology; Leukemia; Biology; Cell biology","score_opus":0.031970253949090525,"score_gpt":0.24696602981415194,"score_spread":0.2149957758650614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006606775","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12597112,0.041677967,0.003632446,0.7186739,0.033602443,0.0002881594,0.0006617845,0.00044539032,0.07504678],"genre_scores_gemma":[0.56536007,0.023283156,0.0032196702,0.31637892,0.032073077,0.00030607873,0.00062771543,0.00008314875,0.058668073],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995832,0.00012284733,0.000037982714,0.000029789928,0.00014409996,0.000082056904],"domain_scores_gemma":[0.9995198,0.00026733076,0.00003509802,0.00003544921,0.00006637137,0.000075899035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066009286,0.0002963035,0.0004558342,0.00022886602,0.00060664007,0.0009694235,0.00037013422,0.0042895987,0.0019926538],"category_scores_gemma":[0.0012141169,0.00015263337,0.00036620622,0.0001696191,0.00041654767,0.00028796383,0.00028156416,0.002873502,0.00122496],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028270155,0.0004813818,0.00738054,0.00042388798,0.00013028477,0.024369273,0.0003203497,0.0007974405,0.07704449,0.0110434,0.6596703,0.21551165],"study_design_scores_gemma":[0.0007168875,0.0012004878,0.009502439,0.00011019264,0.000107881744,0.021446189,0.00034895047,0.0023008352,0.049790066,0.0061464915,0.9082918,0.00003772187],"about_ca_topic_score_codex":0.00078259746,"about_ca_topic_score_gemma":0.0017804573,"teacher_disagreement_score":0.0042895987,"about_ca_system_score_codex":0.0010809582,"about_ca_system_score_gemma":0.00042139893,"threshold_uncertainty_score":0.007842958},"labels":[],"label_agreement":null},{"id":"W3007168498","doi":"10.3324/haematol.2020.248385","title":"FcγRI and FcγRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia","year":2020,"lang":"en","type":"letter","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network; St. Michael's Hospital","funders":"National Center for Advancing Translational Sciences; Department of Medicine, University of Toronto; Health Canada; National Cancer Institute; University of Rochester; University of Toronto; National Center for Research Resources; Medical Center, University of Rochester; Amgen; Lunds Universitet; National Institutes of Health; Toronto General Hospital Research Institute, University Health Network; Universiteit van Amsterdam; Canadian Blood Services; Amsterdam University Medical Centers; Australian Government; Pfizer","keywords":"Autoantibody; Immune thrombocytopenia; Opsonin; Phagocytosis; Platelet; Immunology; Immune system; Antibody; Glycoprotein; Platelet Glycoprotein GPIb-IX Complex; Platelet membrane glycoprotein; Medicine; Biology; Molecular biology","score_opus":0.023574175739878318,"score_gpt":0.27163567722217674,"score_spread":0.2480615014822984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007168498","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.068856515,0.011576527,0.0012640957,0.83989793,0.025634084,0.0000962953,0.00012391641,0.00012766889,0.05242304],"genre_scores_gemma":[0.51077765,0.0068732537,0.0013315848,0.3494729,0.083186656,0.00015248884,0.000129021,0.00006301435,0.04801342],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99929273,0.00028633038,0.000069670445,0.000057080848,0.00014085053,0.00015331862],"domain_scores_gemma":[0.9986847,0.0008594789,0.00007510387,0.00007447856,0.00016914091,0.00013709196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012223078,0.00065493316,0.0009045329,0.000335629,0.0016071361,0.0013838309,0.0010172301,0.01763216,0.003308969],"category_scores_gemma":[0.004018491,0.0005005596,0.0007520979,0.00016636556,0.0010845202,0.0011528558,0.0005596392,0.007454664,0.00203248],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026549161,0.00065305474,0.01109813,0.00036031537,0.00017014267,0.21843785,0.00090970285,0.00048410887,0.009754607,0.01470024,0.70694137,0.033835527],"study_design_scores_gemma":[0.0027896783,0.0014985311,0.029744748,0.0006826133,0.0004307722,0.25941497,0.0022464443,0.011955543,0.014770928,0.040484905,0.6357977,0.00018320113],"about_ca_topic_score_codex":0.0022619544,"about_ca_topic_score_gemma":0.0023319412,"teacher_disagreement_score":0.01763216,"about_ca_system_score_codex":0.0024810962,"about_ca_system_score_gemma":0.00064523006,"threshold_uncertainty_score":0.018001735},"labels":[],"label_agreement":null},{"id":"W3008822255","doi":"10.3324/haematol.2018.204040","title":"Human leukocyte antigen-G upregulates immunoglobulin-like transcripts and corrects dysfunction of immune cells in immune thrombocytopenia","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; National Natural Science Foundation of China; Shandong University","keywords":"Antigen; Immunology; Immune system; Immunoglobulin G; Antibody; Biology; Human leukocyte antigen; CD80; Autoantibody; Cytotoxic T cell; CD40; In vitro","score_opus":0.025642566777456216,"score_gpt":0.25114915522725645,"score_spread":0.22550658844980023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008822255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99721223,0.0013185055,0.0008230186,0.000056920413,0.000034755085,0.000018891653,0.00006454309,0.000046886427,0.000424371],"genre_scores_gemma":[0.9976235,0.000820003,0.00048283886,0.00006364685,0.000015397556,0.000021354936,0.0001496966,0.000008164646,0.000815439],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999455,0.000015287873,0.0000051931797,0.000007995844,0.000008930631,0.000016995591],"domain_scores_gemma":[0.99997735,0.0000033147442,0.0000071711434,0.000003474279,0.0000021457224,0.0000065759054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004653045,0.00018842015,0.00017763111,0.00012336869,0.00006313797,0.00013169405,0.000084052124,0.00014113117,0.0008673812],"category_scores_gemma":[0.000062743035,0.000043657907,0.00015731562,0.000097109565,0.00010656088,0.000070810915,0.00012457102,0.00032551558,0.00017386844],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032746096,0.00007565047,0.00030998918,0.000054244265,0.000008630286,0.00011577198,0.000011310689,0.000040626535,0.9957354,0.000049164628,0.00006547589,0.0032061872],"study_design_scores_gemma":[0.00014844855,0.0027382553,0.017789418,0.000018035873,0.000091210175,0.0008335938,0.00006269693,0.00080514624,0.97106826,0.00014471741,0.006293698,0.0000066237158],"about_ca_topic_score_codex":0.00008355553,"about_ca_topic_score_gemma":0.00011439596,"teacher_disagreement_score":0.0008673812,"about_ca_system_score_codex":0.00006668554,"about_ca_system_score_gemma":0.00007802162,"threshold_uncertainty_score":0.0029016137},"labels":[],"label_agreement":null},{"id":"W3011365044","doi":"10.3324/haematol.2019.244160","title":"Low incidence of &lt;i&gt;EPOR&lt;/i&gt; mutations in idiopathic erythrocytosis","year":2020,"lang":"en","type":"letter","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; University of Alberta","funders":"Université de Recherche Paris Sciences et Lettres; Centre Hospitalier Universitaire de Nantes; Centre National de la Recherche Scientifique; Alberta Health Services; Université de Bourgogne; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche; University of Alberta","keywords":"Erythropoietin receptor; Incidence (geometry); Proband; Medicine; Mutation; Internal medicine; Genetics; Biology; Erythropoietin; Gene","score_opus":0.027471021382167452,"score_gpt":0.2705137380996264,"score_spread":0.24304271671745897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011365044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4534842,0.010298288,0.002849502,0.29085132,0.0040785014,0.000077805795,0.001961971,0.00040579113,0.23599255],"genre_scores_gemma":[0.92862934,0.0021570025,0.0012577701,0.029735956,0.003365486,0.000024929013,0.0003801701,0.00007068061,0.034378603],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99976915,0.00006016681,0.000020781754,0.000034464607,0.00006424225,0.000051268922],"domain_scores_gemma":[0.99938107,0.00028133093,0.00009030953,0.000027361943,0.000107211876,0.00011273263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015260965,0.00015296323,0.0002469311,0.00037521406,0.00048811623,0.0003899026,0.00021830761,0.002391912,0.005139799],"category_scores_gemma":[0.0016144286,0.0000760377,0.000099784054,0.0003138629,0.00032865413,0.00022891468,0.000118260505,0.0008984738,0.0018148187],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043642326,0.00014197397,0.12922364,0.00019157752,0.000024356663,0.553172,0.00047212822,0.00063738227,0.010420673,0.004887611,0.23550946,0.06488284],"study_design_scores_gemma":[0.00006114049,0.00022556353,0.06858777,0.00018216537,0.000027412205,0.7975084,0.00045655755,0.0012620244,0.0033374305,0.0035504254,0.12476502,0.000036048197],"about_ca_topic_score_codex":0.0016875193,"about_ca_topic_score_gemma":0.0019521697,"teacher_disagreement_score":0.005139799,"about_ca_system_score_codex":0.0005058704,"about_ca_system_score_gemma":0.00034381813,"threshold_uncertainty_score":0.01719433},"labels":[],"label_agreement":null},{"id":"W3011696612","doi":"10.3324/haematol.2019.240846","title":"The variable manifestations of disease in pyruvate kinase deficiency and their management","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Pyruvate kinase deficiency; Medicine; Extramedullary hematopoiesis; Disease; Pyruvate kinase; Anemia; Immunology; Stem cell; Bioinformatics; Internal medicine; Haematopoiesis; Glycolysis; Biology; Genetics","score_opus":0.02466773587017328,"score_gpt":0.24474196986468363,"score_spread":0.22007423399451034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011696612","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14597629,0.7371426,0.03202014,0.040837165,0.0030327258,0.00035397417,0.00034431566,0.00030430002,0.039988462],"genre_scores_gemma":[0.6128557,0.33987245,0.026937785,0.010301687,0.003286943,0.00022620903,0.0006625556,0.00010912232,0.005747634],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99889827,0.00038671657,0.00022151275,0.00009322927,0.0002402937,0.00015998434],"domain_scores_gemma":[0.9988617,0.0003147966,0.00022158366,0.000056783403,0.0002972926,0.00024786434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028631834,0.00046858506,0.0008018811,0.0011160515,0.000556087,0.0011654994,0.0006339508,0.0007867245,0.00088789203],"category_scores_gemma":[0.0040270695,0.00014428586,0.00044819084,0.0009684607,0.00064358284,0.0010963028,0.00159482,0.0016598563,0.00033773688],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037124398,0.00019726303,0.061872665,0.0017700522,0.00014014509,0.017931135,0.0015293454,0.0011805679,0.0047947834,0.0068366337,0.022737954,0.8806381],"study_design_scores_gemma":[0.0001739273,0.001228811,0.13649674,0.0121872295,0.0005482805,0.2696496,0.005936243,0.0023112039,0.006603879,0.01601766,0.54864067,0.00020588144],"about_ca_topic_score_codex":0.0007429428,"about_ca_topic_score_gemma":0.00095914176,"teacher_disagreement_score":0.0028631834,"about_ca_system_score_codex":0.000794224,"about_ca_system_score_gemma":0.0011027572,"threshold_uncertainty_score":0.015142143},"labels":[],"label_agreement":null},{"id":"W3015129246","doi":"10.3324/haematol.2020.246603","title":"Donor sex, age and ethnicity impact stored red blood cell antioxidant metabolism through mechanisms in part explained by glucose 6-phosphate dehydrogenase levels and activity","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Hemolysis; Oxidative stress; Red blood cell; Glutathione; Antioxidant; Biology; Internal medicine; Immunology; Biochemistry; Medicine; Enzyme","score_opus":0.04113521748334037,"score_gpt":0.274631982799414,"score_spread":0.2334967653160736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015129246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99330115,0.0021967755,0.0011703565,0.00015987437,0.00003187103,0.000016955883,0.0016463902,0.00002350919,0.0014531601],"genre_scores_gemma":[0.99641573,0.00066463725,0.0006132913,0.00014915392,0.000017350148,0.000016759728,0.0010913942,0.000017026221,0.0010146858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995185,0.00011931518,0.000059008766,0.00012871748,0.00011226981,0.00006218912],"domain_scores_gemma":[0.99943393,0.000086026346,0.0002631839,0.000094106115,0.00006803954,0.00005474534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007733201,0.0003132949,0.00033249045,0.00043571947,0.0003234115,0.0008453723,0.0002186926,0.00023431604,0.0033211934],"category_scores_gemma":[0.0013039521,0.00014202499,0.00036568916,0.00072492973,0.0002348056,0.000302507,0.00041304433,0.0003048646,0.0005256327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021385709,0.00017608819,0.9163336,0.00014942771,0.0004436154,0.0005298289,0.0004865202,0.0001735744,0.036974676,0.0005885626,0.0013908044,0.040614724],"study_design_scores_gemma":[0.0000178702,0.0003037776,0.9839886,0.00003845549,0.00020641013,0.0015999508,0.0002895906,0.0003580911,0.008983379,0.0005921564,0.0036030165,0.000018790604],"about_ca_topic_score_codex":0.0013463263,"about_ca_topic_score_gemma":0.0016078791,"teacher_disagreement_score":0.0033211934,"about_ca_system_score_codex":0.00022032972,"about_ca_system_score_gemma":0.00024992306,"threshold_uncertainty_score":0.011110544},"labels":[],"label_agreement":null},{"id":"W3015964023","doi":"10.3324/haematol.2019.242206","title":"Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma","year":2020,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Medical Research Council; King's Health Partners; Blood Cancer UK; University of Southampton; BC Cancer Agency; Engineering and Physical Sciences Research Council; European Hematology Association; National Institute for Health and Care Research; Department of Health and Social Care; Cancer Research UK; King's College London; Queen Mary University of London","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Positron emission tomography; Cancer research; Medicine; Biology; Pathology; Nuclear medicine","score_opus":0.01638253983460799,"score_gpt":0.24610225658477844,"score_spread":0.22971971675017044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015964023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77279687,0.010475057,0.002229476,0.17181216,0.00254233,0.00009468829,0.0003670343,0.00015844908,0.039523944],"genre_scores_gemma":[0.98240095,0.001185158,0.0008316399,0.011225822,0.003181296,0.000017449143,0.00007906258,0.000026173142,0.0010525293],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.999138,0.0002800009,0.00010025768,0.00012071791,0.00012368702,0.0002373922],"domain_scores_gemma":[0.9975909,0.0015266776,0.00017875218,0.0001291552,0.00024697106,0.0003275644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084626366,0.0004847063,0.00075357396,0.0010192634,0.0009268461,0.0014575196,0.0008624755,0.004987603,0.0018804749],"category_scores_gemma":[0.007127483,0.00040904304,0.0004708468,0.0008590459,0.0012582246,0.000952708,0.0005876967,0.0025474885,0.00072950893],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000485997,0.000060913593,0.06347883,0.00009584919,0.000035063367,0.89969724,0.00042560938,0.0005205166,0.0043631475,0.0014641267,0.016281717,0.01309104],"study_design_scores_gemma":[0.000084334446,0.000113260154,0.029445086,0.00009755129,0.00006327899,0.95058817,0.00074335793,0.0028517097,0.001560334,0.0034683645,0.0109596485,0.000024793455],"about_ca_topic_score_codex":0.001722254,"about_ca_topic_score_gemma":0.0019313248,"teacher_disagreement_score":0.004987603,"about_ca_system_score_codex":0.0014925274,"about_ca_system_score_gemma":0.00047798848,"threshold_uncertainty_score":0.010829091},"labels":[],"label_agreement":null},{"id":"W3021433538","doi":"10.3324/haematol.2019.230771","title":"International recommendations on the diagnosis and treatment of acquired hemophilia A","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":373,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novo Nordisk","keywords":"Medicine; Partial thromboplastin time; Autoantibody; Rituximab; Cyclophosphamide; Internal medicine; Recombinant factor VIIa; Factor IX; Coagulation; Prothrombin time; Immunology; Gastroenterology; Antibody; Chemotherapy","score_opus":0.15131201299746294,"score_gpt":0.36058468039560293,"score_spread":0.20927266739814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021433538","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024629792,0.4034822,0.017204635,0.29187417,0.050285015,0.0024150852,0.0077822744,0.0012212148,0.22327244],"genre_scores_gemma":[0.02762002,0.41617683,0.16342807,0.23557156,0.017530449,0.007138203,0.027950807,0.00069895876,0.10388515],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9893055,0.0037868582,0.002331133,0.00038002984,0.0034541364,0.0007423251],"domain_scores_gemma":[0.9819292,0.0038733755,0.002345901,0.00067730615,0.009650085,0.0015240734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011528927,0.0016812275,0.0016949793,0.0044260137,0.0009787971,0.0019944108,0.0052834284,0.0077954996,0.0129923755],"category_scores_gemma":[0.020165391,0.0006845326,0.0029204574,0.0037155095,0.0013459617,0.0016944032,0.0017302114,0.0079147015,0.007494606],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011775511,0.00025373203,0.0011671367,0.0023735499,0.0001019738,0.00036582322,0.00018363721,0.0005797315,0.0005878437,0.0063363,0.735354,0.2525786],"study_design_scores_gemma":[0.00011420038,0.00007148624,0.0026533133,0.0065828995,0.00014205286,0.00051391963,0.00014163066,0.00014208944,0.00021273612,0.0025831705,0.98681426,0.000028181761],"about_ca_topic_score_codex":0.01614394,"about_ca_topic_score_gemma":0.012565729,"teacher_disagreement_score":0.01614394,"about_ca_system_score_codex":0.002377004,"about_ca_system_score_gemma":0.01145503,"threshold_uncertainty_score":0.0609715},"labels":[],"label_agreement":null},{"id":"W3022331569","doi":"10.3324/haematol.2019.240705","title":"Dasatinib response in acute myeloid leukemia is correlated with FLT3/ITD, PTPN11 mutations and a unique gene expression signature","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Rising Tide Foundation; Applebaum Foundation","keywords":"Dasatinib; Myeloid leukemia; Medicine; PTPN11; Cancer research; Leukemia; Oncology; Gene expression profiling; Internal medicine; Gene expression; Gene; Biology; Cancer; KRAS; Imatinib; Genetics","score_opus":0.023620898027407133,"score_gpt":0.2867136705403618,"score_spread":0.26309277251295465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022331569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983664,0.00015393566,0.00031877813,0.000022794527,0.0000014457344,0.000005156565,0.0008937612,0.00001968571,0.0002179919],"genre_scores_gemma":[0.9972204,0.00008161857,0.00039345626,0.000015414838,0.000002279164,0.000008836301,0.0020946474,0.0000030926324,0.00018023018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974555,0.000026952468,0.00003500782,0.000075885844,0.00008147958,0.000035025187],"domain_scores_gemma":[0.99968755,0.00007171543,0.00015267446,0.000021383576,0.00002995092,0.000036844336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015606909,0.00014952212,0.00029708084,0.0004288126,0.00010883432,0.00024858772,0.00010525811,0.00018975939,0.0007701185],"category_scores_gemma":[0.00047495362,0.00008233306,0.0001738068,0.00066587934,0.0001397413,0.000097128184,0.00016171257,0.00023642214,0.00019793058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001634144,0.00018785165,0.52173585,0.0001460304,0.00022419884,0.00030527904,0.00006151473,0.004480914,0.44390076,0.000107331594,0.00073897163,0.026477154],"study_design_scores_gemma":[0.000014802501,0.00021662436,0.96228313,0.0000027525216,0.000055626788,0.000806773,0.000037035043,0.004464288,0.031193458,0.00011794039,0.00079958135,0.000007931675],"about_ca_topic_score_codex":0.00056596735,"about_ca_topic_score_gemma":0.0011364666,"teacher_disagreement_score":0.0007701185,"about_ca_system_score_codex":0.00020167127,"about_ca_system_score_gemma":0.00013759636,"threshold_uncertainty_score":0.0025762916},"labels":[],"label_agreement":null},{"id":"W3022745897","doi":"10.3324/haematol.2019.243063","title":"Immunological consequences of extramedullary erythropoiesis: immunoregulatory functions of CD71<sup>+</sup> erythroid cells","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Erythropoiesis; Ineffective erythropoiesis; Transferrin receptor; Immunology; Iron Isotopes; Medicine; Transferrin; Anemia; Internal medicine; Physics","score_opus":0.03414929395453651,"score_gpt":0.2531330761790776,"score_spread":0.2189837822245411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022745897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98924834,0.0051425043,0.0016143243,0.00024098168,0.00004454262,0.000011825649,0.00005009796,0.000023654353,0.003623639],"genre_scores_gemma":[0.9973648,0.0008262925,0.00058118114,0.00007263259,0.000050964987,0.00000658422,0.000055358756,0.0000043805017,0.0010377442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998474,0.00004914247,0.000012251896,0.000015838086,0.000028780936,0.000046579542],"domain_scores_gemma":[0.9999087,0.00002133379,0.000017341123,0.000011587195,0.000014329482,0.000026811418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024151125,0.00020350225,0.0001661422,0.00022903517,0.00020206391,0.00039540214,0.00015094907,0.00029445783,0.0018176144],"category_scores_gemma":[0.00021533179,0.00006152903,0.0001487291,0.00012359748,0.00021675971,0.00030629654,0.00022318069,0.00047128194,0.00021955863],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097094104,0.000060490656,0.0036119225,0.00011783627,0.000013897495,0.0012553167,0.00006112641,0.000081138896,0.9811369,0.0015631245,0.00013374531,0.010993556],"study_design_scores_gemma":[0.00011601133,0.0015865891,0.08813662,0.000047467052,0.00011293575,0.015502365,0.0004986619,0.0011909552,0.88126755,0.0012778315,0.010248348,0.000014667954],"about_ca_topic_score_codex":0.00011125349,"about_ca_topic_score_gemma":0.00014087086,"teacher_disagreement_score":0.0018176144,"about_ca_system_score_codex":0.0001775815,"about_ca_system_score_gemma":0.00009964257,"threshold_uncertainty_score":0.006080508},"labels":[],"label_agreement":null},{"id":"W3025072273","doi":"10.3324/haematol.2019.238675","title":"Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"National Cancer Institute","keywords":"Brentuximab vedotin; Medicine; Rituximab; Prednisone; Internal medicine; Cyclophosphamide; Oncology; Lymphoma; Vincristine; Regimen; B-cell lymphoma; CD30; Gastroenterology; Surgery; Chemotherapy","score_opus":0.010123700756752741,"score_gpt":0.22607936747927676,"score_spread":0.21595566672252403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025072273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911404,0.007126053,0.00035299017,0.0003160459,0.00008066655,0.00023886263,0.00013209703,0.000048721442,0.0005640724],"genre_scores_gemma":[0.9943031,0.0029350952,0.0011355204,0.0003167449,0.00014916548,0.0002065766,0.00042007264,0.000010896806,0.0005229058],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996437,0.0001828372,0.000024997951,0.000052829342,0.000044566255,0.00005105582],"domain_scores_gemma":[0.9995641,0.00008337854,0.00008171736,0.000029274146,0.0000221532,0.0002193259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012057729,0.0007272776,0.001143248,0.00032499,0.00022571698,0.0006261954,0.0007064171,0.00044391738,0.0008466004],"category_scores_gemma":[0.0006596992,0.00032847337,0.0005590972,0.00028775362,0.00038523073,0.00056138297,0.00023311719,0.0016137457,0.00027717187],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2716695,0.030347893,0.024624513,0.0013987548,0.0016455728,0.00085764483,0.00051846483,0.0062060966,0.06191503,0.00032040206,0.0045368136,0.59595925],"study_design_scores_gemma":[0.37389073,0.5378444,0.060573384,0.00015671826,0.0012475839,0.0016791999,0.00013025549,0.0061723078,0.008818871,0.0002980677,0.009126871,0.00006154178],"about_ca_topic_score_codex":0.0004977771,"about_ca_topic_score_gemma":0.0016728864,"teacher_disagreement_score":0.0012057729,"about_ca_system_score_codex":0.00048474624,"about_ca_system_score_gemma":0.00052061776,"threshold_uncertainty_score":0.006376803},"labels":[],"label_agreement":null},{"id":"W3031629527","doi":"10.3324/haematol.2019.242735","title":"Kreuth V initiative: European consensus proposals for treatment of hemophilia using standard products, extended half-life coagulation factor concentrates and non-replacement therapies","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Medicine; Context (archaeology); Health care; Regimen; Intensive care medicine; Family medicine; Surgery; Political science","score_opus":0.15696893263582237,"score_gpt":0.36237707985624673,"score_spread":0.20540814722042436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031629527","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011958805,0.19478223,0.12858792,0.44111732,0.0717361,0.010137611,0.017100075,0.0025406545,0.12203929],"genre_scores_gemma":[0.07092262,0.0851744,0.44983995,0.24126756,0.0099726515,0.010839885,0.05530692,0.0018199215,0.074856095],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9457287,0.019922089,0.009746531,0.0024457602,0.01818667,0.003970152],"domain_scores_gemma":[0.94854033,0.013980686,0.0076472173,0.002586422,0.02104316,0.0062022614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10109213,0.001588964,0.0019870016,0.0054810992,0.0014617529,0.007958639,0.009975165,0.012198607,0.005342871],"category_scores_gemma":[0.06311048,0.0010545986,0.004939935,0.0047262064,0.002553169,0.0032399152,0.007878391,0.0096822055,0.0034642136],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005591145,0.00048126085,0.0029053367,0.0067143636,0.00039802387,0.0008378647,0.0019990976,0.0023926217,0.002547512,0.061670814,0.6308726,0.2886214],"study_design_scores_gemma":[0.00030255588,0.00021939045,0.003787993,0.010193092,0.00034166212,0.00047162815,0.000669358,0.00043643068,0.0013804259,0.010644125,0.97143966,0.00011376921],"about_ca_topic_score_codex":0.015802424,"about_ca_topic_score_gemma":0.009294,"teacher_disagreement_score":0.10109213,"about_ca_system_score_codex":0.0070801247,"about_ca_system_score_gemma":0.05921498,"threshold_uncertainty_score":0.5346327},"labels":[],"label_agreement":null},{"id":"W3033337455","doi":"10.3324/haematol.2020.249243","title":"Epigenetic and functional changes imposed by NUP98-HOXA9 in a genetically engineered model of chronic myeloid leukemia progression","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; Terry Fox Research Institute; BC Cancer Agency","funders":"BC Cancer Agency; Université Paris-Est Créteil Val-de-Marne; Université Paris-Sud; Terry Fox Research Institute; Institut National de la Santé et de la Recherche Médicale; Canadian Institutes of Health Research; Canada's Michael Smith Genome Sciences Centre","keywords":"Myeloid leukemia; Epigenetics; Genetically engineered; Cancer research; Leukemia; Biology; Medicine; Computational biology; Bioinformatics; Immunology; Genetics; Gene","score_opus":0.0364780637644815,"score_gpt":0.27953285423043717,"score_spread":0.24305479046595568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033337455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966708,0.0002128038,0.001932208,0.00006854127,0.000034085675,0.000015692327,0.000372012,0.000074953205,0.00061890675],"genre_scores_gemma":[0.996642,0.0001255129,0.00082068506,0.000019725388,0.0000034090656,0.000021008524,0.00021237007,0.000022271532,0.0021330114],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981314,0.000028954877,0.000018152587,0.00004672935,0.0000521596,0.000040860108],"domain_scores_gemma":[0.9998436,0.00002637976,0.000057920934,0.000024593259,0.000009042956,0.000038365928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013845223,0.00024398796,0.0002123633,0.00030928993,0.00022865031,0.00036341613,0.0003040136,0.00042545467,0.001804907],"category_scores_gemma":[0.00011084209,0.00014986756,0.00022535982,0.0001871398,0.0003657687,0.00018187397,0.0002901296,0.00074700505,0.00032362435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022019767,0.000056365086,0.000110275,0.00000846616,0.0000028465706,0.00005586238,0.00001233893,0.00014235332,0.9986071,0.0002602875,0.000023357345,0.00050055044],"study_design_scores_gemma":[0.00006255735,0.00040257332,0.0032525314,0.0000036942342,0.000016802418,0.00028281196,0.000053644868,0.0027353272,0.99096817,0.00011190386,0.002101617,0.000008320434],"about_ca_topic_score_codex":0.0008417291,"about_ca_topic_score_gemma":0.0010716312,"teacher_disagreement_score":0.001804907,"about_ca_system_score_codex":0.00030213804,"about_ca_system_score_gemma":0.00019190811,"threshold_uncertainty_score":0.0060380697},"labels":[],"label_agreement":null},{"id":"W3039887493","doi":"10.3324/haematol.2020.252916","title":"ABL-class fusion positive acute lymphoblastic leukemia: can targeting ABL cure ALL?","year":2020,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Cancer Institute","keywords":"ABL; Lymphoblastic Leukemia; Medicine; Cancer research; Class (philosophy); Leukemia; Immunology; Internal medicine; Computer science; Tyrosine kinase; Receptor; Artificial intelligence","score_opus":0.021530595997862858,"score_gpt":0.274821907016485,"score_spread":0.2532913110186222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039887493","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011064243,0.0027560785,0.00012243414,0.9823078,0.0063751373,0.000012522832,0.00005930401,0.00002155955,0.0072387285],"genre_scores_gemma":[0.017625345,0.008608589,0.0006501547,0.89710796,0.060341623,0.000049264687,0.000116508956,0.00004020602,0.015460359],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991266,0.00027167203,0.000085923006,0.00008558941,0.0002386204,0.00019163852],"domain_scores_gemma":[0.9982784,0.00090950145,0.00009627449,0.00005018423,0.00019915446,0.00046647235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013594286,0.0005666445,0.0010301253,0.00047358382,0.0016751727,0.0021148832,0.0009207026,0.023582254,0.006655397],"category_scores_gemma":[0.0062552462,0.00033771453,0.00077525177,0.00035181304,0.0015515581,0.002276084,0.0008206532,0.016176306,0.00487713],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025240134,0.00011504862,0.0022051272,0.00012032055,0.00002984705,0.011852556,0.00012802084,0.00028261327,0.0009518561,0.0131928185,0.9239245,0.046944886],"study_design_scores_gemma":[0.00028940733,0.00020768889,0.0018013034,0.00038227678,0.000055705106,0.0142333675,0.00042624996,0.00083313027,0.00044616708,0.03154204,0.9497346,0.000048086244],"about_ca_topic_score_codex":0.0025403919,"about_ca_topic_score_gemma":0.005500161,"teacher_disagreement_score":0.023582254,"about_ca_system_score_codex":0.0031519576,"about_ca_system_score_gemma":0.0024749306,"threshold_uncertainty_score":0.02286911},"labels":[],"label_agreement":null},{"id":"W3043245960","doi":"10.3324/haematol.2020.247023","title":"Genetic variation near CXCL12 is associated with susceptibility to HIV-related non-Hodgkin lymphoma","year":2020,"lang":"en","type":"review","venue":"Haematologica","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Cancer Institute; National Institutes of Health; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Lymphoma; Genome-wide association study; Immunology; Population; Genetic association; Biology; Case-control study; Chemokine; Genetic variation; Genetics; Oncology; Medicine; Single-nucleotide polymorphism; Genotype; Internal medicine; Gene; Environmental health; Inflammation","score_opus":0.02416659836648613,"score_gpt":0.2900074486349837,"score_spread":0.2658408502684976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043245960","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037285185,0.9990651,0.00003159868,0.00019472797,0.000052375995,0.0000021133467,0.000020754605,0.0000026994978,0.00025772402],"genre_scores_gemma":[0.002166686,0.99738556,0.000059867696,0.0001112126,0.00007900961,0.000003983614,0.00003596348,7.274091e-7,0.00015702826],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99985397,0.00003469495,0.000029472925,0.00002989985,0.000037787402,0.000014230934],"domain_scores_gemma":[0.99965596,0.0001941557,0.000063399195,0.0000069874823,0.000057409343,0.000022037564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042351134,0.00041927802,0.0011087914,0.0014395543,0.00015066737,0.00057065143,0.00050662266,0.00053895486,0.0027416444],"category_scores_gemma":[0.00087915844,0.0001432305,0.000534282,0.0017655375,0.00026450478,0.0003673771,0.0003516075,0.0005721688,0.0005278964],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002376992,0.00004369746,0.0025869764,0.030700576,0.0006326377,0.00025011358,0.00004343749,0.00019893706,0.00060030667,0.00078864204,0.015027132,0.9488898],"study_design_scores_gemma":[0.00018008843,0.00039253797,0.04290666,0.03561313,0.0044091153,0.010174526,0.00021506909,0.00031919457,0.0008193875,0.0026748045,0.9022316,0.00006393058],"about_ca_topic_score_codex":0.0011094286,"about_ca_topic_score_gemma":0.0015611426,"teacher_disagreement_score":0.0027416444,"about_ca_system_score_codex":0.0002972664,"about_ca_system_score_gemma":0.000800838,"threshold_uncertainty_score":0.009171665},"labels":[],"label_agreement":null},{"id":"W3049070288","doi":"10.3324/haematol.2020.255950","title":"Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphoma","year":2020,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; Princess Margaret Cancer Centre; Spinal Cord Injury BC; University Health Network","funders":"BC Cancer Foundation; Princess Margaret Cancer Foundation; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; European Hematology Association; Genome Canada; Hospital for Sick Children; Genome British Columbia","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Central nervous system; Medicine; Pathology; Internal medicine","score_opus":0.02799313388997275,"score_gpt":0.24356126216853355,"score_spread":0.2155681282785608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049070288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78752244,0.015411587,0.0021941538,0.13781966,0.0032343871,0.00017273909,0.0005632907,0.00022744224,0.05285436],"genre_scores_gemma":[0.9690847,0.002913482,0.0010367911,0.017290823,0.005768912,0.00004221755,0.00020174662,0.000027246628,0.0036341988],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9996124,0.00008306477,0.000052132968,0.000046738416,0.00007803674,0.00012772791],"domain_scores_gemma":[0.9990062,0.0004970354,0.000121077486,0.0000854557,0.00013573632,0.00015442261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006042842,0.00037623203,0.00064480276,0.0007823216,0.00080048357,0.0012818316,0.00066533696,0.0041219126,0.001933326],"category_scores_gemma":[0.0026976948,0.0002932842,0.00043887962,0.0006641621,0.0010259999,0.00094638695,0.0005159709,0.0024267246,0.0007177496],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001013334,0.00015954657,0.069070466,0.0002182291,0.00006386353,0.8511531,0.00043678988,0.0005046337,0.011711203,0.0042893332,0.036132693,0.025246846],"study_design_scores_gemma":[0.00019270752,0.00019140636,0.060791254,0.00009343662,0.000117343174,0.89538234,0.00062833243,0.0032740585,0.0036208313,0.006261055,0.029412076,0.000035233752],"about_ca_topic_score_codex":0.00112313,"about_ca_topic_score_gemma":0.0014658644,"teacher_disagreement_score":0.0041219126,"about_ca_system_score_codex":0.0013370164,"about_ca_system_score_gemma":0.0004605541,"threshold_uncertainty_score":0.009700835},"labels":[],"label_agreement":null},{"id":"W3086465642","doi":"10.3324/haematol.2021.279046","title":"Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research","year":2021,"lang":"en","type":"erratum","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre; CancerCare Manitoba; BC Children's Hospital; University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; U.S. Department of Defense; National Heart, Lung, and Blood Institute; University of Minnesota; U.S. Navy; Health Resources and Services Administration","keywords":"Hazard ratio; Internal medicine; Transplantation; Medicine; Monosomy; Cytogenetics; Hematopoietic stem cell transplantation; Leukemia; Oncology; International Prognostic Scoring System; Acute lymphocytic leukemia; Myelodysplastic syndromes; Acute leukemia; Karyotype; Bone marrow; Confidence interval; Biology; Lymphoblastic Leukemia; Genetics","score_opus":0.03173605185265883,"score_gpt":0.319849606834028,"score_spread":0.2881135549813692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3086465642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.808848,0.02475218,0.0014606889,0.025767328,0.04545616,0.00017434047,0.05187464,0.00018457609,0.041482095],"genre_scores_gemma":[0.92443043,0.00715945,0.0010903956,0.008236352,0.0065919785,0.00018281965,0.02123775,0.00014802138,0.030922849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931824,0.00017985614,0.00016568587,0.00008765171,0.00020454597,0.000043993838],"domain_scores_gemma":[0.99384624,0.0035343352,0.0008746926,0.00033380103,0.0011588645,0.00025211452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013316579,0.00026601588,0.00029945586,0.0005204843,0.000341936,0.00053588604,0.0004889204,0.00047894602,0.009376202],"category_scores_gemma":[0.011461404,0.00013124663,0.00032234585,0.001173821,0.00017306443,0.00048376122,0.00021311482,0.0008444822,0.0013837814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036002693,0.00019946616,0.6089691,0.0007325865,0.00030011003,0.0019398034,0.00033047696,0.00021148438,0.00024518324,0.0010519336,0.2957317,0.08668794],"study_design_scores_gemma":[0.0009706277,0.000704582,0.87903565,0.0015540334,0.001118401,0.006546981,0.0009277676,0.00059616315,0.0005912993,0.0013887871,0.106482714,0.00008302912],"about_ca_topic_score_codex":0.0038240168,"about_ca_topic_score_gemma":0.005727435,"teacher_disagreement_score":0.009376202,"about_ca_system_score_codex":0.00029158735,"about_ca_system_score_gemma":0.0004592374,"threshold_uncertainty_score":0.031366527},"labels":[],"label_agreement":null},{"id":"W3093120364","doi":"10.3324/haematol.2020.259093","title":"The survival impact of maintenance lenalidomide: an analysis of real-world data from the Canadian Myeloma Research Group national database","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Dalhousie University; Saint John Regional Hospital; Princess Margaret Cancer Centre; Vancouver General Hospital; McGill University; CancerCare Manitoba; Ottawa Hospital; Université de Montréal; University of Saskatchewan; Queen Elizabeth II Health Sciences Centre; University of Alberta","funders":"Dalhousie University; University of Alberta; Celgene; Sanofi; Amgen; Pfizer; McGill University","keywords":"Lenalidomide; Multiple myeloma; Medicine; Database; Oncology; Internal medicine; Computer science","score_opus":0.33194027255700204,"score_gpt":0.4670194784622977,"score_spread":0.13507920590529565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093120364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7617296,0.008330049,0.0002817824,0.0018795761,0.00003945331,0.00010111979,0.22590472,0.000052465755,0.0016812369],"genre_scores_gemma":[0.8695271,0.002426562,0.00060888357,0.0003477766,0.000025483158,0.00006656043,0.12672071,0.00002357135,0.00025331805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941731,0.00087437296,0.00070189196,0.0009725266,0.0023144397,0.00096368656],"domain_scores_gemma":[0.9840703,0.004840801,0.003777912,0.0012257607,0.0048557743,0.0012294103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004732729,0.00062652846,0.0015224743,0.0040817866,0.0010747019,0.002391202,0.002667307,0.0009342253,0.0014514972],"category_scores_gemma":[0.024107805,0.0004321041,0.0017403946,0.013904301,0.0007269955,0.0010791349,0.0012152437,0.0011861336,0.0002224645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014148512,0.00006620038,0.97166497,0.0005734605,0.0020911018,0.00013502172,0.00025912467,0.0022575364,0.00009385133,0.00045043183,0.0123072835,0.008686157],"study_design_scores_gemma":[0.000121498655,0.00004948902,0.98997086,0.00016201296,0.00062845554,0.00019626503,0.0004512944,0.0037278978,0.00007397114,0.00011956094,0.0044509335,0.00004783434],"about_ca_topic_score_codex":0.92089826,"about_ca_topic_score_gemma":0.94245297,"teacher_disagreement_score":0.07910174,"about_ca_system_score_codex":0.01987786,"about_ca_system_score_gemma":0.026441608,"threshold_uncertainty_score":0.1591351},"labels":[],"label_agreement":null},{"id":"W3093257661","doi":"10.3324/haematol.2020.253740","title":"Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Interleukin-3 receptor; RUNX1; Myeloid; CD34; Myeloid leukemia; Chronic myelomonocytic leukemia; Phenotype; Plasmacytoid dendritic cell; Cancer research; Leukemia; Biology; Immunology; Immunophenotyping; Gene; Haematopoiesis; Flow cytometry; Dendritic cell; Antigen; Bone marrow; Myelodysplastic syndromes; Stem cell; Genetics","score_opus":0.012032518843336238,"score_gpt":0.21571780718578654,"score_spread":0.2036852883424503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093257661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99899954,0.00019250726,0.00020540462,0.000005467123,7.824286e-7,0.0000074195686,0.000113325455,0.000004097983,0.00047151037],"genre_scores_gemma":[0.9993462,0.000095771575,0.00020853004,0.000005800284,0.0000029156313,0.000005283304,0.0001766756,0.0000021240576,0.00015675374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987674,0.000015961403,0.000014184591,0.00003910095,0.000028564607,0.00002537146],"domain_scores_gemma":[0.9998832,0.00002181313,0.000031770473,0.00001480179,0.000018124,0.000030204867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001123008,0.00010582905,0.00012012491,0.0006938851,0.00015746374,0.00026434267,0.000108759516,0.00020441976,0.0012989203],"category_scores_gemma":[0.00029057806,0.000073896466,0.00007749131,0.00035330115,0.00014908079,0.00010586114,0.000218986,0.00011070931,0.00030072042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084253045,0.00007710328,0.6638136,0.000076115364,0.00003473233,0.0024717173,0.00038102173,0.00019523926,0.31315354,0.00034082725,0.0001671101,0.018446509],"study_design_scores_gemma":[0.000021632994,0.00025384212,0.94758147,0.000011884181,0.000041576423,0.022197705,0.00037817677,0.00075393525,0.024874931,0.00035260813,0.003523619,0.000008629764],"about_ca_topic_score_codex":0.00020428804,"about_ca_topic_score_gemma":0.00022396662,"teacher_disagreement_score":0.0012989203,"about_ca_system_score_codex":0.00012820914,"about_ca_system_score_gemma":0.00006118078,"threshold_uncertainty_score":0.0043453574},"labels":[],"label_agreement":null},{"id":"W3094388801","doi":"10.3324/haematol.2020.260158","title":"Recapitulation of erythropoiesis in congenital dyserythropoietic anemia type I (CDA-I) identifies defects in differentiation and nucleolar abnormalities","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Biotechnology and Biological Sciences Research Council; University of Oxford; Wellcome Trust; Academy of Medical Sciences; Medical Research Council; Engineering and Physical Sciences Research Council; National Institute for Health and Care Research","keywords":"Erythropoiesis; Ineffective erythropoiesis; Nucleolus; Biology; Chromatin; Pathognomonic; Cell biology; Erythroblast; Abnormality; Cellular differentiation; Genetics; Gene; Cancer research; Anemia; Haematopoiesis; Pathology; Disease; Stem cell; Medicine; Internal medicine","score_opus":0.029735586862759796,"score_gpt":0.25875963826862114,"score_spread":0.22902405140586135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094388801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775988,0.0031536075,0.013985423,0.00020390903,0.00011604909,0.00012098712,0.0012353285,0.00020359541,0.003382259],"genre_scores_gemma":[0.98677295,0.0013488466,0.008040926,0.00007227009,0.00001048248,0.00006241841,0.00093274424,0.000046357916,0.002713003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977225,0.00004667689,0.000032529802,0.000059240298,0.00005897187,0.000030318304],"domain_scores_gemma":[0.9998104,0.000052814274,0.000057501395,0.00003575597,0.000011247639,0.00003241936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022836096,0.0002839286,0.000225492,0.00040021524,0.00018496648,0.0002713064,0.0003045317,0.00031988812,0.0013415994],"category_scores_gemma":[0.00024326207,0.00012720923,0.00027048792,0.00019067967,0.0004053353,0.00015050454,0.0005361098,0.00065992464,0.00041550846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043820633,0.000019535737,0.0006225656,0.000043728378,0.0000078494995,0.00043437222,0.000049018967,0.00010291199,0.9959603,0.00043239043,0.00010475347,0.0021788017],"study_design_scores_gemma":[0.000017378266,0.0005080868,0.014710625,0.000025658414,0.000027858587,0.006521286,0.00010227234,0.00085488905,0.96765643,0.00018996937,0.009373414,0.000012052689],"about_ca_topic_score_codex":0.00074927293,"about_ca_topic_score_gemma":0.0014270779,"teacher_disagreement_score":0.0013415994,"about_ca_system_score_codex":0.0002649553,"about_ca_system_score_gemma":0.00022594762,"threshold_uncertainty_score":0.0044881105},"labels":[],"label_agreement":null},{"id":"W3097563180","doi":"10.3324/haematol.2020.261107","title":"Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase Ib study (GO28440)","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Celgene; MorphoSys; F. Hoffmann-La Roche; Pharmacyclics; Genentech; Gilead Sciences; BeiGene; Sanofi; Servier; Amgen; Pfizer; GlaxoSmithKline","keywords":"Bendamustine; Ven; Tumor lysis syndrome; Medicine; Venetoclax; Tolerability; Obinutuzumab; Neutropenia; Internal medicine; Chronic lymphocytic leukemia; Gastroenterology; Discontinuation; Rituximab; Leukemia; Toxicity; Chemotherapy; Lymphoma; Adverse effect","score_opus":0.12996967499448986,"score_gpt":0.3799866589269263,"score_spread":0.25001698393243643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097563180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952343,0.0026983002,0.00020739631,0.00013043064,0.00003326617,0.00039760987,0.00034996629,0.000047183647,0.00090150046],"genre_scores_gemma":[0.99262893,0.002756357,0.0010106494,0.0002665891,0.000095317984,0.00044672063,0.0013610658,0.000018913783,0.0014153278],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99966705,0.0001856955,0.000013830224,0.000036780704,0.000028718612,0.0000679138],"domain_scores_gemma":[0.9996358,0.00008754997,0.00006166028,0.000023602257,0.000016602606,0.00017482821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014476444,0.0007115839,0.0012104333,0.00034582656,0.00021446607,0.00062833016,0.00058519235,0.0006488789,0.0017244393],"category_scores_gemma":[0.00048207547,0.00031587717,0.00051084167,0.00035058142,0.00054063473,0.00040716285,0.00017666948,0.0016643727,0.00033625533],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55853844,0.069754444,0.008020387,0.0013107477,0.001338939,0.0004264137,0.000371194,0.0035020937,0.119808786,0.00034729138,0.0037196795,0.23286164],"study_design_scores_gemma":[0.33202854,0.6331796,0.019380948,0.0000719258,0.00060765754,0.0004731652,0.000053686428,0.0011530231,0.00873213,0.00014967383,0.0041394685,0.000030121791],"about_ca_topic_score_codex":0.0013133254,"about_ca_topic_score_gemma":0.0039650165,"teacher_disagreement_score":0.0017244393,"about_ca_system_score_codex":0.0006630146,"about_ca_system_score_gemma":0.0008009723,"threshold_uncertainty_score":0.007655978},"labels":[],"label_agreement":null},{"id":"W3114964641","doi":"10.3324/haematol.2020.265827","title":"Genome wide association study of silent cerebral infarction in sickle cell disease (HbSS and HbSC)","year":2020,"lang":"en","type":"letter","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Medical Research Council","keywords":"Medicine; Disease; Cerebral infarction; Genome-wide association study; Internal medicine; Genetics; Biology; Gene; Ischemia; Genotype; Single-nucleotide polymorphism","score_opus":0.012474983673794293,"score_gpt":0.22541386323852364,"score_spread":0.21293887956472934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114964641","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032417625,0.0039528795,0.00035329975,0.92812765,0.01134878,0.000048851074,0.0015785082,0.00006595968,0.022106478],"genre_scores_gemma":[0.24184962,0.0039015342,0.000946278,0.6760775,0.03344213,0.00015019285,0.0010971543,0.00007234557,0.042463202],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9989778,0.00045387767,0.00011118518,0.00012251454,0.00018124685,0.00015343205],"domain_scores_gemma":[0.9958525,0.0026080075,0.00023178275,0.00018572829,0.00049621717,0.0006258272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013921957,0.00025877258,0.00084518216,0.00049671327,0.0019716995,0.00079693226,0.0006386796,0.011510091,0.0062269345],"category_scores_gemma":[0.007285959,0.00029702135,0.00038098468,0.00054088345,0.00075149717,0.0006304784,0.0004361265,0.0052320245,0.0031988532],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011363053,0.00017861644,0.06169741,0.00010189757,0.00012886836,0.05185646,0.00038070697,0.0001449326,0.0013852288,0.0029331713,0.85375065,0.026305696],"study_design_scores_gemma":[0.0015339687,0.0011056152,0.23522426,0.0008759876,0.0004901961,0.096641995,0.0023577977,0.0029397213,0.0018599511,0.022759128,0.6340329,0.00017843724],"about_ca_topic_score_codex":0.0119337635,"about_ca_topic_score_gemma":0.019692466,"teacher_disagreement_score":0.0119337635,"about_ca_system_score_codex":0.0010594184,"about_ca_system_score_gemma":0.0011588582,"threshold_uncertainty_score":0.02372861},"labels":[],"label_agreement":null},{"id":"W3115671232","doi":"10.3324/haematol.2020.267757","title":"Symptom burden in transplant-ineligible patients with newly diagnosed multiple myeloma: a population-based cohort study","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"Ontario Ministry of Health and Long-Term Care; Amgen; McMaster University; Cancer Care Ontario; Celgene; Sanofi","keywords":"Medicine; Multiple myeloma; Cohort; Internal medicine; Population; Oncology; Environmental health","score_opus":0.021667831886878514,"score_gpt":0.27253379591813964,"score_spread":0.25086596403126116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115671232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99677974,0.00038084228,0.00008621769,0.00007271989,0.000011450328,0.000019830277,0.00225669,0.000004010334,0.00038850002],"genre_scores_gemma":[0.99779737,0.00016513202,0.000045678036,0.000080333535,0.00001640509,0.000024456782,0.0016961185,0.0000026827377,0.00017180252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935085,0.00014868769,0.00008364983,0.00019293507,0.000091952,0.00013190675],"domain_scores_gemma":[0.9985305,0.00019931972,0.000707067,0.00022149603,0.00009878641,0.0002427879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077234535,0.00031771165,0.0006019736,0.0005329618,0.0006070712,0.0011307079,0.00064094673,0.0006704933,0.0019909523],"category_scores_gemma":[0.002189868,0.0004521406,0.0008379603,0.0016226463,0.00029314778,0.0010302691,0.00061623816,0.0009533837,0.00031310978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046139062,0.0000750036,0.99799156,0.000020031508,0.00021398978,0.00009971504,0.00005635463,0.000031590385,0.0001454178,0.000022724902,0.00028812478,0.00059413293],"study_design_scores_gemma":[0.00006288771,0.00015669323,0.9989128,0.000009897736,0.00011909763,0.00022969372,0.0001229973,0.00010570239,0.000022629561,0.00002757243,0.00022435552,0.0000056835797],"about_ca_topic_score_codex":0.0064225774,"about_ca_topic_score_gemma":0.007671071,"teacher_disagreement_score":0.0064225774,"about_ca_system_score_codex":0.0003981292,"about_ca_system_score_gemma":0.00046955756,"threshold_uncertainty_score":0.012770414},"labels":[],"label_agreement":null},{"id":"W3115869600","doi":"10.3324/haematol.2020.271908","title":"CD38 knockout natural killer cells expressing an affinity optimized CD38 chimeric antigen receptor successfully target acute myeloid leukemia with reduced effector cell fratricide","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Science Foundation Ireland; Irish Cancer Society; Health Research Board; Health Service Executive; Wellcome Trust; Canadian Institute for Theoretical Astrophysics","keywords":"CD38; Chimeric antigen receptor; Myeloid leukemia; Cancer research; Leukemia; Interleukin 12; Lymphokine-activated killer cell; Biology; Cytotoxic T cell; Immunology; Immunotherapy; Interleukin 21; Antigen; Cell biology; Stem cell; Immune system; CD8; CD34; In vitro; Biochemistry","score_opus":0.011177358172089646,"score_gpt":0.22384499296343946,"score_spread":0.2126676347913498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115869600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982767,0.000582877,0.013264765,0.00014453976,0.000032290725,0.00006970309,0.0003846178,0.00032778672,0.002426423],"genre_scores_gemma":[0.9887405,0.00033457173,0.0048539042,0.000036752714,0.000004698155,0.00004652536,0.00039255497,0.000039084764,0.0055513578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999866,0.00001430701,0.000012580243,0.000027970897,0.000049291375,0.000029696],"domain_scores_gemma":[0.9999498,0.000008152525,0.000017228556,0.000009171394,0.0000048894044,0.000010695485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010469811,0.0002669852,0.000231414,0.00012724138,0.000094494775,0.00024823958,0.000177451,0.00021236409,0.0017289593],"category_scores_gemma":[0.000082850594,0.0000895837,0.000134601,0.00007373837,0.00020947725,0.00018397569,0.00019064514,0.00056629465,0.00051429804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043671345,0.00001706838,0.0000639632,0.000015946835,0.000002091171,0.000047745445,0.000010128201,0.00012258087,0.9979937,0.00020121262,0.000052175626,0.0014297608],"study_design_scores_gemma":[0.000015749936,0.0001377924,0.0007422374,0.000002153871,0.0000078497715,0.00032866708,0.000010825464,0.000999918,0.9931492,0.00006656023,0.0045367023,0.0000023762775],"about_ca_topic_score_codex":0.00034973887,"about_ca_topic_score_gemma":0.00051709375,"teacher_disagreement_score":0.0017289593,"about_ca_system_score_codex":0.00023187141,"about_ca_system_score_gemma":0.0001821315,"threshold_uncertainty_score":0.0057839155},"labels":[],"label_agreement":null},{"id":"W3118040066","doi":"10.3324/haematol.2020.270595","title":"Molecular and phenotypic diversity of &lt;I&gt;CBL&lt;/I&gt;-mutated juvenile myelomonocytic leukemia","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Alberta Children's Hospital","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; York University; European Hematology Association","keywords":"Juvenile myelomonocytic leukemia; Phenotype; Cancer research; Juvenile; Biology; Genetics; Molecular biology; Gene; Haematopoiesis","score_opus":0.029000979285829294,"score_gpt":0.26218188366792006,"score_spread":0.23318090438209077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118040066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992867,0.0001609794,0.00009592829,0.000010951298,8.7349946e-7,0.0000047105523,0.00012612063,0.000004134291,0.0003096187],"genre_scores_gemma":[0.99970955,0.00006142378,0.00006892014,0.00000791846,0.0000025427853,0.0000025313143,0.00009817354,0.00000253386,0.000046516703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981207,0.000027197242,0.00002274344,0.000053146417,0.000038582482,0.000046242363],"domain_scores_gemma":[0.9996722,0.00009254946,0.00010172066,0.000027333264,0.00002544734,0.000080738784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022424653,0.00018541588,0.00022784705,0.00093928765,0.00021929291,0.00044910025,0.00016659971,0.00015398792,0.0009632141],"category_scores_gemma":[0.00067764614,0.000091125774,0.00012123573,0.00035101385,0.00029559503,0.00015710035,0.00027952334,0.00016883377,0.00014414052],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037271206,0.000037628157,0.89511925,0.00003222389,0.000061242696,0.005497886,0.00034260776,0.00024779036,0.0873919,0.00015771796,0.00018074972,0.010558257],"study_design_scores_gemma":[0.000011693297,0.00016390107,0.97279674,0.000008572705,0.000046361904,0.02136432,0.00031583724,0.0003293327,0.0041356315,0.00011006106,0.000709798,0.000007709613],"about_ca_topic_score_codex":0.00088074896,"about_ca_topic_score_gemma":0.0013528649,"teacher_disagreement_score":0.0009632141,"about_ca_system_score_codex":0.00021847984,"about_ca_system_score_gemma":0.00012240921,"threshold_uncertainty_score":0.0032222867},"labels":[],"label_agreement":null},{"id":"W3118088258","doi":"10.3324/haematol.2020.271619","title":"Epigenetic changes in human model KMT2A leukemias highlight early events during leukemogenesis","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hôpital Maisonneuve-Rosemont; Université de Montréal; Université Laval; Centre hospitalier de l'Université Laval; Hôpital de l'Enfant-Jésus; Institute for Research in Immunology and Cancer","funders":"Université de Montréal; CHU Sainte-Justine Foundation; Molson Foundation","keywords":"Biology; Epigenetics; Epigenome; Genetics; Cancer research; DNA methylation; Chromatin; Regulation of gene expression; Epigenomics; Transcription factor; Demethylase; Histone; Gene expression; Gene","score_opus":0.05493851507936829,"score_gpt":0.2996878199912756,"score_spread":0.2447493049119073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118088258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990547,0.0010818555,0.0036362663,0.00006176484,0.000014321291,0.000037763795,0.0035999413,0.00015737902,0.0008636305],"genre_scores_gemma":[0.99130297,0.0005721651,0.0019603393,0.000054754753,0.0000034896682,0.000063519896,0.0046997694,0.000031856485,0.0013110773],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999299,0.0000071577056,0.000005472449,0.000022854885,0.000022570337,0.00001204501],"domain_scores_gemma":[0.9999671,0.0000063196658,0.0000091024185,0.000005940486,0.000004752026,0.0000068175787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008982363,0.00014382336,0.00018084023,0.00022424804,0.00014582461,0.0002007701,0.00008530102,0.00019083427,0.001441426],"category_scores_gemma":[0.000076498145,0.000089848996,0.00019777137,0.00024010224,0.00011404558,0.00006123682,0.00015528339,0.00024969658,0.00033509894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001787982,0.000024469846,0.0011056295,0.000029238376,0.00000887843,0.00007935235,0.000031870866,0.00031117396,0.99657625,0.00008082812,0.00011388444,0.0014596606],"study_design_scores_gemma":[0.000051999992,0.0007195849,0.04513548,0.000010064848,0.0000444109,0.001237789,0.00015299178,0.0045134476,0.9374008,0.0002742789,0.010444195,0.000014968188],"about_ca_topic_score_codex":0.0012051,"about_ca_topic_score_gemma":0.0015410513,"teacher_disagreement_score":0.001441426,"about_ca_system_score_codex":0.00021855274,"about_ca_system_score_gemma":0.00010067223,"threshold_uncertainty_score":0.0048220158},"labels":[],"label_agreement":null},{"id":"W3119553533","doi":"10.3324/haematol.2020.271106","title":"Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burden","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"GlaxoSmithKline; Amgen","keywords":"Medicine; Evans syndrome; Hazard ratio; Confidence interval; Pediatrics; Thrombocytopenic purpura; Internal medicine; Proportional hazards model; Autoimmune hemolytic anemia; Cohort; Anemia; Prospective cohort study; Platelet","score_opus":0.022778601063894725,"score_gpt":0.2802806230786389,"score_spread":0.25750202201474415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119553533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99903023,0.0005485487,0.000051580326,0.000033949174,0.0000022106162,0.0000019493204,0.00017262052,0.0000021477952,0.00015672928],"genre_scores_gemma":[0.9993773,0.00015200565,0.000023952956,0.000015855887,0.000006208692,0.0000029095168,0.00036852632,9.360537e-7,0.00005236029],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956435,0.00011680094,0.00004101436,0.00009005884,0.000078216435,0.00010961786],"domain_scores_gemma":[0.99829954,0.00035841655,0.0007677197,0.00010154467,0.00015875134,0.00031407777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069728045,0.00016223335,0.00036099867,0.00046196044,0.00033278504,0.00043614436,0.00022493563,0.00039556558,0.0005707529],"category_scores_gemma":[0.002047362,0.00012590963,0.00030640926,0.00059568003,0.00017453403,0.0005057392,0.00039466197,0.00047800897,0.00014327366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012074175,0.000017701868,0.9971296,0.0000043768464,0.000028915963,0.0002385897,0.000050431587,0.000047176894,0.00011807915,0.0000075124676,0.000055597087,0.0021812702],"study_design_scores_gemma":[0.000004476707,0.00011595223,0.99882954,0.0000056482877,0.000031401098,0.0006319822,0.000069328096,0.00009775058,0.00004248548,0.000012851282,0.0001556607,0.0000029439736],"about_ca_topic_score_codex":0.0033314626,"about_ca_topic_score_gemma":0.00300994,"teacher_disagreement_score":0.0033314626,"about_ca_system_score_codex":0.00039767777,"about_ca_system_score_gemma":0.00027234099,"threshold_uncertainty_score":0.0066241026},"labels":[],"label_agreement":null},{"id":"W3120252752","doi":"10.3324/haematol.2020.269944","title":"Reversible switching of leukemic cells to a drug-resistant, stem-like subset via IL-4-mediated cross-talk with mesenchymal stroma","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"College of Medicine, Catholic University of Korea; Seoul National University","keywords":"Mesenchymal stem cell; Stroma; Stromal cell; Cancer research; Biology; Cell biology; Progenitor cell; Cell; Stem cell; Immunology; Genetics","score_opus":0.01705753678729018,"score_gpt":0.25828674109819205,"score_spread":0.24122920431090186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120252752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99711835,0.00031508447,0.0016934704,0.00003388084,0.0000042686943,0.000016930415,0.000038093545,0.0000416982,0.00073830324],"genre_scores_gemma":[0.9989429,0.000074578704,0.00045170492,0.000018179559,0.0000027421152,0.000010112661,0.000040576597,0.0000039679735,0.00045528766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998479,0.000038457823,0.000010428484,0.00002722297,0.000040272254,0.00003569653],"domain_scores_gemma":[0.9999325,0.000018950506,0.000018664126,0.000012229778,0.000005079455,0.00001248546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009909375,0.00015278334,0.00014395399,0.00020408558,0.00011504302,0.0003406441,0.00011240836,0.00012399447,0.0013589517],"category_scores_gemma":[0.00011979992,0.00009258679,0.00012865983,0.000115524286,0.00014230859,0.00013858841,0.00024456534,0.00033247937,0.00016871774],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006661412,0.000019673376,0.0010120209,0.000009522619,0.000005057053,0.00011579525,0.000026917283,0.000065012384,0.9965407,0.0001729913,0.000022318402,0.0019432718],"study_design_scores_gemma":[0.000014584692,0.00027345476,0.009600768,0.0000025556624,0.000016194068,0.00088169717,0.000054921504,0.0013440778,0.98625946,0.00008749079,0.0014624255,0.0000023023576],"about_ca_topic_score_codex":0.00011774324,"about_ca_topic_score_gemma":0.00022774018,"teacher_disagreement_score":0.0013589517,"about_ca_system_score_codex":0.00013666796,"about_ca_system_score_gemma":0.00008641539,"threshold_uncertainty_score":0.0045461655},"labels":[],"label_agreement":null},{"id":"W3120771996","doi":"10.3324/haematol.2020.268656","title":"Comparison of CD38 antibodies &lt;i&gt;in vitro&lt;/i&gt; and &lt;i&gt;ex vivo&lt;/i&gt; mechanisms of action in multiple myeloma","year":2021,"lang":"en","type":"letter","venue":"Haematologica","topic":"Calcium signaling and nucleotide metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Servier; Celgene; Sanofi; Bristol-Myers Squibb; Amgen","keywords":"Ex vivo; In vivo; Antibody; CD38; In vitro; Multiple myeloma; Chemistry; Cancer research; Molecular biology; Biology; Medicine; Internal medicine; Immunology; Genetics; Biochemistry; Stem cell","score_opus":0.03111439075457691,"score_gpt":0.27740873787342607,"score_spread":0.24629434711884915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120771996","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07715775,0.042961396,0.0035728812,0.72561854,0.08219592,0.00026106386,0.0010197073,0.00055052276,0.06666226],"genre_scores_gemma":[0.43777767,0.02478388,0.0044136303,0.35034743,0.11201302,0.0005862004,0.0010399419,0.00027098355,0.06876726],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99949217,0.00015103612,0.00006206804,0.00005341997,0.00016123883,0.000080086334],"domain_scores_gemma":[0.9984743,0.0010341196,0.00007063886,0.0001139954,0.00018327324,0.00012365119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010219282,0.0004877946,0.00074433634,0.00042903423,0.00052424846,0.00091813545,0.0010587303,0.0049249544,0.004229149],"category_scores_gemma":[0.0026920035,0.00021155631,0.00054453313,0.00031427463,0.00056065596,0.0006462877,0.00017740887,0.004013624,0.0021881205],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012728177,0.0016419512,0.00479727,0.0007406418,0.00016466831,0.029450115,0.00026050408,0.0007915745,0.054995924,0.011404027,0.68463534,0.19838989],"study_design_scores_gemma":[0.0025966794,0.0034982467,0.011501188,0.00017334307,0.00033481588,0.019899188,0.00024534718,0.002211461,0.072576545,0.009762235,0.87712574,0.000075283184],"about_ca_topic_score_codex":0.0012837767,"about_ca_topic_score_gemma":0.0022467265,"teacher_disagreement_score":0.0049249544,"about_ca_system_score_codex":0.0019670583,"about_ca_system_score_gemma":0.00045171392,"threshold_uncertainty_score":0.014272094},"labels":[],"label_agreement":null},{"id":"W3126189506","doi":"10.3324/haematol.2020.260059","title":"Sequence-specific 2'-O-methoxyethyl antisense oligonucleotides activate human platelets through glycoprotein VI, triggering formation of platelet-leukocyte aggregates","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Platelet; Platelet activation; Chemistry; Platelet membrane glycoprotein; Glycoprotein; Molecular biology; Phenotype; Platelet Glycoprotein GPIb-IX Complex; Immunology; Pharmacology; Biochemistry; Biology; Gene","score_opus":0.06964216701490133,"score_gpt":0.3171490339214843,"score_spread":0.24750686690658297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126189506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603707,0.001053271,0.0015973991,0.000041383857,0.000027607608,0.00004631445,0.00009627313,0.000033743516,0.0010669618],"genre_scores_gemma":[0.9945714,0.0010643924,0.002147225,0.00006421667,0.000019138371,0.000054848282,0.00023172378,0.000008658682,0.0018383854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998915,0.000028811017,0.000010475069,0.000020941558,0.000027295442,0.000020969615],"domain_scores_gemma":[0.99994385,0.000019513032,0.000017451379,0.000004231773,0.000004836968,0.000010128712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010713155,0.000350809,0.00020001021,0.00011534565,0.000057730653,0.00014403486,0.00009817763,0.00022325176,0.0011112696],"category_scores_gemma":[0.0001230327,0.00010672756,0.00014415673,0.00007941049,0.00010351745,0.00006687552,0.00009510897,0.00030490267,0.00022282857],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076637974,0.00001642372,0.000057345136,0.000018599601,0.0000034361371,0.00001602481,0.000006259273,0.000025991192,0.9989371,0.000023350984,0.000014279167,0.0008045022],"study_design_scores_gemma":[0.000052812513,0.0017874313,0.0019714788,0.0000034645748,0.000016788448,0.00015517414,0.000010425427,0.00031647884,0.99465394,0.00001918702,0.0010107206,0.0000020654288],"about_ca_topic_score_codex":0.00019456068,"about_ca_topic_score_gemma":0.00042822293,"teacher_disagreement_score":0.0011112696,"about_ca_system_score_codex":0.000114224065,"about_ca_system_score_gemma":0.000085464504,"threshold_uncertainty_score":0.0037175417},"labels":[],"label_agreement":null},{"id":"W3128469796","doi":"10.3324/haematol.2020.266791","title":"An early start of Coup-TFII promotes γ-globin gene expression in adult erythroid cells","year":2021,"lang":"en","type":"letter","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research","keywords":"Globin; Gene expression; Gene; Biology; Molecular biology; Cell biology; Genetics","score_opus":0.015347205408942355,"score_gpt":0.24273877922147968,"score_spread":0.22739157381253733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128469796","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13513456,0.015014294,0.0039930777,0.75716436,0.042046413,0.00007367916,0.00043656141,0.00040655324,0.045730527],"genre_scores_gemma":[0.60835326,0.008149279,0.0024480873,0.27173766,0.052610155,0.000113661605,0.0002664183,0.00009099314,0.05623048],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99969363,0.00011432263,0.000025466094,0.000027206364,0.00006823522,0.000071111106],"domain_scores_gemma":[0.9988845,0.0006895332,0.000067390436,0.00007354621,0.00012494583,0.00016008133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044932147,0.00021844129,0.0002843197,0.0001721881,0.00052964425,0.0006732877,0.0002648793,0.00437357,0.0032467905],"category_scores_gemma":[0.0021845119,0.00014994589,0.00031059215,0.00008897625,0.00039425676,0.00028627214,0.00021891041,0.0035628781,0.0015184617],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003010331,0.00032276093,0.025774682,0.0005246924,0.0001197215,0.13715643,0.00086328405,0.00058167096,0.10433937,0.013852714,0.63981926,0.07363515],"study_design_scores_gemma":[0.0005449208,0.0010749423,0.033833895,0.00028484696,0.00010755319,0.093637206,0.0011913418,0.0024287386,0.05583622,0.011938297,0.7990413,0.00008066217],"about_ca_topic_score_codex":0.00084219524,"about_ca_topic_score_gemma":0.0011779813,"teacher_disagreement_score":0.00437357,"about_ca_system_score_codex":0.0010304434,"about_ca_system_score_gemma":0.00028955977,"threshold_uncertainty_score":0.010861576},"labels":[],"label_agreement":null},{"id":"W3132517371","doi":"10.3324/haematol.2020.261354","title":"The &lt;i&gt;EBF1-PDGFRB&lt;/i&gt; T681I mutation is highly resistant to imatinib and dasatinib &lt;i&gt;in vitro&lt;/i&gt; and detectable in clinical samples prior to treatment","year":2021,"lang":"en","type":"letter","venue":"Haematologica","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Cancer Institute; National Institutes of Health; Children’s Oncology Group; Frank A. Campini Foundation; American Lebanese Syrian Associated Charities; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Dasatinib; PDGFRB; In vitro; Imatinib; Cancer research; Mutation; Medicine; Molecular biology; Internal medicine; Pharmacology; Biology; Genetics; Gene; Myeloid leukemia","score_opus":0.03705287857448447,"score_gpt":0.3001651211904886,"score_spread":0.26311224261600413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132517371","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021844164,0.0027949915,0.00049574027,0.9009035,0.012235914,0.00007640772,0.00049113337,0.00014996446,0.06100813],"genre_scores_gemma":[0.349691,0.0071821087,0.0021956332,0.50449777,0.032266874,0.000154561,0.0007178702,0.00019977985,0.103094354],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9994993,0.0001350559,0.000039582617,0.00008509953,0.00011288627,0.00012808316],"domain_scores_gemma":[0.99904925,0.00039975095,0.00006731161,0.000056889472,0.00015641317,0.00027045727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045759525,0.0006457105,0.00063141464,0.00045111752,0.0020704758,0.0014137103,0.0007407043,0.013635682,0.008091429],"category_scores_gemma":[0.0032899305,0.0004044146,0.0004655021,0.0004145103,0.0011883253,0.001095679,0.00038844824,0.008207613,0.0062477184],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034671696,0.00013788107,0.0072366716,0.000092668,0.000034771747,0.23750329,0.00033691264,0.00034405422,0.0023278033,0.005506824,0.72973925,0.016393198],"study_design_scores_gemma":[0.0002786758,0.00027655184,0.010399148,0.00033152563,0.00007346345,0.23995721,0.0009818481,0.002572875,0.0023469878,0.013960147,0.7287287,0.00009294483],"about_ca_topic_score_codex":0.0056230454,"about_ca_topic_score_gemma":0.0075768824,"teacher_disagreement_score":0.013635682,"about_ca_system_score_codex":0.0019890915,"about_ca_system_score_gemma":0.001182726,"threshold_uncertainty_score":0.027068496},"labels":[],"label_agreement":null},{"id":"W3132531164","doi":"10.3324/haematol.2020.271304","title":"Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia","year":2021,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"National Institutes of Health; Canadian Institutes of Health Research; Centre hospitalier régional universitaire de Lille; Medizinische Universität Wien; Oesterreichische Nationalbank; Universität Wien; Centre Hospitalier Universitaire de Québec; Austrian Science Fund; Institut National de la Santé et de la Recherche Médicale; Broad Institute; Université de Lille; Centre National de la Recherche Scientifique; Österreichischen Akademie der Wissenschaften; Vienna Science and Technology Fund; Université Laval","keywords":"Venetoclax; Ibrutinib; Prolymphocytic leukemia; Medicine; Leukemia; Oncology; Cancer research; Internal medicine; Chronic lymphocytic leukemia","score_opus":0.05991853302489981,"score_gpt":0.31065509164948746,"score_spread":0.25073655862458766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132531164","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014980498,0.0062312465,0.00060198625,0.96381485,0.0119479615,0.000057822563,0.00010660116,0.00004952585,0.015691938],"genre_scores_gemma":[0.031230245,0.006214364,0.0020002557,0.8546374,0.08815509,0.0002302144,0.00013133368,0.00005270984,0.017348418],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980077,0.00067470217,0.00021105526,0.00030399175,0.0005121375,0.0002904053],"domain_scores_gemma":[0.9968701,0.0017313918,0.00021433475,0.00010478848,0.00045573158,0.00062365003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027811169,0.0006162787,0.0013374921,0.0008392624,0.0022170742,0.003331078,0.0015888285,0.023687381,0.0061920746],"category_scores_gemma":[0.009049007,0.00046762367,0.001459168,0.000557682,0.0025865654,0.0019008116,0.0010460025,0.031283807,0.004961626],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071572664,0.00021996089,0.0023597241,0.00022916961,0.0000922225,0.015135981,0.00020175969,0.0011517324,0.0017328318,0.05759326,0.8615995,0.05896821],"study_design_scores_gemma":[0.0011070973,0.00040545533,0.0017796415,0.0008656852,0.00010251438,0.012025991,0.00024361807,0.0017257878,0.0009606147,0.057262298,0.9234276,0.000093630864],"about_ca_topic_score_codex":0.0016450376,"about_ca_topic_score_gemma":0.00392539,"teacher_disagreement_score":0.023687381,"about_ca_system_score_codex":0.004818486,"about_ca_system_score_gemma":0.003531571,"threshold_uncertainty_score":0.034960687},"labels":[],"label_agreement":null},{"id":"W3133800890","doi":"10.3324/haematol.2020.261842","title":"Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab + bortezomib/thalidomide/dexamethasone in the phase 3 CASSIOPEIA study","year":2021,"lang":"en","type":"letter","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Erasmus Universitair Medisch Centrum Rotterdam; Vrije Universiteit Amsterdam; Servier; Sorbonne Université; Institut National de la Santé et de la Recherche Médicale; Amsterdam University Medical Centers; Sanofi; Université de Lille; Assistance publique-Hôpitaux de Paris; Celgene; Bristol-Myers Squibb; Amgen","keywords":"Daratumumab; Bortezomib; Multiple myeloma; Medicine; Dexamethasone; Internal medicine; Thalidomide; Transplantation; Autologous stem-cell transplantation; Oncology","score_opus":0.058757850347967176,"score_gpt":0.3123871978541202,"score_spread":0.25362934750615307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133800890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91968834,0.005420559,0.0002536032,0.065319575,0.0011619191,0.000077022574,0.0018770067,0.000027404352,0.0061745676],"genre_scores_gemma":[0.96671337,0.0017984825,0.0003335289,0.026885195,0.001737395,0.00006732225,0.0010593141,0.000011532515,0.0013939374],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99916923,0.00042200473,0.000083744846,0.00007121262,0.00014748421,0.000106439016],"domain_scores_gemma":[0.99689,0.001535429,0.00054723053,0.00006634039,0.00017515528,0.00078581466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012708058,0.00018220462,0.00073321647,0.00023965875,0.0005559776,0.0010434923,0.00038022,0.0016019921,0.00094773143],"category_scores_gemma":[0.004047443,0.0001857946,0.00049418147,0.0008258121,0.00024337087,0.00044327043,0.00028013886,0.0017069954,0.00023041641],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016565673,0.0007789704,0.8934413,0.000118609074,0.00045030066,0.007908871,0.00033255474,0.00051454036,0.0018630693,0.00069619896,0.034650363,0.042679545],"study_design_scores_gemma":[0.0041454583,0.004487821,0.9377892,0.00017381077,0.0010366087,0.013328302,0.0008824322,0.003766601,0.0012517682,0.0029032668,0.030147607,0.0000872236],"about_ca_topic_score_codex":0.0016803504,"about_ca_topic_score_gemma":0.005833243,"teacher_disagreement_score":0.0016803504,"about_ca_system_score_codex":0.0011336025,"about_ca_system_score_gemma":0.0011936614,"threshold_uncertainty_score":0.008224905},"labels":[],"label_agreement":null},{"id":"W3135433679","doi":"10.3324/haematol.2020.267914","title":"T-cell dysfunction in chronic lymphocytic leukemia from an epigenetic perspective","year":2021,"lang":"en","type":"review","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Cancer Research UK","keywords":"Epigenetics; Chronic lymphocytic leukemia; Epigenomics; Immunology; T cell; Epigenetic therapy; Immune system; Immune Dysfunction; Tumor microenvironment; Biology; Cell; Immunotherapy; Chimeric antigen receptor; Cancer research; Leukemia; Medicine; DNA methylation; Genetics","score_opus":0.06693291355595138,"score_gpt":0.3874413583571703,"score_spread":0.32050844480121893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135433679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012592897,0.9986945,0.00008936295,0.00028800755,0.00013818606,0.0000018940268,0.0000092061555,0.0000047357603,0.000648216],"genre_scores_gemma":[0.0010668024,0.99801093,0.000109782544,0.00018266153,0.00015856308,0.000003514633,0.000017072387,8.1322764e-7,0.00044980607],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99990404,0.000022214374,0.00001455578,0.000016910573,0.00003048604,0.000011785156],"domain_scores_gemma":[0.999841,0.000084826745,0.000021349726,0.0000051948505,0.00003501226,0.000012615478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003343315,0.0005097203,0.00072248036,0.0014774321,0.00018419807,0.00063552125,0.00049133954,0.0008159066,0.0022389637],"category_scores_gemma":[0.00041429023,0.00013853186,0.00034071459,0.0011602936,0.0004178733,0.00085057056,0.00042993145,0.0011620302,0.0008324971],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075814874,0.000047139936,0.00031061427,0.014910829,0.0000739783,0.00028726357,0.000081873775,0.00036381875,0.003240599,0.005353175,0.021949606,0.9533053],"study_design_scores_gemma":[0.000015917376,0.00013574798,0.0016540075,0.0035393846,0.00012012024,0.003259639,0.00008261185,0.000111163215,0.0009092137,0.00299806,0.9871574,0.000016765729],"about_ca_topic_score_codex":0.00095718354,"about_ca_topic_score_gemma":0.001536038,"teacher_disagreement_score":0.0022389637,"about_ca_system_score_codex":0.00048483844,"about_ca_system_score_gemma":0.00078882114,"threshold_uncertainty_score":0.007490039},"labels":[],"label_agreement":null},{"id":"W3149640503","doi":"10.3324/haematol.2020.274258","title":"Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"Lymphoma; Mantle cell lymphoma; Biology; Follicular lymphoma; Cancer research; Comparative genomic hybridization; B cell; Malignancy; B-cell lymphoma; Non-Hodgkin's lymphoma; Genetics; Gene; Immunology; Genome; Antibody","score_opus":0.02294369896182233,"score_gpt":0.2724843191269026,"score_spread":0.24954062016508025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3149640503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986255,0.00046664765,0.00037939328,0.00000654542,7.068157e-7,0.0000050661247,0.00015452135,0.00001077996,0.00035082622],"genre_scores_gemma":[0.99912065,0.00017570614,0.00037257647,0.000013442321,0.0000014314428,0.000003764917,0.00017482063,0.0000030804233,0.00013446712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998851,0.000015851587,0.000009584848,0.00003567587,0.000036649948,0.00001723416],"domain_scores_gemma":[0.9998846,0.00002192361,0.00004221617,0.000020319967,0.00001747711,0.0000133995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016662895,0.00007592249,0.00013830657,0.0006190127,0.00015405062,0.0002627937,0.000111247005,0.00012729854,0.0005021026],"category_scores_gemma":[0.00032534308,0.000105809064,0.000106297324,0.00042705663,0.000134788,0.00013029607,0.0001555015,0.00009612037,0.000101243306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021431048,0.00003294697,0.6119333,0.000069812086,0.00010312265,0.00046161172,0.00017716906,0.0006310146,0.36382684,0.00016896677,0.00013301887,0.022247972],"study_design_scores_gemma":[0.0000048040465,0.00006518451,0.98291934,0.0000043270716,0.000054103853,0.0017761384,0.00016540075,0.00070110237,0.013433977,0.00014349505,0.00072787853,0.0000042290126],"about_ca_topic_score_codex":0.0021407695,"about_ca_topic_score_gemma":0.0054590777,"teacher_disagreement_score":0.0021407695,"about_ca_system_score_codex":0.00019808824,"about_ca_system_score_gemma":0.00012661709,"threshold_uncertainty_score":0.004256606},"labels":[],"label_agreement":null},{"id":"W3155291105","doi":"10.3324/haematol.2020.270835","title":"The post-hematopoietic cell transplantation microbiome: relationships with transplant outcome and potential therapeutic targets","year":2021,"lang":"en","type":"review","venue":"Haematologica","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Cancer Institute","keywords":"Transplantation; Microbiome; Antibiotics; Dysbiosis; Bacteremia; Hematopoietic stem cell transplantation; Hematopoietic cell; Immunology; Medicine; Disease; Gut flora; Biology; Haematopoiesis; Internal medicine; Stem cell; Bioinformatics; Microbiology","score_opus":0.031205789050676804,"score_gpt":0.2878973889872526,"score_spread":0.2566915999365758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155291105","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010946881,0.9990233,0.00007032385,0.0002832103,0.00014600428,0.0000020827647,0.000014795353,0.000004141408,0.00034672412],"genre_scores_gemma":[0.0005770292,0.99882835,0.00009560207,0.00013680253,0.00013105368,0.0000035826558,0.000025625302,8.722566e-7,0.00020113043],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999871,0.00002776173,0.000020134854,0.000021612115,0.000044617478,0.000014859598],"domain_scores_gemma":[0.9996332,0.00020048268,0.000048814534,0.0000075461976,0.00007753859,0.0000322882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046865808,0.0005840798,0.0011911143,0.0014118126,0.00016670523,0.00082939037,0.00054117275,0.0008715816,0.002638957],"category_scores_gemma":[0.0009395271,0.0001480954,0.00039949975,0.0012657491,0.00029620042,0.0007638162,0.0005428549,0.0012378708,0.00096922816],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011184398,0.000057484074,0.00033446983,0.014254813,0.00010994222,0.00016630952,0.000033638968,0.0002360851,0.0011575714,0.0017688697,0.019496527,0.9622725],"study_design_scores_gemma":[0.000031044572,0.0002307588,0.0032352707,0.010431413,0.0003370308,0.002392277,0.00009221813,0.0001657084,0.0006698779,0.0024187248,0.9799641,0.000031667532],"about_ca_topic_score_codex":0.00056929846,"about_ca_topic_score_gemma":0.0011367032,"teacher_disagreement_score":0.002638957,"about_ca_system_score_codex":0.00043344407,"about_ca_system_score_gemma":0.00087624055,"threshold_uncertainty_score":0.008828223},"labels":[],"label_agreement":null},{"id":"W3158601594","doi":"10.3324/haematol.2020.271957","title":"MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"European Regional Development Fund; National Cancer Institute; Agència de Gestió d'Ajuts Universitaris i de Recerca; National Institutes of Health; Ministerio de Economía y Competitividad; Generalitat de Catalunya","keywords":"Lymphoma; Biology; Cancer research; Neuroblastoma RAS viral oncogene homolog; Comparative genomic hybridization; Plasmablastic lymphoma; Fluorescence in situ hybridization; MAPK/ERK pathway; PAX5; Mutation; Signal transduction; Gene; Genetics; Immunology; Chromosome; KRAS; Transcription factor","score_opus":0.02286479361307594,"score_gpt":0.24197304219745885,"score_spread":0.2191082485843829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158601594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936813,0.0041167573,0.00075543637,0.000071953225,0.000006354354,0.000011244691,0.00028348295,0.000055254754,0.001018088],"genre_scores_gemma":[0.99838173,0.0008020833,0.00040262222,0.000027520111,0.0000060162065,0.000009058196,0.00013769008,0.0000035979233,0.00022952407],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988866,0.000017620556,0.000008704609,0.000026050735,0.00003610032,0.000022895083],"domain_scores_gemma":[0.9999484,0.000008633794,0.000020037869,0.0000036397137,0.000008232793,0.00001112418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011527725,0.000281696,0.00016382296,0.0006329495,0.00016883021,0.0002934836,0.0001255472,0.00025946283,0.0010465074],"category_scores_gemma":[0.00018038126,0.00013094286,0.00018194386,0.0003607365,0.00017813809,0.00022639961,0.00019379251,0.00019322202,0.00026861674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001578285,0.00010969603,0.29344085,0.00050580286,0.00015582566,0.0085849445,0.00040554864,0.0009355846,0.63593554,0.0005653584,0.000636057,0.05714654],"study_design_scores_gemma":[0.00005956569,0.00032470858,0.9084989,0.00006375332,0.00021898356,0.028904498,0.00047388906,0.0029774653,0.05139778,0.0012980604,0.005760268,0.00002206713],"about_ca_topic_score_codex":0.00030952267,"about_ca_topic_score_gemma":0.00044754086,"teacher_disagreement_score":0.0010465074,"about_ca_system_score_codex":0.00025474883,"about_ca_system_score_gemma":0.0001956566,"threshold_uncertainty_score":0.0035009384},"labels":[],"label_agreement":null},{"id":"W3164370350","doi":"10.3324/haematol.2021.278722","title":"Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Universität Leipzig","keywords":"Acute promyelocytic leukemia; Medicine; Arsenic trioxide; Internal medicine; Confidence interval; Gastroenterology; Surgery; Leukemia; Retinoic acid; Arsenic","score_opus":0.005825080949332106,"score_gpt":0.24143705572774735,"score_spread":0.23561197477841525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164370350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992731,0.00017769495,0.00006051586,0.000020833042,0.0000020933026,0.000007137229,0.00016447657,0.0000018662697,0.0002922319],"genre_scores_gemma":[0.99930894,0.00009555161,0.00005598695,0.000018702718,0.000008773649,0.00000847001,0.00045786105,0.0000014408583,0.00004426074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996295,0.000111620124,0.00005728477,0.00009620807,0.000059527323,0.000045808807],"domain_scores_gemma":[0.9986614,0.00021941702,0.0006433833,0.00013273876,0.00012484491,0.00021816262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006397332,0.00024918903,0.0003871909,0.0007987197,0.00035292882,0.000541984,0.0003515552,0.00034922044,0.00060732674],"category_scores_gemma":[0.001945104,0.000130654,0.00032041676,0.0008478829,0.00026144445,0.0004086058,0.00041976932,0.00029251736,0.0002197731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017050808,0.00002931185,0.99793124,0.000008137247,0.00003923174,0.00011861805,0.00008206189,0.000040220857,0.00023727943,0.000010757066,0.000050932354,0.001281604],"study_design_scores_gemma":[0.000027401516,0.00026031723,0.99794906,0.0000076046135,0.00005884861,0.0008840216,0.00023704823,0.00011062827,0.00008632706,0.00002649461,0.0003461322,0.0000059733256],"about_ca_topic_score_codex":0.0012227998,"about_ca_topic_score_gemma":0.00123626,"teacher_disagreement_score":0.0012227998,"about_ca_system_score_codex":0.0002610698,"about_ca_system_score_gemma":0.00023496796,"threshold_uncertainty_score":0.0033832788},"labels":[],"label_agreement":null},{"id":"W3171577343","doi":"10.3324/haematol.2021.278990","title":"Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health; Texas Children's Hospital; Howard Hughes Medical Institute","keywords":"Haematopoiesis; Germline mutation; Germline; Mutation; Somatic cell; Biology; Somatic evolution in cancer; Immunology; Cancer research; Stem cell; Genetics; Cancer; Gene","score_opus":0.01034443955069764,"score_gpt":0.2404323652131387,"score_spread":0.23008792566244107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171577343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986082,0.00017580084,0.0005904069,0.000017853941,0.0000027751228,0.000009983998,0.00013839305,0.00002781865,0.00042893577],"genre_scores_gemma":[0.9990295,0.00009964773,0.0005560873,0.000013952861,0.0000025564468,0.000004769744,0.00007692964,0.000007811954,0.0002087984],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998336,0.000027741291,0.00002005199,0.000057620644,0.0000422813,0.00001865098],"domain_scores_gemma":[0.9998691,0.000031173575,0.000052474363,0.0000107321175,0.00001076991,0.00002583439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001405837,0.00047151066,0.00022290953,0.0011479618,0.00023078446,0.00022430278,0.00014893444,0.00025758293,0.0015177852],"category_scores_gemma":[0.00043754542,0.00015257807,0.00017282003,0.0003453016,0.00038397167,0.00012310006,0.00032524104,0.00020408869,0.000117823656],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010920551,0.00010613399,0.31814173,0.00014862462,0.00020438421,0.04506077,0.0013984393,0.0007480457,0.60532653,0.00089413294,0.0003759143,0.026503198],"study_design_scores_gemma":[0.000040401133,0.0008312095,0.7692144,0.0000450583,0.00025941627,0.15198207,0.0005109091,0.0017941816,0.07250892,0.00048064525,0.0022987623,0.00003402262],"about_ca_topic_score_codex":0.0012137422,"about_ca_topic_score_gemma":0.0012829859,"teacher_disagreement_score":0.0015177852,"about_ca_system_score_codex":0.00015500616,"about_ca_system_score_gemma":0.000118713004,"threshold_uncertainty_score":0.0050774813},"labels":[],"label_agreement":null},{"id":"W3171756032","doi":"10.3324/haematol.2021.278770","title":"A &lt;i&gt;Grammastola spatulata&lt;/i&gt; mechanotoxin-4 (GsMTx4)-sensitive cation channel mediates increased cation permeability in human hereditary spherocytosis of multiple genetic etiologies","year":2021,"lang":"en","type":"letter","venue":"Haematologica","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Quest Diagnostics; Doris Duke Charitable Foundation","keywords":"Hereditary spherocytosis; Chemistry; Ion channel; Genetics; Biology; Biophysics","score_opus":0.02905353610106688,"score_gpt":0.2488160849502858,"score_spread":0.21976254884921892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171756032","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005480926,0.00308661,0.00032760753,0.9522648,0.019408485,0.00003166534,0.00015723953,0.00009879169,0.019143987],"genre_scores_gemma":[0.12983923,0.008016101,0.0013812375,0.71474177,0.074658275,0.00013094784,0.0002813942,0.00010018378,0.07085093],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945456,0.000190319,0.00006323626,0.00009589565,0.00011265473,0.0000832615],"domain_scores_gemma":[0.99845374,0.0009276916,0.00009847191,0.00008419994,0.00026629385,0.000169718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006278705,0.0005737771,0.00069615705,0.00040134977,0.0014537273,0.0011045787,0.0008629202,0.0170786,0.0055953297],"category_scores_gemma":[0.005096732,0.00037821705,0.000540593,0.00030333063,0.001015958,0.001139263,0.0003301694,0.01096014,0.0049571246],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004301728,0.00013630629,0.0025789144,0.00014152472,0.00004165401,0.090025805,0.00016415215,0.00022149712,0.001899931,0.0054771286,0.8778962,0.020986762],"study_design_scores_gemma":[0.00041215844,0.0003283188,0.005882016,0.0002930397,0.00009695622,0.054549217,0.00036681822,0.002139636,0.0022902659,0.017244522,0.91632587,0.00007120776],"about_ca_topic_score_codex":0.0037942394,"about_ca_topic_score_gemma":0.0038381296,"teacher_disagreement_score":0.0170786,"about_ca_system_score_codex":0.002283254,"about_ca_system_score_gemma":0.0009331644,"threshold_uncertainty_score":0.018718243},"labels":[],"label_agreement":null},{"id":"W3180995513","doi":"10.3324/haematol.2021.278762","title":"The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"NHLBI Division of Intramural Research; Medical Research Council; University of Texas MD Anderson Cancer Center; Directorate for Biological Sciences; National Institutes of Health; Deutschen Konsortium für Translationale Krebsforschung; National University Health System; Masarykova Univerzita; Canterbury District Health Board; National Health and Medical Research Council; Universidade de São Paulo; Medizinischen Hochschule Hannover; Government of South Australia; Vanderbilt University; University of Chicago; Università degli Studi di Pavia; Sociedade Beneficente Israelita Brasileira Albert Einstein; University of Tokyo; Institut Gustave-Roussy; Semmelweis Egyetem; European Hematology Association; Erasmus Medisch Centrum; University of South Australia; Institut National de la Santé et de la Recherche Médicale; Cancer Research UK; Vanderbilt University Medical Center; Queen Mary University of London; Hospital Research Foundation; Associazione Italiana per la Ricerca sul Cancro; National Cancer Institute; Universität Heidelberg; Australian Cancer Research Foundation; Cancer Council South Australia; Université de Montréal; Ligue Contre le Cancer; Deutsches Krebsforschungszentrum; Royal Adelaide Hospital; Fondazione IRCCS Policlinico San Matteo; Bundesministerium für Bildung und Forschung; Assistance publique-Hôpitaux de Paris; Massachusetts General Hospital","keywords":"Database; RUNX1; Genomics; Medicine; Biology; Computer science; Genetics; Gene; Genome; Transcription factor","score_opus":0.03186096913012081,"score_gpt":0.30008672457718183,"score_spread":0.268225755447061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180995513","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02379069,0.0026195752,0.05743166,0.0049540144,0.00045082794,0.002313743,0.8566279,0.022701997,0.029109668],"genre_scores_gemma":[0.022019641,0.0009594597,0.052894145,0.00091085397,0.00020842011,0.0010103594,0.91560197,0.0022681458,0.0041269367],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953819,0.0010217467,0.0009838616,0.00081921095,0.001309455,0.00048374882],"domain_scores_gemma":[0.9815413,0.0033151098,0.0020260327,0.0036063576,0.0060015856,0.003509676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010596499,0.0009512138,0.0020809607,0.0092072645,0.0011505707,0.0032619084,0.0039818143,0.001511107,0.02188062],"category_scores_gemma":[0.01799016,0.00073625345,0.001145546,0.008529418,0.0005049524,0.0023401668,0.0040582116,0.0015663354,0.014415352],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016039099,0.00044752492,0.018758148,0.0015876308,0.00033297215,0.0009024429,0.00057639135,0.0012072312,0.011344382,0.008076619,0.84650767,0.10865509],"study_design_scores_gemma":[0.00097298593,0.0001918264,0.04219301,0.0006648569,0.0005626001,0.0016018628,0.00039735038,0.004754358,0.01207033,0.003863386,0.9325331,0.00019431373],"about_ca_topic_score_codex":0.01473996,"about_ca_topic_score_gemma":0.011658389,"teacher_disagreement_score":0.02188062,"about_ca_system_score_codex":0.0021501235,"about_ca_system_score_gemma":0.013040581,"threshold_uncertainty_score":0.07319796},"labels":[],"label_agreement":null},{"id":"W3185716747","doi":"10.3324/haematol.2021.279052","title":"Timely diagnosis and treatment of acute promyelocytic leukemia should be available to all","year":2021,"lang":"en","type":"letter","venue":"Haematologica","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Acute promyelocytic leukemia; Medicine; Intensive care medicine; Leukemia; Internal medicine; Biology; Retinoic acid; Genetics","score_opus":0.05607474922266552,"score_gpt":0.282901071275792,"score_spread":0.22682632205312647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185716747","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007397919,0.0031083922,0.00019811955,0.9750054,0.0145890545,0.000016064245,0.000048670056,0.00004149308,0.0062530255],"genre_scores_gemma":[0.010255312,0.0051413393,0.00066873984,0.9197828,0.048425283,0.00004523291,0.00009146794,0.00002869131,0.015560972],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988869,0.0003649795,0.00013917164,0.00010697151,0.0003170891,0.00018481749],"domain_scores_gemma":[0.99662423,0.0017058653,0.00015645684,0.00015939135,0.00050474936,0.00084931374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013638942,0.00050495286,0.0011075236,0.0004038531,0.0020834347,0.0018067266,0.0009168648,0.028825164,0.0077768816],"category_scores_gemma":[0.010452072,0.00038741317,0.00085441273,0.00039302802,0.0016602601,0.002341325,0.0009079947,0.02551135,0.0073139933],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012987833,0.000082416605,0.0018129416,0.000082546554,0.000015057968,0.008879332,0.00007119644,0.00008333691,0.0006069308,0.0031233823,0.95919484,0.025918154],"study_design_scores_gemma":[0.0001395739,0.00012937041,0.0020464377,0.00035012994,0.000023225783,0.012601961,0.00030900596,0.0003271051,0.0003210495,0.018194323,0.9655177,0.00004000171],"about_ca_topic_score_codex":0.0029920537,"about_ca_topic_score_gemma":0.005327756,"teacher_disagreement_score":0.028825164,"about_ca_system_score_codex":0.0020176885,"about_ca_system_score_gemma":0.002515247,"threshold_uncertainty_score":0.026016295},"labels":[],"label_agreement":null},{"id":"W3187155906","doi":"10.3324/haematol.2021.279232","title":"Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-François d'Assise","funders":"","keywords":"Daratumumab; Cytopenia; Medicine; Refractory (planetary science); Oncology; Dermatology; Internal medicine; Lenalidomide; Multiple myeloma; Biology; Bone marrow","score_opus":0.053576595386962134,"score_gpt":0.3268228384538645,"score_spread":0.2732462430669024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187155906","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16136135,0.72852457,0.0137552,0.015421606,0.006599202,0.0008745825,0.00092339615,0.0005498481,0.07199029],"genre_scores_gemma":[0.6687579,0.24058723,0.024738014,0.013496557,0.005130151,0.0006572507,0.0018453015,0.00009809443,0.044689342],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9998771,0.000026978903,0.000015172652,0.000023986246,0.000033636617,0.000023152108],"domain_scores_gemma":[0.99992466,0.00001265711,0.000011725892,0.00000666703,0.000019541374,0.000024741606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027832374,0.0004036414,0.0003984474,0.0005446829,0.00041552034,0.0004934227,0.00025222544,0.00045146293,0.0020641987],"category_scores_gemma":[0.00035504694,0.00007841179,0.00037474526,0.0003657516,0.00020597361,0.00024223655,0.00031535153,0.0012900776,0.0009229497],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002899798,0.00066137617,0.00242518,0.002085688,0.00035992192,0.0047199107,0.0001361452,0.0005052671,0.040068183,0.00515997,0.040034965,0.9009436],"study_design_scores_gemma":[0.0044275383,0.0044311937,0.010874575,0.00077956106,0.00070905895,0.0415433,0.000064058775,0.0012696849,0.032971166,0.002744161,0.90012306,0.00006247748],"about_ca_topic_score_codex":0.00049247075,"about_ca_topic_score_gemma":0.0012054915,"teacher_disagreement_score":0.0020641987,"about_ca_system_score_codex":0.0004179942,"about_ca_system_score_gemma":0.0003579289,"threshold_uncertainty_score":0.0069054365},"labels":[],"label_agreement":null},{"id":"W3193510908","doi":"10.3324/haematol.2021.278663","title":"Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Spinal Cord Injury BC; University of British Columbia","funders":"Mundipharma EDO; Genentech; EUSA Pharma; Celgene; MorphoSys; H. Lundbeck A/S; Juno Therapeutics; Incyte; F. Hoffmann-La Roche; Bristol-Myers Squibb; AstraZeneca; Kite Pharma; Gilead Sciences; Servier; Amgen","keywords":"Hazard ratio; Standardized uptake value; Medicine; Positron emission tomography; Retrospective cohort study; Internal medicine; Nuclear medicine; Quartile; Proportional hazards model; Diffuse large B-cell lymphoma; Oncology; Confidence interval; Lymphoma","score_opus":0.011200039875509236,"score_gpt":0.2461010715508001,"score_spread":0.23490103167529086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193510908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992562,0.00024853117,0.00006105161,0.000015232874,0.0000016953638,0.0000063954303,0.00024094187,0.0000026987166,0.00016720255],"genre_scores_gemma":[0.99941516,0.00005052766,0.000034779023,0.000012855911,0.0000043142472,0.000008583539,0.0004292255,0.0000018947159,0.00004266981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966824,0.000144844,0.000025166391,0.00006178866,0.000042844476,0.00005707867],"domain_scores_gemma":[0.9991487,0.00018567039,0.00035332202,0.00010970904,0.000064708656,0.00013798234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008001957,0.00021262484,0.000365041,0.00040232757,0.00021777126,0.0005017591,0.0002491686,0.00028434006,0.00044874466],"category_scores_gemma":[0.0016581623,0.00018292356,0.00035724248,0.00064847956,0.00020101797,0.00036492947,0.000412462,0.00038429152,0.000085376945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007556589,0.000013882578,0.9978896,0.0000067020906,0.00006514572,0.000061497005,0.00002298008,0.00007674073,0.00030570204,0.000011444388,0.00005999714,0.00073069276],"study_design_scores_gemma":[0.00005058086,0.00021196784,0.9988877,0.0000038494954,0.000058908237,0.00022058222,0.000049658294,0.00020304715,0.00007104382,0.000022499833,0.00021657092,0.000003573195],"about_ca_topic_score_codex":0.0021218837,"about_ca_topic_score_gemma":0.0033168318,"teacher_disagreement_score":0.0021218837,"about_ca_system_score_codex":0.00023002415,"about_ca_system_score_gemma":0.0002753865,"threshold_uncertainty_score":0.00423187},"labels":[],"label_agreement":null},{"id":"W3201791129","doi":"10.3324/haematol.2021.279317","title":"Integrating genetic and epigenetic factors in chronic myeloid leukemia risk assessment: toward gene expression-based biomarkers","year":2021,"lang":"en","type":"review","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Medical Research Council; Medical Research Council","keywords":"Myeloid leukemia; Epigenetics; Bioinformatics; Clinical trial; Gene expression profiling; Medicine; Computational biology; Profiling (computer programming); DNA microarray; Oncology; Biology; Gene; Cancer research; Gene expression; Genetics; Computer science","score_opus":0.0483749563130761,"score_gpt":0.34039579600795566,"score_spread":0.2920208396948796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201791129","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024713917,0.5129717,0.42129463,0.03073241,0.0014368622,0.00062068773,0.0010030095,0.0006693372,0.006557403],"genre_scores_gemma":[0.13985708,0.32268965,0.52086806,0.008479877,0.002207853,0.0006368371,0.00092647463,0.00011074726,0.004223514],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987872,0.0005432483,0.00016553974,0.00017503282,0.00026262386,0.00006631994],"domain_scores_gemma":[0.9981968,0.0008566991,0.00022736263,0.000088372166,0.00054757646,0.000083195264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074224262,0.00094513845,0.0011275944,0.0031507802,0.00034031706,0.003113025,0.0011751109,0.0017780928,0.0005587651],"category_scores_gemma":[0.0044465684,0.00056584115,0.000992606,0.002048398,0.0011992056,0.002715511,0.0014512014,0.0028358474,0.0005563006],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004342871,0.00029165082,0.048548065,0.0046488172,0.00047847177,0.0010087247,0.00092837814,0.0082943905,0.04919715,0.057123788,0.016601015,0.8124451],"study_design_scores_gemma":[0.00009580942,0.0019667891,0.057292882,0.0070790807,0.0015403249,0.007029536,0.0024038833,0.07164961,0.0812772,0.16085994,0.6081545,0.00065051904],"about_ca_topic_score_codex":0.0018106056,"about_ca_topic_score_gemma":0.0024228238,"teacher_disagreement_score":0.0074224262,"about_ca_system_score_codex":0.0013610227,"about_ca_system_score_gemma":0.0015385405,"threshold_uncertainty_score":0.03925407},"labels":[],"label_agreement":null},{"id":"W3205650804","doi":"10.3324/haematol.2021.279928","title":"SARS-CoV-2 infection in aplastic anemia","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Cancer Research UK","keywords":"Aplastic anemia; Medicine; Virology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Anemia; Immunology; Internal medicine; Bone marrow; Outbreak; Disease; Infectious disease (medical specialty)","score_opus":0.06549907473900365,"score_gpt":0.3635650253734051,"score_spread":0.29806595063440144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205650804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49326584,0.06310601,0.003581598,0.021230925,0.008272606,0.0032098899,0.17318064,0.00041581667,0.23373672],"genre_scores_gemma":[0.9243635,0.013334255,0.0017814384,0.004303476,0.001641473,0.0008769496,0.03253794,0.000028185277,0.021132762],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9987889,0.00066113117,0.00017818125,0.00009246073,0.00012891063,0.00015038732],"domain_scores_gemma":[0.99798524,0.0011644782,0.00021921202,0.00015761162,0.00028154012,0.00019194426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015332979,0.00025244654,0.00040171167,0.00053611,0.0003738628,0.0006072726,0.0006601092,0.0011612838,0.02901144],"category_scores_gemma":[0.004588993,0.00016892911,0.0003481448,0.0010488194,0.00027052042,0.00053108175,0.00028710443,0.00056167785,0.0029900756],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052579254,0.0029608214,0.16721389,0.0099225165,0.0015292689,0.013601868,0.00054706313,0.001271912,0.01638813,0.0040573347,0.44241416,0.28751367],"study_design_scores_gemma":[0.0072046495,0.015863268,0.3927596,0.004902164,0.0009537335,0.013107004,0.0010312888,0.0015016473,0.008703363,0.0032530031,0.55061775,0.000102520266],"about_ca_topic_score_codex":0.0030538205,"about_ca_topic_score_gemma":0.0037635108,"teacher_disagreement_score":0.02901144,"about_ca_system_score_codex":0.00041131506,"about_ca_system_score_gemma":0.0004953671,"threshold_uncertainty_score":0.09705287},"labels":[],"label_agreement":null},{"id":"W3207809849","doi":"10.3324/haematol.2021.279229","title":"Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in relapsed multiple myeloma patients with renal impairment: IKEMA subgroup analysis","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Sanofi Genzyme; Sanofi","keywords":"Carfilzomib; Medicine; Renal function; Hazard ratio; Internal medicine; Dexamethasone; Multiple myeloma; Population; Confidence interval; Adverse effect; Urology; Gastroenterology; Subgroup analysis; Creatinine; Oncology; Lenalidomide","score_opus":0.022369191073017495,"score_gpt":0.27161218656555364,"score_spread":0.24924299549253615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207809849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9573057,0.030782836,0.0012551777,0.0009541268,0.00051155064,0.0017780529,0.0050193127,0.00009271465,0.0023004173],"genre_scores_gemma":[0.9892412,0.0027263789,0.0009015921,0.0008196612,0.00040158516,0.0011158633,0.0036309706,0.000035159897,0.001127747],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9974535,0.0010752933,0.00046651604,0.00034462765,0.0002762424,0.00038392332],"domain_scores_gemma":[0.9980204,0.0007500636,0.0004378804,0.00032506962,0.00017782373,0.000288768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039172973,0.0017755126,0.006714929,0.0011726805,0.00029161657,0.0017849172,0.0011273759,0.0011897938,0.0035407518],"category_scores_gemma":[0.0045259027,0.00049028924,0.016966555,0.0011766163,0.00033431654,0.0008037618,0.0011213121,0.002264222,0.0005298571],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7456892,0.0011428513,0.05471723,0.0034161077,0.14714691,0.00028329305,0.00021313828,0.0021834208,0.0039043324,0.00020785852,0.0029437584,0.038151782],"study_design_scores_gemma":[0.32425782,0.07780719,0.25282657,0.0012173973,0.3124425,0.0013031745,0.0010988099,0.01140297,0.0033240747,0.0032310684,0.010778103,0.00031034084],"about_ca_topic_score_codex":0.0017598573,"about_ca_topic_score_gemma":0.0033325157,"teacher_disagreement_score":0.006714929,"about_ca_system_score_codex":0.0009868569,"about_ca_system_score_gemma":0.0012860837,"threshold_uncertainty_score":0.020716846},"labels":[],"label_agreement":null},{"id":"W3215635656","doi":"10.3324/haematol.2021.276048","title":"The retinoic acid receptor co-factor NRIP1 is uniquely upregulated and represents a therapeutic target in acute myeloid leukemia with chromosome 3q rearrangements","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Downregulation and upregulation; Myeloid leukemia; Cancer research; Biology; Transcription factor; Gene knockdown; Retinoic acid; Genetics; Gene","score_opus":0.02573987258448401,"score_gpt":0.30085714445774797,"score_spread":0.27511727187326396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215635656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98715925,0.0066437046,0.0033052887,0.00022903112,0.000021480537,0.000041643292,0.00062753964,0.00014719614,0.001824802],"genre_scores_gemma":[0.9941723,0.0019137554,0.0022899827,0.00007219448,0.000010008601,0.000025826028,0.00062067294,0.00002368425,0.0008717279],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998723,0.000015922411,0.0000071666714,0.00003490354,0.0000372087,0.000032529893],"domain_scores_gemma":[0.99993217,0.000009849163,0.000028922968,0.000008365814,0.000006667856,0.0000139664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001110232,0.00022883873,0.00031430522,0.00016830255,0.00014089988,0.00026607627,0.00012411085,0.00018552445,0.0011876769],"category_scores_gemma":[0.00013112366,0.00012300267,0.00019496887,0.0002212311,0.00020100264,0.00011791876,0.00018038678,0.0004695222,0.00048001437],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010016327,0.000009448985,0.00094604143,0.000027177713,0.0000048005104,0.00005827814,0.000008821932,0.0000659861,0.9956814,0.00003447525,0.000039141058,0.003024317],"study_design_scores_gemma":[0.00002864448,0.000543891,0.0283128,0.0000099328945,0.000059431073,0.001445995,0.000060730647,0.00070345623,0.9635492,0.00009561619,0.00518348,0.0000068380705],"about_ca_topic_score_codex":0.00021641918,"about_ca_topic_score_gemma":0.0005692559,"teacher_disagreement_score":0.0011876769,"about_ca_system_score_codex":0.00024198425,"about_ca_system_score_gemma":0.00018936662,"threshold_uncertainty_score":0.003973186},"labels":[],"label_agreement":null},{"id":"W4200215914","doi":"10.3324/haematol.2021.280366","title":"Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Université François-Rabelais; Universitätsklinikum Hamburg-Eppendorf; Royal College of Surgeons in Ireland; McMaster University","keywords":"Antibody; Monoclonal gammopathy; Monoclonal antibody; Platelet; Immunology; Medicine; Platelet factor 4; Monoclonal","score_opus":0.038727634481298276,"score_gpt":0.2957517276168515,"score_spread":0.2570240931355532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200215914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930971,0.00052094687,0.00044250995,0.0008234786,0.000074499425,0.000045010063,0.00008234869,0.000053398093,0.0048608393],"genre_scores_gemma":[0.998909,0.00015412673,0.00019492346,0.00028514015,0.00009361238,0.0000040989717,0.000049524708,0.0000062062554,0.00030342332],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996792,0.000050398205,0.0000320264,0.00006666147,0.000056131004,0.00011554629],"domain_scores_gemma":[0.99928623,0.00032894476,0.00008067999,0.000050045248,0.000045051576,0.0002091339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022442493,0.0008541942,0.00045409793,0.0009896344,0.0010560463,0.0007263782,0.0006989986,0.0026718723,0.0016543431],"category_scores_gemma":[0.0023925048,0.00041752247,0.00040924686,0.0006037108,0.0007347931,0.00080015144,0.00048080203,0.001749294,0.00040384752],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021027852,0.00017580659,0.05642485,0.00003479193,0.000017197766,0.9344074,0.00040195906,0.00017162187,0.0036520462,0.00024358516,0.00048977765,0.0037706688],"study_design_scores_gemma":[0.000044401513,0.0008610446,0.059116703,0.000024348568,0.000034291395,0.93563724,0.00021594165,0.0011158638,0.0019137582,0.00018486522,0.0008344254,0.000017220087],"about_ca_topic_score_codex":0.0027857427,"about_ca_topic_score_gemma":0.002202304,"teacher_disagreement_score":0.0027857427,"about_ca_system_score_codex":0.0006507334,"about_ca_system_score_gemma":0.00040335272,"threshold_uncertainty_score":0.0055390596},"labels":[],"label_agreement":null},{"id":"W4200247655","doi":"10.3324/haematol.2021.280238","title":"VEXAS syndrome in a female patient with constitutional 45,X (Turner syndrome)","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Otitis Media and Relapsing Polychondritis","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Kelowna General Hospital; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; National Institutes of Health; University of British Columbia","keywords":"Turner syndrome; Turner's syndrome; Medicine; Internal medicine; Pediatrics; Gynecology","score_opus":0.015095158973568078,"score_gpt":0.24230374989350906,"score_spread":0.22720859091994097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200247655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98407644,0.0020679387,0.00053263205,0.0023095973,0.00016663977,0.000038632283,0.0006444498,0.000067380206,0.010096347],"genre_scores_gemma":[0.9980233,0.0004045013,0.00021187955,0.00026486232,0.0000957156,0.000005752429,0.00009567316,0.0000067281067,0.0008915857],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997471,0.00003136658,0.00002420523,0.00006511609,0.000034529083,0.00009760663],"domain_scores_gemma":[0.9991239,0.0004013725,0.0001566107,0.000041455336,0.000029103288,0.00024767374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020232881,0.0008413478,0.0004340258,0.0012870652,0.0008452627,0.00066532934,0.0005934708,0.0025611594,0.004143732],"category_scores_gemma":[0.0018299763,0.00034485335,0.00037356533,0.00068340503,0.0008580634,0.0005311083,0.0005260116,0.00096820464,0.0003718302],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013664315,0.000017637354,0.016329296,0.000027303906,0.000015967487,0.979536,0.00009980022,0.00005211745,0.001941314,0.00020639623,0.0003334539,0.0013040173],"study_design_scores_gemma":[0.000030971285,0.00014314639,0.028212259,0.00002202231,0.000023037754,0.9697871,0.00013324287,0.00009944847,0.0005419098,0.00018854374,0.00080807874,0.0000102082695],"about_ca_topic_score_codex":0.0029728143,"about_ca_topic_score_gemma":0.002974556,"teacher_disagreement_score":0.004143732,"about_ca_system_score_codex":0.00037905868,"about_ca_system_score_gemma":0.0005113929,"threshold_uncertainty_score":0.013862193},"labels":[],"label_agreement":null},{"id":"W4200289889","doi":"10.3324/haematol.2021.279410","title":"Rational drug combinations with CDK4/6 inhibitors in acute lymphoblastic leukemia","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Vincristine; Palbociclib; Chemotherapy; Oncology; Leukemia; Pharmacology; Cancer research; Internal medicine; Cancer; Cyclophosphamide; Breast cancer; Metastatic breast cancer","score_opus":0.014941036200126738,"score_gpt":0.2913868434496764,"score_spread":0.2764458072495497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200289889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9268465,0.048258774,0.006077224,0.0020593384,0.0003173409,0.001386818,0.0009774377,0.00042038254,0.013656136],"genre_scores_gemma":[0.9687649,0.020478753,0.006552606,0.00048773727,0.00009259166,0.0003781885,0.0007634691,0.000045089222,0.002436665],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977285,0.00007610687,0.000019528776,0.000036100613,0.000050647508,0.000044740067],"domain_scores_gemma":[0.9999006,0.000021226222,0.00002634815,0.00001054921,0.000010356136,0.00003090489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063959515,0.00045373704,0.0007069309,0.00075162825,0.00020590745,0.0007278815,0.00052256515,0.00025334494,0.0016729534],"category_scores_gemma":[0.0003205616,0.00021976473,0.00033830825,0.0005206066,0.0003828165,0.00037986482,0.0003698522,0.0011880078,0.0004229046],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016286388,0.0077581704,0.004798027,0.0014823477,0.00047687042,0.0009820925,0.00026801,0.015009508,0.37667388,0.007432453,0.0070350664,0.56179726],"study_design_scores_gemma":[0.04942141,0.13009645,0.027596066,0.00064229843,0.0014868388,0.005170161,0.00038780365,0.025351295,0.44318977,0.008688464,0.30772927,0.00024025085],"about_ca_topic_score_codex":0.00040324236,"about_ca_topic_score_gemma":0.0022200372,"teacher_disagreement_score":0.0016729534,"about_ca_system_score_codex":0.000620784,"about_ca_system_score_gemma":0.00043445095,"threshold_uncertainty_score":0.005596578},"labels":[],"label_agreement":null},{"id":"W4205969691","doi":"10.3324/haematol.2021.279012","title":"First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab &lt;i&gt;versus&lt;/i&gt; chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"Cilag; Juno Therapeutics; Kite Pharma; Cancer Research UK; Genentech; Horizon Therapeutics; Pfizer; Moderna; Incyte; Pharmacyclics; Agios Pharmaceuticals; BeiGene; Bristol-Myers Squibb; Constellation Pharmaceuticals; Clovis Oncology; Teva Pharmaceutical Industries; AstraZeneca; Barts Charity; Exelixis; Karyopharm Therapeutics; Unum Therapeutics; Daiichi Sankyo Europe; Calithera Biosciences; Gilead Sciences; MorphoSys; Celgene; TG Therapeutics; Amgen; GlaxoSmithKline","keywords":"Obinutuzumab; Ibrutinib; Chlorambucil; Medicine; Chronic lymphocytic leukemia; Internal medicine; Oncology; Hazard ratio; Leukemia; Chemotherapy; Confidence interval; Cyclophosphamide","score_opus":0.04504888166279691,"score_gpt":0.308024079257522,"score_spread":0.2629751975947251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205969691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827623,0.01082024,0.00066353247,0.0005294747,0.0004005169,0.0013328631,0.00091468845,0.00012851342,0.0024479348],"genre_scores_gemma":[0.99067795,0.0033108238,0.00079559936,0.0007234187,0.00027158047,0.0009546441,0.0015652585,0.00002222164,0.0016784552],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994442,0.0002887214,0.000023945675,0.000076452285,0.000046032703,0.000120679615],"domain_scores_gemma":[0.9992399,0.00012813164,0.00016838653,0.000058400256,0.000038473016,0.0003666448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020503504,0.0011136486,0.0023684583,0.00039422218,0.00033270862,0.001241856,0.0007849457,0.0009775138,0.0019516606],"category_scores_gemma":[0.0010007179,0.00043544456,0.002219978,0.00036034553,0.00066518894,0.0007002068,0.0004055011,0.002703861,0.0005163139],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9085302,0.008273755,0.003339867,0.0005958766,0.0017944116,0.000056878434,0.00009383036,0.0011301227,0.005811094,0.00015327665,0.0017923394,0.0684284],"study_design_scores_gemma":[0.82620883,0.15623654,0.010713084,0.00010448081,0.001114454,0.00018264647,0.000040659248,0.0009774776,0.0018854693,0.00020427146,0.002301817,0.000030363402],"about_ca_topic_score_codex":0.0013904149,"about_ca_topic_score_gemma":0.0051285564,"teacher_disagreement_score":0.0023684583,"about_ca_system_score_codex":0.0014550962,"about_ca_system_score_gemma":0.0012190295,"threshold_uncertainty_score":0.010843456},"labels":[],"label_agreement":null},{"id":"W4210686684","doi":"10.3324/haematol.2021.279520","title":"Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; BC Children's Hospital; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Children's Hospital of Philadelphia; U.S. Department of Defense; Rally Foundation; V Foundation for Cancer Research","keywords":"Medicine; Temsirolimus; Etoposide; Mucositis; Internal medicine; Gastroenterology; Cyclophosphamide; Leukemia; Leukopenia; Pharmacology; PI3K/AKT/mTOR pathway; Toxicity; Chemotherapy; Biology","score_opus":0.007659484694420746,"score_gpt":0.24405063521021292,"score_spread":0.23639115051579218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210686684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920219,0.004253309,0.00028786602,0.00057229644,0.000087167544,0.0005401698,0.0008096453,0.00007368045,0.0013539263],"genre_scores_gemma":[0.98526406,0.0057774954,0.0020416146,0.0010125643,0.00018876742,0.0010880316,0.003057337,0.000024485662,0.0015457184],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99973744,0.00014242953,0.000019087052,0.000032275777,0.00003441133,0.00003438],"domain_scores_gemma":[0.9997818,0.000027730384,0.00006557709,0.000015190129,0.000013173584,0.0000965066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010887966,0.0006535032,0.0011420812,0.00028168393,0.00018140771,0.0005537265,0.00046101835,0.00046937162,0.0012161725],"category_scores_gemma":[0.0003921412,0.00025978885,0.00083735836,0.0004046745,0.00037963004,0.00043504173,0.0003584409,0.0018183059,0.00021459862],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5462185,0.019649748,0.022864738,0.0021611599,0.004524994,0.00073307496,0.00040418663,0.007068035,0.045961913,0.0013642601,0.012632621,0.3364167],"study_design_scores_gemma":[0.65960693,0.24779415,0.056703433,0.00025484952,0.00208254,0.0012876737,0.00014147353,0.0043750983,0.010169352,0.0005454975,0.016989093,0.000049884315],"about_ca_topic_score_codex":0.0009522339,"about_ca_topic_score_gemma":0.0035988495,"teacher_disagreement_score":0.0012161725,"about_ca_system_score_codex":0.000897318,"about_ca_system_score_gemma":0.0013004215,"threshold_uncertainty_score":0.0065105557},"labels":[],"label_agreement":null},{"id":"W4211260249","doi":"10.3324/haematol.2021.279486","title":"A novel CD34-specific T-cell engager efficiently depletes acute myeloid leukemia and leukemic stem cells &lt;i&gt;in vitro&lt;/i&gt; and &lt;i&gt;in vivo&lt;/i&gt;","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"David och Astrid Hageléns Stiftelse; Barncancerfonden; Vetenskapsrådet; Cancerfonden","keywords":"CD34; Stem cell; CD38; Myeloid leukemia; Cancer research; Haematopoiesis; Leukemia; In vivo; Myeloid; Ex vivo; Transplantation; Immunology; Biology; Medicine; Cell biology; Internal medicine","score_opus":0.024029043832638153,"score_gpt":0.25015882293189984,"score_spread":0.22612977909926169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211260249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713897,0.0014944075,0.023545481,0.00016468877,0.000032697484,0.00017272538,0.0003166039,0.00041216312,0.0024715522],"genre_scores_gemma":[0.98699737,0.0006279593,0.008896175,0.00012552192,0.000010564015,0.00008162261,0.0005495167,0.000028151422,0.0026830581],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998411,0.000024834235,0.000010551379,0.000032694617,0.000052311305,0.00003837593],"domain_scores_gemma":[0.9999591,0.0000051655006,0.0000136657,0.000004072809,0.0000041868298,0.000013778819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011012138,0.000433367,0.00017840597,0.00017585,0.000072200135,0.00018215738,0.00021864966,0.00030597224,0.0009346526],"category_scores_gemma":[0.00010789049,0.00011815218,0.00015283856,0.00013161835,0.00012518653,0.0001454921,0.00024169647,0.0005284653,0.00032017037],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075758675,0.000064814354,0.00007339247,0.00002489613,0.000004664164,0.00003205103,0.000006553732,0.00024295105,0.995815,0.00011159852,0.00009430199,0.0034540584],"study_design_scores_gemma":[0.000046309673,0.00097112346,0.0010840963,0.0000040083783,0.00001880886,0.00036054614,0.0000071738314,0.0028732857,0.99051636,0.000052081024,0.0040598325,0.000006425891],"about_ca_topic_score_codex":0.00022536711,"about_ca_topic_score_gemma":0.0003939981,"teacher_disagreement_score":0.0009346526,"about_ca_system_score_codex":0.00015384937,"about_ca_system_score_gemma":0.000153181,"threshold_uncertainty_score":0.0031267405},"labels":[],"label_agreement":null},{"id":"W4212869919","doi":"10.3324/haematol.2022.280677","title":"NOX2: a determinant of acute myeloid leukemia survival","year":2022,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Myeloid leukemia; Medicine; Leukemia; Myeloid; Cancer research; Oncology; Internal medicine; Immunology","score_opus":0.037218316194180666,"score_gpt":0.30629860586863217,"score_spread":0.2690802896744515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212869919","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031130405,0.004586055,0.00012539947,0.974836,0.010618205,0.000011714769,0.00014840122,0.00002856053,0.006532638],"genre_scores_gemma":[0.09419689,0.010569157,0.0005924306,0.74740744,0.114634596,0.00008490179,0.0003600291,0.000047255642,0.03210739],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990994,0.00028598463,0.0001028019,0.00010094504,0.00024193528,0.00016905565],"domain_scores_gemma":[0.99785894,0.000985978,0.00014639762,0.00009970654,0.00042059607,0.00048826166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011900556,0.00030608283,0.00082801096,0.00030292547,0.0012817797,0.0013531136,0.0006457354,0.011330734,0.00583553],"category_scores_gemma":[0.0064597456,0.00027247085,0.00047652586,0.0003535564,0.0010078378,0.0011827919,0.0005546715,0.008617789,0.005182672],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004605963,0.00006672736,0.0073969723,0.00008324226,0.0000316033,0.0049558096,0.00008735285,0.000115224866,0.0013795419,0.005223928,0.9301432,0.050055843],"study_design_scores_gemma":[0.00039053796,0.00028612508,0.014156271,0.00036334593,0.00010081571,0.011240041,0.0005578261,0.0014270239,0.0013841204,0.028226446,0.9418072,0.000060154303],"about_ca_topic_score_codex":0.0022319793,"about_ca_topic_score_gemma":0.0028045184,"teacher_disagreement_score":0.011330734,"about_ca_system_score_codex":0.0021617273,"about_ca_system_score_gemma":0.0012737529,"threshold_uncertainty_score":0.019521832},"labels":[],"label_agreement":null},{"id":"W4213288074","doi":"10.3324/haematol.2021.280394","title":"All-oral triplet combination of ixazomib, lenalidomide, and dexamethasone in newly diagnosed transplant-eligible multiple myeloma patients: final results of the phase II IFM 2013-06 study","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Lenalidomide; Ixazomib; Dexamethasone; Multiple myeloma; Medicine; Oncology; Internal medicine; Carfilzomib","score_opus":0.058924197317112646,"score_gpt":0.32786834550963384,"score_spread":0.2689441481925212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213288074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861953,0.0077497056,0.00040247486,0.0010270089,0.00018889125,0.00064228504,0.0019952995,0.00007008995,0.001728939],"genre_scores_gemma":[0.985531,0.0060018264,0.0013347316,0.0014720646,0.00028413793,0.0006049441,0.0031516165,0.000041392144,0.0015782529],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99943584,0.00025510482,0.000025166564,0.00008658407,0.00006519068,0.00013215054],"domain_scores_gemma":[0.99927694,0.0001102339,0.00017487015,0.000049925995,0.00004057681,0.00034743967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017181326,0.0010460339,0.0036454292,0.00033758077,0.00042650476,0.001407331,0.00083065237,0.00091159996,0.0019715014],"category_scores_gemma":[0.0010261412,0.00044257205,0.002429194,0.00055547437,0.0006694197,0.0010509703,0.0004516035,0.0036646451,0.00056608685],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74942213,0.026314702,0.026283141,0.0008628242,0.0047918707,0.00020792795,0.00021479871,0.0027984178,0.013268963,0.0002870251,0.007952929,0.1675953],"study_design_scores_gemma":[0.6444049,0.2604716,0.07985829,0.00019372553,0.004187122,0.00053619366,0.00019394995,0.0012192485,0.002510726,0.00057698967,0.0057595833,0.00008777245],"about_ca_topic_score_codex":0.002479461,"about_ca_topic_score_gemma":0.009094632,"teacher_disagreement_score":0.0036454292,"about_ca_system_score_codex":0.001561773,"about_ca_system_score_gemma":0.0022297928,"threshold_uncertainty_score":0.011331558},"labels":[],"label_agreement":null},{"id":"W4213418290","doi":"10.3324/haematol.2021.280329","title":"Pseudo-mutant P53 is a unique phenotype of &lt;i&gt;DNMT3A&lt;/i&gt;-mutated pre-leukemia","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Weizmann Institute of Science","keywords":"Mutant; Phenotype; Haematopoiesis; Mutation; Leukemia; Cancer research; Biology; Progenitor cell; Gene; Cell biology; Genetics; Stem cell","score_opus":0.020704750609857478,"score_gpt":0.28283286327596885,"score_spread":0.26212811266611136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213418290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960543,0.00045854072,0.002195961,0.000045961442,0.000010545786,0.000026426758,0.00048597532,0.000115415,0.0006069249],"genre_scores_gemma":[0.99632275,0.0002810596,0.0012648863,0.00003895558,0.000006433119,0.000030176232,0.00058742764,0.00003388427,0.0014343939],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99990714,0.000007976398,0.000012210611,0.000027684184,0.0000277836,0.000017248434],"domain_scores_gemma":[0.99986017,0.000016653403,0.000044212906,0.00002086097,0.000011426978,0.00004657623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060583076,0.0003188544,0.00024697158,0.0003558363,0.00011703245,0.00019190794,0.00015226516,0.00029760812,0.0015276937],"category_scores_gemma":[0.0001072178,0.00019117176,0.00019745124,0.00016652475,0.00021418264,0.00011187327,0.00018300729,0.00040852517,0.00039693434],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007127459,0.000008456059,0.00060826953,0.000009916833,0.000003825997,0.00038884778,0.000010210854,0.00001925417,0.9983235,0.00002982369,0.000019171644,0.000507478],"study_design_scores_gemma":[0.000024832172,0.0005460891,0.09285344,0.000005154911,0.000033458837,0.020278286,0.00006261643,0.0011272812,0.88241214,0.00015323152,0.0024922541,0.0000112461175],"about_ca_topic_score_codex":0.00032772112,"about_ca_topic_score_gemma":0.00040471504,"teacher_disagreement_score":0.0015276937,"about_ca_system_score_codex":0.00013302037,"about_ca_system_score_gemma":0.000072557596,"threshold_uncertainty_score":0.005110681},"labels":[],"label_agreement":null},{"id":"W4220862006","doi":"10.3324/haematol.2021.279459","title":"Final analysis of the phase III non-inferiority COLUMBA study of subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Calgary","funders":"National Cancer Institute; Adaptive Biotechnologies; Regeneron Pharmaceuticals; Janssen Pharmaceuticals; Celgene; Pharmacyclics; Sanofi; Chugai Pharmaceutical; Daiichi-Sankyo; Pfizer; Amgen","keywords":"Daratumumab; Medicine; Internal medicine; Neutropenia; Gastroenterology; Population; Adverse effect; Multiple myeloma; Lenalidomide; Chemotherapy","score_opus":0.037694526573671436,"score_gpt":0.31148603190424057,"score_spread":0.2737915053305691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220862006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891745,0.0022715542,0.001817153,0.0005170977,0.00014756838,0.0028265766,0.0015931384,0.00013554312,0.0015168901],"genre_scores_gemma":[0.9907584,0.00074903667,0.0018876898,0.00046078206,0.00013202157,0.0025570858,0.0016937652,0.000043767006,0.0017174487],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984915,0.0010463037,0.000049874765,0.000119511285,0.00012331744,0.0001694136],"domain_scores_gemma":[0.99824774,0.0005918427,0.0004376651,0.00017120341,0.00014869645,0.00040282798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005415962,0.0011540189,0.0024066532,0.00038179348,0.0003793764,0.0014115336,0.0006442809,0.00092912064,0.0029981849],"category_scores_gemma":[0.0027094162,0.00052108173,0.0028921403,0.0003968246,0.0006648122,0.0005963831,0.00039674915,0.0027780505,0.000572793],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8905142,0.01029985,0.007111968,0.0008476891,0.004382689,0.00019339046,0.00024491907,0.002298887,0.041543547,0.00043958137,0.002141213,0.039982006],"study_design_scores_gemma":[0.69977164,0.25314987,0.031627342,0.000063231324,0.0024735394,0.00022768998,0.00008417029,0.0022662168,0.005264046,0.0004493151,0.004566642,0.000056297056],"about_ca_topic_score_codex":0.0004472451,"about_ca_topic_score_gemma":0.0015934646,"teacher_disagreement_score":0.005415962,"about_ca_system_score_codex":0.00083951507,"about_ca_system_score_gemma":0.0015176731,"threshold_uncertainty_score":0.028642654},"labels":[],"label_agreement":null},{"id":"W4220963583","doi":"10.3324/haematol.2021.279756","title":"The glycolytic enzyme PFKFB3 determines bone marrow endothelial progenitor cell damage after chemotherapy and irradiation","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; School of Medicine, Shanghai Jiao Tong University; Peking University; Shanghai Jiao Tong University; Institute of Genetics and Developmental Biology, Chinese Academy of Sciences; Chinese Academy of Sciences","keywords":"Haematopoiesis; Cancer research; Bone marrow; Progenitor cell; Stem cell; Endothelial stem cell; Chemistry; In vivo; Cell biology; Biology; In vitro; Immunology; Biochemistry","score_opus":0.005893512811003071,"score_gpt":0.21334663377112423,"score_spread":0.20745312096012117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220963583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759537,0.0011447027,0.0006770907,0.000030790474,0.0000047635695,0.000013432721,0.00018225041,0.00001867526,0.00033286042],"genre_scores_gemma":[0.998792,0.00040261543,0.00022811891,0.000018816743,0.000002201032,0.000012020935,0.00021908335,0.0000035149321,0.00032168205],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992406,0.000009517053,0.0000063848424,0.000019344148,0.000015682619,0.000024956244],"domain_scores_gemma":[0.9999527,0.0000033334736,0.000023158584,0.0000028864274,0.0000044648764,0.00001357474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008527442,0.00017765805,0.00014371314,0.00023017026,0.000114795024,0.00016182777,0.000059779173,0.00017727325,0.00068207603],"category_scores_gemma":[0.000097339034,0.00010561069,0.000140437,0.00018238297,0.00016403678,0.00011464539,0.00014573078,0.00033603533,0.000121023426],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056802685,0.000021843236,0.005033992,0.000038446276,0.0000129640475,0.00010817977,0.000025521846,0.000068313944,0.99145526,0.00005788762,0.00005555982,0.0025539815],"study_design_scores_gemma":[0.00005681891,0.00065390964,0.18577826,0.000018463066,0.000084685205,0.0017343364,0.000090512876,0.00104744,0.80779004,0.00019868797,0.0025373795,0.000009519702],"about_ca_topic_score_codex":0.00046939758,"about_ca_topic_score_gemma":0.00046615748,"teacher_disagreement_score":0.00068207603,"about_ca_system_score_codex":0.000214043,"about_ca_system_score_gemma":0.000099971876,"threshold_uncertainty_score":0.002281785},"labels":[],"label_agreement":null},{"id":"W4221132712","doi":"10.3324/haematol.2022.280721","title":"A BAFFling &lt;i&gt;ménage à trois&lt;/i&gt; in mantle cell lymphoma","year":2022,"lang":"fr","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Mantle cell lymphoma; Mantle (geology); Cancer research; Chemistry; Lymphoma; Geology; Internal medicine; Geochemistry; Biology; Medicine","score_opus":0.01933096996494044,"score_gpt":0.24076534449651932,"score_spread":0.22143437453157888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221132712","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00094302313,0.0055253976,0.00011446252,0.94800705,0.018839393,0.000016944487,0.00009991628,0.000048835383,0.02640502],"genre_scores_gemma":[0.023301763,0.0051984927,0.00035762112,0.8144595,0.06668953,0.000046886176,0.000138158,0.00008688166,0.08972119],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9990871,0.00027572154,0.00007337133,0.00011280163,0.00021787835,0.00023316915],"domain_scores_gemma":[0.9985328,0.0005611619,0.000083418905,0.000055217984,0.00029335267,0.00047412835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009871583,0.0004895334,0.00059146085,0.00066333945,0.002769339,0.0017021892,0.0009116607,0.023644758,0.021053107],"category_scores_gemma":[0.005398324,0.00039718926,0.00083588954,0.0004317887,0.0013409263,0.0019800514,0.0006844811,0.015809441,0.0140838],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007633393,0.000026838105,0.0004990107,0.000028483753,0.000007620209,0.0057106735,0.00004470052,0.00004804496,0.00024256788,0.001691664,0.9850519,0.00657208],"study_design_scores_gemma":[0.00017591951,0.0001004679,0.0020140307,0.00028990454,0.000030592888,0.010106497,0.00019918292,0.00044631647,0.00043849568,0.007355445,0.97881114,0.00003197347],"about_ca_topic_score_codex":0.009749307,"about_ca_topic_score_gemma":0.013259437,"teacher_disagreement_score":0.023644758,"about_ca_system_score_codex":0.0028873673,"about_ca_system_score_gemma":0.0017727822,"threshold_uncertainty_score":0.07042968},"labels":[],"label_agreement":null},{"id":"W4224231988","doi":"10.3324/haematol.2021.280404","title":"Persistent DNA damage and oncogenic stress-induced Trem1 promotes leukemia in mice","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Inflammation biomarkers and pathways","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Cincinnati Children's Hospital Medical Center; National Institutes of Health; Université Laval; National Heart, Lung, and Blood Institute; University of Pittsburgh","keywords":"FANCA; Myelodysplastic syndromes; Fanconi anemia; Haematopoiesis; Biology; Stem cell; Myeloid leukemia; Cancer research; Leukemia; Immunology; DNA repair; Gene; Cell biology; Bone marrow; Genetics","score_opus":0.022674068464629635,"score_gpt":0.2224568965446786,"score_spread":0.19978282808004896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224231988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98965466,0.0014373532,0.0033404904,0.00036908442,0.000052997144,0.00011858515,0.0015177154,0.00046113998,0.0030479215],"genre_scores_gemma":[0.9857298,0.0012874539,0.0032189833,0.00022124941,0.00002974967,0.00020021356,0.0011125931,0.0000841669,0.008115806],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996681,0.000060915416,0.000030335534,0.000093405455,0.000055515553,0.00009169952],"domain_scores_gemma":[0.99971133,0.000019749037,0.00011895221,0.00002531733,0.000010969594,0.00011365338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002955249,0.0006868165,0.00034053435,0.0011820102,0.0003525204,0.00044977485,0.00036220005,0.0008000729,0.0037808318],"category_scores_gemma":[0.00013602934,0.0003861928,0.00042207577,0.0002750438,0.00053018803,0.0004719768,0.0005317448,0.0014222519,0.0009975852],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000862175,0.00040914875,0.0006557724,0.0000744684,0.0000128176225,0.0002988134,0.00006607981,0.00013105983,0.992961,0.0008686247,0.0002059131,0.0034541243],"study_design_scores_gemma":[0.0005161499,0.0051585785,0.021713985,0.00010300036,0.0000895289,0.003850157,0.00018938452,0.0048653325,0.94402796,0.0011011545,0.018345406,0.000039266106],"about_ca_topic_score_codex":0.00029003914,"about_ca_topic_score_gemma":0.00055551704,"teacher_disagreement_score":0.0037808318,"about_ca_system_score_codex":0.0005170006,"about_ca_system_score_gemma":0.00029493464,"threshold_uncertainty_score":0.012648165},"labels":[],"label_agreement":null},{"id":"W4224264729","doi":"10.3324/haematol.2021.280203","title":"The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Chronic myelomonocytic leukemia; Transplantation; KRAS; Hematopoietic stem cell transplantation; Neuroblastoma RAS viral oncogene homolog; International Prognostic Scoring System; Oncology; Hematopoietic cell; Multivariate analysis; Gastroenterology; Bone marrow; Haematopoiesis; Myelodysplastic syndromes; Cancer; Stem cell; Biology; Genetics","score_opus":0.037409176900426035,"score_gpt":0.3581258702767788,"score_spread":0.3207166933763527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224264729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99763775,0.00076044723,0.00025089673,0.00011658516,0.0000044847748,0.0000131427505,0.0008639245,0.0000074359014,0.00034523546],"genre_scores_gemma":[0.9987105,0.0002081372,0.00020551447,0.000025343317,0.000012636197,0.00001044769,0.0007738827,0.000003200121,0.000050380208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999332,0.00023264007,0.00007409453,0.00014771408,0.00013330085,0.0000802371],"domain_scores_gemma":[0.9985739,0.00033571577,0.00059132004,0.00015972143,0.00017380541,0.00016556562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002047667,0.00018846884,0.00028753586,0.0010633041,0.00030352647,0.00065960706,0.00036264607,0.00022623368,0.001426063],"category_scores_gemma":[0.0020283107,0.00012300923,0.0005407584,0.0021288595,0.00019574206,0.0002738613,0.00057406403,0.00038660128,0.00012476205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015599892,0.00001762371,0.9934534,0.000018351275,0.00013091578,0.00004140306,0.00002353287,0.00014356621,0.00028461867,0.000060522743,0.00028238542,0.00538775],"study_design_scores_gemma":[0.000012060033,0.0000749535,0.99768853,0.000012133334,0.00021370295,0.00022984907,0.00008283535,0.0009982452,0.00015414465,0.00006799609,0.00046205995,0.0000036327626],"about_ca_topic_score_codex":0.0037440436,"about_ca_topic_score_gemma":0.004142605,"teacher_disagreement_score":0.0037440436,"about_ca_system_score_codex":0.0003697526,"about_ca_system_score_gemma":0.0009268709,"threshold_uncertainty_score":0.01082927},"labels":[],"label_agreement":null},{"id":"W4229059632","doi":"10.3324/haematol.2021.278802","title":"Randomized controlled trial of geriatric consultation versus standard care in older adults with hematologic malignancies","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Frailty in Older Adults","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Center for Advancing Translational Sciences; National Institute on Aging; Dana-Farber/Harvard Cancer Center; Harvard Catalyst; National Cancer Institute; National Institutes of Health; Harvard University; U.S. Department of Veterans Affairs","keywords":"Medicine; Randomized controlled trial; Odds ratio; Confidence interval; Geriatric oncology; Geriatrics; Pediatrics; Internal medicine; Emergency medicine; Cancer","score_opus":0.012822945921910092,"score_gpt":0.27149701798771164,"score_spread":0.25867407206580156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229059632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9636581,0.013034083,0.0009939931,0.0015789889,0.002502094,0.0149461655,0.0007466998,0.00015205673,0.0023877174],"genre_scores_gemma":[0.969522,0.003115621,0.0032086258,0.0020003761,0.0011430782,0.018755525,0.0003927537,0.000011347084,0.0018507125],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99605054,0.0026917749,0.00036333347,0.00043879496,0.00016682026,0.00028873666],"domain_scores_gemma":[0.99530184,0.0024048176,0.0010083573,0.00021230246,0.000231517,0.0008411296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003917906,0.0015920103,0.004601006,0.0006997342,0.0007782514,0.0013338455,0.001207211,0.0035190284,0.00800198],"category_scores_gemma":[0.008768749,0.00075966946,0.0029999414,0.0005590051,0.0014574113,0.0014234715,0.0006782428,0.0032430936,0.0006200789],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98786736,0.0035829465,0.00038137354,0.00094390236,0.001078341,0.00002632292,0.00003536361,0.00013754984,0.0002282997,0.00008321055,0.00023767888,0.0053976495],"study_design_scores_gemma":[0.9731294,0.025387144,0.00042387287,0.00006368288,0.00048716032,0.0000077159275,0.000016358345,0.00018348359,0.00004934147,0.00008134041,0.00016493289,0.0000056615745],"about_ca_topic_score_codex":0.0024427022,"about_ca_topic_score_gemma":0.0042670066,"teacher_disagreement_score":0.00800198,"about_ca_system_score_codex":0.0012773242,"about_ca_system_score_gemma":0.0021014772,"threshold_uncertainty_score":0.02676928},"labels":[],"label_agreement":null},{"id":"W4229065705","doi":"10.3324/haematol.2021.279189","title":"One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":237,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"Core Research for Evolutional Science and Technology; Universitätsspital Basel","keywords":"Latin Americans; Transplantation; Population; Hematopoietic cell; Medicine; Demography; Internal medicine; Haematopoiesis; Stem cell; Political science; Biology; Environmental health; Genetics","score_opus":0.036058196810504796,"score_gpt":0.2567178585938418,"score_spread":0.22065966178333699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229065705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5794146,0.2660481,0.014371254,0.06194081,0.004654282,0.00018728842,0.015206822,0.00093655963,0.057240356],"genre_scores_gemma":[0.8036269,0.14651792,0.004867811,0.012852051,0.0021667473,0.00014402813,0.008962789,0.00015624538,0.020705637],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99934894,0.00020598089,0.00004817221,0.00009929684,0.0002017512,0.00009586056],"domain_scores_gemma":[0.9991416,0.00018605778,0.00020776504,0.00006869048,0.0001564794,0.00023943344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015278901,0.00020485136,0.0002180532,0.00053581933,0.00033611478,0.0007981962,0.0004228528,0.00043019277,0.012820435],"category_scores_gemma":[0.0024107676,0.00010933017,0.00030223196,0.0012078949,0.00038944586,0.0008985766,0.0015096104,0.0009916651,0.002053432],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020600435,0.000067815214,0.053113922,0.000839335,0.00007313605,0.00049720536,0.0005075726,0.00033329413,0.0034263032,0.008073584,0.068781085,0.8640807],"study_design_scores_gemma":[0.000065277,0.0003739613,0.26073146,0.0016994423,0.00015209553,0.008012996,0.0020227102,0.0009060304,0.002742468,0.008662524,0.7145844,0.000046544315],"about_ca_topic_score_codex":0.0023427668,"about_ca_topic_score_gemma":0.0019568093,"teacher_disagreement_score":0.012820435,"about_ca_system_score_codex":0.0005245428,"about_ca_system_score_gemma":0.0015883143,"threshold_uncertainty_score":0.04288858},"labels":[],"label_agreement":null},{"id":"W4229083035","doi":"10.3324/haematol.2021.278438","title":"Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"National Cancer Institute; Takeda Oncology","keywords":"Classical Hodgkin lymphoma; Medicine; Hodgkin lymphoma; Stage (stratigraphy); Lymphoma; Internal medicine; Oncology; Gerontology; Biology","score_opus":0.016657081744397482,"score_gpt":0.28360123698800677,"score_spread":0.26694415524360926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229083035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722086,0.020976314,0.00034392162,0.00014924302,0.00003971576,0.0003174243,0.0050464,0.000008068915,0.0009102159],"genre_scores_gemma":[0.9865044,0.0047693877,0.00034972408,0.0004549771,0.000116500945,0.00028214065,0.0070096804,0.0000108597815,0.00050232006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881554,0.00049829896,0.00018681695,0.00020355865,0.00019525627,0.00010056272],"domain_scores_gemma":[0.9979005,0.00067405566,0.0007971285,0.00020023483,0.0001862745,0.000241751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029043977,0.00034391586,0.0010800111,0.0004619199,0.00019635088,0.00052501005,0.0002138066,0.00030146044,0.001714104],"category_scores_gemma":[0.0027044886,0.00024403752,0.0024904287,0.0008482489,0.0001063821,0.00043110477,0.0005235214,0.00046807234,0.00022723264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12617142,0.00068288925,0.75368017,0.0051431134,0.022841105,0.0005077828,0.00043324532,0.0008094957,0.0053482107,0.00017283163,0.0052888747,0.07892094],"study_design_scores_gemma":[0.0098554315,0.003792647,0.967705,0.00026204064,0.010961094,0.00045927416,0.00012583127,0.0002610163,0.0003964624,0.0001039105,0.0060483315,0.000028986244],"about_ca_topic_score_codex":0.0012877512,"about_ca_topic_score_gemma":0.005282985,"teacher_disagreement_score":0.0029043977,"about_ca_system_score_codex":0.0003283585,"about_ca_system_score_gemma":0.0004163623,"threshold_uncertainty_score":0.015360117},"labels":[],"label_agreement":null},{"id":"W4237529142","doi":"10.3324/haematol.2019.234666","title":"Recurrent stroke: the role of thrombophilia in a large international pediatric stroke population","year":2019,"lang":"en","type":"erratum","venue":"Haematologica","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Thrombophilia; Stroke (engine); Medicine; Population; Pediatric stroke; Physical medicine and rehabilitation; Pediatrics; Physical therapy; Internal medicine; Ischemic stroke; Thrombosis; Environmental health","score_opus":0.01945981740667485,"score_gpt":0.28455484931823705,"score_spread":0.2650950319115622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237529142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8380085,0.045429252,0.003091235,0.063976906,0.00595502,0.00006483339,0.012866034,0.00025455974,0.03035362],"genre_scores_gemma":[0.96457744,0.016582437,0.0015263474,0.0038989787,0.0044094524,0.000043852677,0.0041390336,0.000100898054,0.0047214283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926716,0.00020241285,0.00013258148,0.0001614812,0.00015979468,0.000076609],"domain_scores_gemma":[0.99575555,0.0015777535,0.0016715962,0.00029868344,0.00044262104,0.00025386966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013027913,0.00031582537,0.0003658625,0.0010878552,0.00028071742,0.0010060248,0.00048773855,0.0009576656,0.0063811215],"category_scores_gemma":[0.008740281,0.00019752281,0.00033880124,0.0024575407,0.00038820243,0.0007086003,0.00038767618,0.0011112827,0.0011343072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017010816,0.000016423914,0.92251205,0.00011924672,0.000080287995,0.0013444305,0.00033555867,0.00007431993,0.000090183654,0.00049539556,0.04292367,0.031838357],"study_design_scores_gemma":[0.000026617108,0.00006966766,0.97321814,0.0002711126,0.00019403077,0.0078104716,0.0008438479,0.00040700045,0.00011468414,0.00038703537,0.016630081,0.000027359709],"about_ca_topic_score_codex":0.007786053,"about_ca_topic_score_gemma":0.007720086,"teacher_disagreement_score":0.007786053,"about_ca_system_score_codex":0.0002385517,"about_ca_system_score_gemma":0.0003816805,"threshold_uncertainty_score":0.021346986},"labels":[],"label_agreement":null},{"id":"W4241096387","doi":"10.3324/haematol.2013.092155","title":"Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I","year":2013,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Incyte","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Hazard ratio; Placebo; Internal medicine; Randomized controlled trial; Confidence interval; Janus kinase 2; Myeloproliferative neoplasm; Anemia; Surgery; Gastroenterology; Bone marrow; Pathology","score_opus":0.012935383039976026,"score_gpt":0.23148396466348847,"score_spread":0.21854858162351246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241096387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964812,0.002416633,0.00017202072,0.00007837568,0.00001735463,0.00009205647,0.00033769818,0.000013015446,0.00039162373],"genre_scores_gemma":[0.99808997,0.0003475529,0.0001673628,0.0001182647,0.000052963227,0.00009887842,0.00092669274,0.000002223685,0.00019613866],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99885595,0.00054029364,0.00010899767,0.00018681683,0.00014925236,0.00015879332],"domain_scores_gemma":[0.9978249,0.00045866417,0.00085888227,0.00019005037,0.0001646122,0.0005028867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004015876,0.0006721283,0.0016994026,0.00036282177,0.0004724073,0.00069372513,0.00039333515,0.0009785574,0.0010431082],"category_scores_gemma":[0.0026621441,0.00030301904,0.0019159911,0.0004388947,0.0004230147,0.0006721814,0.00040008154,0.0010955846,0.00024079412],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71729845,0.0083572455,0.17596237,0.0005467067,0.0039820066,0.0003974652,0.00030756596,0.0020976558,0.010361264,0.00009484605,0.001189374,0.079405114],"study_design_scores_gemma":[0.08317186,0.27125132,0.6327778,0.00009152976,0.003992002,0.00055837724,0.00014324854,0.0019079142,0.0037661665,0.00017667373,0.00206632,0.00009676722],"about_ca_topic_score_codex":0.00049845036,"about_ca_topic_score_gemma":0.0008084871,"teacher_disagreement_score":0.004015876,"about_ca_system_score_codex":0.00066417095,"about_ca_system_score_gemma":0.00050595525,"threshold_uncertainty_score":0.021238267},"labels":[],"label_agreement":null},{"id":"W4281571337","doi":"10.3324/haematol.2022.281114","title":"Durable discontinuation of systemic therapy for chronic graft-&lt;i&gt;versus&lt;/i&gt;-host disease: myth or reality?","year":2022,"lang":"en","type":"letter","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"National Institutes of Health","keywords":"Discontinuation; Graft-versus-host disease; Systemic therapy; Mythology; Medicine; Systemic disease; Disease; Immunology; Internal medicine; Theology; Philosophy; Cancer","score_opus":0.047726942434693324,"score_gpt":0.2978000384813579,"score_spread":0.25007309604666456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281571337","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010412506,0.0023978357,0.0003876548,0.9537401,0.00995242,0.000019326131,0.00012382786,0.00004639362,0.022919953],"genre_scores_gemma":[0.123057485,0.0043209703,0.0010159076,0.8016846,0.034600936,0.00004047317,0.0001444559,0.000050062412,0.03508505],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995766,0.000113196445,0.00006689075,0.000049113747,0.00010344624,0.00009073999],"domain_scores_gemma":[0.9984224,0.0006803248,0.00014941124,0.000058378246,0.00038686235,0.00030276924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005621264,0.00018115087,0.000314224,0.00021810312,0.0010723711,0.0007199205,0.00038330417,0.0059015416,0.004517193],"category_scores_gemma":[0.0041024317,0.000115033705,0.0002908527,0.00029433463,0.0006072411,0.00090998237,0.00026203113,0.0058079697,0.0024818918],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014200268,0.00012878138,0.011241911,0.00007144328,0.000016032505,0.028772797,0.0002921048,0.00018472748,0.0006480628,0.0055485065,0.9020175,0.05093603],"study_design_scores_gemma":[0.00017576835,0.00024889095,0.015893133,0.0006643086,0.000034783305,0.09270355,0.0010882386,0.0015244937,0.0007591445,0.011070607,0.87576765,0.00006937603],"about_ca_topic_score_codex":0.0034534368,"about_ca_topic_score_gemma":0.0062319357,"teacher_disagreement_score":0.0059015416,"about_ca_system_score_codex":0.0016914005,"about_ca_system_score_gemma":0.0010286449,"threshold_uncertainty_score":0.015111506},"labels":[],"label_agreement":null},{"id":"W4283311968","doi":"10.3324/haematol.2022.280900","title":"In-depth characterization of intratumoral heterogeneity in refractory B-cell non-Hodgkin lymphoma through the lens of a Research Autopsy Program","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network","funders":"Hospital for Sick Children","keywords":"Lymphoma; Biology; Laser capture microdissection; Pathology; Somatic evolution in cancer; Cancer research; Cancer; Medicine; Genetics; Gene; Immunology","score_opus":0.03622174859452767,"score_gpt":0.32978968303005707,"score_spread":0.2935679344355294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283311968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957124,0.0008261474,0.0028151483,0.000022759486,0.0000020421705,0.000009329302,0.00009333711,0.000020726937,0.0004981728],"genre_scores_gemma":[0.99742967,0.00039307447,0.0017746171,0.000017591023,0.000005584674,0.00000681657,0.00015324762,0.000009341319,0.00021003894],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99991035,0.000020160009,0.0000076137917,0.000029795016,0.000016996484,0.0000149702355],"domain_scores_gemma":[0.99982387,0.00003690556,0.0000528555,0.00003015556,0.000030410712,0.000025871977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028904705,0.00012728482,0.00015889312,0.0009242429,0.00018924948,0.0003968496,0.00013583555,0.00015938704,0.00058740354],"category_scores_gemma":[0.00037966913,0.00012109488,0.000092072965,0.00033111256,0.0002463465,0.00020053497,0.00027451225,0.00017051845,0.00015946655],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004149395,0.000035243007,0.18808961,0.00007240601,0.00004507056,0.0019611926,0.0006509457,0.00058342266,0.78938836,0.0003260249,0.000101273945,0.018331613],"study_design_scores_gemma":[0.000013847385,0.00036538418,0.8696931,0.000029515013,0.00015001917,0.0135522885,0.0012760212,0.0052300226,0.10508772,0.00072095846,0.0038622508,0.000018953342],"about_ca_topic_score_codex":0.00045521176,"about_ca_topic_score_gemma":0.0007246562,"teacher_disagreement_score":0.0009242429,"about_ca_system_score_codex":0.00013698735,"about_ca_system_score_gemma":0.00008791341,"threshold_uncertainty_score":0.001965046},"labels":[],"label_agreement":null},{"id":"W4289793368","doi":"10.3324/haematol.2022.280740","title":"Onset of blast crisis in chronic myeloid leukemia patients in treatment-free remission","year":2022,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Centre Léon Bérard; Pfizer; Incyte; Amgen","keywords":"Blast Crisis; Myeloid leukemia; Medicine; Complete remission; Internal medicine; Oncology; Chemotherapy","score_opus":0.02280471330544193,"score_gpt":0.269305235348068,"score_spread":0.24650052204262607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289793368","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06151821,0.012728818,0.0002830635,0.84072727,0.006806481,0.00006827108,0.0009981678,0.000079662306,0.07678997],"genre_scores_gemma":[0.5016061,0.011510528,0.0004174196,0.42154747,0.036376704,0.00007695294,0.0006757595,0.000042325468,0.02774664],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99952924,0.000185329,0.00004845055,0.000051482708,0.000073291674,0.00011217127],"domain_scores_gemma":[0.99849343,0.0007314652,0.0002279994,0.000046410336,0.00013440296,0.00036636705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043989051,0.00019459834,0.00048526286,0.00039440335,0.0010061982,0.00080968766,0.00040393375,0.0074796323,0.0064725564],"category_scores_gemma":[0.0036317173,0.00019509996,0.0003048466,0.00063765625,0.0005428676,0.0006612505,0.00031703874,0.0038212587,0.00196891],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018535776,0.00023937805,0.078723796,0.00028478605,0.00006254076,0.15543185,0.00038371116,0.0002606894,0.0019640038,0.0048657586,0.6956146,0.060315374],"study_design_scores_gemma":[0.00134588,0.0009773317,0.22544964,0.0015157635,0.00018275376,0.30115405,0.0023630764,0.0019616503,0.001488801,0.019835666,0.44359356,0.0001319073],"about_ca_topic_score_codex":0.004243217,"about_ca_topic_score_gemma":0.0067313565,"teacher_disagreement_score":0.0074796323,"about_ca_system_score_codex":0.0012093685,"about_ca_system_score_gemma":0.0008335758,"threshold_uncertainty_score":0.021652877},"labels":[],"label_agreement":null},{"id":"W4289855872","doi":"10.3324/haematol.2022.281431","title":"Mass spectrometry-based proteomics in clinical practice amyloid typing: state-of-the-art from a French nationwide cohort","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Région Occitanie Pyrénées-Méditerranée; Agence Nationale de la Recherche","keywords":"Proteomics; Cohort; Mass spectrometry; Medicine; Amyloid (mycology); Cohort study; Computational biology; Internal medicine; Chemistry; Chromatography; Pathology; Biology","score_opus":0.017322024303209706,"score_gpt":0.2983294327472847,"score_spread":0.28100740844407496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289855872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91844326,0.048921194,0.008386687,0.0072226063,0.00041263402,0.00013424503,0.0077103972,0.00027593775,0.00849303],"genre_scores_gemma":[0.96845233,0.016085533,0.0036948281,0.002940089,0.0006802961,0.000110009925,0.0070246127,0.00014259579,0.0008696989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99368215,0.0024333652,0.0006383289,0.001464295,0.0012113493,0.00057052745],"domain_scores_gemma":[0.98097014,0.006076795,0.002852252,0.002225755,0.006822314,0.0010527419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017587245,0.00092331826,0.0014068144,0.0031054767,0.00085226615,0.004162768,0.0012413942,0.0012632885,0.0027950862],"category_scores_gemma":[0.023276549,0.0003096909,0.0011527796,0.0032632558,0.00093644205,0.0013211865,0.0013968586,0.00082598603,0.0008938097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000544248,0.00011461974,0.9174356,0.0003205635,0.00078136846,0.0004164839,0.0008287054,0.00031704525,0.0016020176,0.0004923195,0.0071606054,0.06998649],"study_design_scores_gemma":[0.000065592845,0.000347639,0.97569174,0.0005694951,0.0004640368,0.0020357056,0.0009659973,0.0005700977,0.00053413975,0.00043231912,0.018275624,0.000047588335],"about_ca_topic_score_codex":0.027748175,"about_ca_topic_score_gemma":0.020059291,"teacher_disagreement_score":0.027748175,"about_ca_system_score_codex":0.0021711562,"about_ca_system_score_gemma":0.0027938944,"threshold_uncertainty_score":0.09301138},"labels":[],"label_agreement":null},{"id":"W4292478418","doi":"10.3324/haematol.2022.280723","title":"High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Sunnybrook Health Science Centre; Jewish General Hospital; St. Paul's Hospital; Dr. Georges-L.-Dumont University Hospital Centre; Queen Elizabeth II Health Sciences Centre; University of Alberta; Vancouver General Hospital; Princess Margaret Cancer Centre; CancerCare Manitoba; Saskatchewan Cancer Agency; Ottawa Hospital; Health Sciences Centre; McGill University Health Centre; Juravinski Cancer Centre","funders":"Celgene","keywords":"Medicine; Ferritin; Internal medicine; Gastroenterology; Transferrin saturation; Myelodysplastic syndromes; International Prognostic Scoring System; Univariate analysis; Anemia; Serum ferritin; Multivariate analysis; Bone marrow","score_opus":0.02863820880396554,"score_gpt":0.3032478793550697,"score_spread":0.27460967055110413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292478418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989605,0.00022575985,0.000025234027,0.000059967086,0.000003588851,0.000004290081,0.00018461637,0.0000030326885,0.00053308345],"genre_scores_gemma":[0.9995321,0.0000703011,0.000023241197,0.000011740709,0.000004989692,0.000001920728,0.00025912363,7.635036e-7,0.00009582283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988425,0.000015353413,0.000010050969,0.000018186109,0.00003418494,0.00003792042],"domain_scores_gemma":[0.9993838,0.00007695597,0.0002333821,0.000021711934,0.000093656614,0.00019052073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028088584,0.00023797674,0.00020602548,0.0005553338,0.0004466723,0.00042131075,0.00025785223,0.00031161244,0.0013531271],"category_scores_gemma":[0.0013199294,0.0001048041,0.0001825157,0.00061061705,0.00039622642,0.0001530099,0.00025907005,0.00039729127,0.00019197473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012545359,0.000008637182,0.9986117,0.000003882742,0.000008401861,0.000069632384,0.000024374109,0.000038268186,0.0001498526,0.000012887356,0.00009620281,0.00085067586],"study_design_scores_gemma":[0.0000054263237,0.00004151413,0.99923253,0.0000052751716,0.0000136242115,0.00022824128,0.000081947044,0.00017293743,0.000040778592,0.00003551481,0.00013990924,0.0000022556842],"about_ca_topic_score_codex":0.05424581,"about_ca_topic_score_gemma":0.05800945,"teacher_disagreement_score":0.05424581,"about_ca_system_score_codex":0.00079586415,"about_ca_system_score_gemma":0.0012207831,"threshold_uncertainty_score":0.10786009},"labels":[],"label_agreement":null},{"id":"W4292478663","doi":"10.3324/haematol.2022.281864","title":"Bence Jones Island in Shepherd Bay, Nunavut: a little known tribute to the legendary physician and chemist’s “thé de voyage”","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"High Altitude and Hypoxia","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bay; Tribute; History; Archaeology; Art history","score_opus":0.008939515093991645,"score_gpt":0.23515372236634458,"score_spread":0.22621420727235292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292478663","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03788268,0.14047705,0.0003021141,0.6190567,0.075383924,0.000035192643,0.0002473649,0.00009390551,0.12652107],"genre_scores_gemma":[0.3166692,0.07183241,0.0007344149,0.23818706,0.018736098,0.000051307943,0.0002366934,0.00032435008,0.35322845],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954164,0.00008031051,0.0000142967365,0.00011837303,0.00012111973,0.00012437253],"domain_scores_gemma":[0.9991934,0.00014228484,0.000054551234,0.00004553199,0.0002122919,0.0003519871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055942585,0.0004225105,0.0003011677,0.0005153858,0.012932556,0.0040273564,0.0013977335,0.0023191993,0.01365021],"category_scores_gemma":[0.0025797482,0.00025384958,0.00013575437,0.00071445276,0.008310601,0.0025478667,0.0032113972,0.005823658,0.0017972833],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007916376,0.000030620522,0.0053649466,0.00020983601,0.000011903596,0.001834048,0.03899034,0.00005716849,0.0006651521,0.012043293,0.907496,0.03321765],"study_design_scores_gemma":[0.000004689652,0.000008852231,0.0039023214,0.0003200457,0.0000035796209,0.00035929168,0.031689305,0.000018912911,0.00009902214,0.0008016801,0.9627744,0.000017959523],"about_ca_topic_score_codex":0.69521195,"about_ca_topic_score_gemma":0.82334065,"teacher_disagreement_score":0.30478805,"about_ca_system_score_codex":0.007041229,"about_ca_system_score_gemma":0.015404021,"threshold_uncertainty_score":0.613166},"labels":[],"label_agreement":null},{"id":"W4296629879","doi":"10.3324/haematol.2022.280786","title":"Genome-wide CRISPR screens identify ferroptosis as a novel therapeutic vulnerability in acute lymphoblastic leukemia","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; National Research Council Canada","funders":"Centre hospitalier universitaire Sainte-Justine","keywords":"CRISPR; Biology; Cancer research; Lymphoblastic Leukemia; Gene; GPX4; Genome editing; Bystander effect; Genome; Leukemia; Genetics; Oxidative stress; Immunology","score_opus":0.0250091142453089,"score_gpt":0.2948795382554464,"score_spread":0.2698704240101375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296629879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98037684,0.0010127188,0.012479862,0.0002732139,0.000041286243,0.00011563078,0.0020220685,0.00059819676,0.003080256],"genre_scores_gemma":[0.9885684,0.0008493103,0.0067112017,0.000184287,0.0000064855535,0.0000747052,0.0013815735,0.00006964048,0.0021543722],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998024,0.00003425518,0.000017823868,0.000040549356,0.00007386055,0.000031071595],"domain_scores_gemma":[0.9998857,0.000049575916,0.000022284836,0.000014386127,0.00001110199,0.000016927672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023510576,0.00034450277,0.00032242757,0.00024099462,0.00016507882,0.00039698824,0.00021228474,0.00033336043,0.0012953498],"category_scores_gemma":[0.00026565217,0.000124404,0.00021257579,0.00012329507,0.00021949541,0.00009628752,0.00028987328,0.0005068038,0.0002515398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007401839,0.000019425765,0.00038041582,0.00004750468,0.000012456759,0.0000964789,0.000015718508,0.00032530562,0.99610907,0.000100123274,0.00012903448,0.0026904703],"study_design_scores_gemma":[0.00001909544,0.00034039142,0.0049740253,0.000012889631,0.00005094842,0.0005515895,0.000044171684,0.002543075,0.9849465,0.0001409336,0.0063665397,0.0000097596485],"about_ca_topic_score_codex":0.0006174183,"about_ca_topic_score_gemma":0.0018758605,"teacher_disagreement_score":0.0012953498,"about_ca_system_score_codex":0.0002674392,"about_ca_system_score_gemma":0.00016943224,"threshold_uncertainty_score":0.004333377},"labels":[],"label_agreement":null},{"id":"W4302287941","doi":"10.3324/haematol.2022.280653","title":"CD56&lt;sup&gt;bright&lt;/sup&gt;CD16&lt;sup&gt;–&lt;/sup&gt; natural killer cells as an important regulatory mechanism in chronic graft-&lt;I&gt;versus&lt;/i&gt;-host disease","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of Manitoba; CancerCare Manitoba; BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; BC Children's Hospital","keywords":"Perforin; Immunology; Granzyme B; Population; Biology; Interleukin 21; CD16; Natural killer cell; CD8; Cytotoxic T cell; Cancer research; Immune system; Medicine; CD3; In vitro; Genetics","score_opus":0.0101338901872905,"score_gpt":0.22538859530337085,"score_spread":0.21525470511608036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302287941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99352247,0.0020124728,0.0016960568,0.00010129737,0.000013699921,0.000039560386,0.00020569107,0.000052468353,0.002356322],"genre_scores_gemma":[0.99596184,0.0006398739,0.0013449843,0.00007912974,0.000020142888,0.000029996678,0.00031784872,0.000019651132,0.0015866101],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998926,0.000019145238,0.000013315531,0.000026902757,0.000023988676,0.000023983184],"domain_scores_gemma":[0.99992394,0.0000087290655,0.000024327084,0.000011175467,0.000006628328,0.000025208938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023757706,0.00022364355,0.00018966243,0.00032217163,0.00013118958,0.00041705507,0.00017403415,0.00017570386,0.0019456706],"category_scores_gemma":[0.000156455,0.000084207284,0.00010771625,0.00017465022,0.00025187962,0.0002930807,0.000292608,0.0003557727,0.00050347304],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006888195,0.000060591527,0.027447091,0.00012610859,0.000014674873,0.0005797124,0.00012746596,0.00016182258,0.94704807,0.00073071825,0.00035872153,0.022656174],"study_design_scores_gemma":[0.00023374561,0.0021120892,0.31656903,0.00015202779,0.00020406563,0.017323159,0.00059098314,0.005380006,0.6076003,0.0020087955,0.04778902,0.000036792797],"about_ca_topic_score_codex":0.00019340098,"about_ca_topic_score_gemma":0.00032667082,"teacher_disagreement_score":0.0019456706,"about_ca_system_score_codex":0.00016516511,"about_ca_system_score_gemma":0.00011396926,"threshold_uncertainty_score":0.0065089464},"labels":[],"label_agreement":null},{"id":"W4304845645","doi":"10.3324/haematol.2022.281180","title":"Variation and impact of polygenic hematologic traits in monogenic sickle cell disease","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Montreal Heart Institute","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Fondation Charles-Bruneau","keywords":"Acute chest syndrome; Fetal hemoglobin; Locus (genetics); Medicine; Disease; Genotype; Epistasis; Context (archaeology); Mendelian randomization; Genome-wide association study; Sickle cell anemia; Mendelian inheritance; Internal medicine; Biology; Immunology; Genetics; Single-nucleotide polymorphism; Gene; Pregnancy; Genetic variants","score_opus":0.010647031821667477,"score_gpt":0.24875977128370713,"score_spread":0.23811273946203965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304845645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779344,0.00032219727,0.0015371011,0.000051705625,0.000006727879,0.000003536914,0.00014145815,0.000012022829,0.00013180973],"genre_scores_gemma":[0.9993001,0.00006402928,0.00043443908,0.000019090297,0.0000070083756,0.0000026890725,0.00010243282,0.0000057393586,0.00006449129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821365,0.0009898805,0.000105348525,0.0004215334,0.00016175091,0.000107907086],"domain_scores_gemma":[0.99786925,0.0012290708,0.00040781545,0.000260637,0.00007133435,0.00016191021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015598914,0.00041954013,0.00042585089,0.00072274066,0.0003698108,0.00055414834,0.00030989025,0.00047295765,0.0014588992],"category_scores_gemma":[0.0032637583,0.00017949186,0.00061459147,0.00077826733,0.0005175558,0.00020172397,0.0004984463,0.00049008033,0.000105823594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010496799,0.00008359226,0.9597731,0.000046779656,0.0016247493,0.0009164512,0.00042856578,0.0025763751,0.018836766,0.0009288472,0.00024062187,0.013494505],"study_design_scores_gemma":[0.000015745523,0.00012695837,0.99333316,0.00000896149,0.0001815481,0.00050809095,0.000056766847,0.0044911155,0.000353069,0.0007294978,0.00018052118,0.000014612729],"about_ca_topic_score_codex":0.003274263,"about_ca_topic_score_gemma":0.0038502556,"teacher_disagreement_score":0.003274263,"about_ca_system_score_codex":0.00016639571,"about_ca_system_score_gemma":0.00017263475,"threshold_uncertainty_score":0.00824964},"labels":[],"label_agreement":null},{"id":"W4306867613","doi":"10.3324/haematol.2021.280051","title":"Prognostic value of positron emission tomography/computed tomography in transplant-eligible newly diagnosed multiple myeloma patients from CASSIOPEIA: the CASSIOPET study","year":2022,"lang":"en","type":"letter","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Institut National Du Cancer; Direction Générale de l’offre de Soins; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche; CHIST-ERA; Labex Iron","keywords":"Positron emission tomography; Medicine; Multiple myeloma; Cassiopeia A; Positron Emission Tomography-Computed Tomography; Nuclear medicine; Radiology; Tomography; Internal medicine; Physics; Astronomy","score_opus":0.02303871682484634,"score_gpt":0.27348528004051986,"score_spread":0.25044656321567355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306867613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78916895,0.022096759,0.0002867818,0.15183246,0.002327352,0.00007817903,0.0035904353,0.00004752772,0.030571528],"genre_scores_gemma":[0.96990967,0.0036437346,0.00026272307,0.01955828,0.003278373,0.000050377777,0.0014534062,0.000014398693,0.0018290294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959415,0.00015677632,0.000040778763,0.000061069,0.000069027155,0.00007823293],"domain_scores_gemma":[0.99788743,0.0009624405,0.00030497837,0.00012921283,0.00024211238,0.0004738694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080805353,0.0001968009,0.0006700279,0.00036201207,0.00042528092,0.0010497661,0.0004276137,0.0018606996,0.002045907],"category_scores_gemma":[0.004051185,0.00013573689,0.00034432643,0.001074921,0.0002654347,0.00034621268,0.00020935126,0.0014923818,0.00046068316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0093702655,0.00019432625,0.8324428,0.0002078803,0.00050169404,0.016205551,0.00021860944,0.0007728585,0.0018479162,0.0011039433,0.06914382,0.06799029],"study_design_scores_gemma":[0.0031503872,0.0011111092,0.88854796,0.0006657051,0.0013818596,0.030819839,0.0008055594,0.004759366,0.0011882437,0.0057149036,0.061754607,0.00010052206],"about_ca_topic_score_codex":0.002806353,"about_ca_topic_score_gemma":0.005760512,"teacher_disagreement_score":0.002806353,"about_ca_system_score_codex":0.0010226298,"about_ca_system_score_gemma":0.00078718126,"threshold_uncertainty_score":0.007419765},"labels":[],"label_agreement":null},{"id":"W4306867618","doi":"10.3324/haematol.2022.280678","title":"Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Gilead Sciences","keywords":"Medicine; Refractory (planetary science); Gastroenterology; Internal medicine; Cytokine release syndrome; Adverse effect; Anemia; Incidence (geometry); Surgery; Chimeric antigen receptor; Immunotherapy","score_opus":0.03940613311196696,"score_gpt":0.3146591669903849,"score_spread":0.27525303387841793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306867618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99203813,0.0040573096,0.0011377899,0.00016462039,0.00002649,0.00030331704,0.000922916,0.0000746844,0.0012747741],"genre_scores_gemma":[0.9893444,0.0024202624,0.0014626937,0.00037602033,0.000050352624,0.0003617161,0.0042481953,0.000040396044,0.001695972],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995401,0.00018435126,0.000035551093,0.0000448709,0.00007273298,0.00012250566],"domain_scores_gemma":[0.99908745,0.00021749313,0.00025703415,0.00009230429,0.00009719717,0.0002485973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024767679,0.0006795465,0.0011573794,0.000342948,0.0004413377,0.00069203397,0.00036501122,0.0004852203,0.001005413],"category_scores_gemma":[0.00091293117,0.00016537201,0.00085785775,0.00024032805,0.00030177587,0.00041525005,0.0003353599,0.0013491574,0.0003139443],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13345951,0.042785697,0.10433478,0.0011970011,0.0026548866,0.0013963211,0.0011081673,0.015005554,0.20273565,0.0005133575,0.009308071,0.48550102],"study_design_scores_gemma":[0.034244016,0.5867185,0.2622934,0.00014381998,0.0028524783,0.00295885,0.00042720794,0.0058041024,0.0803152,0.0005183661,0.023641346,0.00008269922],"about_ca_topic_score_codex":0.0008964498,"about_ca_topic_score_gemma":0.0016936928,"teacher_disagreement_score":0.0024767679,"about_ca_system_score_codex":0.0005892012,"about_ca_system_score_gemma":0.0005515103,"threshold_uncertainty_score":0.013098538},"labels":[],"label_agreement":null},{"id":"W4308007975","doi":"10.3324/haematol.2022.281644","title":"What doesn’t kill you makes you stronger – &lt;i&gt;bcl-2&lt;/i&gt; promotes survival independent of proliferation","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Cancer research; Biology; Molecular biology; Chemistry; Internal medicine; Medicine","score_opus":0.02814590347934173,"score_gpt":0.28616002641516736,"score_spread":0.25801412293582565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308007975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7933979,0.066204,0.012373903,0.017278941,0.0036228911,0.00020504885,0.0013718551,0.0037083668,0.10183705],"genre_scores_gemma":[0.93729484,0.010422414,0.004598931,0.0023015244,0.0005454851,0.00010029213,0.0006369933,0.00020406183,0.04389538],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983394,0.00002732541,0.000007877249,0.00003642841,0.000057600275,0.000036892136],"domain_scores_gemma":[0.999795,0.000027585731,0.000046834914,0.000035392783,0.000025416946,0.00006983874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024115277,0.00035841647,0.00039011208,0.00038914676,0.00023759337,0.0006409477,0.00028625494,0.000349916,0.0073927543],"category_scores_gemma":[0.00018851718,0.00017168692,0.00022052706,0.00029930315,0.00065786304,0.00063026143,0.00030767385,0.0015580114,0.002230681],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019764944,0.00070097233,0.0013817616,0.0006888213,0.00008999783,0.0003933783,0.00009582403,0.00022995894,0.80290705,0.0044836546,0.031159112,0.15589303],"study_design_scores_gemma":[0.00075755693,0.0045551974,0.013860172,0.00014139456,0.00018518591,0.0032527975,0.00015116135,0.0012347241,0.7126126,0.002127745,0.26107818,0.00004325516],"about_ca_topic_score_codex":0.00044688798,"about_ca_topic_score_gemma":0.001109743,"teacher_disagreement_score":0.0073927543,"about_ca_system_score_codex":0.0004452952,"about_ca_system_score_gemma":0.00024851924,"threshold_uncertainty_score":0.024731278},"labels":[],"label_agreement":null},{"id":"W4308060958","doi":"10.3324/haematol.2022.281146","title":"Prognostic impact of pretreatment immunoglobulin clonal composition in pediatric B-lymphoblastic leukemia","year":2022,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Lymphoblastic Leukemia; Antibody; Medicine; Leukemia; Immunology","score_opus":0.020992387842895987,"score_gpt":0.2955415563074582,"score_spread":0.27454916846456223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308060958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9548245,0.0099341,0.00031461834,0.017975453,0.00042194786,0.000028561994,0.00224629,0.00004905237,0.014205433],"genre_scores_gemma":[0.9927649,0.002284827,0.00033710035,0.0020858834,0.0005310535,0.000023672654,0.0009409438,0.000011051408,0.0010205801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995925,0.00016208157,0.000042393913,0.000040945484,0.00007187184,0.000090255184],"domain_scores_gemma":[0.99732864,0.0015225525,0.00038025642,0.00017799762,0.00026353853,0.00032696585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005972539,0.00020054205,0.00040086263,0.0004310809,0.00023943152,0.0004164639,0.00028944167,0.00101518,0.0020321945],"category_scores_gemma":[0.0039951233,0.00012693962,0.00017225296,0.0011572856,0.00030427167,0.00043386512,0.00017372808,0.0006817573,0.0006942502],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002676227,0.00006773579,0.90903515,0.000088124754,0.000049646063,0.012731889,0.00008258329,0.0004545175,0.0021011387,0.00029392488,0.015087257,0.057331756],"study_design_scores_gemma":[0.0001686606,0.0008273597,0.9308926,0.00014328299,0.00013481927,0.04383969,0.00038556533,0.0016149703,0.0016172628,0.0010683035,0.01928147,0.000026061118],"about_ca_topic_score_codex":0.0017362136,"about_ca_topic_score_gemma":0.0032741462,"teacher_disagreement_score":0.0020321945,"about_ca_system_score_codex":0.0005604201,"about_ca_system_score_gemma":0.00041859414,"threshold_uncertainty_score":0.006798327},"labels":[],"label_agreement":null},{"id":"W4309243711","doi":"10.3324/haematol.2022.281926","title":"Clinical response to dabrafenib and chemotherapy in clonally-related histiocytosis and acute lymphoblastic leukemia","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Lymphoblastic Leukemia; Dabrafenib; Medicine; Chemotherapy; Oncology; Leukemia; Cancer research; Immunology; Internal medicine; Melanoma; Vemurafenib","score_opus":0.01658346714027838,"score_gpt":0.3049279870172312,"score_spread":0.2883445198769528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309243711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9534648,0.024400514,0.00025540162,0.0020308178,0.00021447103,0.00026888,0.004877681,0.000028245173,0.014459176],"genre_scores_gemma":[0.9901017,0.003368969,0.0002556521,0.0006500698,0.000083566905,0.000118591204,0.0039522885,0.0000046070504,0.0014645603],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99926454,0.00038858104,0.00010073187,0.00005156631,0.00009299585,0.00010154545],"domain_scores_gemma":[0.9988617,0.00055721373,0.00022824036,0.000076239805,0.00008378057,0.00019277628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010765858,0.0001867019,0.0006437982,0.00038942433,0.00021227279,0.00038816413,0.00030223053,0.00040006268,0.0034433228],"category_scores_gemma":[0.0026497848,0.00010205626,0.00040631002,0.00067701587,0.00025166574,0.0003249621,0.00018327762,0.0004483263,0.00043928038],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12702885,0.0015176277,0.5196855,0.0016916457,0.0018045226,0.005808717,0.00022008937,0.0018973576,0.008423181,0.0006500393,0.01685548,0.314417],"study_design_scores_gemma":[0.0067240195,0.013813203,0.9279409,0.0003709072,0.00082482357,0.01024388,0.00035395788,0.0012179307,0.0028857589,0.00089577265,0.03468394,0.000044858974],"about_ca_topic_score_codex":0.001811453,"about_ca_topic_score_gemma":0.00490582,"teacher_disagreement_score":0.0034433228,"about_ca_system_score_codex":0.0006961245,"about_ca_system_score_gemma":0.0004379197,"threshold_uncertainty_score":0.011519074},"labels":[],"label_agreement":null},{"id":"W4310564872","doi":"10.3324/haematol.2022.282025","title":"&lt;i&gt;DUSP22&lt;/i&gt;-rearranged ALK-negative anaplastic large cell lymphoma is a pathogenetically distinct disease but can have variable clinical outcome","year":2022,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Lymphoma; Anaplastic large-cell lymphoma; Disease; Medicine; Anaplastic lymphoma kinase; Cancer research; Oncology; Internal medicine; Lung cancer","score_opus":0.0348352812346705,"score_gpt":0.28881175528688846,"score_spread":0.25397647405221796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310564872","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0075577605,0.00253614,0.00021831023,0.94765157,0.011376384,0.000031057993,0.00021169164,0.00008147962,0.030335605],"genre_scores_gemma":[0.13536407,0.0065481197,0.0011778249,0.746799,0.04850516,0.00009934047,0.00034508386,0.00012759473,0.06103388],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9992699,0.00024969273,0.000063467065,0.00009868407,0.00017573257,0.00014257923],"domain_scores_gemma":[0.998665,0.00055060093,0.00008028554,0.000058508933,0.00026281568,0.0003828518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006308459,0.0006129351,0.00067454594,0.0005793571,0.002293218,0.0016753505,0.00084223616,0.016501248,0.010615353],"category_scores_gemma":[0.0053927125,0.00040239756,0.0006836193,0.0005298187,0.0012397269,0.0017768651,0.0005378905,0.009852372,0.007619479],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002695651,0.00012754319,0.006998969,0.00008678127,0.000041980533,0.109027274,0.00020293637,0.0003689105,0.0011762363,0.0042574205,0.85916966,0.018272737],"study_design_scores_gemma":[0.00041199126,0.00030345755,0.012296321,0.00058663584,0.00009451367,0.16063207,0.0011108525,0.0034597854,0.00119391,0.022974087,0.7968139,0.0001224955],"about_ca_topic_score_codex":0.008404883,"about_ca_topic_score_gemma":0.0105746435,"teacher_disagreement_score":0.016501248,"about_ca_system_score_codex":0.002686088,"about_ca_system_score_gemma":0.0014834646,"threshold_uncertainty_score":0.03551185},"labels":[],"label_agreement":null},{"id":"W4310567835","doi":"10.3324/haematol.2022.282014","title":"Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience","year":2022,"lang":"en","type":"letter","venue":"Haematologica","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; St. Michael's Hospital; University of Toronto","funders":"","keywords":"Primary central nervous system lymphoma; Rituximab; Chemoimmunotherapy; Cytarabine; Medicine; ThioTEPA; Methotrexate; Oncology; Central nervous system; Lymphoma; Internal medicine; Chemotherapy; Cyclophosphamide","score_opus":0.018462106856659277,"score_gpt":0.27964529372819324,"score_spread":0.26118318687153397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310567835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67170095,0.06624072,0.0008217506,0.13900712,0.0023498822,0.00016946133,0.0010969326,0.00007058577,0.118542515],"genre_scores_gemma":[0.91200846,0.03178407,0.00079216855,0.01956958,0.0024088575,0.000048681646,0.0007271147,0.000042681175,0.03261832],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99957174,0.000120645185,0.00005021255,0.000030944204,0.00010177128,0.00012479033],"domain_scores_gemma":[0.9990715,0.00031700768,0.00012651022,0.00004297837,0.00013318047,0.0003088629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044931032,0.00045626043,0.00029564745,0.00027459313,0.0013836141,0.00074403355,0.0006957243,0.0024854275,0.0024873791],"category_scores_gemma":[0.0016442633,0.00026033705,0.00042901517,0.0009928822,0.00074933964,0.00051873643,0.00037323567,0.0012281763,0.00067233876],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004740105,0.0010806835,0.13808855,0.0011715654,0.0004340379,0.4571918,0.006638782,0.003916002,0.009614629,0.0037575946,0.22402382,0.14934254],"study_design_scores_gemma":[0.0013568031,0.0034205797,0.35308242,0.00078116904,0.00067039754,0.30053684,0.00426888,0.002695208,0.0031598918,0.0015623486,0.32832205,0.00014338529],"about_ca_topic_score_codex":0.12886596,"about_ca_topic_score_gemma":0.3325996,"teacher_disagreement_score":0.12886596,"about_ca_system_score_codex":0.005104439,"about_ca_system_score_gemma":0.0027838345,"threshold_uncertainty_score":0.25623173},"labels":[],"label_agreement":null},{"id":"W4312093790","doi":"10.3324/haematol.2022.282191","title":"Under the surface: scratching the acute lymphoblastic leukemia niche","year":2022,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Scratching; Lymphoblastic Leukemia; Niche; Medicine; Leukemia; Immunology; Biology; Materials science","score_opus":0.030239462634373646,"score_gpt":0.29128296734931197,"score_spread":0.2610435047149383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312093790","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001210405,0.0043093218,0.00007116479,0.97874856,0.0071895802,0.0000071288387,0.0000255599,0.000024572442,0.008413747],"genre_scores_gemma":[0.022002062,0.0057534925,0.00023749472,0.9291315,0.024642874,0.000023269411,0.000033547505,0.0000386353,0.018137116],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99845994,0.0006509912,0.00009327344,0.0001346874,0.0003258284,0.00033527418],"domain_scores_gemma":[0.9977095,0.0010817243,0.00014000756,0.00011992132,0.000240021,0.0007088356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012373504,0.0005417962,0.0007523025,0.00039607327,0.0042673894,0.0032306968,0.0012251927,0.032433487,0.010940769],"category_scores_gemma":[0.007596039,0.00047070187,0.0007379277,0.00043811198,0.0023101566,0.0048827035,0.0017203268,0.026941964,0.008237683],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001057056,0.000045405046,0.0012069744,0.00007008944,0.000018845632,0.023135278,0.00036199353,0.00006793392,0.00058426947,0.00524403,0.9525576,0.016601915],"study_design_scores_gemma":[0.00011233205,0.00012686144,0.0015690853,0.00023740563,0.00003011603,0.028291708,0.0020718651,0.00028766273,0.00033654604,0.015262567,0.951634,0.00004002119],"about_ca_topic_score_codex":0.004128822,"about_ca_topic_score_gemma":0.005835693,"teacher_disagreement_score":0.032433487,"about_ca_system_score_codex":0.0025722685,"about_ca_system_score_gemma":0.0017864471,"threshold_uncertainty_score":0.03660047},"labels":[],"label_agreement":null},{"id":"W4312095146","doi":"10.3324/haematol.2022.280482","title":"Adjusted comparison of outcomes between patients from CARTITUDE-1 &lt;i&gt;versus&lt;/i&gt; multiple myeloma patients with prior exposure to proteasome inhibitors, immunomodulatory drugs and anti-CD38 antibody from the prospective, multinational LocoMMotion study of real-world clinical practice","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"Legend Biotech","keywords":"Medicine; Hazard ratio; Internal medicine; Multiple myeloma; Confidence interval; Dexamethasone; Gastroenterology; Pomalidomide; Cyclophosphamide; Proportional hazards model; Oncology; Bortezomib; Chemotherapy","score_opus":0.03679352061212361,"score_gpt":0.35022404532614887,"score_spread":0.31343052471402527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312095146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828833,0.00037409682,0.0002232947,0.000029449682,0.000020511798,0.000021140722,0.0007559919,0.000005779563,0.00028146585],"genre_scores_gemma":[0.99881613,0.000039825787,0.00010368605,0.00003791826,0.000015472315,0.000029409275,0.000829905,0.000003636681,0.00012401951],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759907,0.001048784,0.0001900784,0.00069015013,0.00024441836,0.00022758759],"domain_scores_gemma":[0.9948949,0.0020776498,0.0017883419,0.00059490086,0.00017719348,0.00046697198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031055193,0.0004679307,0.0008488051,0.00045320473,0.00014139248,0.0005148378,0.00055877306,0.0005343039,0.0016999762],"category_scores_gemma":[0.0052900407,0.0002730859,0.0016170801,0.00054859323,0.00029092483,0.0005082851,0.000621743,0.000914151,0.0000823552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17050838,0.0003712078,0.80001295,0.00024246346,0.00867808,0.00026578992,0.00015820973,0.0022492884,0.0036363923,0.00024783154,0.0013821869,0.01224719],"study_design_scores_gemma":[0.00262269,0.015893763,0.97241694,0.000028546934,0.0028440496,0.00028226935,0.00019619954,0.0035941666,0.00091199117,0.00020839393,0.00096603023,0.00003493846],"about_ca_topic_score_codex":0.001803697,"about_ca_topic_score_gemma":0.002028833,"teacher_disagreement_score":0.0031055193,"about_ca_system_score_codex":0.00041329698,"about_ca_system_score_gemma":0.0003717097,"threshold_uncertainty_score":0.016423762},"labels":[],"label_agreement":null},{"id":"W4315753261","doi":"10.3324/haematol.2022.282265","title":"Low T-cell proportion in the tumor microenvironment is associated with immune escape and poor survival in diffuse large B-cell lymphoma","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"National Cancer Institute; National Institutes of Health; City of Hope","keywords":"Tumor microenvironment; Diffuse large B-cell lymphoma; Immune system; CD8; T cell; Lymphoma; Cancer research; Biology; Immunology; Medicine","score_opus":0.011364487942087954,"score_gpt":0.22063610256699678,"score_spread":0.20927161462490884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315753261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996356,0.00018314636,0.00006831551,0.000008425697,9.61504e-7,9.931726e-7,0.000022915543,0.000003007471,0.00007664368],"genre_scores_gemma":[0.99980384,0.000042309326,0.00003845264,0.0000070197098,0.0000030681176,0.0000016421949,0.00005494949,0.0000012395323,0.000047393823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998779,0.000027947712,0.000015899983,0.000028465221,0.000020098043,0.000029654979],"domain_scores_gemma":[0.9995265,0.00009374274,0.00021410869,0.000028805744,0.000041534855,0.000095274736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021750585,0.00015078536,0.00029817244,0.0006789332,0.0002511248,0.00042234804,0.00013054853,0.000236931,0.00063189474],"category_scores_gemma":[0.0007284571,0.00013221636,0.00013784746,0.00044055062,0.00025638065,0.00020081204,0.00024819982,0.00026657266,0.00015193288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007786855,0.000034829387,0.98048806,0.000015155182,0.0000372393,0.0004658294,0.000078419725,0.00012100068,0.014782578,0.000016093638,0.0000507522,0.003131257],"study_design_scores_gemma":[0.0000099350045,0.00016990922,0.99592775,0.0000029328073,0.000030259753,0.0020824287,0.00013636377,0.00039044235,0.0010341785,0.000040353054,0.00017087901,0.000004579829],"about_ca_topic_score_codex":0.00066476496,"about_ca_topic_score_gemma":0.00063006836,"teacher_disagreement_score":0.0006789332,"about_ca_system_score_codex":0.00017882272,"about_ca_system_score_gemma":0.00010111315,"threshold_uncertainty_score":0.0021139383},"labels":[],"label_agreement":null},{"id":"W4315754473","doi":"10.3324/haematol.2022.281955","title":"The E3 ligase TRIM31 regulates hematopoietic stem cell homeostasis and MLL-AF9 leukemia","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Biology; Ubiquitin ligase; Stem cell; Haematopoiesis; Progenitor cell; Myeloid leukemia; Hematopoietic stem cell; Cell biology; Leukemia; Cancer research; Cyclin-dependent kinase; Ubiquitin; Cell cycle; Immunology; Cell; Biochemistry","score_opus":0.01627379435404735,"score_gpt":0.22466568191504063,"score_spread":0.20839188756099328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315754473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99154186,0.0037477678,0.0024370658,0.00015848615,0.000016202597,0.00001571671,0.00025919557,0.00014469147,0.0016788915],"genre_scores_gemma":[0.9971643,0.00041137592,0.0005683412,0.00003384262,0.0000045668367,0.0000069642983,0.00021127204,0.0000072096273,0.0015921185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988806,0.000018931798,0.000008044625,0.0000233686,0.000022308428,0.00003939221],"domain_scores_gemma":[0.9999181,0.000005002489,0.000029914374,0.0000064237765,0.000008348218,0.00003225945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103328006,0.00019027284,0.00015399672,0.00028195718,0.00027259687,0.00029075483,0.0001613003,0.00027469342,0.0009825189],"category_scores_gemma":[0.00009392961,0.000098448014,0.00015086806,0.00013703387,0.00022776105,0.00017678458,0.0002582183,0.0003460081,0.0004821695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020415949,0.000018643357,0.0013661995,0.000024389119,0.000004521651,0.0001915753,0.000015485924,0.00009229804,0.9951023,0.00027616983,0.00015108862,0.002553144],"study_design_scores_gemma":[0.00002687286,0.00019980912,0.036867235,0.0000093734025,0.000019850231,0.001182013,0.00008261108,0.0026565928,0.9517696,0.00032530757,0.006852851,0.000007804883],"about_ca_topic_score_codex":0.00041613076,"about_ca_topic_score_gemma":0.00049304374,"teacher_disagreement_score":0.0009825189,"about_ca_system_score_codex":0.00041261967,"about_ca_system_score_gemma":0.00016363905,"threshold_uncertainty_score":0.0032868385},"labels":[],"label_agreement":null},{"id":"W4318915833","doi":"10.3324/haematol.2022.281806","title":"Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Hematopoietic stem cell transplantation; Transplantation; Medicine; Haematopoiesis; Internal medicine; Stem cell; Oncology; Minimal residual disease; Myeloid leukemia; Myeloid; Malignancy; Immunology; Gastroenterology; Leukemia; Biology; Genetics","score_opus":0.04714548301508147,"score_gpt":0.31095091825305016,"score_spread":0.2638054352379687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318915833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994468,0.00013982225,0.00009608303,0.000007138626,0.000002643734,0.00000432691,0.00011285936,0.0000026170906,0.00018762336],"genre_scores_gemma":[0.9993168,0.0000662813,0.00004562447,0.000009141695,0.0000056177073,0.000004424106,0.0003705734,0.0000022326099,0.00017931538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968815,0.000053273434,0.000031577554,0.00006688087,0.00007400002,0.00008610315],"domain_scores_gemma":[0.9990694,0.00017760009,0.00029181308,0.00012493452,0.00013314615,0.0002031108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079445855,0.0002218202,0.00040733442,0.00042931794,0.000378574,0.00052327366,0.00027444185,0.00035205446,0.0007197624],"category_scores_gemma":[0.0012174033,0.00011017369,0.00043276616,0.00048211665,0.00026683864,0.0003111618,0.0003693561,0.00042500693,0.00024898932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013555124,0.00021381152,0.9825005,0.000014529743,0.000096379656,0.00092412124,0.0001838804,0.00017998862,0.004845657,0.00001895726,0.000083702325,0.009582898],"study_design_scores_gemma":[0.000010536534,0.00079320255,0.99615186,0.0000045120773,0.00012773264,0.00088085426,0.000090218826,0.00018063695,0.0014775912,0.00002226576,0.00025288892,0.0000076183323],"about_ca_topic_score_codex":0.0014375568,"about_ca_topic_score_gemma":0.0013058604,"teacher_disagreement_score":0.0014375568,"about_ca_system_score_codex":0.00033155255,"about_ca_system_score_gemma":0.00025239913,"threshold_uncertainty_score":0.0042015314},"labels":[],"label_agreement":null},{"id":"W4319786746","doi":"10.3324/haematol.2022.281958","title":"Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Kite Pharma; Sanofi Genzyme; Takeda Oncology; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Daiichi-Sankyo; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; TG Therapeutics; Medical College of Wisconsin; StemCyte; HistoGenetics; Karyopharm Therapeutics; CareDx; Actinium Pharmaceuticals; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; Amgen; Accenture; Sanofi; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; Astellas Pharma US; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Medac; Jazz Pharmaceuticals; Seagen; Be The Match Foundation","keywords":"Busulfan; Fludarabine; Medicine; Hazard ratio; Internal medicine; Melphalan; Cyclophosphamide; Myelofibrosis; Transplantation; Gastroenterology; Regimen; Surgery; Hematopoietic stem cell transplantation; Hematopoietic cell; Proportional hazards model; Oncology; Chemotherapy; Confidence interval; Bone marrow; Haematopoiesis; Stem cell","score_opus":0.03062084220648969,"score_gpt":0.2970089551485368,"score_spread":0.2663881129420471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319786746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99810743,0.0010388502,0.00005866501,0.00010562513,0.00001274355,0.0000053101035,0.00016615975,0.0000019660936,0.0005032381],"genre_scores_gemma":[0.99947995,0.00020071841,0.000028657701,0.00003521537,0.000017526407,0.0000037388008,0.0001563987,0.0000012114748,0.00007663051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999607,0.00011749246,0.000048509617,0.000070835296,0.000073071096,0.00008312233],"domain_scores_gemma":[0.99837327,0.0004301944,0.000779454,0.000084023595,0.00009731786,0.00023570101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090702577,0.00014440244,0.00020542525,0.00022257376,0.00017686012,0.000391593,0.00024025154,0.00031131072,0.0013692694],"category_scores_gemma":[0.0026846498,0.00010412512,0.000414038,0.00038041873,0.00020352747,0.00022323475,0.0002956207,0.00075569726,0.00010391583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009168481,0.00006341888,0.99474734,0.000024542363,0.00013809207,0.00007970015,0.000023181463,0.00018264384,0.0002925847,0.00004824681,0.00019797611,0.0032853752],"study_design_scores_gemma":[0.000037685855,0.00022097325,0.9982527,0.00003284236,0.00013129994,0.00022024049,0.00007104105,0.0005124415,0.00012967658,0.000090786234,0.0002948993,0.000005402841],"about_ca_topic_score_codex":0.0020976018,"about_ca_topic_score_gemma":0.0037813797,"teacher_disagreement_score":0.0020976018,"about_ca_system_score_codex":0.00033858797,"about_ca_system_score_gemma":0.00034365855,"threshold_uncertainty_score":0.004796803},"labels":[],"label_agreement":null},{"id":"W4321598875","doi":"10.3324/haematol.2022.281375","title":"Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Spinal Cord Injury BC; University of British Columbia","funders":"Royal Australasian College of Physicians; BeiGene; AstraZeneca; Celgene; Gilead Sciences; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; International Prognostic Index; Follicular lymphoma; Lymphoma; Diffuse large B-cell lymphoma; Prospective cohort study; Cohort; Oncology; Gastroenterology","score_opus":0.037713355729774856,"score_gpt":0.32978408898951506,"score_spread":0.2920707332597402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321598875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978684,0.00069025095,0.0001335373,0.0001219665,0.000007870241,0.000059391296,0.000429389,0.0000036842214,0.00068549125],"genre_scores_gemma":[0.99827814,0.00041173294,0.00017872015,0.0001298644,0.000024017874,0.000093123504,0.0007571119,0.0000052660735,0.000121979465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872094,0.00062257337,0.00012292655,0.00019050807,0.00017765841,0.00016527336],"domain_scores_gemma":[0.9959947,0.00056594994,0.0016339084,0.00035203306,0.0006847045,0.000768677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031703687,0.00042334647,0.00042880952,0.0010049993,0.00042082448,0.00083596323,0.00044337733,0.0005180459,0.0006642865],"category_scores_gemma":[0.0037468353,0.00027411862,0.00058948743,0.0018395222,0.0006313201,0.00080632366,0.0010180139,0.00070856384,0.0002065089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013673736,0.00021833665,0.98902905,0.000067756,0.00018496462,0.00013033088,0.0008858916,0.00007291759,0.00032190885,0.000072788425,0.0005067622,0.007141962],"study_design_scores_gemma":[0.00019425462,0.0005670748,0.996938,0.000042420474,0.00011424543,0.0003091618,0.0006300489,0.00012753617,0.000060207472,0.00006441491,0.00094205624,0.000010634347],"about_ca_topic_score_codex":0.013508961,"about_ca_topic_score_gemma":0.009140219,"teacher_disagreement_score":0.013508961,"about_ca_system_score_codex":0.0013069005,"about_ca_system_score_gemma":0.0010029423,"threshold_uncertainty_score":0.026860714},"labels":[],"label_agreement":null},{"id":"W4322757874","doi":"10.3324/haematol.2022.281106","title":"Relapsed pediatric acute myeloid leukaemia: state-of-the-art in 2023","year":2023,"lang":"en","type":"review","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; Toronto Public Health","funders":"National Cancer Institute; National Institutes of Health; Leukemia and Lymphoma Society; U.S. Department of Defense","keywords":"Medicine; Clinical trial; Intensive care medicine; Myeloid leukaemia; Disease; Orphan drug; Family medicine; Oncology; Internal medicine; Bioinformatics","score_opus":0.07228254196953478,"score_gpt":0.36433259856424816,"score_spread":0.2920500565947134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322757874","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005797538,0.9992613,0.000025605379,0.00024702627,0.000110587025,0.0000019392214,0.000014804538,0.0000029573857,0.00027778652],"genre_scores_gemma":[0.0003169949,0.99925035,0.00005685612,0.00020194515,0.00006670727,0.00000257559,0.000021827515,9.024055e-7,0.000081813254],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961346,0.00008501636,0.00007752472,0.000054685035,0.00013204235,0.000037280824],"domain_scores_gemma":[0.9990231,0.00055964827,0.00013278823,0.000018744466,0.00021826744,0.00004745374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011633188,0.0006670687,0.0016736933,0.0018059579,0.00026507987,0.0013957655,0.00085298275,0.0010768905,0.0030110131],"category_scores_gemma":[0.0018493086,0.0003182613,0.0007654159,0.0022629576,0.00038287125,0.0015760994,0.00075094955,0.0015327783,0.0009812098],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012716552,0.00003179854,0.00019030312,0.035211883,0.0001479021,0.00011652782,0.00008424364,0.00028929592,0.00060995866,0.0040644975,0.03068582,0.9284406],"study_design_scores_gemma":[0.000021262278,0.00010675293,0.0008724495,0.022702595,0.00034284533,0.00083977537,0.0000935666,0.00009829272,0.00021709023,0.0016346436,0.9730522,0.000018629524],"about_ca_topic_score_codex":0.0015703097,"about_ca_topic_score_gemma":0.0034764127,"teacher_disagreement_score":0.0030110131,"about_ca_system_score_codex":0.0009172828,"about_ca_system_score_gemma":0.0022442609,"threshold_uncertainty_score":0.010072887},"labels":[],"label_agreement":null},{"id":"W4327621016","doi":"10.3324/haematol.2022.281973","title":"The Glanzmann Thrombasthenia Registry: safety of platelet therapy in patients with Glanzmann thrombasthenia and changes in alloimmunization status","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"Novo Nordisk","keywords":"Glanzmann's thrombasthenia; Thrombasthenia; Medicine; Platelet; Pediatrics; Internal medicine; Platelet aggregation","score_opus":0.014870093963736423,"score_gpt":0.23727623536907666,"score_spread":0.22240614140534024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327621016","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02056447,0.001981656,0.00023970434,0.94559366,0.009402063,0.00004562294,0.0011632785,0.000067176275,0.020942353],"genre_scores_gemma":[0.17698768,0.00301244,0.00075799285,0.74493307,0.055511374,0.00018651575,0.001358681,0.00008053186,0.017171709],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99799156,0.0008268496,0.00036754954,0.00017234324,0.0004193982,0.00022233046],"domain_scores_gemma":[0.99246466,0.0037934317,0.0012804059,0.00026332887,0.0008350493,0.0013631461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019992809,0.00031687645,0.00084120594,0.00051856093,0.0010415532,0.0016971615,0.00061026105,0.012763091,0.002611074],"category_scores_gemma":[0.011597963,0.00026872332,0.00058564404,0.0009928202,0.00078142376,0.00090376363,0.0004355631,0.0061002444,0.0017889488],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010771467,0.00030178286,0.06567175,0.00011741181,0.00012860935,0.011737409,0.0001970571,0.00033887237,0.00063714816,0.0024645664,0.88574207,0.0315862],"study_design_scores_gemma":[0.0035077648,0.0013136485,0.19495712,0.0014172845,0.00059230434,0.029865231,0.0011252327,0.006242193,0.0019088998,0.014232626,0.74458265,0.00025500907],"about_ca_topic_score_codex":0.0063592815,"about_ca_topic_score_gemma":0.009971686,"teacher_disagreement_score":0.012763091,"about_ca_system_score_codex":0.0025014076,"about_ca_system_score_gemma":0.0025923068,"threshold_uncertainty_score":0.018149137},"labels":[],"label_agreement":null},{"id":"W4360599615","doi":"10.3324/haematol.2023.282791","title":"Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabine","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Université de Montréal; Institute for Research in Immunology and Cancer; McGill University; Jewish General Hospital","funders":"Janssen Pharmaceuticals; Genentech; Fondation de l'Hôpital général juif; Leukemia and Lymphoma Society; Jazz Pharmaceuticals; F. Hoffmann-La Roche; Gilead Sciences; Jewish General Hospital; Sanofi","keywords":"Decitabine; Cytarabine; Myeloid leukemia; Pharmacology; Medicine; Internal medicine; Deoxycytidine kinase; Oncology; Cancer research; Biology; Deoxycytidine; Chemotherapy; Gemcitabine; Biochemistry; Gene expression","score_opus":0.01726773215579263,"score_gpt":0.2759986050334017,"score_spread":0.25873087287760904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360599615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99511164,0.002063277,0.00027143452,0.0003959996,0.00012935697,0.0009262977,0.00027866624,0.000042379117,0.00078103767],"genre_scores_gemma":[0.99383533,0.0013513296,0.0009115766,0.0005492215,0.000106700856,0.0011473923,0.0004757243,0.000017629189,0.0016051347],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99973243,0.00009987983,0.000016760087,0.000059756887,0.000023443172,0.00006761934],"domain_scores_gemma":[0.9997888,0.000032827153,0.000045510707,0.000019849076,0.000013532526,0.00009942908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008871999,0.00090348464,0.0013215502,0.0002923317,0.00023839234,0.0008140928,0.00041585971,0.0007103738,0.0031227057],"category_scores_gemma":[0.0005230206,0.00041975614,0.0010074471,0.00022499461,0.0006385244,0.00064324896,0.00029145452,0.0022180227,0.00036439844],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7990423,0.030500812,0.0028653522,0.00066469563,0.0014205986,0.000100459074,0.0001478063,0.0018930866,0.06743988,0.00044172202,0.0016655398,0.09381774],"study_design_scores_gemma":[0.6446667,0.32648078,0.009120935,0.000048877137,0.0011282717,0.00021242401,0.00007164522,0.0018191583,0.011836139,0.00042912975,0.0041410066,0.000044937984],"about_ca_topic_score_codex":0.00051986205,"about_ca_topic_score_gemma":0.0021710414,"teacher_disagreement_score":0.0031227057,"about_ca_system_score_codex":0.00065926864,"about_ca_system_score_gemma":0.00075147214,"threshold_uncertainty_score":0.010446548},"labels":[],"label_agreement":null},{"id":"W4360599974","doi":"10.3324/haematol.2022.282030","title":"Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"University of Texas MD Anderson Cancer Center; Astellas Pharma; Servier; Gilead Sciences; Pfizer","keywords":"Medicine; Internal medicine; Cumulative incidence; KRAS; Gastroenterology; Myeloid leukemia; Hematopoietic stem cell transplantation; White blood cell; Neuroblastoma RAS viral oncogene homolog; Myeloid; Transplantation; Oncology; Cancer; Colorectal cancer","score_opus":0.04069498217841501,"score_gpt":0.3371159216637637,"score_spread":0.2964209394853487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360599974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99957246,0.00010673188,0.000033076165,0.000016897908,0.0000022805734,0.0000031553384,0.000110169385,0.0000013426223,0.0001539957],"genre_scores_gemma":[0.99949145,0.00004595838,0.000024687715,0.0000143715715,0.0000081802755,0.0000050330746,0.00032366568,7.10814e-7,0.00008583397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998185,0.00003024067,0.000031357697,0.00004279815,0.000030510275,0.000046648922],"domain_scores_gemma":[0.99921906,0.0001712563,0.00032438108,0.000033353117,0.000051477382,0.00020047474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002369509,0.00017628634,0.0002597133,0.00045444106,0.00024110817,0.00029765238,0.00016616755,0.00035007746,0.0007329757],"category_scores_gemma":[0.0010969442,0.00014439996,0.00021202966,0.000499022,0.00026177743,0.00028772617,0.00020668501,0.00025542665,0.00024325556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016703492,0.000029317009,0.9976101,0.0000044404374,0.0000133957565,0.00042793265,0.0000496988,0.00006321437,0.00043299582,0.0000112357375,0.00006675387,0.0011239441],"study_design_scores_gemma":[0.000016130747,0.0002664239,0.99592197,0.0000033208983,0.000015147598,0.0030843627,0.00012375996,0.00016863618,0.00011484042,0.000031999978,0.00024824345,0.000005189992],"about_ca_topic_score_codex":0.00089104817,"about_ca_topic_score_gemma":0.0011508458,"teacher_disagreement_score":0.00089104817,"about_ca_system_score_codex":0.0002346816,"about_ca_system_score_gemma":0.00019398551,"threshold_uncertainty_score":0.0024520755},"labels":[],"label_agreement":null},{"id":"W4360600096","doi":"10.3324/haematol.2022.282296","title":"Survival outcomes with oral azacitidine maintenance in patients with acute myeloid leukemia in remission by receipt of initial chemotherapy: subgroup analyses from the phase III QUAZAR AML-001 trial","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Bristol-Myers Squibb","keywords":"Azacitidine; Myeloid leukemia; Medicine; Internal medicine; Receipt; Chemotherapy; Oncology; Subgroup analysis; Complete remission; Maintenance therapy; Confidence interval; Biology; World Wide Web","score_opus":0.05211788543983863,"score_gpt":0.3642380091814488,"score_spread":0.31212012374161013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360600096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8952423,0.05208202,0.00044374302,0.02471382,0.0016069133,0.00033076183,0.014609732,0.000079401616,0.010891455],"genre_scores_gemma":[0.9764565,0.0053951507,0.0003104027,0.007862008,0.001309579,0.00027968964,0.0057702917,0.000022880688,0.0025936244],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99901164,0.00050622394,0.00010468571,0.00014059717,0.000109534056,0.00012728682],"domain_scores_gemma":[0.99759114,0.0011936709,0.00053370645,0.00024208204,0.00015036062,0.00028904786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018442079,0.00039456415,0.0014633252,0.00025961132,0.00030521795,0.0008380693,0.0005490049,0.0012749023,0.0025155882],"category_scores_gemma":[0.004807523,0.00021907956,0.0021395353,0.00073208497,0.00022668108,0.00045287848,0.0002789467,0.0017018726,0.00041712684],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54006386,0.0006192839,0.1720584,0.0027854703,0.021874972,0.001345428,0.00028541894,0.0029786865,0.00490704,0.001128122,0.104896255,0.14705706],"study_design_scores_gemma":[0.22857903,0.01674142,0.6346891,0.0012250779,0.051656008,0.0021589026,0.00053404673,0.0054027056,0.0030778036,0.008138632,0.047566757,0.00023063998],"about_ca_topic_score_codex":0.0026856512,"about_ca_topic_score_gemma":0.009132246,"teacher_disagreement_score":0.0026856512,"about_ca_system_score_codex":0.0009873515,"about_ca_system_score_gemma":0.00081585563,"threshold_uncertainty_score":0.009753227},"labels":[],"label_agreement":null},{"id":"W4362656958","doi":"10.3324/haematol.2022.282637","title":"Clinical responses in pediatric patients with relapsed/refractory leukemia treated with azacitidine and venetoclax","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Children's Hospital of Philadelphia; Canadian Institutes of Health Research; Leukemia and Lymphoma Society; American Society of Hematology; V Foundation for Cancer Research; National Cancer Institute; National Institutes of Health; Conquer Cancer Foundation; U.S. Department of Defense","keywords":"Venetoclax; Azacitidine; Medicine; Refractory (planetary science); Leukemia; Oncology; Internal medicine; Pediatrics; Genetics; Biology; Chronic lymphocytic leukemia","score_opus":0.040125126004362105,"score_gpt":0.31240697663451167,"score_spread":0.27228185063014954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362656958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977888,0.0012052519,0.00008566667,0.000025595727,0.0000037589875,0.0000340432,0.00021060144,0.000007825517,0.0006383664],"genre_scores_gemma":[0.9980149,0.00073797716,0.00018310038,0.00005451756,0.00002325548,0.000028557683,0.0008397245,0.0000037677648,0.00011417682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997682,0.000040579922,0.000028254262,0.000045586352,0.00005426766,0.00006312473],"domain_scores_gemma":[0.99958557,0.00008984115,0.00016238571,0.00001927248,0.000028410259,0.0001145626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023385204,0.00019179085,0.00047289048,0.00042310037,0.00031508587,0.00038144007,0.00017269058,0.00021047569,0.00079425686],"category_scores_gemma":[0.0007669309,0.00009804367,0.00021203894,0.000627691,0.00028549152,0.00020338083,0.00028875863,0.000313145,0.0001578427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014843266,0.00017155711,0.9643825,0.00006124027,0.000050149825,0.005536372,0.00045280607,0.00039001895,0.003653392,0.00007195623,0.00046510453,0.02328052],"study_design_scores_gemma":[0.00017076904,0.0032331843,0.9677287,0.000028464056,0.000080272126,0.023298016,0.0005620031,0.00044270235,0.0014311002,0.00005348725,0.0029574558,0.000013855032],"about_ca_topic_score_codex":0.0012094267,"about_ca_topic_score_gemma":0.0015826336,"teacher_disagreement_score":0.0012094267,"about_ca_system_score_codex":0.00047365404,"about_ca_system_score_gemma":0.0004063836,"threshold_uncertainty_score":0.0034365654},"labels":[],"label_agreement":null},{"id":"W4362657140","doi":"10.3324/haematol.2022.281894","title":"Simultaneous inhibition of Sirtuin 3 and cholesterol homeostasis targets acute myeloid leukemia stem cells by perturbing fatty acid β-oxidation and inducing lipotoxicity","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Canada First Research Excellence Fund; Government of Ontario; Princess Margaret Cancer Foundation; University of Toronto; Canadian Institutes of Health Research; Cancer Center, University of Colorado; Leukemia and Lymphoma Society","keywords":"SIRT3; Sirtuin; Myeloid leukemia; Biology; Cancer research; Oxidative phosphorylation; Context (archaeology); Stem cell; Cell biology; Cancer cell; Haematopoiesis; Biochemistry; Cancer; NAD+ kinase; Genetics","score_opus":0.016222287703152396,"score_gpt":0.2506516030337123,"score_spread":0.2344293153305599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362657140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98811334,0.0034668657,0.004395714,0.0002683082,0.00009849087,0.00011759081,0.0008445044,0.0004167585,0.0022784304],"genre_scores_gemma":[0.99313617,0.0015545234,0.0025465884,0.0001741436,0.00001702864,0.00010021258,0.00077957375,0.000024767787,0.0016669334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998379,0.0000154833,0.000018110843,0.000029603354,0.000052594365,0.000046364417],"domain_scores_gemma":[0.9999409,0.000006885629,0.000016157612,0.000008326226,0.000009067264,0.000018619516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013374139,0.0003752806,0.00043724835,0.00028755012,0.00017596608,0.00032258287,0.00023702184,0.00024196232,0.001208022],"category_scores_gemma":[0.00009736548,0.00010401636,0.00044886037,0.0002803622,0.0002258662,0.00014904697,0.00025521754,0.0008167439,0.00035627044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039569818,0.00010525429,0.00053139875,0.000082218656,0.00001946927,0.00004806569,0.000022022934,0.00016653957,0.9917721,0.00015465743,0.00018500735,0.0065174685],"study_design_scores_gemma":[0.00007740916,0.0008967177,0.0045375926,0.000009743925,0.00006132574,0.00016796117,0.000035863148,0.0011237308,0.98682344,0.00009637576,0.0061627333,0.0000072074213],"about_ca_topic_score_codex":0.0006014179,"about_ca_topic_score_gemma":0.0012782862,"teacher_disagreement_score":0.001208022,"about_ca_system_score_codex":0.00029952923,"about_ca_system_score_gemma":0.0004001269,"threshold_uncertainty_score":0.004041195},"labels":[],"label_agreement":null},{"id":"W4368361225","doi":"10.3324/haematol.2022.281580","title":"Germline loss of function &lt;i&gt;BRCA1&lt;/i&gt; and &lt;i&gt;BRCA2&lt;/i&gt; mutations and risk of &lt;i&gt;de novo&lt;/i&gt; hematopoietic malignancies","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"National Heart, Lung, and Blood Institute","keywords":"Germline; Germline mutation; Mutation; Genetics; Biology; Cancer research; Internal medicine; Medicine; Gene","score_opus":0.014106610951789311,"score_gpt":0.24499447945287703,"score_spread":0.23088786850108772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4368361225","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007414412,0.0032600227,0.0002346084,0.93791705,0.017022414,0.00002306059,0.0006566375,0.00009118039,0.033380613],"genre_scores_gemma":[0.15403703,0.006282728,0.0008780179,0.67381614,0.06638845,0.00009425872,0.00080134126,0.00011225047,0.09758974],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99957925,0.00014493529,0.00003169857,0.000063262785,0.00010417198,0.00007666086],"domain_scores_gemma":[0.99822444,0.0009206436,0.00011654252,0.00009750372,0.00028924376,0.00035158242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006276458,0.0003788363,0.0006111999,0.00049028685,0.001321203,0.0009898739,0.0006170498,0.012420614,0.011421956],"category_scores_gemma":[0.0039995657,0.00034875766,0.00046847007,0.00041674072,0.00082257285,0.00081568427,0.00027098195,0.006191687,0.007258093],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003657839,0.00010232652,0.0095086135,0.00004399532,0.000035883015,0.0219474,0.00008301873,0.00018590588,0.0007820398,0.0029379413,0.94892704,0.015080049],"study_design_scores_gemma":[0.00047956198,0.00034637182,0.023185106,0.00052922487,0.00013685567,0.07894551,0.0005339823,0.002792243,0.0017321656,0.02119217,0.8700189,0.00010780842],"about_ca_topic_score_codex":0.0080452915,"about_ca_topic_score_gemma":0.009514942,"teacher_disagreement_score":0.012420614,"about_ca_system_score_codex":0.0016910577,"about_ca_system_score_gemma":0.0010090272,"threshold_uncertainty_score":0.038210213},"labels":[],"label_agreement":null},{"id":"W4376133764","doi":"10.3324/haematol.2022.282411","title":"Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health; F. Hoffmann-La Roche","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Oncology; Internal medicine; Clinical trial; Stage (stratigraphy); Phases of clinical research; Pharmacology; Bone marrow; Biology","score_opus":0.03954079516253714,"score_gpt":0.34076388170347427,"score_spread":0.3012230865409371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376133764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533904,0.0015869674,0.00027933237,0.00028267383,0.00005982473,0.0007709738,0.0005268758,0.000049521866,0.0011047524],"genre_scores_gemma":[0.9949189,0.00092358293,0.00053706777,0.00036259583,0.00009976046,0.00090182514,0.0011436045,0.000016808444,0.0010957551],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995615,0.00019445979,0.000026745016,0.00007667382,0.00004204445,0.00009864313],"domain_scores_gemma":[0.99951935,0.00008011319,0.00010307292,0.000036234687,0.000032634725,0.00022863124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015545299,0.00109779,0.0018358887,0.00032389318,0.00033978847,0.0009488667,0.0006464189,0.0010456467,0.0022074308],"category_scores_gemma":[0.0008851683,0.00046170023,0.0011251384,0.00024373057,0.00063297094,0.000709498,0.00022416232,0.0024235859,0.00067243096],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8421683,0.030959105,0.0054015694,0.00043533702,0.0011199112,0.00018427933,0.00023782787,0.001547766,0.042118557,0.00018032132,0.003103646,0.07254353],"study_design_scores_gemma":[0.61824656,0.3593827,0.013687573,0.000039120892,0.00055552577,0.0002718586,0.000046529123,0.0013771441,0.004415264,0.00015275109,0.0017928015,0.000032147087],"about_ca_topic_score_codex":0.0005154985,"about_ca_topic_score_gemma":0.0013144478,"teacher_disagreement_score":0.0022074308,"about_ca_system_score_codex":0.0007270253,"about_ca_system_score_gemma":0.00080336904,"threshold_uncertainty_score":0.008221269},"labels":[],"label_agreement":null},{"id":"W4378172267","doi":"10.3324/haematol.2023.282734","title":"Patient-reported treatment response in chronic graft-&lt;i&gt;versus&lt;/i&gt;-host disease","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Pharmacyclics; Genentech; Astellas Pharma; Omeros Corporation; Incyte; CTI Biopharma; Horizon Therapeutics; Regeneron Pharmaceuticals; Syndax Pharmaceuticals; Sanofi; CSL Behring; AstraZeneca; Amgen; Pfizer","keywords":"Medicine; Graft-versus-host disease; Internal medicine; Multivariate analysis; Quality of life (healthcare); Prospective cohort study; Observational study; Disease; Clinical trial","score_opus":0.03949272140279008,"score_gpt":0.29741349296268405,"score_spread":0.25792077155989396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378172267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987589,0.00030436655,0.00015824698,0.000028017384,0.0000041547014,0.00001827863,0.00044915266,0.0000039179017,0.00027485585],"genre_scores_gemma":[0.99938023,0.00004218397,0.000077701116,0.000021440763,0.0000066074167,0.000024169203,0.0003934062,0.0000014630094,0.000052881544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950406,0.0029552688,0.0006831359,0.0005346804,0.00056430727,0.00022205009],"domain_scores_gemma":[0.98742247,0.003827931,0.007307072,0.000589481,0.00044925994,0.00040369766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056440225,0.00019580012,0.0005975557,0.0008401897,0.00024476874,0.00051866897,0.00030639902,0.0004157981,0.0010490468],"category_scores_gemma":[0.008898018,0.00013301897,0.00063521,0.0012548675,0.0003965041,0.00057559647,0.00047071063,0.0005144471,0.00016173569],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005043011,0.000054141103,0.99713033,0.000028624163,0.00010302041,0.000025533916,0.00009008689,0.000086855194,0.000110945286,0.000010562425,0.00006970377,0.0017858762],"study_design_scores_gemma":[0.000026923975,0.00043020304,0.9987734,0.000008927209,0.000038124585,0.000142135,0.00007206459,0.00026494413,0.000088163455,0.000019873767,0.00012908554,0.000006214166],"about_ca_topic_score_codex":0.00072861713,"about_ca_topic_score_gemma":0.0009129246,"teacher_disagreement_score":0.0056440225,"about_ca_system_score_codex":0.00029351606,"about_ca_system_score_gemma":0.0001356092,"threshold_uncertainty_score":0.029848814},"labels":[],"label_agreement":null},{"id":"W4378952054","doi":"10.3324/haematol.2023.282781","title":"Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; MorphoSys; Swedish Orphan Biovitrum; Vertex Pharmaceuticals; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; TG Therapeutics; Jazz Pharmaceuticals; Actinium Pharmaceuticals; CareDx; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Bristol-Myers Squibb; CSL Behring; BeiGene; HistoGenetics; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences; Sanofi; Amgen; StemCyte; Mallinckrodt Pharmaceuticals; Astellas Pharma US; U.S. Department of Health and Human Services","keywords":"Medicine; Population; Confidence interval; Transplantation; Internal medicine; Aplastic anemia; Standardized mortality ratio; Hematopoietic stem cell transplantation; Hematopoietic cell; Surgery; Haematopoiesis; Bone marrow; Stem cell","score_opus":0.024026651734487776,"score_gpt":0.25876444584491914,"score_spread":0.23473779411043136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378952054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99387395,0.0009046234,0.00053765875,0.00008844165,0.000022624063,0.000011068546,0.0036432275,0.000036287107,0.00088221364],"genre_scores_gemma":[0.9954888,0.00018794234,0.00020751722,0.00003087682,0.00003790843,0.000015553791,0.0038401126,0.0000051257507,0.00018615494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915075,0.00026867227,0.0000962699,0.00025139155,0.000112720845,0.000120297904],"domain_scores_gemma":[0.9925368,0.002526966,0.0034645426,0.000540686,0.00042495527,0.0005060293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002069105,0.00032947605,0.00039664021,0.0011107821,0.00012535485,0.00035352688,0.00038627678,0.0003714327,0.0019939428],"category_scores_gemma":[0.006361023,0.00016766634,0.0012691047,0.0007960981,0.00023875263,0.00063096016,0.00054306886,0.0008809201,0.00020778323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009434248,0.000027669043,0.99213284,0.000050795537,0.0008268241,0.000067222405,0.00004514528,0.0011770126,0.0002506088,0.0002406044,0.00070685364,0.0035308928],"study_design_scores_gemma":[0.0000334405,0.00046539187,0.99392986,0.000014183482,0.00039152306,0.00050976605,0.000109160355,0.0036102969,0.0002149123,0.00021709481,0.00048423154,0.000020219306],"about_ca_topic_score_codex":0.003857846,"about_ca_topic_score_gemma":0.0031702332,"teacher_disagreement_score":0.003857846,"about_ca_system_score_codex":0.00025894435,"about_ca_system_score_gemma":0.00026871,"threshold_uncertainty_score":0.010942578},"labels":[],"label_agreement":null},{"id":"W4378953442","doi":"10.3324/haematol.2023.283106","title":"Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech; Italfarmaco; Astellas Pharma; Sierra Oncology; CTI Biopharma; Incyte; Jazz Pharmaceuticals; Gilead Sciences; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Internal medicine; Oncology; Bone marrow","score_opus":0.029609548292402355,"score_gpt":0.29878744014817415,"score_spread":0.2691778918557718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378953442","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62727123,0.022583418,0.00049409416,0.26216927,0.0034640443,0.00010535484,0.0067157983,0.00008078514,0.07711598],"genre_scores_gemma":[0.9535268,0.0035557246,0.00024133369,0.032863047,0.0026934508,0.00006344531,0.0020020083,0.00001319212,0.0050409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993586,0.000187094,0.000072547715,0.0000683697,0.00014326237,0.00017006761],"domain_scores_gemma":[0.99721813,0.001148905,0.0005043945,0.000089823116,0.00043551144,0.0006032012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070433045,0.00012072077,0.0004363758,0.0003112505,0.0005465134,0.00068773155,0.00035529176,0.0016411289,0.0026820567],"category_scores_gemma":[0.00527776,0.00008841541,0.0003537486,0.00084333756,0.00027493632,0.0004591514,0.00023991299,0.0011711669,0.00090425037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007503169,0.0004481693,0.585239,0.00032289306,0.0002552977,0.06481975,0.00048761026,0.0013157099,0.0023224093,0.00208026,0.19090223,0.1443035],"study_design_scores_gemma":[0.0011622058,0.0019431532,0.79955673,0.0007969417,0.00030825727,0.08518253,0.0017299543,0.0022372266,0.0010603046,0.008186023,0.09769054,0.00014613042],"about_ca_topic_score_codex":0.003200657,"about_ca_topic_score_gemma":0.0061878706,"teacher_disagreement_score":0.003200657,"about_ca_system_score_codex":0.0012839021,"about_ca_system_score_gemma":0.00073753786,"threshold_uncertainty_score":0.0093153715},"labels":[],"label_agreement":null},{"id":"W4379769519","doi":"10.3324/haematol.2023.283031","title":"Correcting the aberrant Fanconi anemia transcriptional program by gene therapy","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"","keywords":"Fanconi anemia; Genetic enhancement; Anemia; Medicine; Gene; Genetics; Biology; Cancer research; Internal medicine; DNA repair","score_opus":0.02181332958894403,"score_gpt":0.30484142083161403,"score_spread":0.28302809124267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379769519","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000721286,0.0037171845,0.00029096377,0.9534284,0.03220687,0.000020038855,0.00012994463,0.000078143756,0.009407231],"genre_scores_gemma":[0.013435664,0.0043166555,0.0006426564,0.8892484,0.043142065,0.00007411872,0.00014133702,0.000052594743,0.048946526],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988005,0.00028492816,0.000112213136,0.00012437682,0.00049706484,0.00018089628],"domain_scores_gemma":[0.99745315,0.0014735362,0.00012813072,0.00011198655,0.00042636658,0.00040678287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015667358,0.00047286006,0.0007284221,0.0004093639,0.0017160632,0.001567288,0.00090807345,0.024707638,0.007827583],"category_scores_gemma":[0.0072392784,0.00035130174,0.0008452511,0.0003281801,0.0014906079,0.0012951955,0.00059739145,0.016587336,0.0077104704],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093902316,0.00004351133,0.00034310683,0.000042409858,0.000012672243,0.00219796,0.000027706903,0.00006334279,0.0006815765,0.0027737361,0.9759829,0.017737223],"study_design_scores_gemma":[0.00009594707,0.000090983835,0.0007278321,0.00008088921,0.000022333534,0.0030745901,0.00008187948,0.0003548331,0.0008263811,0.0068924977,0.9877296,0.000022270407],"about_ca_topic_score_codex":0.0031615547,"about_ca_topic_score_gemma":0.0061029075,"teacher_disagreement_score":0.024707638,"about_ca_system_score_codex":0.0024507383,"about_ca_system_score_gemma":0.001591445,"threshold_uncertainty_score":0.02618587},"labels":[],"label_agreement":null},{"id":"W4381597464","doi":"10.3324/haematol.2023.283510","title":"Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"University of Texas MD Anderson Cancer Center; Ontario Institute for Cancer Research; Princess Margaret Cancer Foundation","keywords":"Isocitrate dehydrogenase; Myeloid leukemia; Minimal residual disease; Cancer research; IDH1; Disease; RNA splicing; Gene; Residual; Medicine; Mutation; Oncology; Leukemia; Biology; Internal medicine; Genetics; Enzyme; Biochemistry; Computer science","score_opus":0.031026215968207538,"score_gpt":0.30257728020387314,"score_spread":0.2715510642356656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381597464","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044295296,0.0064988034,0.0008688543,0.9194241,0.011456682,0.00003554593,0.0003578281,0.000108898734,0.016953882],"genre_scores_gemma":[0.410727,0.009094863,0.0021265764,0.4991547,0.05830029,0.00007597789,0.00051563716,0.000118681724,0.019886296],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9990939,0.0003737407,0.00012604122,0.00009149157,0.00018652821,0.00012839767],"domain_scores_gemma":[0.9959265,0.002736786,0.00016667417,0.00014637815,0.0005696123,0.00045404534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012183464,0.00038538425,0.00079297466,0.0005218927,0.00089161133,0.0009416618,0.0006503577,0.008336587,0.002603282],"category_scores_gemma":[0.010571726,0.000239886,0.00047452937,0.00045763864,0.0009162967,0.0009345181,0.00033517243,0.006022959,0.0026144264],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019446862,0.00025482936,0.065146245,0.00018772027,0.00008083934,0.055071786,0.0002914231,0.00091367186,0.0040317555,0.0034862931,0.70928764,0.15930311],"study_design_scores_gemma":[0.0011541775,0.0016639805,0.1080253,0.0010651719,0.0003065756,0.22167999,0.0011258421,0.011172459,0.005897624,0.03868095,0.60905254,0.00017543962],"about_ca_topic_score_codex":0.002760371,"about_ca_topic_score_gemma":0.004432795,"teacher_disagreement_score":0.008336587,"about_ca_system_score_codex":0.0014035332,"about_ca_system_score_gemma":0.00080651045,"threshold_uncertainty_score":0.010183454},"labels":[],"label_agreement":null},{"id":"W4383302075","doi":"10.3324/haematol.2023.283426","title":"Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Hazard ratio; Internal medicine; Transplantation; Myeloproliferative neoplasm; Myelodysplastic syndromes; Cyclophosphamide; Hematopoietic stem cell transplantation; Confidence interval; Gastroenterology; International Prognostic Scoring System; Graft-versus-host disease; Surgery; Oncology; Myelofibrosis; Chemotherapy; Bone marrow","score_opus":0.023679462404266074,"score_gpt":0.3013200057034748,"score_spread":0.27764054329920873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383302075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99859804,0.00048417068,0.0001482141,0.00006478558,0.0000041848684,0.000010086692,0.00021985134,0.0000030757658,0.00046764125],"genre_scores_gemma":[0.9986375,0.00039123368,0.00024598697,0.000058715872,0.000012070951,0.000012491856,0.0005090066,0.0000041200447,0.00012895121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842775,0.0007734032,0.00012599095,0.00018792998,0.0003844303,0.000100471065],"domain_scores_gemma":[0.99475807,0.0016403788,0.0016919442,0.00045545766,0.0008960133,0.0005580339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003067032,0.00017449558,0.00021302888,0.0005038218,0.00028185558,0.00065063575,0.00022038435,0.0001642426,0.00055040326],"category_scores_gemma":[0.003378272,0.0001081211,0.0003237018,0.0007925051,0.0002469099,0.00022244116,0.0005852414,0.00025200142,0.0000974964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078862516,0.00020103152,0.97456735,0.00004704571,0.00028407364,0.00019057747,0.0009052369,0.00020617268,0.000989862,0.000095319054,0.00082182896,0.020902775],"study_design_scores_gemma":[0.0001657114,0.0007048644,0.9928421,0.00006647032,0.0003293381,0.00083028455,0.0008798823,0.00064004184,0.0009642203,0.000045609762,0.0025143155,0.000017276647],"about_ca_topic_score_codex":0.0049969945,"about_ca_topic_score_gemma":0.012860872,"teacher_disagreement_score":0.0049969945,"about_ca_system_score_codex":0.0004787657,"about_ca_system_score_gemma":0.00089239446,"threshold_uncertainty_score":0.016220212},"labels":[],"label_agreement":null},{"id":"W4384119997","doi":"10.3324/haematol.2023.282905","title":"Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort study","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McMaster University; Ottawa Hospital","funders":"Hamilton Health Sciences; Sanofi; Pfizer; Prothena; Amgen","keywords":"Medicine; Multiple myeloma; Internal medicine; Retrospective cohort study; Cause of death; Population; Cancer; Cohort; Oncology; Disease; Surgery","score_opus":0.07943408511965692,"score_gpt":0.3647558882724021,"score_spread":0.28532180315274513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384119997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99732333,0.0005385442,0.00022022899,0.00006406475,0.000010027415,0.000025187388,0.0015788795,0.0000076039705,0.00023218065],"genre_scores_gemma":[0.99807787,0.00032871342,0.00014880052,0.00005659774,0.000019001416,0.000029159173,0.0012557817,0.000003145967,0.00008091425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917954,0.00018198811,0.00011037295,0.0002853001,0.00014023765,0.00010251887],"domain_scores_gemma":[0.9987871,0.00014974433,0.00046370874,0.00021636001,0.0001810043,0.00020202697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010645342,0.0003590353,0.00064997195,0.00096041645,0.000558332,0.00078923884,0.000494148,0.0005536711,0.0007434747],"category_scores_gemma":[0.0018658433,0.00053809356,0.0007627844,0.0021647576,0.00022447265,0.00064113067,0.000650738,0.000859975,0.0002209103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006918483,0.000022125436,0.9989304,0.000009666348,0.00012578597,0.00006736898,0.0000420866,0.000029680212,0.00009854222,0.000010096874,0.000117668285,0.00047737922],"study_design_scores_gemma":[0.000013290164,0.00009406902,0.9987923,0.0000064149776,0.00010547939,0.00034783393,0.000121013,0.00020840034,0.000028405666,0.000016237424,0.00026071692,0.000005878619],"about_ca_topic_score_codex":0.0077815447,"about_ca_topic_score_gemma":0.008897842,"teacher_disagreement_score":0.0077815447,"about_ca_system_score_codex":0.00051782647,"about_ca_system_score_gemma":0.0006110586,"threshold_uncertainty_score":0.015472472},"labels":[],"label_agreement":null},{"id":"W4384120732","doi":"10.3324/haematol.2022.281944","title":"Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Princess Margaret Cancer Centre","funders":"Pfizer","keywords":"Bosutinib; Philadelphia chromosome; Term (time); Medicine; Tyrosine kinase; Internal medicine; Genetics; Biology; Nilotinib; Chromosomal translocation; Gene; Receptor","score_opus":0.028718520755449044,"score_gpt":0.33212614158053844,"score_spread":0.3034076208250894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384120732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9503062,0.0074619334,0.0012260353,0.029692901,0.0011414514,0.00030778846,0.0011735715,0.000086672604,0.008603429],"genre_scores_gemma":[0.95624864,0.0015372351,0.00056231115,0.03681156,0.0009290238,0.00009474668,0.00091103354,0.00003299888,0.0028723986],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99892247,0.0004873963,0.00010186922,0.00014561301,0.0002008672,0.00014189561],"domain_scores_gemma":[0.9967859,0.0013305122,0.0006386334,0.00018392027,0.00025165186,0.00080938044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020427112,0.0004647357,0.00091535953,0.00022371755,0.00075152767,0.0013292751,0.0005282905,0.0031562978,0.0012052424],"category_scores_gemma":[0.0032247459,0.00019048814,0.0010526644,0.0004786238,0.0004912571,0.00054850226,0.00026446796,0.0027675114,0.00043281133],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057796326,0.0122145545,0.4584944,0.0008914643,0.0042724307,0.097795084,0.0011748468,0.0016952525,0.04022921,0.0017908603,0.080533095,0.24311247],"study_design_scores_gemma":[0.02311153,0.0933658,0.563438,0.00043975454,0.00416998,0.16093855,0.000996979,0.0068689142,0.013434456,0.00242193,0.13063511,0.00017895484],"about_ca_topic_score_codex":0.0009434952,"about_ca_topic_score_gemma":0.0021819097,"teacher_disagreement_score":0.0031562978,"about_ca_system_score_codex":0.0016280798,"about_ca_system_score_gemma":0.00078018935,"threshold_uncertainty_score":0.011812627},"labels":[],"label_agreement":null},{"id":"W4384120739","doi":"10.3324/haematol.2023.283225","title":"Down syndrome and leukemia: from basic mechanisms to clinical advances","year":2023,"lang":"en","type":"review","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Cancer Council Western Australia; National Institutes of Health; Ministerio de Ciencia e Innovación; Bundesministerium für Bildung und Forschung; Deutsche Forschungsgemeinschaft; European Commission; St. Jude Children's Research Hospital; Children's Hospital of Philadelphia; American Lebanese Syrian Associated Charities; U.S. Department of Defense","keywords":"Down syndrome; Trisomy; Myeloid leukemia; Leukemia; Medicine; Acute leukemia; Population; Lymphoblastic Leukemia; Immunology; Bioinformatics; Oncology; Biology; Genetics; Psychiatry","score_opus":0.14615426216856228,"score_gpt":0.4390545652284838,"score_spread":0.29290030305992154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384120739","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000065475724,0.99869627,0.00003403824,0.00063148164,0.00022470448,0.0000014565002,0.000009421111,0.0000032439784,0.00033406683],"genre_scores_gemma":[0.00037273022,0.9989754,0.000048857655,0.00024052893,0.00023117436,0.0000019176382,0.000013392807,5.232306e-7,0.00011551263],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972266,0.000055414795,0.00005475426,0.000040501756,0.00009697703,0.000029714944],"domain_scores_gemma":[0.999278,0.0004338908,0.00007346672,0.00001489173,0.00015069173,0.000048978836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088661176,0.00072229,0.0014355676,0.0019161827,0.0003089127,0.0013696084,0.0007609254,0.0011043319,0.0031765609],"category_scores_gemma":[0.0014815808,0.00024784272,0.0005511653,0.0018690465,0.0006423175,0.0018928421,0.00074831,0.002190492,0.0009772708],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015074309,0.00007058889,0.0005212068,0.024305273,0.00012500855,0.0006828904,0.00014784577,0.00036565543,0.0013011019,0.008063031,0.055190694,0.90907604],"study_design_scores_gemma":[0.000021858128,0.000098730125,0.0012372419,0.009612341,0.00013059973,0.0022059956,0.00012817683,0.000071035705,0.0002438284,0.004723067,0.9815044,0.000022786937],"about_ca_topic_score_codex":0.0012960309,"about_ca_topic_score_gemma":0.0018192658,"teacher_disagreement_score":0.0031765609,"about_ca_system_score_codex":0.00084840815,"about_ca_system_score_gemma":0.0017077016,"threshold_uncertainty_score":0.010626674},"labels":[],"label_agreement":null},{"id":"W4384820346","doi":"10.3324/haematol.2022.282469","title":"Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"Servier; AstraZeneca","keywords":"Mantle cell lymphoma; Internal medicine; Medicine; Refractory (planetary science); Oncology; Lymphoma; Overall survival; Materials science; Metallurgy","score_opus":0.1030738814372394,"score_gpt":0.31948936529747396,"score_spread":0.21641548386023457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384820346","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28931883,0.037121482,0.002516038,0.47962382,0.013082077,0.001089245,0.05714324,0.00029736242,0.11980796],"genre_scores_gemma":[0.6829986,0.010528828,0.0039528785,0.2181592,0.009269403,0.0010353634,0.036140975,0.00013383114,0.03778088],"study_design_codex":"not_applicable","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9989556,0.00046394754,0.00012669113,0.00008756844,0.00020800807,0.00015807225],"domain_scores_gemma":[0.99696976,0.0015603037,0.00024733707,0.00015342007,0.0006121074,0.0004571192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017188003,0.00040279477,0.00084810134,0.00026237912,0.00057485304,0.00096916687,0.00046978457,0.002497665,0.0035139704],"category_scores_gemma":[0.004380456,0.00016741264,0.00049352786,0.0006978429,0.00028046407,0.0004953008,0.0001724441,0.0017385681,0.0017795254],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041504733,0.0011004243,0.047198232,0.00054005015,0.00064841594,0.013462394,0.00022691535,0.0016834484,0.008029231,0.0011345606,0.76864076,0.115830846],"study_design_scores_gemma":[0.019901475,0.011326883,0.19892082,0.00049750926,0.0013873162,0.025856469,0.0005826499,0.0035258878,0.010720251,0.006831235,0.7202988,0.00015058886],"about_ca_topic_score_codex":0.0020595137,"about_ca_topic_score_gemma":0.0060096364,"teacher_disagreement_score":0.0035139704,"about_ca_system_score_codex":0.0013243373,"about_ca_system_score_gemma":0.00070494623,"threshold_uncertainty_score":0.011755347},"labels":[],"label_agreement":null},{"id":"W4385514316","doi":"10.3324/haematol.2022.281780","title":"Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Swedish Orphan Biovitrum; BioCryst; Apellis Pharmaceuticals; Regeneron Pharmaceuticals; UCB Pharma; Alexion Pharmaceuticals; Amgen","keywords":"Paroxysmal nocturnal hemoglobinuria; Hemoglobinuria; Medicine; Internal medicine; Anemia","score_opus":0.11289929139092401,"score_gpt":0.3572159072057279,"score_spread":0.24431661581480385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385514316","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15284345,0.14915814,0.0019478142,0.5686402,0.035256483,0.0015351928,0.005029912,0.00037141715,0.08521757],"genre_scores_gemma":[0.6128189,0.04161352,0.0024103152,0.26202407,0.01608179,0.0012954946,0.003717703,0.00007648431,0.05996161],"study_design_codex":"not_applicable","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996674,0.0001459785,0.000022693874,0.000027817978,0.00006424674,0.00007194292],"domain_scores_gemma":[0.9992539,0.00034320532,0.000079931524,0.000026958156,0.0000530607,0.00024297558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000767337,0.00034417512,0.0008329743,0.00018865026,0.0004691252,0.00071898324,0.0007238021,0.0050065466,0.0063298997],"category_scores_gemma":[0.0014329097,0.00016009074,0.00061151973,0.00026220607,0.00036005845,0.0005495724,0.00017795405,0.0032737835,0.0015923164],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07271931,0.0022252118,0.0052572507,0.001485472,0.00081626355,0.009110217,0.00014915066,0.0008436175,0.0106397765,0.0035957,0.5885355,0.3046226],"study_design_scores_gemma":[0.18788432,0.029176531,0.018071672,0.0010976088,0.0008140018,0.011733369,0.00034392386,0.002993977,0.0067410334,0.010453146,0.7306108,0.0000796125],"about_ca_topic_score_codex":0.00090385834,"about_ca_topic_score_gemma":0.0030534647,"teacher_disagreement_score":0.0063298997,"about_ca_system_score_codex":0.00087726634,"about_ca_system_score_gemma":0.00064733595,"threshold_uncertainty_score":0.021175623},"labels":[],"label_agreement":null},{"id":"W4385851839","doi":"10.3324/haematol.2023.283073","title":"Isatuximab plus carfilzomib and dexamethasone in patients with early &lt;i&gt;versus&lt;/i&gt; late relapsed multiple myeloma: IKEMA subgroup analysis","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Sanofi","keywords":"Carfilzomib; Multiple myeloma; Subgroup analysis; Dexamethasone; Oncology; Internal medicine; Medicine; Lenalidomide; Meta-analysis","score_opus":0.024619686835252442,"score_gpt":0.2661916376063397,"score_spread":0.24157195077108723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385851839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96871626,0.02209849,0.0010355829,0.00069762854,0.0003273838,0.0009362102,0.003941654,0.00004963398,0.0021972794],"genre_scores_gemma":[0.9933426,0.0016545084,0.00052086025,0.0004620187,0.00022842636,0.0006179343,0.0023787064,0.000017092876,0.0007780255],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99874926,0.00046083756,0.00022581847,0.00021083957,0.00013612538,0.00021710934],"domain_scores_gemma":[0.99914086,0.00028637698,0.00021242474,0.0001550961,0.00008086975,0.00012438065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022161282,0.0010467058,0.0036910041,0.0007371574,0.00022300647,0.0012236055,0.00063863426,0.0007169802,0.001917218],"category_scores_gemma":[0.0027134859,0.00032804714,0.011395007,0.00075703894,0.00021028573,0.0005523889,0.00070543546,0.001375657,0.0002700826],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5736742,0.0011417923,0.17816456,0.0045114183,0.14137414,0.0006442617,0.00041524766,0.0039987597,0.005991459,0.00046122546,0.006453982,0.08316901],"study_design_scores_gemma":[0.17701443,0.052354593,0.4719706,0.0014235126,0.257243,0.001756591,0.0013905024,0.0135401515,0.0036360095,0.0045503033,0.01479143,0.00032890157],"about_ca_topic_score_codex":0.0015548859,"about_ca_topic_score_gemma":0.0041980497,"teacher_disagreement_score":0.0036910041,"about_ca_system_score_codex":0.0006053405,"about_ca_system_score_gemma":0.0009854767,"threshold_uncertainty_score":0.0117201805},"labels":[],"label_agreement":null},{"id":"W4386910272","doi":"10.3324/haematol.2023.282884","title":"Bone mineral density in adult patients with pyruvate kinase deficiency on long-term mitapivat treatment","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Novo Nordisk; Moderna; Swedish Orphan Biovitrum; Apellis Pharmaceuticals; Argenx; Sanofi Genzyme; Incyte; bluebird bio; Ionis Pharmaceuticals; Celgene; Sanofi; Alexion Pharmaceuticals; Amgen; Pfizer; Agios Pharmaceuticals; Bristol-Myers Squibb","keywords":"Pyruvate kinase deficiency; Pyruvate kinase; Bone mineral; Term (time); Medicine; Internal medicine; Pediatrics; Glycolysis; Metabolism; Osteoporosis","score_opus":0.0272006064339276,"score_gpt":0.2528535681545815,"score_spread":0.22565296172065388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386910272","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29246214,0.057608217,0.0010478162,0.5928703,0.006271212,0.00007471189,0.0011678733,0.0001357474,0.04836208],"genre_scores_gemma":[0.89483804,0.011917702,0.0006007981,0.07737807,0.009838224,0.00004509382,0.00034442364,0.0000149592615,0.00502265],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9995778,0.00015036567,0.000060964656,0.000041879102,0.00009609893,0.00007289086],"domain_scores_gemma":[0.99878985,0.00067798194,0.00015172591,0.000043596618,0.00012578147,0.00021119286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005214936,0.0002414477,0.00061384356,0.0005613744,0.0006674156,0.00044222755,0.0005309522,0.0045749214,0.0016958364],"category_scores_gemma":[0.0034061344,0.00020776519,0.0002855743,0.00096584146,0.0005859232,0.00042322138,0.00019701007,0.0023239749,0.00048563056],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028179816,0.00024040355,0.26688278,0.0004699656,0.0001797566,0.46872336,0.0005666854,0.00061375235,0.003523707,0.0028931631,0.17886594,0.07422238],"study_design_scores_gemma":[0.0006128818,0.0011920927,0.26940757,0.00095853634,0.00029150426,0.59978366,0.0015854473,0.0021488755,0.0010964836,0.010684587,0.11215498,0.00008344396],"about_ca_topic_score_codex":0.004959717,"about_ca_topic_score_gemma":0.0069303834,"teacher_disagreement_score":0.004959717,"about_ca_system_score_codex":0.00091295247,"about_ca_system_score_gemma":0.00060732587,"threshold_uncertainty_score":0.009861648},"labels":[],"label_agreement":null},{"id":"W4387114848","doi":"10.3324/haematol.2023.283557","title":"Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II study","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; Jewish General Hospital","funders":"National Cancer Institute; Pharmacyclics; Genentech; F. Hoffmann-La Roche; Incyte; H. Lundbeck A/S; BeiGene; CSL Behring; AstraZeneca; MorphoSys; Celgene; Gilead Sciences; Teva Pharmaceutical Industries; Servier; TG Therapeutics; Amgen","keywords":"Bendamustine; Medicine; Obinutuzumab; Follicular lymphoma; Internal medicine; Tolerability; Rituximab; Adverse effect; Phases of clinical research; Gastroenterology; Lymphoma; Chemotherapy","score_opus":0.042731580876233986,"score_gpt":0.328386806788105,"score_spread":0.28565522591187104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387114848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847436,0.0050863707,0.00071680936,0.0005388901,0.0001740218,0.0046557058,0.0014964194,0.000089548164,0.0024986928],"genre_scores_gemma":[0.979954,0.0048929825,0.002374349,0.0017137516,0.00038653243,0.005076889,0.003107764,0.00004808338,0.0024455767],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990312,0.000529761,0.000060625218,0.00015267554,0.00008391498,0.00014186004],"domain_scores_gemma":[0.99894804,0.00014130103,0.00016497061,0.00013670989,0.00008086903,0.00052820955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033511098,0.0014901381,0.002735879,0.00044194647,0.0003988065,0.0012553971,0.0011613552,0.0012814893,0.0030108944],"category_scores_gemma":[0.0012007802,0.00079181977,0.0019580063,0.000553512,0.00090980594,0.0009228869,0.0004372127,0.0029586074,0.0009277036],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7799641,0.090082176,0.0040659695,0.0012631007,0.0022567208,0.00025387236,0.00034747328,0.0016056601,0.034978736,0.00032860434,0.0031188044,0.081734866],"study_design_scores_gemma":[0.7167279,0.27263826,0.0046246313,0.000058041936,0.0008712637,0.00018439713,0.00004775465,0.0005252669,0.0014339047,0.00014890342,0.002717725,0.000021916552],"about_ca_topic_score_codex":0.001061633,"about_ca_topic_score_gemma":0.0021492038,"teacher_disagreement_score":0.0033511098,"about_ca_system_score_codex":0.0011744743,"about_ca_system_score_gemma":0.0023501576,"threshold_uncertainty_score":0.017722547},"labels":[],"label_agreement":null},{"id":"W4387357326","doi":"10.3324/haematol.2023.283303","title":"Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Seagen","keywords":"Brentuximab vedotin; Classical Hodgkin lymphoma; Chemotherapy; Medicine; Stage (stratigraphy); Hodgkin lymphoma; Oncology; Internal medicine; Lymphoma; Pediatrics; Biology","score_opus":0.019321271487194744,"score_gpt":0.25608773366937543,"score_spread":0.23676646218218067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387357326","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33365887,0.025244705,0.0010080406,0.5321506,0.012259153,0.00017697342,0.00037613648,0.00015967675,0.0949658],"genre_scores_gemma":[0.82845384,0.0075615956,0.0009805043,0.13090622,0.015240852,0.00007121347,0.00020070167,0.000054333803,0.016530734],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996518,0.0000976449,0.000047063208,0.00003885235,0.00005391425,0.00011082676],"domain_scores_gemma":[0.9990514,0.00037135722,0.00011750165,0.000021868354,0.000059826307,0.00037798952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035299108,0.00031383988,0.0004585736,0.00037393125,0.0013392549,0.0007993147,0.0005185144,0.004945113,0.002874814],"category_scores_gemma":[0.0028046828,0.00031714063,0.000518321,0.0003161619,0.00060266396,0.0008568905,0.00042042168,0.0039610886,0.0006634235],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006778596,0.0004689453,0.11508852,0.00022487476,0.00009294043,0.7167567,0.00054842775,0.0006377285,0.0015745189,0.0031730712,0.12747028,0.033286087],"study_design_scores_gemma":[0.00058303244,0.0011358492,0.093068644,0.0008411491,0.0001833659,0.75081825,0.0012975622,0.0029288642,0.0011827678,0.005279835,0.14262559,0.00005508337],"about_ca_topic_score_codex":0.0047276826,"about_ca_topic_score_gemma":0.013586674,"teacher_disagreement_score":0.004945113,"about_ca_system_score_codex":0.0015309601,"about_ca_system_score_gemma":0.0011312675,"threshold_uncertainty_score":0.011107922},"labels":[],"label_agreement":null},{"id":"W4388537425","doi":"10.3324/haematol.2023.283437","title":"Extended exposure to low doses of azacitidine induces differentiation of leukemic stem cells through activation of myeloperoxidase","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Celgene","keywords":"Azacitidine; Myeloid leukemia; Myeloid; Cancer research; Stem cell; Myeloperoxidase; CD34; Leukemia; Pharmacology; Medicine; Immunology; Biology; DNA methylation; Cell biology; Biochemistry; Gene expression","score_opus":0.04790925169331383,"score_gpt":0.30722279638420724,"score_spread":0.2593135446908934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388537425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99088705,0.005119867,0.0017023578,0.00012267318,0.00003816189,0.000047220816,0.00019379062,0.000080627855,0.0018083559],"genre_scores_gemma":[0.994562,0.0024479346,0.0009714,0.000041187657,0.000018722118,0.00003172862,0.00029312194,0.0000059793842,0.0016279211],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999434,0.000010062007,0.0000037830425,0.000012198925,0.00001899687,0.000011644625],"domain_scores_gemma":[0.9999713,0.0000046646683,0.000008393217,0.0000051109746,0.0000025993684,0.000008024827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009808238,0.00018362762,0.00022687585,0.0001358485,0.000070314796,0.00021516636,0.000115766125,0.00015667087,0.0011367893],"category_scores_gemma":[0.000064499196,0.00008030956,0.00013108541,0.00010390889,0.00018453965,0.000119611344,0.00014655407,0.0006275247,0.00021129465],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059087586,0.00022468917,0.00069300516,0.00009644748,0.00001633722,0.00006186306,0.000029147972,0.00021761988,0.9781939,0.00018530486,0.00019271046,0.019498156],"study_design_scores_gemma":[0.00023106449,0.00915544,0.0259986,0.000036288246,0.00010134694,0.0006446262,0.00005726337,0.0014924628,0.9464249,0.00024021656,0.015609456,0.000008428531],"about_ca_topic_score_codex":0.0003435282,"about_ca_topic_score_gemma":0.0011700869,"teacher_disagreement_score":0.0011367893,"about_ca_system_score_codex":0.0001822536,"about_ca_system_score_gemma":0.0001985871,"threshold_uncertainty_score":0.0038028955},"labels":[],"label_agreement":null},{"id":"W4388732699","doi":"10.3324/haematol.2023.284188","title":"First-line MAPK inhibition in pediatric histiocytosis: are we ready?","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Line (geometry); MAPK/ERK pathway; Medicine; Biology; Genetics; Signal transduction","score_opus":0.06669837523109853,"score_gpt":0.28752932263255937,"score_spread":0.22083094740146084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388732699","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00094313174,0.022493824,0.0001654704,0.9624588,0.008835125,0.000011046155,0.00009313943,0.000050953622,0.0049484973],"genre_scores_gemma":[0.020236382,0.04144715,0.0010268367,0.8549938,0.0734428,0.00007499823,0.00020571702,0.000050326085,0.008521832],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990067,0.00030282623,0.00013307128,0.00007642603,0.0003103389,0.00017071268],"domain_scores_gemma":[0.996157,0.0018850815,0.0002609245,0.00011338915,0.00062591943,0.00095776306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014864122,0.00050978636,0.0014173243,0.0005746701,0.0015243639,0.0019511906,0.0012904438,0.017152578,0.007390012],"category_scores_gemma":[0.0075620664,0.00034804025,0.0012313864,0.00048750918,0.0014155249,0.003465867,0.0007356412,0.021302463,0.0062332284],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021504315,0.00012103274,0.0015003573,0.00020340044,0.000040072857,0.0070083668,0.000074595555,0.0002955527,0.00056171534,0.004384281,0.9163415,0.069254026],"study_design_scores_gemma":[0.0003764723,0.0002932294,0.002213969,0.0014021548,0.000076994795,0.016685296,0.00039905042,0.0006077187,0.00045889904,0.01689686,0.96051973,0.00006964623],"about_ca_topic_score_codex":0.00252292,"about_ca_topic_score_gemma":0.006731544,"teacher_disagreement_score":0.017152578,"about_ca_system_score_codex":0.0025180804,"about_ca_system_score_gemma":0.0020006523,"threshold_uncertainty_score":0.0247221},"labels":[],"label_agreement":null},{"id":"W4389236480","doi":"10.3324/haematol.2021.280275","title":"Past, present and future therapeutic approaches in nodal peripheral T-cell lymphomas","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Brentuximab vedotin; Anaplastic large-cell lymphoma; Vincristine; Oncology; CHOP; Peripheral T-cell lymphoma; Medicine; Prednisone; Lymphoma; Internal medicine; T cell; Immunology; Cancer research; CD30; Chemotherapy; Cyclophosphamide; Immune system","score_opus":0.05974935561026039,"score_gpt":0.2606493981969898,"score_spread":0.2009000425867294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389236480","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026965803,0.9601132,0.0016216214,0.023190109,0.0019330741,0.000020704974,0.000077678356,0.00005861564,0.010288364],"genre_scores_gemma":[0.043367516,0.92259,0.0052842298,0.015599789,0.0072538424,0.00011835627,0.0002560414,0.00004639427,0.005483888],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99904674,0.00035704562,0.0001139392,0.00014491139,0.00018665091,0.0001506823],"domain_scores_gemma":[0.9986671,0.0005465301,0.00016015414,0.000076519056,0.00027138065,0.00027828402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040413793,0.00045363262,0.00078989234,0.0009072673,0.00051514094,0.0025534409,0.0010137386,0.0018615377,0.0056762425],"category_scores_gemma":[0.0025415195,0.0002100709,0.00074785977,0.00072880945,0.0013530968,0.0032783553,0.0010659564,0.0036101975,0.0017123871],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065896334,0.00035305286,0.0010392934,0.004732125,0.000103443774,0.0006588874,0.00035597835,0.0010099785,0.0030822349,0.028206008,0.040779673,0.91902035],"study_design_scores_gemma":[0.00019362212,0.0011572003,0.0019469609,0.005185304,0.0001927788,0.002702349,0.0005496913,0.0008854515,0.0013029105,0.022492029,0.9633314,0.000060293616],"about_ca_topic_score_codex":0.0005243934,"about_ca_topic_score_gemma":0.0022154872,"teacher_disagreement_score":0.0056762425,"about_ca_system_score_codex":0.001485873,"about_ca_system_score_gemma":0.001675337,"threshold_uncertainty_score":0.021373093},"labels":[],"label_agreement":null},{"id":"W4389244392","doi":"10.3324/haematol.2023.282719","title":"Introduction to the peripheral T-cell lymphoma review series: advances in molecular characterization, classification refinement and treatment optimization","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Series (stratigraphy); Computational biology; Characterization (materials science); Lymphoma; Peripheral T-cell lymphoma; Medicine; Computer science; Biology; Pathology; Immunology; T cell; Materials science; Nanotechnology; Immune system","score_opus":0.016698499312848013,"score_gpt":0.26887717057554317,"score_spread":0.25217867126269516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244392","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009849996,0.95519584,0.0056651034,0.012738602,0.021085713,0.00006261148,0.00034906119,0.00017961506,0.0037384247],"genre_scores_gemma":[0.0066494904,0.8943633,0.007934988,0.017742436,0.063796416,0.00009812096,0.0009855776,0.00012256444,0.008307195],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99938345,0.00016308813,0.00010335033,0.0001470254,0.00015777645,0.000045237135],"domain_scores_gemma":[0.9969272,0.0012099156,0.0002536543,0.00011339254,0.0012191928,0.00027671905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018800775,0.00080852647,0.0014839923,0.0027836317,0.00031145415,0.0015685122,0.000950648,0.0012086492,0.005721201],"category_scores_gemma":[0.0046683275,0.00033475025,0.00084701716,0.0018987546,0.0005745145,0.0019367158,0.0009433249,0.0036106345,0.004264094],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001871309,0.0000768992,0.00094919145,0.004339488,0.00012446361,0.00032333567,0.000052480777,0.0005568911,0.002762339,0.002861297,0.36451787,0.6232486],"study_design_scores_gemma":[0.00002444382,0.00021450876,0.0024204287,0.0021049236,0.00014567169,0.0035612658,0.000051015013,0.00031338137,0.0010628412,0.0020503239,0.9880028,0.000048447208],"about_ca_topic_score_codex":0.0011501521,"about_ca_topic_score_gemma":0.0022106038,"teacher_disagreement_score":0.005721201,"about_ca_system_score_codex":0.0011211087,"about_ca_system_score_gemma":0.0013685804,"threshold_uncertainty_score":0.01913935},"labels":[],"label_agreement":null},{"id":"W4389244542","doi":"10.3324/haematol.2023.282716","title":"Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions","year":2023,"lang":"en","type":"review","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Anaplastic large-cell lymphoma; Peripheral T-cell lymphoma; Lymphoma; Biology; T cell; CD8; NODAL; Epigenetics; Anaplastic lymphoma kinase; Cell of origin; Cancer research; Immunology; Pathology; Medicine; Cell; Genetics; Immune system; Gene","score_opus":0.13516869267368736,"score_gpt":0.36153845979951,"score_spread":0.22636976712582263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244542","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036464218,0.99802893,0.00023470604,0.0007920717,0.00016140867,0.0000028497943,0.000021029275,0.0000117138,0.00038265833],"genre_scores_gemma":[0.0014878393,0.99709034,0.00033424003,0.00036063703,0.00050299364,0.0000065203913,0.00004566422,0.0000023365487,0.00016929497],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975127,0.000047092173,0.00005191302,0.000060632643,0.00005328188,0.000035817302],"domain_scores_gemma":[0.9993337,0.0003201813,0.00009733932,0.00001895972,0.00016465307,0.000065191045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010402367,0.0006751244,0.0014223367,0.0013580266,0.0002861139,0.001989334,0.00094428565,0.001158547,0.0026863269],"category_scores_gemma":[0.000977763,0.00028143346,0.0006015225,0.0014190233,0.000893275,0.0029520332,0.000731303,0.001798298,0.0009397858],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027154497,0.00008802223,0.0013565301,0.02347989,0.00014542755,0.001110432,0.00044096657,0.0010638819,0.0060783145,0.009424527,0.02814974,0.92839074],"study_design_scores_gemma":[0.0000323645,0.00027809825,0.0033734203,0.0077907457,0.0003858674,0.0065938416,0.00068987993,0.0005155973,0.0011977722,0.013019581,0.96604884,0.00007393063],"about_ca_topic_score_codex":0.00090482866,"about_ca_topic_score_gemma":0.0011333396,"teacher_disagreement_score":0.0026863269,"about_ca_system_score_codex":0.00085222226,"about_ca_system_score_gemma":0.0015784235,"threshold_uncertainty_score":0.008986652},"labels":[],"label_agreement":null},{"id":"W4390344090","doi":"10.3324/haematol.2023.283776","title":"LNK/&lt;i&gt;SH2B3&lt;/i&gt; as a novel driver in juvenile myelomonocytic leukemia","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Heart, Lung, and Blood Institute; Deutsche Krebshilfe; Frank A. Campini Foundation; National Cancer Institute; National Institutes of Health; Children's Hospital of Philadelphia; Leukemia and Lymphoma Society","keywords":"Juvenile myelomonocytic leukemia; Cancer research; KRAS; Ruxolitinib; Biology; Myeloid; Haematopoiesis; Neuroblastoma RAS viral oncogene homolog; Internal medicine; Immunology; Mutation; Medicine; Genetics; Stem cell; Bone marrow; Myelofibrosis; Gene","score_opus":0.0365812657277071,"score_gpt":0.3064503753839696,"score_spread":0.2698691096562625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390344090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976284,0.0003079127,0.0006241831,0.000085998625,0.0000071687564,0.000012934885,0.00010276416,0.000060048627,0.0011706509],"genre_scores_gemma":[0.9992644,0.00008612684,0.0003384122,0.000023443194,0.0000050693275,0.0000033709218,0.00006511731,0.000007580351,0.00020629745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988556,0.000012030494,0.000010135755,0.000021227886,0.00003902098,0.000032058804],"domain_scores_gemma":[0.99985397,0.000024517358,0.000052114,0.000008295179,0.000007958498,0.00005307566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080533646,0.00028995593,0.00014682417,0.00043370182,0.0003040762,0.0003778801,0.00016671365,0.00030537075,0.0006737274],"category_scores_gemma":[0.00023300962,0.00012225394,0.00016692108,0.00032610825,0.0003196354,0.00014312442,0.00021191001,0.0003187511,0.00016756101],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005654246,0.00008216942,0.21850458,0.00009757971,0.00003577522,0.19802032,0.00052634283,0.0009615739,0.54382306,0.0011686188,0.0008187916,0.03539578],"study_design_scores_gemma":[0.000085293264,0.0003238672,0.38730386,0.00003294579,0.00011111551,0.4543486,0.00046324634,0.0039480887,0.14323013,0.00052812696,0.00958596,0.0000388407],"about_ca_topic_score_codex":0.0018398244,"about_ca_topic_score_gemma":0.003863848,"teacher_disagreement_score":0.0018398244,"about_ca_system_score_codex":0.00034247103,"about_ca_system_score_gemma":0.00028395889,"threshold_uncertainty_score":0.003658235},"labels":[],"label_agreement":null},{"id":"W4390484306","doi":"10.3324/haematol.2023.284289","title":"&lt;i&gt;Erratum&lt;/i&gt; to: &lt;i&gt;DUSP22&lt;/i&gt;-rearranged ALK-negative anaplastic large cell lymphoma is a pathogenetically distinct disease but can have variable clinical outcome","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Lymphoma; Medicine; Anaplastic large-cell lymphoma; Cancer research; Internal medicine","score_opus":0.02840536132505914,"score_gpt":0.298310698904237,"score_spread":0.26990533757917784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390484306","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002340244,0.00047126404,0.001026747,0.07676542,0.9129758,0.00003776145,0.0010452523,0.00053371734,0.006910021],"genre_scores_gemma":[0.022641806,0.0036619608,0.012644867,0.21003166,0.32209346,0.0002698103,0.0031147706,0.0047059404,0.4208357],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968405,0.00047383067,0.00081769476,0.00041186443,0.0010841149,0.00037208333],"domain_scores_gemma":[0.9670706,0.01004845,0.0018146298,0.0019836873,0.01798796,0.0010946211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002426997,0.0011642711,0.0013547641,0.0024146882,0.0019857017,0.0031576739,0.0020013656,0.0040281424,0.07025313],"category_scores_gemma":[0.04782913,0.00093804323,0.0013374698,0.0011943727,0.0019325946,0.0015492633,0.0010179082,0.011089665,0.06234697],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024230549,0.000005128,0.00006556114,0.00003889043,0.000004632369,0.0001576128,0.000016361142,0.000022551778,0.00009599155,0.00060922676,0.9961384,0.002821498],"study_design_scores_gemma":[0.000027537679,0.0000144760625,0.00069252134,0.00015090706,0.000020325953,0.000543658,0.000110070694,0.00019893325,0.0006565834,0.0011079739,0.9964509,0.000026116868],"about_ca_topic_score_codex":0.014059245,"about_ca_topic_score_gemma":0.01914479,"teacher_disagreement_score":0.07025313,"about_ca_system_score_codex":0.0032641508,"about_ca_system_score_gemma":0.002944446,"threshold_uncertainty_score":0.23502016},"labels":[],"label_agreement":null},{"id":"W4391438115","doi":"10.3324/haematol.2024.285005","title":"&lt;i&gt;Erratum to&lt;/i&gt;: Introduction to the peripheral T-cell lymphoma review series: advances in molecular characterization, classification refinement and treatment optimization","year":2024,"lang":"en","type":"erratum","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Series (stratigraphy); Characterization (materials science); Computational biology; Medicine; Peripheral T-cell lymphoma; Lymphoma; Biology; Internal medicine; Immunology; Nanotechnology; T cell; Materials science","score_opus":0.012532389194545813,"score_gpt":0.2569160452565248,"score_spread":0.24438365606197898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391438115","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012440789,0.009182808,0.00095118576,0.07509372,0.90337586,0.00004763071,0.0004229801,0.0002617731,0.010539703],"genre_scores_gemma":[0.003599742,0.032011192,0.004776386,0.1616301,0.574212,0.00014813223,0.0012810971,0.00092346146,0.22141786],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981761,0.00028524414,0.00033050173,0.0001927579,0.00085919525,0.00015615251],"domain_scores_gemma":[0.99008465,0.0024825376,0.0005497026,0.00043345938,0.005653085,0.0007966299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023705696,0.0012024244,0.001478977,0.0028132228,0.0013708371,0.0032854727,0.0017084593,0.0041222903,0.030964024],"category_scores_gemma":[0.016452048,0.00062838173,0.0010316544,0.00147088,0.0014161754,0.0019538065,0.0010266942,0.008574234,0.03671596],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014286203,0.0000054252496,0.00003086435,0.000050190796,0.0000024705505,0.0000894287,0.0000039688043,0.000016971855,0.00004221828,0.00027721387,0.98661345,0.012853587],"study_design_scores_gemma":[0.000014860603,0.000020422187,0.00031403947,0.0002126643,0.000014538691,0.00056412775,0.00002246237,0.00007776292,0.00019731281,0.000709779,0.99783903,0.000012972134],"about_ca_topic_score_codex":0.0071107354,"about_ca_topic_score_gemma":0.016584955,"teacher_disagreement_score":0.030964024,"about_ca_system_score_codex":0.0025960885,"about_ca_system_score_gemma":0.0032842846,"threshold_uncertainty_score":0.103584945},"labels":[],"label_agreement":null},{"id":"W4392287332","doi":"10.3324/haematol.2023.283713","title":"Adjusting for subsequent therapies in the TOURMALINE-MM1 study shows clinically meaningful improvement in overall survival with addition of ixazomib to lenalidomide and dexamethasone","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; University of Calgary","funders":"Loxo Oncology; Adaptive Biotechnologies; Regeneron Pharmaceuticals; Genentech; Celgene; BeiGene; Sanofi; Pfizer; Amgen","keywords":"Lenalidomide; Medicine; Internal medicine; Hazard ratio; Ixazomib; Population; Confidence interval; Dexamethasone; Surgery; Oncology; Carfilzomib","score_opus":0.08382698583699201,"score_gpt":0.375925104901556,"score_spread":0.292098119064564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392287332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98500556,0.0067602526,0.005280269,0.0005607627,0.00011177828,0.00020042682,0.0011228172,0.000102257254,0.00085574953],"genre_scores_gemma":[0.9960296,0.00064487796,0.0017464273,0.00017140985,0.000049442267,0.00010414206,0.0006201825,0.000018310064,0.00061570166],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9936326,0.0047557075,0.00020386728,0.0007461417,0.00040561336,0.00025618993],"domain_scores_gemma":[0.9943204,0.0034822999,0.0011829158,0.00070247875,0.00009599508,0.00021582772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008617246,0.0006547384,0.0011464499,0.00027674355,0.00014498454,0.0007405377,0.00062026293,0.0005609158,0.0014871194],"category_scores_gemma":[0.0116281435,0.0002484375,0.0061625633,0.0003617892,0.00029277545,0.0004409462,0.00061488646,0.0016607835,0.00012408318],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40698192,0.001541018,0.23433936,0.002949172,0.050667357,0.0002935655,0.00058358506,0.022044238,0.0060367137,0.0025676766,0.0037258014,0.2682695],"study_design_scores_gemma":[0.04469047,0.1461057,0.6524412,0.00072792463,0.05149832,0.00064698205,0.00026050297,0.074293494,0.0104563655,0.0061553535,0.012568988,0.00015472918],"about_ca_topic_score_codex":0.002624129,"about_ca_topic_score_gemma":0.004086443,"teacher_disagreement_score":0.008617246,"about_ca_system_score_codex":0.0006360881,"about_ca_system_score_gemma":0.001160365,"threshold_uncertainty_score":0.045572937},"labels":[],"label_agreement":null},{"id":"W4393265067","doi":"10.3324/haematol.2023.284138","title":"Gut microbiome alterations at acute myeloid leukemia diagnosis are associated with muscle weakness and anorexia","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Walloon excellence in life sciences and biotechnology; Fonds Wetenschappelijk Onderzoek; Fonds De La Recherche Scientifique - FNRS; Génome Québec; Gilead Sciences; University of Minnesota; Vlaamse regering; European Society for Clinical Nutrition and Metabolism; Pfizer; Université Catholique de Louvain; Fondation Louvain","keywords":"Gut flora; Anorexia; Microbiome; Biology; Metabolome; Internal medicine; Physiology; Immunology; Medicine; Metabolomics; Bioinformatics","score_opus":0.011340949009278492,"score_gpt":0.24594396970166654,"score_spread":0.23460302069238806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393265067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989072,0.0006157117,0.00010845691,0.00002605571,0.0000043086593,0.0000064453056,0.00016935164,0.000003704706,0.00015871198],"genre_scores_gemma":[0.9991061,0.00027750747,0.00017865785,0.000031045543,0.000008633864,0.0000065142863,0.00024841397,0.000001679933,0.00014153702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997782,0.00005326096,0.000025493133,0.000056103436,0.000041336683,0.000045631085],"domain_scores_gemma":[0.99967134,0.000030748473,0.0001841105,0.00001366406,0.000031934196,0.00006822817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020193256,0.00026093744,0.00044813936,0.000631217,0.00033923727,0.00041958046,0.000117468604,0.00026225683,0.0010128012],"category_scores_gemma":[0.0005601467,0.00014817153,0.00022112588,0.000599015,0.00018164866,0.00018137971,0.00045745194,0.00029787066,0.00015483791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009698068,0.00006939366,0.9714867,0.000059897913,0.00008591893,0.00032915242,0.00012515504,0.000075757125,0.020289825,0.000027024842,0.0001324835,0.0063488497],"study_design_scores_gemma":[0.000005805144,0.00015055251,0.99826247,0.0000094255465,0.000033804914,0.00046996988,0.00010213683,0.000108060245,0.00058895536,0.0000244951,0.00024090458,0.0000034690222],"about_ca_topic_score_codex":0.0009598429,"about_ca_topic_score_gemma":0.0015576102,"teacher_disagreement_score":0.0010128012,"about_ca_system_score_codex":0.00020098538,"about_ca_system_score_gemma":0.00014492084,"threshold_uncertainty_score":0.0033881664},"labels":[],"label_agreement":null},{"id":"W4393277437","doi":"10.3324/haematol.2024.285031","title":"Non-myeloma light chain cast nephropathy: a multicenter retrospective study on clinicopathological characteristics","year":2024,"lang":"en","type":"letter","venue":"Haematologica","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Multiple myeloma; Medicine; Retrospective cohort study; Multicenter study; Nephropathy; Immunoglobulin light chain; Internal medicine; Oncology; Immunology; Endocrinology","score_opus":0.019856196132632932,"score_gpt":0.2939163035963683,"score_spread":0.2740601074637353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393277437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99349505,0.00079742883,0.00016691642,0.001081914,0.000045484816,0.000028913506,0.002685892,0.000011064885,0.0016872846],"genre_scores_gemma":[0.99763656,0.00020681483,0.00011870408,0.0006255669,0.00011428875,0.000035623387,0.0009569361,0.000005041083,0.00030038253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988501,0.00043392737,0.00014946656,0.00021992886,0.00017872486,0.00016780315],"domain_scores_gemma":[0.99601823,0.0012100955,0.0013807815,0.0005252687,0.00038578233,0.00047987196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013936443,0.00028156978,0.0005659274,0.0007252379,0.00058939896,0.00061768823,0.00056946126,0.0010046092,0.002289981],"category_scores_gemma":[0.0044997553,0.00044084262,0.00033452726,0.0024851747,0.00034085233,0.00081582874,0.00041367166,0.00060724805,0.0006070823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031451546,0.000040623745,0.9944259,0.000011351083,0.000040723942,0.002240509,0.00004898253,0.000028609757,0.00014685829,0.0000339542,0.0012464676,0.0014214371],"study_design_scores_gemma":[0.0001235686,0.00018852136,0.98574835,0.0000309788,0.00006929185,0.011237197,0.00032340182,0.0003973215,0.00009216459,0.00022838361,0.0015434246,0.00001735299],"about_ca_topic_score_codex":0.004776768,"about_ca_topic_score_gemma":0.0049178344,"teacher_disagreement_score":0.004776768,"about_ca_system_score_codex":0.00051372015,"about_ca_system_score_gemma":0.00054730347,"threshold_uncertainty_score":0.009497941},"labels":[],"label_agreement":null},{"id":"W4394725118","doi":"10.3324/haematol.2024.285041","title":"Unfriendly protein of GATA1 and mechanisms of bone marrow failure","year":2024,"lang":"en","type":"letter","venue":"Haematologica","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Bone marrow; GATA1; Bone marrow failure; Medicine; Cancer research; Immunology; Cell biology; Internal medicine; Haematopoiesis; Biology; Erythropoiesis; Anemia; Stem cell","score_opus":0.010840507314403282,"score_gpt":0.22801900187705562,"score_spread":0.21717849456265234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394725118","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042360527,0.01805231,0.00040016262,0.932865,0.031721275,0.000022135642,0.00014055311,0.000067927715,0.012494533],"genre_scores_gemma":[0.08963534,0.022900715,0.0011019486,0.6808714,0.15057498,0.0001253217,0.00021902067,0.00006592456,0.0545054],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993449,0.00023021597,0.00006919875,0.000082284634,0.00016308385,0.00011028483],"domain_scores_gemma":[0.99862206,0.0008771265,0.00010506307,0.00008165054,0.00014729371,0.0001668315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011209416,0.0003947131,0.0007530144,0.0003791602,0.0008719566,0.0011516804,0.00093522185,0.015699059,0.005496039],"category_scores_gemma":[0.0041161776,0.00030740205,0.0005356508,0.0002545597,0.0016949606,0.0012427897,0.00047200872,0.00831828,0.0042804354],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007284859,0.00010019366,0.0022525694,0.00020716128,0.000058063455,0.035897456,0.000090736095,0.00025001843,0.0032028477,0.0143829435,0.9037771,0.039052475],"study_design_scores_gemma":[0.000320072,0.00018135941,0.0026432083,0.00019549261,0.000055380275,0.023765087,0.00016725436,0.0008253427,0.001950426,0.027723847,0.94212854,0.00004407467],"about_ca_topic_score_codex":0.0010361993,"about_ca_topic_score_gemma":0.0014855766,"teacher_disagreement_score":0.015699059,"about_ca_system_score_codex":0.0017234784,"about_ca_system_score_gemma":0.0007720344,"threshold_uncertainty_score":0.018386006},"labels":[],"label_agreement":null},{"id":"W4394725168","doi":"10.3324/haematol.2024.284967","title":"Oral iron supplementation: new formulations, old questions","year":2024,"lang":"en","type":"review","venue":"Haematologica","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Tolerability; Anemia; Iron deficiency; Iron-deficiency anemia; Ferrous; Medicine; Iron supplement; Iron sulfate; Iron supplementation; Pharmacology; Internal medicine; Chemistry; Sulfate; Adverse effect","score_opus":0.08397059795947864,"score_gpt":0.4065818136440817,"score_spread":0.32261121568460305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394725168","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013050169,0.9988943,0.00006324133,0.00036090327,0.00014789458,0.0000034095792,0.000011587612,0.0000031577779,0.00038502738],"genre_scores_gemma":[0.00075936946,0.9981844,0.00017737765,0.00029210845,0.00028540735,0.000007845825,0.000017780469,0.0000019918716,0.000273614],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999668,0.00007348488,0.00008187915,0.000055775632,0.00010491826,0.000016053871],"domain_scores_gemma":[0.9992217,0.0005392653,0.00009095777,0.000020660513,0.00010510932,0.00002234895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009913127,0.00059011613,0.0012358715,0.001670293,0.00022332542,0.0011977723,0.00063572265,0.0011921187,0.0042985226],"category_scores_gemma":[0.0015941543,0.00030061093,0.0006501637,0.0011648324,0.00054430537,0.0017981697,0.00046213,0.0016004797,0.0014156799],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013735318,0.000071840885,0.00015387888,0.029276567,0.000078135155,0.00024048396,0.00007975697,0.00012151642,0.0011693467,0.0025838227,0.014481629,0.95160574],"study_design_scores_gemma":[0.000045901703,0.00018653182,0.0007274381,0.013891108,0.00022962631,0.002497386,0.00012284599,0.00009767098,0.00064016506,0.002579318,0.97895825,0.000023865918],"about_ca_topic_score_codex":0.00070941955,"about_ca_topic_score_gemma":0.0011329952,"teacher_disagreement_score":0.0042985226,"about_ca_system_score_codex":0.00037540207,"about_ca_system_score_gemma":0.00066750945,"threshold_uncertainty_score":0.014379919},"labels":[],"label_agreement":null},{"id":"W4394919587","doi":"10.3324/haematol.2024.285257","title":"‘One way, or another, I’m gonna find ya’: miR-221-3p finds its targets via small extracellular vesicles","year":2024,"lang":"en","type":"editorial","venue":"Haematologica","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Extracellular vesicles; Vesicle; Extracellular; Chemistry; Molecular biology; Cell biology; Biophysics; Biology; Biochemistry; Membrane","score_opus":0.02172669775936194,"score_gpt":0.2613766853722104,"score_spread":0.23964998761284848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394919587","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025235482,0.097219065,0.0034304706,0.38619155,0.5024099,0.0000906167,0.00020295562,0.00037859613,0.0075533367],"genre_scores_gemma":[0.020540766,0.084362805,0.0024344616,0.27691332,0.5798553,0.00010275077,0.0002635738,0.00029572457,0.035231296],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998257,0.0004268087,0.00017011879,0.00029597658,0.00065188506,0.00019817843],"domain_scores_gemma":[0.99680954,0.0013725332,0.00033260774,0.00016399255,0.0007424672,0.0005788094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025539484,0.0010192144,0.0011012481,0.0011730593,0.0015803477,0.0048460695,0.0018821823,0.0047564567,0.0091595035],"category_scores_gemma":[0.0066282847,0.0006120285,0.0011144244,0.0005983678,0.0023699754,0.0042504193,0.0017166882,0.010230393,0.0043975087],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043160448,0.000056094275,0.0011078591,0.0005798603,0.000106486914,0.00080104935,0.00019619946,0.00011515288,0.001856443,0.004364462,0.90314406,0.0872408],"study_design_scores_gemma":[0.000038140097,0.0000696607,0.0005881724,0.00014299148,0.000043243333,0.0007786978,0.00016737162,0.00017448966,0.0007712517,0.0019069213,0.9952957,0.000023353961],"about_ca_topic_score_codex":0.00045874366,"about_ca_topic_score_gemma":0.0010951192,"teacher_disagreement_score":0.0091595035,"about_ca_system_score_codex":0.0013780186,"about_ca_system_score_gemma":0.0011997358,"threshold_uncertainty_score":0.030641615},"labels":[],"label_agreement":null},{"id":"W4395077641","doi":"10.3324/haematol.2024.285425","title":"Central nervous system prophylaxis: it’s time to start from scratch","year":2024,"lang":"en","type":"editorial","venue":"Haematologica","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Scratch; Central nervous system; Medicine; Computer science; Internal medicine; Operating system","score_opus":0.011279503501672075,"score_gpt":0.2530312432106314,"score_spread":0.24175173970895936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395077641","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018659299,0.0068810247,0.00006634787,0.049308732,0.9423149,0.000013667667,0.00003750958,0.000048353468,0.0013108348],"genre_scores_gemma":[0.00025179386,0.0053194743,0.00008553262,0.03857627,0.94935673,0.000016844879,0.000028320002,0.000027219656,0.006337899],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939474,0.0015100491,0.0008677273,0.0005420786,0.0028002753,0.00033261342],"domain_scores_gemma":[0.96305823,0.017887425,0.0017958051,0.00081164966,0.011772232,0.004674639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0086912755,0.0034782686,0.0049416837,0.0030302627,0.0034049982,0.007502186,0.004333925,0.020097125,0.016007125],"category_scores_gemma":[0.04093533,0.0016679167,0.0028916139,0.0016721188,0.0029788862,0.006884759,0.0013717421,0.03399654,0.018683903],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031920874,0.000009131792,0.000013245877,0.00020930757,0.000018722218,0.000066832916,0.0000074396653,0.000013937272,0.000022129509,0.00016847729,0.9959824,0.003456381],"study_design_scores_gemma":[0.00015091886,0.000048994832,0.00028272526,0.0010770175,0.00011469965,0.0004567683,0.00005395536,0.00014557947,0.000089558744,0.0013883557,0.9961612,0.00003020272],"about_ca_topic_score_codex":0.0034670131,"about_ca_topic_score_gemma":0.008794612,"teacher_disagreement_score":0.020097125,"about_ca_system_score_codex":0.0039949524,"about_ca_system_score_gemma":0.0038881018,"threshold_uncertainty_score":0.05354917},"labels":[],"label_agreement":null},{"id":"W4396762306","doi":"10.3324/haematol.2024.285002","title":"Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Cancer Institute","keywords":"Medicine; Transplantation; Cord blood; Hematopoietic cell; Population; Hematopoietic stem cell transplantation; Stem cell; Internal medicine; Immunology; Haematopoiesis; Oncology; Biology; Environmental health","score_opus":0.015563875858783244,"score_gpt":0.26814670619031655,"score_spread":0.2525828303315333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396762306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63081694,0.2200766,0.006349367,0.062852986,0.003815083,0.00017398286,0.025194842,0.00078578026,0.049934376],"genre_scores_gemma":[0.8537066,0.10197493,0.004022123,0.007789667,0.003497775,0.00012350353,0.016362805,0.00013689381,0.01238578],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998995,0.00022442728,0.000101042555,0.00023557399,0.0002838872,0.00016015737],"domain_scores_gemma":[0.99640536,0.00051415403,0.0010296436,0.00015593051,0.001022415,0.0008724869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013490282,0.00030899077,0.0003018982,0.0012731289,0.0003330409,0.0015418886,0.00049449434,0.00064971496,0.009715034],"category_scores_gemma":[0.003219909,0.00011665341,0.00037945728,0.003944397,0.0005805643,0.0013728151,0.0015256164,0.0012907886,0.0021038975],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037568473,0.00011577429,0.2722418,0.0023335554,0.000113727045,0.0008850946,0.0010426287,0.0006384801,0.0044260933,0.008751388,0.08529814,0.6237776],"study_design_scores_gemma":[0.000025903784,0.00022005916,0.66660476,0.0008744613,0.00007279599,0.0034527106,0.001566556,0.00046143343,0.0013614513,0.0018186567,0.32349434,0.0000468081],"about_ca_topic_score_codex":0.0036394068,"about_ca_topic_score_gemma":0.0022765354,"teacher_disagreement_score":0.009715034,"about_ca_system_score_codex":0.0009915271,"about_ca_system_score_gemma":0.0014786251,"threshold_uncertainty_score":0.03249997},"labels":[],"label_agreement":null},{"id":"W4396774026","doi":"10.3324/haematol.2024.285285","title":"Management of hyperleukocytosis in pediatric acute myeloid leukemia using immediate chemotherapy without leukapheresis: results from the NOPHO-DBH AML 2012 Protocol","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Leukapheresis; Etoposide; Medicine; Chemotherapy; Internal medicine; Leukocytosis; White blood cell; Leukostasis; Myeloid leukemia; Myeloid; Surgery; Leukemia; Gastroenterology; Stem cell","score_opus":0.03800216772601007,"score_gpt":0.3311627107403944,"score_spread":0.2931605430143843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396774026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93976855,0.005047325,0.0026582293,0.0022186055,0.00016178879,0.02944443,0.011163107,0.000069910886,0.009468085],"genre_scores_gemma":[0.8758471,0.0069353255,0.012721823,0.003320386,0.00040217052,0.07082225,0.026961427,0.00006030853,0.0029291408],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99769896,0.0016758619,0.00016455454,0.000116271854,0.00021519302,0.00012913275],"domain_scores_gemma":[0.998374,0.00036859617,0.00041335964,0.00015060697,0.00019607478,0.0004974471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040914062,0.0004632333,0.0009009105,0.00021481952,0.00035078422,0.0006140633,0.0009907858,0.0007298764,0.0017574966],"category_scores_gemma":[0.0029893664,0.00016886,0.0007948735,0.000373406,0.00035375057,0.00034960886,0.0008357697,0.000998082,0.00031583474],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45667636,0.039940625,0.07428839,0.0057715476,0.0018979127,0.0004295114,0.00093239284,0.008016107,0.02611332,0.0017722306,0.027032087,0.35712954],"study_design_scores_gemma":[0.32871446,0.21026832,0.3253574,0.0021273794,0.002918813,0.001254266,0.00044667182,0.0029239894,0.018761512,0.00096625544,0.10612779,0.00013304259],"about_ca_topic_score_codex":0.0018130031,"about_ca_topic_score_gemma":0.0036654023,"teacher_disagreement_score":0.0040914062,"about_ca_system_score_codex":0.0013797415,"about_ca_system_score_gemma":0.003262347,"threshold_uncertainty_score":0.021637738},"labels":[],"label_agreement":null},{"id":"W4396948326","doi":"10.3324/haematol.2024.285371","title":"Right at your fingertips!","year":2024,"lang":"en","type":"editorial","venue":"Haematologica","topic":"Trade Secret Protection Methods","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.10862637145324554,"score_gpt":0.48010682467096466,"score_spread":0.3714804532177191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396948326","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028977924,0.0028212043,0.00015056168,0.037582353,0.9308964,0.000052385043,0.00021741755,0.00028004992,0.027970735],"genre_scores_gemma":[0.00067428255,0.0033378867,0.00022005307,0.03479261,0.723625,0.00008496262,0.0002754898,0.00021359438,0.23677605],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970253,0.00052210345,0.00028681796,0.00026799415,0.0016838991,0.0002138505],"domain_scores_gemma":[0.9831867,0.00618435,0.0009726986,0.00060386845,0.005874689,0.003177722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033372513,0.002139182,0.0022473948,0.003140866,0.0026547331,0.0075546806,0.0021127216,0.00888663,0.2137965],"category_scores_gemma":[0.026233897,0.0010521279,0.0016981177,0.0012545616,0.0016535296,0.0035371063,0.0012852007,0.011053849,0.18324041],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018360954,0.0000051360794,0.000005712001,0.000069454945,0.0000028642446,0.000027673308,0.000002304512,0.0000055755177,0.000023405248,0.00013155318,0.99711525,0.0025928146],"study_design_scores_gemma":[0.000040619183,0.000014201202,0.00012278173,0.00019990774,0.000008406394,0.0000611557,0.000017173019,0.00004171343,0.0000489944,0.0005329086,0.99890375,0.000008397893],"about_ca_topic_score_codex":0.0033007374,"about_ca_topic_score_gemma":0.009130661,"teacher_disagreement_score":0.2137965,"about_ca_system_score_codex":0.002043495,"about_ca_system_score_gemma":0.0017585116,"threshold_uncertainty_score":0.7152206},"labels":[],"label_agreement":null},{"id":"W4398761348","doi":"10.3324/haematol.2024.285382","title":"Safety of outpatient management of cancer-associated pulmonary embolism: a retrospective study","year":2024,"lang":"en","type":"letter","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Pulmonary embolism; Retrospective cohort study; Medicine; Cancer; Intensive care medicine; Internal medicine; Emergency medicine","score_opus":0.023155287411070105,"score_gpt":0.2945700972757691,"score_spread":0.271414809864699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398761348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874942,0.0028110999,0.00042591954,0.0010745234,0.000048918537,0.00009036882,0.0039074365,0.000012777055,0.0041347137],"genre_scores_gemma":[0.99706656,0.00051852106,0.00014482347,0.00064290257,0.00009680271,0.000079540834,0.0011515137,0.000006157736,0.00029329985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99404305,0.0028952612,0.0010832692,0.0005415556,0.0010951447,0.00034163854],"domain_scores_gemma":[0.9609852,0.013800202,0.018921401,0.0027212955,0.002613134,0.000958718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028228424,0.00015092833,0.00043516821,0.00069443916,0.00039063275,0.0006663955,0.00040367717,0.0009329098,0.002286727],"category_scores_gemma":[0.020495905,0.00023885418,0.0005504589,0.0021343841,0.00033992814,0.0005994904,0.0002693371,0.0006313677,0.00048911315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015869234,0.00013052823,0.9904908,0.00011299487,0.00021593532,0.00036063482,0.000085501175,0.000062869825,0.00011025931,0.000058140817,0.0013350191,0.005450588],"study_design_scores_gemma":[0.00032472715,0.00195462,0.99079,0.00015899746,0.0003318023,0.0026379393,0.00042265654,0.000549928,0.00019646266,0.00016939515,0.002445183,0.000018346514],"about_ca_topic_score_codex":0.003005343,"about_ca_topic_score_gemma":0.0022807862,"teacher_disagreement_score":0.003005343,"about_ca_system_score_codex":0.0008598845,"about_ca_system_score_gemma":0.00068059197,"threshold_uncertainty_score":0.014928818},"labels":[],"label_agreement":null},{"id":"W4399600471","doi":"10.3324/haematol.2024.284968","title":"PD-1 blockade and allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma, a matter of time: a national study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire","year":2024,"lang":"fr","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Agence Nationale de la Recherche","keywords":"Medicine; Hematopoietic stem cell transplantation; Blockade; Lymphoma; Transplantation; Hematopoietic cell; Stem cell; Hodgkin lymphoma; Bone marrow transplantation; Oncology; Haematopoiesis; Immunology; Internal medicine; Biology; Receptor","score_opus":0.013621294772128315,"score_gpt":0.26700380028615983,"score_spread":0.2533825055140315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399600471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5064982,0.027102726,0.00022563738,0.41499865,0.0071606515,0.00007138873,0.0023464737,0.000019600435,0.041576706],"genre_scores_gemma":[0.8137018,0.009248356,0.00027346183,0.14517595,0.020095374,0.00011572479,0.0010724736,0.000012908514,0.010303914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990018,0.0005366569,0.00007644403,0.000079744415,0.00015854336,0.00014689303],"domain_scores_gemma":[0.9974281,0.0013126914,0.00043967072,0.000079339174,0.00032699786,0.0004131323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014417953,0.00012091039,0.0005618489,0.00028009398,0.0007250327,0.0008862768,0.00030827135,0.003413452,0.0026105547],"category_scores_gemma":[0.004276935,0.00010566508,0.00034672546,0.00088362914,0.0004039372,0.00049553334,0.00017974121,0.0019637332,0.00043861405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014290482,0.0016624171,0.5015309,0.00040006803,0.0007590488,0.007876805,0.0006094649,0.00040776576,0.0019731545,0.003119051,0.34498844,0.122382365],"study_design_scores_gemma":[0.004755708,0.0028360782,0.7592035,0.00066570856,0.0009294629,0.009271656,0.002519354,0.0011035415,0.0005775569,0.00377133,0.21429393,0.000072193194],"about_ca_topic_score_codex":0.00410018,"about_ca_topic_score_gemma":0.007974112,"teacher_disagreement_score":0.00410018,"about_ca_system_score_codex":0.0015277264,"about_ca_system_score_gemma":0.0016096422,"threshold_uncertainty_score":0.011084497},"labels":[],"label_agreement":null},{"id":"W4401420883","doi":"10.3324/haematol.2024.285973","title":"A &lt;i&gt;nu&lt;/i&gt; mouse model of diffuse large B-cell lymphoma in constitutional &lt;i&gt;Atm&lt;/i&gt; loss","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cancer research; Lymphoma; Diffuse large B-cell lymphoma; Chemistry; Medicine; Internal medicine","score_opus":0.019798043463003054,"score_gpt":0.25487065980390505,"score_spread":0.23507261634090199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401420883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79496783,0.00877723,0.037292298,0.007450701,0.004109613,0.0014718977,0.065904446,0.009023465,0.07100247],"genre_scores_gemma":[0.7626897,0.0034200926,0.020696426,0.0013053481,0.00026599315,0.0017411491,0.020560354,0.0012645614,0.18805626],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985688,0.00017275714,0.00014590989,0.00038312076,0.00042361344,0.00030568906],"domain_scores_gemma":[0.9988109,0.00014105518,0.00028504094,0.00020401247,0.000087750945,0.00047125728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010150273,0.0013725236,0.00081664114,0.0028064942,0.001091633,0.0015614547,0.001290327,0.0037522893,0.024042333],"category_scores_gemma":[0.00036012058,0.00078038976,0.0010182137,0.0009790298,0.001655378,0.0019817557,0.00043231223,0.0051144036,0.0074268463],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019637123,0.0011800529,0.0009436125,0.000403977,0.000100481324,0.0010271963,0.00022861146,0.0005264895,0.96809435,0.0061571505,0.010948581,0.008425688],"study_design_scores_gemma":[0.0007449173,0.0027796624,0.009939356,0.00019937234,0.00029648907,0.0040685013,0.00068763684,0.005778465,0.8728561,0.0016621613,0.100887656,0.00009966112],"about_ca_topic_score_codex":0.0024461544,"about_ca_topic_score_gemma":0.0045854854,"teacher_disagreement_score":0.024042333,"about_ca_system_score_codex":0.0009086044,"about_ca_system_score_gemma":0.000604385,"threshold_uncertainty_score":0.08042961},"labels":[],"label_agreement":null},{"id":"W4401770046","doi":"10.3324/haematol.2024.285768","title":"Comparing the clinical trial efficacy &lt;i&gt;versus&lt;/i&gt; real-world effectiveness of treatments for multiple myeloma: a population-based study","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta; McMaster University; University of Toronto; Sunnybrook Health Science Centre; Eli Lilly (Canada); BC Cancer Agency; Ottawa Hospital","funders":"National Cancer Institute","keywords":"Multiple myeloma; Medicine; Clinical trial; Population; Oncology; World population; Internal medicine; Environmental health","score_opus":0.1593452859384943,"score_gpt":0.4341329201977882,"score_spread":0.27478763425929387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401770046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9366007,0.033046596,0.0030297132,0.0032263235,0.0014628007,0.005409468,0.008276853,0.00009969718,0.008847848],"genre_scores_gemma":[0.98879224,0.0025081693,0.0009800863,0.0014424091,0.0007707395,0.002212543,0.0023841006,0.000019537785,0.0008901191],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9872168,0.00957915,0.0012070491,0.0008831765,0.00064163277,0.00047213762],"domain_scores_gemma":[0.97427183,0.0147146275,0.006814611,0.0020813283,0.0008342584,0.0012833659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014454706,0.0011021921,0.0034800705,0.0005773374,0.00058014976,0.0015776595,0.001154842,0.003293975,0.0076775053],"category_scores_gemma":[0.024434084,0.00057671097,0.006034912,0.0013844518,0.001614674,0.0021387953,0.00063234207,0.0029497535,0.00092977245],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9318538,0.0027686202,0.016045695,0.0027245716,0.02583465,0.00008371838,0.00011364514,0.0006401614,0.0008855281,0.0003898299,0.0020077168,0.016652139],"study_design_scores_gemma":[0.6691409,0.18020453,0.08684311,0.000942409,0.052465316,0.00021233331,0.00022938887,0.0015268271,0.0012536839,0.0017199697,0.0053266096,0.00013493212],"about_ca_topic_score_codex":0.001096869,"about_ca_topic_score_gemma":0.0012924352,"teacher_disagreement_score":0.014454706,"about_ca_system_score_codex":0.0013002717,"about_ca_system_score_gemma":0.001051728,"threshold_uncertainty_score":0.076444685},"labels":[],"label_agreement":null},{"id":"W4402015336","doi":"10.3324/haematol.2024.285740","title":"Characteristics and outcomes associated with CD2 and CD25 expression on bone marrow mast cells in patients with systemic mastocytosis","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Systemic mastocytosis; Medicine; Bone marrow; Mast (botany); Mast cell; Pathology; Immunology","score_opus":0.006752401218315513,"score_gpt":0.18823596803731443,"score_spread":0.1814835668189989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402015336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978775,0.00047975895,0.000067971545,0.000045811714,0.00000844073,0.0000108711965,0.00069796894,0.0000030664287,0.0008086692],"genre_scores_gemma":[0.9989104,0.00009007077,0.00002784061,0.000031905904,0.000015001347,0.000017381068,0.0007074109,0.000001108975,0.00019881509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999729,0.000045434826,0.00003625401,0.000058334906,0.00003841051,0.00009262687],"domain_scores_gemma":[0.9991591,0.00023428263,0.00032913635,0.000067733214,0.000057134916,0.00015256436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042466293,0.00017975304,0.00031371723,0.00044006103,0.00025993402,0.0004069694,0.0002649917,0.00042959183,0.0022428744],"category_scores_gemma":[0.0015748964,0.00011808079,0.00039903977,0.0007666116,0.00025738135,0.00050940213,0.0002991585,0.0004700401,0.0003234229],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011649802,0.000063580585,0.99565506,0.000022106544,0.00006229668,0.0003111981,0.000040492137,0.00008700811,0.00034848312,0.000040461407,0.00026738577,0.001936974],"study_design_scores_gemma":[0.000043875523,0.00044453717,0.99775,0.000015551788,0.00004338926,0.00083207135,0.00012923298,0.00015369366,0.00008447966,0.00010095976,0.00039588552,0.0000062906256],"about_ca_topic_score_codex":0.0009901541,"about_ca_topic_score_gemma":0.0010704212,"teacher_disagreement_score":0.0022428744,"about_ca_system_score_codex":0.00023478812,"about_ca_system_score_gemma":0.00021937532,"threshold_uncertainty_score":0.007503152},"labels":[],"label_agreement":null},{"id":"W4402020309","doi":"10.3324/haematol.2024.285648","title":"Utilization of allogeneic hematopoietic stem cell transplantation among patients with newly diagnosed acute myeloid leukemia in California: a population-based linked dataset study","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Chronic Disease Prevention and Health Promotion; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Kite Pharma; Takeda Oncology; Health Resources and Services Administration; Centers for Disease Control and Prevention; Swedish Orphan Biovitrum; Vertex Pharmaceuticals; Omeros Corporation; Pfizer; Incyte; Kiadis Pharma; TG Therapeutics; Medac; Jazz Pharmaceuticals; StemCyte; Bristol-Myers Squibb; AstraZeneca; CSL Behring; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Astellas Pharma; Adaptive Biotechnologies; MorphoSys; California Department of Public Health; Sanofi; GlaxoSmithKline; Amgen; Mallinckrodt Pharmaceuticals; Astellas Pharma US","keywords":"Medicine; Population; Transplantation; Medicaid; Hematopoietic stem cell transplantation; Myeloid leukemia; Young adult; Relative survival; Gerontology; Demography; Internal medicine; Pediatrics; Cancer; Cancer registry; Health care; Environmental health","score_opus":0.024502288346107653,"score_gpt":0.2877900609250132,"score_spread":0.26328777257890557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402020309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92037743,0.00051666016,0.00015716373,0.00037195897,0.000021331998,0.00007470221,0.07677512,0.000023515691,0.0016822392],"genre_scores_gemma":[0.9359368,0.0006235184,0.00048568603,0.00027070605,0.000040112493,0.00015858855,0.06192794,0.000012682238,0.0005439605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989298,0.00015429348,0.00015183243,0.00043112913,0.00019061788,0.00014229085],"domain_scores_gemma":[0.99636024,0.0005053259,0.0013995288,0.00040944383,0.000795716,0.00052972935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010860536,0.00031223634,0.00046611123,0.0012589799,0.00081592286,0.0012164987,0.0010672143,0.0004512803,0.0022827315],"category_scores_gemma":[0.0035586772,0.0003984263,0.0007171459,0.0035741157,0.00023855695,0.000493319,0.0009987653,0.0010534283,0.00034999338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098910765,0.00007171063,0.9936128,0.00005584356,0.00020060792,0.000044081244,0.00012852576,0.00019987328,0.000049195034,0.00006542573,0.00422312,0.0012498873],"study_design_scores_gemma":[0.00004696424,0.000025626397,0.99712175,0.000048744536,0.00012244258,0.000069652,0.0002904343,0.0005243646,0.00003204785,0.000028245177,0.0016791729,0.000010556726],"about_ca_topic_score_codex":0.3088119,"about_ca_topic_score_gemma":0.3725064,"teacher_disagreement_score":0.3088119,"about_ca_system_score_codex":0.0019088817,"about_ca_system_score_gemma":0.0025748156,"threshold_uncertainty_score":0.6140288},"labels":[],"label_agreement":null},{"id":"W4402259999","doi":"10.3324/haematol.2024.285552","title":"BCAT1 is a NOTCH1 target and sustains the oncogenic function of NOTCH1","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Cancer research; Acetylation; Progenitor cell; PTEN; Chemistry; Medicine; Stem cell; Biochemistry; Biology; Cell biology; Gene; Apoptosis; PI3K/AKT/mTOR pathway","score_opus":0.008330774134721261,"score_gpt":0.23861317385633846,"score_spread":0.23028239972161718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402259999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856806,0.0046703313,0.0041563474,0.00025063448,0.000034997815,0.000034440247,0.0012160685,0.00015355293,0.003802999],"genre_scores_gemma":[0.98858553,0.0014788066,0.0025840192,0.00007153639,0.0000098831515,0.000024224822,0.0017965212,0.000039917322,0.0054095183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998932,0.000010051892,0.000007429592,0.00002704245,0.000036744215,0.000025584384],"domain_scores_gemma":[0.99991286,0.000008530692,0.000021844942,0.000011675896,0.000018652478,0.000026482669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009856984,0.0002715955,0.00019382281,0.00020978446,0.0003155518,0.0004136675,0.0002510465,0.00021075443,0.0016865354],"category_scores_gemma":[0.0001193517,0.00012897575,0.00015613265,0.00023925306,0.00016331732,0.00023070132,0.00021837675,0.00046898992,0.0007337854],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010449702,0.00001206912,0.00025896728,0.000025803429,0.000003257586,0.000027580476,0.0000061697024,0.0001026436,0.9972356,0.00014720035,0.00007103957,0.0020051976],"study_design_scores_gemma":[0.000009290123,0.000072028284,0.0031506165,0.0000041208827,0.000008261128,0.000290973,0.000011550646,0.0009311331,0.98904514,0.00007410141,0.0063993833,0.0000034370344],"about_ca_topic_score_codex":0.0017820827,"about_ca_topic_score_gemma":0.0026097267,"teacher_disagreement_score":0.0017820827,"about_ca_system_score_codex":0.0008216442,"about_ca_system_score_gemma":0.00044245188,"threshold_uncertainty_score":0.0059615374},"labels":[],"label_agreement":null},{"id":"W4403497619","doi":"10.3324/haematol.2024.286532","title":"Pirtobrutinib: the ‘brute’ with a softer side","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Brute force; Side channel attack; Computer science; Computer security; Cryptography","score_opus":0.02305823980501282,"score_gpt":0.30563447598735743,"score_spread":0.2825762361823446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403497619","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030750562,0.15869832,0.0070645683,0.24920207,0.03730978,0.00071393716,0.016945224,0.0031334364,0.49618214],"genre_scores_gemma":[0.32664892,0.10967213,0.013349047,0.176272,0.014900252,0.0009778201,0.016862389,0.0013396686,0.33997783],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99931896,0.00020266035,0.00008238246,0.00009433673,0.00015027841,0.00015135281],"domain_scores_gemma":[0.9992586,0.00021805275,0.0001048895,0.00012067136,0.000107782646,0.0001899365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008794256,0.00052010437,0.0010514446,0.0004620758,0.0006914173,0.0018520922,0.0009208359,0.0017848323,0.061761174],"category_scores_gemma":[0.0021375949,0.00021849856,0.000773884,0.0005813368,0.000787756,0.001743645,0.00068807113,0.003854437,0.024244027],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040968913,0.00018654342,0.00070435874,0.001250439,0.0001787607,0.0015143956,0.000049169652,0.00023257209,0.008114963,0.0074507436,0.5989517,0.37726948],"study_design_scores_gemma":[0.0013828657,0.00058696786,0.0010960384,0.0005370566,0.00014835311,0.0033288358,0.00003756209,0.00019541028,0.0032353308,0.0049441257,0.98447293,0.000034659766],"about_ca_topic_score_codex":0.001041003,"about_ca_topic_score_gemma":0.0025091842,"teacher_disagreement_score":0.061761174,"about_ca_system_score_codex":0.0006928559,"about_ca_system_score_gemma":0.00079463574,"threshold_uncertainty_score":0.2066117},"labels":[],"label_agreement":null},{"id":"W4403497627","doi":"10.3324/haematol.2024.285893","title":"Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: a real-world observational study in the United States","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"National Cancer Institute; Memorial Sloan-Kettering Cancer Center","keywords":"Observational study; Multiple myeloma; Refractory (planetary science); Medicine; Internal medicine; Oncology; Intensive care medicine; Astrobiology; Biology","score_opus":0.19924721023739833,"score_gpt":0.41256001151294147,"score_spread":0.21331280127554314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403497627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875789,0.0042346134,0.00027222818,0.00048516403,0.000053603064,0.000066340726,0.00623031,0.000010972583,0.0010679545],"genre_scores_gemma":[0.9951074,0.0009143852,0.00013228782,0.00042052293,0.00004402604,0.000053649455,0.0031556597,0.000005716717,0.00016630076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978003,0.00095569773,0.00031100845,0.00043479493,0.0002490494,0.00024908525],"domain_scores_gemma":[0.9944916,0.001043609,0.0031698598,0.0004701804,0.0003555965,0.00046926277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018203771,0.00038288752,0.0009011303,0.0005742528,0.0006004588,0.0013261713,0.0005430179,0.0007002185,0.0024804568],"category_scores_gemma":[0.003783383,0.000555678,0.0010798855,0.0022403118,0.00050308474,0.0010371903,0.00063780276,0.001245918,0.00033308595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005822943,0.00035525553,0.98367393,0.00024241461,0.0026172441,0.00020995588,0.00008318766,0.0001447427,0.00031160837,0.000121931036,0.0032932311,0.0031235889],"study_design_scores_gemma":[0.0018254576,0.0009741123,0.99008536,0.00015916284,0.0019792055,0.0008130983,0.00053202326,0.000740045,0.00013606326,0.00015928445,0.0025644647,0.000031651995],"about_ca_topic_score_codex":0.010947345,"about_ca_topic_score_gemma":0.016621118,"teacher_disagreement_score":0.010947345,"about_ca_system_score_codex":0.0010265998,"about_ca_system_score_gemma":0.0011102263,"threshold_uncertainty_score":0.021767259},"labels":[],"label_agreement":null},{"id":"W4404360765","doi":"10.3324/haematol.2024.285647","title":"Challenges associated with access to recently developed hemophilia treatments in routine care: perspectives of healthcare professionals","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Haemophilia; Mandate; Medicine; Health care; Universal design; Product (mathematics); Health professionals; Family medicine; Business; Nursing; Medical education; Political science; Pediatrics","score_opus":0.11528854909521859,"score_gpt":0.4207723818345558,"score_spread":0.3054838327393372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404360765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.924237,0.004370383,0.0007497654,0.057979915,0.00020203636,0.0000688466,0.00008109731,0.000010814036,0.012300128],"genre_scores_gemma":[0.9896998,0.0025833165,0.00050669495,0.0061841896,0.00009757822,0.000044231805,0.000031483363,0.0000049465298,0.00084784295],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9823437,0.011340711,0.0009206915,0.00065810216,0.0022916547,0.0024451506],"domain_scores_gemma":[0.96153563,0.02052624,0.0063852575,0.00045218423,0.0044298046,0.0066709328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011534396,0.00021320832,0.00045401914,0.0009221907,0.005064809,0.006272785,0.0006631985,0.0026027285,0.0034456619],"category_scores_gemma":[0.03586686,0.0005131671,0.0004488561,0.0009475685,0.0028507581,0.0041537913,0.004731085,0.002701586,0.00044164492],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001696592,0.0004293956,0.2439815,0.00075251254,0.000060824626,0.0041402658,0.6728431,0.00014983355,0.0006892948,0.0028034442,0.0100053735,0.063974865],"study_design_scores_gemma":[0.000020593134,0.00027840902,0.043373946,0.0007618196,0.00002398975,0.0016795145,0.9399349,0.0002286442,0.00013255709,0.0008907937,0.012627378,0.000047424164],"about_ca_topic_score_codex":0.015543764,"about_ca_topic_score_gemma":0.015917525,"teacher_disagreement_score":0.015543764,"about_ca_system_score_codex":0.0034244808,"about_ca_system_score_gemma":0.009337452,"threshold_uncertainty_score":0.061000407},"labels":[],"label_agreement":null},{"id":"W4404360795","doi":"10.3324/haematol.2024.285916","title":"Ixazomib, pomalidomide and dexamethasone in relapsed or refractory multiple myeloma characterized with high-risk cytogenetics: the IFM 2014-01 study","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"National Cancer Institute","keywords":"Pomalidomide; Ixazomib; Dexamethasone; Multiple myeloma; Medicine; Oncology; Lenalidomide; Internal medicine; Refractory (planetary science); Cytogenetics; Carfilzomib; Biology; Genetics; Chromosome","score_opus":0.035197362417903034,"score_gpt":0.30476384999350237,"score_spread":0.2695664875755993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404360795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829228,0.012057132,0.00018819892,0.00029815006,0.00010508236,0.00034865283,0.0024093322,0.000013643841,0.0016570165],"genre_scores_gemma":[0.99085313,0.0031741133,0.00030120692,0.0004986555,0.00023854256,0.00031018493,0.003285085,0.000011070258,0.0013278862],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.998938,0.00046901236,0.00010756932,0.00015710657,0.00013695606,0.00019138448],"domain_scores_gemma":[0.9988576,0.00028177412,0.00036238943,0.00013823803,0.00009043654,0.00026952874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002045248,0.000928729,0.0019650308,0.0004959329,0.00043751416,0.0011518592,0.0008000931,0.0013498443,0.0026071626],"category_scores_gemma":[0.0020269232,0.000616814,0.0022607679,0.0010183612,0.0005014065,0.0007831749,0.0006047163,0.0011716322,0.0006208689],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54473156,0.008876488,0.34182397,0.0020973547,0.022204507,0.0011901689,0.00036464693,0.001289544,0.0053655426,0.00042474596,0.0074577057,0.06417373],"study_design_scores_gemma":[0.16302773,0.10095558,0.6844938,0.0006998748,0.026131265,0.0017581531,0.0005149236,0.001041134,0.0016919931,0.0006731018,0.01888509,0.00012735314],"about_ca_topic_score_codex":0.0033977085,"about_ca_topic_score_gemma":0.004390452,"teacher_disagreement_score":0.0033977085,"about_ca_system_score_codex":0.0010974224,"about_ca_system_score_gemma":0.0012061617,"threshold_uncertainty_score":0.010816395},"labels":[],"label_agreement":null},{"id":"W4404360817","doi":"10.3324/haematol.2024.286513","title":"Germline genetics, disease, and exposure to medication influence longitudinal dynamics of clonal hematopoiesis","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Center for Advancing Translational Sciences; National Institute for Occupational Safety and Health; National Center for Research Resources; National Institute of General Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institutes of Health; Alexander and Margaret Stewart Trust","keywords":"Germline; Genetics; Disease; Biology; Haematopoiesis; Somatic evolution in cancer; Medicine; Internal medicine; Stem cell; Cancer; Gene","score_opus":0.020920657141438388,"score_gpt":0.3146771251211383,"score_spread":0.29375646797969995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404360817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868161,0.0021390375,0.0011707252,0.00068829226,0.00009562231,0.000052139392,0.0053899004,0.000046930447,0.0036012416],"genre_scores_gemma":[0.9956137,0.00023739148,0.00043646654,0.00014942067,0.000032252417,0.00005445926,0.001217309,0.0000146944885,0.002244254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987889,0.00051868416,0.00011696817,0.00022896801,0.00013674104,0.00020987354],"domain_scores_gemma":[0.99268734,0.0035445786,0.0017613815,0.000992822,0.00047886733,0.0005349687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019059487,0.0003325139,0.00029142064,0.0005473241,0.0005787806,0.00076002866,0.00086449296,0.00086136593,0.010196727],"category_scores_gemma":[0.012905399,0.00019816872,0.0007272221,0.00085660926,0.00036321144,0.0010608379,0.00049839285,0.00062815624,0.00079414295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028861156,0.00016007543,0.9693173,0.000112203015,0.00056101085,0.00025021832,0.00022567538,0.00022502505,0.0013634131,0.00030203312,0.002294215,0.022302747],"study_design_scores_gemma":[0.00010697131,0.00072015455,0.9913254,0.0000903885,0.00042498927,0.00061761995,0.00018838796,0.00076348154,0.0007851483,0.00069128774,0.00427228,0.000013956979],"about_ca_topic_score_codex":0.0062927282,"about_ca_topic_score_gemma":0.0075303945,"teacher_disagreement_score":0.010196727,"about_ca_system_score_codex":0.00032882902,"about_ca_system_score_gemma":0.00055734033,"threshold_uncertainty_score":0.03411144},"labels":[],"label_agreement":null},{"id":"W4404585739","doi":"10.3324/haematol.2024.286587","title":"Arkadia: a new player in hematopoietic stem and progenitor cell development","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Agricultural Research Institute of Ontario","funders":"","keywords":"Progenitor cell; Haematopoiesis; Stem cell; Progenitor; Hematopoietic stem cell; Biology; Immunology; Cell biology","score_opus":0.016754458777951856,"score_gpt":0.24081958636144776,"score_spread":0.2240651275834959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404585739","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20426406,0.41092882,0.03941263,0.03708844,0.019817276,0.00074830226,0.059925407,0.0057035135,0.22211155],"genre_scores_gemma":[0.5825591,0.11295122,0.019150686,0.0051854355,0.0013878507,0.0008537007,0.06053122,0.00046266807,0.21691811],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99919647,0.00012101176,0.000100867095,0.00016347942,0.00026763094,0.0001504672],"domain_scores_gemma":[0.9992704,0.00013822332,0.0001198716,0.00013216557,0.00009236699,0.00024702025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092235196,0.00060083956,0.00086576113,0.00097240123,0.0009193115,0.0034410376,0.0015902907,0.0024613077,0.045977104],"category_scores_gemma":[0.0009987135,0.00039620977,0.00076364697,0.0015315149,0.00079499587,0.0029493314,0.0014043094,0.003035495,0.019208774],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071933437,0.00040359196,0.003146145,0.005038944,0.00028479757,0.0025023997,0.00031152283,0.0007667277,0.61672187,0.03895774,0.078314975,0.24635786],"study_design_scores_gemma":[0.00022500599,0.0005807119,0.0033619814,0.00030980352,0.00015485051,0.0025385532,0.0002448679,0.0005577721,0.16971217,0.0041619325,0.81810266,0.000049652328],"about_ca_topic_score_codex":0.0005560579,"about_ca_topic_score_gemma":0.0006710482,"teacher_disagreement_score":0.045977104,"about_ca_system_score_codex":0.0010175048,"about_ca_system_score_gemma":0.001437268,"threshold_uncertainty_score":0.15380877},"labels":[],"label_agreement":null},{"id":"W4404588201","doi":"10.3324/haematol.2024.286018","title":"Acute myeloid leukemia drug-tolerant persister cells survive chemotherapy by transiently increasing plasma membrane rigidity, that also increases their sensitivity to immune cell killing","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Chemotherapy; Daunorubicin; Myeloid leukemia; Leukemia; Drug resistance; Cancer research; Immune system; Cell; Immunology; Biology; Doxorubicin; Medicine; Internal medicine; Genetics","score_opus":0.01313633930100579,"score_gpt":0.2218791358512197,"score_spread":0.2087427965502139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404588201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779,0.00063962553,0.0009857755,0.000055861936,0.0000046997307,0.000014451814,0.00006146389,0.000020905996,0.0004272698],"genre_scores_gemma":[0.9987213,0.00020256368,0.0005052577,0.000029332652,0.0000069298403,0.000009527831,0.00008151324,0.00000255135,0.0004410796],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999137,0.000016428241,0.000008128646,0.000019431292,0.0000205759,0.000021728772],"domain_scores_gemma":[0.9999361,0.000008581022,0.000021970704,0.000012664005,0.0000073337055,0.000013266664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008808695,0.0001349548,0.00017256597,0.00017668094,0.00012647602,0.0003051903,0.00008868815,0.00014081942,0.0009987835],"category_scores_gemma":[0.00011867509,0.00005953937,0.00011063607,0.00011390005,0.0001291308,0.00016449494,0.00020725947,0.00025247326,0.00018784004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073503856,0.000016375872,0.001972477,0.000016961003,0.0000037732489,0.00009444042,0.000029931225,0.000030229854,0.9943944,0.00013114167,0.00003062282,0.0032060968],"study_design_scores_gemma":[0.000051076237,0.0019523074,0.111274324,0.000016112703,0.000047269565,0.0057186014,0.00023887925,0.0015701794,0.86894065,0.00036505726,0.009814783,0.000010854844],"about_ca_topic_score_codex":0.00014836153,"about_ca_topic_score_gemma":0.00020514122,"teacher_disagreement_score":0.0009987835,"about_ca_system_score_codex":0.000110272915,"about_ca_system_score_gemma":0.00007577089,"threshold_uncertainty_score":0.0033413172},"labels":[],"label_agreement":null},{"id":"W4404806732","doi":"10.3324/haematol.2024.285874","title":"Intracranial hemorrhage before start of prophylaxis in children with hemophilia: incidence, timing, and potential for prevention","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Novo Nordisk; Sanofi; Swedish Orphan Biovitrum; CSL Behring; Bayer; Pfizer","keywords":"Medicine; Incidence (geometry); Pediatrics; Cumulative incidence; Population; Intracranial haemorrhage; Surgery; Complication","score_opus":0.018633915529934354,"score_gpt":0.29656158599412163,"score_spread":0.27792767046418726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404806732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.952378,0.036235027,0.0013910746,0.0010563412,0.00012754073,0.00008754926,0.004811097,0.000037515823,0.0038759897],"genre_scores_gemma":[0.9807411,0.01420468,0.001746938,0.00015661452,0.00016765742,0.00008373,0.002684332,0.000013154506,0.00020175417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984478,0.0004780012,0.00021248579,0.00026070527,0.00040290656,0.00019818208],"domain_scores_gemma":[0.99286956,0.0020555463,0.0040404955,0.00022520612,0.0005002305,0.00030896996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013135807,0.0002877956,0.00059880974,0.0012278167,0.0002844672,0.0007300643,0.0004126187,0.0004741177,0.001231814],"category_scores_gemma":[0.0096499985,0.0002822743,0.00086028234,0.0021370375,0.00032540978,0.00093532435,0.0004820061,0.0012023328,0.00017482517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004794113,0.00004548011,0.98074645,0.0003003752,0.00015811899,0.00040724664,0.0001309126,0.00015264154,0.00009293182,0.00030026492,0.0009735284,0.016212536],"study_design_scores_gemma":[0.00005094551,0.00031710093,0.9921747,0.0005528593,0.000252579,0.0029922884,0.00028169915,0.0005590589,0.00025618658,0.0004674354,0.0020723396,0.000022839105],"about_ca_topic_score_codex":0.0064248536,"about_ca_topic_score_gemma":0.008439088,"teacher_disagreement_score":0.0064248536,"about_ca_system_score_codex":0.0007496772,"about_ca_system_score_gemma":0.0012542605,"threshold_uncertainty_score":0.012774885},"labels":[],"label_agreement":null},{"id":"W4404888990","doi":"10.3324/haematol.2023.284612","title":"Minor trauma and venous thromboembolism: the threshold for antithrombotic prophylaxis","year":2024,"lang":"en","type":"review","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Ambulatory; Venous thromboembolism; Minor (academic); Antithrombotic; Intensive care medicine; Major trauma; Emergency medicine; Surgery; Internal medicine; Thrombosis","score_opus":0.08985798920612728,"score_gpt":0.37256239612054776,"score_spread":0.28270440691442045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404888990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006648969,0.99931264,0.000035631343,0.00023894927,0.00008613831,0.000004585501,0.000013828472,0.0000016613762,0.00024008637],"genre_scores_gemma":[0.00074629474,0.99880147,0.00009964931,0.00017707492,0.000060489085,0.0000063998878,0.000018022274,6.354503e-7,0.00008985633],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99919957,0.0002272176,0.00020724279,0.000083122846,0.00024370963,0.000039120663],"domain_scores_gemma":[0.9986307,0.000918751,0.00023953775,0.000017406419,0.00016750315,0.000026078475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011583726,0.0008014896,0.0021835247,0.0024906998,0.00023080251,0.0014845526,0.0010210118,0.0012472995,0.0037116003],"category_scores_gemma":[0.003417935,0.0003587944,0.001565519,0.002402645,0.00056728267,0.0011141268,0.00055225356,0.0016810042,0.00095468754],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015560116,0.00005016474,0.0006842548,0.17148837,0.0008041418,0.00016335408,0.00013552309,0.00030348828,0.00055347575,0.0037120387,0.027703667,0.79424596],"study_design_scores_gemma":[0.00008753526,0.0001806831,0.0050308355,0.15012048,0.0029499123,0.0024876064,0.00027582087,0.00021370672,0.0004133787,0.0043717492,0.83381903,0.00004918166],"about_ca_topic_score_codex":0.0025121146,"about_ca_topic_score_gemma":0.0034635453,"teacher_disagreement_score":0.0037116003,"about_ca_system_score_codex":0.0010524964,"about_ca_system_score_gemma":0.0019751554,"threshold_uncertainty_score":0.012416601},"labels":[],"label_agreement":null},{"id":"W4407187841","doi":"10.3324/haematol.2024.287056","title":"Context and timing matters in acute myeloid leukemia: females are the superior hosts","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myeloid leukemia; Context (archaeology); Myeloid; Leukemia; Medicine; Biology; Immunology","score_opus":0.034466295304956554,"score_gpt":0.31275989987857,"score_spread":0.27829360457361346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407187841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51053905,0.102460414,0.004616668,0.26062608,0.010577412,0.00013009795,0.009938635,0.000123188,0.100988515],"genre_scores_gemma":[0.94608986,0.025523432,0.0013673003,0.014532651,0.0037398506,0.00006631759,0.001026884,0.000084856525,0.00756884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997922,0.001145046,0.0001528049,0.00024787075,0.00018240242,0.0003499681],"domain_scores_gemma":[0.9947339,0.001959117,0.0013566173,0.0003184414,0.00050384336,0.0011280976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022980494,0.00022172673,0.0005153848,0.00040428064,0.0013729177,0.0020281796,0.00040992213,0.0010693392,0.022497213],"category_scores_gemma":[0.01621005,0.00020386542,0.00028771054,0.0010105092,0.00069019175,0.0021710661,0.0008068467,0.0017300466,0.0035530187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049352935,0.00024635892,0.50916195,0.0012171931,0.00023839608,0.0031345617,0.0028459348,0.00038827545,0.002805913,0.017778937,0.1496307,0.30761647],"study_design_scores_gemma":[0.00050112535,0.001679834,0.40744868,0.006064845,0.00068801106,0.027870223,0.018586213,0.00065762945,0.0036951397,0.048402417,0.48421943,0.00018648477],"about_ca_topic_score_codex":0.0035170275,"about_ca_topic_score_gemma":0.0053006276,"teacher_disagreement_score":0.022497213,"about_ca_system_score_codex":0.0006609408,"about_ca_system_score_gemma":0.0015543676,"threshold_uncertainty_score":0.07526064},"labels":[],"label_agreement":null},{"id":"W4407188092","doi":"10.3324/haematol.2024.286973","title":"Multinational cohort study of intracranial hemorrhage in patients with brain metastases receiving anticoagulation","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Intracranial Hemorrhages; Cohort; Brain hemorrhage; Internal medicine; Surgery; Neurosurgery; Subarachnoid hemorrhage","score_opus":0.011169505612823797,"score_gpt":0.2769404697889744,"score_spread":0.2657709641761506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407188092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921852,0.00066736236,0.00018728737,0.0001420925,0.00003421765,0.000045167602,0.0057173898,0.000008170691,0.0010131923],"genre_scores_gemma":[0.99583566,0.00025579426,0.00012813733,0.00011380935,0.000037965783,0.00007400957,0.003059278,0.0000059144304,0.00048939366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935395,0.00020457376,0.00008704423,0.00015226327,0.00009302918,0.00010908707],"domain_scores_gemma":[0.9980678,0.0002855796,0.0007749765,0.00047481508,0.00013656988,0.00026020128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009864602,0.0003581644,0.0005854186,0.00043861617,0.0006949582,0.0008069651,0.00069179037,0.00067812356,0.0026900824],"category_scores_gemma":[0.0027616355,0.0006111285,0.0007667161,0.0016917556,0.00030552628,0.0007053222,0.0004831575,0.00090839964,0.0003545813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019025166,0.00008312232,0.9951023,0.000030472213,0.00060048286,0.00017996113,0.00005893311,0.00004993605,0.0003343695,0.00004719602,0.0008142878,0.00079642603],"study_design_scores_gemma":[0.00032288663,0.0002489093,0.99763083,0.000021615084,0.0003751249,0.0003610561,0.00010546409,0.00019970631,0.0000567328,0.00005328842,0.0006131652,0.000011216175],"about_ca_topic_score_codex":0.01399188,"about_ca_topic_score_gemma":0.016356276,"teacher_disagreement_score":0.01399188,"about_ca_system_score_codex":0.0003580565,"about_ca_system_score_gemma":0.000546886,"threshold_uncertainty_score":0.027820885},"labels":[],"label_agreement":null},{"id":"W4408204842","doi":"10.3324/haematol.2024.286019","title":"A machine learning approach for the rapid identification of measurable residual disease in acute myeloid leukemia","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Digital Imaging for Blood Diseases","field":"Computer Science","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Myeloid leukemia; Identification (biology); Minimal residual disease; Residual; Medicine; Disease; Leukemia; Myeloid; Immunology; Computational biology; Computer science; Internal medicine; Biology","score_opus":0.021884079648391796,"score_gpt":0.2579899449668189,"score_spread":0.2361058653184271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408204842","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.253922,0.022330849,0.7007069,0.0043483316,0.0011140266,0.0007250645,0.0034959125,0.0055565857,0.007800291],"genre_scores_gemma":[0.74221873,0.003038536,0.24403924,0.00070914,0.00033804067,0.00031151925,0.0021349818,0.00013984891,0.00706992],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99953294,0.00011539141,0.00005184311,0.000090264955,0.00015071795,0.000058818925],"domain_scores_gemma":[0.9993326,0.0003107502,0.000068869194,0.000073853866,0.00016734231,0.000046499295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013359415,0.00040372778,0.00057706697,0.0010909947,0.0002999839,0.0010383179,0.00089831674,0.0011170848,0.002973603],"category_scores_gemma":[0.003158384,0.00023343081,0.00055185053,0.0005195264,0.00022613555,0.00064710435,0.0005824118,0.0011754844,0.0013463084],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012679821,0.00026359418,0.020012774,0.00040622096,0.00015588778,0.0005281959,0.000049400704,0.017208718,0.04989987,0.0019082604,0.0098709585,0.8984282],"study_design_scores_gemma":[0.00018624304,0.0010795488,0.028504005,0.00018081808,0.00018470349,0.0033068773,0.00012299306,0.86459064,0.0674884,0.009320172,0.024945153,0.00009043452],"about_ca_topic_score_codex":0.0012574202,"about_ca_topic_score_gemma":0.002084328,"teacher_disagreement_score":0.002973603,"about_ca_system_score_codex":0.00036451535,"about_ca_system_score_gemma":0.0005713557,"threshold_uncertainty_score":0.009947717},"labels":[],"label_agreement":null},{"id":"W4408415307","doi":"10.3324/haematol.2024.287057","title":"Regulation of immune responses to therapeutic factor VIII by transplacental delivery of Fc-fused immunodominant factor VIII domains or peptides","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Agence Nationale de la Recherche","keywords":"Transplacental; Immune tolerance; Immune system; Offspring; Immunology; Antibody; Von Willebrand factor; Fetus; Placenta; Biology; Pregnancy; Platelet; Genetics","score_opus":0.0381505450178042,"score_gpt":0.3281099921600438,"score_spread":0.2899594471422396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408415307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952565,0.0016453326,0.00196033,0.000042484397,0.000013123052,0.00001745065,0.000021524029,0.000026348287,0.0010168899],"genre_scores_gemma":[0.99747914,0.0006970831,0.0008304318,0.000027993496,0.000007968503,0.000013355618,0.00003429586,0.000006576377,0.00090327236],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989307,0.000040890278,0.000006206732,0.000021275368,0.000020058978,0.000018474651],"domain_scores_gemma":[0.99991727,0.000026959258,0.000026198575,0.000011432111,0.000006668654,0.000011440203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016903803,0.00021263842,0.00010959759,0.00009070591,0.000066208224,0.00020838778,0.000114926355,0.00019094748,0.0007250365],"category_scores_gemma":[0.00016788421,0.000048598766,0.00009757136,0.000045456527,0.00020320773,0.00010992949,0.00014088403,0.00042764976,0.0001241401],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017151043,0.00008173753,0.0007597205,0.00003056984,0.0000059345807,0.00021346509,0.00003558939,0.00007467078,0.9901966,0.00025345717,0.0000358317,0.008140971],"study_design_scores_gemma":[0.000055943772,0.0030098492,0.01594926,0.000015717684,0.000048159905,0.0032024817,0.00009248373,0.001140357,0.9693766,0.00018440954,0.006918967,0.0000057463094],"about_ca_topic_score_codex":0.00015050209,"about_ca_topic_score_gemma":0.00014110479,"teacher_disagreement_score":0.0007250365,"about_ca_system_score_codex":0.00012913499,"about_ca_system_score_gemma":0.00011184084,"threshold_uncertainty_score":0.0024254918},"labels":[],"label_agreement":null},{"id":"W4408675643","doi":"10.3324/haematol.2024.287200","title":"Isatuximab plus bortezomib, lenalidomide, and dexamethasone for transplantineligible newly diagnosed multiple myeloma patients: a frailty subgroup analysis of the IMROZ trial","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Lenalidomide; Hazard ratio; Internal medicine; Multiple myeloma; Confidence interval; Adverse effect; Odds ratio; Bortezomib","score_opus":0.03638377731833328,"score_gpt":0.32255061909428157,"score_spread":0.2861668417759483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408675643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955195,0.0031893402,0.0001658086,0.00014540498,0.00008125781,0.00028026794,0.000316325,0.000011195331,0.00029074962],"genre_scores_gemma":[0.9967438,0.00082159473,0.00029101613,0.00020846279,0.00013665589,0.0002946696,0.0010638895,0.0000064168507,0.0004334763],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99915934,0.00045640583,0.00008541429,0.00011709439,0.000060027094,0.0001217424],"domain_scores_gemma":[0.999292,0.00017392593,0.00018127325,0.00013008586,0.000048203565,0.00017435706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029655371,0.001283575,0.0026496588,0.00037966153,0.0002370919,0.0009194827,0.0005196019,0.0006079826,0.001076653],"category_scores_gemma":[0.0017077342,0.00033890462,0.0047047758,0.00039561384,0.00034507154,0.0004604343,0.000470557,0.0013277745,0.0001715102],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9300525,0.001503064,0.02329549,0.00049437897,0.015822308,0.0001616339,0.000129617,0.0011018344,0.0057346122,0.0000820845,0.0007868829,0.020835621],"study_design_scores_gemma":[0.58090097,0.18448487,0.17956917,0.00017441367,0.042171154,0.00049979624,0.00044985287,0.0049997573,0.0027286946,0.00055801834,0.003338462,0.0001248565],"about_ca_topic_score_codex":0.0009408927,"about_ca_topic_score_gemma":0.0031825744,"teacher_disagreement_score":0.0029655371,"about_ca_system_score_codex":0.0005385048,"about_ca_system_score_gemma":0.00072945154,"threshold_uncertainty_score":0.015683472},"labels":[],"label_agreement":null},{"id":"W4409778054","doi":"10.3324/haematol.2024.287280","title":"Changes in cardiac parameters during venetoclax treatment","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Venetoclax; Medicine; Intensive care medicine; Internal medicine; Oncology; Leukemia","score_opus":0.022309197668820623,"score_gpt":0.28453893987424644,"score_spread":0.26222974220542583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409778054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97321385,0.008762119,0.0013149955,0.0005847861,0.00034880353,0.0003561582,0.0053129457,0.00012723847,0.009979141],"genre_scores_gemma":[0.994001,0.00095207186,0.0004760321,0.00027611764,0.000066356326,0.00020200158,0.0015980831,0.000007752896,0.0024206128],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99979323,0.000077706245,0.00002047198,0.000028759403,0.000039716335,0.000040099054],"domain_scores_gemma":[0.99921036,0.00029618185,0.00017245008,0.00015238547,0.00008204594,0.000086517735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003249519,0.00015755054,0.00036529615,0.00013807477,0.00019590992,0.0002764825,0.00016457433,0.00039626932,0.004360471],"category_scores_gemma":[0.0010786447,0.000056726407,0.00016145526,0.00029470638,0.00020843804,0.00022890703,0.00010747074,0.00075176294,0.00038560948],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15469716,0.006307263,0.18864119,0.0027143385,0.0011527932,0.0061357333,0.000640905,0.0011798539,0.2645617,0.000849475,0.020360436,0.35275912],"study_design_scores_gemma":[0.0018178335,0.06178206,0.7829214,0.0004342038,0.0005279872,0.006369164,0.0004847429,0.0016628463,0.09671995,0.0005252925,0.046677615,0.0000768977],"about_ca_topic_score_codex":0.00057344604,"about_ca_topic_score_gemma":0.0010534357,"teacher_disagreement_score":0.004360471,"about_ca_system_score_codex":0.00021520143,"about_ca_system_score_gemma":0.0001973799,"threshold_uncertainty_score":0.0145872235},"labels":[],"label_agreement":null},{"id":"W4410414256","doi":"10.3324/haematol.2024.287141","title":"Clinical benefit of tafasitamab plus lenalidomide in relapsed or refractory diffuse large Bcell lymphoma: real-world data from the EarlyMIND study","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"","keywords":"Medicine; Lenalidomide; Refractory (planetary science); Internal medicine; Cohort; Population; Progression-free survival; Retrospective cohort study; Surgery; Overall survival; Multiple myeloma","score_opus":0.10806593627858142,"score_gpt":0.3951758313215723,"score_spread":0.2871098950429909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410414256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947566,0.002916863,0.000117626165,0.0000963196,0.000013188998,0.00005754815,0.0015291389,0.000011922621,0.0005009098],"genre_scores_gemma":[0.9953752,0.00056560175,0.00017482857,0.00012483442,0.0000473212,0.00005592042,0.0034797776,0.000005493919,0.00017100065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782395,0.0014345516,0.00017835967,0.00022156908,0.00019701105,0.00014463828],"domain_scores_gemma":[0.9964799,0.0011704117,0.0013111759,0.00034846863,0.00021144439,0.00047861732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004281521,0.0005880001,0.0012430045,0.00055525947,0.0002566335,0.0013112013,0.0005529939,0.0006064906,0.001133785],"category_scores_gemma":[0.0034913155,0.00023740067,0.0012575669,0.0006384523,0.00045761067,0.00064111967,0.00052584667,0.00072139775,0.0002671943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38032013,0.005069203,0.5069219,0.00076712266,0.0048424774,0.00072626525,0.00039937848,0.0048349,0.0064163846,0.00017588449,0.0029124732,0.08661386],"study_design_scores_gemma":[0.026879758,0.047659926,0.9073419,0.0001486142,0.0027820992,0.001398892,0.00021188713,0.003651942,0.0024541512,0.00020113752,0.0071443375,0.00012535545],"about_ca_topic_score_codex":0.0011124176,"about_ca_topic_score_gemma":0.0014472937,"teacher_disagreement_score":0.004281521,"about_ca_system_score_codex":0.0010845393,"about_ca_system_score_gemma":0.00041634127,"threshold_uncertainty_score":0.02264309},"labels":[],"label_agreement":null},{"id":"W4410617859","doi":"10.3324/haematol.2024.286963","title":"Anticoagulant treatment for isolated distal deep vein thrombosis: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Fondazione Cariplo","keywords":"Medicine; Deep vein; Thrombosis; Incidence (geometry); Pulmonary embolism; Relative risk; Internal medicine; Surgery; Anticoagulant; Meta-analysis; Post-thrombotic syndrome; Randomized controlled trial; Confidence interval","score_opus":0.13991649110288945,"score_gpt":0.4058915410669656,"score_spread":0.26597504996407617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410617859","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004640591,0.9940315,0.00030428235,0.00014858389,0.000090950154,0.00014016136,0.00041636385,0.000014534355,0.00021298561],"genre_scores_gemma":[0.12566838,0.870723,0.0012777649,0.0006616783,0.00020537128,0.00051398476,0.00070293766,0.000016302864,0.00023049787],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99562895,0.0019569509,0.0012546577,0.00048740563,0.00049637514,0.00017570029],"domain_scores_gemma":[0.9915063,0.005976084,0.0014659374,0.00022620623,0.000683678,0.00014175064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071661905,0.002019203,0.014620869,0.00391946,0.0005321053,0.0023585642,0.0014494986,0.0016569353,0.0034746758],"category_scores_gemma":[0.014267294,0.0010122639,0.026658114,0.005730483,0.00046595867,0.001223792,0.000953733,0.001431282,0.00026768562],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027623184,0.00003888758,0.004533936,0.40211225,0.5702575,0.00016861671,0.000074527954,0.0006333634,0.00028524207,0.00013997225,0.0009844508,0.018008932],"study_design_scores_gemma":[0.00067983905,0.00020773197,0.0040468993,0.021413986,0.97139627,0.0001154466,0.000030828316,0.00018246239,0.000093097806,0.00015189605,0.0016635301,0.000017999088],"about_ca_topic_score_codex":0.006012697,"about_ca_topic_score_gemma":0.014233901,"teacher_disagreement_score":0.014620869,"about_ca_system_score_codex":0.0018423392,"about_ca_system_score_gemma":0.0023997356,"threshold_uncertainty_score":0.037898898},"labels":[],"label_agreement":null},{"id":"W4410869236","doi":"10.3324/haematol.2024.287136","title":"T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Rijksinstituut voor Volksgezondheid en Milieu; Leids Universitair Medisch Centrum; Universitair Medisch Centrum Groningen; ZonMw; H2020 European Research Council; Genentech; Celgene; Gilead Sciences; Amsterdam University Medical Centers; Eli Lilly and Company","keywords":"Antibody; Virology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); Immunology; Hematologic Neoplasms; 2019-20 coronavirus outbreak; Medicine; Hematology; Biology; Cancer; Infectious disease (medical specialty); Disease; Genetics; Outbreak; Internal medicine","score_opus":0.027397590929468935,"score_gpt":0.3283156643040673,"score_spread":0.30091807337459836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410869236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804185,0.0061415327,0.0006264468,0.00078445394,0.00013725925,0.0000999721,0.0006522268,0.00006175889,0.011077804],"genre_scores_gemma":[0.9956204,0.0012629856,0.00027123786,0.00057078345,0.000129143,0.00004516533,0.000577082,0.000006261952,0.0015167757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997701,0.00009996498,0.000017599323,0.000032374337,0.00002941741,0.000050495735],"domain_scores_gemma":[0.99921405,0.00046068983,0.00011172931,0.00006114448,0.00007288769,0.00007948396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038833308,0.0002422236,0.00032630385,0.0002424341,0.00022145841,0.0004015126,0.00011913248,0.00047484002,0.0063746725],"category_scores_gemma":[0.0013537323,0.000071690316,0.00021532315,0.00024853158,0.00018924261,0.00025961327,0.00014501509,0.000591292,0.0008383508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012508785,0.0019012335,0.6378447,0.0015123006,0.00032738168,0.008080308,0.0008388703,0.0009268457,0.11763499,0.0008428522,0.00920485,0.20837694],"study_design_scores_gemma":[0.0006519543,0.027687175,0.8689692,0.00031860376,0.00042827503,0.020020211,0.0013801216,0.0008955699,0.03399971,0.0010085222,0.044607,0.00003365741],"about_ca_topic_score_codex":0.00034493802,"about_ca_topic_score_gemma":0.00037926144,"teacher_disagreement_score":0.0063746725,"about_ca_system_score_codex":0.00014084898,"about_ca_system_score_gemma":0.00015995662,"threshold_uncertainty_score":0.021325469},"labels":[],"label_agreement":null},{"id":"W4411460229","doi":"10.3324/haematol.2025.288065","title":"Olverembatinib in chronic myeloid leukemia: is less actually better?","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myeloid leukemia; Medicine; Cancer research; Immunology","score_opus":0.02647662499174571,"score_gpt":0.2971282614366661,"score_spread":0.2706516364449204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411460229","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012533073,0.6082147,0.0007646547,0.33610135,0.008718388,0.0000821361,0.0026956468,0.00013878013,0.030751336],"genre_scores_gemma":[0.2595356,0.49160832,0.00275357,0.21085523,0.018032592,0.00026723483,0.0036803994,0.00015728928,0.013109728],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971704,0.0011727947,0.0005970493,0.00025662858,0.00054255885,0.00026062984],"domain_scores_gemma":[0.99342525,0.0029782453,0.0010990212,0.0003546623,0.0012273586,0.0009154798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042474074,0.00027844877,0.0021577412,0.00061778625,0.0006643973,0.002742209,0.0010324705,0.002043919,0.022372039],"category_scores_gemma":[0.011736169,0.00022732277,0.0013719957,0.0011333509,0.0010040404,0.0041573825,0.000832987,0.0045730527,0.0054575973],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005224237,0.00018184495,0.0036458324,0.0069005,0.0010909063,0.0003085934,0.00014888165,0.00037098615,0.0010286814,0.008355798,0.18123473,0.7915089],"study_design_scores_gemma":[0.003528209,0.0020188722,0.010926542,0.00947304,0.0017552522,0.0018577678,0.000673279,0.00029716027,0.00071957754,0.02611749,0.94250697,0.00012585988],"about_ca_topic_score_codex":0.0013336786,"about_ca_topic_score_gemma":0.0047667366,"teacher_disagreement_score":0.022372039,"about_ca_system_score_codex":0.0012160242,"about_ca_system_score_gemma":0.0013162155,"threshold_uncertainty_score":0.07484192},"labels":[],"label_agreement":null},{"id":"W4411701092","doi":"10.3324/haematol.2025.288157","title":"Should we move past erythropoietin-stimulating agent monotherapy in lower-risk myelodysplastic syndromes?","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Erythropoietin; Myelodysplastic syndromes; Medicine; Oncology; Internal medicine; Bone marrow","score_opus":0.042568391868135026,"score_gpt":0.3386231535157654,"score_spread":0.29605476164763034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411701092","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047392705,0.18955648,0.0011836318,0.76238865,0.015108889,0.00011739174,0.0020835707,0.00013896215,0.024683151],"genre_scores_gemma":[0.0974331,0.23515327,0.011606016,0.5947315,0.043715365,0.00055743044,0.0033318228,0.00017312235,0.013298346],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977665,0.0009320257,0.0005137925,0.00022636003,0.00036858552,0.00019274384],"domain_scores_gemma":[0.98421097,0.0070027644,0.0019116332,0.00048924575,0.0035408214,0.0028445954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041636475,0.0003477495,0.0015286555,0.0008500613,0.001030973,0.0036258863,0.0015496903,0.004558231,0.030868731],"category_scores_gemma":[0.030282957,0.0003074161,0.0015744338,0.00096883264,0.00094768946,0.0062496285,0.00101982,0.008096272,0.009617265],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023446458,0.00032256104,0.005556765,0.0045698956,0.0005740933,0.00061464595,0.00017714247,0.00050951075,0.0008320443,0.006479964,0.43624973,0.54176897],"study_design_scores_gemma":[0.0022358296,0.0010640419,0.009878273,0.025412971,0.0011278056,0.001533542,0.001103326,0.0004426934,0.0005884307,0.023916243,0.93255496,0.00014184411],"about_ca_topic_score_codex":0.0041308226,"about_ca_topic_score_gemma":0.014169514,"teacher_disagreement_score":0.030868731,"about_ca_system_score_codex":0.0018545813,"about_ca_system_score_gemma":0.004281838,"threshold_uncertainty_score":0.10326624},"labels":[],"label_agreement":null},{"id":"W4412178506","doi":"10.3324/haematol.2025.288391","title":"Advancing quality of life research in chronic myeloid leukemia: where do we stand?","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer","keywords":"Myeloid leukemia; Medicine; Quality of life (healthcare); Internal medicine; Oncology; Nursing","score_opus":0.07511564801604897,"score_gpt":0.3993944169620986,"score_spread":0.3242787689460496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412178506","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010411133,0.5463731,0.0005947438,0.43790102,0.010325276,0.00009481551,0.0011261817,0.00003213003,0.0025116182],"genre_scores_gemma":[0.04306043,0.75128335,0.009733227,0.15804471,0.033406984,0.0009972805,0.0019113987,0.00008454915,0.0014780529],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97066396,0.017718377,0.004428663,0.0011804233,0.0046125418,0.0013961218],"domain_scores_gemma":[0.68047965,0.19149058,0.021570753,0.008224778,0.077604964,0.020629287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07515804,0.0011186299,0.0048975563,0.0025223263,0.0027872424,0.011902414,0.004130516,0.0070358203,0.024028335],"category_scores_gemma":[0.19979934,0.00086041185,0.0033303273,0.005118377,0.0033649171,0.017786952,0.0061926115,0.013991938,0.005634757],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014322908,0.00038326782,0.0066412003,0.029232653,0.0017239965,0.00008460987,0.00066723645,0.00025752396,0.00022532785,0.016920611,0.29562604,0.6468053],"study_design_scores_gemma":[0.0015307482,0.0016311987,0.023684269,0.29190996,0.0033597837,0.00022619044,0.006024559,0.0007633323,0.00035483338,0.05393799,0.6162219,0.00035519636],"about_ca_topic_score_codex":0.009899452,"about_ca_topic_score_gemma":0.024101514,"teacher_disagreement_score":0.07515804,"about_ca_system_score_codex":0.0062868153,"about_ca_system_score_gemma":0.025289563,"threshold_uncertainty_score":0.39747846},"labels":[],"label_agreement":null},{"id":"W4412178530","doi":"10.3324/haematol.2025.287772","title":"Improving chronic myeloid leukemia management and quality of life: patient and physician survey on unmet needs from the CML SUN survey","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Respiratory Research Network","funders":"","keywords":"Medicine; Tolerability; Family medicine; Quality of life (healthcare); Disease; Myeloid leukemia; Internal medicine; Nursing; Adverse effect","score_opus":0.036523565505358006,"score_gpt":0.28499122384251957,"score_spread":0.24846765833716156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412178530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99040854,0.00021555404,0.00011459895,0.0007181593,0.000010425694,0.00017630027,0.006142388,0.000010005727,0.002204075],"genre_scores_gemma":[0.99320847,0.0003469002,0.00044430862,0.0005070067,0.00001841824,0.00029392983,0.004572496,0.0000045378442,0.00060385617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986827,0.0005841249,0.00019715862,0.00008513426,0.00027755523,0.00017340214],"domain_scores_gemma":[0.99630713,0.00075105677,0.0015848762,0.00012891978,0.00060372474,0.0006243792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023236566,0.0001313895,0.00030339658,0.00067739794,0.0003284928,0.0004359419,0.00022570408,0.0003991412,0.0014628056],"category_scores_gemma":[0.0048422604,0.00015292793,0.0003210381,0.0010727441,0.0001916501,0.0005414395,0.0008732895,0.0005204952,0.00023635656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015811187,0.00016179979,0.9879068,0.000081256,0.00005236405,0.000045792847,0.000803982,0.00017686779,0.0001323176,0.0000593988,0.0037214346,0.0066998345],"study_design_scores_gemma":[0.000022492997,0.00015249838,0.9963003,0.000024939398,0.000010954645,0.00007160213,0.00089064677,0.00022271468,0.000054012933,0.000018674064,0.0022240025,0.0000071918344],"about_ca_topic_score_codex":0.008171739,"about_ca_topic_score_gemma":0.012421334,"teacher_disagreement_score":0.008171739,"about_ca_system_score_codex":0.0006946526,"about_ca_system_score_gemma":0.0005519108,"threshold_uncertainty_score":0.016248345},"labels":[],"label_agreement":null},{"id":"W4412178544","doi":"10.3324/haematol.2025.287777","title":"Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; University of Toronto; Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"Astellas Pharma; Alexion Pharmaceuticals; Amgen","keywords":"Myeloid leukemia; Medicine; Internal medicine; Oncology","score_opus":0.019669385114657715,"score_gpt":0.2956154064342636,"score_spread":0.2759460213196059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412178544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99929845,0.000054713284,0.00031431855,0.000014956438,0.00000630471,0.000017905531,0.00014742116,0.0000059808553,0.0001399971],"genre_scores_gemma":[0.9989312,0.000023648574,0.0003137237,0.000013115913,0.00000964606,0.000019862202,0.00062993256,0.0000030115261,0.000055848275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982936,0.0009169067,0.000082919585,0.00034107247,0.00025987742,0.000105648745],"domain_scores_gemma":[0.99505746,0.0019269914,0.0012879835,0.00073433015,0.00048326034,0.00050995225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033781966,0.00048565856,0.00038508605,0.00051083555,0.00022889329,0.00077447644,0.0005370803,0.00046389387,0.0005525063],"category_scores_gemma":[0.008314921,0.00019138548,0.00034515598,0.0004329502,0.0005835979,0.00033950727,0.00067170727,0.00055236334,0.00035216036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015907006,0.0001282647,0.99122393,0.000011260151,0.00011546978,0.00005125314,0.00012284334,0.00056562346,0.0014574291,0.00004874544,0.00025052132,0.004433974],"study_design_scores_gemma":[0.00021021329,0.0012629945,0.9887045,0.0000070240635,0.00009251463,0.00044060624,0.00014059534,0.0068978365,0.0013552583,0.000100512785,0.0007695724,0.000018363959],"about_ca_topic_score_codex":0.00082324765,"about_ca_topic_score_gemma":0.00067762646,"teacher_disagreement_score":0.0033781966,"about_ca_system_score_codex":0.00035236217,"about_ca_system_score_gemma":0.00029971718,"threshold_uncertainty_score":0.017865837},"labels":[],"label_agreement":null},{"id":"W4412178557","doi":"10.3324/haematol.2025.288026","title":"&lt;i&gt;CSF3R&lt;/i&gt; mutations and variants in myeloid neoplasms: associated phenotypes, comutations, and survival trends","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Phenotype; Myeloid; Genetics; Biology; Cancer research; Oncology; Medicine; Gene","score_opus":0.018981944478283434,"score_gpt":0.2943129052595669,"score_spread":0.27533096078128344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412178557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94237936,0.011963145,0.0009889805,0.0013801159,0.00016779709,0.000059418842,0.027289001,0.00011696287,0.015655138],"genre_scores_gemma":[0.9844684,0.0022860446,0.00076220866,0.00024916657,0.0000616907,0.000032738913,0.008328582,0.000024907853,0.0037861757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983466,0.000030320196,0.0000270321,0.000038106904,0.000040142073,0.000029704814],"domain_scores_gemma":[0.99951565,0.00014008788,0.00017192891,0.000043111133,0.00006797239,0.000061297185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002481932,0.00017481933,0.00016761167,0.0005958666,0.0001717868,0.0004249357,0.00027908344,0.00040016355,0.005675516],"category_scores_gemma":[0.0011190819,0.00005436283,0.00019936192,0.0013666657,0.00017450257,0.00029023612,0.00017382136,0.00024399586,0.000927017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071104355,0.00016531626,0.6803753,0.00080582354,0.0005904041,0.008965959,0.00041477673,0.0016816704,0.04904542,0.0028235358,0.032851454,0.21517],"study_design_scores_gemma":[0.00021335305,0.0005810576,0.88233715,0.00045975877,0.0004041951,0.019408327,0.0005723381,0.0013370578,0.009436279,0.002948716,0.08226213,0.000039706905],"about_ca_topic_score_codex":0.0032617939,"about_ca_topic_score_gemma":0.004076229,"teacher_disagreement_score":0.005675516,"about_ca_system_score_codex":0.00026129393,"about_ca_system_score_gemma":0.00017239132,"threshold_uncertainty_score":0.018986523},"labels":[],"label_agreement":null},{"id":"W4412488863","doi":"10.3324/haematol.2025.287351","title":"Bispecific antibody therapy-associated opportunistic infections: cytomegalovirus retinitis and chronic salmonellosis in a non-HIV patient","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Cytomegalovirus retinitis; Retinitis; Medicine; Cytomegalovirus; Antibody; Human immunodeficiency virus (HIV); Virology; Immunology; AIDS-Related Opportunistic Infections; Opportunistic infection; Sida; Human cytomegalovirus; Viral disease; Virus; Herpesviridae","score_opus":0.03078206127885176,"score_gpt":0.3291933607798476,"score_spread":0.2984112995009959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412488863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778023,0.0017842151,0.00024170666,0.003646094,0.00014629884,0.00010116339,0.00091413595,0.000024096817,0.01534009],"genre_scores_gemma":[0.99468404,0.000908484,0.00019645442,0.0014083327,0.00020043062,0.000021288564,0.0003519244,0.0000060436437,0.0022231077],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997509,0.00003980304,0.000028247927,0.00004370783,0.000028731323,0.00010861883],"domain_scores_gemma":[0.9994861,0.00018104151,0.000075191594,0.000029048691,0.00003324201,0.00019531453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002555979,0.0005392421,0.00048246118,0.0007008624,0.0016018852,0.00076436123,0.0005737891,0.002492064,0.0052133203],"category_scores_gemma":[0.0011889548,0.00035322318,0.00052076817,0.0008155245,0.00064797356,0.0009619907,0.00046951795,0.0015724883,0.00083708396],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089660694,0.00047519838,0.1945846,0.00010198437,0.00006177547,0.7938365,0.0004175304,0.00021216666,0.0017306658,0.00041378505,0.0024923796,0.0047769267],"study_design_scores_gemma":[0.00017195426,0.0014718706,0.23320109,0.000121249905,0.00008036509,0.7577113,0.0012832467,0.0006146319,0.00071774545,0.0006198237,0.0039705564,0.000036257457],"about_ca_topic_score_codex":0.0049883015,"about_ca_topic_score_gemma":0.0070016733,"teacher_disagreement_score":0.0052133203,"about_ca_system_score_codex":0.0007175441,"about_ca_system_score_gemma":0.00091542356,"threshold_uncertainty_score":0.017440319},"labels":[],"label_agreement":null},{"id":"W4412779709","doi":"10.3324/haematol.2025.288041","title":"The impact of age on survival and excess mortality after autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McMaster University","funders":"Sanofi","keywords":"Medicine; Multiple myeloma; Internal medicine; Hematopoietic cell; Cumulative incidence; Transplantation; Incidence (geometry); Population; Hematopoietic stem cell transplantation; Surgery; Gastroenterology; Haematopoiesis; Stem cell","score_opus":0.0236028157870531,"score_gpt":0.32334170441655197,"score_spread":0.2997388886294989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412779709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99867284,0.0006739443,0.00008930308,0.00006171519,0.000007973468,0.0000022024974,0.00023089924,0.0000022629054,0.00025879004],"genre_scores_gemma":[0.9993907,0.00022542843,0.000049321683,0.000023573912,0.000019307116,0.0000018476599,0.00023892854,0.0000012207628,0.000049727576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942917,0.00019191552,0.000082150975,0.0001065058,0.000099776524,0.00009045446],"domain_scores_gemma":[0.99641967,0.0010280801,0.0017049989,0.00021108567,0.00022461834,0.00041149746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001119326,0.00015058478,0.00031153846,0.0005900487,0.00021405546,0.00049852947,0.00020313641,0.0002571545,0.00080482673],"category_scores_gemma":[0.0044943374,0.00010855995,0.0006415405,0.0007287539,0.00015509473,0.00052521826,0.00042066746,0.00059569255,0.00014714371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009139443,0.000006883609,0.9986071,0.0000040692344,0.000033216704,0.00003161994,0.000018277648,0.000049126367,0.00003796731,0.000008176741,0.000025837437,0.001086261],"study_design_scores_gemma":[0.000002402375,0.00005510271,0.99931455,0.00000544469,0.000046766578,0.00014174488,0.000049037415,0.00021294606,0.000043266573,0.000028835995,0.00009740598,0.0000023786815],"about_ca_topic_score_codex":0.0025617175,"about_ca_topic_score_gemma":0.004313965,"teacher_disagreement_score":0.0025617175,"about_ca_system_score_codex":0.00027325598,"about_ca_system_score_gemma":0.00033180203,"threshold_uncertainty_score":0.0059196353},"labels":[],"label_agreement":null},{"id":"W4412779753","doi":"10.3324/haematol.2025.288227","title":"Recurrence of minimal residual disease in acute myeloid leukemia: a window of opportunity for intervention","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Minimal residual disease; Myeloid leukemia; Medicine; Residual; Window of opportunity; Intervention (counseling); Therapeutic window; Disease; Internal medicine; Oncology; Leukemia; Pediatrics; Computer science; Psychiatry; Algorithm; Pharmacology","score_opus":0.04320646628438361,"score_gpt":0.35392626466955174,"score_spread":0.3107197983851681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412779753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75001293,0.13056989,0.008543897,0.06898608,0.0015547787,0.00012394557,0.00026609565,0.0002164564,0.03972596],"genre_scores_gemma":[0.9893266,0.0057373894,0.0007757337,0.0017248392,0.0013898148,0.000021304751,0.00009336823,0.0000141809305,0.00091684924],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995105,0.00016749826,0.00004071722,0.000045687833,0.000071647104,0.00016394789],"domain_scores_gemma":[0.99849474,0.00076346233,0.0002947731,0.00006050876,0.000087081185,0.00029947454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009240945,0.00013011294,0.00049326324,0.00022697347,0.0004056248,0.0016407813,0.00037896325,0.0007476542,0.0021228853],"category_scores_gemma":[0.0043043876,0.000087816385,0.0002804791,0.00015225992,0.0005546242,0.0011650982,0.0004964605,0.001572609,0.0003083648],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00681238,0.0009940382,0.14074716,0.00088725716,0.00021811457,0.027520198,0.002142038,0.0014003019,0.014368278,0.0356337,0.026974974,0.74230146],"study_design_scores_gemma":[0.0010759017,0.014121612,0.42096835,0.0039113285,0.0009054084,0.15834852,0.012525296,0.008294017,0.013694944,0.08839682,0.27744284,0.00031495513],"about_ca_topic_score_codex":0.00038593443,"about_ca_topic_score_gemma":0.0008252217,"teacher_disagreement_score":0.0021228853,"about_ca_system_score_codex":0.0005640674,"about_ca_system_score_gemma":0.0007724241,"threshold_uncertainty_score":0.0071017146},"labels":[],"label_agreement":null},{"id":"W4413796318","doi":"10.3324/haematol.2025.288203","title":"Belantamab mafodotin does not induce B-cell maturation antigen loss or systemic immune dysfunction in multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Chimeric antigen receptor; TIGIT; Antigen; Immunology; B cell; Antibody; Multiple myeloma; T cell; CD19; Medicine; Cancer research; Immune system","score_opus":0.02896208532303257,"score_gpt":0.2932672466752372,"score_spread":0.2643051613522046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413796318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972766,0.00089988264,0.00079738296,0.0000535479,0.00001609352,0.000021204505,0.00015296522,0.000034670593,0.0007476207],"genre_scores_gemma":[0.99869245,0.00018030149,0.00024007929,0.000023793817,0.0000037290208,0.000018231716,0.00019317809,0.000006346195,0.00064192596],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998423,0.000036544963,0.000014210789,0.000031167303,0.000041696396,0.00003403047],"domain_scores_gemma":[0.9998944,0.000032657746,0.000022685956,0.0000183215,0.00000948115,0.000022461978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018512562,0.00018889703,0.00030888297,0.0001633653,0.000102224665,0.00022458441,0.00017006055,0.00023479776,0.00105591],"category_scores_gemma":[0.00022332053,0.000117519914,0.00021334291,0.00015071995,0.00018500087,0.00027421143,0.00013250008,0.0006041722,0.00022711047],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091698096,0.00023864872,0.00047428434,0.000041836505,0.000018803335,0.00010451335,0.000019974417,0.00025294727,0.9939143,0.00007116989,0.00010138546,0.0038452034],"study_design_scores_gemma":[0.00017788008,0.0072767283,0.012995989,0.0000055771275,0.000046635214,0.0010943307,0.00002801513,0.0021761924,0.9731951,0.00007699575,0.0029203324,0.0000061757905],"about_ca_topic_score_codex":0.0006574641,"about_ca_topic_score_gemma":0.0006177141,"teacher_disagreement_score":0.00105591,"about_ca_system_score_codex":0.00031679944,"about_ca_system_score_gemma":0.00015588006,"threshold_uncertainty_score":0.00353235},"labels":[],"label_agreement":null},{"id":"W4413798012","doi":"10.3324/haematol.2025.288379","title":"The age of fit-equity: ignoring age and fitness in treatment selection for chronic lymphocytic leukemia","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Chronic lymphocytic leukemia; Selection (genetic algorithm); Leukemia; Equity (law); Medicine; Internal medicine; Oncology; Gerontology; Computer science; Political science; Artificial intelligence","score_opus":0.059695221212627284,"score_gpt":0.37441940071600227,"score_spread":0.314724179503375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413798012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7419365,0.03979126,0.0281116,0.11461527,0.007261366,0.0011035816,0.01900016,0.0001941125,0.04798615],"genre_scores_gemma":[0.9855075,0.0013474122,0.0034668988,0.0057258713,0.00094036554,0.00027691503,0.0008314255,0.000026693677,0.0018769593],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9761345,0.019277556,0.0012559425,0.0010608684,0.0012445397,0.0010266082],"domain_scores_gemma":[0.917152,0.0683832,0.006018937,0.0040931874,0.0020012378,0.0023514726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025721898,0.00040613345,0.0011263577,0.0007102364,0.00083863246,0.0016081395,0.0018997515,0.0019952718,0.014537669],"category_scores_gemma":[0.15109092,0.00027613685,0.0023750134,0.001429546,0.00073813734,0.0020913868,0.0013622177,0.0026368403,0.0009862577],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015702475,0.0005941223,0.57537985,0.0017283112,0.0046430416,0.0006171346,0.00064656127,0.0060982294,0.00032549986,0.014461559,0.053017113,0.32678607],"study_design_scores_gemma":[0.004206591,0.007969893,0.71779037,0.0069459374,0.012583035,0.0018523638,0.0028516373,0.06944841,0.0016998254,0.08144749,0.0929011,0.00030330737],"about_ca_topic_score_codex":0.010413738,"about_ca_topic_score_gemma":0.023408307,"teacher_disagreement_score":0.025721898,"about_ca_system_score_codex":0.0013988228,"about_ca_system_score_gemma":0.0021650635,"threshold_uncertainty_score":0.13603199},"labels":[],"label_agreement":null},{"id":"W4413994504","doi":"10.3324/haematol.2025.288332","title":"Caffeine impairs red blood cell storage quality by dual inhibition of ADORA2b signaling and G6PD activity","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Neonatal Health and Biochemistry","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute","keywords":"Caffeine; Red blood cell; Pharmacology; Medicine; Hematocrit; Hemolysis; Oxidative stress; Physiology; Immunology; Internal medicine","score_opus":0.014733884373006404,"score_gpt":0.29853938106728073,"score_spread":0.28380549669427435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413994504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99337006,0.003998111,0.0011783084,0.00013243813,0.000022041217,0.000023957755,0.00062507374,0.000072270646,0.0005777592],"genre_scores_gemma":[0.9960945,0.0012485556,0.00093223195,0.00009004671,0.0000141327155,0.0000386648,0.0007169909,0.000019381383,0.0008454996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982303,0.00003321499,0.000018839257,0.000054185104,0.00003472804,0.0000361326],"domain_scores_gemma":[0.9998797,0.000015953841,0.000051413655,0.000016696857,0.0000130117,0.000023304176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022010715,0.00032318928,0.00036472408,0.00024883932,0.00020816019,0.00041040755,0.00017241547,0.0002364048,0.001127371],"category_scores_gemma":[0.00022899479,0.00015948723,0.0004087495,0.0001903017,0.00017989999,0.00015853232,0.000288844,0.00027106854,0.00016195097],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033600845,0.00011629502,0.006999726,0.00019290991,0.00015322436,0.00010262823,0.000072097886,0.0001428042,0.9783578,0.00008556334,0.00022864963,0.010188135],"study_design_scores_gemma":[0.00021388459,0.0037572694,0.23655516,0.000058513637,0.00056286686,0.000839604,0.00015845336,0.002189647,0.74681383,0.00024050329,0.008572168,0.000038117436],"about_ca_topic_score_codex":0.0013917403,"about_ca_topic_score_gemma":0.0027220014,"teacher_disagreement_score":0.0013917403,"about_ca_system_score_codex":0.00026402154,"about_ca_system_score_gemma":0.0002504949,"threshold_uncertainty_score":0.0037714243},"labels":[],"label_agreement":null},{"id":"W4413994539","doi":"10.3324/haematol.2023.283896","title":"CHIP ahoy: charting a decade of discovery in clonal hematopoiesis","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Biology; Disease; Clinical trial; Germline; Bioinformatics; Computational biology; Medicine; Genetics; Internal medicine; Gene","score_opus":0.025414745909700998,"score_gpt":0.32885372574500993,"score_spread":0.30343897983530893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413994539","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00949408,0.42522365,0.13525784,0.30683768,0.07698349,0.00035373628,0.0067802942,0.012012377,0.02705698],"genre_scores_gemma":[0.13885929,0.2995088,0.19576317,0.21208182,0.08350055,0.0015884128,0.008943493,0.004622834,0.055131704],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9905032,0.0031822077,0.00052752235,0.001600764,0.0033707465,0.0008154967],"domain_scores_gemma":[0.9543916,0.023225836,0.00203745,0.0034497927,0.0101591535,0.0067361807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02162786,0.0013843963,0.0020810142,0.0042216815,0.0016716804,0.009775485,0.003516668,0.005062858,0.016215973],"category_scores_gemma":[0.048249193,0.0011412373,0.0017239387,0.0027329428,0.004769284,0.009432096,0.0072779753,0.0105016455,0.0064033535],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069849764,0.00008160795,0.0028087525,0.002432571,0.00025709014,0.000272434,0.00075854396,0.0012277993,0.0048842137,0.052628845,0.4398778,0.49407187],"study_design_scores_gemma":[0.00014701276,0.00023848175,0.0018271302,0.0014536143,0.00016855933,0.00030382085,0.00038080805,0.002749,0.0037803166,0.06355358,0.9252548,0.00014294234],"about_ca_topic_score_codex":0.0031430826,"about_ca_topic_score_gemma":0.0043762675,"teacher_disagreement_score":0.02162786,"about_ca_system_score_codex":0.0036913517,"about_ca_system_score_gemma":0.0076314374,"threshold_uncertainty_score":0.11438042},"labels":[],"label_agreement":null},{"id":"W4414133977","doi":"10.3324/haematol.2025.287910","title":"Blinatumomab restores asparaginase activity in pediatric B-cell acute lymphoblastic leukemia patients with PEG-Asparaginase hypersensitivity","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Sanming Project of Medicine in Shenzhen","keywords":"Blinatumomab; Lymphoblastic Leukemia; Asparaginase; Acute lymphocytic leukemia; Chemotherapy; Leukemia","score_opus":0.008894512271582146,"score_gpt":0.2574623038537237,"score_spread":0.24856779158214157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414133977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916487,0.0034928855,0.0005905489,0.00064843893,0.00010946921,0.000103183,0.00042036574,0.00019112427,0.002795321],"genre_scores_gemma":[0.9975647,0.0008645341,0.00033540893,0.00020384615,0.000021350173,0.00003332375,0.0004289246,0.000012553874,0.0005353615],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99987423,0.00004286017,0.000009769835,0.0000122630845,0.000017071898,0.000043788034],"domain_scores_gemma":[0.99984705,0.000040859235,0.000031937798,0.000016414713,0.000011152326,0.000052553834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002962979,0.00025697483,0.0005066712,0.00020656444,0.00021703125,0.0004508368,0.00030777563,0.0003810261,0.0022238123],"category_scores_gemma":[0.0005028488,0.00012258395,0.00027444918,0.00024176491,0.00018798589,0.00022631718,0.00018710643,0.00087849726,0.00046018546],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.067488946,0.008145835,0.0930235,0.0006939818,0.0007125742,0.018466966,0.0006922398,0.0017357243,0.3373239,0.0010926877,0.012500306,0.45812336],"study_design_scores_gemma":[0.022032192,0.09391726,0.4587868,0.00043639448,0.0014650984,0.06192307,0.0016312455,0.0073315417,0.24961644,0.0019730215,0.10081155,0.00007540015],"about_ca_topic_score_codex":0.0009689503,"about_ca_topic_score_gemma":0.0010294346,"teacher_disagreement_score":0.0022238123,"about_ca_system_score_codex":0.00040664015,"about_ca_system_score_gemma":0.00037068015,"threshold_uncertainty_score":0.0074394345},"labels":[],"label_agreement":null},{"id":"W4414134014","doi":"10.3324/haematol.2025.289055","title":"HLA matching in the PTCy era: the locus still matters. Comment on: Selection of unrelated donors for allogeneic transplantation using post-transplant cyclophosphamide in acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Cyclophosphamide; Human leukocyte antigen; Transplantation; Lymphoblastic Leukemia; Locus (genetics); Acute leukemia; Selection (genetic algorithm); Acute lymphocytic leukemia","score_opus":0.013866531810900964,"score_gpt":0.26896962605014335,"score_spread":0.2551030942392424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414134014","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006510213,0.0017272884,0.00009488302,0.97533107,0.020963877,0.000012720584,0.00017223356,0.00003331479,0.0010135565],"genre_scores_gemma":[0.0028202455,0.0011821077,0.00013698284,0.97210836,0.022390842,0.000017532531,0.00007312757,0.000013569244,0.0012572417],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967541,0.0006516512,0.00071470067,0.00050570414,0.00096006884,0.0004137443],"domain_scores_gemma":[0.98370737,0.010583915,0.0011984269,0.0005015263,0.0023808938,0.0016278255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050858944,0.0010963886,0.0018304094,0.0009897872,0.0026895928,0.0015030025,0.0041802367,0.04904981,0.0073980405],"category_scores_gemma":[0.023281615,0.0007034443,0.0018394389,0.0012457027,0.0026826756,0.004352124,0.0014356963,0.035239268,0.0050106053],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014008784,0.000030830317,0.0019664557,0.00009869767,0.000022913593,0.001112621,0.00015169094,0.00006213332,0.0002593722,0.0017488117,0.98878956,0.0056168386],"study_design_scores_gemma":[0.00042142396,0.00025943475,0.013022503,0.0012710473,0.00021086929,0.004445383,0.0017689815,0.00073476764,0.0012616866,0.011881229,0.96442896,0.00029357607],"about_ca_topic_score_codex":0.019999955,"about_ca_topic_score_gemma":0.02454031,"teacher_disagreement_score":0.04904981,"about_ca_system_score_codex":0.0028972686,"about_ca_system_score_gemma":0.0038087852,"threshold_uncertainty_score":0.039767087},"labels":[],"label_agreement":null},{"id":"W4414745045","doi":"10.3324/haematol.2025.288835","title":"Taming neutrophil extravasation: a promising therapeutic approach to dampen inflammation?","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Therapeutic approach; MEDLINE; Neutrophil extracellular traps; Inflammation; Immunotherapy","score_opus":0.02284966986835783,"score_gpt":0.29637316516004747,"score_spread":0.2735234952916896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414745045","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014824972,0.897316,0.0038499665,0.05773937,0.006241084,0.00029432375,0.0010952832,0.0002479114,0.018391108],"genre_scores_gemma":[0.13198338,0.809775,0.0060589267,0.023204068,0.005824627,0.00068248465,0.0014175889,0.000054972308,0.020998975],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99949837,0.00017480884,0.00006270682,0.00006022502,0.000097191725,0.00010673862],"domain_scores_gemma":[0.999173,0.00025034923,0.00016138976,0.0001117796,0.00015880162,0.00014473386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014560581,0.00066147425,0.0014001335,0.00039699505,0.00050641695,0.002646971,0.0012654117,0.0025492471,0.018744633],"category_scores_gemma":[0.0013923608,0.00029248503,0.0010650413,0.0005518752,0.00093240984,0.0029127654,0.00073083484,0.0036212897,0.006172267],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004860768,0.0012394674,0.0018671465,0.011626509,0.0008273047,0.0012843111,0.00019857359,0.00067361625,0.041498117,0.021909611,0.11413715,0.79987746],"study_design_scores_gemma":[0.0023708197,0.009290212,0.0033103668,0.0047915247,0.00090714864,0.0033289634,0.00059277134,0.0007618681,0.020462178,0.014467192,0.939595,0.00012198226],"about_ca_topic_score_codex":0.00045708823,"about_ca_topic_score_gemma":0.0019889579,"teacher_disagreement_score":0.018744633,"about_ca_system_score_codex":0.0006097418,"about_ca_system_score_gemma":0.0013312991,"threshold_uncertainty_score":0.06270701},"labels":[],"label_agreement":null},{"id":"W4414745051","doi":"10.3324/haematol.2025.288699","title":"Utility of the Central Nervous System International Prognostic Index in patients with primary mediastinal large B-cell lymphoma treated with rituximab-containing chemoimmunotherapy","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"Seagen; BeiGene; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; Genentech; AstraZeneca; Bristol-Myers Squibb","keywords":"Chemoimmunotherapy; International Prognostic Index; Primary central nervous system lymphoma; Central nervous system; Lymphoma; Index (typography)","score_opus":0.005123391789369006,"score_gpt":0.20472902019307018,"score_spread":0.19960562840370116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414745051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885776,0.0044651898,0.00020876435,0.0006553975,0.00009521483,0.000036469562,0.001340286,0.000018669441,0.0046023196],"genre_scores_gemma":[0.9981061,0.0004963347,0.00016613894,0.000108702916,0.00007287557,0.00002210621,0.0007579758,0.0000024760127,0.00026721807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996383,0.00016806598,0.000049990842,0.00003801761,0.00005662814,0.000048946433],"domain_scores_gemma":[0.9986412,0.00058952306,0.0003420938,0.00008100255,0.00015603083,0.00019005824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007779107,0.00026452445,0.00048743782,0.0005657877,0.00019826113,0.00056856504,0.00032632935,0.00036330995,0.0012558493],"category_scores_gemma":[0.00374084,0.00008266458,0.00034831942,0.0006475834,0.00016196193,0.00042579387,0.00023528136,0.00040947375,0.00025572832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003797726,0.00013350877,0.97038895,0.00006472196,0.00023321301,0.00034408254,0.000037049802,0.00048390022,0.00052884885,0.00006773876,0.0012694363,0.022650894],"study_design_scores_gemma":[0.00020764722,0.001133251,0.99280447,0.00006010933,0.00031050574,0.0008143188,0.00008944996,0.0024919698,0.0003733119,0.00018823448,0.0015142732,0.000012414143],"about_ca_topic_score_codex":0.0016803689,"about_ca_topic_score_gemma":0.002894779,"teacher_disagreement_score":0.0016803689,"about_ca_system_score_codex":0.00038345734,"about_ca_system_score_gemma":0.00032860588,"threshold_uncertainty_score":0.004201174},"labels":[],"label_agreement":null},{"id":"W4414975794","doi":"10.3324/haematol.2025.288780","title":"Real-world safety and tolerability of rapid infusion obinutuzumab in chronic lymphocytic leukemia, small lymphocytic lymphoma and non-Hodgkin lymphoma: a provincial review","year":2025,"lang":"en","type":"review","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"CancerCare Manitoba Foundation; Biogen; Gilead Sciences; Leukemia and Lymphoma Society; BeiGene; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Obinutuzumab; Tolerability; Chronic lymphocytic leukemia; Hematology; Ibrutinib; Lymphoma","score_opus":0.03306404265306265,"score_gpt":0.3343913292221242,"score_spread":0.3013272865690616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414975794","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015821993,0.99949133,0.000023075585,0.00007197561,0.000034981364,0.000007911539,0.000048410147,0.0000017010543,0.0001624903],"genre_scores_gemma":[0.001821852,0.99777067,0.00006590735,0.00015289438,0.00004009181,0.000013020548,0.000054810767,8.7514877e-7,0.000079994395],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994667,0.00015888632,0.00015970759,0.00005964491,0.00012458613,0.00003052483],"domain_scores_gemma":[0.99795914,0.0013354294,0.00038629878,0.000032282212,0.00024852573,0.0000383284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016520142,0.00051395135,0.0024694556,0.0014281423,0.000177506,0.0009432893,0.00085559406,0.0007069241,0.004500742],"category_scores_gemma":[0.0035845167,0.00022505212,0.0021198078,0.0016965508,0.00023447539,0.00067149574,0.00043879054,0.0007401589,0.0004669769],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077241816,0.000052738003,0.00040174086,0.309892,0.0023901786,0.00011396593,0.00008692226,0.00031487085,0.0009252645,0.00068016385,0.0146169765,0.6697528],"study_design_scores_gemma":[0.0012115113,0.0019404906,0.0076302993,0.3160273,0.030272305,0.0029335637,0.00032862986,0.00029188165,0.0012032744,0.0020870655,0.6359788,0.00009474898],"about_ca_topic_score_codex":0.0012631075,"about_ca_topic_score_gemma":0.003192366,"teacher_disagreement_score":0.004500742,"about_ca_system_score_codex":0.00057477085,"about_ca_system_score_gemma":0.0015333147,"threshold_uncertainty_score":0.015056491},"labels":[],"label_agreement":null},{"id":"W4414975841","doi":"10.3324/haematol.2025.288058","title":"Long-term cardiac morbidity in adolescent and young adult survivors of classical Hodgkin lymphoma: the British Columbia experience","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Foundation; Canadian Centre for Applied Research in Cancer Control; Occupational Cancer Research Centre; BC Cancer Agency; BC Children's Hospital","funders":"Seagen; Pfizer","keywords":"ABVD; Young adult; Incidence (geometry); Disease; Risk factor; Cumulative incidence; Hodgkin lymphoma; Radiation therapy; Heart failure","score_opus":0.018417311775531665,"score_gpt":0.27541564926819495,"score_spread":0.25699833749266326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414975841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987633,0.00030054516,0.000013546909,0.0001000834,0.000002862537,0.000006256704,0.00018123075,0.0000016495613,0.00063055696],"genre_scores_gemma":[0.9987766,0.0005547245,0.000024505565,0.00008874393,0.0000040571604,0.000005736839,0.00023487963,0.0000012261995,0.00030938894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998233,0.000024969584,0.000014027895,0.000020367377,0.00005576594,0.000061611114],"domain_scores_gemma":[0.9993656,0.000050038347,0.00012769103,0.000015747652,0.00014364837,0.0002972611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016969659,0.00012620316,0.00018102034,0.0004451819,0.0008198195,0.0005797642,0.00028525537,0.00025637355,0.0007988803],"category_scores_gemma":[0.0006728031,0.00015184701,0.000112795555,0.0009212128,0.0003099798,0.00015199215,0.00044950694,0.0003915887,0.00012578686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022864782,0.000023016506,0.9952739,0.000009765955,0.000009223524,0.0003093002,0.00037955388,0.000022013019,0.000101888756,0.000014501814,0.0002465067,0.0035874918],"study_design_scores_gemma":[0.0000032205353,0.000019727097,0.9984341,0.000016221406,0.000007221135,0.0002877749,0.0007478962,0.000046270412,0.000021674865,0.000009000245,0.00040421617,0.0000025476043],"about_ca_topic_score_codex":0.7313905,"about_ca_topic_score_gemma":0.86230725,"teacher_disagreement_score":0.26860952,"about_ca_system_score_codex":0.002361509,"about_ca_system_score_gemma":0.002467753,"threshold_uncertainty_score":0.5403828},"labels":[],"label_agreement":null},{"id":"W4415787584","doi":"10.3324/haematol.2024.286478","title":"Histiocyte Society blueprint for Langerhans cell histiocytosis research: from cell-of-origin to a more comprehensive cure","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Langerhans cell histiocytosis; Histiocyte; Histiocytosis; Disease; Presentation (obstetrics); Organ dysfunction; Multisystem disease; Myeloid","score_opus":0.12541149878339414,"score_gpt":0.4126545538098677,"score_spread":0.28724305502647357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415787584","genre_codex":"editorial","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012316487,0.07282237,0.0015721832,0.31621084,0.5496004,0.00007907288,0.0006247618,0.0005630059,0.05729578],"genre_scores_gemma":[0.013265402,0.08311314,0.0026756388,0.1158015,0.41877714,0.0001299057,0.0011664585,0.0003650925,0.36470568],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99853635,0.00027134665,0.0001409719,0.00033417932,0.00048137753,0.00023581886],"domain_scores_gemma":[0.9939464,0.0009088701,0.00034693885,0.00033838398,0.002050504,0.002408906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001740257,0.0009994084,0.0008613827,0.0015522528,0.00076580036,0.0036659422,0.0012185948,0.005324341,0.06766217],"category_scores_gemma":[0.004759241,0.00033433308,0.0006131843,0.0009597528,0.001508978,0.0025660428,0.0016755515,0.0073379204,0.043991603],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006731372,0.000023224184,0.00019435136,0.00021773629,0.000009734162,0.00022671567,0.000017664826,0.000033650136,0.0007617528,0.0028368838,0.9321135,0.06349742],"study_design_scores_gemma":[0.000015406022,0.000023438117,0.00030996036,0.00012113499,0.0000043168225,0.00042606512,0.000022412893,0.000033766213,0.00016950333,0.0013364691,0.99753237,0.0000051469533],"about_ca_topic_score_codex":0.00057910674,"about_ca_topic_score_gemma":0.0010382567,"teacher_disagreement_score":0.06766217,"about_ca_system_score_codex":0.0015964493,"about_ca_system_score_gemma":0.0021719867,"threshold_uncertainty_score":0.22635251},"labels":[],"label_agreement":null},{"id":"W4415952016","doi":"10.3324/haematol.2025.288838","title":"CD19 directed CAR T therapy for intravascular large B-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; BC Cancer Agency","funders":"Cancer Moonshot; National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Astellas Pharma US; Health Resources and Services Administration; National Institutes of Health; Gilead Sciences; Actinium Pharmaceuticals; Adaptive Biotechnologies; Moonshot Research and Development Program; AstraZeneca; Gateway for Cancer Research; Astellas Pharma; Alexion Pharmaceuticals; Amgen","keywords":"Lymphoma; CD19; Chimeric antigen receptor; Aggressive lymphoma; CAR T-cell therapy; Antibody therapy","score_opus":0.023826367591453696,"score_gpt":0.3159687436674928,"score_spread":0.2921423760760391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415952016","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23875707,0.34233493,0.010030768,0.037728157,0.0117267035,0.0027067375,0.021928422,0.0011119472,0.33367518],"genre_scores_gemma":[0.74356574,0.11237425,0.0076520336,0.0113985175,0.0022343546,0.0017104308,0.014895888,0.00014722122,0.10602149],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99973005,0.00009951393,0.000023597011,0.000026774205,0.0000531814,0.00006695374],"domain_scores_gemma":[0.9997143,0.00011859451,0.000031622414,0.000034363864,0.000028031513,0.00007305978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004931218,0.00024202044,0.0004304014,0.00027295706,0.00027911272,0.0007172139,0.0007704165,0.0012149336,0.03400837],"category_scores_gemma":[0.0006789484,0.00012794022,0.0004220011,0.0003578772,0.00023609865,0.00071388413,0.00022209043,0.0010589865,0.005534154],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021376781,0.0033904337,0.002253462,0.0039236885,0.00069578935,0.0021233442,0.00011335042,0.0010931436,0.037849292,0.006236964,0.17573076,0.74521303],"study_design_scores_gemma":[0.008517837,0.014926378,0.0059605893,0.0009649885,0.00067373284,0.003341764,0.000108702516,0.0008285246,0.025885582,0.0022756967,0.9364857,0.000030463862],"about_ca_topic_score_codex":0.0005537537,"about_ca_topic_score_gemma":0.0016364955,"teacher_disagreement_score":0.03400837,"about_ca_system_score_codex":0.0005688152,"about_ca_system_score_gemma":0.0006419191,"threshold_uncertainty_score":0.11376929},"labels":[],"label_agreement":null},{"id":"W4415952024","doi":"10.3324/haematol.2025.288743","title":"&lt;i&gt;IDH2&lt;/i&gt; mutation is associated with favorable outcome among older adults with newly diagnosed acute myeloid leukemia treated with hypomethylating agent-based therapy","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; Sun Pharma; MorphoSys; Astellas Pharma; Sierra Oncology; Incyte; Swedish Orphan Biovitrum; Daiichi Sankyo Europe; Oregon Health and Science University; Gilead Sciences; Amgen; Pfizer; Syndax Pharmaceuticals; Foghorn Therapeutics","keywords":"NPM1; Myeloid leukemia; Isocitrate dehydrogenase; IDH1; Hypomethylating agent; Azacitidine; Retrospective cohort study; Cohort; Mutation","score_opus":0.01789843076102343,"score_gpt":0.274959400748029,"score_spread":0.25706096998700556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415952024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99946266,0.00022257646,0.000028545783,0.000017078675,0.0000039097263,0.000003413091,0.000102808284,0.0000011107271,0.00015801],"genre_scores_gemma":[0.9996111,0.00009088194,0.00002239494,0.000019452626,0.00001102705,0.0000031504362,0.00017567223,7.127122e-7,0.00006567585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998394,0.000027191396,0.000023387885,0.000046569356,0.000034058652,0.000029293436],"domain_scores_gemma":[0.9992704,0.00008393812,0.00043499682,0.000036301295,0.000037209607,0.0001372298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028577013,0.00011384967,0.0003159784,0.0002905678,0.00021497707,0.0003505385,0.0001191936,0.00018382644,0.0008256603],"category_scores_gemma":[0.00090641546,0.00010853998,0.00024390865,0.00041012594,0.00015749001,0.00024602492,0.00020769883,0.0002842132,0.00011377761],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039359732,0.000023106306,0.9966132,0.000007418934,0.000026873147,0.00011257717,0.000019279676,0.00004089163,0.00066465675,0.000011274568,0.00006931241,0.0020177835],"study_design_scores_gemma":[0.00001881085,0.00018008737,0.99855727,0.000003988967,0.000039735467,0.000577005,0.00004479934,0.00014155374,0.0001294228,0.000016935617,0.00028792047,0.0000024741853],"about_ca_topic_score_codex":0.0010017443,"about_ca_topic_score_gemma":0.0017257452,"teacher_disagreement_score":0.0010017443,"about_ca_system_score_codex":0.00016451736,"about_ca_system_score_gemma":0.00018558976,"threshold_uncertainty_score":0.0027621388},"labels":[],"label_agreement":null},{"id":"W4415952046","doi":"10.3324/haematol.2025.289031","title":"Interleukin-6 in Castleman disease subtypes: look to tissues, not just blood","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Nova Scotia Health Authority; University of British Columbia","funders":"","keywords":"Castleman disease; Disease; MEDLINE; Immunopathology; Systemic disease","score_opus":0.022872756364728228,"score_gpt":0.3063727286181574,"score_spread":0.28349997225342916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415952046","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2595998,0.61117494,0.0054163206,0.061048664,0.0050248206,0.00015401654,0.0029671853,0.00031463843,0.054299552],"genre_scores_gemma":[0.8378028,0.11517237,0.008396648,0.012076105,0.008567816,0.00009760702,0.0017455221,0.000095160634,0.016045904],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997402,0.00007449877,0.00004624609,0.000026080968,0.00006805039,0.000044883906],"domain_scores_gemma":[0.99925405,0.00027781999,0.00008843,0.00007531593,0.00020057509,0.00010378068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065658207,0.00027217407,0.0005691205,0.0008621653,0.00027739498,0.0009043309,0.0003612123,0.0006837046,0.003376343],"category_scores_gemma":[0.0017257228,0.00017237487,0.00035373206,0.0010505955,0.00037334618,0.0008923405,0.0002083971,0.0012981453,0.00080372934],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00613525,0.00021450855,0.3553136,0.0028001387,0.00043301532,0.015150169,0.0007669428,0.00046319087,0.044164404,0.002173141,0.06677907,0.50560653],"study_design_scores_gemma":[0.00044660157,0.0025795752,0.5703745,0.0047318856,0.0010560987,0.11986659,0.0046063154,0.0011649498,0.01599843,0.008229248,0.27082565,0.00012005335],"about_ca_topic_score_codex":0.0017284836,"about_ca_topic_score_gemma":0.002199547,"teacher_disagreement_score":0.003376343,"about_ca_system_score_codex":0.00019202929,"about_ca_system_score_gemma":0.0003052034,"threshold_uncertainty_score":0.011294961},"labels":[],"label_agreement":null},{"id":"W4416166919","doi":"10.3324/haematol.2025.287443","title":"Novel and emerging therapeutic strategies for clonal haematopoiesis","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Epigenetics; Haematopoiesis; Bone marrow; Somatic evolution in cancer; Stem cell; Epigenesis; Leukemia; Hematopoietic stem cell","score_opus":0.04390705616631437,"score_gpt":0.35304966535192706,"score_spread":0.3091426091856127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416166919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013262428,0.94071174,0.017622082,0.0092520295,0.0020358134,0.00018004008,0.00024423597,0.00032955167,0.016362114],"genre_scores_gemma":[0.12770903,0.8306503,0.018943952,0.007830095,0.0026332117,0.00035979127,0.0007616832,0.000074296775,0.01103773],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973875,0.00006990824,0.000020233627,0.000037984173,0.00008114434,0.000051877032],"domain_scores_gemma":[0.99981314,0.00006144157,0.000039304905,0.000011909401,0.000039642007,0.00003451783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063968933,0.0005335377,0.00070651865,0.00081193744,0.00031102388,0.0010298907,0.00067827123,0.00087738596,0.005172136],"category_scores_gemma":[0.0005786568,0.00013223212,0.00061337044,0.00034141316,0.00045946092,0.00096257654,0.00084258337,0.0026237597,0.00096732186],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055606576,0.00055294624,0.0008877334,0.0057266927,0.00025385062,0.00120032,0.00022656971,0.0013298183,0.04067437,0.03230955,0.035223022,0.8810591],"study_design_scores_gemma":[0.00036370524,0.0011986003,0.0020176838,0.0019216113,0.00028219647,0.0036931722,0.0002213843,0.001339803,0.014513199,0.018557567,0.9558478,0.000043251923],"about_ca_topic_score_codex":0.00030239712,"about_ca_topic_score_gemma":0.0010917713,"teacher_disagreement_score":0.005172136,"about_ca_system_score_codex":0.00044166468,"about_ca_system_score_gemma":0.0006543962,"threshold_uncertainty_score":0.017302513},"labels":[],"label_agreement":null},{"id":"W4416397582","doi":"10.3324/haematol.2025.288392","title":"Loss of nuclear myosin 1 causes hemostatic defects and immune dysregulation","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Cardiomyopathy and Myosin Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ústav Molekulární Genetiky, Akademie Věd České Republiky; Tamkeen; Akademie Věd České Republiky; York University; New York University Abu Dhabi","keywords":"Immune dysregulation; Immune system; Myosin; Hemostasis; Platelet; Coagulation; Myosin light-chain kinase","score_opus":0.013225077373867793,"score_gpt":0.2690248519532449,"score_spread":0.2557997745793771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416397582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95867157,0.0055829026,0.0035275219,0.00337401,0.000825234,0.00018723017,0.0074288314,0.00030108265,0.020101622],"genre_scores_gemma":[0.9857978,0.0020736968,0.0009371572,0.0005790822,0.0001396741,0.00009289034,0.0029202998,0.000036468773,0.0074229436],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99944824,0.00012079133,0.00009185281,0.00010575218,0.0001026857,0.00013061754],"domain_scores_gemma":[0.9988821,0.0005556151,0.00016486489,0.00015466368,0.000092687515,0.00015001158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058094016,0.0004823504,0.0003852777,0.0009217238,0.0003545548,0.0004560652,0.00074076187,0.0016443102,0.0098569505],"category_scores_gemma":[0.0011726252,0.0001892134,0.00042739793,0.0005125551,0.00064593944,0.0005025328,0.0002690884,0.00061205623,0.0016363006],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010162012,0.0018438222,0.101302475,0.0015345094,0.0008851473,0.15772948,0.0010126985,0.0006297608,0.60399675,0.004290234,0.026237315,0.0903758],"study_design_scores_gemma":[0.00076181826,0.0060412963,0.35369712,0.00063704525,0.0008564817,0.21510613,0.0013453241,0.0022418208,0.30887243,0.0029641902,0.10733718,0.0001391805],"about_ca_topic_score_codex":0.00065692264,"about_ca_topic_score_gemma":0.00059455645,"teacher_disagreement_score":0.0098569505,"about_ca_system_score_codex":0.00021377011,"about_ca_system_score_gemma":0.00014153344,"threshold_uncertainty_score":0.03297472},"labels":[],"label_agreement":null},{"id":"W4416397923","doi":"10.3324/haematol.2025.288654","title":"JAK inhibitor selection in challenging scenarios of myelofibrosis: a review","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"MorphoSys; Swedish Orphan Biovitrum; Sierra Oncology; Incyte; Celgene","keywords":"Ruxolitinib; Myelofibrosis; Janus kinase; Context (archaeology); Clinical trial; Constitutional symptoms; Venetoclax; Selection (genetic algorithm)","score_opus":0.015796766915338285,"score_gpt":0.30762751780376535,"score_spread":0.2918307508884271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416397923","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026042084,0.9984719,0.00016764639,0.00038484842,0.00015370853,0.000007718214,0.000017192415,0.0000069195858,0.00052962505],"genre_scores_gemma":[0.0021693907,0.99648154,0.0004020468,0.00046258493,0.0003189032,0.0000116248475,0.00003830466,0.0000027108695,0.00011281011],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994905,0.00012294023,0.00016452021,0.00007319138,0.00012193511,0.000026953818],"domain_scores_gemma":[0.9972331,0.0021154399,0.0003150438,0.000029962443,0.000239616,0.0000668556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011290035,0.00066997716,0.0014326887,0.0026670294,0.00035229232,0.0011868112,0.0010482855,0.001324314,0.0016465255],"category_scores_gemma":[0.0043960246,0.0002963219,0.00093394716,0.0021698838,0.0004593913,0.0014194882,0.00054042635,0.0014024202,0.0005254924],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001141254,0.000060749153,0.00088753016,0.029660353,0.00024195558,0.0010037075,0.00015480666,0.0007241745,0.00035033253,0.0016822714,0.024083905,0.94103616],"study_design_scores_gemma":[0.00007065856,0.00030553262,0.0034456735,0.05665937,0.0013503698,0.019191194,0.00034040233,0.0006766878,0.0006083321,0.0035131993,0.91376144,0.00007715863],"about_ca_topic_score_codex":0.0009877717,"about_ca_topic_score_gemma":0.0018263437,"teacher_disagreement_score":0.0026670294,"about_ca_system_score_codex":0.0005889202,"about_ca_system_score_gemma":0.0015179247,"threshold_uncertainty_score":0.005970776},"labels":[],"label_agreement":null},{"id":"W7117871030","doi":"10.3324/haematol.2024.286014","title":"Molecular genetic testing in von Willebrand disease: past, present, and beyond","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand disease; Von Willebrand factor; Genetic testing; Gene; Missense mutation; Molecular genetics; Genetic variation; Genetic analysis","score_opus":0.01282278433244914,"score_gpt":0.26421942424842737,"score_spread":0.2513966399159782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117871030","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004463563,0.99540555,0.0004405883,0.0018091911,0.00052808865,0.0000057989732,0.00001540198,0.000013862119,0.0013352459],"genre_scores_gemma":[0.0031191849,0.99353796,0.0007376789,0.0011636888,0.0010948523,0.000009222896,0.00003727551,0.0000049698638,0.00029513365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99912757,0.00026650255,0.00017178318,0.000104998835,0.0002738929,0.00005524255],"domain_scores_gemma":[0.99787426,0.0014664715,0.00017796716,0.000044707176,0.00034159314,0.0000949456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017747056,0.00071152963,0.001158633,0.0029574893,0.00030204013,0.0013486654,0.0011118747,0.0014896642,0.0011695827],"category_scores_gemma":[0.0031020155,0.00028778217,0.00071310793,0.0020048192,0.0014114241,0.0020250354,0.00063179806,0.0022964848,0.0005431921],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009734416,0.00006492049,0.0021801323,0.01015832,0.00014122824,0.003505807,0.00043261034,0.0006013585,0.0030973149,0.0074114497,0.039511506,0.932798],"study_design_scores_gemma":[0.000033660683,0.00019295014,0.006018656,0.013582259,0.00024070767,0.031449113,0.00033881265,0.000443725,0.0008017982,0.009050492,0.9377795,0.00006833468],"about_ca_topic_score_codex":0.0016304338,"about_ca_topic_score_gemma":0.0016402238,"teacher_disagreement_score":0.0029574893,"about_ca_system_score_codex":0.0008828599,"about_ca_system_score_gemma":0.0012903387,"threshold_uncertainty_score":0.009385586},"labels":[],"label_agreement":null}]}